<SEC-DOCUMENT>0001213900-25-025602.txt : 20250320
<SEC-HEADER>0001213900-25-025602.hdr.sgml : 20250320
<ACCEPTANCE-DATETIME>20250320171857
ACCESSION NUMBER:		0001213900-25-025602
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		85
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250320
DATE AS OF CHANGE:		20250320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wearable Devices Ltd.
		CENTRAL INDEX KEY:			0001887673
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41502
		FILM NUMBER:		25757792

	BUSINESS ADDRESS:	
		STREET 1:		5 HA-TNUFA ST.
		CITY:			YOKNE'AM ILLIT
		STATE:			L3
		ZIP:			2066736
		BUSINESS PHONE:		97246185670

	MAIL ADDRESS:	
		STREET 1:		5 HA-TNUFA ST.
		CITY:			YOKNE'AM ILLIT
		STATE:			L3
		ZIP:			2066736
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>ea0234654-20f_wearable.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 20 21:08:44 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:wlds="http://www.wearabledevices.co.il/20241231" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-15916">20-F</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentRegistrationStatement" id="ixv-21"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="ixv-32"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric>
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-15917"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-15918">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-15919">2024</ix:nonNumeric></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="ixv-47"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="ixv-58"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File No.: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-15920">001-41502</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-68"><b>Wearable Devices Ltd.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Exact name of registrant as specified in its
charter)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Translation of registrant&#8217;s name into
English: Not applicable</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="ixv-82"><b>Israel</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Jurisdiction of incorporation or organization)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-91"><b>5 Ha-Tnufa Street</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2" id="ixv-15921">Yokne&#8217;am Illit</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-15922">2066736</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-15923"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-15924">Israel</ix:nonNumeric></ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Address of principal executive offices)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName" id="ixv-106"><b>Asher Dahan</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Chief Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Tel: +<ix:nonNumeric contextRef="c1" name="dei:CityAreaCode" id="ixv-15925">972</ix:nonNumeric>.<ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber" id="ixv-15926">4.6185670</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress" id="ixv-116"><b>asher.dahan@wearabledevices.co.il</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1" id="ixv-120"><b>5 Ha-Tnufa Street</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine2" id="ixv-15927">Yokne&#8217;am Illit</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode" id="ixv-15928">2066736</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-15929"><ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown" id="ixv-15930">Israel</ix:nonNumeric></ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Name, Telephone, E-mail and/or Facsimile number
and Address of Company Contact Person)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities registered or to
be registered pursuant to Section 12(b) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle" id="ixv-155"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares, no par value per share</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol" id="ixv-160"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WLDS</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-15931">Nasdaq</ix:nonNumeric> Capital Market</span></td></tr> <tr style="vertical-align: top; "> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:Security12bTitle" id="ixv-168"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to Purchase Ordinary Shares</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:TradingSymbol" id="ixv-173"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WLDSW</span></ix:nonNumeric></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c3" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-15932">Nasdaq</ix:nonNumeric> Capital Market</span></td></tr> </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities registered or to
be registered pursuant to Section 12(g) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities for which there
is a reporting obligation pursuant to Section 15(d) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate the number of outstanding shares of each
of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-15933">707,463</ix:nonFraction> ordinary
shares as of December 31, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-15934">No</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this report is an annual or transition report,
indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act of 1934.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-15935">No</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant (1)
has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-15936">Yes</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span>&#160;&#160;No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant has
submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-15937">Yes</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span>&#160;&#160;No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant is
a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of &#8220;large
accelerated filer, &#8220;accelerated filer,&#8221; and emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="white-space: nowrap; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Large accelerated filer <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></span></td> <td style="text-align: justify; white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt">Accelerated filer <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></span></td> <td style="text-align: justify; white-space: nowrap; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-259"><span style="font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td style="text-align: justify; white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; white-space: nowrap">&#160;</td> <td style="text-align: justify; white-space: nowrap">&#160;</td> <td style="text-align: justify; white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt">Emerging growth company</span></td> <td style="text-align: justify; white-space: nowrap; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-269"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards &#8224; provided pursuant to Section 13(a) of the Exchange
Act. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="ixv-275"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8224;The term &#8220;new or revised financial
accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification
after April 5, 2012.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether the registrant has
filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting
under Section 404(b) of the Sarbanes Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its
audit report. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="ixv-285"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-291"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark which basis of accounting
the registrant has used to prepare the financial statements included in this filing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:DocumentAccountingStandard" id="ixv-15938">U.S. GAAP</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">International Financial Reporting Standards as
issued by the International Accounting Standards Board <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If &#8220;Other&#8221; has been checked in response
to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
Item 17&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span> Item 18</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this is an annual report, indicate by check
mark whether the registrant is a shell company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>&#160;&#160;No <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentShellCompanyReport" id="ixv-336"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="text-align: left; font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 11%">&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 80%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 9%"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="2"><span style="font-size: 10pt"><a href="#D_001">INTRODUCTION</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">iii</span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="2"><span style="font-size: 10pt"><a href="#D_002">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">iv</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="3" style="text-align: center"><span style="font-size: 10pt"><a href="#D_003">PART I</a></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 1.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_004">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 2.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_005">OFFER STATISTICS AND EXPECTED TIMETABLE.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 3.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_006">KEY INFORMATION.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-size: 10pt"><a href="#D_007">[Reserved]</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_008">Capitalization and Indebtedness.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">C.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_009">Reasons for the Offer and Use of Proceeds.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">D.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_010">Risk Factors.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_011">Summary Risk Factors</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 4.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_012">INFORMATION ON THE COMPANY.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">34</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_013">History and Development of the Company.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">34</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_014">Business Overview.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">34</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">C.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_015">Organizational Structure.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">54</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">D.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_016">Property, Plants and Equipment.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">54</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 4A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_017">UNRESOLVED STAFF COMMENTS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">54</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 5.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_018">OPERATING AND FINANCIAL REVIEW AND PROSPECTS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">55</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_018">Operating Results.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">55</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_020">Liquidity and Capital Resources.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">58</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">C.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_021">Research and development, patents and licenses, etc.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">62</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">D.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_022">Trend information.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">62</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">E.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_023">Critical Accounting Estimates.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">63</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 6.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_024">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">64</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_025">Directors and Senior Management.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">64</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_026">Compensation.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">66</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">C.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_027">Board Practices.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">68</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">D.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_028">Employees.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">83</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">E.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_029">Share Ownership.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">84</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">F.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_030">Action to Recover Erroneously Awarded Compensation</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">84</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 7.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_031">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">84</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_032">Major Shareholders.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">84</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_033">Related Party Transactions.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">87</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">C.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_034">Interests of Experts and Counsel.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">88</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 8.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_035">FINANCIAL INFORMATION.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">88</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_036">Consolidated Statements and Other Financial Information.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">88</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_037">Significant Changes.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 9.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_038">THE OFFER AND LISTING.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_039">Offer and Listing Details.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#c_001">Plan of Distribution.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">C.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_040">Markets.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">D.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_041">Selling Shareholders.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">E.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_042">Dilution.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">F.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_043">Expenses of the Issue.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 10.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_044">ADDITIONAL INFORMATION.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_045">Share Capital.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">89</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_046">Memorandum and Articles of Association.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">90</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">C.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_047">Material Contracts.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">90</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">D.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_048">Exchange Controls.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">91</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">E.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_049">Taxation.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">91</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">F.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_050">Dividends and Paying Agents.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">100</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">G.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_051">Statement by Experts.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">100</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">H.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_052">Documents on Display.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">100</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">I.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_053">Subsidiary Information.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">100</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">J.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_054">Annual Report to Security Holders.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">100</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 11.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_055">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">100</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 12.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_056">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">101</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">A.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_057">Debt Securities.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">101</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">B.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_058">Warrants and rights.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">101</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">C.</span></td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#D_059">Other Securities.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">101</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="3" style="text-align: center"><span style="font-size: 10pt"><a href="#D_060">PART II</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="width: 11%"><span style="font-size: 10pt">ITEM 13.</span></td>
    <td style="width: 80%"><span style="font-size: 10pt"><a href="#D_061">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES.</a></span></td>
    <td style="text-align: center; width: 9%"><span style="font-size: 10pt">102</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 14.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_062">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">102</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 15.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_063">CONTROLS AND PROCEDURES.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">102</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 16.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_064">[RESERVED]</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">103</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 16A.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_065">AUDIT COMMITTEE FINANCIAL EXPERT.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">103</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 16B.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_066">CODE OF ETHICS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">103</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 16C.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_067">PRINCIPAL ACCOUNTANT FEES AND SERVICES.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">103</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 16D.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_068">EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">104</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 16E.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_069">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">104</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 16F.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_070">CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">104</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 16G.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_071">CORPORATE GOVERNANCE.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">104</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 16H.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_072">MINE SAFETY DISCLOSURE.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">106</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 16I.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_073">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">106</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 16J.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_074">INSIDER TRADING POLICIES</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">106</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 16K.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_074">CYBERSECURITY</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">106</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="3" style="text-align: center"><span style="font-size: 10pt"><a href="#D_076">PART III</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 17.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_077">FINANCIAL STATEMENTS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">108</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-size: 10pt">ITEM 18.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_078">FINANCIAL STATEMENTS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">108</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">ITEM 19.</span></td>
    <td><span style="font-size: 10pt"><a href="#D_079">EXHIBITS.</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">108</span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="2"><span style="font-size: 10pt"><a href="#D_080">SIGNATURES</a></span></td>
    <td style="text-align: center"><span style="font-size: 10pt">110</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_001.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Wearable Devices Ltd.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="D_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTRODUCTION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In this annual report, &#8220;we,&#8221;
&#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; and &#8220;WLDS&#8221; refer to Wearable Devices Ltd.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Wearable Devices Ltd. was
incorporated in Israel in 2014 under the name &#8220;Wearable Devices Ltd.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
are a growth company developing a non-invasive neural input interface in the form of a wrist wearable band for controlling digital devices
using subtle touchless finger movements. Since our technology was introduced to the market in 2014, we have been working with both Business-to-Business,
or B2B, and Business to Consumer, or B2C, customers as part of our push-pull strategy. We have completed the transition phase from research
and development to commercialization of our technology into B2B and B2C products. At the same time, we are manufacturing our first B2C
consumer product, the Mudra Band, an aftermarket accessory band for the Apple Watch which allows touchless operation and control of Apple
ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our reporting currency and
functional currency is the U.S. dollar. Unless otherwise expressly stated or the context otherwise requires, references in this annual
report to &#8220;NIS&#8221; are to New Israeli Shekels, and references to &#8220;dollars&#8221; or &#8220;$&#8221; mean U.S. dollars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless derived from our financial
statements or otherwise noted, amounts presented in this annual report are translated at the rate of NIS 3.647 = USD 1.00, the exchange
rate between the NIS and the U.S. dollar reported by the Bank of Israel as of December 31, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">This
annual report includes statistical, market and industry data and forecasts which we obtained from publicly available information and independent
industry publications and reports that we believe to be reliable sources. These publicly available industry publications and reports generally
state that they obtain their information from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness
of the information. Although we believe that these sources are reliable, we have not independently verified the information contained
in such publications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We report our financial statements
in accordance with generally accepted accounting principles in the United States, or U.S. GAAP.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 7, 2024, we effectuated
a 1-for-20 reverse share split of our issued and outstanding Ordinary Shares, no par value per share, or the Ordinary Shares in order
to regain compliance with Nasdaq Listing Rule 5550(a)(2), and on March 17, 2025, we effectuated an additional 1-for-4 reverse share split
of our issued and outstanding Ordinary Shares.&#160;All historical quantities of the Ordinary Shares and per share data herein are presented
on a post-split basis to give effect to our 1-for-20 reverse share split and our 1-for-4 reverse share split effected prior to the start
of trading on Nasdaq on October 10, 2024 and on March 17, 2025, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="D_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain information included
or incorporated by reference in this annual report on Form 20-F may be deemed to be &#8220;forward-looking statements&#8221;. Forward-looking
statements are often characterized by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221;
&#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;believe,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221;
&#8220;project&#8221; or other similar words, but are not the only way these statements are identified.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These forward-looking statements
may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections
of results of operations or of financial condition, expected capital needs, and expenses, statements relating to the research, development,
completion and use of our products, and all statements (other than statements of historical facts) that address activities, events or
developments that we intend, expect, project, believe or anticipate will or may occur in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward-looking statements
are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on
assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions,
expected future developments, and other factors they believe to be appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Important factors that could
cause actual results, developments, and business decisions to differ materially from those anticipated in these forward-looking statements
include, among other things:</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"/><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">our financial statements for the year ended December 31, 2024,
contained an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern, which could prevent
us from obtaining new financing on reasonable terms or at all;</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">Surface Nerve Conductance, or SNC, becoming the industry standard input method for wearable computing and consumer electronics;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to maintain and expand our existing customer base;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to maintain and expand compatibility of our devices with a broad range of mobile devices and operating systems;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to maintain our business models;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to correctly predict the market growth;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to remediate material weaknesses in our internal control over financial reporting;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to retain our founders;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to maintain, protect, and enhance our intellectual property;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">our ability to raise capital through the issuance of additional securities;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">the impact of competition and new technologies;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">general market, political and economic conditions in the countries in which we operate;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">projected capital expenditures and liquidity;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">changes in our strategy;</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">litigation; and</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"/><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify">other risks and uncertainties, including those factors referred to in &#8220;Item 3. Key Information - D. Risk Factors,&#8221; &#8220;Item
4. Information on the Company,&#8221; and &#8220;Item 5. Operating and Financial Review and Prospects&#8221;, as well as in this annual
report on Form 20-F generally.</td></tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Readers are urged to carefully review and consider
the various disclosures made throughout this annual report on Form 20-F which are designed to advise interested parties of the risks and
factors that may affect our business, financial condition, results of operations and prospects.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You should not put undue reliance on any forward-looking
statements. Any forward-looking statements in this annual report on Form 20-F are made as of the date hereof, and we undertake no obligation
to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except
as required by law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_003"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">PART I</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_004"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT
AND ADVISERS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_005"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_006"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 3. KEY INFORMATION</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><div><a id="D_007"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">A. [Reserved]</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><div><a id="D_008"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">B. Capitalization and Indebtedness</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><div><a id="D_009"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">C. Reasons for the Offer and Use
of Proceeds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><div><a id="D_010"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">D. Risk Factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business faces significant
risks. You should carefully consider the risks described below, together with all of the other information in this annual report on Form
20-F. The risks described below are not the only risks facing us. Additional risks and uncertainties not currently known to us or that
we currently deem to be immaterial may also materially and adversely affect our business operations. If any of these risks actually occurs,
our business and financial condition could suffer and the price of our securities could decline. This annual report also contains forward-looking
statements that involve risks and uncertainties. Our results could materially differ from those anticipated in these forward-looking statements,
as a result of certain factors including the risks described below and elsewhere in this report and our other Securities and Exchange
Commission, or SEC, filings. See &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks Related to Our Business</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We are a growth company with limited operating history. We
may never be able to effectuate our business plan or achieve sufficient revenue or reach profitability;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We invest effort and money into seeking validation of our
technology and products with B2B companies. There can be no assurance that we will enter into license agreements, which could adversely
affect our future business, results of operations and financial condition;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">There is no assurance that wrist SNC will be the dominant
input method in the wearable computing and consumer electronics industry;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">If we are unable to successfully develop and timely introduce
new products and services or enhance existing products and services, our business may be affected;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">If we are unable to develop and introduce new gesture input
functions and improve existing functions in a cost-effective and timely manner, our business, results of operations and financial condition
would be adversely affected;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Our current and future products and services may experience
quality problems from time to time that can result in adverse publicity, product recalls, litigation, regulatory proceedings, and warranty
claims resulting in significant direct or indirect costs, decreased revenue and operating margin, and harm to our brand;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The period of time from a license agreement to implementation
of our technology is long and we are subject to the risks of cancellation or postponement of the contract or unsuccessful implementation;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We rely on a limited number of suppliers, contract manufacturers,
and logistics providers, and each of our products is manufactured by a single contract manufacturer;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Our actual or perceived failure to comply with legal obligations
with respect to personal information and customer data could harm our business.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks Related to the Industry in Which We Operate</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The forecasts of market growth included in this annual report
on Form 20-F may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, we cannot assure
you our business will grow at similar rates, if at all;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The market for wearable computing devices is still in the
early stages of growth and if it does not continue to grow, grows more slowly than we expect, or fails to grow as large as we expect,
our business and operating results would be harmed;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">If we do not compete effectively, our prospects, operating
results, and financial condition could be adversely affected.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>Risks Related to Our Financial Condition
and Operations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We may need to raise additional capital required to grow our
business. We may not be able to raise capital on terms acceptable to us or at all, and the sale of additional shares, equity or debt
securities could result in additional dilution to our shareholders;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We have a going concern opinion which could prevent us from
obtaining new financing on reasonable terms or at all;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Our operating results could be materially harmed if we are
unable to accurately forecast consumer demand for our products and services and adequately manage our inventory.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>Risks Related to Ownership of our Ordinary
Shares and Warrants</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Our current officers and directors and holders of more than
5% of our Ordinary Shares currently beneficially own an aggregate of approximately 18.7% of our Ordinary Shares and are able to exert
significant control over matters submitted to our shareholders for approval;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Our Warrants, which are speculative in nature, are listed
on Nasdaq separately and may provide investors with an arbitrage opportunity that could adversely affect the trading price of our Ordinary
Shares;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We do not know whether a market for the Ordinary Shares or
Warrants will be sustained or what the trading price of the Ordinary Shares or Warrants will be. As a result, it may be difficult for
you to sell your securities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">If we are unable to regain compliance with all applicable
continued listing requirements and standards of Nasdaq, our Ordinary Shares could be delisted from Nasdaq.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks Related to Our Intellectual Property</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We may not be able to adequately protect or enforce our intellectual
property rights. Our efforts to do so may be costly;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">If we are unable to protect our domain names, our brand, business,
and operating results could be adversely affected;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We may become subject to litigation brought by third parties
claiming infringement by us of their intellectual property rights;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Our use of &#8220;open source&#8221; software could negatively
affect our ability to sell our products and subject us to possible litigation.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>Risks Related to Operations in Israel</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Conditions in Israel, including <span>implications
of political, economic and military instability arising from the multi-front war</span>, affect our operations and may limit our ability
to produce or sell our products and our ability to raise additional funds;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We may be subject to the limitations resulting from our receipt
of Israeli government grants for certain of our research and development activities, the terms of which may require us to pay royalties
and to satisfy specified conditions;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Provisions of Israeli law and our amended and restated articles
of association may delay, prevent or otherwise impede a merger with, or an acquisition of, us, which could prevent a change of control,
even when the terms of such a transaction are favorable to us and our shareholders.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>General Risk Factors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">We incur significant costs as a result of our being a public
company. Our management is required to devote substantial time to compliance with ongoing SEC and Nasdaq requirements;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to Our Business</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
are a growth company with limited operating history. We may never be able to effectuate our business plan or achieve sufficient revenue
or reach profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">For
some aspects of our technology, we are still a growth company, and are subject to all of the risks inherent in the establishment of a
new business enterprise. We have a limited operating history and only a preliminary and unproven business plan upon which investors may
evaluate our prospects. Although we have produced a working development kit &#8211; the Mudra Development Kit (formerly named Mudra Inspire)
&#8211; we have not mass produced any product planned for global consumers. Even if we are able to do so, we may not be able to manufacture
the product at the low costs needed to support our business models. We have not yet entered into any commercial arrangement for the licensing
of our technology under a licensing model.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Furthermore,
even if our technology becomes commercially viable, our business models may not generate sufficient revenue necessary to support our business.
The consumer electronics industry is highly competitive, and our technology, products, services or business models may not achieve widespread
market acceptance. If we are unable to address any of the aforementioned issues, or encounter other problems, expenses, difficulties,
complications, and delays in connection with the starting and expansion of our business, our entire business may fail.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
ability to generate revenue from our operations and, ultimately, achieve profitability will depend on, among other things, whether we
can complete the development and commercialization of our technology, our ability to integrate and license our technology into consumer
electronic devices, our future products and our services, whether we can manufacture products on a commercial scale in such amounts and
at such costs as we anticipate, and whether we can achieve market acceptance of our products, services and business models. We may never
generate any revenue or operate on a profitable basis. Even if we achieve profitability, we may not be able to sustain it.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
invest effort and money into seeking validation of our technology and products with B2B companies, such as consumer electronics companies
and consumer electronics brands, and there can be no assurance that we will enter into license agreements, which could adversely affect
our future business, results of operations and financial condition.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
invest effort and money from the time of our initial contact with a B2B company, be it a consumer electronics company or a consumer electronics
brand, to the date on which the B2B company chooses to integrate our technology into one or more of its products. The B2B company integrates
our products and our proprietary software and hardware into a complete consumer electronics product that it manufactures. Successful validation
of our technology will result in a signed commercial license agreement with the B2B company. However, we estimate there will be a three-to-five-year
period from the time we are first introduced to such a customer to signing a licensing agreement and as of March 19, 2025, we have not
entered into any licensing agreements. This is a significant amount of time and negotiations may break down during the course of such
negotiations. Accordingly, there is a possibility that we could expend our resources without success.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
addition, a B2B company&#8217;s current solution, internally developed or integrated with a third-party solution, may have an advantage
with the company going forward because of the established trust and relationship between the parties, which could make it more difficult
for competitors, like us, to integrate new solutions for other products or product lines. If we fail to sign a significant number of B2B
license agreements in the future, our business, results of operations and financial condition would be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>There
is no assurance that wrist SNC will be the dominant input method in the wearable computing and consumer electronics industry.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Although
we believe that SNC, the technology behind our Mudra gesture recognition system that tracks neural signals in the user&#8217;s wrist,
will become the industry standard input method for wearable computing and consumer electronics, it is possible that other input methods,
such as electroencephalography, electromyography voice or camera gestures-or a new, disruptive sensor based on new or existing technology-will
achieve acceptance or dominance in the market. If wearable computing and consumer electronics based on other input methods gain acceptance
by the market, consumer electronics companies, consumer electronics brands and consumers in place of or as a substitute to SNC, and we
do not sign license and integration agreements to the same extent as we expect, our business, results of operations and financial condition
would be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>If
we are unable to successfully develop and timely introduce new products and services or enhance existing products and services, our business
may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
must continually develop and introduce new products and services and improve and enhance our existing products and services to maintain
or increase our sales. The success of new or enhanced products and services may depend on a number of factors, including anticipating
and effectively addressing consumer preferences and demand, the success of our sales and marketing efforts, timely and successful research
and development, effective forecasting and management of product demand, purchase commitments and inventory levels, effective management
of manufacturing and supply costs, and the quality of or defects in our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
development of our products and services is a complex and costly process, and we typically have several products and services in development
at the same time. Given the complexity, we occasionally have experienced, and could experience in the future, delays in completing the
development and introduction of new and enhanced products, product features, and services. Problems in the design or quality of our products
or services may also have an adverse effect on our business, financial condition, brand, and operating results. Unanticipated problems
in developing products and services could also divert substantial research and development resources, which may impair our ability to
develop new products and services and enhancements of existing products and services, and could substantially increase our costs. If new
or enhanced product and service introductions are delayed or not successful, we may not be able to achieve an acceptable return, if any,
on our research and development efforts, and our business may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>If
we are unable to develop and introduce new gesture input functions and improve existing functions in a cost-effective and timely manner,
our business, results of operations and financial condition would be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business and future operating
results will depend on our ability to complete development of existing finger and hand gestures and to develop and introduce new and enhanced
gesture functions that incorporate the latest technological advancements in user experience and user interaction, software, algorithms
and electrode technologies and to satisfy our customers and consumers. This will require us to invest resources in research and development
and also require that we:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">design new innovative, intuitive natural and accurate gestures
to suit a large variety of wearable computing devices, operating system platforms and form factors, that differentiate our products from
those of our competitors;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">integrate successfully the hardware and the software into
consumer electronics companies&#8217; products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">respond effectively to technological changes or product announcements
by our competitors; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">adjust to changing market conditions and consumer preferences
quickly and cost-effectively.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">If
there are delays in or we fail to complete our existing and new development programs, we may not be able to meet the requirements, needs
and preferences of our customers and consumers and our results of operations and financial condition would be adversely affected. In addition,
we cannot assure you that our investment in research and development will lead to any corresponding revenue, in which case our business,
results of operations and financial condition would also be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>The
failure to effectively manage the introduction of new or enhanced products may adversely affect our operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
make efforts to release new consumer products or enhanced product features successfully. The release of new consumer products could adversely
impact the sales of our existing products to consumers. For instance, consumers may decide to purchase new products instead of existing
products. Moreover, future consumer electronics customers may decide to integrate enhanced features which do not yet exist in our own
consumer products. This could lead to excess inventory and discounting of our existing products. In addition, we anticipate incurring
higher levels of sales and marketing expenses accompanying each product introduction. Accordingly, if we fail to effectively manage introductions
of new consumer products or enhanced product features, our operating results would be harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
current and future products and services may experience quality problems from time to time that can result in adverse publicity, product
recalls, litigation, regulatory proceedings, and warranty claims resulting in significant direct or indirect costs, decreased revenue
and operating margin, and harm to our brand.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
sell complex products and services that could contain design and manufacturing defects in their materials, hardware, software, and firmware.
These defects could include defective materials or components, or &#8220;bugs&#8221; that can unexpectedly interfere with the products&#8217;
intended operations or cause injuries to users. Although we significantly and thoroughly test new and enhanced products and services before
their release, there can be no assurance we will be able to detect, prevent, or fix all defects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Failure
to detect, prevent, or fix defects could result in a variety of consequences, including a greater number of returns of products than expected
from our customers and consumers, or future retail customers, regulatory proceedings, product recalls, and litigation, which could harm
our revenue and operating results. The occurrence of real or perceived quality problems or material defects in our current and future
products could expose us to warranty claims. If we experience relatively large returns from our retail customers or our other customers
and consumers, our business and operating results could be harmed. In addition, any negative publicity or lawsuits filed against us related
to the perceived quality and safety of our products could also affect our brand and decrease demand for our products and services, and
adversely affect our operating results and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Furthermore,
our products are used to monitor our users&#8217; hand bio-potentials activity and to operate control functions on a large variety of
digital devices which operate on different users&#8217; wrist physiology and device operating system and model. It may happen that our
products do not provide accurate measurements or correctly classify gestures to users, which may result in negative publicity, and, in
some cases, may require us to expend time and resources to defend litigation. If our products fail to provide accurate measurements and
control functions to users, or if there are reports or claims of inaccurate measurements or claims regarding the overall benefits of our
products and services in the future, we may become the subject of negative publicity, litigation, including class action litigation, regulatory
proceedings, and warranty claims, and our brand, operating results, and business could be harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>The
period of time from a license agreement to implementation of our technology is long and we are subject to the risks of cancellation or
postponement of the contract or unsuccessful implementation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
products are technologically complex, incorporate many technological innovations and are typically intended for use in interface input
applications. Prospective consumer electronics customers generally must make significant commitments of resources to test and validate
our technology before including it in any particular product device. The development cycles of our products with new consumer electronics
customers may take approximately one to three years after an initial agreement is reached, depending on the customer and the complexity
of the input solution. These development cycles result in our investment of our resources prior to realization of any revenues. Further,
we are subject to the risk that a consumer electronics company cancels or postpones implementation of our technology, as well as that
we may not be able to implement our technology successfully. Further, our sales could be less than forecast if the product device is unsuccessful,
due to reasons related or unrelated to our technology. Long development cycles and product cancellations or postponements may adversely
affect our business, results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>If
we are unable to anticipate and satisfy consumer preferences in a timely manner, our business may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
success depends on our ability to anticipate and satisfy consumer preferences in a timely manner. All of our products are subject to changing
consumer preferences that cannot be predicted with certainty. Consumers may decide not to choose our solutions or purchase our products
and services as their preferences could shift rapidly to different types of input methods or away from these types of products and services
altogether, and our future success depends in part on our ability to anticipate and respond to shifts in consumer preferences. In addition,
future products may have higher prices than our current products and the products of some of our competitors, which may not appeal to
consumers or only appeal to a smaller subset of consumers. It is also possible that competitors could introduce new products and services
that negatively impact consumer preferences for our input method and technology, which could result in decreased sales of our products
and services and a loss in market share. Accordingly, if we fail to anticipate and satisfy consumer preferences in a timely manner, our
business may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>If
we are unable to successfully comply with Apple Inc.&#8217;s, or Apple, &#8220;Accessory Design Guidelines for Apple Devices&#8221;, our
business, results of operation and financial condition may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
consumer product, the Mudra Band, is an aftermarket accessory band for the Apple Watch which allows touchless operation and control of
the watch and iPhone. Apple enforces strict guidelines which address the physical design of cases, covers, screen overlays, and camera
attachments for Apple devices and specifications for hardware accessories that use Bluetooth to communicate with Apple products including
Mac, iPhone, iPad and iPod touch models. All accessories must meet requirements which include, and may not be limited to, compliance testing,
integrated USB receptacles, user supplied cables and AC power adapters, attachments, magnetic interference, radio frequency performance,
thermal management and tripod connections. In particular, watch bands, such as the Mudra Band, have to meet certain requirements with
respect to lugs, magnetic chargers, band sizes and dimensions, band material, and environmental regulations. Accessories have to also
comply with Bluetooth accessory identification, accessory power (lighting), app discovery, device power, power and communications protocols,
Bluetooth, Bluetooth low energy and connectors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Apple
reserves the right to change specifications and the terms and conditions at its sole consideration, and, therefore, we may be required
to change the Mudra Band specifications to comply with future Apple change requirements. Our company is investing significant resources
to ensure that the Mudra Band is compatible with all the relevant guidelines. Therefore, a significant change in the Apple guidelines
may cause our business, results of operations and financial condition to be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
rely on a limited number of suppliers, contract manufacturers, and logistics providers, and each of our products is manufactured by a
single contract manufacturer.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
rely on a limited number of suppliers, contract manufacturers, and logistics providers. In particular, we use contract manufacturers located
in Asia and Israel, and each of our products&#8217; sub-components are manufactured by a different single contract manufacturer. Our reliance
on single contract manufacturers for each of our products&#8217; components increases our risks since we do not currently have any alternative
or replacement manufacturers. In the event of an interruption from a contract manufacturer, we may not be able to develop alternate or
secondary sources without incurring material additional costs and substantial delays. While component shortages have historically been
immaterial, they could be material in the future. Furthermore, these risks could materially and adversely affect our business if one of
our contract manufacturers is impacted by a natural disaster or other interruption at a particular location because each of our contract
manufacturers produces our product&#8217;s components in a single location. In addition, some of our suppliers, contract manufacturers,
and logistics providers may have more established relationships with our competitors and potential competitors, and as a result of such
relationships, such suppliers, contract manufacturers, and logistics providers may choose to limit or terminate their relationship with
us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">If
we experience significantly increased demand, or if we need to replace an existing supplier, contract manufacturer, or logistics provider,
we may be unable to supplement or replace such supply, contract manufacturing, or logistics capacity on terms that are acceptable to us,
which may undermine our ability to deliver our products to customers in a timely manner. For example, for certain of our products, it
may take a significant amount of time to identify a contract manufacturer that has the capability and resources to build the product to
our specifications in sufficient volume. Identifying suitable suppliers, contract manufacturers, and logistics providers is an extensive
process that requires us to become satisfied with their quality control, technical capabilities, responsiveness and service, financial
stability, regulatory compliance, and labor and other ethical practices. Accordingly, a loss of any key supplier, contract manufacturer,
or logistics provider could adversely impact our revenue and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Because
many of the key components in our products come from limited or sole sources of supply, we are susceptible to supply shortages, long lead
times for components, and supply changes, any of which could disrupt our supply chain.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Many
of the key components used to manufacture our products come from limited or sole sources of supply. Our contract manufacturers generally
purchase these components on our behalf, subject to certain approved supplier lists, and we do not have any long-term arrangements with
our suppliers. We are therefore subject to the risk of shortages and long lead times in the supply of these components and the risk that
our suppliers discontinue or modify components used in our products. In addition, the lead times associated with certain components are
lengthy and preclude rapid changes in quantities and delivery schedules. We have in the past experienced and may in the future experience
component shortages, and the predictability of the availability of these components may be limited. While component shortages have historically
been immaterial, they could be material in the future. In the event of a component shortage or supply interruption from suppliers of these
components, we may not be able to develop alternate sources in a timely manner. Developing alternate sources of supply for these components
may be time-consuming, difficult, and costly and we may not be able to source these components on terms that are acceptable to us, or
at all, which may undermine our ability to meet our requirements or to fill our orders in a timely manner. Any interruption or delay in
the supply of any of these parts or components, or the inability to obtain these parts or components from alternate sources at acceptable
prices and within a reasonable amount of time, would harm our ability to meet our scheduled product deliveries to our customers and users.
This could harm our relationships with our channel partners and users and could cause delays in shipment of our products and adversely
affect our operating results. In addition, increased component costs could result in lower gross margins. If we are unable to buy these
components in quantities sufficient to meet our requirements on a timely basis, we will not be able to deliver products and services to
our customers and users.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
have limited control over our suppliers, contract manufacturers, and logistics providers, which subjects us to significant risks, including
the potential inability to obtain or produce quality products on a timely basis or in sufficient quantity.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
have limited control over our suppliers, contract manufacturers, and logistics providers, including aspects of their specific manufacturing
processes and their labor, environmental, or other practices, which subjects us to significant risks, including the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">inability to satisfy demand for our products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reduced control over delivery timing and product reliability;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reduced ability to oversee the manufacturing process and components
used in our products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reduced ability to monitor compliance with our product manufacturing
specifications;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reduced ability to develop comprehensive manufacturing specifications
that take into account materials shortages, materials substitutions, and variance in the manufacturing capabilities of our third-party
contract manufacturers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">price increases;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the failure of a key supplier, contract manufacturer, or logistics
provider to perform its obligations to us for technical, market, or other reasons;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">difficulties in establishing additional contract manufacturing
relationships if we experience difficulties with our existing contract manufacturers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">shortages of materials or components;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">misappropriation of our intellectual property;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">exposure to natural catastrophes, political unrest, war, terrorism,
labor disputes, and economic instability resulting in the disruption of trade from foreign countries in which our products are manufactured;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes in local economic conditions in countries where our
suppliers, contract manufacturers, or logistics providers are located;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the imposition of new laws and regulations, including those
relating to labor conditions, quality and safety standards, imports, duties, taxes, and other charges on imports, as well as trade restrictions
and restrictions on currency exchange or the transfer of funds; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">insufficient warranties and indemnities on components supplied
to our contract manufacturers.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
future success depends on the continuing efforts of our key employees, including our founders, Asher Dahan, Guy Wagner and Leeor Langer,
and on our ability to attract and retain highly skilled personnel and senior management.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
future success depends, in part, on our ability to continue to attract and retain highly skilled personnel. In particular, we are highly
dependent on the contributions of our co-founders, Asher Dahan, Guy Wagner and Leeor Langer, as well as other members of our management
team. The loss of any key personnel could make it difficult to manage our operations and research and development activities, reduce our
employee retention and revenue, and impair our ability to compete. Although we have entered into employment agreements with our key personnel,
these agreements have no specific duration and provide for at-will employment, which means they may terminate their employment relationship
with us at any time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Competition
for highly skilled personnel is often intense, especially in Israel where we are located, and we may incur significant costs to attract
them. We may not be successful in attracting, integrating, or retaining qualified personnel to fulfill our current or future needs. We
have, from time to time, experienced, and we expect to continue to experience, difficulty in hiring and retaining highly skilled employees
with appropriate qualifications. In addition, job candidates and existing employees often consider the value of the equity awards they
receive in connection with their employment. If the perceived value of our equity or equity awards declines, it may adversely affect our
ability to retain highly skilled employees. If we fail to attract new personnel or fail to retain and motivate our current personnel,
our business and future growth prospects could be severely harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
collect, store, process, and use personal information and other customer data, which subjects us to governmental regulation and other
legal obligations related to privacy, cybersecurity, and data protection, and our actual or perceived failure to comply with such obligations
could harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
collect, store, process, and use personal information and other user data, and we rely on third parties that are not directly under our
control to do so as well. Our users&#8217; neural finger and hand signals and movement-related data and other personal information may
include, but is not limited to, names, addresses, phone numbers, email addresses, payment account information, wrist size and circumference,
and biometric information such as neural signals, hand movement rotation and acceleration, GPS-based location, and hand activity patterns.
Due to the volume and sensitivity of the personal information and data we manage and the nature of our products, the security features
of our platform and information systems are critical. If our security measures, some of which are managed by third parties, are breached
or fail, unauthorized persons may be able to obtain access to sensitive user data. If we or our third-party service providers, business
partners, or third-party apps with which our users choose to share their data were to experience a breach of systems compromising our
users&#8217; sensitive data, use of our products and services could decrease, our brand and reputation could be adversely affected, and
we could be exposed to a risk of loss, litigation, and regulatory proceedings. Depending on the nature of the information compromised,
in the event of a data breach or other unauthorized access to our user data, we may also have obligations to notify users about the incident
and we may need to provide some form of remedy for the individuals affected by the incident.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
the United States, the U.S. Federal Trade Commission and numerous state attorneys general are applying federal and state consumer protection
laws to impose standards on the online collection, use and dissemination of data, and to the security measures applied to such data. We
continue to see increased regulation of privacy cybersecurity and data protection, including the adoption of more stringent subject matter
specific state laws in the United States. For example, in 2018, California enacted the California Consumer Privacy Act, or the CCPA, which
took effect on January 1, 2020. The CCPA gives California residents expanded rights to access and delete their personal information, opt
out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides
for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation.
The CCPA may increase our compliance costs and potential liability, and we may be required to modify our practices and take additional
steps in an effort to comply with the CCPA. Some observers have noted that the CCPA could mark the beginning of a trend toward more stringent
state privacy legislation in the United States, which could increase our potential liability and adversely affect our business. In addition,
various U.S. state privacy laws in that became effective in 2024, and upcoming laws in various other states taking effect in 2025, impose
additional obligations that vary by jurisdiction. Compliance requirements continue to evolve, creating additional operational challenges
and potential liabilities. Such breach notification laws continue to evolve and may be inconsistent from one jurisdiction to another.
Complying with these obligations could cause us to incur substantial costs and could increase negative publicity surrounding any incident
that compromises user data. Our users may also accidentally disclose or lose control of their passwords, creating the perception that
our systems are not secure against third-party access. Additionally, if third parties we work with, such as vendors, developers, or consumer
electronics customers who licensed our technology, violate applicable laws, agreements, or our policies, such violations may also put
our users&#8217; information at risk and could in turn have an adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Similarly,
many other countries and governmental bodies, including the EU member states, have laws and regulations concerning the collection and
use of personal data obtained from individuals located in the EU or by businesses operating within their jurisdiction, which are often
more restrictive than those in the United States. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage,
disclosure and security of personal data that identifies or may be used to identify an individual, such as names, telephone numbers, email
addresses and, in certain circumstances, IP addresses and other online identifiers. For example, under the General Data Protection Regulation
in Europe, or the GDPR, and its UK equivalent, or the U.K. GDPR, and the CCPA, non-compliance could result in fines, penalties, or sanctions,
including penalties of up to 4% of annual worldwide turnover or EUR 20 million (approximately $21 million), whichever is greater. Given
the breadth and depth of its obligations, working to meet the requirements of the GDPR has required significant time and resources, including
a review of our technology and systems currently in use against the requirements of the GDPR. There are also additional EU laws and regulations
(and member states implementations thereof) which govern the protection of consumers and of electronic communications. We have taken measures
to address certain obligations under the GDPR and to make us GDPR compliant, but we may be required to take additional steps in order
to comply with the GDPR. If our efforts to comply with GDPR or other applicable EU laws and regulations are not successful, we may be
subject to penalties and fines that would adversely impact our business and operating results, and our ability to conduct business in
the EU could be significantly impaired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
also continue to see jurisdictions imposing data localization laws, which require personal information, or certain subcategories of personal
information to be stored in the jurisdiction of origin. These regulations may inhibit our ability to expand into those markets or prohibit
us from continuing to offer services in those markets without significant additional costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Additionally,
although we endeavor to have our products and platform comply with applicable laws and regulations, these and other obligations may be
modified, they may be interpreted and applied in an inconsistent manner from one jurisdiction to another, and they may conflict with one
another, other regulatory requirements, contractual commitments or our practices. We expect that there will continue to be new proposed
laws, rules of self- regulatory bodies, regulations and industry standards concerning privacy, data protection and information security
in the United States, the EU and other jurisdictions, and we cannot yet determine the impact such future laws, rules, regulations and
standards may have on our business. The uncertainty and changes in the requirements of multiple jurisdictions may increase the cost of
compliance, delay or reduce demand for our services, restrict our ability to offer services in certain locations, impact our customers&#8217;
ability to deploy our products and solutions in certain jurisdictions, or subject us to claims and litigation from private actors and
investigations, proceedings, and sanctions by data protection regulators, all of which could harm our business, financial condition and
operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
also may be bound by contractual obligations relating to our collection, use and disclosure of personal, financial and other data or may
find it necessary or desirable to join industry or other self-regulatory bodies or other privacy, cybersecurity or data protection-related
organizations that require compliance with their rules pertaining to privacy and data protection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Moreover,
as global legislation, enforcement, and policy activity expand, we are subject to increasingly complex and varying international, federal,
and state data privacy and cybersecurity laws, including those requiring specific protections for the transfer, storage, and use of personal
data. Ensuring compliance with these laws, such as the GDPR, U.K. GDPR, CCPA, and similar legislation in other jurisdictions, is costly
and resource-intensive, and failure to comply could result in significant financial and reputational harm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Any
failure or perceived failure by us, our products or our platform to comply with new or existing U.S., EU or other foreign privacy, cybersecurity
or data protection laws, regulations, policies, industry standards or legal obligations, any failure to bind our suppliers and contractors
to appropriate agreements or to manage their practices or any systems failure or security incident that results in the unauthorized access
to, or acquisition, release or transfer of, personally identifiable information or other data relating to customers or individuals may
result in governmental investigations, inquiries, enforcement actions and prosecutions, private claims and litigation, fines and penalties,
adverse publicity or potential loss of business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
rely on third-party application stores to distribute our mobile application.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
are dependent on third-party application stores that may prevent us from timely updating our applications, building new features, integrations,
capabilities and enhancements or charging for access.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
distribute the mobile Mudra Inspire, Mudra Band application, and other future applications, through smartphone and tablet application
stores managed by Apple and Google LLC, or Google, among others. We cannot assure you that the third-party application stores through
which we distribute our mobile applications will maintain their current structures or that such application stores will not charge us
fees to list our application for download. We are also depending on these third-party application stores to enable us and our users to
timely update our mobile applications and to incorporate new features, integrations, capabilities and enhancements. In addition, certain
of these companies are now, and others may in the future become, competitors of ours and could stop allowing or supporting access to our
platform through their products, could allow access for us only at an unsustainable cost, or could make changes to the terms of access
in order to make our platform less desirable or harder to access, in each case for competitive reasons.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
management team has limited experience managing a public company.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Most
members of our management team have limited experience managing a publicly-traded company, interacting with public company investors,
and complying with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently
manage our obligations as a public company subject to significant regulatory oversight and reporting obligations under the federal securities
laws and the continuous scrutiny of securities analysts and investors. These obligations and constituents require significant attention
from our senior management and could divert their attention away from the day-to-day management of our business, which could adversely
affect our business, financial condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>If
we experience a period of significant growth or expansion, it could place a substantial strain on our resources, and we may be unable
to execute our business plan or maintain high levels of service and customer satisfaction.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
may experience rapid growth, which will place significant demands on our management and our operational and financial resources. We may
also experience significant growth in the number of customers and organizations using our products, and in the amount of data that we
collect and process. Additionally, our organizational structure and our operations may become more complex, requiring us to scale our
operational, financial and management controls as well as our reporting systems and procedures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">As
we continue to grow our business, we will face challenges in integrating, developing, training and motivating a growing employee base
and maintaining our company culture. Moreover, our potential continued growth will require significant capital expenditures and the allocation
of valuable management resources. Our growth could place a significant strain on our management, customer experience, research and development,
sales and marketing, and other resources. In addition, as we expand our business and our customer base continues to grow, it is important
that we continue to maintain a high level of customer service and satisfaction. As such, we will need to expand our account management,
our customer service and other personnel so we can continue providing personalized account management and customer service as well as
personalized features, integrations, capabilities and enhancements. If we fail to manage our growth in a manner that preserves high levels
of customer service and the key aspects of our corporate culture, the quality of our products and services may suffer, which could negatively
affect our reputation and harm our ability to attract employees, users and organizations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
spend significant amounts on advertising and other marketing campaigns to acquire new users, and we expect to increase these advertising
and marketing efforts, which may not be successful or cost effective.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
spend significant amounts on advertising and other marketing campaigns, such as online advertising and social media, to acquire new users
and we expect our marketing expenses to increase in the future as we continue to spend significant amounts to acquire new users and increase
awareness of our products and services. We expect to increase advertising and marketing efforts. While we seek to structure our advertising
campaigns in the manner that we believe is most likely to encourage people to use our products and services, we may fail to identify advertising
opportunities that satisfy our anticipated return on advertising spend as we scale our investments in marketing, accurately predict user
acquisition, or fully understand or estimate the conditions and behaviors that drive user behavior. If for any reason any of our advertising
campaigns prove less successful and/or cost effective than anticipated in attracting new users, we may not be able to recover our advertising
spend, and our rate of user acquisition may fail to meet market expectations, either of which could have an adverse effect on our business.
There can be no assurance that our advertising and other marketing efforts will result in increased sales of our products and services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
depend on third-party data center service providers. Any disruption in the operation of the data center facilities or failure to renew
the services could adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
services are hosted using data centers operated by third parties. We control neither the operation of the data centers nor our third-party
data center service providers. The third-party data center service providers may have no obligation to renew their services with us on
commercially reasonable terms, or at all. If we are unable to renew these services on commercially reasonable terms, we may be required
to transfer our servers or data to new data center facilities or engage new service providers, and we may incur significant costs and
a possible interruption in our platform in connection with doing so.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Problems
with our third-party data center service providers, the telecommunications network providers with whom they contract, or with the systems
by which telecommunications providers allocate capacity among their users could adversely affect the experience of our users. Our third-party
data center service providers could decide to close their facilities or cease to provide us services without adequate notice. In addition,
any financial difficulties, such as bankruptcy, faced by our third-party data center service providers or parties they contract with may
have negative effects on our business, the nature and extent of which are difficult to predict. Additionally, any failure of our data
centers to meet our needs for capacity could have an adverse effect on our business. Any changes in third-party service levels at our
data centers or any errors, defects, disruptions, or other performance problems with our platform could harm our brand and may damage
the data of our users. Outages at our data centers, and future interruptions to our platform, might reduce our revenue, cause us to issue
refunds, subject us to potential liability, or harm our ability to retain users and attract new customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Disruptions
to our Information Technology, or IT, system may disrupt our operations and materially adversely affect our business and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
depend on our IT systems, as well as those of third parties, to develop new products and services, operate our websites, host and manage
our services, store data, process transactions, respond to user inquiries, and manage inventory and our supply chain. Our servers and
equipment may be subject to cyber-security crimes, ransom hijacking, computer viruses, break-ins and similar disruptions from unauthorized
tampering with computer systems. We can provide no assurance that our current IT system is fully protected against third-party intrusions,
viruses, hacker attacks, information or data theft or other similar threats. A cyber-attack that bypasses our IT security systems causing
an IT security breach may lead to a material disruption of our IT business systems and/or the loss of business information. Any such event
could have a material adverse effect on our business until we recover using our back-up information. To the extent that such disruptions
or uncertainties result in delays or cancellations of customer programs or misappropriation or release of our confidential data or our
intellectual property, our business and results of operations could be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
business is subject to data security risks, and our data security measures may be inadequate to address these risks, making our systems
susceptible to compromise, which could materially adversely affect our business, financial condition, results of operations, and prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">During
the ordinary course of our business, we may collect, process, store and transmit substantial amounts of data and information, including
users&#8217; data. We have implemented measures to separate the data stored in our internet data centers and those stored with the third-party
vendors. Security incidents may occur in the future, causing unauthorized access to, loss of, or unauthorized disclosure of such information,
resulting in regulatory enforcement actions, litigation, indemnification obligations, and other potential liabilities, as well as negative
publicity, which could materially adversely affect our business, reputation, financial condition, results of operations, and prospects.
Cyberattacks, computer malware, and other compromises of information security measures or malicious internet-based activity continue to
increase, and cloud-native platform providers of products and services have been targeted, resulting in breaches of their information
security, and are expected to continue to be targeted. We and our third-party vendors are at risk of suffering from similar attacks and
breaches.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
products may also be subject to fraudulent usage and schemes, including third parties accessing customer accounts or viewing data from
our platform without our authorization. While we undertake significant efforts to protect the security and integrity of the information
we collect, process, store, and transmit, we cannot entirely mitigate these risks, and there is no guarantee that inadvertent or unauthorized
use or disclosure of such information will not occur or that third parties will not gain unauthorized access to such information despite
our efforts. In addition, we rely on our third-party vendors to take appropriate measures to protect the security and integrity of the
information on their information systems. We may not be able to anticipate or prevent all techniques that could be used to obtain unauthorized
access or to compromise our systems because such techniques change frequently and are generally not detected until after an incident has
occurred. Additionally, we cannot be certain that we will be able to address any vulnerabilities in our software that we may become aware
of in the future. We expect similar issues to arise in the future as we continue to expand the features and functionality of our products
and platform and introduce new products, and we expect to expend significant resources in an effort to protect against security incidents.
In addition, any actual or suspected cybersecurity incident or other compromise of our security measures, or those of our third-party
vendors, whether as a result of hacking efforts, denial-of-service attacks, viruses, malicious software, break-ins, phishing attacks,
social engineering, or otherwise, could result in governmental investigations or enforcement actions, litigation, harm to our business,
damage to our brand and reputation, significant costs for remediating the effects of such an incident and preventing future incidents,
lost revenue due to network downtime, and a decrease in customer and user trust. Concerns regarding privacy, data protection, and information
security may also cause some of our customers to stop using our products and platform and make it harder to acquire new customers. To
the extent we do not effectively address these risks, our business, financial condition, results of operations, and prospects could be
materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Many
governments have enacted laws requiring companies to provide notice of data security incidents involving certain types of personal data.
We are also contractually required to notify certain customers of certain data security breaches. To protect customers&#8217; information,
we have adopted multiple security measures that address security risks associated with data transmission, usage, storage, export and presentation.
We have adopted an access control policy that requires user authentication every time there is a request to access non-public data. In
addition, we have implemented an encryption program that encrypts the sensitive and confidential information stored by us. Despite our
efforts, security incidents experienced by us, or by others, such as our competitors or customers, may lead to public disclosures and
widespread negative publicity for us, our customers, or the construction software industry generally.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Regulatory
requirements regarding the protection of personal information are constantly evolving and can be subject to differing interpretations,
making the extent of our responsibilities in that regard uncertain. We currently adopt a data privacy policy with respect to how we collect,
store, process and use user data and information, and we may only use such data and information to provide and improve our services, content
and advertising in strict compliance with such policy. Despite the absence of any material data breach or similar incidents and our continuous
efforts to comply with our privacy policy as well as all applicable laws and regulations, any failure or perceived failure to comply with
these laws, regulations or policy may result in inquiries and other proceedings or actions against us by governmental authorities or others,
which could cause us to lose users and business partners.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">There
can be no assurance that any limitations of liability provisions with customers would be enforceable or adequate or would otherwise protect
us from any such liabilities or damages with respect to any particular claim. The successful assertion of one or more large claims against
us could materially adversely affect our business, financial condition, results of operations, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Significant
changes or developments in U.S. laws or policies, including changes in U.S. trade policies and tariffs and the reaction of other countries
thereto, may have a material adverse effect on our business and financial statements.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Significant
changes or developments in U.S. laws and policies, such as laws and policies surrounding international trade, foreign affairs, manufacturing
and development and investment in the territories and countries where we or our customers operate, can materially adversely affect our
business and financial statements. For example, President Donald&#160;Trump has&#160;signed executive orders imposing tariffs on certain
imports from Mexico, Canada and China, although some have been delayed. The extent and duration of the tariffs and the resulting impact
on general economic conditions and on our business are uncertain and depend on various factors, such as negotiations between the U.S.
and affected countries, the responses of other countries or regions, exemptions or exclusions that may be granted, availability and cost
of alternative sources of supply, and demand for our products in affected markets. Further, actions we take to adapt to new tariffs or
trade restrictions may cause us to modify our operations or forgo business opportunities </p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Artificial intelligence&#160;presents risks
and challenges that can impact our business by posing security risks to our confidential information, proprietary information and personal
data.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Issues
in the development and use of&#160;artificial intelligence, combined with an uncertain regulatory environment, may result in reputational
harm, liability or other adverse consequences to our business operations. As with many technological innovations,&#160;artificial intelligence&#160;presents
risks and challenges that could impact our business. We utilize AI tools and features in our products and the provision of our services,
and work with vendors that incorporate&#160;artificial intelligence&#160;tools into their offerings and the providers of these&#160;artificial
intelligence&#160;tools may not meet existing or rapidly evolving regulatory or industry standards with respect to privacy and data protection
and may inhibit our or our vendors&#8217; ability to maintain an adequate level of service and experience. If we, our vendors, or our
third-party partners experience an actual or perceived breach or privacy or security incident because of the use of generative&#160;artificial
intelligence, we may lose valuable intellectual property and confidential information and our reputation and the public perception of
the effectiveness of our security measures could be harmed. Further, bad actors around the world use increasingly sophisticated methods,
including the use of&#160;artificial intelligence, to engage in illegal activities involving the theft and misuse of personal information,
confidential information and intellectual property. Any of these outcomes could damage our reputation, result in the loss of valuable
property and information and adversely impact our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b>Risks
Related to the Industry in Which We Operate</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>The
forecasts of market growth included in this annual report on Form 20-F may prove to be inaccurate, and even if the markets in which we
compete achieve the forecasted growth, we cannot assure you our business will grow at similar rates, if at all.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Growth
forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. The forecasts
in this annual report on Form 20-F relating to the expected growth in the market for wearable computing devices, wearable devices, and
consumer electronics industry may prove to be inaccurate. Even if these markets experience the forecasted growth described herein, we
may not grow our business at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our
business strategy, which is subject to many risks and uncertainties. Accordingly, the forecasts of market growth included in this annual
report on Form 20-F should not be taken as indicative of our future growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>The
market for wearable computing devices is still in the early stages of growth and if it does not continue to grow, grows more slowly than
we expect, or fails to grow as large as we expect, our business and operating results would be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
market for wearable computing devices is relatively new and unproven, and it is uncertain whether wearable devices and wearable computers
will sustain high levels of demand and wide market acceptance. Our success will depend to a substantial extent on the willingness of people
to widely adopt these products and services. In part, adoption of our products and services will depend on the increasing prevalence of
connected wearable computing devices as well as new entrants to the wearable computing device market to raise the profile of both the
market as a whole and our own platform. Our input technology devices have largely been used to control the Apple Watch and explore input
methods for wearable computers and consumer electronics. However, they have not been widely adopted for other consumer electronics devices
such as AR glasses, VR headsets, and large displays for which other products are more often used. Furthermore, some individuals may be
reluctant or unwilling to use wearable input devices because they have concerns regarding the risks associated with data privacy, security,
accuracy and comfortability. If the wider public does not perceive the benefits of our neural input devices or chooses not to adopt them
as a result of concerns regarding privacy, data security, accuracy, comfortability, or for other reasons, then the market for these products
and services may not further develop, it may develop more slowly than we expect, or it may not achieve the growth potential we expect
it to, any of which would adversely affect our operating results. The development and growth of this relatively new market may also prove
to be a short-term trend.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
operate in a highly competitive market. If we do not compete effectively, our prospects, operating results, and financial condition could
be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
market of input methods and peripheral devices for digital computers is highly competitive, with companies offering a variety of competitive
products and services. We plan to develop and offer additional consumer electronics products for controlling and interacting with computers
and digital devices. Additional consumer offerings will include applications for a variety of devices which will add value to the consumer
beyond hardware functions. However, if we are unable to successfully develop additional consumer products, our results of operation may
suffer. We expect competition in our market to intensify in the future as new and existing competitors introduce new or enhanced products
and services that are potentially more competitive than our products and services. The digital devices input methods market has a multitude
of participants, including specialized consumer electronics companies, such as Apple, Meta Platforms Inc. (formerly Facebook, Inc.), or
Meta, and Google, and traditional peripheral and input solutions companies, such as Microsoft Corporation, or Microsoft, Logitech International
S.A. and Razer Inc. In addition, many large, broad-based consumer electronics companies either compete in our market or adjacent markets
or have announced plans to do so, including Apple and Facebook. For example, in September 2024, Meta announced that it is developing a
&#8220;neural interface&#8221; that can be used to control its prototypical&#160;Orion AR glasses. In October 2023, Apple released the
Apple Watch Ultra2 Double Tap capability, which allows users to tap the index finger and thumb together twice to answer a call, reply
to a message, see and scroll through the Smart Stack and more based on the watch&#8217;s inertial measurement unit, or&#160;IMU, and photoplethysmography,
or PPG, sensors. We also compete with a wide range of after-market periphery-related input devices that can be purchased in retail and
online stores from a multitude of manufacturers. We believe that many of our competitors and potential competitors have significant competitive
advantages, including longer operating histories, ability to leverage their sales efforts and marketing expenditures across a broader
portfolio of products and services, larger and broader customer bases, more established relationships with a larger number of suppliers,
contract manufacturers, and channel partners, greater brand recognition, ability to leverage app stores which they may operate, and greater
financial, research and development, marketing, distribution, and other resources than we do. Our competitors and potential competitors
may also be able to develop products or services that are equal or superior to ours, achieve greater market acceptance of their products
and services, and increase sales by utilizing different distribution channels than we do. Some of our competitors may aggressively discount
their products and services in order to gain market share, which could result in pricing pressures, reduced profit margins, lost market
share, or a failure to grow market share for us. If we are not able to compete effectively against our current or potential competitors,
our prospects, operating results, and financial condition could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>An
economic downturn or economic uncertainty may adversely affect consumer discretionary spending and demand for our products and services.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
products and services may be considered discretionary items for consumers. Factors affecting the level of consumer spending for such discretionary
items include general economic conditions, and other factors, such as consumer confidence in future economic conditions, fears of recession,
the availability and cost of consumer credit, levels of unemployment, and tax rates. As global economic conditions continue to be volatile
or economic uncertainty remains, trends in consumer discretionary spending also remain unpredictable and subject to reductions. Unfavorable
economic conditions may lead consumers to delay or reduce purchases of our products and services and consumer demand for our products
and services may not grow as we expect. Our sensitivity to economic cycles and any related fluctuation in consumer demand for our products
and services may have an adverse effect on our operating results and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Changes
in laws and regulations related to the internet or changes in the internet infrastructure itself may diminish the demand for our services
and have a negative impact on our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
future success of our business depends upon the continued use of the internet as a primary medium for commerce, communication and business
solutions. We may be required to comply with laws or regulations regarding the use of the internet in foreign jurisdictions, such as the
General Data Protection Regulation in the European Union, or the GDPR, and the California Consumer Privacy Act in the United States. Changes
in these laws or regulations could require us to modify our products in order to comply with these changes. While we have implemented
measures to promote compliance with applicable laws and regulations and track their developments, we cannot assure you that we will always
be in compliance. In addition, the modification of our products to ensure compliance can be time-consuming, if not technically impossible.
If we are unable to comply with these laws and regulations, or if we cannot modify our products in a timely fashion, our reputation, business,
results of operations and financial condition could be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
addition, government agencies may begin to impose taxes, fees or other charges for accessing the internet. These laws and changes could
limit the growth of internet-related commerce or communications generally and reduce the demand for internet-based services such as ours.
As our suppliers also carry out their services on the internet, such measures could increase our operating costs and we may not be able
to maintain our competitive pricing as compared to the legacy software. These effects combined could adversely affect our business, results
of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
addition, use of the internet as a business tool could be adversely affected. The performance of the internet and its acceptance as a
business tool has been adversely affected by &#8220;viruses,&#8221; &#8220;worms&#8221; and similar malicious programs and the internet
has experienced a variety of outages and other delays as a result of damage to portions of its infrastructure. If the use of the internet
is adversely affected by these issues, demand for our services could suffer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
business is subject to the risk of earthquakes, fire, power outages, floods, and other catastrophic events, and to interruption by manmade
problems such as terrorism.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
business is vulnerable to damage or interruption from earthquakes, fires, floods, pandemics, power losses, telecommunications failures,
terrorist attacks, acts of war, human errors, break-ins, and similar events. The third-party systems and operations and contract manufacturers
we rely on, such as the data centers we lease, are subject to similar risks. For example, a significant natural disaster, such as an earthquake,
fire, or flood, could have an adverse effect on our business, operating results, and financial condition, and our insurance coverage may
be insufficient to compensate us for losses that may occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
corporate offices are located in Israel, a state that frequently experiences terrorist attacks and acts of war. In addition, the facilities
at which our contract manufacturers manufacture our products are located in parts of Asia that frequently endure typhoons and earthquakes.
Acts of terrorism, which may be targeted at metropolitan areas that have higher population density than rural areas, could also cause
disruptions in our or our suppliers&#8217;, contract manufacturers&#8217;, and logistics providers&#8217; businesses or the economy as
a whole. Our servers may also be vulnerable to computer viruses, break-ins, denial-of-service attacks, and similar disruptions from unauthorized
tampering with our computer systems, which could lead to interruptions, delays, and loss of critical data. We may not have sufficient
protection or recovery plans in some circumstances, such as natural disasters affecting Israel or other locations where we have data centers
or store significant inventory of our products. As we rely heavily on our data center facilities, computer and communications systems,
and the Internet to conduct our business and provide high-quality customer service, these disruptions could negatively impact our ability
to run our business and either directly or indirectly disrupt suppliers&#8217; businesses, which could have an adverse effect on our business,
operating results, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 22.3pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 22.3pt"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 22.3pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 22.3pt"><b>Risks Related to Our Financial
Condition and Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
financial statements for the year ended December 31, 2024, contained an explanatory paragraph regarding substantial doubt about our ability
to continue as a going concern. This going concern opinion could prevent us from obtaining new financing on reasonable terms or at all
and risk our ability to continue operating as a going concern.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In part because we have incurred
losses in each year since our inception, our audited consolidated financial statements for the period ended December 31, 2024 contained
an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern. These events and conditions, along
with other matters, indicated that a material uncertainty existed as of December 31, 2024, that could cast significant doubt on our ability
to continue as a going concern. The financial statements for the year ended December 31, 2024 have been prepared assuming that we will
continue as a going concern. <span>To date, the Company has not generated significant revenues from its
activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating
losses and to continue to fund its operations primarily through the utilization of its current financial resources, sales of its products,
and through additional raises of capital. </span>As of December 31, 2024, we incurred accumulated losses of approximately $29.1 million.
A going concern opinion could materially limit our ability to raise additional funds through the issuance of equity or debt securities
or otherwise in the future. Further financial statements may also include an explanatory paragraph with respect to our ability to continue
as a going concern. Until we can generate significant recurring revenues, we expect to satisfy our future cash needs through existing
cash, debt or equity financing. We have completed our IPO and follow on fund raising, but we require additional financing in the near
future. We cannot be certain that additional funding will be available to us on acceptable terms, if at all. If funds are not available,
we may be required to delay, reduce the scope of, or eliminate research or development plans for, or commercialization efforts with respect
to our products and it risks our ability to continue operating as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may need to raise additional capital required to grow our business, and we may not be able to raise capital on terms acceptable to us
or at all, and the sale of additional shares or equity or debt securities could result in additional dilution to our shareholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Growing
and operating our business will require significant cash outlays and capital expenditures and commitments. If cash on hand and cash from
operating activities are not sufficient to meet our cash requirements, we will need to seek additional capital, potentially through debt
or equity financing, to fund our growth. We may not be able to raise needed cash on terms acceptable to us or at all. Financing may be
on terms that are dilutive or potentially dilutive to our shareholders, as described below, and the prices at which new investors would
be willing to purchase our securities may be lower than the current price per share. The holders of new securities may also have rights,
preferences, or privileges which are senior to those of existing holders of Ordinary Shares. If new sources of financing are required,
but are insufficient or unavailable, we will be required to modify our growth and operating plans based on available funding, if any,
which would harm our ability to grow our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
may need to raise additional capital through a combination of private and public equity offerings, debt financings and collaborations,
and strategic and licensing arrangements. To the extent that we raise additional capital through the issuance of equity or convertible
debt securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect
your rights as a holder of our Ordinary Shares. Debt financing, if available, may involve agreements that include covenants limiting or
restricting our ability to take certain actions, such as incurring debt, making capital expenditures or declaring dividends. If we raise
additional funds through strategic partnerships and alliances and licensing arrangements with third parties, we may have to relinquish
valuable rights to our technologies or product candidates or grant licenses on terms that are not favorable to us. If we are unable to
raise additional funds through equity or debt financing when needed, we may be required to delay, limit, reduce or terminate our product
development or commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop
and market ourselves.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
operating results or other operating metrics may fluctuate significantly, which could cause the trading price of our securities to decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
operating results and other operating metrics have fluctuated in the past and may continue to fluctuate in each reported period. We expect
that this trend will continue as a result of a number of factors, many of which are outside of our control and may be difficult to predict,
including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the level of demand for our neural input devices and our ability
to maintain or increase the size and engagement of our users;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the demand and volume of our licensing agreements with third-party
companies such as computer electronics manufacturers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the continued market acceptance of, and the growth of the
market for, neural input technology for wearable computing devices;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the timing and success of new product and service introductions
by us or our competitors or any other change in the competitive landscape of our market;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">pricing pressure as a result of competition or otherwise;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">delays or disruptions in our supply, manufacturing, or distribution
chain;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">errors in our forecasting of the demand for our products,
which could lead to lower revenue or increased costs, or both;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the mix of products sold in a reported period;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">seasonal buying patterns of consumers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">increases in and timing of sales and marketing and other operating
expenses that we may incur to grow and expand our operations and to remain competitive;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">insolvency, credit, or other difficulties confronting our
suppliers, contract manufacturers, or logistics providers leading to disruptions in our supply or distribution chain;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">levels of product returns, stock rotation, and price protection
rights;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">adverse litigation judgments, settlements, or other litigation-related
costs;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes in the legislative or regulatory environment, such
as with respect to privacy, information security, consumer product safety, and advertising;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">product recalls, regulatory proceedings, or other adverse
publicity about our products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">fluctuations in foreign exchange rates;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">costs related to the acquisition of businesses, talent, technologies,
or intellectual property, including potentially significant amortization costs and possible write-downs;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the overall global political and economic environment in the
countries in which we operate including those related to recent unrest and actual or potential armed conflict in Israel and other parts
of the Middle East, such as the recent multi-front war that Israel is facing; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">general economic conditions in either domestic or international
markets.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Any
one of the factors above or the cumulative effect of some of the factors above may result in significant fluctuations in our operating
results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
variability and unpredictability of our operating results or other operating metrics could result in our failure to meet our expectations
or those of any analysts that cover us or investors with respect to revenue or other operating results for a particular period. If we
fail to meet or exceed such expectations for these or any other reasons, the market price of our securities could fall substantially,
and we could face costly lawsuits, including securities class action suits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
operating results could be materially harmed if we are unable to accurately forecast consumer demand for our products and services and
adequately manage our inventory.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">To
ensure adequate inventory supply, we must forecast inventory needs and expenses and place orders with our suppliers and contract manufacturers
sufficiently in advance based on our estimates of future demand for our products. Our ability to accurately forecast demand for our products
could be affected by many factors, including an increase or decrease in customer demand for our products and services or for products
and services of our competitors, product and service introductions by competitors, unanticipated changes in general market conditions,
and the weakening of economic conditions or consumer confidence in future economic conditions. We may face challenges acquiring adequate
and timely supplies of our products to satisfy the levels of demand, which we believe negatively affects our revenue. This risk may be
exacerbated by the fact that we may not carry a significant amount of inventory, either directly or with our contract manufacturers or
logistics providers, to satisfy short-term demand increases. If we fail to accurately forecast customer demand, we may experience excess
inventory levels or a shortage of products available for sale.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Inventory
levels in excess of customer demand may result in inventory write-downs or write-offs and the sale of excess inventory at discounted prices,
which would cause our gross margin to suffer and could impair the strength of our brand. Conversely, if we underestimate customer demand
for our products and services, our contract manufacturers may not be able to deliver products to meet our requirements, and this could
result in damage to our brand and customer relationships and adversely affect our revenue and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
financial performance is subject to risks associated with changes in the value of the U.S. dollar, Israeli shekel, versus local currencies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
primary exposure to movements in foreign currency exchange rates relates to non-U.S. dollar denominated sales and operating expenses worldwide.
Weakening of foreign currencies relative to the U.S. dollar adversely affects the U.S. dollar value of our foreign currency-denominated
sales and earnings, and generally leads us to raise international pricing, potentially reducing demand for our products. In some circumstances,
for competitive or other reasons, we may decide not to raise local prices to fully offset the dollar&#8217;s strengthening, or at all,
which would adversely affect the U.S. dollar value of our foreign currency denominated sales and earnings. Conversely, a strengthening
of the Israeli shekel or foreign currencies relative to the U.S. dollar will increase our Israeli operations costs and could cause us
to increase our international pricing and become less competitive.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may not be able to sustain our revenue growth rate or profitability in the future.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
recent revenue growth should not be considered indicative of our future performance. As we grow our business, we expect our revenue growth
rates to slow in future periods due to a number of reasons, which may include increasing competition, slowing demand for our products
and services, a decrease in the growth of our overall market, our failure, for any reason, to continue to capitalize on growth opportunities,
or the maturation of our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
have not achieved profitability on a quarterly or annual basis. We expect our expenses to increase substantially in the near term, particularly
as we make significant investments in our research and development and sales and marketing organizations, expand our operations and infrastructure
internationally, develop new products and services, and enhance our existing products and services. In addition, in connection with operating
as a public company, we will incur additional significant legal, accounting, and other expenses that we did not incur as a private company.
If our revenue does not increase to offset these increases in our operating expenses, we may not be profitable in future periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>Risks Related to the
Ownership of the Ordinary Shares and Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
current officers and directors and holders of more than 5% of our Ordinary Shares currently beneficially own an aggregate of approximately
18.7% of our Ordinary Shares and they will be able to exert significant control over matters submitted to our shareholders for approval.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">As
of March 19, 2025, our current officers and directors and holders of more than 5% of our Ordinary Shares beneficially own an aggregate
of approximately 18.7% of our Ordinary Shares. Consequently, they are able to exert significant control over matters submitted to our
shareholders for approval. This significant concentration of share ownership may adversely affect the trading price for our Ordinary Shares
because investors often perceive disadvantages in owning shares in companies with controlling shareholders. As a result, these shareholders,
if they acted together, could significantly influence or even unilaterally approve matters requiring approval by our shareholders, including
the election of directors and the approval of mergers or other business combination transactions. The interests of these shareholders
may not always coincide with our interests or the interests of other shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
do not know whether a market for the Ordinary Shares or Warrants will be sustained or what the trading price of the Ordinary Shares or
Warrants will be and as a result it may be difficult for you to sell your securities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Although
our Ordinary Shares and Warrants are listed on Nasdaq, an active trading market for the Ordinary Shares or Warrants may not be sustained.
It may be difficult for you to sell your Ordinary Shares or Warrants without depressing the market price for the Ordinary Shares or Warrants
at all. As a result of these and other factors, you may not be able to sell your securities at or above the offering price or at all.
Further, an inactive market may also impair our ability to raise capital through the sale of additional equity securities and may impair
our ability to enter into strategic partnerships or acquire companies, products, or services by using our equity securities as consideration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
have never paid cash dividends on our share capital, and we do not anticipate paying any cash dividends in the foreseeable future.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared or
paid cash dividends, and we do not anticipate paying cash dividends in the foreseeable future. Therefore, you should not rely on an investment
in Ordinary Shares as a source for any future dividend income. Our board of directors has complete discretion as to whether to distribute
dividends. Even if our board of directors decides to declare and pay dividends, the timing, amount and form of future dividends, if any,
will depend on our future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any,
received by us from our subsidiaries, our financial condition, contractual restrictions and other factors deemed relevant by our board
of directors. For more information, see &#8220;Item 8.A. - Consolidated Statements and Other Financial Information - Dividends.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Management
will have broad discretion as to the use of the proceeds from the potential exercise of the Warrants and from our recently completed public
offering.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
management will have broad discretion in the allocation of the net proceeds, if any, from the exercise of the Warrants and from our recently
completed public offering, which closed on January 30, 2025. Our shareholders may not agree with the manner in which our management chooses
to allocate and spend the net proceeds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>The
Warrants are listed on Nasdaq separately from our Ordinary Shares and this may provide investors with an arbitrage opportunity that could
adversely affect the trading price of our Ordinary Shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Because
the Warrants are traded on Nasdaq, investors may be provided with an arbitrage opportunity that could depress the price of our Ordinary
Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We have been notified
by The Nasdaq Stock Market LLC of our failure to comply with certain continued listing requirements and, if we are unable to regain compliance
with all applicable continued listing requirements and standards of Nasdaq, our Ordinary Shares could be delisted from Nasdaq.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 24, 2023, we received
a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC notifying us that we were not in compliance
with the Minimum Bid Price Requirement because the closing bid price of our Ordinary Shares was below $1.00 per Ordinary Share for the
previous 30 consecutive business days. We were granted 180 calendar days, or until April 22, 2024, to regain compliance with the Minimum
Bid Price Requirement. In the event we do not regain compliance with the Minimum Bid Price Requirement by April 22, 2024, we may be eligible
for an additional 180-calendar day grace period. On April 24, 2024, we announced that we received a letter from the Nasdaq Stock Market
LLC pursuant to which Nasdaq granted us an extension until October 21, 2024, to regain compliance with the minimum bid price requirement.
On October 7, 2024, we effectuated a 1-for-20 reverse share split in order to regain compliance with Nasdaq Listing Rule 5550(a)(2). As
a result, we were informed by Nasdaq on October 28, 2024 that we had regained compliance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 16, 2025, we received
a written notification from Nasdaq, which stated that we were no longer in compliance with the minimum stockholders&#8217; equity requirement
for continued listing on Nasdaq, listing Nasdaq Rule 5550(b)(1), due to our failure to maintain a minimum of $2,500,000 in stockholders&#8217;
equity. In our Report of Foreign Private Issuer on Form 6-K, dated September 23, 2024, we reported stockholders&#8217; equity of approximately
$1,695,000 as of June 30, 2024. In accordance with Nasdaq rules, we submitted a plan to regain compliance. If the plan is accepted, Nasdaq
can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance. The notification letter has no immediate
effect on our listing on Nasdaq, and during the grace period, as may be extended, our ordinary shares and warrants will continue to trade
on Nasdaq under the symbol &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221; respectively. Although we believe that our stockholders&#8217;
equity exceeds $2,500,000, there is no guarantee that we will regain compliance with Nasdaq rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A future decline in the closing
price of our Ordinary Shares on Nasdaq or other factors that cause us not to meet any Nasdaq continued listing requirements could result
in suspension or delisting procedures in respect of our Ordinary Shares. The commencement of suspension or delisting procedures by an
exchange remains, at all times, at the discretion of such exchange and would be publicly announced by the exchange. If a suspension or
delisting were to occur, there would be significantly less liquidity in the suspended or delisted securities. In addition, our ability
to raise additional necessary capital through equity or debt financing would be greatly impaired. Furthermore, with respect to any suspended
or delisted Ordinary Shares, we would expect decreases in institutional and other investor demand, analyst coverage, market making activity
and information available concerning trading prices and volume, and fewer broker-dealers would be willing to execute trades with respect
to such Ordinary Shares. A suspension or delisting would likely decrease the attractiveness of our Ordinary Shares to investors and cause
the trading volume of our Ordinary Shares to decline, which could result in a further decline in the market price of our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>The
Warrants are speculative in nature.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Except
as otherwise set forth therein, our Warrants do not confer any rights of Ordinary Share ownership on their holders, such as voting rights,
but rather merely represent the right to acquire Ordinary Shares at a fixed price for a limited period of time. Specifically, holders
of the Warrants may exercise their right to acquire Ordinary Shares and pay an exercise price of $160.00 per Ordinary Share, prior to
five years from the date of issuance, after which date any unexercised Warrants will expire and have no further value. There can be no
assurance that the market price of our Ordinary Shares will ever equal or exceed the exercise price of the Warrants. In the event that
our Ordinary Shares price does not exceed the exercise price of such Warrants during the period when such Warrants are exercisable, the
Warrants may not have any value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>The
JOBS Act will allow us to postpone the date by which we must comply with some of the laws and regulations intended to protect investors
and to reduce the amount of information we provide in our reports filed with the SEC, which could undermine investor confidence in our
company and adversely affect the market price of our securities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">For
so long as we remain an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS
Act, we intend to take advantage of certain exemptions from various requirements that are applicable to public companies that are not
&#8220;emerging growth companies&#8221; including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">the provisions of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, requiring that our independent
registered public accounting firm provide an attestation report on the effectiveness of our internal control over financial reporting</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Section 107 of the JOBS Act, which provides that an &#8220;emerging growth company&#8221; can take advantage
of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards.
This means that an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards until those standards
would otherwise apply to private companies. However, we are electing not to delay such adoption of new or revised accounting standards.
Our election not to use this extended transition period for complying with new or revised accounting standards is irrevocable;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">exemption from compliance with any requirement that may be adopted by the Public Company Accounting Oversight
Board with respect to mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about
the audit and the financial statements (i.e., critical audit matters); and</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">our ability to present only two years of audited financial statements and only two years of related disclosure
in certain SEC filings.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
intend to take advantage of some of these exemptions until we are no longer an &#8220;emerging growth company.&#8221; We will remain an
emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the date of our
first sale of ordinary equity securities pursuant to an effective registration statement under the Securities Act, (b) in which we have
total annual gross revenue of at least $1.235 billion), or (c) in which we are deemed to be a large accelerated filer, which means the
market value of our Ordinary Shares that is held by non-affiliates exceeds $700 million as of the prior June 30, and (2) the date on which
we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
cannot predict if investors will find our securities less attractive because we may rely on these exemptions. If some investors find our
securities less attractive as a result, there may be a less active trading market for our securities, and our market prices may be more
volatile and may decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>As
a &#8220;foreign private issuer&#8221; we are subject to less stringent disclosure requirements than domestic registrants and are permitted,
and may in the future elect to follow certain home country corporate governance practices instead of otherwise applicable SEC and Nasdaq
requirements, which may result in less protection than is accorded to investors under rules applicable to domestic U.S. registrants.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">As
a foreign private issuer and emerging growth company, we may be subject to different disclosure and other requirements than domestic U.S.
registrants and non-emerging growth companies. For example, as a foreign private issuer, in the United States, we are not subject to the
same disclosure requirements as a domestic U.S. registrant under the Exchange Act, including the requirements to prepare and issue quarterly
reports on Form 10-Q or to file current reports on Form 8-K upon the occurrence of specified significant events, the proxy rules applicable
to domestic U.S. registrants under Section 14 of the Exchange Act or the insider reporting and short-swing profit rules applicable to
domestic U.S. registrants under Section 16 of the Exchange Act. In addition, we intend to rely on exemptions from certain U.S. rules which
will permit us to follow Israeli legal requirements rather than certain of the requirements that are applicable to U.S. domestic registrants.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
will follow Israeli laws and regulations that are applicable to Israeli companies. However, Israeli laws and regulations applicable to
Israeli companies do not contain any provisions comparable to the U.S. proxy rules, the U.S. rules relating to the filing of reports on
Form 10-Q or Form 8-K or the U.S. rules relating to liability for insiders who profit from trades made in a short period of time, as referred
to above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Furthermore,
foreign private issuers are required to file their annual report on Form 20-F within 120 days after the end of each fiscal year, while
U.S. domestic registrants that are non-accelerated filers are required to file their annual report on Form 10-K within 90 days after the
end of each fiscal year. Foreign private issuers are also exempt from Regulation Fair Disclosure, aimed at preventing issuers from making
selective disclosures of material information, although we will be subject to Israeli laws and regulations having substantially the same
effect as Regulation Fair Disclosure. As a result of the above, even though we are required to file reports on Form 6-K disclosing the
limited information which we have made or are required to make public pursuant to Israeli law, or are required to distribute to shareholders
generally, and that is material to us, you may not receive information of the same type or amount that is required to be disclosed to
shareholders of a U.S. registrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">These
exemptions and leniencies will reduce the frequency and scope of information and protections to which you are entitled as an investor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
determination of foreign private issuer status is made annually on the last business day of an issuer&#8217;s most recently completed
second fiscal quarter and, accordingly, the next determination will be made with respect to us on June 30, 2025. In the future, we would
lose our foreign private issuer status if a majority of our shareholders, directors or management are U.S. citizens or residents and we
fail to meet additional requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance costs to
us under U.S. securities laws as a U.S. domestic registrant may be significantly higher.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may be a &#8220;passive foreign investment company,&#8221; or PFIC, for U.S. federal income tax purposes in the current taxable year or
may become one in any subsequent taxable year. There generally would be negative tax consequences for U.S. taxpayers that are holders
of the Ordinary Shares if we are or were to become a PFIC.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
may be considered a PFIC or become a PFIC in the future. The determination of whether we are a PFIC is made on an annual basis and will
depend on the composition of our income and assets from time to time. We will be treated as a PFIC for U.S. federal income tax purposes
in any taxable year in which either (1) at least 75% of our gross income is &#8220;passive income&#8221; or (2) on average at least 50%
of our assets by value produce passive income or are held for the production of passive income. Passive income for this purpose generally
includes, among other things, certain dividends, interest, royalties, rents and gains from commodities and securities transactions and
from the sale or exchange of property that gives rise to passive income. Passive income also includes amounts derived by reason of the
temporary investment of funds, including those raised in a public offering. In determining whether a non-U.S. corporation is a PFIC, a
proportionate share of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by
value) is taken into account. The tests for determining PFIC status are applied annually, and it is difficult to make accurate projections
of future income and assets which are relevant to this determination. In addition, our PFIC status may depend in part on the market value
of the Ordinary Shares. Accordingly, there can be no assurance that we currently are not or will not become a PFIC in the future. If we
are a PFIC in any taxable year during which a U.S. taxpayer holds the Ordinary Shares, such U.S. taxpayer would be subject to certain
adverse U.S. federal income tax rules. A U.S. taxpayer that holds our warrants is taxed in a manner similar to a U.S. taxpayer owning
Ordinary Shares if such taxpayer realizes gain on the sale of the warrants. If the U.S. taxpayer holding the warrants exercises the warrants
to purchase common shares, the holding period over which any income realized is allocated includes the holding period of the warrants.
The U.S. warrant holder is treated as a holder of PFIC stock taxable under the ordinary income allocation and interest charge regime described
above. If the U.S. taxpayer did not make an election to treat us as a &#8220;qualified electing fund&#8221;, or QEF, or make a &#8220;mark-to-market&#8221;
election, then &#8220;excess distributions&#8221; to the U.S. taxpayer, and any gain realized on the sale or other disposition of the
Ordinary Shares and Warrants by the U.S. taxpayer: (1) would be allocated ratably over the U.S. taxpayer&#8217;s holding period for the
Ordinary Shares and Warrants; (2) the amount allocated to the current taxable year and any period prior to the first day of the first
taxable year in which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years
would be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge
for the deemed deferral benefit would be imposed with respect to the resulting tax attributable to each such other taxable year. In addition,
if the U.S. Internal Revenue Service, or the IRS, determines that we are a PFIC for a year with respect to which we have determined that
we were not a PFIC, it may be too late for a U.S. taxpayer to make a timely QEF or mark-to-market election. U.S. taxpayers that have held
the Ordinary Shares and Warrants during a period when we were a PFIC will be subject to the foregoing rules, even if we cease to be a
PFIC in subsequent years, subject to exceptions for U.S. taxpayer who made a timely QEF or mark-to-market election. A U.S. taxpayer can
make a QEF election by completing the relevant portions of and filing IRS Form 8621 in accordance with the instructions thereto. We do
not intend to notify U.S. taxpayers that hold the Ordinary Shares and Warrants if we believe we will be treated as a PFIC for any taxable
year in order to enable U.S. taxpayers to consider whether to make a QEF election. In addition, we do not intend to furnish such U.S.
taxpayers annually with information needed in order to complete IRS Form 8621 and to make and maintain a valid QEF election for any year
in which we or any of our subsidiaries are a PFIC. U.S. taxpayers that hold the Ordinary Shares and Warrants are strongly urged to consult
their tax advisors about the PFIC rules, including tax return filing requirements and the eligibility, manner, and consequences to them
of making a QEF or mark-to-market election with respect to the Ordinary Shares and Warrants in the event that we are a PFIC. See &#8220;Item
10.E. Taxation - U.S. Federal Income Tax Considerations - Passive Foreign Investment Companies&#8221; for additional information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>Risks Related to Our
Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may not be able to adequately protect or enforce our intellectual property rights throughout the world, and our efforts to do so may be
costly.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">If
we are not able to adequately protect or enforce the proprietary aspects of our technology, competitors may be able to access our proprietary
technology and our business, results of operations and financial condition could be adversely affected. We currently attempt to protect
our technology through a combination of patent, copyright, trademark and trade secret laws, unfair competition laws, employee and third
party nondisclosure agreements and similar means. Despite our efforts, other parties may attempt to disclose, obtain or use our technologies
or systems. Our competitors may also be able to independently develop similar products or design around our patents. In addition, the
laws of some countries do not protect our proprietary rights as fully as do the laws of other countries. As a result, we may not be able
to protect our proprietary rights adequately in the United States, China or abroad.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Filing,
prosecuting, and defending patents on products and services, as well as monitoring their infringement in all countries throughout the
world would be prohibitively expensive, and our intellectual property rights in some countries can be less extensive than those according
to federal and state laws in the United States or laws in China. Competitors may use our technologies to develop their own products or
services in jurisdictions where we have not obtained patent protection and may export infringing products or services to territories where
we have patent protection, but where patents are not enforced as strictly as they are in the United States. These products or services
may compete with our products or services. Future patents or other intellectual property rights may not be effective or sufficient to
prevent them from competing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Many
companies have encountered significant problems in protecting and defending intellectual property rights in some jurisdictions. The legal
systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other
intellectual property protection, which could make it difficult for us to stop the marketing of competing products or services in violation
of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions, whether or not successful, could
result in substantial costs and divert our efforts and attention from other aspects of our business, could put our future patents at risk
of being invalidated or interpreted narrowly, put the issuance of our patent applications at risk, and could provoke third parties to
assert claims against us. We may not prevail in any lawsuits that we initiate, and any damages or other remedies that we may be awarded,
may not be commercially meaningful. Accordingly, our efforts to monitor and enforce our intellectual property rights around the world
may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
addition, any litigation initiated by us concerning the violation by third parties of our intellectual property rights is likely to be
expensive and time-consuming and could lead to the invalidation of, or render unenforceable, our intellectual property, or could otherwise
have negative consequences for us. In the future, we may be a party to claims and litigation as a result of alleged infringement by third
parties of our intellectual property. Even when we sue other parties for such infringement, that suit may have adverse consequences for
our business. Any such suit may be time-consuming and expensive to resolve and may divert our management&#8217;s time and attention from
our business. Furthermore, such a lawsuit could result in a court or governmental agency invalidating or rendering unenforceable our patents
or other intellectual property rights upon which the suit is based, which would seriously harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>If
we are unable to protect our domain names, our brand, business, and operating results could be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
have registered domain names for websites, or URLs, that we use in our business, such as wearabledevices.co.il and mudra-band.com. We
have registered digital names for social media handlers, that we use in our business, such as Facebook and LinkedIn. If we are unable
to maintain our rights in these domain and digital names, our competitors or other third parties could capitalize on our brand recognition
by using these domain names for their own benefit. In addition, we might not be able to, or may choose not to, acquire or maintain other
country-specific versions of the &#8220;Wearable Devices&#8221; or &#8220;Mudra&#8221; domain and digital names or other potentially similar
URLs. The regulation of domain and digital names in the United States and elsewhere is generally conducted by Internet regulatory bodies
and is subject to change. If we lose the ability to use a domain or digital name in a particular country, we may be forced to either incur
significant additional expenses to market our solutions within that country, including the development of a new brand and the creation
of new promotional materials, or elect not to sell our solutions in that country. Either result could substantially harm our business
and operating results. Regulatory bodies could establish additional top-level domains, appoint additional domain or digital name registrars,
or modify the requirements for holding domain or digital names. As a result, we may not be able to acquire or maintain the domain or digital
names that utilize the name &#8220;Wearable Devices&#8221; or &#8220;Mudra&#8221; in all of the countries in which we currently conduct
or intend to conduct business. Further, the relationship between regulations governing domain and digital names and laws protecting trademarks
and similar proprietary rights varies among jurisdictions and is unclear in some jurisdictions. Domain and digital names similar to ours
have already been registered in the United States and elsewhere, and we may be unable to prevent third parties from acquiring and using
domain or digital names that infringe, are similar to, or otherwise decrease the value of, our brand or our trademarks. Protecting and
enforcing our rights in our domain and digital names and determining the rights of others may require litigation, which could result in
substantial costs, divert management attention, and not be decided favorably to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may become subject to litigation brought by third parties claiming infringement by us of their intellectual property rights.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
industry in which our business operates is characterized by a large number of patents, some of which may be of questionable scope, validity
or enforceability, and some of which may appear to overlap with other issued patents. As a result, there is a significant amount of uncertainty
in the industry regarding patent protection, enforcement and infringement. In recent years, there has been significant litigation globally
involving patents and other intellectual property rights. We could become subject to claims and litigation alleging infringement by us
of third-party patents and other intellectual property generally. These claims and any resulting lawsuits, if resolved adversely to us,
could subject us to significant liability for damages, impose temporary or permanent injunctions against our products or business operations,
or invalidate or render unenforceable our intellectual property. In addition, because patent applications can take many years until the
patents are issued, there currently may be pending applications of which we are unaware, which may later result in issued patents that
our products may infringe. If any of our products infringes a valid and enforceable patent, or if we wish to avoid potential intellectual
property litigation on any alleged infringement of such products, we may be prevented from selling, or elect not to sell, such products
unless we obtain a license, which may be unavailable. Alternatively, we may be forced to pay substantial royalties or to redesign one
or more of our products to avoid any infringement or allegations thereof. Additionally, we may face liability to our customers, business
partners or third parties for indemnification or other remedies in the event that they are sued for infringement in connection with their
use of our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
also may not be successful in any attempt to redesign our products to avoid any alleged infringement. A successful claim of infringement
against us, or our failure or inability to develop and implement non-infringing technology, or license the infringed technology, on acceptable
terms and on a timely basis, could materially adversely affect our business and results of operations. Furthermore, such lawsuits, regardless
of their success, would likely be time-consuming and expensive to resolve and would divert management&#8217;s time and attention from
our business, which could seriously harm our business. Also, such lawsuits, regardless of their success, could seriously harm our reputation
with our consumer electronics customers and in the industry at large.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
use of &#8220;open source&#8221; software could negatively affect our ability to sell our products and subject us to possible litigation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">A
portion of the technologies we use incorporates &#8220;open source&#8221; software, and we may incorporate open source software in the
future. Such open source software is generally licensed by its authors or other third parties under open source licenses. These licenses
may subject us to certain unfavorable conditions, including requirements that we offer our products and services that incorporate the
open source software for no cost, that we make publicly available source code for modifications or derivative works we create based upon,
incorporating, or using the open source software, or that we license such modifications or derivative works under the terms of the particular
open source license, or limitations on intellectual property protection and enforcement. Additionally, if a third-party software provider
has incorporated open source software into software that we license from such provider, we could be required to disclose or provide at
no cost any of our source code that incorporates or is a modification of such licensed software. If an author or other third party that
distributes open source software that we use or license were to allege that we had not complied with the conditions of the applicable
license, we could be required to incur significant legal expenses defending against such allegations and could be subject to significant
damages and enjoined from the sale of our products and services that contained the open source software. Any of the foregoing could disrupt
the distribution and sale of our products and services and harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Patent
policy and rule changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement
or defense of any issued patents.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Changes
in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of any
patents that may issue from our patent applications or narrow the scope of our patent protection. The laws of foreign countries may not
protect our rights to the same extent as the laws of the United States. Publications of discoveries in the scientific literature often
lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until
18 months after filing, or in some cases not at all. We therefore cannot be certain that we were the first to file the invention claimed
in our owned and licensed patent or pending applications, or that we or our licensor were the first to file for patent protection of such
inventions. Assuming all other requirements for patentability are met, in the United States prior to March 15, 2013, the first to make
the claimed invention without undue delay in filing, is entitled to the patent, while generally outside the United States, the first to
file a patent application is entitled to the patent. After March 15, 2013, under the Leahy-Smith America Invents Act, or the Leahy-Smith
Act, enacted on September 16, 2011, the United States has moved to a first to file system. The Leahy-Smith Act also includes a number
of significant changes that affect the way patent applications will be prosecuted and may also affect patent litigation. In general, the
Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications
and the enforcement or defense of any issued patents, all of which could have a material adverse effect on our business and financial
condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may be subject to claims challenging the inventorship of our intellectual property.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
may be subject to claims that former employees, collaborators or other third parties have an interest in, or right to compensation, with
respect to our current patent and patent applications, future patents or other intellectual property as an inventor or co-inventor. For
example, we may have inventorship disputes arise from conflicting obligations of consultants or others who are involved in developing
our products or services. Litigation may be necessary to defend against these and other claims challenging inventorship or claiming the
right to compensation. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual
property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material
adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs
and be a distraction to management and other employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to Operations in Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span><b><i>We
conduct our operations in Israel.</i></b></span><b><i> Conditions in Israel, including conditions affected by the recent attack by Hamas
and other terrorist organizations and Israel&#8217;s war against them, may affect our operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our offices are located in
Yokne&#8217;am Illit, Israel, thus, political, economic, and military conditions in Israel may directly affect our business. On October
7, 2023, Hamas terrorists infiltrated Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian
and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel&#8217;s
border with the Gaza Strip and in other areas within the State of Israel. Following the attack, Israel&#8217;s security cabinet declared
war against Hamas and the Israeli military began to call-up reservists for active duty. As of March 18, 2025, the ceasefire that had been
in place since January 2025 has ended, and hostilities have resumed. The continuation of the conflict has led to heightened security concerns,
potential disruptions to business operations, and economic instability. There remains significant uncertainty regarding the duration and
escalation of the conflict, and further military actions, restrictions, or government-imposed measures could adversely affect our operations,
supply chains, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the attack by Hamas
on Israel&#8217;s southern border, Hezbollah, a terrorist organization in Lebanon, has also launched missile, rocket, and shooting attacks
against Israeli military sites, troops, and Israeli towns in northern Israel. In response to these attacks, the Israeli army has carried
out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon, and in October 2024, the Israeli military initiated
a ground operation in Lebanon, primarily near the Israel-Lebanon border. As of the end of November 2024, Israel entered into a ceasefire
agreement with Hezbollah, but there are no guarantees as to whether the agreement will hold or whether further hostilities will resume.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April and October 2024,
Iran launched missile and unmanned aerial vehicle, or UAV, attacks on Israel. Most of the missiles and UAVs were intercepted by Israel&#8217;s
defense systems, with support from the United States and other countries, including regional allies, preventing significant damage and
resulting in no casualties. Despite the successful interceptions, the attacks posed an elevated threat to Israel&#8217;s security. In
response to the Iranian attack in April 2024, Israel conducted targeted military strikes against Iranian military assets in Syria, aiming
to degrade Iran&#8217;s operational capabilities in the region and deliver a strong deterrent message. On April 19, 2024, the air force
base in Esfahan, Iran, and the A-T&#8217;ala airport in the A-Sweida area of southern Syria were attacked, with these strikes attributed to
Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2024, Ba&#8217;athist
Syria, led by President Bashar al-Assad, collapsed during a major offensive by opposition forces made up of several competing rebel groups.
In response, the Israeli Defense Forces took control over a United Nations-designated buffer zone over Mount Hermon that separated Israel
and Syria. Simultaneously, Israel conducted targeted military strikes against military assets in Syria, aiming to eliminate any chemical
weapons storage sites that could be used by rebel groups and further weaken Iran&#8217;s operational capabilities in the region. While
the transitional government of Syria has indicated that it is interested in reconstruction and stability rather than a continuation of
conflicts with Israel, there are no guarantees that there is no future escalation of hostilities or that Syria will permit other neighboring
countries to launch attacks at Israel from its territory.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is possible that other
terrorist organizations, including Palestinian military organizations in the West Bank, as well as other hostile countries, will join
the hostilities. Additionally, Iran may continue its direct aggression against Israel. Such hostilities may include terror and missile
attacks. Any hostilities involving Israel, or the interruption or curtailment of trade between Israel and its trading partners could adversely
affect our operations and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of today, these events
have had no material impact on the Company&#8217;s operations. According to the recent guidelines of the Israeli government, the Company&#8217;s
offices are open and functioning as usual. However, if the war escalates and expands to the Northern border with Lebanon, the Israeli
government potentially will impose additional restrictions on movement and travel, and our management and employees&#8217; ability to
effectively perform their daily tasks might be temporarily disrupted, which may result in delays in some of our projects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company currently has
the supply of materials needed for its regular operations. While there may be some possible delays in supply, those are currently not
anticipated to be material to the Company&#8217;s operations. However, if the war continues for a significant amount of time, this situation
may change.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any hostilities involving
Israel, terrorist activities, political instability or violence in the region, or the interruption or curtailment of trade or transport
among Israel and its trading partners could make it more difficult for us to raise capital, if needed in the future, and adversely affect
our operations and results of operations and the market price of our Ordinary Shares. Moreover, we cannot predict how this war will ultimately
affect Israel&#8217;s economy in general, which may involve a downgrade in Israel&#8217;s credit rating by rating agencies (such as the
second downgrade by Moody&#8217;s of its credit rating of Israel from A2 to Baa1 in September 2024).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our commercial insurance does
not cover losses that may occur as a result of an event associated with the security situation in the Middle East. Although the Israeli
government is currently committed to covering the reinstatement value of direct damages that are caused by terrorist attacks or acts of
war, we cannot assure you that this government coverage will be maintained or, if maintained, will be sufficient to compensate us fully
for damages incurred. Any losses or damages incurred by us could have a material adverse effect on our business, financial condition,
and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, many Israeli citizens
are obligated to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of
40 (or older for certain reservists) and, in the event of a military conflict, may be called to active duty. In response to the series
of attacks on civilian and military targets in October 2023, there have been significant call-ups of military reservists. Currently, none
of the Company&#8217;s employees are in military reserve service. However, if the number of reservists in our Company increases and becomes
significant, our operations could be disrupted by such call-ups.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any armed conflicts, terrorist
activities or political instability in the region could adversely affect business conditions, could harm our results of operations and
the market price of our Ordinary Shares, and could make it more difficult for us to raise capital. Parties with whom we do business may
sometimes decline to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when
necessary, in order to meet our business partners face to face.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The intensity and duration
of Israel&#8217;s current war against Hamas is difficult to predict at this stage, as are such war&#8217;s economic implications on the
Company&#8217;s business and operations and on Israel&#8217;s economy in general. However, if the war extends for a long period of time
or expands to other fronts, such as Lebanon, Syria and the West Bank, our operations may be harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is currently not possible
to predict the duration or severity of the ongoing conflict or its effects on our business, operations and financial condition. The ongoing
conflict is rapidly evolving and developing, and could disrupt our business and operations, and adversely affect our ability to raise
additional funds or sell our securities, among other impacts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may be required to pay monetary remuneration to our Israeli employees for their inventions, even if the rights to such inventions have
been duly assigned to us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
enter into agreements with our Israeli employees pursuant to which such individuals agree that any inventions created in the scope of
their employment are either owned exclusively by us or are assigned to us, depending on the jurisdiction, without the employee retaining
any rights. A portion of our intellectual property has been developed by our Israeli employees during their employment for us. Under the
Israeli Patent Law, 5727-1967, or the Patent Law, inventions conceived by an employee during the course of his or her employment and within
the scope of said employment are considered &#8220;service inventions&#8221;. Service inventions belong to the employer by default, absent
a specific agreement between the employee and employer otherwise. The Patent Law also provides that if there is no agreement regarding
the remuneration for the service inventions, even if the ownership rights were assigned to the employer, the Israeli Compensation and
Royalties Committee, or the Committee, a body constituted under the Patent Law, shall determine whether the employee is entitled to remuneration
for these inventions. The Committee has not yet determined the method for calculating this Committee-enforced remuneration. While it has
previously been held that an employee may waive his or her rights to remuneration in writing, orally or by conduct, litigation is pending
in the Israeli labor court is questioning whether such waiver under an employment agreement is enforceable. Although our Israeli employees
have agreed that we exclusively own any rights related to their inventions, we may face claims demanding remuneration in consideration
for employees&#8217; service inventions. As a result, we could be required to pay additional remuneration or royalties to our current
and/or former employees, or be forced to litigate such claims, which could negatively affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
received Israeli government grants for certain of our research and development activities, the terms of which may require us to pay royalties
and to satisfy specified conditions in order to manufacture products and transfer technologies outside of Israel. If we fail to satisfy
these conditions, we may be required to pay penalties and refund grants previously received.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our research and development
efforts have been financed in part through royalty-bearing and non-royalty-bearing grants in an aggregate principal amount of approximately
$2.4 million that we accrued or received from the Israeli Innovation Authority, or the IIA as of December 31, 2024. With respect to the
royalty-bearing grants we are committed to pay royalties at a rate of 3.0%-3.5% on sales proceeds from our products that were developed
under IIA programs up to the total amount of grants received, linked to the U.S. dollar and bearing interest at an annual rate of SOFR
applicable to U.S. dollar deposits. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable to
US Dollar deposits. However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration
of the LIBOR. Under such directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter,
as of January 1, 2024 the annual interest is calculated at a rate based on 12-month Secured Overnight Financing Rate, or SOFR, or at an
alternative rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest
shall be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%. As of December 31, 2024,
our contingent liabilities regarding IIA grants accrued or received by us were in an aggregate principal amount of approximately $2.4
million plus SOFR interest. The terms of the grants under the of the Israeli Encouragement of Industrial Research, Development and Technological
Innovation Law, 5744-1984, as amended, and related regulations, or the Research Law, and the related IIA rules and regulations, require
that the manufacturing of products resulting from IIA-funded programs be carried out in Israel, unless a prior written approval of the
IIA is obtained. In December 2022, we received an approval from the IIA to transfer some of our manufacturing activities abroad.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a condition for obtaining
approval to manufacture outside of Israel (or following a declaration that up to 10% of the production is transferred abroad), we would
be required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate 3%-3.5%, and also the total
amount of our liability to IIA may be increased to between 100% and 150% of the grants we received from IIA, depending on the manufacturing
volume that is performed outside of Israel (less royalties already paid to IIA).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
are further required to comply with the requirements of the Research Law with respect to those past grants. When a company develops know-how,
technology or products using IIA grants, the terms of these grants and the Research Law restrict the transfer or license of such know-how,
and the transfer of manufacturing or manufacturing rights of such products, technologies or know-how outside of Israel, without the prior
approval of the IIA. Our obligations in regard to know-how, technology or products that may be subject to these restrictions are not to
transfer to anyone the information, rights thereon and production rights to be derived from the research and development, in whole or
part, of our Mudra Inspire product and our Mudra Band product, without the IIA Research Committee approval. Therefore, the discretionary
approval of an IIA committee would be required for any transfer or license to third parties inside or outside of Israel of know how or
for the transfer outside of Israel of manufacturing or manufacturing rights related to those aspects of such technologies. We may not
receive those approvals. Furthermore, the IIA may impose certain conditions on any arrangement under which it permits us to transfer technology
or development.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
transfer or license of IIA-supported technology or know-how outside of Israel and the transfer of manufacturing of IIA-supported products,
technology or know-how outside of Israel may involve the payment of significant amounts, depending upon the value of the transferred or
licensed technology or know-how, our research and development expenses, the amount of IIA support, the time of completion of the IIA-supported
research project and other factors. These restrictions and requirements for payment may impair our ability to sell, license or otherwise
transfer our technology assets outside of Israel or to outsource or transfer development or manufacturing activities with respect to any
product or technology outside of Israel. Furthermore, the consideration available to our shareholders in a transaction involving the transfer
outside of Israel of technology or know-how developed with IIA funding (such as a merger or similar transaction) may be reduced by any
amounts that we are required to pay to the IIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may not be able to enforce covenants not-to-compete under current Israeli law that might result in added competition for our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
have non-competition agreements with all of our employees, all of which are governed by Israeli law. These agreements prohibit our employees
from competing with or working for our competitors, generally during their employment and for up to 12 months after termination of their
employment. However, Israeli courts are reluctant to enforce non-compete undertakings of former employees and tend to enforce those provisions
for relatively brief periods of time in restricted geographical areas, if at all, and only when the employee has provided unique value
to the employer specific to that employer&#8217;s business and not just regarding the professional development of the employee. If we
are not able to enforce non-compete covenants, we may be faced with added competition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Provisions
of Israeli law may delay, prevent or otherwise impede a merger with, or an acquisition of, us, which could prevent a change of control,
even when the terms of such a transaction are favorable to us and our shareholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Israeli
corporate law regulates mergers, requires tender offers for acquisitions of shares above specified thresholds, requires special approvals
for transactions involving directors, officers or significant shareholders and regulates other matters that may be relevant to such types
of transactions. For example, a merger may not be consummated unless at least 50 days have passed from the date on which a merger proposal
is filed by each merging company with the Israel Registrar of Companies and at least 30 days have passed from the date on which the shareholders
of both merging companies have approved the merger. In addition, a majority of each class of securities of the target company must approve
a merger. Moreover, a tender offer for all of a company&#8217;s issued and outstanding shares can only be completed if the acquirer receives
positive responses from the holders of at least 95% of the issued share capital. Completion of the tender offer also requires approval
of a majority of the offerees that do not have a personal interest in the tender offer, unless, following consummation of the tender offer,
the acquirer would hold at least 98% of the Company&#8217;s outstanding shares. Furthermore, the shareholders, including those who indicated
their acceptance of the tender offer, may, at any time within six months following the completion of the tender offer, claim that the
consideration for the acquisition of the shares does not reflect their fair market value, and petition an Israeli court to alter the consideration
for the acquisition accordingly, unless the acquirer stipulated in its tender offer that a shareholder that accepts the offer may not
seek such appraisal rights, and the acquirer or the company published all required information with respect to the tender offer prior
to the tender offer&#8217;s response date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Furthermore,
Israeli tax considerations may make potential transactions unappealing to us or to our shareholders whose country of residence does not
have a tax treaty with Israel exempting such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free share
exchanges to the same extent as U.S. tax law. With respect to mergers, Israeli tax law allows for tax deferral in certain circumstances
but makes the deferral contingent on the fulfillment of a number of conditions, including, in some cases, a holding period of two years
from the date of the transaction during which sales and dispositions of shares of the participating companies are subject to certain restrictions.
Moreover, with respect to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes
payable even if no disposition of the shares has occurred. These provisions could delay, prevent or impede an acquisition of us or our
merger with another company, even if such an acquisition or merger would be beneficial to us or to our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>It
may be difficult to enforce a judgment of a U.S. court against us and our executive officers and directors in Israel or the United States,
to assert U.S. securities laws claims in Israel or to serve process on our executive officers and directors and these experts.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
were incorporated in Israel. Most of our executive officers and directors reside outside of the United States, and all of our assets and
most of the assets of these persons are located outside of the United States. Therefore, a judgment obtained against us, or any of these
persons, including a judgment based on the civil liability provisions of the U.S. federal securities laws, may not be collectible in the
United States and may not be enforced by an Israeli court. It also may be difficult for you to effect service of process on these persons
in the United States or to assert U.S. securities law claims in original actions instituted in Israel. Additionally, it may be difficult
for an investor, or any other person or entity, to initiate an action with respect to U.S. securities laws in Israel. Israeli courts may
refuse to hear a claim based on an alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum in
which to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S.
law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proven as a fact by
expert witnesses, which can be a time consuming and costly process. Certain matters of procedure will also be governed by Israeli law.
There is little binding case law in Israel that addresses the matters described above. As a result of the difficulty associated with enforcing
a judgment against us in Israel, you may not be able to collect any damages awarded by either a U.S. or foreign court.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
amended and restated articles of association may be deemed to have an anti-takeover effect.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Certain
provisions of our amended and restated articles of association may make a change in control of us more difficult to effect. Our amended
and restated articles of association will provide for a staggered board of directors consisting of three classes of directors. Directors
of each class are chosen for three-year terms upon the expiration of their current terms and each year one class of our directors will
be elected by our shareholders. This classified board provision could have the effect of making the replacement of incumbent directors
more time consuming and difficult. At least two annual meetings of shareholders, instead of one, will generally be required to effect
a change in a majority of our board of directors. Thus, the classified board provision could increase the likelihood that incumbent directors
will retain their positions. The staggered terms of directors may delay, defer or prevent an attempt to change control of us, even though
a change in control might be considered by our shareholders to be in their best interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Your
rights and responsibilities as a shareholder will be governed in key respects by Israeli laws, which differs in some material respects
from the rights and responsibilities of shareholders of U.S. companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
rights and responsibilities of the holders of our Ordinary Shares are governed by our amended and restated articles of association and
by Israeli law. These rights and responsibilities differ in some material respects from the rights and responsibilities of shareholders
in U.S. companies. In particular, a shareholder of an Israeli company has a duty to act in good faith and in a customary manner in exercising
its rights and performing its obligations towards the company and other shareholders, and to refrain from abusing its power in such company,
including, among other things, in voting at a general meeting of shareholders on matters such as amendments to a company&#8217;s amended
and restated articles of association, increases in a company&#8217;s authorized share capital, mergers and acquisitions and related party
transactions requiring shareholder approval, as well as a general duty to refrain from discriminating against other shareholders. In addition,
a shareholder who is aware that it possesses the power to determine the outcome of a vote at a meeting of the shareholders or to appoint
or prevent the appointment of a director or executive officer in the company has a duty of fairness toward the company. However, Israeli
law does not define the substance of this duty of fairness. There is limited case law available to assist us in understanding the nature
of these duties or the implications of these provisions. These provisions may be interpreted to impose additional obligations and liabilities
on holders of our Ordinary Shares that are not typically imposed on shareholders of U.S. companies (see &#8220;Description of Share Capital
- Provisions Restricting Change in Control of Our Company&#8221; for additional information).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>General Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
incur significant costs as a result of our being a public company. Our management is required to devote substantial time to compliance
with ongoing SEC and Nasdaq requirements.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">As
a public company in the United States, we incur significant accounting, legal and other expenses. We also incur costs associated with
corporate governance requirements of the SEC, and incur costs in connection with the requirements under Section 404 and other provisions
of the Sarbanes-Oxley Act. These rules and regulations have increased our legal and financial compliance costs, introduce new costs such
as investor relations, stock exchange listing fees and shareholder reporting, and make some activities more time consuming and costly.
The maintenance and testing of such processes and systems may require us to hire outside consultants and incur other significant costs.
Any future changes in the laws and regulations affecting public companies in the United States, including Section 404 and other provisions
of the Sarbanes-Oxley Act, and the rules and regulations adopted by the SEC, for so long as they apply to us, will result in increased
costs to us as we respond to such changes. These laws, rules and regulations could make it more difficult or more costly for us to obtain
certain types of insurance, including director and officer liability insurance, and we may be forced to accept reduced policy limits and
coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these requirements could also make
it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees, or as executive
officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>If
we engage in future merger and acquisition activities or strategic partnerships, this could require significant management attention,
may increase our capital requirements, dilute our shareholders, cause us to incur debt or assume contingent liabilities, and subject us
to other risks.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">As
part of our business strategy, we may make investments in other companies, products, or technologies. We may not be able to find suitable
acquisition candidates and we may not be able to complete acquisitions on favorable terms, if at all. If we do complete acquisitions,
we may not ultimately strengthen our competitive position or achieve our goals, and any acquisitions we complete could be viewed negatively
by users or investors. In addition, if we fail to successfully integrate such acquisitions, or the technologies associated with such acquisitions,
into our company, the revenue and operating results of the combined company could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Additionally,
we may evaluate various strategic partnerships, including licensing or acquiring complementary products, intellectual property rights,
technologies or businesses. Any potential acquisition or strategic partnership may entail numerous risks, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">increased operating expenses and cash requirements;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">the assumption of additional indebtedness or contingent liabilities;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">the issuance of our equity securities;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">assimilation of operations, intellectual property and products of an acquired company, including difficulties
associated with integrating new personnel;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">the diversion of our management&#8217;s attention from our existing product programs and initiatives in
pursuing such a strategic merger or acquisition;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">retention of key employees, the loss of key personnel and uncertainties in our ability to maintain key
business relationships;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">risks and uncertainties associated with the other party to such a transaction, including the prospects
of that party and their existing products or product candidates and marketing approvals; and</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">our inability to generate revenue from acquired technology and/or products sufficient to meet our objectives
in undertaking the acquisition or even to offset the associated acquisition and maintenance costs.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
are subject to risks associated with doing business globally.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
operations are subject to risks inherent in conducting business globally and under the laws, regulations and customs of various jurisdictions
and geographies. In addition to risks related to currency exchange rates, these risks include changes in exchange controls, changes in
taxation, importation limitations, export control restrictions, changes in or violations of applicable laws, including the U.S. Foreign
Corrupt Practices Act and the U.K. Bribery Act of 2010, economic and political instability, disputes between countries, diminished or
insufficient protection of intellectual property, and disruption or destruction of operations in a significant geographic region regardless
of cause, including war, terrorism, riot, civil insurrection or social unrest. Failure to comply with, or material changes to, the laws
and regulations that affect our global operations could have an adverse effect on our business, results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
operating margins may decline as a result of increasing product costs.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
business is subject to significant pressure on pricing and costs caused by many factors, including intense competition, the cost of components
used in our products, labor costs, constrained sourcing capacity, inflationary pressure, pressure from users to reduce the prices we charge
for our products and services, and changes in consumer demand. Costs for the raw materials used in the manufacture of our products are
affected by, among other things, energy prices, consumer demand, fluctuations in commodity prices and currency, global pandemic slowing
down manufacturing capacity, and other factors that are generally unpredictable and beyond our control. Increases in the cost of raw materials
used to manufacture our products or in the cost of labor and other costs of doing business in the United States and internationally could
have an adverse effect on, among other things, the cost of our products, gross margins, operating results, financial condition, and cash
flows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Sales
of a significant number of shares of our Ordinary Shares in the public markets or significant short sales of our Ordinary Shares, or the
perception that such sales could occur, could depress the market price of our Ordinary Shares and impair our ability to raise capital.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Sales
of a substantial number of shares of our Ordinary Shares or other equity-related securities in the public markets, could depress the market
price of our Ordinary Shares. For example, in January 2025, we issued 345,000 Ordinary Shares in a public offering. If there are significant
short sales of our Ordinary Shares, the price decline that could result from this activity may cause the share price to decline more so,
which, in turn, may cause long holders of the Ordinary Shares to sell their shares, thereby contributing to sales of Ordinary Shares in
the market. Such sales also may impair our ability to raise capital through the sale of additional equity securities in the future at
a time and price that our management deems acceptable, if at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>The
market price of our Ordinary Shares and Warrants may be highly volatile, and you could lose all or part of your investment.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
market price of our Ordinary Shares and Warrants is likely to be volatile. This volatility may prevent you from being able to sell your
securities at or above the price you paid for your securities. The market price of our Ordinary Shares and Warrants may fluctuate significantly
in response to numerous factors, some of which are beyond our control, which include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">whether we achieve our anticipated corporate objectives;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">actual or anticipated fluctuations in our quarterly or annual operating results;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">changes in our financial or operational estimates or projections;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">our ability to implement our operational plans;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">termination of the lock-up agreement or other restrictions on the ability of our shareholders to sell
shares;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">changes in the economic performance or market valuations of companies similar to ours; and</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">general economic or political conditions in the United States or elsewhere, including those related to
the multi-front war in Israel and unrest in other parts of the Middle East.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
addition, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our securities,
regardless of our actual operating performance, and we have little or no control over these factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may be subject to securities litigation, which is expensive and could divert management attention.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation.
We may be the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion
of management&#8217;s attention and resources, which could seriously hurt our business. Any adverse determination in litigation could
also subject us to significant liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>If
securities or industry analysts do not publish or cease publishing research or reports about us, our business or our market, or if they
adversely change their recommendations or publish negative reports regarding our business or the Ordinary Shares, our share price and
trading volume could decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
trading market for the Ordinary Shares and/or Warrants will be influenced by the research and reports that industry or securities analysts
may publish about us, our business, our market or our competitors. We do not have any control over these analysts and we cannot provide
any assurance that analysts will cover us or provide favorable coverage. If any of the analysts who may cover us adversely change their
recommendation regarding the Ordinary Shares, or provide more favorable relative recommendations about our competitors, the price of our
Ordinary Shares and/or Warrants would likely decline. If any analyst who may cover us were to cease coverage of our company or fail to
regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause the price of our Ordinary
Shares or trading volume to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>Our
internal control over financial reporting currently meets all of the standards contemplated by Section 404 of the Sarbanes-Oxley Act,
but failure to maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could
have a material adverse effect on our business, our operating results, investor confidence in our reported financial information, and
the market price of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
have established formal policies, processes and practices related to our internal control over financial reporting and to identify key
financial reporting risks, including an assessment of the potential impact and linkage of those risks to specific areas and activities
within our organization, in order to satisfy the requirements of Section 404 (a) of the Sarbanes-Oxley Act, which requires an annual management
assessment of the effectiveness of our internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
are required to comply with the requirements of Sections 302 and 404 of the Sarbanes-Oxley Act, which require our management to certify
financial and other information in our annual reports and require that we provide an annual management report on the effectiveness of
control over financial reporting. Additionally, while we remain an emerging growth company, we will not be required to include an attestation
report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance
with Section 404 within the prescribed period, we engaged in a process to document and evaluate our internal control over financial reporting.
In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work
plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as
appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement
process for internal control over financial reporting. We believe we are in compliance with Section 404 of the Sarbanes-Oxley Act as of
the date of March 19, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are not able to continue
to implement and document the necessary policies, processes and controls to mitigate financial reporting risks, we may not be able to
comply with the requirements of Sections 404(a) in a timely manner or with adequate compliance. Matters impacting our internal controls
may cause us to be unable to report our financial information on a timely basis and thereby subject us to adverse regulatory consequences,
including sanctions by the SEC or violations of applicable stock exchange listing rules. There could also be a negative reaction in the
financial markets due to a loss of investor confidence in our company and the reliability of our financial statements. Confidence in the
reliability of our financial statements could also suffer if we were to report a material weakness in our internal control over financial
reporting. This could materially adversely affect us and lead to a decline in the price of our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
efforts to comply with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, governing internal control and procedures for
financial reporting have resulted in increased general and administrative expenses and a diversion of management time and attention, and
we expect these efforts to require the continued commitment of significant resources. We may identify material weaknesses or significant
deficiencies in our assessments of our internal control over financial reporting. Failure to maintain effective internal control over
financial reporting could result in investigations or sanctions by regulatory authorities, and could have a material adverse effect on
our operating results, investor confidence in our reported financial information, and the market price of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our amended and restated
articles of association provide that, unless we consent to an alternative forum, the federal district courts of the United States shall
be the exclusive forum for resolution of any complaint asserting a cause of action arising under the Securities Act, which could limit
our shareholders&#8217; ability to choose the judicial forum for disputes with us, our directors, shareholders, or other employees.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated articles
of association provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the
United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities
Act. Section 22 of the Securities Act creates concurrent jurisdiction for U.S. federal and state courts over all such Securities Act actions.
Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple
jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated
articles of association provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts
of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities
Act. This exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act, and
our shareholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations
promulgated under the Securities Act or the Exchange Act as a result of our exclusive forum provision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any person or entity purchasing
or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to the foregoing provision
of our amended and restated articles of association. However, the enforceability of similar forum provisions (including exclusive federal
forum provisions for actions, suits, or proceedings asserting a cause of action arising under the Securities Act) in other companies&#8217;
organizational documents has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the exclusive
forum provision in our amended and restated articles of association. If a court were to find the exclusive forum provision contained in
our amended and restated articles of association to be inapplicable or unenforceable in an action, we may incur additional costs associated
with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and results
of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we believe the exclusive
forum provision benefits us by providing increased consistency in the application of U.S. federal securities laws, <span>the
Israeli Companies Law 5759-1999, or together with applicable regulations promulgated thereunder the Companies Law, or New York law</span>,
as applicable, in the types of lawsuits to which they apply, such exclusive forum provision may limit a shareholder&#8217;s ability to
bring a claim in the judicial forum that they find favorable and may increase certain litigation costs for disputes with us or any of
our directors, shareholders, officers, or other employees, which may discourage lawsuits with respect to such claims against us and our
current and former directors, shareholders, officers, or other employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><b><i>We
may be subject to liability claims if we breach our contracts, and our insurance may be inadequate to cover our losses.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
are subject to numerous obligations in our contracts with organizations and our partners. Despite the procedures, systems and internal
controls we have implemented to comply with our contracts, we may breach these commitments, whether through a weakness in these procedures,
systems and internal controls, negligence or the willful act of an employee or contractor. Our insurance policies may be inadequate to
compensate us for the potentially significant losses that may result from claims arising from breaches of our contracts, disruptions in
our services, failures or disruptions to our infrastructure, catastrophic events, and disasters or otherwise. Further, our insurance may
not cover all claims made against us and defending a suit, regardless of its merit, could be costly and divert management&#8217;s attention.
In addition, such insurance may not be available to us in the future on economically reasonable terms, or at all.<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_012"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 4. INFORMATION ON THE COMPANY</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_013"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">A. History and Development of the
Company</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We were incorporated in 2014
in Israel. <span>Our Ordinary Shares and Warrants are currently listed for trading on the Capital Market
under the symbols &#8220;WLDS&#8221; and &#8220;WLDSW&#8221;, respectively.</span> We are a growth company developing a non-invasive neural
input interface in the form of a wearable wristband band for controlling digital devices using subtle touchless finger movements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal executive offices
are located at 5 Ha-Tnufa St., Yokne&#8217;am Illit, 2066736 Israel. Our telephone number in Israel is 972.4.6185670. Our website address
is <i>www.wearabledevices.co.il</i>. The information contained on our website or available through our website is not incorporated by
reference into and should not be considered a part of this annual report on Form 20-F, and the reference to our website in this annual
report on Form 20-F is an inactive textual reference only. Mudra Wearable, Inc. is our agent in the United States and its address is 24A
Trolley Square #2203, Wilmington, DE 19806.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &#8220;emerging
growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the
JOBS Act. As such, we are eligible to, and intend to, take advantage of certain exemptions from various reporting requirements applicable
to other public companies that are not &#8220;emerging growth companies&#8221; such as not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act. We could remain an &#8220;emerging growth company&#8221;
for up to five years, or until the earliest of (a) the last day of the first fiscal year in which our annual gross revenues exceeds $1.235
billion, (b) the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the U.S. Securities Exchange
Act of 1934, as amended, or the Exchange Act, which would occur if the market value of our Ordinary Shares that is held by non-affiliates
exceeds $700 million as of the last business day of our most recently completed second fiscal quarter, or (c) the date on which we have
issued more than $1 billion in nonconvertible debt during the preceding three-year period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a foreign private issuer
as defined by the rules under the Securities Act and the Exchange Act. Our status as a foreign private issuer also exempts us from compliance
with certain laws and regulations of the SEC and certain regulations of the Nasdaq Stock Market, including the proxy rules, the short-swing
profits recapture rules, and certain governance requirements such as independent director oversight of the nomination of directors and
executive compensation. In addition, we are not required to file annual, quarterly and current reports and financial statements with the
SEC as frequently or as promptly as U.S. domestic companies registered under the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt">The
SEC maintains an internet site, </span>http://www.sec.gov <span style="font-size: 10pt">that contains reports, proxy and information statements,
and other information regarding issuers that file electronically with the SEC. Our internet address is <i>www.mudra-band.com</i>. The
information on that website is not part of this Annual Report and is not incorporated by reference herein.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="D_014"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">B. Business Overview</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a growth company developing
a non-invasive neural input interface in the form of a wearable wristband for controlling digital devices using subtle finger gestures
and hand movements. Since our technology was introduced to the market in 2014, we have been working with both B2B and B2C customers as
part of our push-pull strategy. We are now in the transition phase from research and development to commercialization of our technology
into B2B products. At the same time, starting in December 2023, we have commenced shipment of the Mudra Band, our first B2C consumer product,
and aftermarket accessory band for Apple Watch that enables gesture control across Apple ecosystem devices such as iPhone, Mac computer,
Apple TV, and iPad, inter alia. In September 2024, we launched the Mudra Link, a universal gesture control wearable wristband. The Mudra
Link is open for orders and we have started shipping the Mudra Link to customers in the first quarter of 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our vision is to create a
world in which the user&#8217;s hand becomes a universal input device to touchlessly interacting with technology. We believe that our
technology is setting the standard input interface for the Metaverse. We intend to transform interaction and control of digital devices
to be as natural and intuitive as real-life experiences. We imagine a future in which humans can share skills, thoughts, emotions, and
movements with each other and with a bi-directional connection with computers, using wearable interfaces and devices. We believe that
neural-based interfaces will become as ubiquitous to interact with wearable computing and digital devices in the near future as the touchscreen
is a universal input method for smartphones.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Combining our own proprietary
sensors and AI algorithms into a stylish wristband, our Mudra platform enables users to control digital devices through subtle finger
movements and hand gestures, without physical touch or contact. These digital devices include consumer electronics, smart watches, smartphones,
augmented reality, or AR, glasses, virtual reality, or VR, headsets, televisions, personal computers and laptop computers, drones, robots,
etc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Mudra Inspire, our B2B
development kit product, started selling to B2B customers in 2018 as the first point of business engagement and contributed to our early-stage
revenues. At CES 2024, the Mudra Band for Apple Watch, our flagship B2C product was included in the &#8220;Best of CES 2024&#8221; products
list by SlashGear. At CES 2025, the Mudra Link, our gesture control stand-alone wristband for all Bluetooth compatible devices won the
CES 2025 Honoree Award in XR Technologies &amp; Accessories.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2024 and 2023, we had revenues
of $522 thousand and $82 thousand, respectively, and comprehensive and net loss of $7.9 million and $7.8 million, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Over 100 companies have purchased
our Mudra Inspire, 30 of which are multinational technology companies. These companies are exploring various input and control use-cases
for their products, ranging over multiple countries and industry sectors, including consumer electronics manufacturers, consumer electronics
brands, electronic components manufacturers, IT services and software development companies, industrial companies, and utility providers.
Our objective with these companies is to commercialize the Mudra technology by licensing it for integration in the hardware and software
of these companies&#8217; products and services. We estimate that there will be a three-to-five-year period from the time we are first
introduced to a customer to signing a licensing agreement. As of March 19, 2025, we have not signed a license agreement with any of these
companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to consumer electronics,
we have recently expanded our brand to include neurotech and brain-computer interface sensors, with additional verticals that include
Industry 4.0 &#8211; a new phase in the Industrial Revolution that focuses on interconnectivity, automation, machine learning, and real-time
data, digital health, sport analytics, and more.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The core of our platform is
Mudra, which means &#8220;gesture&#8221; in Sanskrit. The Mudra technology, our SNC sensors, and the wristband tracks neural signals on
the user&#8217;s wrist skin surface, which our algorithms decipher to predict as gestures made by finger and hand movements. The interface
binds each gesture with a specific digital function, allowing users to input commands without physical touch or contact. Mudra gestures
are natural to perform, and gestures can be tailored per a user&#8217;s intent, desired function, and the controlled digital device. Mudra
can detect multiple gesture types, including hand movements, finger movements, and fingertip pressure gradations. In addition to the control
use-case, the Mudra technology can be utilized in multiple monitoring use-cases where we can monitor neural and hand movements for digital
health purposes, sport analytics performance, and Industry 4.0 solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_002.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Figure 1: Our Mudra Platform</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Figure 1 above displays the
appearance and major features of our current products: the Mudra Band for Apple Watch and the Mudra Link. Our gestures are discrete or
continuous hand and finger movements, deciphered from neural signals at the wrist. Our interface can control multiple digital devices
using a single interface. In addition to consumer electronics, we have recently expanded our brand to include neurotech and brain/computer
interface monitoring, with additional verticals including Industry 4.0, digital health, sport analytics, and more.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Strengths</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our strengths
include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Direct relationships with the world&#8217;s leading multinational technology consumer electronics companies</b>.
Our B2B customers are seeking new, intuitive and natural methods for input and control of wearable computers, including smartwatches,
AR glasses, VR headsets, smartphones, and other consumer entertainment devices (such as smart televisions, large displays, voice assistants,
etc.).</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Vertically integrated platform that is difficult to replicate. </b>We believe that we are setting the
standard of using gestures to interact with wearable computers. Our technology is based on six layers which form three pillars - hardware,
software and humanware, which is the method of adding a human facet into the development of hardware and software with the main goal of
making it as functional as possible. Our hardware and software emphasize natural, intuitive, easy to use user-experience and user interface
humanware. Our technologies are interdependent and are optimized to sense wrist area bio-potentials, which are electrical potentials generated
in the tissues of the wrist. There is a very high interdependency between each layer, and we believe that we possess the expertise for
all technological layers.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Expanding our products to multiple market verticals. </b>In addition to working with businesses and
individual customers in the consumer electronics market, we have developed several use-cases for digital health, Industry 4.0, and sport
analytics markets. These use-cases involve utilizing the Mudra SNC sensor as a platform to be used in additional verticals, such as frontline
workers, patients, and athletes and sport enthusiasts.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>A Push-Pull strategy to win both B2B and B2C sales</b>. Using a &#8220;Push-Pull&#8221; strategy and
working directly with manufacturers of digital devices and with consumers using wearable computing devices, we have successfully created
customer demand for consumer products and proved to manufacturers the validity of our solution to consumers. Working with both manufacturers
and consumers allows us to develop products that are based on needs, inputs, demands, requests and behaviors of all stakeholders along
the value chain.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>World-class research, engineering and product teams. </b>Our employees have a diverse set of skills
and industry experience, including expertise in highly scalable distributed software systems, machine learning algorithms, artificial
intelligence architecture, and user-centric product design. Our engineering, product, and design teams work together to bring our products
to life, from conception to implementation. We are committed to leveraging data to continuously improve our customer experience by studying
and understanding points of interaction and how our customers use our platform features.</td></tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Strong, advantageous platform that contains</b>:</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><b>-</b></td><td style="text-align: justify"><b>A proprietary sensor to capture neural signals. </b>Our proprietary Mudra SNC sensor can be utilized
to decipher signal patterns for gesture control as input for digital devices, and it can also be utilized to monitor and track the neural
activity of the hand motor neurons for short and long-term diagnosis.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><b>-</b></td><td style="text-align: justify"><b>Natural, intuitive operation using subtle finger movements. </b>By making communication with computers
much easier, we intend to empower users to interact with computers and work, enjoy entertainment, and live better. Our stylish, elegant
devices are of small size and shape, and support familiar gestures in comfortable body postures.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><b>-</b></td><td style="text-align: justify"><b>Human-centered design that optimizes user experience. </b>Our products are designed around our customers&#8217;
user experience. Our large global network of consumers and business customers provides highly useful feedback and insights, which we use
to constantly improve our products and the value we offer to our users.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><b>-</b></td><td style="text-align: justify"><span style="font-size: 10pt"><b>A large hand and finger gesture database. </b>Through anonymized data
from cloud-based calibrations and mobile apps, we are building a large database of finger and hand gestures. This will allow us to gain
unparalleled insights on trends, behaviors, and usage.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><b>-</b></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Flexible gestures and user-interaction choices.</b> Our platform supports
the development and implementation of a large variety of new gestures. We can tailor gestures for each use-case per user requests or our
own internal insights. Defining the right gesture and binding it with the correct function is important for high adoption of our input
solution for wearable computing, and for our platform solution to become ubiquitous in multiple digital devices.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Industry Overview and Market Opportunity</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Total Addressable Market</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Every digital device - whether
worn on the body, placed on a desk, held in the hands, or hung on a wall - requires an interface. The Total Addressable Market, or TAM,
of digital devices that we are targeting can be categorized into three segments: wearable computers, face computers (for example, AR glasses,
MR products, VR headsets) and home digital devices. We view Mudra as an all-encompassing input, operation, and control interface for all
digital devices, connecting the physical world with digital devices using subtle finger movements and gestures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The basic pillars of Human-Computer
Interface, or HCI, input are text, navigation, and digital element interaction. The most common interface solutions include the keyboards
and mice for PCs. Additional common interfaces are the touchscreens for mobile phones and tablet computers, handheld controllers for televisions,
game consoles, VR headsets, and temple area touchpads and/or gesture cameras for AR glasses. Voice assistants are now commonly used with
smart home devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The pace of technology advancements
has always been dictated by user interfaces. With the future of computers tilting increasingly toward wearable devices, especially as
smartwatches and smart glasses enter the market, HCI methods for wearable computing will need to be reinvented as well. We believe that
the industry&#8217;s foreseeable future is based on wearable computers for different body parts, instead of computers that are restricted
to lying on a desk.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The industry of digital computers
peripherals and input devices has evolved dramatically in the past 70 years. It started in the 1950s with punch-cards as the major input
method. Punch-cards were replaced by the QWERTY keyboard to input text and for two-dimensional navigation starting in the 1960s. The computer
mouse, which allowed users to navigate and interact with digital elements on a Graphical User-Interface, was introduced in the 1980s.
Touchpads became popular as a mouse replacement for laptop computers in the 1990s. Gesture recognition cameras to detect body, hand and
finger movement were introduced in the early 2000s. Touchscreens as inputs for mobile smartphones became ubiquitous at the end of 2010.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Technologies which are used in all devices for
input, interaction, control and operation, include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Handheld devices </b>such as computer mice, presentation clickers, gaming controllers, and styluses.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Touch based devices</b> such as the touchpad or touchscreen.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Keyboard technology devices</b> or digital displays which contain alphanumeric symbols to input text
and for navigation.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Voice assistant devices and services </b>which interpret human speech to digital commands and speech-to-text
input.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Gesture detection sensors</b> such as gesture detection cameras, LiDar, Radar and additional optional
technologies that sense the finger and hand movements.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Wearable input devices</b> such as smart gloves, wearable keyboards, wearable computer mice, smart
rings, and smart wearable clickers.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Neural interface devices</b> that are based on capturing bio-potential signals and transforming signal
patterns to input commands, in invasive implant and in non-invasive wearable methods.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to an International
Data Corporation, or the IDC, publication from September 2024, or the IDC Publication, in 2024, a total of 533.9 million units of wearable
devices will be shipped to consumers, of which approximately 156.5 million are smartwatches, and approximately 35.2 million smart wristbands.
The IDC forecasts the market for wearable devices will reach 606.2 million units shipped to consumers in 2028, of which 175.2 million
will be smartwatches. This represents a 2.9% five-year compound annual growth rate, or CAGR, for smartwatches.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, the IDC opines that
in 2024, a total of 1.8 million units of smart glasses without a display, such as Meta-Ray Ban glasses, were shipped. The IDC forecasts
that this market will reach 2.4 million in shipped units in 2028, with a 7.5% five-year CAGR.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, according to
the IDC Publication, by 2024 shipments of face computers will reach a total of 6.6 million units. The IDC forecasts that the face computers
market will reach 23.1 million shipped units in 2028. This category is expected to show a 36.6% year-over-year growth. Face computers
are considered devices that have a potential to replace smartphones by the end of the decade. This product category includes devices by
Meta, Apple, HTC Corporation, Samsung Electronics Co., Ltd., or Samsung, Google, Microsoft, Sony Group Corporation, Xreal Technology Co.,
Ltd., and others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the IDC Publication,
shipments of smart-computing consumer devices that include personal computers, tablets, smartphones, and video entertainment (set-top
box/streaming stick, TV, and others) were expected to reach approximately 1.88 billion units shipped in 2024. IDC forecasts this market
will reach 2.03 billion units shipped in 2028.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Taking
the aforementioned figures into consideration, the TAM that we are targeting is approximately 12.7 billion devices shipped between 2024
to 2028. The smart-computing and smart-home device categories present several challenges that need to be addressed before we will be able
to take advantage of this opportunity. One of our major challenges is to determine whether consumers will be reluctant to adopt our products
and services as an alternative to established, traditional devices, such as remote controls, touchscreens, camera gesture control solutions,
keyboards and mice.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result, we plan to focus
on delivering the greatest value to users by first focusing on the wearables and face computer device categories. We believe that as we
continue to expand our platform and as consumers increasingly view a connected world of ambient computing and smart-home products and
services as an alternative or complement to wearable devices, there will be an opportunity to extend our addressable market to the broader
consumer electronics categories and markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Neural control interface market</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The global neural control interface market is expanding
due to several significant trends, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>The pace of technology advancements is always dictated by user interfaces: </b>Input methods have evolved
in the past 70 years from paper printed punch-cards to touchscreens and gesture sensing technologies. The purpose of input is to lower
the cognitive load of the user and provide a natural and intuitive method to communicate intentions and commands into a computer. The
computer mouse helped place a personal computer in every home, and the touchscreen revolution put a smartphone in every pocket. Input
technology is the enabler and herald of the next computing platform. We believe that the input method for wearable computing will have
to be re-invented as well, with interactions beyond the touchscreen.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Spatial computing is reshaping business processes and consumer entertainment patterns:</b> The use
of wearable technology makes it easier for frontline and assembly line workers to operate more efficiently and provide better service.
It boosts labor efficiency, reduces quality defects and revisions, and improves safety. Wearable consumer products are already an integral
part of consumers&#8217; lives. The Apple Vision Pro and the Meta Quest 3 are two examples of spatial computing products.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>The &#8220;Metaverse&#8221; is widely considered to become the future of the internet</b>. Instead
of just viewing content - users will be in it, experiencing it all around. Users will remotely create and explore with other users as
if they are present with them - socialize, work, play, learn, shop, and more. Accessible across multiple computing platforms such as VR,
AR, mobile devices and computers, the Metaverse will offer rich immersive experiences and reach content. Already termed as &#8220;the
next computing platform,&#8221; it is becoming the major catalyst to adopting wearable computing. We believe that our technology is setting
the standard input interface for the Metaverse, by providing a wearable-based gesture control input which goes beyond the boundaries of
vision-based solutions.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>The human wrist is a highly valuable tool for sensing the human body:</b> Nerve bundles and arteries
pass directly beneath the skin making it possible to sense the electrical conductance of nerves and other bodily functions and to collect
valuable data. Today, physical tools are being replaced with digital accessories such as wristbands and smartwatches. These devices measure
wrist movement, heartbeat, electroencephalography, rhythm, skin temperature, hydration, and blood oxygen. Recent advancements in sensors
and signal processing combined with artificial intelligence algorithms have enabled the emergence of wrist-based wearable neural input
technology, thus opening a wide range of applications in HCI and bio-potential signals monitoring.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Neurotech market and brain-computer interfaces are gaining traction:</b> The neurotech industry is
based on connecting human brains to computers, so that brain-computer interfaces open up a new area of economic enterprise. Brain-computer
interfaces and neural inputs are starting to move beyond the confines of academia and toward industry and the consumer market. In January
2024, Neuralink announced the first human patient has received a Neuralink brain implant. As of February 2025, two additional human patients
have received a Neuralink brain implant. In February 2024, Synchron announced it is one step closer to brain chip commercialization. In
July 2024, Synchron also announced the first human patient has received a brain-computer interface implant. We believe a wearable interface
which can supply pointing functionality of tap, pinch, pinch and drag and slide and glide, using gestures is the key to mass consumer
market adoption, whereas brain implants may be common only years ahead.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Technology</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our technology is based on
six layers which form three pillars-- hardware, software and humanware. We develop the hardware and the software from the bottom up and
define the user-experience. Using the domain expertise and the insights we have gathered and continue to gather as users provide feedback,
we define the standard for interaction with wearables and digital devices. Our technology layers are interdependent and are optimized
to the wrist area thus creating a significant protection moat - there is a very high interdependency between each layer to adjacent layers,
and developing similar solutions requires expertise in each individual layer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The first pillar is <b>hardware</b>,
which includes electrodes, band design, including form factor and materials, the SNC sensor and the miniaturized flex-rigid electronics.
We research and develop electrode materials and geometry to achieve a durable electrode that sustains its physical properties on wrist
skin contact and endures thousands of wear/off cycles. Band design includes the modeling of the curvature of the band to snuggly fit the
wrist area, and feel pleasant and comfortable to be worn on daily basis. The SNC sensors were developed specifically for the inner wrist
area; therefore, they are able to sense low energy biopotentials and to maintain optimal bandwidth and minimize external interference
sources. The miniaturized flex-rigid electronics design and manufacturing offer a flexible shell with dynamic semi flex-rigid printed
circuit board, to meet strict bill of materials and design for assembly requirements, and consumer laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_003.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Figure 2: The Three Pillars of the Mudra Technology</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Figure 2 above displays the three pillars of our
technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The first pillar is <b>hardware</b>,
which includes electrodes, band design, including form factor and materials, the SNC sensor and the miniaturized flex-rigid electronics.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The second pillar is <b>software</b>,
which includes cross platform software engine, artificial intelligence learning algorithms and software applications. We developed a unique
cross-platform software engine, which supports real-time signal processing and is capable of cross-platform algorithms mitigation on multiple
operating systems. This allows us to run our software on low compute power wearables and digital devices, and to mitigate algorithms across
platforms without the need to re-write the algorithms for each operating system. Our machine learning algorithms and deep learning neural
networks artificial intelligence architecture leverages the most advanced approaches of few-shot learning algorithms, making classification
based on a very small number of samples, on a unique bio-signal for which we create the unique, and non-available, training and validation
sets. We achieved over 96% accuracy with a very short calibration procedure for multiple users. We develop software applications for mobile
and desktop operating systems which integrate the algorithms and supply the users with the desired gestures and functions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third pillar is the <b>humanware
and user experience</b> which is the hand and finger gestures that the user performs and the functions that bind with these gestures to
input commands and control devices. We developed a set of gestures that create a natural interaction and are optimized for humans rather
than for computers. As a result, we immerse users naturally to control their devices and increase the fidelity of intention. Furthermore,
we developed functionality that allows users to toggle and switch between connected devices and provides a seamless transition of control
across devices such as an iPhone, iPad, Mac computer, and Apple TV devices, as well as other connected devices including smart glasses,
using handsfree and touchless subtle finger and wrist movements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Mudra platform supports
discrete gestures, continuous gestures, and air-touch gestures:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Discrete gestures.</b> Moving a single finger or softly tapping the finger or thumb.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Continuous gestures.</b> Applying various gradations of fingertip pressure to manipulate digital objects.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Air-touch gestures.</b> Combining the above with hand and forearm movements, such as &#8220;slide-to-unlock&#8221;.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_004.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Figure 3: The Mudra Platform Gestures Types</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Figure 3 above displays the
three types of Mudra gestures - discrete gestures, continuous gestures, and air-touch gestures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We specifically tailor the
set of gestures to each controlled device and scenario, as we deeply believe each device&#8217;s form factor and user input should be
tailored specifically to the user&#8217;s intent, rather than having a set of pre-defined gestures for all devices and functions. Each
electronics company or electronic brand may require different bundles of hardware, software, and humanware solutions, with integration
interfaces for its device, system and design.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Core Products and Solutions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The Mudra Platform</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mudra, our neural interface
platform, is designed to enable our customers and users to improve interaction and control of digital devices by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Creating a natural and intuitive collaboration with computers.</b> We empower users to interact, entertain,
work, and live more natural, relaxed, and productive lifestyles by lowering the burden of communicating with computers and enabling an
intuitive mode of interacting with computers. Our technology includes both a non-invasive neural input interface for the wrist that allows
building innovative user experiences and applications for digital devices and a smart watch band that lets the user control the Apple
ecosystem using gestures, subtle hand and finger movements. These devices span over multiple styles, form factors, capabilities, and functions,
addressing the needs of everyone - from consumers using their favorite wearable for infotainment and relaxation to business and enterprise
customers serving their customers and helping their employees to maximize their performance.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Designing products with a human-centered design, focusing on optimizing the customer experience. </b>Our
products are designed bottom up from the user experience, through the gestures used and the device design and form factor. We have a global
network of businesses customers and consumers who share their thoughts, insights, and activities with us, which allows us to aggregate
the best solutions to interact with any wearable device. We are conducting extensive user-tests and observations to custom-tailor each
gesture with the right control function. We use familiar gestures such as tap and pinch and glide, which can be performed in relaxed and
comfortable body postures.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Learning through cloud-based calibrations and mobile apps. </b>We are building a large hand and fingers
gesture database. The information is stored anonymized on cloud-based servers, which allows us to gain meaningful insights on user trends,
behaviors, and usage of our products. We then use transfer learning, a machine learning method for storing knowledge gained while solving
one problem and applying it to a different but related problem, to implement new insights and wisdom into our next generation algorithms,
devices, and user experiences.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Products</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are offering both B2B and
B2C products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i>B2B products.</i></b> We offer
two ways for our business customers to access our technology: (i) paid pilot projects which include the purchase of Mudra Inspire to evaluate
the experience and to validate the technology, and (ii) an SNC sensor module to integrate into a customer device (including AR/VR headsets,
smartphones, smartwatches, televisions, and laptops) under a license agreement. Typically, we work with the B2B customer on validating
our technology with the goal of integrating our technology into the customer&#8217;s device. We also offer licensing of a SNC sensor module,
with the option to license our operating system, or OS, software package and algorithm software package.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our B2B product offerings
include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>SNC sensor module</b>. We provide the SNC sensor, OS software package and an algorithm package to customers.
The customer can then integrate the SNC sensor in its own wrist-worn device, and use our OS software package and algorithm package to
offer Mudra capabilities integrated in its own product. After the validation phase, we create a reference design for the SNC sensor and
electronics that are built around our SNC sensor. The customer, based on our reference design, builds a module for the complete sensor
system that includes the motherboard board, our proprietary SNC sensor, and our software and algorithm package. This complete sensor system
with the required gesture functionalities is then integrated into the customer device. We also give the customer the option to develop
its own OS software and algorithm software.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Mudra Development Kit</b>. We provide access to our platform via the Mudra Development Kit (formerly
named Mudra Inspire), which contains the Mudra wristband, to allow the customer to evaluate the device form factor and user experience,
and through the API, which grants access to development of new applications and user experiences, based on the Mudra gesture set, with
no commercial rights. This was used as the first point of engagement with B2B clients to validate our technology. It was launched in June
2018 under the name Mudra Inspire, and over 200 kits have been sold since. This product is now sold only to B2B customers as part of a
pilot transaction.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that offering our
own consumer products presents vast monetization opportunities because we can utilize meta-data mining for the purpose of building a large
hand and finger gestures database.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our B2C product offerings
include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Mudra Band. </b>A neural input wristband which allows users to control Apple ecosystem devices such as iPhone, Mac computer, Apple
TV, and iPad using subtle touchless finger movements and gestures. The product was launched in June 2020 and was delivered to consumers
for the first time in September 2023. The retail price of the Mudra Band is $349 and is currently offered for a special discount price
of $299.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Mudra Link</b>. A universal gesture control neural wristband wearable which allows users to control any Bluetooth compatible device
regardless of the operating system. We launched the product for pre-orders during September 2024 and commenced initial shipments of the
product in January 2025. The retail price of the Mudra Link is $299 and is currently offered at a special pre-order price of $199.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>What our platform devices track</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products track the following
signals which our algorithms decipher to classify the user intent hand and finger gestures:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Fingertip Pressure</b>. Our SNC sensors are placed in proximity to the ulnar, median and radial nerves
close to the inner wrist skin surface area. These signals are directly correlated with the hand and finger movements and with fingertip
pressure between fingers or on external objects.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Acceleration and Movement</b>. We use an inertia measurement unit to measure the wrist acceleration
in three-axes and to measure the wrist rotation on four quaternions. These measurements are used to estimate the direction the hand is
moving and the palm orientation in relationship to the forearm and body.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compatibility and Wireless Syncing</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to reach the widest
set of corporate customers and customer users, we focus on ensuring that our devices are compatible with a broad range of mobile devices
and OSs. Currently, our platform can sync with mobile devices operating with iOS8 and above, Android 8.0 and above, and Windows 10 and
above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Customers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customers include businesses
and private consumers, as we operate in both the B2B and B2C sectors. We define &#8220;customer&#8221; as an individual or entity that
has purchased our products. We consider individuals that are or could be interested in our products as &#8220;consumers.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>B2B Market</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our B2B customer market includes
consumer electronics companies, consumer electronics brands, industrial manufacturing companies, IT and software solutions providers,
software development studios, and academic institutions. As the rate of adoption for neural input solution among companies and users increases,
the likelihood of our platform becoming universally compatible with any wearable device or computer also increases, creating positive
network effects that enhance our growth. In addition, the data we accept from our large user and customer base enables us to enhance our
product features, provide improved insights, and offer more valuable experiences for our users.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We explore a large variety
of use-cases with our customers. A use-case is a well-defined scenario, which involves a user, a user objective or task, a controlled
device, and the user&#8217;s environment. An example for a use-case is a bike-rider that controls the display of data layers on AR smart
glasses designed for cycling, and uses touchless subtle finger movements to scroll, swipe and select data layers and digital items. While
cycling, the rider wears gloves and has the fingers clenched on the bike steering wheel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_005.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>Figure 4: Number of Our B2B Customers and Use-Cases</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In Figure 4 above, the chart
on the left illustrates the number of total business customers buying the Mudra Inspire, which was 27 in the second half of 2018 (all
of which were new customers), 82 in 2019 (55 of which were new customers), 103 in 2020 (21 of which were new customers), 121 in 2021 (18
of which were new customers), and 126 in 2022 (5 of which are new customers). If a separate team from a company bought the Mudra Inspire,
we consider such team as a new customer. If the same team bought the Mudra Inspire, we do not consider it as a new customer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The chart on the right above
illustrates the number of total business customer use-cases for integrating or implementing our Mudra technology into their devices, products
or services: 21 in the second half of 2018 (all of which were new use-cases), 59 in 2019 (38 of which were new use-cases), 74 in 2020
(15 of which were new use-cases), 89 in 2021 (15 of which were new use-cases), and 92 in 2022 (3 of which were new use-cases).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In January 2024, we launched
the B2B Mudra Development Kit, in order to replace the Mudra Inspire which was at the &#8220;end of life&#8221; during 2023. The new Mudra
Development Kit provides our customers with enhanced capabilities and additional features, including surface nerve conductance sensors
optimized for capturing nerve signals from major wrist nerve bundles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also in January 2024, we announced
a new revolutionary &#8220;Spatial Depth&#8221; control functionality which allows users to use the Mudra Band for depth navigation, adding
an extra dimension to user interactions. Adding depth to navigation enhances user interactions by allowing more intuitive control. This
is particularly useful in spatial computing applications, where perception is important in rich 3-dimensional environments. It provides
a more immersive experience, enabling users to interact with 3-dimensional elements in digital space, making tasks more natural and efficient.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Consumer Electronics
Companies</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We define consumer electronics
companies as a B2B market, where these customers have all the resources needed to develop, manufacture and market a wide variety of consumer
electronic devices. Our customers in this market are exploring our Mudra technology as an input-method for current and future products,
which include AR glasses, smartwatches, VR headsets, gaming consoles, mobile phones, smart televisions, voice assistants, smart homes,
and large displays.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We estimate there will be
a three-to-five-year period from the time we are first introduced to a customer to signing a licensing agreement. Some of the following
seven phases may be introduced earlier to qualify the customer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The first phase of engagement
usually occurs when the customer receives the Mudra Inspire dev-kit after a paid pilot was signed. In this phase, we educate the customer
about our technology, including our cutting-edge algorithms, the product form factor, the gestures and binding functions, and the user
experience. During this period, the customer usually evaluates these factors and validates the technology as a whole.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the second phase the customer
defines a use-case for evaluating our Mudra technology for its business goals. This includes defining user functions, and defining the
gestures that will be used to control the device. The second phase is mostly focused on the end-user experience, or what we term as the
&#8220;humanware&#8221; layer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third phase focuses on
the customer&#8217;s needs, desires and &#8220;nice-to-have&#8221; features that it lists in a technical document. This phase has a prolonged
direct interaction with the customer which includes support, conversations, and further explorations of our technology scope.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fourth phase includes
a detailed written software requirement specification document which is part of the pilot transaction. The outcome is, generally, a software
or a mobile application which includes customer specific requests for which gestures perform certain functions on a specific device and
operating system. This phase may also include defining new gestures, collecting new gesture data from users, developing algorithms, and
writing the program.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the fifth phase, upon successful
completion of the customer&#8217;s pilot transaction, a full technical specification of the solution and the integration method are discussed,
including: definition of the wrist device form factor, material, and design; definition of the software, and compute unit requirements;
the full set of gestures and interactions; and finally, the complete product specification and integration methods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the sixth phase, we define
the business model and revenue model, the licensing scope, the site license rights, and the license period. We offer a business model
which includes a mix of fixed annual license fee and variable royalties per each device sold. The business model and pricing are dependent
on the integration level required, the development period, the exclusivity rights, the scope of the reference engineering design, and
the expected volume of units that the customer is expected to sell.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the seventh and final phase,
the commercial contract with the customer is signed. All necessary integration design information to start serial manufacturing and integration
into the consumer electronics customer device are delivered.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Consumer Electronics
Brands</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We define consumer electronics
brands as a B2B market, where these customers have all the necessary resources to develop, manufacture and market a single product or
product line of a consumer electronic device. Customers in this market are exploring our Mudra technology as an input method for current
and future products. We are working with leading consumer electronics brands on integrating the Mudra technology into their products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With this type of customer,
we seek to get enter into a bulk purchase order or to create a co-branded device or a white label. We are in charge of the development
and manufacturing of the wrist device, based on the customer&#8217;s specifications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The business model with this
customer segment is to charge for research and development costs to adjust our Mudra technology per customer specification. We sell a
bulk order of the devices at an agreed price to the customer. The minimum order quantity for this customer segment is 10,000 units per
year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Industrial Companies</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We define industrial companies
as a B2B market segment, where the customer operates in various Industry 4.0 areas such as automotive, aircraft, energy, medical, infrastructure,
and utilities, among others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As explained briefly above,
Industry 4.0 refers to a new phase in the Industrial Revolution that focuses heavily on interconnectivity, automation, machine learning,
and real-time data. Industry 4.0, which encompasses the Industrial Internet of Things, or IoT, and smart manufacturing, unites physical
production and operations with smart digital technology, machine learning, and big data to create a more holistic and better-connected
ecosystem for companies that focus on manufacturing and supply chain management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Customers in this market are
seeking ways to increase profitability and reduce costs in production and assembly lines, optimize manufacturing processes, and make their
employees more efficient and less vulnerable to mistakes or physical harm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conducted several evaluations
of the Mudra technology with industrial companies, which included developing new gestures for monitoring manual activity of assembly line
employees. The motivations of the customers are:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">inadvertent error prevention for an equipment operator to avoid mistakes and defects by monitoring, correcting,
drawing attention, or preventing human errors as they occur; and</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">process engineering and business activities to continuously improve all functions and involve all employees
from senior management to the assembly line workers</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Manufacturing and assembly
lines contain multiple manual tasks that employees perform repeatedly without being monitored with regard to accuracy or the employees&#8217;
physical conditions. Using our Mudra technology to monitor employee actions and the way they perform tasks can reduce mistakes on assembly
lines, and continuously improve employee productivity and engineering processes. Principally, a manual hand operation on a production
line or an assembly line can be defined as a gesture with our Mudra technology. We offer these customers wristbands that their employees
can wear and monitor hand and finger movements. A local computer unit such as smartphone, tablet or PC, is connected to a cloud-based
server to collect, analyze and identify if a certain manual task is performed accurately, thus preventing incurring losses on later stages
of production. It can also monitor the movement frequency and infer stress of the employee to alert when performance is degrading during
a work day, or over time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on customer feedback
and pilot transactions, the business model for this customer segment may be SaaS. In such model, we will supply the wrist devices, specific
software, and the cloud and integration solution. The customer will pay per site where the solution is implemented and on the number of
users, on monthly or annual automatic renewable subscription.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Information Technology,
Software Solutions Providers</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We define information technology,
or software solutions providers, as a B2B market, where the customers offer third-party clients with project management needs, from conception
to installation. Customers in this market are traditionally hired as vendors for consumer electronics companies, consumer electronics
brands, or industrial company segments, to integrate the Mudra technology as part of a solution to their clients. The common use-cases
include defining new input methods for industrial robots, drones, and other machines or devices. The business model is similar to the
business model we will use when directly facing the customer&#8217;s client, which can be a license agreement, a bulk order, or a SaaS
model.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Software Development
Studios</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We define software development
studios as a B2B market, where the customers seek new opportunities in computer games and mobile applications. The customers can leverage
their existing users and install-base with new innovative digital health, entertainment, and gaming applications. The business model is
revenue sharing from the install base, based on monthly or annual revenues. The software segment includes developers, designers and artists,
all working together towards delivering engaging, high visual and technical quality games.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Academia</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have a few customers from
academia and research universities which explored the use of our Mudra technology to aid individuals with physical disabilities, and new
alternative methods of input and interaction for individuals with limited hand movements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>B2C Market</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have started offering our
products directly to consumers, in the form of pre-orders, or early bookings. The Mudra Band for Apple Watch is our first consumer product,
launched in June 2020. The band connects to the Apple Watch and allows a user touchless operation and control Apple ecosystem products.
So far we have delivered over 3,000 units of the Mudra Band for Apple Watch since the first batch was delivered to customers in September
2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Mudra Link, a personalized
gesture control wristband for any operating system, is our second consumer product, launched in September 2024. The wristband connects
to Bluetooth enabled devices and allows a user touchless operation and control of computers, robots, smart glasses, applications and other
smart devices. As of March 19, 2025, we have delivered a couple hundred pre-orders of the Mudra Link in several batches.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Establishing a direct connection
with customers and users enables us to learn, improve and enhance our product offerings. This also enables us to mine meta-data to build
hand and finger movements and gestures database, which we believe has huge monetization opportunities. The Mudra Band for Apple Watch
is designed for users who are Apple afficionados and like buying Apple related products and active sport and fitness users. The Mudra
Link is designed for users who are technology early adopters and like purchasing innovative consumer gadgets, and crowd-funding and innovation
seekers audiences.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We plan to develop and offer
additional consumer electronics products for controlling and interacting with computers and digital devices. We expect additional consumer
offerings will include applications for a variety of devices which will add value to the consumer beyond hardware functions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>The value of Mudra Input
Technology to Our Customers</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Smartwatch </b>operation
methods include touchscreen, buttons, digital crown, bezel, and wrist gestures. By integrating our Mudra technology into a smartwatch,
our business customers can:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Offer a touchless input operation method feature for the smartwatch;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Diversify their product line offering by introducing new hardware products, software applications, and
user service;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Integrate touchless interaction into existing applications;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Enable developers to introduce exciting new applications in entertainment, gaming, fitness, digital health,
using a gesture-based watch OS; and</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Increase eco-system products connectivity by controlling multiple connected devices from the watch, using
gestures.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Mudra technology enables
the smartwatch end-user to enjoy a touchless watch operation experience. The user can operate applications and watch OS functions without
physical touch using same-hands subtle finger movements, while multi-tasking or on-the-go, keeping a visible display.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Mobile phone</b> usage
has been limited by the touchscreen, an interface which requires constant physical touch. By linking a Mudra wristband with a mobile phone,
our business customers can:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Turn the phone to a content-hub by streaming video, music, games and applications to larger screens, and
input provided using a mudra wristband;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Establish a strong products eco-system integration, where connected devices work together and are controlled
using a common interface;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Create an additional input method for mobile phones, with interactions beyond the touchscreen; and</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Increase their market differentiation and add revenue streams by providing additional value to their phone
users by providing ambient computing features.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Mudra technology allows
the mobile phone end-user to benefit from turning the phone into a stationary hub for work, video streaming, and gaming. The user can
access a world of new experiences by integrating touchless interactions with connected eco-system devices to achieve more of the phone.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>AR glasses</b> use semi-transparent
display lenses to overlay digital data and digital holograms into the user&#8217;s real-world view. AR glasses input solutions include
gesture recognition cameras, temple area touchpads, wired remote, handheld clicker, handheld remote, and voice commands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By integrating our Mudra technology
with AR glasses, our business customers can:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Manufacture a stylish, light weight, and smaller form factor pair of glasses, by removing the gesture
recognition hardware from the device;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Reduce research and development costs related to the development of hardware and software for the gesture
camera;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Increase device battery life by eliminating central processing units and sensor gesture recognition related
power consumption;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Offer a natural and intuitive interaction experience which does not block real-world view and is discrete
and socially acceptable; and</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Provide an input solution that works well indoors and outdoors, is not dependent on a line of sight or
limited by field of view, not affected by ambient light conditions, and is robust to environmental conditions.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When using our Mudra technology,
the AR glasses end-user enjoys a natural, hands-free, and safer input method to interact with digital overlays. The user can operate the
device using natural and intuitive hand postures and gestures along the waist, with less fatigue caused by waving the hands in mid-air.
The user&#8217;s real-world environment is clear and not blocked by the hands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>VR headsets</b> use digital
displays which cover eyes to immerse the user in a fully computer-generated alternative environment, displaying computer-generated video
capture which entirely occludes the user&#8217;s natural surroundings. VR headset input solutions include handheld controllers, a gesture
camera, a keyboard, a mouse, input gloves, and voice commands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By integrating our Mudra technology
with VR glasses, our business customers can:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Diversify after-market input solutions, alongside existing controllers and input methods;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Support multiple additional natural and exciting interactions with video games, where the user can use
the hands to grab, hold and manipulate digital objects;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Enrich digital content by turning daily simple physical objects to smart digital peripherals, for example,
turn any pencil into a stylus to capture and input digital data such as handwriting;</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Reduce the user&#8217;s loss of proprioception (kinesthesia) by using natural hand and finger movements
where the finger is not clenched around handheld controllers; and</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;  border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Reduce costs by integrating hand and finger tracking without developing expensive sensor hardware and
the accompanying software and algorithms.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When using our Mudra technology,
the VR headset end-user is immersed in a real-life VR experience. Interaction with digital holograms such as grabbing, throwing, holding,
and dragging is done using hand and finger movements instead of by pressing buttons. Using our Mudra technology allows the user to be
fully immersed into an entertaining digital experience that feels like a real-life interaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The basic input pillars of
HCI are through text, navigation, and digital element interaction. The most common interface solutions include keyboard and mouse for
PC, touchscreen for mobile phones and tablet computers, handheld controllers for television, game consoles, and VR headsets, temple area
touchpads and/or gesture cameras for AR glasses, and voice recognition for smart home devices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market of input methods
and peripheral for digital devices is both evolving and competitive, with companies offering a variety of competitive products in multiple
price points. The established industry-standard technologies include physical or digital keyboards, PC-mice, handheld controllers, touch
surfaces, voice assistants, and gesture cameras. These categories have a multitude of participants including specialized consumer electronics
companies such as Logitech International S.A., Razer Inc., and Microsoft. There is also a wide range of after-market products that can
be purchased on retail and online stores from a multitude of manufacturers. Voice assistants are now available through multiple technology
consumer companies such as Apple, Google, Amazon.com, Inc., Microsoft, and Samsung.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are also many large,
broad-based consumer electronics companies that either compete in our market or adjacent markets or have announced plans to do so. For
example, in September 2024, Meta unveiled Orion AR glasses, a pair of smart glasses that can be controlled using a neural wristband. In
September 2019, Meta acquired our former direct competitor, CTRL-Labs (now Facebook Reality Labs). In February 2025, TapWithUS unveiled
the TapClip, a camera-based wrist input device that can translate finger movements as keyboard input or mouse.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2023, Apple released
the Apple Watch Ultra2 Double Tap capability, which allows users to tap the index finger and thumb together twice to answer a call, reply
to a message, see and scroll through the Smart Stack, and more, based on the watch&#8217;s IMU and PPG sensors. In December 2023, Doublepoint
Technologies unveiled a wristband controller with continuous touch-based gesture tracking. In February 2023, Pison launched Ready, a new
sports performance wearable tool designed to measure, track and enhance athletes&#8217; readiness, mental agility, and focus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are also multiple participants
which utilize emerging wearable, sensor, and bio-potential signals to offer neural and wearable interfaces such as Coolso Technology Inc.
and CenWatch, whereas electroencephalogram-based companies include Neuralink Corporation and NextMind SAS (acquired by Snap Inc. in March
2022). In February 2025, Humane Inc., the company behind the AI Pin wearable which can be controlled using gestures, announced it has
been acquired by HP Inc..</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our competitive
advantages include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9675;</td><td style="text-align: justify"><b>Push-Pull strategy all along the value chain and creating
a blue ocean business environment. </b>We have strong relationships with consumer electronics companies, and we also communicate directly
with consumers. Thus, we gain meaningful insights on the market and consumer needs, and constantly improve our products along the value
chain. We aim towards a &#8220;blue ocean&#8221; strategy, where we do not compete with established market solutions, but rather we create
a whole new arena where multiple input methods can co-exist together to provide the best user experience for the consumer.</td>
</tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9675;</td><td style="text-align: justify"><b>We seek to work with multiple consumer electronics companies
and consumer electronics brands. </b>We seek to integrate elements of our Mudra technology - sensors, electronics, software, and user
experience - with multiple consumer electronics manufacturers and companies. We believe in our Push-Pull strategy approach of working
directly with consumers to validate demand and we are working with companies to customize our technology integrated into their specific
needs. Because we provide the hardware specification and the actual software and user-experience, each company can tailor our technology
to fit its own wrist-worn device or watch band, form factor, appearance and style, material, user experience and gesture set. We have
a very strong track record of connecting with global leading companies and our positioning leverages us to familiarize ourselves with
their needs, requirements, limitations, and use-cases; thus, we can tailor the right product specification and user-experience.</td>
</tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9675;</td><td style="text-align: justify"><b>Advanced, purpose-built hardware and software technologies</b>. Our devices leverage industry-standard
technologies, such as Bluetooth low energy, as well as proprietary technologies, such as our SNC sensors, and our algorithms that more
accurately track and decipher user intent and action. Our technology layers are interdependent and are optimized to the wrist area from
the start, focusing first on device style, form factor, gestures, and user experience. Thus, we&#8217;ve created a significant moat -
a key advantage that sets us apart from our competitors. There is a very high interdependency between each layer to adjacent layers, and
developing similar solutions requires expertise in each individual layer. New entrants that move from the forearm or the wrist back to
the inner wrist area will need to develop all these layers, reduce the number of sensors to fit the wrist area size, re-design device
form factor and electronics, collect and train algorithms using new biopotential signals patterns, re-design their data communication
protocol, and define the gestures and user interaction, as if they are developing a new device altogether.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9675;</td><td style="text-align: justify"><b>Broad mobile, API, and algorithms compatibility.</b> Our broad mobile compatibility means our users
will be able to sync their Mudra devices with multiple mobile phone models, including iOS, Android, and Windows products. Our API allows
access and exploration of our Mudra technology to various industry sectors in consumer electronics, industry, IT and software solutions,
academia, and software development. Our cross-platform software engine supports real-time signal processing and supports cross-platform
algorithms mitigation on multiple operating systems. This allows us to activate our software on low compute power wearables and digital
devices, and to mitigate algorithms across platforms without the need to re-write the algorithms for each operating system.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9675;</td><td style="text-align: justify"><b>Agile go-to-market strategy for consumer products</b>. We are launching our products after communicating
product benefits, receiving meaningful and valuable feedback from our users and then implementing the feedback into the design phase,
while generating demand to the product before it has been manufactured. This strategy ensures that we only produce and market products
that are suitable to the market and to customers&#8217; demand.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9675;</td><td style="text-align: justify"><b>First mover advantage</b>. We are in the final phases of serial production of the world&#8217;s first
consumer wrist neural controller. This enables us to gain a competitive advantage by being the first to market with a neural input device.
This supports us to establish strong brand recognition and customer loyalty before other competitors enter the market. This advantage
also allows us additional time to perfect the product, define our interactions and gestures as industry standard, and set pricing points.
We plan to establish sufficient market share and a solid customer base to maintain a majority of market share.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Based on these variables, we
believe that we compete favorably when compared with the global competition in this market, which will enable us to maintain and extend
our leadership position.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Growth Strategy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We intend to achieve a leading
position for neural input technology, and to expand our operations to digital and wearable computers. Key elements of our growth strategy
include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Offer a broad range of platform devices.</b> We believe everyone&#8217;s needs are unique, so we will
offer our users a wide range of connected devices to interact and control in multiple styles, form factors, and price points, to allow
people to find the devices that fit their lifestyles and goals. We believe that we can leverage the growing public acceptance and awareness
of wearable neural technologies and the rising adoption of wearable device to market multiple Mudra-based consumer products.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Introduce new features, use-cases, software applications, and services.</b> We plan to continue introducing
new features and services to increase user engagement and revenue. For example, we are investing in building a diverse user-gesture data
bank, which will enable us to develop additional new gestures. It is our belief that the gestures should be natural for the user and tailored
based on the use-case and controlled device, instead of a &#8220;one size fits all&#8221; approach which forces the user to learn new
interactions. In addition to the control use-case, our Mudra technology and SNC sensor can be utilized in multiple monitoring use-cases
where we can monitor neural and hand movements for digital health purposes, sport analytics performance, and Industry solutions. The platform
serves multiple corporations, businesses and individuals in the form of customized mobile and computer applications with a broad range
of business models that include hardware sales, licensing, and SaaS model.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Integrate our Mudra technology into existing devices</b>. We intend to leverage our strong relationships
with multiple consumer electronics companies and brands to sign software and hardware licenses and royalty contracts to make ourselves
a fundamental input component for all digital devices and platforms. We also believe our superior software and hardware integration ability
to work with companies will enable us to sign agreements with leading global and smaller companies for consumer devices and industry use-cases.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Further penetrate the additional markets.</b> We intend to increase our focus on building relationships
with corporations in Industry 4.0, wellness and digital health, and sports analytics. Our main advantage is the ability to continuously
and securely track the user&#8217;s engagement over lengthened periods of times and supply meaningful insights for employee performance
and safety and the user&#8217;s physiology.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Expand brand awareness, global distribution and drive sales of our products and services.</b> We intend
to increase our marketing efforts to further expand global awareness of our brand and drive greater sales of our products and services.
The international markets represent a significant growth opportunity for us, and we intend to expand sales of our products and services
globally through select retailers and strategic partnerships.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><b>Data monetization</b>. Once we have a sufficiently large database, we intend to monetize data derived
from a combination of gestures that authenticates a user, identification of patterns of daily behavior, and monitoring of metrics and
identification. This will expand our offerings related to data and user behavior, which can open multiple new markets and opportunities.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our ability to compete effectively
depends in part on our ability to develop and maintain the proprietary aspects of our technology in hardware, software, sensors, and user
experience. Our policy is to obtain appropriate proprietary rights protection for any potentially significant new technology acquired
or developed by us. We currently hold two U.S. patents: the first patent concerns a wrist wearable gesture control system that uses bio-potential
signals to control digital devices and provides user feedback, and the second patent is a continuation in part of the first patent and
adds the ability to detect user applied fingertip pressure for analog control of digital devices. In addition, we have one China patent
for interface for wearable devices. In addition, we have one patent application in South Korea, an additional two patent applications
in the United States and five patent applications in China, all of which are still pending.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition to patent laws,
we rely upon a combination of designs, copyrights, trade secrets, domain names and trademark rights, and contractual restrictions such
as confidentiality agreements, licenses, and intellectual property assignment agreements. We attempt to protect our trade secrets and
other proprietary information through agreements with all our B2B customer segments, other customers and suppliers, distributors, proprietary
information agreements with our employees and consultants, and other similar measures. Our primary U.S. registered trademark is for our
product line name &#8220;Mudra&#8221;. We cannot be certain that we will be successful in protecting our proprietary rights. While we
believe our patents, patent applications, hardware, software and other proprietary know-how have value, changing technology makes our
future success dependent principally upon our ability to successfully achieve continuing innovation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Litigation may be necessary
in the future to enforce our proprietary rights, to determine the validity and scope of the proprietary rights of others, or to defend
us against claims of infringement or invalidity by others. An adverse outcome in such litigation or similar proceedings could subject
us to significant liabilities to third parties, require disputed rights to be licensed from others or require us to cease marketing or
using certain products, any of which could have a material adverse effect on our business, financial condition and results of operations.
In addition, the cost of addressing any intellectual property litigation claim, both in legal fees and expenses, as well as from the diversion
of management&#8217;s resources, regardless of whether the claim is valid, could be significant and could have a material adverse effect
on our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">At this time, we are not a
party to any pending litigation for infringement of intellectual property rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Research and Development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We are passionate about developing
innovative products and services that allow interaction and control of computers to become natural and intuitive as real-life experiences.
We believe our future success depends on our ability to develop new products and features that expand the versatility and performance
of our existing platform, and we plan to continue to invest significant resources to enhance performance, functionality, and convenience
and style for our users. Our research and development team supports the design and development of our wrist-worn devices, proprietary
sensors, firmware, algorithms, and mobile apps. The team is composed of dedicated research employees, electrical engineers, mechanical
engineers, firmware engineers, site operations engineers, and mobile app developers. Our research and development team is primarily based
at our headquarters in Yokne&#8217;am Illit, Israel. Our subsidiary, Mudra Wearable, Inc., or Mudra Wearable, established an office in
Redwood City, California to enhance the Company&#8217;s market presence and partner relations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our research and development
expenses, net were approximately $2.96 million and approximately $3.3 million for the years ended December 31, 2024 and 2023, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Research
and development expenses, net decreased by approximately $352 thousand, or 11%, to approximately $2,964 thousand for the year ended December
31, 2024, from approximately $3,316 thousand for the year ended December 31, 2023. The decrease was primarily due to a decrease of approximately
$171 thousand in labor costs, a decrease in materials expenses of approximately $302 thousand, a decrease in subcontractors expenses of
approximately $182 thousand and a decrease in travel expenses of approximately $89 thousand due to a decrease in transition costs from
development to production. This decrease was partially offset by a decrease in IIA participation of approximately $322 thousand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We believe that the receipt
of these IIA grants in the years 2015 to 2024 is a positive signal that our technology is innovative and feasible. We received these grants
for the purpose of developing the Mudra SNC core technology, for developing the Mudra Band for Apple Watch hardware architecture, and
for developing a manufacturing process for the Mudra Band.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We continue to pursue non-dilutive
grants from the IIA as well as other organizations in Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Manufacturing, Logistics and Fulfillment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We outsource the manufacturing
of our products to several contract manufacturers. These contract manufacturers produce components of our products in their facilities
located in Asia and Israel. The components used in our products are sourced either directly by us or on behalf of us by our contract manufacturers
from a variety of component suppliers selected by us and located worldwide.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our operations employees coordinate
our relationships with our contract manufacturers and component suppliers. We believe that using outsourced manufacturing enables greater
scale and flexibility at lower costs than establishing our own manufacturing facilities. We evaluate on an ongoing basis our current contract
manufacturers and component suppliers, including, whether or not to utilize new or alternative contract manufacturers or component suppliers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We work with third-party fulfillment
partners to deliver our products from final manufacturing facilities worldwide, which allows us to reduce order fulfillment time, reduce
shipping costs, and improve inventory flexibility.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Sales Channels</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><b>Direct to consumer channel.</b>
We market and offer our products directly to consumers in the United States and other countries through our online stores at Mudra-band.com.
We drive consumers to our website through online and offline advertising as well as marketing promotions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We plan to offer additional
channels as we increase our production capability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><b>Retail channel.</b> We plan
to offer our products in retail stores and are currently focused on building close relationships with our retailers, working with them
to merchandise our products in a compelling manner both in-store and on their e-commerce sites, promote our products through their marketing
efforts, and educate their sales forces about our products. Retail channel stores may also include consumer electronics and specialty
retailers, e-commerce retailers, mass merchant, department store, and club retailers, as well as wireless carriers&#8217; stores.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Marketing and Advertising</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our marketing and advertising
programs are focused on building global brand awareness, increasing product adoption, and driving sales. Our B2C marketing and advertising
efforts target consumers primarily by digital marketing, channel marketing, newsletters, and public relations. We are also exploring opportunities
of endorsements by micro-influencers and brand ambassadors. Our B2B marketing and advertising efforts target business customers by thought
leadership content creation, inbound marketing, conferences, and tradeshows.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_015"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">C. Organizational Structure</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have one wholly-owned subsidiary,
Mudra Wearable, which was incorporated in Delaware. Mudra Wearable has one full-time employee who acts as a general manager and chief
marketing officer. Mudra Wearable is responsible for the marketing and distribution of our products in the United States.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_016"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">D. Property, Plant and Equipment</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have headquarters which
are located at 5 Ha-Tnufa St., Yokne&#8217;am Illit, Israel. This facility comprises approximately 732 square meters, or 7,880 square
feet of space. This lease will expire on January 31, 2025, with an option to extend the lease period by two additional lease periods,
each for an additional 12 months. Our monthly rent payment for this facility was NIS 57,794 (approximately $16,000) during the first lease
year and increased to NIS 72,722 (approximately $20,000) during the second lease year. During the option lease periods, the lease payment
may be increased up to 10% as compared to the second lease year. We exercised the option for an additional 12 month lease period and are
currently in the process of negotiating the rental fee for such an additional lease period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In September 2024, our subsidiary,
Mudra Wearable, established an office located at 3 East Third Avenue, San Mateo, California. The lease is on month-to-month basis and
this facility comprises approximately 40 square feet of space. Our monthly rent payment for this facility is $495.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We consider that our current
office space is sufficient to meet our anticipated needs for the foreseeable future and is suitable for the conduct of our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><b>ITEM 4. </b></span><b>A.
UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">None.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0cm">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0cm"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0cm">&#160;</p><div>

</div><div><a id="D_018"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0cm">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_019"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">A. Operating Results</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><i>The following discussion
and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the
related notes included elsewhere in this annual report on Form 20-F. The discussion below contains forward-looking statements that are
based upon our current expectations and are subject to uncertainty and changes in circumstances. Actual results </i>may <i>differ materially
from these expectations due to inaccurate assumptions and known or unknown risks and uncertainties, including those identified in &#8220;Cautionary
Note Regarding Forward-Looking Statements&#8221; and under &#8220;Risk Factors&#8221; elsewhere in this annual report on Form 20-F. Our
discussion and analysis for the year ended December 31, 2022 and December 31, 2023 can be found in our Annual Report on Form 20-F for
the fiscal year ended December 31, 2023, filed with the SEC on March 15, 2024.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We
are a growth company developing a non-invasive neural input interface in the form of a wearable wristband for controlling digital devices
using subtle finger gestures and hand movements. Since our technology was introduced to the market in 2014, we have been working with
both B2B and B2C customers as part of our push-pull strategy. We are now in the transition phase from research and development to commercialization
of our technology into B2B products. At the same time, starting in December 2023, we have commenced shipment of the Mudra Band, our first
B2C consumer product, and aftermarket accessory band for Apple Watch that enables gesture control across Apple ecosystem devices such
as iPhone, Mac computer, Apple TV, and iPad, inter alia. In September 2024, we launched the Mudra Link, a universal gesture control wearable
wristband. The Mudra Link is open for orders and we have started shipping the Mudra Link to customers in the first quarter of 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mudra Development Kit, originally named Mudra Inspire,
our B2B development kit product, started selling to B2B customers in 2018 as the first point of business engagement and contributed to
our early-stage revenues. At CES 2024, the Mudra Band for Apple Watch, our flagship B2C product was included in the &#8220;Best of CES
2024&#8221; products list by SlashGear. At CES 2025, the Mudra Link, our gesture control stand-alone wristband for all Bluetooth compatible
devices won the CES 2025 Honoree Award in XR Technologies &amp; Accessories.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Over
100 companies have purchased our Mudra Development Kit, 30 of which are multinational technology companies. These companies are exploring
various input and control use-cases for their products, ranging over multiple countries and industry sectors, including consumer electronics
manufacturers, consumer electronics brands, electronic components manufacturers, IT services and software development companies, industrial
companies, and utility providers. Our objective with these companies is to commercialize the Mudra technology by licensing it for integration
in the hardware and software of these companies&#8217; products and services. We estimate that there will be a three-to-five-year period
from the time we are first introduced to a customer to signing a licensing agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">In
addition to consumer electronics, we have recently expanded our brand to include neurotech and brain-computer interface sensors, with
additional verticals that include Industry 4.0 &#8211; a new phase in the Industrial Revolution that focuses on interconnectivity, automation,
machine learning, and real-time data, digital health, sport analytics, and more.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Components
of Results of Operations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>Revenues</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Revenue
is recognized when (or as) control of the promised goods or services is transferred to the customer, and in an amount that reflects the
consideration we are contractually due in exchange for those services or goods. We follow five steps to record revenue: (i) identify the
contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate
the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy our performance
obligations. We generate revenues from the sales of our Mudra Band, our Mudra Inspiredevelopment kits and sales of pilot transactions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; "></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">In
2023, we started production of our B2C consumer product, the Mudra Band, and started to generate revenues, all of which were pre-paid.
The Mudra Band allows touchless operation and control of the watch and iPhone by using an app which is considered combined with the band
as one performance obligation. Revenue derived from the sale of Mudra Band is recognized at a point of time when control transfers to
the customer. We believe that the delivery date is the most appropriate point in time indicating control has transferred to the customer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">A pilot transaction has multiple
performance obligations and it generally takes a few months but less than one year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Each Mudra Inspire development
kit sale also has multiple performance obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In those transactions, each
obligation: hardware and API (for Mudra Inspire development kit) and tailor-made software application and technical support (for a pilot
transaction) is distinct and separately identifiable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The amount allocated to the
delivered items is recognized upon delivery, the amount allocated to API is recognized over the API period and the amount allocated to
the technical support is recognized over the service period (a pilot period).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">The
payment terms of the Mudra Inspire development kits are upon delivery of the hardware, while the payment terms of the pilot transactions
are within the pilot period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Operating Expenses</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Our
current operating expenses consist of four components-cost of revenues, research and development expenses, sales and marketing expenses
and general and administrative expenses. Labor costs are the most significant component of operating expenses and consist of salaries
(including benefits) and share-based compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Cost of revenues</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Cost
of revenues consists primarily of cost of component parts of our products sold and outbound freight charges.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Research and Development Expenses, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Research
and development expenses consist primarily of labor cost, subcontractors and materials. Costs are expensed as incurred, net of governmental
grants from the IIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sales and Marketing Expenses, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>Sales
and marketing expenses consist primarily of labor cost, </span>consultants, and digital advertising.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General and Administrative Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">General
and administrative expenses consist primarily of labor cost, professional service fees and facilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><i>Public Offering Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Public
offering expenses consist of professional service fees relating to a firm commitment underwritten initial public offering we closed on
September 15, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><i>Financial
Income and Expense</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>Financial
income mainly consists of interest on deposits while financial expenses consist of interest on convertible promissory note, bank charges
and net currency exchange rates differences</span>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Comparison of the Years Ended December 31,
2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Results of Operations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following table summarizes our results of
operations for the periods presented.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">U.S. dollars in thousands</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">522</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">82</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(437</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(62</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Research and development expenses, net</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,964</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(3,316</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing expenses, net</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,096</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,008</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">General and administrative expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,845</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,882</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,820</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(8,186</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Finance (expense) income, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(52</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">372</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before tax expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,872</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,814</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net loss and the total comprehensive loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(7,879</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(7,814</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenues</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>Revenues
increased by approximately $</span>440 <span>thousand, or </span>537<span>%,
to approximately $</span>522 <span>thousand for the year ended December 31, 2024, from approximately $82
thousand for the year ended December 31, 2023. The increase was mainly due to revenue growth from the sale of our B2C Mudra Bands.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Cost of revenues</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>The
cost of revenues increased by approximately $</span>375 <span>thousand, or </span>600<span>%,
to approximately $</span>437 <span>thousand for the year ended December 31, 2024, from approximately $62
thousand for the year ended December 31, 2023. The increase was mainly due to an increase in costs of goods and manufacturing costs as
a result of an increase in sales of our B2C Mudra Bands.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Research and development expenses, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Research
and development expenses, net decreased by approximately $352 thousand, or 11%, to approximately $2,964 thousand for the year ended December
31, 2024, from approximately $3,316 thousand for the year ended December 31, 2023. The decrease was primarily due to a decrease of approximately
$171 thousand in labor costs, a decrease in materials expenses of approximately $302 thousand, a decrease in subcontractors expenses of
approximately $182 thousand and a decrease in travel expenses of approximately $89 thousand, due to a decrease in transition costs from
development to production. This decrease was partially offset by a decrease in IIA participation of approximately $322 thousand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sales and marketing expenses, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Sales
and marketing expenses, net increased by approximately $88 thousand, or 4%, to approximately $2,096 thousand for the year ended December
31, 2024, from approximately $2,008 thousand for the year ended December 31, 2023. The increase was primarily due to an increase in advertising
expenses in 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General and administrative expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">General
and administrative expenses decreased by approximately $37 thousand, or 1.3%, to approximately $2,845 thousand for the year ended December
31, 2024, from approximately $2,882 thousand for the year ended December 31, 2023. The decrease was primarily due to a decrease in directors
and officers&#8217; insurance costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Finance income (expense), net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Finance expense, net was approximately
$52 <span>thousand</span> for the year ended December 31, 2024, compared to finance income, net of approximately
$372 <span>thousand</span> for the year ended December 31, 2023. Finance expense, net in 2024 was primarily
due to interest on convertible promissory note, partially offset by interest income on short-term deposits. Finance income, net in 2023
was primarily due to interest on bank deposits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Net loss and the total comprehensive loss</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As a result of the foregoing,
our total comprehensive and net loss for the year ended December 31, 2024 was approximately $7.9 million, compared to approximately $7.8
million for the same period ended December 31, 2023, an increase of approximately $65 thousand, or 0.8%.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_020"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">B. Liquidity and Capital Resources</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We
are still in a transition phase from development stage to an early stage of generating revenues. Therefore, we have suffered recurring
losses from operations and negative cash flows from operations since inception. Our operations have been funded substantially through
issuance of convertible securities to certain investors which were converted to equity, issuance of shares and warrants, through Israeli
governmental grants, an underwritten public offering in November 2023, registered direct offering and concurrent private placement of
warrants in November 2024, best efforts offering in January 2025 and our IPO. Considering the above, our dependency on external funding
for our operations raises a substantial doubt about our ability to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">As
of December 31, 2024, the Company had incurred accumulated losses of $29.1 million and expects to continue to fund its operations through
issuances of Ordinary Shares and warrants, convertible securities, and through Israeli governmental grants. There is no assurance that
such financing will be obtained. We believe that our existing cash, including the proceeds from our recent offerings of Ordinary Shares,
will be sufficient to support working capital and capital expenditure requirements through September 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Our
future capital requirements will depend on many factors, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">the progress and costs of our research and development activities;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the costs of manufacturing our products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the time that we will be able to generate significant revenues;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the costs of filing, prosecuting, enforcing and defending
patent claims and other intellectual property rights;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the potential costs of contracting with third parties to provide
marketing and distribution services for us or for building such capacities internally; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the magnitude of our general and administrative expenses.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Until
we can generate significant recurring revenues, profit and cash flow provided by operating activity we expect to satisfy future cash needs
through existing cash, debt or equity financings as well as governmental grants and proceeds from exercises of options and warrants. In
the event that we require additional financing, we may not be able to raise such financing on terms acceptable to us or at all. If we
are unable to raise additional capital or generate cash flows necessary to expand our operations and invest in continued innovation, we
may not be able to compete successfully, which would harm our business, results of operations, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The table below summarizes
our cash flows for the periods indicated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Year Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">U.S. dollars</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net cash used in operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(7,613</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(8,434</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net cash provided by (used in) investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,248</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,695</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,119</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Net increase (decrease) in cash and cash equivalents</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,279</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(9,563</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Operating Activities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have generated negative
cash flow. Our primary uses of cash from operating activities are for labor costs, research and development expenses for materials and
subcontractors and professional services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Cash
used in operating activities mainly consists of our net loss adjusted for certain non-cash items, including share-based compensation,
depreciation expenses and changes in operating assets and liabilities during each period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>During
the years ended December 31, 2024 and 2023, net cash used in operating activities was approximately $</span>7.6 <span>million
and approximately $8.4 million, respectively. The primary factors affecting operating cash flows were a net loss of approximately $</span>7.9
<span>million and an increase of inventory of approximately $</span>194 <span>thousand
during the year ended December 31, 2024, as compared to net loss of approximately $7.8 million and increase of inventory of approximately
$1 million during the year ended December 31, 2023. Cash used in operating activities was partially offset by non-cash adjustments of
approximately $</span>458 <span>thousand and approximately $196 thousand during the years ended December
31, 2024 and 2023, respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Net cash provided by (used in) investing
activities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Cash
provided by investing activities for the year ended December 31, 2024, was approximately $3.2 million, primary due to a decrease in short-term
deposits. Cash used in investing activities for the year ended December 31, 2023, was approximately $4.2 million, mainly due to an increase
in short-term deposits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Net cash provided by financing activities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Cash
provided by financing activities during the year ended December 31, 2024 totaled approximately $6.7 million, mainly due to proceeds of
approximately $4.4 million, net from issuance of shares pursuant to the SEPA (as defined below), $0.8 million, net from issuance of a
convertible promissory note and approximately $1.6 million proceeds from a public offering, net of issuance cost.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On July 4, 2022, we entered
into a three-year consulting agreement, or the Credit Facility Agreement, with Pure Capital Ltd., or Pure Capital, which did not include
a provision of termination by us for convenience after the consulting commencement date. Pursuant to the Credit Facility Agreement, Pure
Capital renders press release related services and other related strategic services to us in exchange for a current monthly base fee of
$35,000 plus VAT. If 70% or more of the warrants (or other convertible securities) issued in connection with our IPO are exercised during
the term of such instrument, then the base monthly fee will immediately increase to $70,000, which increase shall apply retroactively;
and, for the avoidance of any doubt, the base increase shall remain effective and in full force notwithstanding the lapse of three years.
Pure Capital started providing consulting services to us on September 15, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Credit Facility Agreement
also provided that from July 4, 2022 to, June 30, 2024, Pure Capital would serve as our strategic consultant in connection with any offering
or financing transaction of our company, each in excess of $5,000,000, in exchange for a per offering and/or transaction fee of $100,000
for the closing(s) of any such offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On February 16, 2023, we issued
an aggregate of 2,114 Ordinary Shares to certain investors in our April 2021 financing pursuant to certain provisions in our agreements
with such investors as a result of issuing Ordinary Shares at a price lower than the price they had paid for their Ordinary Shares. We
do not have any remaining obligation to issue additional securities to such investors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In June 2023, we issued an
additional 9,052 Ordinary Shares upon the exercise of Warrants at an exercise price of $160.00 per share for aggregate proceeds of $1.4
million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">On
November 13, 2023, we closed a public offering with gross proceeds to the Company of $2.0 million, before deducting underwriting discounts
and other expenses paid by the Company, and net proceeds of approximately $1.7 million after such discounts and expenses.<b><i>&#160;</i></b>The
offering consisted of 55,555 ordinary shares priced to the public at $36.00 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On June 6, 2024, we entered
into a Standby Equity Purchase Agreement, or SEPA, with YA II PN, Ltd., or YA, a fund managed by Yorkville Advisors Global, L.P. Pursuant
to the terms of the SEPA, YA committed to purchase up to $10 million, or the Commitment Amount, of Ordinary Shares at any time during
the three-year period following the execution date of the SEPA. In connection with the SEPA, we could request pre-paid advances of the
Commitment Amount, in an amount up to $3.0 million, each a Pre-Paid Advance. Each Pre-Paid Advance was evidenced by a promissory note,
each, a Promissory Note. Each Promissory Note was to fully mature 12-months following its issuance and accrued interest on the outstanding
principal balance thereon at a rate of 6% per annum, increasing to 18% per annum upon an Event of Default (as defined in the Promissory
Note). Beginning 60 days after the issuance of a Promissory Note, we were required to pay to YA a monthly installment payment of 10% of
the original principal amount of the Promissory Note and accrued interest, payable in cash or by submitting an Advance Notice, where YA
would offset the amount due to be paid to us under such notice against an equal amount of the monthly installment amount, at our option.
If we elected to pay in cash, the installment amount also included a payment premium in the amount of 5% of the principal amount of the
installment payment. We started to raise funds under the SEPA at the end of June 2024 and sold 307,175 Ordinary Shares for aggregate gross
proceeds of approximately $4.6 million. We requested and received a Pre-Paid Advance in the amount of $2.0 million. On February 6, 2025,
we repaid our outstanding balance pursuant to the SEPA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Following approval by our shareholders
in September 2024, after market close on October 7, 2024, we effected a reverse share split of our issued and outstanding Ordinary Shares,
at a ratio of 1-for-20. As a result of the reverse share split, every 20 Ordinary Shares were consolidated into one Ordinary Share, and
every 20 tradable warrants were consolidated into one warrant. In addition, the exercise price underlying each warrant was proportionately
adjusted. Our Ordinary Shares began trading on the Nasdaq Capital Market on a post-reverse split basis at the open of the market on October
10, 2024. The implementation of the reverse share split did not amend our registered share capital under our amended and restated articles
of association, as currently in effect, which consists of&#160;50,000,000 Ordinary Shares. This reverse share split adjusted the number
of issued and outstanding Ordinary Shares of the Company from approximately 24,438,030 Ordinary Shares to approximately 1,254,622 Ordinary
Shares and the number of warrants from 7,860,861 warrants to 393,043 warrants. Following approval by our shareholders in February 2025,
after market close on March 13, 2025, we effected an additional reverse share split of our issued and outstanding Ordinary Shares, at
a ratio of 1-for-4. As a result of the reverse share split, every 4 Ordinary Shares were consolidated into one Ordinary Share, and every
4 tradable warrants were consolidated into one warrant. In addition, the exercise price underlying each warrant was proportionately adjusted.
Our Ordinary Shares began trading on the Nasdaq Capital Market on a post-reverse split basis at the open of the market on March 17, 2025.
The implementation of the reverse share split did not amend our registered share capital under our amended and restated articles of association,
as currently in effect, which consists of&#160;50,000,000 Ordinary Shares. This reverse share split adjusted the number of issued and
outstanding Ordinary Shares of the Company from approximately 3,939,911 Ordinary Shares to approximately 1,028,980 Ordinary Shares and
the number of warrants from 393,043 warrants to 98,261 warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The number of Ordinary Shares
available for issuance under our equity incentive plans has been adjusted by the same 1-for-20 ratio and additional 1-for-4 ratio. In
addition, a proportionate, upwards adjustment to the per share exercise price, and a corresponding decrease to the number of Ordinary
Shares issuable upon exercise, was made to all outstanding options entitling the holders to purchase Ordinary Shares. Similarly, a proportionate
downwards adjustment was made to the number of Ordinary Shares issuable upon settlement of our outstanding Restricted Share Units, or
RSUs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On November 27, 2024, we closed
a registered direct offering for the issuance and sale of 63,000 Ordinary Shares and pre-funded warrants to purchase up to 142,500 Ordinary
Shares and a concurrent private placement for the sale of warrants to purchase up to 205,500 Ordinary Shares, at a combined purchase price
of $9.00 per Ordinary Share and accompanying warrant and a combined purchase price of $8.9996 per pre-funded warrant and accompanying
warrant. We received aggregate gross proceeds of approximately $1.85 million, before deducting placement agent fees and other offering
expenses The warrants issued pursuant to the concurrent private placement have an exercise price of $10.00 per Ordinary Share, were immediately
exercisable and will expire five years following the date of issuance. Following the reasonable best efforts&#8221; public offering from
January 30, 2025, the exercise price of these warrants was reduced to $4.00. The pre-funded warrants have an exercise price of $0.0004
per Ordinary Share, were immediately exercisable upon issuance and may be exercised at any time until the pre-funded warrants are exercised
in full (subject to certain beneficial ownership limitations).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On January 30, 2025, we closed
a &#8220;reasonable best efforts&#8221; public offering with a single institutional investor for the purchase and sale of 86,250 Ordinary
Shares, pre-funded warrants to purchase up to 538,750 Ordinary Shares and warrants to purchase up to 625,000 Ordinary Shares, at a combined
offering price of $4.00 per share and accompanying warrant and a combined offering price of $3.9996 per pre-funded warrant and warrant.
We received aggregate gross proceeds of approximately $2.5 million, before deducting placement agent fees and other offering expenses.
The warrants have an exercise price of $4.00 per Ordinary Share, are exercisable immediately and expire five years from the issuance date.
The pre-funded warrants have an exercise price of $0.0004 per Ordinary Share, were immediately exercisable upon issuance and may be exercised
at any time until the pre-funded Warrants are exercised in full (subject to certain beneficial ownership limitations).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Off-Balance Sheet Arrangements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our headquarters are located
at 5 Ha-Tnufa St., Yokne&#8217;am Illit, Israel. This facility comprises approximately 732 square meters, or 7,880 square feet of space.
We have leased this office since February 1, 2023 and on January 31, 2025 we exercised an option to extend the lease for an additional
12 months period. Our monthly rent payment for this facility was NIS 57,794 (approximately $16,000) during the first lease year and increased
to NIS 72,722 (approximately $20,000) during the second lease year. We are currently negotiating the monthly rent payment for the extended
lease period, which according to the terms of the lease agreement, may be increased up to 10% as compared to the second lease year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have off-balance sheet arrangements
in connection with our research and development agreements with the IIA. Under the applicable laws, we are required to pay royalties at
the rate of 3%-3.5% of sales of products developed with the funds provided by the IIA, up to an amount equal to 100% of the IIA research
and development grants received, linked to the dollar including accrued interest. Until October 25, 2023, the interest was calculated
at a rate based on 12-month LIBOR applicable to US Dollar deposits. IIA grants approved by the IIA prior to January 1, 2024 but which
are outstanding thereafter, as of January 1, 2024, the annual interest is calculated at a rate based on 12-month Secured Overnight Financing
Rate, or SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January
1, 2024 the annual interest is the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%.
We obligated to repay the Israeli government for the grants received only to the extent that there are revenues of the funded products
(currently all the Company&#8217;s products). The royalty payments to the IIA are on a semi-annual basis. As December 31, 2024, we had
a contingent obligation to pay royalties to the IIA in the principal amounted of $2.4 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition, the terms of the
grants under the Research Law require that the manufacturing of products resulting from IIA-funded programs be carried out in Israel,
unless a prior written approval of the IIA is obtained. In December 2022, we received an approval from the IIA to transfer some of our
manufacturing activities abroad. As a condition for obtaining approval to manufacture outside of Israel (or following a declaration that
up to 10% of the production is transferred abroad), we would be required to pay increased royalties, which usually amount to 1% in addition
to the standard royalties rate 3%-3.5%, and also the total amount of our liability to IIA may be increased to between 100% and 150% of
the grants we received from IIA, depending on the manufacturing volume that is performed outside of Israel (less royalties already paid
to IIA). For more information, see also &#8220;Item 10.E - Taxation - Israeli Tax Considerations and Government Programs - Tax Benefits
and Grants for Research and Development.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In January 2023, the IIA approved
a program to finance further development of our manufacturing process of our wearable neural interface in Israel, for a period of 12 months
starting February 1, 2023. The IIA approved extension of the program until April 30, 2024. The approved program is in the amount of approximately
$900 thousand, of which the IIA will finance 60%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We also have off-balance sheet
arrangements in connection with our sales and marketing agreement with the IMEI. Under the applicable laws, if the export revenues in
the defined target market increase by $311 thousand compared to the base year, the Company would be required to pay royalties at the rate
of 3% of the increase. The royalty payments to the IMEI are calculated as 3% annually of the excess of Company&#8217;s annual revenues
from the Mudra Band in the U.S. market in each year commencing 2022 over the Company&#8217;s 2020 actual revenues from the U.S. market
plus NIS 1 million (i.e., 3% on revenues in the U.S. market in each year exceeding approximately $311 thousand). The royalty payments
to the IMEI are on an annual basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As of December 31, 2024, the
maximum obligation with respect to the grant received from the IMEI, contingent upon entitled future sales, was $95 thousand linked to
the consumer price index.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We do not believe that off-balance
sheet arrangements and commitments (with the exception of our lease contract, which may have some impact on our expenses and results of
operations) are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues
or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_021"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">C. Research and development, patents
and licenses, etc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For a description of our research
and development programs and the amounts that we have incurred over the last two years pursuant to those programs, please see &#8220;Item
5.A. Operating Results- Operating Expenses- Research and Development Expenses, net&#8221; and &#8220;Item 5.A. Results of Operations-
Comparison of the years ended December 31, 2024 and December 31, 2023- Research and Development Expenses, net.&#8221;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_022"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">D. Trend information</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As of March 19, 2025, we employed
25 full-time employees (including one employee located in Lithuania and one employee located in the United States), and nine part-time
employees. We have two sub-contractors located in India, performing front-end software application development. We intend to maintain
this number of employees and expenses during 2025, mainly to support our business development activities, the continuous research and
development activity of our Mudra technology, and to manufacture the Mudra Band, which includes the purchase of components, manufacturing
of components, and assembly of the product.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">In September 2024, we launched the Mudra Link, a
universal gesture control wearable wristband. The Mudra Link is open for orders and we have started shipping the Mudra Link to customers
in the first quarter of 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Adverse macroeconomic conditions,
including recent inflation, slower growth, changes to fiscal and monetary policy, higher interest rates, and currency fluctuations have
impacted companies in Israel and around the world, and as the future market conditions and possible recession remain highly uncertain,
we cannot predict severity of the possible recession and its effects on our customers and their spending habits. See also Item 3.D. &#8220;Risk
Factors&#8221; - General economic factors may adversely affect our business, financial performance and results of operations.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_023"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">E. Critical Accounting Estimates</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The preparation of the consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and
the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that are the most important
to the portrayal of the Company&#8217;s financial condition and results of operations, and that require the most difficult, subjective
and complex judgments. The most critical accounting policies, discussed below, pertain to areas where judgment of management, historical
factors and estimates require a high degree of involvement when determining the final reported balance in the Company&#8217;s consolidated
financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue recognition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Revenue is recognized when
(or as) control of the promised goods or services is transferred to the customer, and in an amount that reflects the consideration we
are contractually due in exchange for those services or goods. We follow five steps to record revenue: (i) identify the contract with
a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction
price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy our performance obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generate revenues from
the sales of B2C Mudra Band, sales of B2B Mudra Development Kits and sales of pilot transactions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Mudra Band is an aftermarket
accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app, which is considered
combined with the band as one performance obligation. Revenue derived from the sale of Mudra Band is recognized at a point of time when
control transfers to the customer. We believe that the delivery date is the most appropriate point in time indicating control has been
transferred to the customer.&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We allow return and refund
of Mudra Band within 30 days from the delivery of Mudra Band. We record an appropriate provision for such refunds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenue derived from freight
charges is considered as a separate performance obligation recognized when the related product revenue is recognized.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A pilot transaction has multiple
performance obligations, and it generally takes a few months but less than one year. Each Mudra Development Kit sale also has multiple
performance obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The payment terms of the Mudra
Development Kit sales are upon delivery of the hardware, while the payment terms of the pilot transactions are within the pilot period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In those transactions, each
obligation- hardware and API (for Mudra Development Kit) and tailor-made software application and technical support (for a pilot transaction)
- is distinct and separately identifiable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The amount allocated to the
delivered items is recognized upon delivery, the amount allocated to API is recognized over the API period and the amount allocated to
technical support is recognized over the service period (a pilot period).&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Governmental grants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Company receives royalty-bearing
grants from the Israeli government for approved research and development projects and marketing efforts. These grants are recognized at
the time the Company is entitled to such grants based on the costs incurred or milestones achieved as provided by the relevant agreement
and included as a deduction from research and development or sales and marketing expenses, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Share based compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Share-based compensation expenses
related to employees&#8217; and consultants&#8217; awards (including without limitations, options, restricted shares and restricted share
units) are measured at the grant date based on the fair value of the award and are generally expensed over the requisite service period
(generally the vesting period). We recognize compensation expense on a straight-line basis from the beginning of the service period. For
awards with graded-vesting features, each vesting tranche is separately expensed over the related vesting period. We estimate the fair
value of each stock option grant using the Black-Scholes option pricing model, which requires management to make certain assumptions of
future expectations based on historical and current data include the expected term of the stock option, expected volatility, dividend
yield, and risk-free interest rate.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0cm">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0cm"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0cm">&#160;</p><div>

</div><div><a id="D_024"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0cm">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_025"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">A. Directors and Senior Management</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The following table sets forth
information regarding our executive officers, key employees and directors as of March 19, 2025:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font-size: 10pt; width: 20%"><span style="font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center; width: 5%"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center; width: 50%"><span style="font-size: 10pt"><b>Position </b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: center; width: 20%"><span style="font-size: 10pt"><b>Class</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Asher Dahan</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">47</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Chief Executive Officer, Chairman of the Board of Directors</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Class III<sup>(6)</sup></span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Alon Mualem</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">57</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">N/A</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Tamar Fleisher</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">44</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Chief Operating Officer</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">N/A</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Guy Wagner</span></td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">47</span></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Chief Scientific Officer, President and Director</span></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Class III<sup>(6)</sup></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Leeor Langer</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">43</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Chief Technology Officer</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">N/A</span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Shmuel Barel</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">49</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Chief Marketing Officer</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">N/A</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Offir Remez</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">54</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Executive Vice President of Business Development</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">N/A</span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Eli Bachar<sup>(1)(2)(3)</sup></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">42</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Class II<sup>(5)</sup></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Yaacov Goldman<sup>(1)(2)(3)</sup></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">69</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Class II<sup>(5)</sup></span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Ilana Lurie<sup>(1)(2)(3)</sup></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt">52</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; font-size: 10pt"><span style="font-size: 10pt">Class I<sup>(4)</sup></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td style="vertical-align: top; width: 0.25in; font-size: 10pt"><span style="font-size: 10pt">(1)</span></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-size: 10pt">Member of the Compensation Committee</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-size: 10pt">(2)</span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Member of the Audit Committee and Financial Statement Examination Committee</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-size: 10pt">(3)</span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Independent Director (as defined under Nasdaq Stock Market rules)</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Class I directors shall hold office until the annual general meeting to be held in 2026 and until their successors shall have been elected and qualified.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-size: 10pt">(5)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Class II directors shall hold office until the annual general meeting to be held in 2027 and until their successors shall have been elected and qualified.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt"><span style="font-size: 10pt">(6)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Class III directors shall hold office until the annual general meeting to be held in 2025 and until their successors shall have been elected and qualified.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Asher
Dahan, Chief Executive Officer, Chairman of the Board of Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>Mr.
Asher Dahan has served as our director since March 2014 and as our Chief Executive Officer and as acting Chief Financial Officer since
March 2016 and as the chairman of our board of directors since March 6, 2022. Mr. Dahan founded our company together with Mr. Guy Wagner
and Mr. Leeor Langer in March 2014. From 2013 to 2015, Mr. Dahan worked as Electrical Validation Manager at Intel Haifa, Israel. He worked
for Intel Haifa, Israel from 2006 to 2012 as Technical Leader and Engineer for High Speed Interfaces. Mr. Dahan has a BSc. in Electrical
Engineering from Ort Braude College. Mr. Dahan serves both as our Chief Executive Officer and as the Chairman of our board of directors,
in accordance with the provisions of the Companies Law and the Companies Regulations (Validity Period of a Decision According to Section
121 of the Companies Law), 5776-2016, which allows such dual office for a period of five years following the completion of the IPO.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Alon
Mualem, Chief Financial Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>Mr.
Alon Mualem has served as our Chief Financial Officer since January 7, 2022. Mr. Mualem previously served as the Chief Financial Officer
of Eltek Ltd. (Nasdaq: ELTK), an Israeli public company, from January 2019 to January 2022. Mr. Mualem served as the Chief Financial Officer
of SharpLink Gaming Ltd. (Nasdaq: SBET), formerly known as Mer Telemanagement Solutions Ltd., an Israeli public company, from 2007 to
September 2018. Prior thereto, between 2005 and 2007, Mr. Mualem served as the Chief Financial Officer of Xfone, Inc. (AMEX and TASE:
XFN), an international communications services company. Previously, Mr. Mualem served as a controller and Chief Financial Officer of hi-tech
companies, and as an audit manager at Somekh Chaikin,</span> a member firm of KPMG International<span>.
Mr. Mualem holds a B.A. degree in Accounting and Economics from Tel Aviv University and is a licensed CPA (Israel).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Tamar
Fleisher, Chief Operating Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>Ms.
Tamar Fleisher has served as our Chief Operating Officer since January 2023. As our Chief Operating Officer, Ms. Fleisher leads and scales
our global business operations with the primary responsibility of accelerating operational performance and managing our manufacturing
and production processes for the Mudra Band. Ms. Fleisher previously served as the Chief Operating Officer and Director of Product Management
at Serenno Medical Ltd. from August 2021 to December 2022, a healthcare company with a pioneering technology to improve acute kidney injury
and fluid management. Before then, she served as a director of product management at StemRad Ltd. from January 2018 to August 2021, a
world leader in the provision of personal radiation protection solutions and technology. Prior to that, Ms. Fleisher served as a general
manager and head of design and engineering at Librus Design Ltd. from October 2015 to December 2017, a company specializing in the design
and engineering of plastic products. Ms. Fleisher has a B.A. degree in industrial design from the Holon Institute of Technology.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Guy Wagner,
Chief Scientific Officer, President and Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>Mr.
Guy Wagner has served as our director since March 2014 and as our Chief Scientific Officer and as Company President since March 2016.
Mr. Wagner founded our company together with Mr. Asher Dahan and Mr. Leeor Langer in March 2014. From 2005 to 2014, Mr. Wagner worked
as Hardware Engineer at Intel Haifa, Israel. Mr. Wagner has a BSc. in Electrical Engineering from Ort Braude College.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Leeor
Langer, Chief Technology Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Mr. Leeor Langer has served
as our Chief Technology Officer since March 2016. Mr. Langer founded our company together with Mr. Asher Dahan and Mr. Guy Wagner in March
2014. From 2014 to 2015, Mr. Langer worked as an algorithms developer at CMT Medical Technologies Ltd., developing image processing techniques
for medical x-ray applications. Prior to that, he worked for BrandShield Ltd. from 2012 to 2014 as an algorithms engineer, developing
ranking algorithms for digital brand protection. From 2009 to 2012, Mr. Langer worked as a tools developer and algorithms engineer at
Intel in Israel, developing signal processing methods for electrical validation labs. Mr. Langer has a BSc. in Electrical Engineering
from the Technion - Israel Institute of Technology and an MSc. in Applied Mathematics from the Tel Aviv University. Mr. Langer graduated
cum laude and published his thesis and papers on digital pathology in peer reviewed journals.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Shmuel
Barel, Chief Marketing Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Mr. Shmuel Barel has served
as our Chief Marketing Officer since March 2018 and has served as General Manager of Mudra Wearable since January 2024. Mr. Barel previously
served as owner at SamsProjects, a consultancy business, from January 2014 to March 2018. Mr. Barel served as a Senior Marketing Analyst
at Media World Ltd., a global investment and sales company, from February 2010 to December 2013. Prior thereto, between 2006 and 2010,
Mr. Barel served as Application and Training Engineer at Applied Materials, Inc. (Nasdaq: AMAT), an international semiconductor equipment
and software supplier. Previously, Mr. Barel served as Computer Aided Design Engineer at the Israeli Aircraft Industries, a major aerospace
and aviation manufacturer in Israel, from February 2006 to January 2010. Mr. Barel holds an MBA degree from the Bar Ilan University, a
Master of Systems Engineering degree from the Technion - Israel Institute of Technology, and a BSc in Mechanical Engineering from the
Tel-Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Offir
Remez, Executive Vice President of Business Development</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Mr. Offir Remez has served
as our Executive Vice President of Business Development since November 2021. Before then, Mr. Remez served as an advisor to our Chief
Executive Officer from June 2017 to October 2021. Mr. Remez served as a member on the board of directors of Adshir Ltd. from January 2014
to October 2021. Mr. Remez holds a M.Sc with excellence (magna cum laud) in Mathematics and Computer Science from the Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Eli Bachar,
Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>Mr.
Eli Bachar has served as </span>our <span>director since 2016. From 2013 to 2021, Mr. Bachar is a serial
investor. He was a director of Xjet3D from 2014 to 2021. From 2015 to 2019, Mr. Bachar was a director of 6 Over 6 Vision Ltd. He was a
director of GetSat Ltd. from 2014 to 2021. From 2013 to 2021, Mr. Bachar was a director of Silentium Ltd. He was a director of Cupixel
Ltd. from 2017 to 2021. Mr. Bachar holds a BA in Business Administration and Management from the Reichman University (previously known
as IDC Herzliya).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Yaacov Goldman, Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Mr. Yaacov Goldman has served
as one of our directors since September 2022. He provides consulting services to companies in strategic-financial areas, through his wholly
owned company, Maanit-Goldman Management &amp; Investments (2002) Ltd. Mr. Goldman has served as external director for Can-Fite BioPharma
Ltd. (NYSE:CANF) since August 2017. Mr. Goldman also serves as a director of Avgol Industries 1953 Ltd., Mivne Real Estate (K.D) Ltd.,
and Prashkovsky Investments and Construction Ltd. Mr. Goldman served as the Professional Secretary of the Peer Review Institute of the
Certified Public Accountants Institute in Israel from October 2004 until September 2008. Commencing in 1981, Mr. Goldman worked for Kesselman
&amp; Kesselman (Israeli member firm of PricewaterhouseCoopers) for 19 years, and from 1991 until 2000, as a partner and then senior partner
of such firm. From September 2000 until November 2001, Mr. Goldman served as managing director of Argoquest Holdings, LLC. Mr. Goldman
holds a B.A. degree in Economics and Accounting from Tel Aviv University and is a Certified Public Accountant (Israel).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Ilana Lurie, Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Ms. Ilana Lurie has served
as one of our directors since September 2022. Ms. Lurie is a Chief Financial Officer, Chief Operations Officer, and Director with vast
experience in international finance and operations, within both large technology companies as well as Start-Ups. In a course of last 10
years, Ilana led significant financing rounds, as well as debt restructuring processes. She has served as an external director for Eltek
Ltd. (NASDAQ:ELTK) since September 2018. Ms. Lurie played a critical role in transition from R&amp;D to production in NovelSat and she
is currently leading this activity in IO Tech, in her capacity as Chief Financial Officer and Chief Operations Officer. During 2012 until
2020, Ms. Lurie has been Chief Financial Officer of NovelSat, Landa Ventures portfolio company. Prior to her tenure at NovelSat, Ms. Lurie
served as Finance Manager for the Enterprise Services business unit (formerly EDS) of Hewlett Packard (NYSE:HPQ). From 2006 to 2011, Ms.
Lurie held several financial management positions at Ness Technologies (NASDAQ/TASE:NSTC), which, at the time, was a public company. Ms.
Lurie earned her B.A. degree and an MBA degree with a specialization in Finance and Marketing from Hebrew University of Jerusalem.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>Family Relationships</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">There are no family relationships
between any members of our executive management and our directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>Arrangements for
Election of Directors and Members of Management</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span>There
are no arrangements or understandings with major shareholders, customers, suppliers or others pursuant to which any of our executive management
or our directors were selected.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_026"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">B. Compensation</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The following table presents
in the aggregate all compensation we paid to all of our directors and senior management as a group for the year ended December 31, 2024.
The table does not include any amounts we paid to reimburse any of such persons for costs incurred in providing us with services during
this period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">All amounts reported in the
tables below reflect the cost to the Company, in thousands of U.S. Dollars, for the year ended December 31, 2024. Amounts paid in NIS
are translated into U.S. dollars at the rate of NIS 3.699 = U.S. $1.00, based on the average representative rate of exchange between the
NIS and the U.S. dollar as reported by the Bank of Israel during such period of time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Salary, <br/> bonuses and <br/> Related <br/> Benefits</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pension, <br/> Retirement <br/> and Other <br/> Similar <br/> Benefits</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Share
<br/> Based <br/> Compensation&#160;<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left"><span style="font-size: 10pt">All directors and senior management as a group, consisting of 11<sup>(2)</sup> persons as of December 31, 2024</span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,642,962</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">365,014</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">90,484</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 58.5pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">(1)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Includes: (i) options granted to Alon Mualem to purchase 1,500 Ordinary Shares under the Wearable Devices Ltd. 2015 Share Option Plan, as amended, or the 2015 Plan. The options have expiration dates ranging from January 2032 to August 2033, with exercise prices ranging from $0.24 to $105.60; (ii) options granted to Barry Kaplan (a former director) to purchase 3,180 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from April 2028 to August 2033, and exercise prices ranging from $105.60 to $180 per share; (iii) options granted to Offir Remez to purchase 1,962 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from January 2032 to August 2033, with exercise prices ranging from $0.24 to $105.60, (v) options granted to Shmuel Barel to purchase 2,090 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from December 2027 to August 2033; (vi) options granted to Asher Dahan to purchase 1,000 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from August 2033 to September 2034 with exercise prices ranging from $105.60 to $34.32; (vii) options granted to Guy Wagner to purchase 1,000 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from August 2033 to September 2034 with exercise prices ranging from $105.60 to $34.32; (vii) options granted to Leeor Langer to purchase 375 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $105.60; (vii) options granted to Yaacov Goldman to purchase 250 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $105.60; (vii) options granted to Ilana Lurie to purchase 250 Ordinary Shares under the 2015 Plan. The options expire in August 2033 and have an exercise price of $105.60; and (vii) options granted to Eli Bachar to purchase 2,555 Ordinary Shares under the 2015 Plan. The options have expiration dates ranging from November 2027 to August 2033, with exercise prices ranging from $0.24 to $105.60.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify">&#160;</td>
    <td style="font-size: 10pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">(2)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Barry Kaplan&#8217;s employment agreement was terminated, effective December 31, 2024.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For so long as we qualify as
a foreign private issuer, we will not be required to comply with the proxy rules applicable to U.S. domestic companies regarding disclosure
of the compensation of certain executive officers on an individual basis. In accordance with the Companies Law, we are required to disclose
the compensation granted to our five most highly compensated officers. The table below reflects the compensation granted during or with
respect to the year ended December 31, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-weight: bold">Executive Officer</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary, Bonuses <br/> and Related<br/> Benefits<sup>(1)(3)</sup></b></span></td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Social<br/>
Benefits <br/> and<br/> Perquisite&#160;<sup>(3)</sup></b></span></td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-Based<br/>
Compensation&#160;<sup>(2)</sup></b></span></td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total<sup>(3)</sup></b></span></td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Asher Dahan</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">205,395</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">56,881</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,594</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">266,870</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Guy Wagner</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,395</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">55,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,594</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">265,888</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leeor Langer</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">205,395</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">56,357</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,538</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">274,290</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Alon Mualem</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">186,271</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">53,445</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27,724</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">267,440</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Barry Kaplan<b><sup>(4)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">254,167</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,358</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">307,557</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-size: 10pt">(1)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt; ">Represents the directors&#8217; and senior management&#8217;s gross salary plus payment of mandatory social benefits made by the company on behalf of such persons. Such benefits may include, to the extent applicable to the executive, payments, contributions and/or allocations for savings funds, education funds (referred to in Hebrew as &#8220;Keren Hishtalmut&#8221;), pension, severance, risk insurances (e.g., life or work disability insurance) and payments for social security</span><span style="font-size: 10pt">.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">(2)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt; ">Computed based on the Black-Scholes option pricing model</span><span style="font-size: 10pt">.</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify"><span>Cash compensation amounts
denominated in NIS were converted into U.S. dollars at the rate of NIS 3.699 per $1.00 (the average exchange rate in 2024).</span></td>
</tr></table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">Mr. Barry Kaplan&#8217;s employment agreement was terminated,
effective December 31, 2024.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Employment Agreements with Executive Officers</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have entered into written
employment agreements with each of our executive officers. All of these agreements contain customary provisions regarding noncompetition,
confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions may be limited
under applicable law. In addition, we have entered into agreements with each executive officer and director pursuant to which we will
indemnify each of them up to a certain amount and to the extent that these liabilities are not covered by directors and officers insurance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On March 6, 2022, our board
of directors determined that it is in the best interest of our company to amend the employment agreements and approve new terms of compensation
for each of our officers, subject to the approval of our shareholders. The amendments to the agreements were approved at the shareholders
meeting, which took place on March 14, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On August 21, 2023 and August
23, 2023, the compensation committee and the board of directors, respectively, approved and recommended that the Company&#8217;s shareholders
approve an increase of the per-meeting fee and annual fee of our non-executive directors. On November 30, 2023, at the annual and special
general meeting, our shareholders approved the increase of fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On August 15, 2024, the compensation
committee and the board of directors, respectively, approved and recommended that the shareholders approve, the adoption of an amended
and restated compensation policy pursuant to which the board of directors will be authorized to exchange part of the monthly salary for
the Company&#8217;s office holders with equity-based compensation, at the discretion of, and at such date to be determined by the board
directors, subject to certain limitations and to the instructions of the Company&#8217;s compensation policy, and with the consent of
the subject office holders, and to amend the Company&#8217;s compensation policy to reflect the same. On September 26, 2024, at the annual
and special general meeting, our shareholders approved the proposed exchanges and the Company&#8217;s amended and restated compensation
policy. Subsequently, on December 25, 2024, the board of directors authorized the Company&#8217;s management to exercise an exchange,
in accordance with the shareholders&#8217; resolution, and for a period not exceeding five months.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For a description of the terms
of our options and option plans, see &#8220;Item 6.C. Board Practices - Share Option Plan<span style="font-variant: small-caps">&#8221;
</span>below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Directors&#8217; Service Contracts</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Other than with respect to
our directors who are also executive officers, we do not have written agreements with any director providing for benefits upon the termination
of his employment with our company.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">&#160;</p><div>

</div><div><a id="D_027"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 108pt; text-indent: -108pt">C. Board Practices</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our board of directors presently
consists of five members. Our amended and restated articles of association provide that the number of board of directors&#8217; members
(including external directors, if applicable) shall be set by our board of directors provided that it will consist of not less than three
and not more than twelve. Pursuant to the Companies Law, the management of our business is vested in our board of directors. Our board
of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders or to management.
Our executive officers are responsible for our day-to-day management and have individual responsibilities established by our board of
directors. Our Chief Executive Officer is appointed by, and serves at the discretion of, our board of directors, subject to the employment
agreement that we have entered into with him. All other executive officers are appointed by our Chief Executive Officer. Their terms of
employment are subject to the terms of our amended and restated compensation policy and any applicable law, and are subject to the approval
of the board of directors&#8217; compensation committee, the board of directors, and in some cases of our general meeting of our shareholders,
and are subject to the terms of any applicable employment agreements that we may enter into with them. Our board of directors has established
an audit committee, compensation committee, and a financial statement examination committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our amended and restated articles
of association provide for a split of the board of directors into three classes with staggered three-year terms (excluding external directors,
if applicable). At each annual general meeting of our shareholders, the election or re-election of directors following the expiration
of the term of office of the directors of that class of directors will be for a term of office that expires on the third annual general
meeting following such election or re-election, such that each year the term of office of only one class of directors will expire. The
director whom is to be retired and re-elected shall be the director that served the longest period since its appointment or last re-election
or, if more than one director served the longest time, or if a director who is not to be re-elected agrees to be re-elected, the meeting
of the board of directors which sets the date and agenda for the annual general meeting (acting by a simple majority) will decide which
of such directors will be brought for re-election at the relevant general meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Each director, except external
directors (if applicable), will hold office until the third annual general meeting of our shareholders following his or her appointment
(other than in certain cases as described below), or until he or she resigns or unless he or she is removed by a majority of 70% of our
shareholders&#8217; votes at a general meeting of our shareholders or upon the occurrence of certain events, in accordance with the Companies
Law and our amended and restated articles of association.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition, under certain
circumstances, our amended and restated articles of association allow our board of directors to appoint directors to fill vacancies on
our board of directors, due to a director no longer serving, or due to the number of directors serving being less than the maximum amount,
for the remaining period of time during which the director whose service has ended was filled would have held office (in case the appointment
is due to a director no longer serving), or for a period in accordance with the class to which he was appointed (in case the appointment
is in addition to the acting directors, subject to the limitation on the number of directors). External directors, if applicable, may
be elected for up to two additional three-year terms after their initial three-year term under certain circumstances, and may be removed
from office only under the limited circumstances set forth in the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, any
shareholder holding at least one percent of our outstanding voting power may nominate a director at a general meeting of the shareholders.
However, any such shareholder may make such a nomination only if a written notice and timely of such shareholder&#8217;s intent to make
such nomination has been given to our board of directors, in accordance with the provisions of our amended and restated articles of association
and the Companies Law. Any such notice must include certain information, including the consent of the proposed director nominee to serve
as our director if elected, and a declaration that the nominee signed declaring that he or she possesses the requisite skills and has
the availability to carry out his or her duties. Additionally, the nominee must provide details of such skills, and demonstrate an absence
of any limitation under the Companies Law that may prevent his or her election, and affirm that all of the required election-information
is provided to us, pursuant to the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">However, under exemptions applicable
for Israeli companies whose shares are listed on stock exchanges outside of Israel, or the Exemptions Regulations, one or more shareholders
of such a company, may request the company&#8217;s board of directors to include the appointment of a candidate for a position on the
board of directors or the termination of a board member, as an item on the agenda of a future general meeting (if the company sees fit),
provided that the shareholder hold at least five percent (5%) of the voting rights of the company, instead of one percent (1%) required
in the past.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our board of directors may
call special meetings whenever it sees fit and upon the request of: (a) any two of our directors or such number of directors equal to
one quarter of the directors then at office; and/or (b) one or more shareholders holding, in the aggregate, (i) 5% or more of our outstanding
issued shares and 1% of our outstanding voting power or (ii) 5% or more of our outstanding voting power, or the Non Exempted Holding.
However, under the Exemptions Regulations, the board of directors of an Israeli company whose shares are listed outside of Israel, shall
convene a special general meeting of shareholders at the request of: (i) one or more shareholders holding at least ten percent (10%) of
the issued and outstanding share capital instead of five (5%) in the past, and at least one percent (1%) of the voting rights in the company,
or (ii) one or more shareholders holding at least ten percent (10%) of the voting rights in the company, unless the applicable law incorporated
in the country in which the company is listed for trade, establishes a right to demand convening of such a meeting for those holding less
than ten percent (10%) of the voting rights in the company (in which case, the Non Exempted Holding shall apply).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, our
board of directors must determine the minimum number of directors who are required to have accounting and financial expertise. In determining
the number of directors required to have such expertise, our board of directors must consider, among other things, the type and size of
the company and the scope and complexity of its operations. Our board of directors has determined that the minimum number of directors
of our company who are required to have accounting and financial expertise is one.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The board of directors must
elect one director to serve as the chairman of the board of directors to preside at the meetings of the board of directors, and may also
remove that director as chairman. Pursuant to the Companies Law, neither the chief executive officer nor any of his or her relatives is
permitted to serve as the chairman of the board of directors, and a company may not vest the chairman or any of his or her relatives with
the chief executive officer&#8217;s authorities. In addition, a person who reports, directly or indirectly, to the chief executive officer
may not serve as the chairman of the board of directors; the chairman may not be vested with authorities of a person who reports, directly
or indirectly, to the chief executive officer; and the chairman may not serve in any other position in the company or a controlled company,
but he or she may serve as a director or chairman of a controlled company. However, the Companies Law permits a company&#8217;s shareholders
to determine, for a period not exceeding three years from each such determination, that the chairman or his or her relative may serve
as chief executive officer or be vested with the chief executive officer&#8217;s authorities, and that the chief executive officer or
his or her relative may serve as chairman or be vested with the chairman&#8217;s authorities. Such determination of a company&#8217;s
shareholders requires either: (1) the approval of at least a majority of the shares of those shareholders present and voting on the matter
(other than controlling shareholders and those having a personal interest in the determination) (shares held by abstaining shareholders
shall not be considered); or (2) that the total number of shares opposing such determination does not exceed 2% of the total voting power
in the company. Since March 6, 2022, our Chief Executive Officer, Mr. Asher Dahan, has also served as the chairman of our board of directors.
Mr. Dahan serves both as our Chief Executive Officer and as the Chairman of our board of directors, in accordance with the provisions
of the Companies Law and the Companies Regulations (Validity Period of a Decision According to Section 121 of the Companies Law), 5776-2016,
which allows such dual office for a period of five years following the completion of the IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The board of directors may,
subject to the provisions of the Companies Law, delegate any or all of its powers to committees of the board, and it may, from time to
time, revoke such delegation or alter the composition of any such committees, subject to certain limitations. Unless otherwise expressly
provided by the board of directors, the committees shall not be empowered to further delegate such powers. The composition and duties
of our audit committee, financial statement examination committee and compensation committee are described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The board of directors oversees
how management monitors compliance with our risk management policies and procedures, and reviews the adequacy of the risk management framework
in relation to the risks faced by us. The board of directors is assisted in its oversight role by an internal auditor. The internal auditor
undertakes both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported to our audit
committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>External Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Under
the Companies Law, a public company incorporated in Israel is required to appoint two external directors to serve on its board of directors.
One of the external directors must have &#8220;financial and accounting expertise&#8221;, as defined under the Companies Law. In addition,
external directors must meet stringent standards of independence as set forth in the Companies Law, including regulations regarding: limitations
on the duration of the term of office of the external directors, limitations on compensation terms, etc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under regulations promulgated
under to the Companies Law, a company with no controlling shareholder whose shares are listed for trading on specified exchanges outside
of Israel, including the Nasdaq Capital Market, may adopt exemptions from various corporate governance requirements of the Companies Law,
so long as such company satisfies the requirements of applicable foreign country laws and regulations, including applicable stock exchange
rules, that apply to companies organized in that country and relating to the appointment of independent directors and the composition
of audit and compensation committees. Such exemptions include an exemption from the requirement to appoint external directors and the
requirement that an external director be a member of certain committees, as well as exemption from limitations on directors&#8217; compensation.
We do not currently have a controlling shareholder and we use this exemption from the requirement described herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Independent Directors Under the Companies
Law</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">An &#8220;independent director&#8221;
under the Companies Law is either an external director or a director who meets the same non-affiliation criteria as an external director
(except for (i) the requirement that the director be an Israeli resident (which does not apply to companies such as ours whose securities
have been offered outside of Israel or are listed outside of Israel) and (ii) the requirement for accounting and financial expertise or
professional qualifications), as determined by the audit committee, and who has not served as a director of the company for more than
nine consecutive years. For these purposes, ceasing to serve as a director for a period of two years or less would not be deemed to sever
the consecutive nature of such director&#8217;s service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Regulations promulgated pursuant
to the Companies Law provide that a director in a public company whose shares are listed for trading on specified exchanges outside of
Israel, including the Nasdaq Capital Market, who qualifies as an independent director under the relevant non-Israeli rules and who meets
certain non-affiliation criteria, which are less stringent than those applicable to independent directors as set forth above, would be
deemed an &#8220;independent&#8221; director pursuant to the Companies Law provided: (i) he or she has not served as a director for more
than nine consecutive years; (ii) he or she has been approved as such by the audit committee; and (iii) his or her remuneration shall
be in accordance with the Companies Law and the regulations promulgated thereunder. For these purposes, ceasing to serve as a director
for a period of two years or less would not be deemed to sever the consecutive nature of such director&#8217;s service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Furthermore, pursuant to these
regulations, such company may reappoint a person as an independent director for additional terms, beyond nine years, which do not exceed
three years each, if each of the audit committee and the board of directors determine, in that order, that in light of the independent
director&#8217;s expertise and special contribution to the board of directors and its committees, the reappointment for an additional
term is in the company&#8217;s best interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Alternate Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Our
amended and restated articles of association provide, as allowed by the Companies Law, that any director may, subject to the conditions
set thereto including approval of the nominee by our board of directors, appoint a person as an alternate to act in his place, to remove
the alternate and appoint another in his place and to appoint an alternate in place of an alternate whose office is vacated for any reason
whatsoever. Under the Companies Law, a person who is not qualified to be appointed as a director, a person who is already serving as a
director or a person who is already serving as an alternate director for another director, may not be appointed as an alternate director.
Nevertheless, a director who is already serving as a director may be appointed as an alternate director for a member of a committee of
the board of directors so long as he or she is not already serving as a member of such committee, and if the alternate director is to
replace an external director, he or she is required to be an external director and to have either &#8220;financial and accounting expertise&#8221;
or &#8220;professional expertise,&#8221; depending on the qualifications of the external director he or she is replacing. A person who
does not have the requisite &#8220;financial and accounting experience&#8221; or the &#8220;professional expertise,&#8221; depending on
the qualifications of the external director he or she is replacing, may not be appointed as an alternate director for an external director.
A person who is not qualified to be appointed as an independent director, pursuant to the Companies Law, may not be appointed as an alternate
director of an independent director qualified as such under the Companies Law. Unless the appointing director limits the time or scope
of the appointment, the appointment is effective for all purposes until the appointing director ceases to be a director or terminates
the appointment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Committees of the Board of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our board of directors has
three standing statutory committees, the audit committee, the compensation committee and the Financial Statement Examination Committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, we
are required to appoint an audit committee. The audit committee must be composed of at least three directors, including all of the external
directors, if applicable (one of whom must serve as chairman of the committee). The audit committee may not include the chairman of the
board; a controlling shareholder of the company or a relative of a controlling shareholder; a director employed by or providing services
on a regular basis to the company, to a controlling shareholder or to an entity controlled by a controlling shareholder; or a director
who derives most of his or her income from a controlling shareholder. Pursuant to the Companies Law, chairman of the audit committee is
elected by the members of the audit committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">However, under the Exemptions
Regulations, a company with no controlling shareholder might be exempted from certain obligations mentioned above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition, a majority of
the members of the audit committee of a publicly traded company must be independent directors under the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, our
audit committee is responsible for:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">determining whether there are deficiencies in the business
management practices of our company, and making recommendations to the board of directors to improve such practices;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">determining whether to approve certain related party transactions
(including transactions in which an office holder has a personal interest and whether such transaction is extraordinary or material under
Companies Law) and establishing the approval process for certain transactions with a controlling shareholder or in which a controlling
shareholder has a personal interest (see &#8220;Item 6.C. Board Practices-Approval of Related Party Transactions under Israeli law&#8221;);</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">determining the approval process for transactions that are
&#8220;non-negligible&#8221; (i.e., transactions with a controlling shareholder that are classified by the audit committee as non-negligible,
even though they are not deemed extraordinary transactions), as well as determining which types of transactions would require the approval
of the audit committee, optionally based on criteria which may be determined annually in advance by the audit committee;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">examining our internal controls and internal auditor&#8217;s
performance, including whether the internal auditor has sufficient resources and tools to dispose of its responsibilities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">examining the scope of our auditor&#8217;s work and compensation
and submitting a recommendation with respect thereto to our board of directors or shareholders, depending on which of them is considering
the appointment of our auditor;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">establishing procedures for the handling of employees&#8217;
complaints as to deficiencies in the management of our business and the protection to be provided to such employees; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">where the board of directors approves the working plan of
the internal auditor, examining such working plan before its submission to the board of directors and proposing amendments thereto</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our audit committee may not
conduct any discussions or approve any actions requiring its approval (see &#8220;Management-Approval of Related Party Transactions under
Israeli law&#8221;), unless at the time of the approval a majority of the committee&#8217;s members are present, which majority consists
of independent directors under the Companies Law, including at least one external director, if applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our board of directors has
adopted an audit committee charter setting forth, among others, the responsibilities of the audit committee consistent with the rules
of the SEC and Nasdaq rules (in addition to the requirements for such committee under the Companies Law), including, among others, the
following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">oversight of our independent registered public accounting
firm and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm
to the board of directors in accordance with Israeli law;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">recommending the engagement or termination of the person filling
the office of our internal auditor, reviewing the services provided by our internal auditor and reviewing effectiveness of our system
of internal control over financial reporting;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">recommending the terms of audit and non-audit services provided
by the independent registered public accounting firm for pre-approval by our board of directors; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">reviewing and monitoring, if applicable, legal matters with
significant impact, finding of regulatory authorities&#8217; findings, receive reports regarding irregularities and legal compliance,
acting according to &#8220;whistleblower policy&#8221; and recommend to our board of directors if so required.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq Stock Market Listing Rules for Audit
Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Nasdaq rules, we
are required to maintain an audit committee consisting of at least three members, all of whom are independent and are financially literate
and one of whom has accounting or related financial management expertise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As noted above, the members
of our audit committee are each &#8220;independent,&#8221; as such term is defined in under Nasdaq rules. All members of our audit committee
meet the requirements for financial literacy under the Nasdaq rules. Our board of directors has determined that Mr. Goldman is an audit
committee financial expert as defined by the SEC rules and has the requisite financial experience as defined by the Nasdaq rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial Statement Examination Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, the
board of directors of a public company in Israel must appoint a financial statement examination committee, which consists of members with
accounting and financial expertise or the ability to read and understand financial statements. The function of a financial statements
examination committee is to discuss and provide recommendations to its board of directors (including the report of any deficiency found)
with respect to the following issues: (1) estimations and assessments made in connection with the preparation of financial statements;
(2) internal controls related to the financial statements; (3) completeness and propriety of the disclosure in the financial statements;
(4) the accounting policies adopted and the accounting treatments implemented in material matters of the company; and (5) value evaluations,
including the assumptions and assessments on which evaluations are based and the supporting data in the financial statements. Our independent
registered public accounting firm and our internal auditor are invited to attend all meetings of our financial statements examination
committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, the
board of directors of any public company must establish a compensation committee. The compensation committee must be composed of at least
three directors, including all of the external directors, if applicable, who if applicable must constitute a majority of the members of
the compensation committee. Each compensation committee member that is not an external director must be a director whose compensation
does not exceed an amount that may be paid to an external director. The compensation committee is subject to the same Companies Law restrictions
as the audit committee as to: (a) who may not be a member of the committee; and (b) who may not be present during committee deliberations
as described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">However, under the Exemptions
Regulations, a company with no controlling shareholder might be exempted from certain obligations mentioned above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our compensation committee
acts pursuant to a written charter, and complies with the provisions of the Companies Law, the regulations promulgated thereunder, and
our amended and restated articles of association, on all aspects referring to its independence, authorities and practice. Our compensation
committee follows home country practice as opposed to complying with the compensation committee membership and charter requirements prescribed
under the Nasdaq rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our compensation committee
reviews and recommends to our board of directors (and in accordance with the provisions of our amended and restated compensation policy):
with respect to our executive officers&#8217; and directors&#8217;: (1) annual base compensation (2) annual incentive bonus, including
the specific goals and amounts; (3) equity compensation; (4) employment agreements, severance arrangements, and change in control agreements
and provisions; (5) retirement grants and/or retirement bonuses; and (6) any other benefits, compensation, compensation policies or arrangements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The duties of the compensation
committee will include the recommendation to the company&#8217;s board of directors of a policy regarding the terms of engagement of office
holders, to which we refer as a compensation policy. Such policy was adopted by our board of directors and was approved by the shareholders
(see &#8220;Management-Board Practices-Approval of Related Party Transactions under Israeli law&#8221;). Under the Companies Law and certain
conditions, the board of directors may adopt the compensation policy if it is not approved by the shareholders, provided that after the
shareholders oppose the approval of such policy, the compensation committee and the board of directors revisit the matter and determine
that adopting the compensation policy would be in the best interests of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The compensation policy must
serve as the basis for decisions concerning the financial terms of employment or engagement of executive officers and directors, including
exemption, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation
policy must relate to certain factors, including advancement of the company&#8217;s objectives, the company&#8217;s business and its long-term
strategy, and creation of appropriate incentives for executives. It must also consider, among other things, the company&#8217;s risk management,
size and the nature of its operations. The compensation policy must furthermore consider the following additional factors:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the education, skills, expertise and accomplishments of the
relevant director or executive;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the director&#8217;s or executive&#8217;s roles and responsibilities
and prior compensation agreements with him or her;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the relationship between the cost of the terms of service
of an office holder and the average median compensation of the other employees of the company (including those employed through manpower
companies), including the impact of disparities in salary upon work relationships in the company;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the possibility of reducing variable compensation at the discretion
of the board of directors; and the possibility of setting a limit on the exercise value of non-cash variable compensation; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">as to severance compensation, the period of service of the
director or executive, the terms of his or her compensation during such service period, the company&#8217;s performance during that period
of service, the person&#8217;s contribution towards the company&#8217;s achievement of its goals and the maximization of its profits,
and the circumstances under which the person is leaving the company</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The compensation policy must
also include the following principles:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">with the exception of office holders who report directly to
the chief executive officer, the link between variable compensation and long-term performance and measurable criteria;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the relationship between variable and fixed compensation,
and the ceiling for the value of variable compensation at the time of its grant;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the conditions under which a director or executive would be
required to repay compensation paid to him or her if it was later shown that the data upon which such compensation was based was inaccurate
and was required to be restated in the company&#8217;s financial statements;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the minimum holding or vesting period for variable, equity-based
compensation; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">maximum limits for severance compensation.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The compensation policy must
also consider appropriate incentives from a long-term perspective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The compensation committee is responsible for: (1)
recommending the compensation policy to a company&#8217;s board of directors for its approval (and subsequent approval by the shareholders);
and (2) duties related to the compensation policy and to the compensation of a company&#8217;s office holders, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">recommending whether a compensation policy should continue
in effect, if the then-current policy has a term of greater than three years (approval of either a new compensation policy or the continuation
of an existing compensation policy must in any case occur every three years);</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">recommending to the board of directors periodic updates to
the compensation policy;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">assessing implementation of the compensation policy;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">administering the Company&#8217;s clawback policy;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">determining whether the terms of compensation of certain office
holders of the company need not be brought to approval of the shareholders; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">determining whether to approve the terms of compensation of
office holders that require the committee&#8217;s approval.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our amended and restated compensation
policy is designed to promote our long-term goals, work plan and policy, retain, motivate and incentivize our directors and executive
officers, while considering the risks that our activities involve, our size, the nature and scope of our activities and the contribution
of an officer to the achievement of our goals and maximization of profits, and align the interests of our directors and executive officers
with our long-term performance. To that end, a portion of an executive officer compensation package is targeted to reflect our short and
long-term goals, as well as the executive officer&#8217;s individual performance. On the other hand, our amended and restated compensation
policy includes measures designed to reduce the executive officer&#8217;s incentives to take excessive risks that may harm us in the long-term,
such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and the total
compensation of an executive officer and minimum vesting periods for equity-based compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our amended and restated compensation
policy also addresses our executive officer&#8217;s individual characteristics (such as his or her respective position, education, scope
of responsibilities and contribution to the attainment of our goals) as the basis for compensation variation among our executive officers,
and considers the internal ratios between compensation of our executive officers and directors and other employees. For example, the compensation
that may be granted to an executive officer may include: base salary, annual bonuses, equity-based compensation, benefits and retirement
and termination of service arrangements. All cash bonuses are limited to a maximum amount linked to the executive officer&#8217;s base
salary. In addition, amended and restated our compensation policy provides for maximum permitted ratios between the total variable (cash
bonuses and equity-based compensation) and non-variable (base salary) compensation components, in accordance with an officer&#8217;s respective
position with the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">An annual cash bonus may be
awarded to executive officers upon the attainment of pre-set periodic objectives and individual targets. The annual cash bonus that may
be granted to executive officers other than our chairman or Chief Executive Officer may be based entirely on a discretionary evaluation.
Our Chief Executive Officer will be entitled to recommend performance objectives to such executive officers, and such performance objectives
will be approved by our compensation committee (and, if required by law, by our board of directors).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The performance measurable
objectives of our chairman and Chief Executive Officer will be determined annually by our compensation committee and board of directors.
A less significant portion of the chairman&#8217;s and/or the Chief Executive Officer&#8217;s annual cash bonus may be based on a discretionary
evaluation of the chairman&#8217;s or the Chief Executive Officer&#8217;s respective overall performance by the compensation committee
and the board of directors based on quantitative and qualitative criteria.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The equity-based compensation
under our amended and restated compensation policy for our executive officers (including members of our board of directors) is designed
in a manner consistent with the underlying objectives in determining the base salary and the annual cash bonus, with its main objectives
being to enhance the alignment between the executive officers&#8217; interests with our long-term interests and those of our shareholders
and to strengthen the retention and the motivation of executive officers in the long term. Our amended and restated compensation policy
provides for executive officer compensation in the form of share options or other equity-based awards, such as restricted shares, options,
in accordance with our stock option plan then in place. Share options granted to executive officers shall be subject to vesting periods
in order to promote long-term retention of the awarded executive officers. The equity-based compensation shall be granted from time to
time and be individually determined and awarded according to the performance, educational background, prior business experience, qualifications,
role and the personal responsibilities of the executive officer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In addition, our amended and
restated compensation policy contains compensation recovery provisions which allows us under certain conditions to recover bonuses paid
in excess, will enable our Chief Executive Officer to approve an immaterial change in the terms of employment of an executive officer
(provided that the changes of the terms of employment are in accordance our amended and restated compensation policy) and allows us to
exempt, indemnify and insure our executive officers and directors subject to certain limitations set forth thereto.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our amended and restated compensation
policy also provides for compensation to the members of our board of directors either: (i) in accordance with the amounts provided in
the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director) of 2000, as amended by the Companies
Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel) of 2000, as such regulations may be amended from
time to time; or (ii) in accordance with the amounts determined in our amended and restated compensation policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq Requirements for Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Nasdaq rules, we
are required to maintain a compensation committee consisting of at least two members, each of whom are independent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As noted above, the members
of our compensation committee include Mr. Eli Bachar, Mr. Yaacov Goldman, and Ms. Ilana Lurie, each of whom is &#8220;independent,&#8221;
as such term is defined in under Nasdaq rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Joint Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with the provisions
of the Companies Law and the regulations promulgated pursuant to it and under certain conditions, an Israeli company may unite its audit
committee, the compensation committee and the financial statement examination committee into one committee, or the Joint Committee. As
of March 19, 2025, the Company met such conditions and therefore formed a Joint Committee. The members of our Joint Committee consist
of Mr. Eli Bachar, Mr. Yaacov Goldman and Ms. Ilana Lurie. As of March 17, 2025, Ms. Lurie serves as the chairwoman of the Joint Committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Internal Auditor</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, the
board of directors of an Israeli public company must appoint an internal auditor nominated by the audit committee. The role of the internal
auditor is to examine, among other things, whether a company&#8217;s actions comply with the law and proper business procedure. The audit
committee is required to oversee the activities, and to assess the performance of the internal auditor as well as to review the internal
auditor&#8217;s work plan. An internal auditor may not be an interested party or office holder, or a relative of any interested party
or office holder, and may not be a member of the company&#8217;s independent accounting firm or its representative. The Companies Law
defines an interested party as a holder of 5% or more of the outstanding shares or voting rights of a company, any person or entity that
has the right to appoint at least one director or the general manager of the company or any person who serves as a director or as the
general manager of a company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">On December 15, 2022, our board
of directors appointed Mr. Doron Cohen, of Fahn Kanne &amp; Co., the Israeli member firm of Grant Thornton International Ltd., as our
internal auditor. Our internal auditor is a partner of a firm which specializes in internal auditing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Remuneration of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, remuneration
of directors is subject to the approval of the compensation committee, thereafter by the board of directors and thereafter, unless exempted
under the regulations promulgated under the Companies Law, by the general meeting of the shareholders. In case the remuneration of the
directors is in accordance with regulations applicable to remuneration of the external directors, if applicable, then such remuneration
shall be exempt from the approval of the general meeting. Where the director is also a controlling shareholder, the requirements for approval
of transactions with controlling shareholders apply.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fiduciary Duties of Office Holders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Companies Law imposes a
duty of care and a duty of loyalty on all office holders of a company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The duty of care requires an
office holder to act with the level of care with which a reasonable office holder in the same position would have acted under the same
circumstances. The duty of care of an office holder includes a duty to use reasonable means to obtain:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">information on the advisability of a given action brought
for his approval or performed by him by virtue of his position; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">all other important information pertaining to these actions.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The duty of loyalty of an office holder requires
an office holder to act in good faith and for the benefit of the company, and includes a duty to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">refrain from any conflict of interest between the performance
of his duties in the company and his performance of his other duties or personal affairs;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">refrain from any action that is competitive with the company&#8217;s
business;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">refrain from exploiting any business opportunity of the company
to receive a personal gain for himself or others; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">disclose to the company any information or documents relating
to the company&#8217;s affairs which the office holder has received due to his position as an office holder.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Insurance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, a
company may obtain insurance for any of its office holders against the following liabilities incurred due to acts he or she performed
as an office holder, if and to the extent provided for in the company&#8217;s articles of association:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">breach of his or her duty of care to the company or to another
person, to the extent such a breach arises out of the negligent conduct of the office holder;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">a breach of his or her duty of loyalty to the company, provided
that the office holder acted in good faith and had reasonable cause to assume that his or her act would not prejudice the company&#8217;s
interests; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">a financial liability imposed upon him or her in favor of
another person.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We maintain directors&#8217;
and officers&#8217; liability insurance currently providing for a total coverage of $7.5 million for the benefit of all of our directors
and officers, with an annual premium of $190,000, which expires on September 11, 2025. The terms for the directors&#8217; and officers&#8217;
liability insurance were approved by our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Companies Law, and the
Israeli Securities Law, 5728-1968, or the Securities Law, provide that a company may indemnify an office holder against the following
liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance
of an event or following an event, provided its articles of association include a provision authorizing such indemnification:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">a financial liability imposed on him or her in favor of another
person by any judgment concerning an act performed in his or her capacity as an office holder, including a settlement or arbitrator&#8217;s
award approved by a court;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">reasonable litigation expenses, including attorneys&#8217;
fees, expended by the office holder (a) as a result of an investigation or proceeding instituted against him or her by an authority authorized
to conduct such investigation or proceeding, provided that (1) no indictment (as defined in the Companies Law) was filed against such
office holder as a result of such investigation or proceeding; and (2) no financial liability as a substitute for the criminal proceeding
(as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding, or, if such financial
liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; or (b) in connection
with a monetary sanction;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">reasonable litigation expenses, including attorneys&#8217;
fees, expended by the office holder or imposed on him or her by a court; (1) in proceedings that the company institutes, or that another
person institutes on the company&#8217;s behalf, against him or her; (2) in a criminal proceeding of which he or she was acquitted; or
(3) as a result of a conviction for a crime that does not require proof of criminal intent; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">expenses incurred by an office holder in connection with an
Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys&#8217; fees. An
&#8220;Administrative Procedure&#8221; is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities
Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures
or Interruption of procedures subject to conditions) to the Securities Law.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Companies Law also permits
a company to undertake in advance to indemnify an office holder, provided that if such indemnification relates to financial liability
imposed on him or her, as described above, then the undertaking should be limited and shall detail the following foreseen events and amount
or criterion:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">to events that in the opinion of the board of directors can
be foreseen based on the company&#8217;s activities at the time that the undertaking to indemnify is made; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">in amount or criterion determined by the board of directors,
at the time of the giving of such undertaking to indemnify, to be reasonable under the circumstances.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The board of directors has
approved indemnification agreements with all of our directors and with all members of our senior management, which were also approved
by our shareholders at a general meeting. Such indemnification agreements provide the office holder with indemnification permitted under
applicable law and up to a certain amount, and to the extent that these liabilities are not covered by directors and officers insurance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Exemption</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, an
Israeli company may not exempt an office holder from liability for a breach of his or her duty of loyalty, but may exempt in advance an
office holder from his or her liability to the company, in whole or in part, for damages caused to the company as a result of a breach
of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such exemption is included in
its articles of association. Our amended and restated articles of association provide that we may exempt, in whole or in part, any office
holder from liability to us for damages caused to the company as a result of a breach of his or her duty of care, but prohibit an exemption
from liability arising from a company&#8217;s transaction in which our controlling shareholder or officer has a personal interest. Subject
to the aforesaid limitations, under the indemnification agreements, we will exempt and release our office holders from any and all liability
to us related to any breach by them of their duty of care to us to the fullest extent permitted by law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Limitations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Companies Law provides
that we may not exempt or indemnify an office holder nor enter into an insurance contract that would provide coverage for any liability
incurred as a result of any of the following: (1) a breach by the office holder of his or her duty of loyalty unless (in the case of indemnity
or insurance only, but not exculpation) the office holder acted in good faith and had a reasonable basis to believe that the act would
not prejudice us; (2) a breach by the office holder of his or her duty of care if the breach was carried out intentionally or recklessly
(as opposed to merely negligently); (3) any act or omission committed with the intent to derive an illegal personal benefit; or (4) any
fine, monetary sanction, penalty or forfeit levied against the office holder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Under the Companies Law, exemption,
indemnification and insurance of office holders in a public company must be approved by the compensation committee and the board of directors
(and, with respect to directors and the chief executive officer, by the shareholders). However, under regulations promulgated under the
Companies Law, the insurance of office holders shall not require shareholder approval and may be approved by only the compensation committee
(and, in case a controlling shareholder is an office holder, the board of directors as well), if the engagement terms are determined in
accordance with the company&#8217;s compensation policy that was approved by the shareholders by the same special majority required to
approve a compensation policy, provided that the insurance policy is on market terms and the insurance policy is not likely to materially
impact the company&#8217;s profitability, assets or obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our amended and restated articles
of association permit us to exempt (subject to the aforesaid limitation), indemnify and insure our office holders to the fullest extent
permitted or to be permitted by the Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The foregoing descriptions
summarize the material aspects and practices of our board of directors. For additional details, we also refer you to the full text of
the Companies Law, as well as of our amended and restated articles of association, which are exhibits to this annual report on Form 20-F,
and are incorporated herein by reference.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">There are no service contracts
between us or our Subsidiary, on the one hand, and our directors in their capacity as directors, on the other hand, providing for benefits
upon termination of service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Approval of Related Party Transactions under
Israeli Law</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Under
the Companies Law, we may approve an action by an office holder from which the office holder would otherwise have to refrain, as described
above, if:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the office holder acts in good faith and the act or its approval
does not cause harm to the company; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the office holder disclosed the nature of his or her interest
in the transaction (including any significant fact or document) to the company at a reasonable time before the company&#8217;s approval
of such matter.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Disclosure of Personal Interests of an Office
Holder</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">The
Companies Law requires that an office holder disclose to the company, promptly, and, in any event, not later than the board meeting at
which the transaction is first discussed, any direct or indirect personal interest that he or she may have and all related material information
known to him or her relating to any existing or proposed transaction by the company. If the transaction is an extraordinary transaction,
the office holder must also disclose any personal interest held by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">the office holder&#8217;s relatives; or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">any corporation in which the office holder or his or her relatives
holds 5% or more of the shares or voting rights, serves as a director or general manager or has the right to appoint at least one director
or the general manager.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">An
office holder is not, however, obliged to disclose a personal interest if it derives solely from the personal interest of his or her relative
in a transaction that is not considered an extraordinary transaction. Under the Companies Law, an extraordinary transaction is a transaction:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">not in the ordinary course of business;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">not on market terms; or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">that is likely to have a material effect on the company&#8217;s
profitability, assets or liabilities.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">The
Companies Law does not specify to whom within us nor the manner in which required disclosures are to be made. We require our office holders
to make such disclosures to our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Under
the Companies Law, once an office holder complies with the above disclosure requirement, the board of directors may approve a transaction
between the company and an office holder, or a third party in which an office holder has a personal interest, unless the articles of association
provide otherwise and provided that the transaction is in the company&#8217;s interest. If the transaction is an extraordinary transaction
in which an office holder has a personal interest, first the audit committee and then the board of directors, in that order, must approve
the transaction. Under specific circumstances, shareholder approval may also be required. Generally, a person who has a personal interest
in a matter which is considered at a meeting of the board of directors or the audit committee may not be present at such a meeting unless
the chairman of the audit committee or board of directors (as applicable) determines that he or she should be present in order to present
the transaction that is subject to approval. A director who has a personal interest in a transaction, which is considered at a meeting
of the board of directors or the audit committee, may not be present at this meeting or vote on this matter, unless a majority of members
of the board of directors or the audit committee, as the case may be, has a personal interest. If a majority of the board of directors
has a personal interest, then shareholder approval is generally also required.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Disclosure of Personal Interests of a Controlling
Shareholder</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">Under
the Companies Law, the disclosure requirements that apply to an office holder also apply to a controlling shareholder of a public company.
Extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, including a private
placement in which a controlling shareholder has a personal interest, as well as transactions for the provision of services whether directly
or indirectly by a controlling shareholder or his or her relative, or a company such controlling shareholder controls, and transactions
concerning the terms of engagement and compensation of a controlling shareholder or a controlling shareholder&#8217;s relative, whether
as an office holder or an employee, require the approval of the audit committee or the compensation committee, as the case may be, the
board of directors and a majority of the shares voted by the shareholders of the company participating and voting on the matter in a shareholders&#8217;
meeting. In addition, the shareholder approval must fulfill one of the following requirements:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&#9679;</span></td><td style="text-align: justify">at least a majority of the shares held by shareholders who
have no personal interest in the transaction and are voting at the meeting must be voted in favor of approving the transaction, excluding
abstentions; or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-indent: -18pt"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                            shares voted by shareholders who have no personal interest in the transaction who vote against
                                            the transaction represent no more than 2% of the voting rights in the company.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">In
addition, any extraordinary transaction with a controlling shareholder or in which a controlling shareholder has a personal interest
with a term of more than three years requires the abovementioned approval every three years; however, such transactions not involving
the receipt of services or compensation can be approved for a longer term, provided that the audit committee determines that such longer
term is reasonable under the circumstances.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
Companies Law requires that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction
with a controlling shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in
the vote in question. Failure to so indicate will result in the invalidation of that shareholder&#8217;s vote.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
term &#8220;controlling shareholder&#8221; is defined in the Companies Law as a shareholder with the ability to direct the activities
of the company, other than by virtue of being an office holder. A shareholder is presumed to be a controlling shareholder if the shareholder
holds 50% or more of the voting rights in a company or has the right to appoint 50% or more of the directors of the company or its general
manager. In the context of a transaction involving a shareholder of the company, a controlling shareholder also includes a shareholder
who holds 25% or more of the voting rights in the company if no other shareholder holds more than 50% of the voting rights in the company.
For this purpose, the holdings of all shareholders who have a personal interest in the same transaction will be aggregated.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Approval
of the Compensation of Directors and Executive Officers</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
compensation of, or an undertaking to indemnify, insure or exempt, an office holder who is not a director requires the approval of the
company&#8217;s compensation committee, followed by the approval of the company&#8217;s board of directors, and, if such compensation
arrangement or an undertaking to indemnify, insure or exempt is inconsistent with the company&#8217;s stated compensation policy, or
if the said office holder is the chief executive officer of the company (subject to a number of specific exceptions), then such arrangement
is subject to the approval of our shareholders, by a special majority requirement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>Directors</i>.
Under the Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval
of the board of directors and, unless exempted under the regulations promulgated under the Companies Law, the approval of the general
meeting of our shareholders. If the compensation of our directors is inconsistent with our stated compensation policy, then, provided
that those provisions that must be included in the compensation policy according to the Companies Law have been considered by the compensation
committee and board of directors, shareholder approval by a special majority will be required.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>Executive
officers other than the chief executive officer.</i> The Companies Law requires the approval of the compensation of a public company&#8217;s
executive officers (other than the chief executive officer) in the following order: (i) the compensation committee, (ii) the company&#8217;s
board of directors, and (iii) only if such compensation arrangement is inconsistent with the company&#8217;s stated compensation policy,
the company&#8217;s shareholders by a special majority. However, if the shareholders of the company do not approve a compensation arrangement
with an executive officer that is inconsistent with the company&#8217;s stated compensation policy, the compensation committee and board
of directors may override the shareholders&#8217; decision if each of the compensation committee and the board of directors provide detailed
reasons for their decision, after rediscussing the terms of the compensation and the shareholders&#8217; non-approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>Chief
executive officer.</i> Under the Companies Law, the compensation of a public company&#8217;s chief executive officer is required to be
approved by: (i) the company&#8217;s compensation committee; (ii) the company&#8217;s board of directors, and (iii) the company&#8217;s
shareholders by a special majority. However, if the shareholders of the company do not approve the compensation arrangement with the
chief executive officer, the compensation committee and board of directors may override the shareholders&#8217; decision if each of the
compensation committee and the board of directors provides detailed reasons for their decision, after rediscussing the terms of the compensation
and the shareholders&#8217; non-approval. In addition, the compensation committee may exempt the engagement terms of a candidate to serve
as the chief executive officer from shareholders&#8217; approval, if the compensation committee determines that the compensation arrangement
is consistent with the company&#8217;s stated compensation policy, that the chief executive officer did not have a prior business relationship
with the company or a controlling shareholder of the company, and that subjecting the approval to a shareholder vote would impede the
company&#8217;s ability to attain the candidate to serve as the company&#8217;s chief executive officer (and provide detailed reasons
for the latter).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
approval of each of the compensation committee and the board of directors, with regard to the office holders and directors above, must
be in accordance with the company&#8217;s stated compensation policy; however, under special circumstances, the compensation committee
and the board of directors may approve compensation terms of a chief executive officer that are inconsistent with the company&#8217;s
compensation policy provided that they have considered those provisions that must be included in the compensation policy according to
the Companies Law and that shareholder approval was obtained by a special majority requirement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Duties
of Shareholders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Under
the Companies Law, a shareholder has a duty to refrain from abusing his power in the company and to act in good faith and in an acceptable
manner in exercising his rights and performing his obligations toward the company and other shareholders, including, among other things,
in voting at general meetings of shareholders (and at shareholder class meetings) on the following matters:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">amendment
of the articles of association;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">increase
in the company&#8217;s authorized share capital;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">merger;
and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
approval of related party transactions and acts of office holders that require shareholder approval.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">A
shareholder also has a general duty to refrain from oppressing other shareholders. The remedies generally available upon a breach of
contract will also apply to a breach of the above-mentioned duties, and in the event of oppression of other shareholders, additional
remedies are available to the injured shareholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">In
addition, any controlling shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any
shareholder that, under a company&#8217;s articles of association, has the power to appoint or prevent the appointment of an office holder,
or has another power with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not
describe the substance of this duty except to state that the remedies generally available upon a breach of contract will also apply in
the event of a breach of the duty to act with fairness, taking the shareholder&#8217;s position in the company into account.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Share
Option Plan</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">In
September 2015, our board of directors adopted the 2015 Plan, pursuant to the provisions of the Israeli Income Tax Ordinance, or the
Tax Ordinance. Following several amendments, our board of directors currently has the discretion to grant options to purchase Ordinary
Shares from a pool of up to 39,857 Ordinary Shares. The number of Ordinary Shares in the Pool is also subject to adjustment under certain
circumstances (e.g., reorganization of our equity capital). As of March 19, 2025, 4,660 Ordinary Shares had been issued upon the exercise
of options, 25,990 options had been allocated and/or granted but had not been exercised, and 9,208 Ordinary Shares remained available
for future grants.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the 2015 Plan, options may be granted to employees, consultants and service providers, directors and non-employees of our company
and/or our affiliates, or the Optionees; provided however, that the Optionees who are Israeli employees or directors (who are not controlling
shareholders of our company) may only receive options pursuant to Section 102 of the Tax Ordinance, or Section 102, and non-employees
(and/or employees who are also controlling shareholders), may receive options pursuant to Section 3(i) of the Tax Ordinance. Section
102 options may be either approved options or unapproved options. Approved Section 102 options are: (1) required to be held by a trustee
appointed by our board of directors pursuant to the 2015 Plan; (2) require a holding period as set forth in Section 102; and (3) are
subject to an irrevocable proxy provided to the trustee. Section 102 options may either be subject to a capital gains track or ordinary
income track, as elected and designated by us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
board of directors has the discretion to determine the terms of the options for each option grant, including the exercise price and vesting
dates of the options. If not earlier exercised, the options expire upon the earlier of (i) ten years from the date of grant; (ii) depending
on the circumstances, following a pre-determined time period after the termination of the Optionees employment or engagement with us,
as applicable; or (iii) as provided in the Optionee&#8217;s option agreement. Any Ordinary Shares underlying options which are forfeited,
expired or canceled before expiration of the 2015 Plan, become available for future grants thereunder. Our board of directors has discretion
to change the terms of existing options, including the acceleration of vesting periods in connection with a change of control transaction.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">In
December 2022, our board of directors approved the amendment to our 2015 Plan to include restricted stock units under the 2015 Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">On
August 15, 2024, the board of directors approved the Company&#8217;s 2024 Global Equity Incentive Plan, or the GEIP, which provides for
the reservation&#160;from time-to-time, out of the Company&#8217;s authorized unissued share capital as the board of directors deems
appropriate.&#160;The board of directors has initially authorized the issuance of up to 57,132 Ordinary Shares under the GEIP, which
reflects 20% of our issued and outstanding share capital as of August 14, 2024. On December 20, 2024, the board of directors approved
that the updated number of Ordinary Shares reserved for the GEIP will be 141,492, which reflects 20% of our issued and outstanding share
capital as of December 18, 2024. The GEIP includes an Annex that governs the grants of awards to employees and other service providers
who are citizens or resident aliens of the United States.&#160;The GEIP provides for the grant of options, shares, restricted shares
or RSUs&#160;to employees, non-employee directors, consultants, advisors, or service providers of the Company, as well as employees,
non-employee directors, consultants, advisors, or service providers of any affiliate of the Company. The GEIP will continue for a term
of ten years from the date of adoption by the board of directors, or until August 14, 2034, unless terminated earlier. &#160;As of March
19, 2025, we have granted certain employees, directors and consultants 131,375 RSUs under the GEIP. Additional 10,117 Ordinary Shares
are reserved for future issuance under the GEIP.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Also
on August 15, 2024, the board of directors approved the Company&#8217;s 2024 Employee Stock Purchase Plan, or the ESPP, which provides
for the issuance of up to 62,500 Ordinary Shares and includes an Annex that governs the grants of awards to employees who are Israeli
residents. Generally, all of the Company&#8217;s employees will be eligible to participate in the&#160;ESPP&#160;if they are employed
by the Company, or employees of any participating subsidiary, provided that they have been employed by the Company or subsidiary for
more than five months in a calendar year.&#160;The&#160;ESPP&#160;includes a component that allows the Company to make offerings intended
to qualify under Section 423 of the U.S. Internal Revenue Code of 1986, as amended, and a component that allows the Company to make offerings
not intended to qualify under Section 423. The&#160;ESPP&#160;currently provides that there will be at least one offering in any consecutive
12-month period. There have been no issuances under the ESPP as of March 19, 2025. The&#160;ESPP&#160;permits participants to purchase
Ordinary Shares through payroll deductions in an amount equal to a whole percentage of from one to 15% of their&#160;ESPP&#160;eligible
compensation (or such other limited established by the administrator in accordance with the terms of our&#160;ESPP) in an offering. The
purchase price of the Ordinary Shares will be determined by the share award compensation committee, in accordance with the terms of the&#160;ESPP,
but the option price shall not be less than the lesser of 85% of the fair market value of the Ordinary Shares on the offering date, or
85% of the fair market value of the Ordinary Shares on the exercise date.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_028"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">D.
Employees</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">As
of March 19, 2025, we employed 25 full-time employees (including one employee located in Lithuania and one employee located in the United
States), and nine part-time employees. In addition, we have two sub-contractors located in India, performing front end software application
development. The majority of our employees are located in Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">None
of our employees are members of a union or subject to the terms of a collective bargaining agreement. However, in Israel, we are subject
to certain Israeli Labor laws, regulations and national labor court precedent rulings, as well as certain provisions of collective bargaining
agreements applicable to us by virtue of extension orders issued in accordance with relevant labor laws by the Israeli Industry and Economy
Office, and which apply such agreement provisions to our employees even though they are not part of a union that has signed a collective
bargaining agreement.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_029"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">E.
Share Ownership</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">See
&#8220;Item 7.A. Major Shareholders&#8221; below.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_030"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">F.
Action to Recover Erroneously Awarded Compensation</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_031"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">ITEM
7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_032"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">A.
Major Shareholders</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
following table sets forth information regarding beneficial ownership of our Ordinary Shares as of March 19, 2025 by:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">each
person, or group of affiliated persons, known to us to be the beneficial owner of more than 5% of our outstanding Ordinary Shares;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">each
of our directors, and executive officers; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">all
of our directors, and executive officers as a group.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Beneficial
ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to Ordinary Shares.
Ordinary Shares issuable pursuant to outstanding options or warrants to purchase Ordinary Shares that are exercisable, or securities
that are convertible into Ordinary Shares, within 60 days after March 19, 2025, are deemed outstanding for the purpose of computing the
percentage ownership of the person holding the options, warrants or convertible securities, but are not deemed outstanding for the purpose
of computing the percentage ownership of any other person. Percentage of shares beneficially owned is based on 1,028,980 Ordinary Shares
outstanding on March 19, 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
are not controlled by another corporation, by any foreign government or by any natural or legal persons except as set forth herein, and
there are no arrangements known to us which would result in a change in control of our company at a subsequent date. Except as indicated
in footnotes to this table, we believe that the shareholders named in this table have sole voting and investment power with respect to
all shares shown to be beneficially owned by them, based on information provided to us by such shareholders. Unless otherwise noted below,
each beneficial owner&#8217;s address is c/o Wearable Devices Ltd., 2 Ha-Ta&#8217;asiya St., Yokne&#8217;am Illit, 2069803 Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">No. of Shares<br/>
 Beneficially<br/>
 Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Percentage<br/>
 Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Holders of more than 5% of our voting securities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Armistice Capital, LLC (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">102,795</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9.99</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Directors and senior management who are not 5% holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Asher Dahan * (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Guy Wagner * (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Leeor Langer (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,875</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Eli Bachar * (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,597</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Alon Mualem (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Offir Remez (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,768</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shmuel Barel (8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,618</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.4</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Tamar Fleisher (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,062</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Yaacov Goldman * (10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">139</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Ilana Lurie * (10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">139</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">All directors and senior management as a group (10 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,628</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.4</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
director of the Company.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial ownership is based on information provided by Armistice Capital, LLC to us on March 19, 2025, and consists of (i) 67,163 Ordinary Shares; and (ii) 35,632 Ordinary Shares issuable upon exercise of outstanding pre-funded warrants that are exercisable within 60 days of March 19, 2025 at an exercise price of $0.0004. Pursuant to the terms of the warrants, Armistice Capital, LLC may not hold more than 9.99% of the total issued and outstanding Ordinary Shares of the Company at any given time. Therefore, such number does not include (i) 384,188 Ordinary Shares issuable upon exercise of outstanding pre-funded warrants that are exercisable within 60 days of March 19, 2025 at an exercise price of $0.0004; and (ii) 830,500 Ordinary Shares issuable upon exercise of outstanding warrants exercisable within 60 days of March 19, 2025, with expiration dates in January 2030, with an exercise price of $4.00. Armistice Capital, LLC, or Armistice Capital, is the investment manager of Armistice Capital Master Fund Ltd., or the Master Fund, the direct holder of the Ordinary Shares, and pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power over the Ordinary Shares held by the Master Fund and thus may be deemed to beneficially own the Ordinary Shares held by the Master Fund. Mr. Steven Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the Ordinary Shares held by the Master Fund. The Master Fund specifically disclaims beneficial ownership of the Ordinary Shares directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial ownership is based on a Schedule 13G/A filed by Mr. Dahan with the SEC on February 13, 2025 and other information available to us, and consists of (i) 19,167 Ordinary Shares; (ii) 208 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days of March 19, 2025, with expiration dates in August 2033 and an exercise price of $105.60; and (iii) 2,291 Ordinary Shares issuable upon the vesting of RSUs that vest within 60 days of March 19, 2025, with expiration dates in December 2034. In addition, Mr. Dahan holds options to purchase 167 Ordinary Shares that are not exercisable within 60 days, with expiration dates in November 2033 and an exercise price of $105.60; options to purchase 625 Ordinary Shares that are not exercisable within 60 days, with expiration dates of September 2034, with an exercise price of $34.32; and 9,167 RSUs that are not exercisable within 60 days, with expiration dates of December 2034.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial ownership is based on a Schedule 13G/A filed by Mr. Wagner with the SEC on February 13, 2025 and other information available to us, and consists of (i) 24,792 Ordinary Shares; (ii) 208 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days of March 19, 2025, with expiration dates in August 2033 and an exercise price of $105.60; and (iii) 2,291 Ordinary Shares issuable upon the vesting of RSUs that vest within 60 days of March 19, 2025, with expiration dates in December 2034. In addition, Mr. Wagner holds options to purchase 167 Ordinary Shares that are not exercisable within 60 days, with expiration dates in November 2033 and an exercise price of $105.60; options to purchase 625 Ordinary Shares that are not exercisable within 60 days, with expiration dates in September 2034, with an exercise price of $34.32; and 9,167 RSUs that are not exercisable within 60 days, with expiration dates in December 2034.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial
    ownership is based on a Schedule 13G/A filed by Mr. Langer with the SEC on February 13, 2025, and consists of (i) 19,271 Ordinary
    Shares; (ii) 208 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days of March 19, 2025,
    with expiration dates in August 2033 and an exercise price of $105.60; and (iii) 2,396 Ordinary Shares issuable upon the vesting
    of RSUs that vest within 60 days of March 19, 2025, with expiration dates in December 2034. In addition, Mr. Langer holds options
    to purchase 167 Ordinary Shares that are not exercisable within 60 days, with expiration dates in August 2033 and an exercise price
    of $105.60 and 9,583 RSUs that are not exercisable within 60 days, with expiration dates of December 2034.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial
    ownership consists of (i) 1,153 Ordinary Shares based on transfer agent report dated March 19, 2025; and (ii) 2,444 Ordinary Shares
    issuable upon exercise of outstanding options that are exercisable within 60 days of March 19, 2025, with expiration dates ranging
    from November 2027 to August 2033 with exercise prices ranging from $0.24 to $105.60.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial
    ownership consists of (i) 1,389 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days
    of March 19, 2025, expiration dates ranging from January 2032 to August 2033, with exercise prices ranging from $0.24 to $105.60
    and (ii) 2,083 Ordinary Shares issuable upon the vesting of RSUs that vest within 60 days of March 19, 2025, with expiration dates
    in December 2034. In addition, Mr. Mualem holds options to purchase 111 Ordinary Shares that are not exercisable within 60 days,
    with expiration dates in August 2033 and an exercise price of $105.60 and 4,167 RSUs that are not exercisable within 60 days, with
    expiration dates of December 2034.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial
    ownership consists of 1,712 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days of
    March 19, 2025, with an expiration date of November 1, 2031 and a weighted average exercise price of $0.24. In addition, Mr. Remez
    holds options to purchase 139 Ordinary Shares that are exercisable within 60 days, with an expiration date in August 2033 and an
    exercise price of $105.60 and 2,917 Ordinary Shares issuable upon the vesting of RSUs that vest within 60 days of March 19, 2025,
    with expiration dates in December 2034. In addition, Mr. Remez holds options to purchase 111 Ordinary Shares that are not exercisable
    within 60 days, with expiration dates in August 2033 and an exercise price of $105.60 and 5,833 RSUs that are not exercisable within
    60 days, with expiration dates of December 2034.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial
    ownership consists of (i) 1,951 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days
    of March 19, 2025, expiration dates ranging from November 2027 to August 2033, with exercise prices ranging from $0.24 to $105.60
    and (ii) 1,667 Ordinary Shares issuable upon the vesting of RSUs that vest within 60 days of March 19, 2025, with expiration dates
    in December 2034. In addition, Mr. Barel holds options to purchase 139 Ordinary Shares that are not exercisable within 60 days, with
    expiration dates in August 2033 and an exercise price of $105.60 and 3,333 RSUs that are not exercisable within 60 days, with expiration
    dates of December 2034.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The beneficial
    ownership consists of (i) 396 Ordinary Shares issuable upon exercise of outstanding options that are exercisable within 60 days of
    March 19, 2025, expiration dates ranging from December 2032 to August 2033, with exercise prices ranging from $52.80 to $105.60 and
    (ii) 1,667 Ordinary Shares issuable upon the vesting of RSUs that vest within 60 days of March 19, 2025, with expiration dates in
    December 2034. In addition, Ms. Fleisher holds options to purchase 167 Ordinary Shares that are not exercisable within 60 days, with
    expiration dates in August 2033 and an exercise price of $105.60 and 3,333 RSUs that are not exercisable within 60 days, with expiration
    dates of December 2034.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.35in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Lurie and Mr. Goldman each hold options to purchase 139 Ordinary Shares that are exercisable within 60 days, with expiration dates
    in November 2033, with an exercise price of $105.60. In addition, Ms. Lurie and Mr. Goldman each holds options to purchase 111 Ordinary
    Shares that are not exercisable within 60 days, with expiration dates in November 2033 and an exercise price of $105.60.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Changes
in Percentage Ownership by Major Shareholders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Over
the course of 2024, there was an increase in the percentage ownership of Armistice Capital, LLC. (from 0% to 9.99%). In addition, there
were decreases in the percentage ownership of: (i) Alumot (from 5.9% to 2.1%), (ii) Asher Dahan (from 6.6% to 2.2%), (iii) Leeor Langer
(from 6.6% to 2.2%), (iv) Guy Wagner (from 8.8% to 2.9%), which were due to the dilution as a result of warrant exercises in June 2023
and a public offering in November 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Over
the course of 2023, there was a decrease in the percentage ownership of OurCrowd General Partner, L.P. (from 8.1% to 0%) and a decrease
in the percentage ownership of Mudra CEO LLC (from 6.0% to 0%). In addition, there were decreases in the percentage ownership of: (i)
Alumot (from 7.9% to 5.9%), (ii) Asher Dahan (from 9.0% to 6.6%), (iii) Leeor Langer (from 9.0% to 6.6%), (iv) Guy Wagner (from 12.0%
to 8.8%), which were due to the dilution as a result of warrant exercises in June 2023 and a public offering in November 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Over
the course of 2022, there was an increase in the percentage ownership of OurCrowd General Partner, L.P. (from 0% to 8.1%) as a result
of their purchase of our shares from Hubble Ventures Co., Ltd. On the other hand, there were decreases in the percentage ownership of:
(i) Alumot (from 10.8% to 7.9%), (ii) Asher Dahan (from 12.1% to 9.0%), (iii) Leeor Langer (from 12.1% to 9.0%), (iv) Mudra CEO LLC (from
7.6% to 6%), and (v) Guy Wagner (from 16.2% to 12.0%), which was due to the dilution as a result of our IPO in September 2022. Additionally,
Hubble Ventures Co., Ltd.&#8217;s ownership decreased from 11.0% to 0% as a result of the sale of their shares to OurCrowd General Partner,
L.P.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Record
Holders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">As
of March 19, 2025, there were 23 shareholders of record of our Ordinary Shares. This number is not representative of the number of beneficial
holders of our shares nor is it representative of where such beneficial holders reside, since many of these shares were held of record
by brokers or other nominees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
are not controlled by another corporation, by any foreign government or by any natural or legal persons except as set forth herein, and
there are no arrangements known to us which would result in a change in our control at a subsequent date.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_033"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">B.
Related Party Transactions</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Employment
Agreements</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">We
have entered into written employment agreements with each of our executive officers. All of these agreements contain customary provisions
regarding noncompetition, confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition
provisions may be limited under applicable law. In addition, we have entered into agreements with each executive officer and director
pursuant to which we have agreed to indemnify each of them up to a certain amount and to the extent that these liabilities are not covered
by directors and officers insurance. Members of our senior management are eligible for bonuses each year. The bonuses are payable upon
meeting objectives and targets that are set by our Chief Executive Officer and approved annually by our board of directors that also
set the bonus targets for our Chief Executive Officer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">On
March 6, 2022, our board of directors approved new terms of compensation for each of our officers, subject to the approval of our shareholders.
The new terms of compensation were approved by our shareholders in a meeting that took place on March 14, 2022. On August 15, 2024, our
board of directors approved and recommended to the shareholders of the Company to approve, the adoption of an amended and restated compensation
policy, which was approved by our shareholders in a meeting that took place on September 26, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Options</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Since
our inception, we have granted options to purchase our Ordinary Shares to our officers and certain of our directors. Such option agreements
may contain acceleration provisions upon certain merger, acquisition, or change of control transactions. We describe our option plans
under &#8220;Item 6.C Board Practices - Share Option Plan.&#8221; If the relationship between us and an executive officer or a director
is terminated, except for cause (as defined in the various option plan agreements), options that are vested will generally remain exercisable
for three months after such termination.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Restricted
Share Units</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">In
December 2024, we began granting RSUs to our officers and certain of our directors under the GEIP. See &#8220;Item 6.C Board Practices
- Share Option Plan&#8221; for additional information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
December 2024, we granted certain employees, directors and consultants 131,375 RSUs that started vesting on January 1, 2025 and will settle
in Ordinary Shares, under the GEIP. An additional 10,117 Ordinary Shares are reserved for future issuance under the GEIP.</p><div>
</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_034"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">C.
Interests of Experts and Counsel</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">None.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_035"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">ITEM
8. FINANCIAL INFORMATION.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_036"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">A.
Consolidated Statements and Other Financial Information</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">See
&#8220;Item 18. Financial Statements.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Legal
Proceedings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">From
time to time, we may become involved in legal proceedings that arise in the ordinary course of business. During the period covered by
the financial statements contained herein, we were not subject to any material legal proceedings that have had a material adverse effect
on our financial position. No assurance can be given that future litigation will not have a material adverse effect on our financial
position. When appropriate in management&#8217;s estimation, we may record reserves in our financial statements for pending litigation
and other claims.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Dividends</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
have never declared or paid any cash dividends on our Ordinary Shares and do not anticipate paying any cash dividends in the foreseeable
future. Payment of cash dividends, if any, in the future will be at the discretion of our board of directors and will depend on then-existing
conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects
and other factors our board of directors may deem relevant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Under
the Companies Law, we may declare and pay dividends only if, upon the determination of our board of directors, there is no reasonable
concern that the distribution will prevent us from being able to meet the terms of our existing and foreseeable obligations as they become
due. Under the Companies Law, the distribution amount is further limited to the greater of retained earnings or earnings generated over
the two most recent years legally available for distribution according to our then last reviewed or audited financial statements, provided
that the end of the period to which the financial statements relate is not more than six months prior to the date of distribution. In
the event that we do not meet such earnings criteria, we may seek the approval of the court in order to distribute a dividend. The court
may approve our request if it is convinced that there is no reasonable concern that the payment of a dividend will prevent us from satisfying
our existing and foreseeable obligations as they become due.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Under
the Exemptions Regulations, however, an Israeli company whose shares are listed outside Israel is permitted to execute distributions
through repurchasing its own shares, even if earnings criteria are not met, without the need for a court&#8217;s approval. This exemption
is subject to certain conditions, including, among others: (i) the distribution meets the solvency criteria; and (ii) there had not been
any objection filed by any of the Company&#8217;s creditors to the relevant court. If any creditor objects to such distribution, the
Company will be required to obtain the court&#8217;s approval for such distribution.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Payment
of dividends may be subject to Israeli withholding taxes. See &#8220;Item 10. E. Taxation&#8221; for additional information.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_037"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">B.
Significant Changes</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">No
significant change, other than as otherwise described in this annual report on Form 20-F, has occurred in our operations since the date
of our consolidated financial statements included in this annual report on Form 20-F.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_038"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">ITEM
9. THE OFFER AND LISTING.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_039"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">A.
Offer and Listing Details</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
Ordinary Shares and Warrants were approved for listing on the Nasdaq Capital Market and commenced trading under the symbol &#8220;WLDS&#8221;
and &#8220;WLDSW&#8221;, respectively, on September 13, 2022.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="c_001"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">B.
Plan of Distribution</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_040"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">C.
Markets</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">See
&#8220;Item 9A. Offer and Listing Details.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">On
October 24, 2023, we received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC notifying
us that we were not in compliance with the Minimum Bid Price Requirement because the closing bid price of our Ordinary Shares was below
$1.00 per Ordinary Share for the previous 30 consecutive business days. We were granted 180 calendar days, or until April 22, 2024, to
regain compliance with the Minimum Bid Price Requirement. In the event we do not regain compliance with the Minimum Bid Price Requirement
by April 22, 2024, we may be eligible for an additional 180-calendar day grace period. On April 24, 2024, we announced that we received
a letter from the Nasdaq Stock Market LLC pursuant to which Nasdaq granted us an extension until October 21, 2024, to regain compliance
with the minimum bid price requirement. On October 7, 2024, we effectuated a 1-for-20 reverse share split in order to regain compliance
with Nasdaq Listing Rule 5550(a)(2). As a result, we were informed by Nasdaq on October 28, 2024 that we had regained compliance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">On
January 16, 2025, we received a written notification from Nasdaq, which stated that we were no longer in compliance with the minimum
stockholders&#8217; equity requirement for continued listing on Nasdaq pursuant to Nasdaq listing Rule 5550(b)(1), due to our failure
to maintain a minimum of $2,500,000 in stockholders&#8217; equity. In our Report of Foreign Private Issuer on Form 6-K, dated September
23, 2024, we reported stockholders&#8217; equity of approximately $1,695,000 as of June 30, 2024. In accordance with Nasdaq rules, we
submitted a plan to regain compliance. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date
of the letter to evidence compliance. The notification letter has no immediate effect on our listing on Nasdaq, and during the grace
period, as may be extended, our Ordinary Shares and warrants will continue to trade on Nasdaq under the symbol &#8220;WLDS&#8221; and
&#8220;WLDSW,&#8221; respectively.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_041"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">D.
Selling Shareholders</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_042"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">E.
Dilution</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_043"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">F.
Expenses of the Issue</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_044"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">ITEM
10. ADDITIONAL INFORMATION</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_045"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">A.
Share Capital</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_046"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">B.
Memorandum and Articles of Association</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">A
copy of our amended and restated articles of association is attached as Exhibit 1.1 to this annual report. The information called for
by this Item is set forth in Exhibit 1.1 to this annual report and is incorporated by reference into this annual report.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_047"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">C.
Material Contracts</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
following is a summary of each material contract, other than material contracts entered into in the ordinary course of business, to which
we are or have been a party, for the two years immediately preceding the date of this annual report:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; ">Amended
and Restated Compensation Policy for the Company&#8217;s Executive Officers and Directors (filed as Exhibit 99.1 to Form 6-K (File No.
001-41502) filed on September 26, 2024 and incorporated herein by reference). See &#8220;Item 6. C. Board Practices - Committees of the
Board of Directors - Compensation Committee&#8221; for more information about this document</span><span style="font-family: Times New Roman, Times, Serif">.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Form
of Indemnification Agreement, <span>filed as Exhibit 10.1 to a registration statement on Form F-1 (File
No. 333-262838) filed on September 8, 2022, and incorporated herein by reference. See &#8220;Item 6. C. Board Practices - Indemnification.&#8221;</span></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Standby
Equity Purchase Agreement dated as of June 6, 2024 between the Company and YA II PN, Ltd. filed as Exhibit 10.1 to Form 6-K (File No.
001-41502) filed on June 7, 2024 and incorporated herein by reference. See Item &#8220;5.B Liquidity and Capital Resources - Net Cash
Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Form
of Securities Purchase Agreement, dated as of November 26, 2024, by and between the Company and the purchaser party thereto, filed as
Exhibit 10.2 to Form 6-K (File No. 001-41502) filed on November 27, 2024 and incorporated herein by reference. See Item &#8220;5.B Liquidity
and Capital Resources - Net Cash Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Placement
Agency Agreement, dated as of November 26, 2024, by and between the Company and A.G.P./Alliance Global Partners, filed as Exhibit 10.1
to Form 6-K (File No. 001-41502) filed on November 27, 2024 and incorporated herein by reference. See Item &#8220;5.B Liquidity and Capital
Resources - Net Cash Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Form
of Ordinary Warrant, filed as Exhibit 4.1 to Form 6-K (File No. 001-41502) filed on November 27, 2024 and incorporated herein by reference.
See Item &#8220;5.B Liquidity and Capital Resources - Net Cash Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Form
of Pre-Funded Warrant, filed as Exhibit 4.2 to Form 6-K (File No. 001-41502) filed on November 27, 2024 and incorporated herein by reference.
See Item &#8220;5.B Liquidity and Capital Resources - Net Cash Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Form
of Securities Purchase Agreement, dated as of January 28, 2025, between the Company and the purchaser named in the signature page thereto,
filed as Exhibit 10.1 to Form 6-K (File No. 001-41502) filed on January 30, 2025 and incorporated herein by reference. See Item &#8220;5.B
Liquidity and Capital Resources - Net Cash Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Placement
Agency Agreement, dated as of January 28, 2025, between the Company and A.G.P./Alliance Global Partners, filed as Exhibit 10.2 to Form
6-K (File No. 001-41502) filed on January 30, 2025 and incorporated herein by reference. See Item &#8220;5.B Liquidity and Capital Resources
- Net Cash Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Form
of Warrant, filed as Exhibit 4.1 to Form 6-K (File No. 001-41502) filed on January 30, 2025 and incorporated herein by reference. See
Item &#8220;5.B Liquidity and Capital Resources - Net Cash Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Form
of Pre-Funded Warrant, filed as Exhibit 4.2 to Form 6-K (File No. 001-41502) filed on January 30, 2025 and incorporated herein by reference.
See Item &#8220;5.B Liquidity and Capital Resources - Net Cash Provided by Financing Activities.&#8221;.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Form
of Warrant Amendment Agreement, filed as Exhibit 4.3 to Form 6-K (File No. 001-41502) filed on January 30, 2025 and incorporated herein
by reference. See Item &#8220;5.B Liquidity and Capital Resources - Net Cash Provided by Financing Activities.&#8221;</span></td>
</tr></table><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_048"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">D.
Exchange Controls</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">There
are currently no Israeli currency control restrictions on payments of dividends or other distributions with respect to our Ordinary Shares
or the proceeds from the sale of the shares, except for the obligation of Israeli residents to file reports with the Bank of Israel regarding
certain transactions. However, legislation remains in effect pursuant to which currency controls can be imposed by administrative action
at any time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
ownership or voting of our Ordinary Shares by non-residents of Israel, except with respect to citizens of countries that are in a state
of war with Israel, is not restricted in any way by our memorandum of association or amended and restated articles of association or
by the laws of the State of Israel.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_049"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">E.
Taxation</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><i>The
following description is not intended to constitute a complete analysis of all tax consequences relating to the ownership or disposition
of our Ordinary Shares. You should consult your own tax advisor </i>concerning <i>the tax consequences of your particular situation,
as well as any tax consequences that may arise under the laws of any state, local, foreign, including Israeli, or other taxing jurisdiction.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Israeli
Tax Considerations and Government Programs</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
following is a description of the material Israeli income tax consequences of the ownership of our Ordinary Shares. The following also
contains a description of material relevant provisions of the current Israeli income tax structure applicable to companies in Israel,
with reference to its effect on us. To the extent that the discussion is based on new tax legislation which has not been subject to judicial
or administrative interpretation, there can be no assurance that the tax authorities will accept the views expressed in the discussion
in question. The discussion is not intended, and should not be taken, as legal or professional tax advice and is not exhaustive of all
possible tax considerations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
following description is not intended to constitute a complete analysis of all tax consequences relating to the ownership or disposition
of our Ordinary Shares. Shareholders should consult their own tax advisors concerning the tax consequences of their particular situation,
as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>General
Corporate Tax Structure in Israel</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Israeli
companies are generally subject to corporate tax, currently at the rate of 23%. However, the effective tax rate payable by a company
that derives income from a Preferred Enterprise or Preferred Technological Enterprise (as discussed below) may be considerably less.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Capital
gains derived by an Israeli resident company are subject to tax at the regular corporate tax rate. Under Israeli tax legislation, a corporation
will be considered as an &#8220;Israeli resident company&#8221; if it meets one of the following criteria: (i) it was incorporated in
Israel; or (ii) the control and management of its business are exercised in Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Law
for the Encouragement of Industry (Taxes), 5729-1969</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax
benefits for &#8220;Industrial Companies.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
Industry Encouragement Law defines an &#8220;Industrial Company&#8221; as an Israeli resident-company, which has 90% or more of its income
in any tax year, other than income from defense loans, derived from an &#8220;Industrial Enterprise&#8221; owned by it. An &#8220;Industrial
Enterprise&#8221; is defined as an enterprise whose principal activity in a given tax year is industrial production.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
following corporate tax benefits, among others, are available to Industrial Companies:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">amortization
of the cost to purchase a patent, rights to use a patent, and know-how, which are used for the development or advancement of the company,
over an eight-year period, commencing on the year in which such rights were first exercised;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">under
limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">expenses
related to a public offering are deductible in equal amounts over three years.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Eligibility
for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority, but it quite common
to maintain preapproval from the Israeli Tax Authority, or the ITA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Tax
Benefits and Grants for Research and Development</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Under
the Research Law, programs which meet specified criteria and are approved by the IIA are eligible for grants of up to 85% of the project&#8217;s
expenditure, as determined by the research committee, in exchange for the payment of royalties from the revenues generated from the sale
of products and related services developed, in whole or in part pursuant to, or as a result of, a research and development program funded
by the IIA. The royalties are generally at a range of 3.0% to 3.5% of revenues until the entire IIA grant is repaid, together with an
annual interest. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable to US Dollar deposits.
However, on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under
such directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January
1, 2024 the annual interest is calculated at a rate based on 12-month Secured Overnight Financing Rate, or SOFR, or at an alternative
rate published by the Bank of Israel plus 0.71513%; and, for grants approved on or following January 1, 2024 the annual interest shall
be the higher of (i) the 12 months SOFR interest rate, plus 1%, or (ii) a fixed annual interest rate of 4%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
terms of the Research Law also require that the manufacture of products developed with government grants be performed in Israel. The
transfer of manufacturing activity outside Israel may be subject to the prior approval of the IIA. Under the regulations of the Research
Law, assuming we receive approval from the IIA to manufacture our IIA funded products outside Israel, we may be required to pay increased
royalties. The increase in royalties depends upon the manufacturing volume that is performed outside of Israel as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Manufacturing Volume Outside of Israel</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Royalties<br/> to the IIA as<br/> a Percentage<br/> of Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Up to 50%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">120</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">between 50% and 90%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">90% and more</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">300</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">If
the manufacturing is performed outside of Israel by us, the rate of royalties payable by us on revenues from the sale of products manufactured
outside of Israel will increase by 1% over the regular rates. If the manufacturing is performed outside of Israel by a third party, the
rate of royalties payable by us on those revenues will be equal to the ratio obtained by dividing the amount of the grants received from
the IIA and our total investment in the project that was funded by these grants. The transfer of no more than 10% of the manufacturing
capacity in the aggregate outside of Israel is exempt under the Research Law from obtaining the prior approval of the IIA. A company
requesting funds from the IIA also has the option of declaring in its IIA grant application an intention to perform part of its manufacturing
outside Israel, thus avoiding the need to obtain additional approval. On January 6, 2011, the Research Law was amended to clarify that
the potential increased royalties specified in the table above will apply even in those cases where the IIA approval for transfer of
manufacturing outside of Israel is not required, namely when the volume of the transferred manufacturing capacity is less than 10% of
total capacity or when the company received an advance approval to manufacture abroad in the framework of its IIA grant application.
For applications to manufacture abroad, submitted to the IIA after October 25, 2023, the maximum increased liability is up to 150% of
the IIA grants, plus interest accrued thereon, instead of 300%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
know-how developed within the framework of the IIA plan may not be transferred to third parties outside Israel without the prior approval
of a governmental committee charted under the Research Law. The approval, however, is not required for the export of any products developed
using grants received from the IIA. The IIA approval to transfer know-how created, in whole or in part, in connection with an IIA-funded
project to third party outside Israel where the transferring company remains an operating Israeli entity is subject to payment of a redemption
fee to the IIA calculated according to a formula provided under the Research Law that is based, in general, on the ratio between the
aggregate IIA grants to the company&#8217;s aggregate investments in the project that was funded by these IIA grants, multiplied by the
transaction consideration. The transfer of such know-how to a party outside Israel where the transferring company ceases to exist as
an Israeli entity is subject to a redemption fee formula that is based, in general, on the ratio between the aggregate IIA grants to
the total financial investments in the company, multiplied by the transaction consideration. According to the January 2011 amendment,
the redemption fee in case of transfer of know-how to a party outside Israel will be based on the ratio between the aggregate IIA grants
received by the company and the company&#8217;s aggregate R&amp;D expenses, multiplied by the transaction consideration. According to
regulations promulgated following the 2011 amendment, the maximum amount payable to the IIA in case of transfer of know how outside Israel
shall not exceed 6 times the value of the grants received plus interest, and in the event that the receiver of the grants ceases to be
an Israeli corporation such payment shall not exceed 6 times the value of the grants received plus interest, with a possibility to reduce
such payment to up to 3 times the value of the grants received plus interest if the R&amp;D activity remains in Israel for a period of
three years after payment to the IIA and maintain at least 75% of the research and development employees the Company had for the six
months before the know-how was transferred, subject to additional conditions specified in the regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Transfer
of know-how within Israel is subject to an undertaking of the recipient Israeli entity to comply with the provisions of the Research
Law and related regulations, including the restrictions on the transfer of know-how and the obligation to pay royalties, as further described
in the Research Law and related regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">These
restrictions may impair our ability to outsource manufacturing, engage in change of control transactions or otherwise transfer our know-how
outside Israel and may require us to obtain the approval or the IIA for certain actions and transactions and pay additional royalties
to the IIA. In particular, any change of control and any change of ownership of our Ordinary Shares that would make a non-Israeli citizen
or resident an &#8220;interested party,&#8221; as defined in the Research Law, requires a prior written notice to the IIA in addition
to any payment that may be required of us for transfer of manufacturing or know-how outside Israel. If we fail to comply with the Research
Law, we may be subject to criminal charges or to mandatory repayment of grants received by us (together with interest and penalties).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Tax
Benefits for Research and Development</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Israeli
tax law allows, under certain conditions, a tax deduction for expenditures, including capital expenditures, for the year in which they
are incurred. Expenditures are deemed related to scientific research and development projects, if:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
expenditures are approved by the relevant Israeli government ministry, determined by the field of research;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
research and development must be for the promotion of the company; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
research and development is carried out by or on behalf of the company seeking such tax deduction.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific
research and development projects. No deduction under these research and development deduction rules is allowed if such deduction is
related to an expense invested in an asset depreciable under the general depreciation rules of the Tax Ordinance. Expenditures not so
approved are deductible in equal amounts over three years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">From
time to time we may apply the Office of the Chief Scientist for approval to allow a tax deduction for all research and development expenses
during the year incurred. There can be no assurance that such application will be accepted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Law
for the Encouragement of Capital Investments, 5719-1959</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
Law for the Encouragement of Capital Investments, 5719-1959, generally referred to as the Investment Law, provides certain incentives
for capital investments in production facilities (or other eligible assets).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
Investment Law was significantly amended effective as of as of January 1, 2011, or the 2011 Amendment, and as of January 1, 2017, or
the 2017 Amendment. The 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment
Law in effect prior to the 2011 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing
tax benefits.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>Tax
benefits under the 2011 Amendment</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
2011 Amendment canceled the availability of the benefits granted under the Investment Law prior to 2011 and, instead, introduced new
benefits for income generated by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; (as such terms are
defined in the Investment Law) as of January 1, 2011. The definition of a Preferred Company includes a company incorporated in Israel
that is not fully owned by a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and
managed from Israel. Pursuant to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 16% with respect
to its income derived from its Preferred Enterprise, unless the Preferred Enterprise is located in a specified development zone, in which
case the rate will be 7.5%. Income derived by a Preferred Company from a &#8220;Special Preferred Enterprise&#8221; (as such term is
defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or 5% if
the Special Preferred Enterprise is located in a certain development zone.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Dividends
distributed from income which is attributed to a &#8220;Preferred Enterprise&#8221; should generally be subject to withholding tax at
source at the following rates: (i) Israeli resident corporations - 0%, (although, if such dividends are subsequently distributed to individuals
or a non-Israeli company the below rates detailed in sub sections (ii) and (iii) shall apply), (ii) Israeli resident individuals - 20%
and (iii) non-Israeli residents (individuals and corporations) - subject to the receipt in advance of a valid certificate from the ITA
allowing for a reduced tax rate, 20% or such lower rate as may be provided under the provisions of any applicable double tax treaty.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">We
currently do not intend to implement the 2011 Amendment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>Tax
benefits under the 2017 Amendment that became effective on January 1, 2017</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December 29, 2016, and is effective as of January
1, 2017. The 2017 Amendment provided new tax benefits for two types of &#8220;Technological Enterprises,&#8221; as described below, and
is in addition to the other existing tax beneficial programs under the Investment Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
2017 Amendment provides that a technology company satisfying certain conditions should qualify as a Preferred Technological Enterprise,
or PTE, and thereby enjoy a reduced corporate tax rate of 12% on income that qualifies as &#8220;Preferred Technological Income&#8221;,
as defined in the Investment Law. The tax rate is further reduced to 7.5% for a PTE located in development zone &#8220;A&#8221;. In addition,
a PTE will enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain &#8220;Benefited Intangible Assets&#8221;
(as defined in the Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company
on or after January 1, 2017 for at least NIS 200 million, and the sale received prior approval from the National Authority for Technological
Innovation previously known as the Israeli Office of the Chief Scientist), to which we refer as IIA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">The
2017 Amendment further provides that a technology company satisfying certain conditions (group turnover of at least NIS 10 billion) should
qualify as a &#8220;Special Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced corporate tax rate of 6% on &#8220;Preferred
Technological Income&#8221; regardless of the company&#8217;s geographic location within Israel. In addition, a Special Preferred Technological
Enterprise should enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain &#8220;Benefited Intangible
Assets&#8221; to a related foreign company if the Benefited Intangible Assets were either developed by the Special Preferred Enterprise
or acquired from a foreign company on or after January 1, 2017, and the sale received prior approval from IIA. A Special Preferred Technological
Enterprise that acquires Benefited Intangible Assets from a foreign company for more than NIS 500 million should be eligible for these
benefits for at least ten years, subject to certain approvals as specified in the Investment Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Dividends
distributed out of Preferred Technological Income to Israeli shareholders by a PTE or a Special Preferred Technology Enterprise, paid
out of Preferred Technological Income, should generally subject to withholding tax at source at the rate of 20% (in the case of non-Israeli
shareholders, a lower rate may be provided in an applicable tax treaty) but in either case, subject to the receipt in advance of a valid
certificate from the ITA allowing for a reduced tax rate. However, if such dividends are paid to an Israeli company, no tax is generally
required to be withheld (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, withholding
tax at a rate of 20% or such lower rate as may be provided in an applicable tax treaty, should apply). If such dividends are distributed
to a foreign company that holds solely or together with other foreign companies 90% or more in the Israeli company and other conditions
are met, the withholding tax rate should be 4% (or such lower rate as may be provided in an applicable tax treaty, in either case, subject
to the receipt in advance of a valid certificate from the ITA allowing for such reduced tax rate).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Taxation
of our Shareholders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>Capital
Gains Taxes Applicable to Non-Israeli Resident Shareholders</i>. A non-Israeli resident who derives capital gains from the sale of shares
in an Israeli resident company will be exempt from Israeli tax so long as the shares were not held through a permanent establishment
that the non-resident maintains in Israel. However, non-Israeli corporations will not be entitled to the foregoing exemption if Israeli
residents: (i) have a controlling interest of 25% or more in such non-Israeli corporation or (ii) are the beneficiaries of, or are entitled
to, 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">Additionally,
a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax
treaty. For example, under Convention Between the Government of the United States of America and the Government of the State of Israel
with respect to Taxes on Income, as amended, or the United States-Israel Tax Treaty, the sale, exchange or other disposition of shares
by a shareholder who is a United States resident (for purposes of the treaty) holding the shares as a capital asset and is entitled to
claim the benefits afforded to such a resident by the U.S.- Israel Tax Treaty, or a Treaty U.S. Resident, is generally exempt from Israeli
capital gains tax unless: (i) the capital gain arising from such sale, exchange or disposition is attributed to real estate located in
Israel; (ii) the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii) the capital gain arising
from the such sale, exchange or disposition is attributed to a permanent establishment in Israel, under certain terms; (iv) such Treaty
U.S. Resident holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period
preceding the disposition, subject to certain conditions; or (v) such Treaty U.S. Resident is an individual and was present in Israel
for 183 days or more during the relevant taxable year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif">In
some instances where our shareholders may be liable for Israeli tax on the sale of their Ordinary Shares, the payment of the consideration
may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they are exempt from tax
on their capital gains in order to avoid withholding at source at the time of sale.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><i>Taxation
of Non-Israeli Shareholders on Receipt of Dividends</i>. Non-Israeli residents are generally subject to Israeli income tax on the receipt
of dividends paid on our Ordinary Shares at the rate of 25% (before surtax at a rate of up to 5% on income above certain threshold),
which tax will be withheld at source, unless relief is provided in a treaty between Israel and the shareholder&#8217;s country of residence.
With respect to a person who is a &#8220;substantial shareholder&#8221; at the time of receiving the dividend or at any time during the
preceding twelve months, the applicable tax rate is 30% (before surtax at a rate of up to 5% on income above certain threshold). A &#8220;substantial
shareholder&#8221; is generally a person who alone or together with such person&#8217;s relative or another person who collaborates with
such person on a permanent basis, holds, directly or indirectly, at least 10% of any of the &#8220;means of control&#8221; of the corporation
at the time of receiving the dividend or at any time during the preceding twelve months. &#8220;Means of control&#8221; generally include
the right to vote, receive profits, nominate a director or an executive officer, receive assets upon liquidation, or order someone who
holds any of the aforesaid rights how to act, regardless of the source of such right. However, a distribution of dividends to non-Israeli
residents is subject to withholding tax at source at a rate of 20% if the dividend is distributed from income attributed to a Preferred
Enterprise or PTE, unless a reduced tax rate is provided under an applicable tax treaty. For example, under the United States-Israel
Tax Treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder of our Ordinary Shares who is a Treaty
U.S. Resident is 25%. However, generally, the maximum rate of withholding tax on dividends, not generated by a Preferred Enterprise or
PTE, that are paid to a United States corporation holding 10% or more of the outstanding voting capital throughout the tax year in which
the dividend is distributed as well as during the previous tax year, is 12.5%, provided that not more than 25% of the gross income for
such preceding year consists of certain types of dividends and interest. Notwithstanding the foregoing, dividends distributed from income
attributed to an Preferred Enterprise or PTE are not entitled to such reduction under the tax treaty but are subject to a withholding
tax rate of 15% for a shareholder that is a U.S. corporation, provided that the condition related to our gross income for the previous
year (as set forth in the previous sentence) is met. If the dividend is attributable partly to income derived from a Preferred Enterprise
or PTE, and partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two
types of income. We cannot assure you that we will designate the profits that we may distribute in a way that will reduce shareholders&#8217;
tax liability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>U.S.
Federal Income Tax Considerations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">THE
FOLLOWING SUMMARY IS INCLUDED HEREIN FOR GENERAL INFORMATION AND IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSIDERED TO BE, LEGAL OR
TAX ADVICE. EACH U.S. HOLDER SHOULD CONSULT WITH HIS OR HER OWN TAX ADVISOR AS TO THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES
OF THE PURCHASE, OWNERSHIP AND SALE OF ORDINARY SHARES, <span style="text-transform: uppercase">the Warrants, and the Ordinary Shares
issued or issuable upon exercise of the Warrants</span>, INCLUDING THE EFFECTS OF APPLICABLE STATE, LOCAL, FOREIGN OR OTHER TAX LAWS
AND POSSIBLE CHANGES IN THE TAX LAWS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Subject
to the limitations described in the next paragraph, the following discussion summarizes the material U.S. federal income tax consequences
to a &#8220;U.S. Holder&#8221; arising from the purchase, ownership and sale of the Ordinary Shares, the Warrants, and the Ordinary Shares
issued or issuable upon exercise of the Warrants, collectively, the &#8220;securities&#8221;. For this purpose, a &#8220;U.S. Holder&#8221;
is a holder of Ordinary Shares that is: (1) an individual citizen or resident of the United States, including an alien individual who
is a lawful permanent resident of the United States or meets the substantial presence residency test under U.S. federal income tax laws;
(2) a corporation (or entity treated as a corporation for U.S. federal income tax purposes) or a partnership (other than a partnership
that is not treated as a U.S. person under any applicable U.S. Treasury regulations) created or organized under the laws of the United
States or the District of Columbia or any political subdivision thereof; (3) an estate, the income of which is includable in gross income
for U.S. federal income tax purposes regardless of source; (4) a trust if a court within the United States is able to exercise primary
supervision over the administration of the trust and one or more U.S. persons have authority to control all substantial decisions of
the trust; or (5) a trust that has a valid election in effect to be treated as a U.S. person to the extent provided in U.S. Treasury
regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">This
summary is for general information purposes only and does not purport to be a comprehensive description of all of the U.S. federal income
tax considerations that may be relevant to a decision to purchase our securities. This summary generally considers only U.S. Holders
that will own our securities as capital assets. Except to the limited extent discussed below, this summary does not consider the U.S.
federal tax consequences to a person that is not a U.S. Holder, nor does it describe the rules applicable to determine a taxpayer&#8217;s
status as a U.S. Holder. This summary is based on the provisions of the Internal Revenue Code of 1986, as amended, or the Code, final,
temporary and proposed U.S. Treasury regulations promulgated thereunder, administrative and judicial interpretations thereof, (including
with respect to the Tax Cuts and Jobs Act of 2017), and the U.S.-Israel Income Tax Treaty, all as in effect as of the date hereof and
all of which are subject to change, possibly on a retroactive basis, and all of which are open to differing interpretations. We will
not seek a ruling from the IRS with regard to the U.S. federal income tax treatment of an investment in our securities by U.S. Holders
and, therefore, can provide no assurances that the IRS will agree with the conclusions set forth below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">This
discussion does not address all of the aspects of U.S. federal income taxation that may be relevant to a particular U.S. holder based
on such holder&#8217;s particular circumstances and in particular does not discuss any estate, gift, generation-skipping, transfer, state,
local, excise or foreign tax considerations. In addition, this discussion does not address the U.S. federal income tax treatment of a
U.S. Holder who is: (1) a bank, life insurance company, regulated investment company, or other financial institution or &#8220;financial
services entity;&#8221; (2) a broker or dealer in securities or foreign currency; (3) a person who acquired our securities in connection
with employment or other performance of services; (4) a U.S. Holder that is subject to the U.S. alternative minimum tax; (5) a U.S. Holder
that holds our securities as a hedge or as part of a hedging, straddle, conversion or constructive sale transaction or other risk-reduction
transaction for U.S. federal income tax purposes; (6) a tax-exempt entity; (7) real estate investment trusts or grantor trusts; (8) a
U.S. Holder that expatriates out of the United States or a former long-term resident of the United States; or (9) a person having a functional
currency other than the U.S. dollar. This discussion does not address the U.S. federal income tax treatment of a U.S. Holder that owns,
directly or constructively, at any time, securities representing 10% or more of our voting power. Additionally, the U.S. federal income
tax treatment of partnerships (or other pass-through entities) or persons who hold securities through a partnership or other pass-through
entity are not addressed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Each
prospective investor is advised to consult his or her own tax adviser for the specific tax consequences to that investor of purchasing,
holding or disposing of our securities, including the effects of applicable state, local, foreign or other tax laws and possible changes
in the tax laws.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>Exercise
or Expiry of Warrants</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">No
gain or loss will be realized on the exercise of a Warrant. When a Warrant is exercised, the U.S. Holder&#8217;s cost of the common share
acquired thereby will be equal to the U.S. Holder&#8217;s adjusted cost basis of the Warrant plus the exercise price paid for the common
share. The expiry of an unexercised Warrant will generally give rise to a capital loss equal to the adjusted cost basis to the U.S. Holder
of the expired Warrant. The holding period of the common share acquired thru the exercise of a Warrant includes the holding period of
the Warrant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>Taxation
of Dividends Paid on Securities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
do not intend to pay dividends in the foreseeable future and U.S. Holders of Warrants are not entitled to dividends. In the event that
we do pay dividends, and subject to the discussion under the heading &#8220;Passive Foreign Investment Companies&#8221; below and the
discussion of &#8220;qualified dividend income&#8221; below, a U.S. Holder, other than certain U.S. Holder&#8217;s that are U.S. corporations,
will be required to include in gross income as ordinary income the amount of any distribution paid on securities (including distributions
paid on Warrants if such warrants were to become entitled to dividends and the amount of any Israeli tax withheld on the date of the
distribution), to the extent that such distribution does not exceed our current and accumulated earnings and profits, as determined for
U.S. federal income tax purposes. The amount of a distribution which exceeds our earnings and profits will be treated first as a non-taxable
return of capital, reducing the U.S. Holder&#8217;s tax basis for the securities to the extent thereof, and then capital gain. We do
not expect to maintain calculations of our earnings and profits under U.S. federal income tax principles and, therefore, U.S. Holders
should expect that the entire amount of any distribution generally will be reported as dividend income.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">In
general, preferential tax rates for &#8220;qualified dividend income&#8221; and long-term capital gains are applicable for U.S. Holders
that are individuals, estates or trusts. For this purpose, &#8220;qualified dividend income&#8221; means, inter alia, dividends received
from a &#8220;qualified foreign corporation.&#8221; A &#8220;qualified foreign corporation&#8221; is a corporation that is entitled to
the benefits of a comprehensive tax treaty with the United States which includes an exchange of information program. The IRS has stated
that the U.S.-Israel Tax Treaty satisfies this requirement and we believe we are eligible for the benefits of that treaty.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">In
addition, our dividends will be qualified dividend income if our securities are readily tradable on the Nasdaq Capital Market or another
established securities market in the United States. Dividends will not qualify for the preferential rate if we are treated, in the year
the dividend is paid or in the prior year, as a PFIC, as described below under &#8220;Passive Foreign Investment Companies.&#8221; A
U.S. Holder will not be entitled to the preferential rate: (1) if the U.S. Holder has not held our securities for at least 61 days of
the 121 day period beginning on the date which is 60 days before the ex-dividend date, or (2) to the extent the U.S. Holder is under
an obligation to make related payments on substantially similar property. Any days during which the U.S. Holder has diminished its risk
of loss on our securities are not counted towards meeting the 61-day holding period. Finally, U.S. Holders who elect to treat the dividend
income as &#8220;investment income&#8221; pursuant to Code section 163(d)(4) will not be eligible for the preferential rate of taxation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
amount of a distribution with respect to our securities will be measured by the amount of the fair market value of any property distributed,
and for U.S. federal income tax purposes, the amount of any Israeli taxes withheld therefrom. Cash distributions paid by us in NIS will
be included in the income of U.S. Holders at a U.S. dollar amount based upon the spot rate of exchange in effect on the date the dividend
is includible in the income of the U.S. Holder, and U.S. Holders will have a tax basis in such NIS for U.S. federal income tax purposes
equal to such U.S. dollar value. If the U.S. Holder subsequently converts the NIS into U.S. dollars or otherwise disposes of it, any
subsequent gain or loss in respect of such NIS arising from exchange rate fluctuations will be U.S. source ordinary exchange gain or
loss.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>Taxation
of the Disposition of Securities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Except
as provided under the PFIC rules described below under &#8220;Passive Foreign Investment Companies,&#8221; upon the sale, exchange or
other disposition of our securities, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between such
U.S. Holder&#8217;s tax basis for the securities in U.S. dollars and the amount realized on the disposition in U.S. dollar (or its U.S.
dollar equivalent determined by reference to the spot rate of exchange on the date of disposition, if the amount realized is denominated
in a foreign currency). The gain or loss realized on the sale, exchange or other disposition of securities will be long-term capital
gain or loss if the U.S. Holder has a holding period of more than one year at the time of the disposition. Individuals who recognize
long-term capital gains may be taxed on such gains at reduced rates of tax. The deduction of capital losses is subject to various limitations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>Passive
Foreign Investment Companies</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Special
U.S. federal income tax laws apply to U.S. taxpayers who own shares of a corporation that is a PFIC. We will be treated as a PFIC for
U.S. federal income tax purposes for any taxable year that either:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">75%
or more of our gross income (including our pro rata share of gross income for any company, in which we are considered to own 25% or more
of the shares by value), in a taxable year is passive; or</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">At
least 50% of our assets, averaged over the year and generally determined based upon fair market value (including our pro rata share of
the assets of any company in which we are considered to own 25% or more of the shares by value) are held for the production of, or produce,
passive income.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">For
this purpose, passive income generally consists of dividends, interest, rents, royalties, annuities and income from certain commodities
transactions and from notional principal contracts. Cash is treated as generating passive income.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Based
on the projected composition of our income and valuation of our assets, we cannot determine if we will become a PFIC for 2024 or in the
future. The tests for determining PFIC status are applied annually, and it is difficult to make accurate projections of future income
and assets which are relevant to this determination. In addition, our PFIC status may depend in part on the market value of our securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">If
we currently are or become a PFIC, each U.S. Holder who has not elected to mark the shares to market (as discussed below), would, upon
receipt of certain distributions by us and upon disposition of our securities at a gain: (1) have such distribution or gain allocated
ratably over the U.S. Holder&#8217;s holding period for the securities, as the case may be; (2) the amount allocated to the current taxable
year and any period prior to the first day of the first taxable year in which we were a PFIC would be taxed as ordinary income; and (3)
the amount allocated to each of the other taxable years would be subject to tax at the highest rate of tax in effect for the applicable
class of taxpayer for that year, and an interest charge for the deemed deferral benefit would be imposed with respect to the resulting
tax attributable to each such other taxable year. In addition, when shares of a PFIC are acquired by reason of death from a decedent
that was a U.S. Holder, the tax basis of such shares would not receive a step-up to fair market value as of the date of the decedent&#8217;s
death, but instead would be equal to the decedent&#8217;s basis if lower, unless all gain were recognized by the decedent. Indirect investments
in a PFIC may also be subject to these special U.S. federal income tax rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
PFIC rules described above would not apply to a U.S. Holder who makes a QEF election for all taxable years that such U.S. Holder has
held the securities while we are a PFIC, provided that we comply with specified reporting requirements. Instead, each U.S. Holder who
has made such a QEF election is required for each taxable year that we are a PFIC to include in income such U.S. Holder&#8217;s pro rata
share of our ordinary earnings as ordinary income and such U.S. Holder&#8217;s pro rata share of our net capital gains as long-term capital
gain, regardless of whether we make any distributions of such earnings or gain. In general, a QEF election is effective only if we make
available certain required information. The QEF election is made on a shareholder-by-shareholder basis and generally may be revoked only
with the consent of the IRS. We do not intend to notify U.S. Holders if we believe we will be treated as a PFIC for any tax year. In
addition, we do not intend to furnish U.S. Holders annually with information needed in order to complete IRS Form 8621 and to make and
maintain a valid QEF election for any year in which we or any of our subsidiaries are a PFIC. Therefore, the QEF election will not be
available with respect to our securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">In
addition, the PFIC rules described above would not apply if we were a PFIC and a U.S. Holder made a mark-to-market election. A U.S. Holder
of our securities which are regularly traded on a qualifying exchange, including the Nasdaq Capital Market, can elect to mark the securities
to market annually, recognizing as ordinary income or loss each year an amount equal to the difference as of the close of the taxable
year between the fair market value of the securities and the U.S. Holder&#8217;s adjusted tax basis in the securities. Losses are allowed
only to the extent of net mark-to-market gain previously included income by the U.S. Holder under the election for prior taxable years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">U.S.
Holders who hold our securities during a period when we are a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC.
U.S. Holders are strongly urged to consult their tax advisors about the PFIC rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b>Tax
on Net Investment Income</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">U.S.
Holders who are individuals, estates or trusts will generally be required to pay a 3.8% Medicare tax on their net investment income (including
dividends on and gains from the sale or other disposition of our securities), or in the case of estates and trusts on their net investment
income that is not distributed. In each case, the 3.8% Medicare tax applies only to the extent the U.S. Holder&#8217;s total adjusted
income exceeds applicable thresholds.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif"><b><i>Information
Reporting and Withholding</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">A
U.S. Holder may be subject to backup withholding at a rate of 24% with respect to cash dividends and proceeds from a disposition of securities.
In general, backup withholding will apply only if a U.S. Holder fails to comply with specified identification procedures. Backup withholding
will not apply with respect to payments made to designated exempt recipients, such as corporations and tax-exempt organizations. Backup
withholding is not an additional tax and may be claimed as a credit against the U.S. federal income tax liability of a U.S. Holder, provided
that the required information is timely furnished to the IRS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">A
U.S. Holder with interests in &#8220;specified foreign financial assets&#8221; (including, among other assets, our securities, unless
such securities are held on such U.S. Holder&#8217;s behalf through a financial institution) may be required to file an information report
with the IRS if the aggregate value of all such assets exceeds $50,000 on the last day of the taxable year or $75,000 at any time during
the taxable year (or such higher dollar amount as may be prescribed by applicable IRS guidance); and may be required to file a Report
of Foreign Bank and Financial Accounts if the aggregate value of the foreign financial accounts exceeds $10,000 at any time during the
calendar year. You should consult your own tax advisor as to the possible obligation to file such information report.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_050"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">F.
Dividends and Paying Agents</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_051"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">G.
Statement by Experts</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_052"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">H.
Documents on Display</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
are subject to certain information reporting requirements of the Exchange Act, applicable to foreign private issuers and under those
requirements will file reports with the SEC. The SEC maintains an Internet website that contains reports and other information regarding
issuers that file electronically with the SEC. Our filings with the SEC will also available to the public through the SEC&#8217;s website
at www.sec.gov.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">As
a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements,
and our officers, directors and principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained
in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports
and financial statements with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the
Exchange Act. However, we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required
by the SEC, an annual report containing financial statements audited by an independent registered public accounting firm, and may submit
to the SEC, on a Form 6-K, unaudited half-yearly financial information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
maintain a corporate website <i>www.mudra-band.com</i>. Information contained on, or that can be accessed through, our website and the
other websites referenced above do not constitute a part of this annual report. We have included these website addresses in this annual
report solely as inactive textual references.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_053"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">I.
Subsidiary Information</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_054"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in"><span style="font-family: Times New Roman, Times, Serif">J.
Annual Report to Security Holders</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><div><a id="D_055"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">ITEM
11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
are exposed to market risks in the ordinary course of our business. <span>Market risk represents the
risk of loss that may impact </span>our <span>financial position due to adverse changes in financial
market prices and rates.</span> Our market risk exposure is primarily the result of <span>foreign currency
exchange rates</span>.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; "><b><i>Foreign
Currency Exchange Risk</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Currency
Fluctuations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
reporting currency and the functional currency is the U.S. dollar. Our funding was in U.S. dollars and our sales are currently denominated
in U.S. dollars. Our operating expenses are denominated mainly in NIS, and therefore, our NIS denominated operating expenses are currently
subject to foreign currency risk. To date, we have been affected by changes in the rate of inflation and NIS currency compared to the
U.S. dollar, as shown below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The NIS devaluated against
the U.S. dollar by approximately 0.6% in 2024 and devaluated against the U.S. dollar by approximately 3.1% in 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A decrease of 10% in the U.S.
dollar/NIS exchange rate would have increased our cost of revenues and operating expenses by approximately $455 thousand and $580 thousand,
for the years ended December 31, 2024 and 2023, respectively. If the NIS fluctuates significantly against the U.S. dollar, it may have
a negative impact on our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2023 we partially hedged our foreign currency exchange risk. During the year ended December 31, 2024, we partially hedged our foreign
currency exchange risk. If we were to determine that it is in our best interests to continue hedging transactions in the future in order
to protect ourselves in part from currency fluctuations, we may not be able to do so, or such transactions, if entered into, may not materially
reduce the effect of fluctuations in foreign currency exchange rates on our results of operations and may result in additional expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure you that
we will not be adversely affected by currency fluctuations in the future.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_056"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN
EQUITY SECURITIES</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><div><a id="D_057"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">A. Debt Securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><div><a id="D_058"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">B. Warrants and rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><div><a id="D_059"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">C. Other Securities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">D. American Depositary Shares</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="D_060"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">PART II</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_061"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_062"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS
OF SECURITY HOLDERS AND USE OF PROCEEDS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the IPO
(including a partial exercise of over-allotment option), the Company issued and sold 46,875 Ordinary Shares and 107,812 Warrants and received
aggregate gross proceeds of approximately $16 million, before deducting underwriting discounts, commissions and offering expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
net proceeds from IPO have been used, and are expected to continue to be used, as described in the final prospectus for the IPO filed
with the SEC on September 15, 2022.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_063"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 15. CONTROLS AND PROCEDURES</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">A. Disclosure Controls and Procedures</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain disclosure controls
and procedures designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange
Act is recorded, processed, summarized and reported within the specified time periods and accumulated and communicated to our management,
including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management, with the participation
of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures
(as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2024, or the Evaluation Date. Based
on such evaluation, those officers have concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">B. Management&#8217;s Annual Report
on Internal Control over Financial Reporting</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
management is responsible for establishing and maintaining adequate internal control over our financial reporting. Internal control over
financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the
supervision of, the Company&#8217;s principal executive and principal financial officers and effected by the board of directors, management
and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures
that:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions
and dispositions of the assets of the Company;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made
only in accordance with authorizations of management and directors of the Company; and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use
or disposition of the Company&#8217;s assets that could have a material effect on our financial statements.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
management assessed the effectiveness of our internal control over financial reporting as of December 31, 2024. In making this assessment,
our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal
Control-Integrated Framework. Based on that assessment, our management concluded that as of December 31, 2024, our internal control over
financial reporting is effective.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">C. Attestation Report of the Registered
Public Accounting Firm</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This annual report does not
include an attestation report of the company&#8217;s registered public accounting firm regarding internal control over financial reporting,
due to a transition period established by rules of the SEC for newly public companies and due to an exemption for emerging growth companies
under the JOBS Act.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -1.5in">D. Changes in Internal Control
over Financial Reporting</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2024, we completed the process of documenting our internal control procedures to satisfy the requirements of Section 404(a) of the
Sarbanes-Oxley Act, which requires an annual management assessment of the effectiveness of our internal control over financial reporting.
We have established formal policies, processes and practices related to our internal control over financial reporting and to identify
key financial reporting risks, including an assessment of the potential impact and linkage of those risks to specific areas and activities
within our organization.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_064"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 16. [RESERVED]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_065"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 A. AUDIT COMMITTEE FINANCIAL
EXPERT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has
determined that Mr. Goldman is an audit committee financial expert as such term is defined by the SEC rules and has the requisite financial
experience as defined by the Nasdaq Rules. Each of the members of our audit committee is &#8220;independent&#8221; as such term is defined
in Rule 10A-3(b)(1) under the Exchange Act and satisfies the independent director requirements under the Nasdaq Rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_066"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 B. CODE OF ETHICS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Code of Business Conduct and Ethics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a written
Code of Business Ethics that applies to our officers and employees, including the Chief Executive Officer, President, Chief Financial
Officer, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, Controller and persons performing similar
functions, as well as our directors. Our Code of Business Ethics is posted on our website at <span>www.wearabledevices.co.il</span>.
Information contained on, or that can be accessed through, our website does not constitute a part of this annual report on Form 20-F and
is not incorporated by reference herein. If we make any amendment to the Code of Business Ethics or grant any waivers, including any implicit
waiver, from a provision of the code, we will disclose the nature of such amendment or waiver on our website to the extent required by
the rules and regulations of the SEC including the instructions to Item 16B of Form 20-F. Any waiver of this Code for any Covered Person
may be made only by the Board or the Audit Committee and will be promptly disclosed to stockholders and others, as required by applicable
law. The Company must disclose changes to and waivers of the Code in accordance with applicable law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_067"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Pre-Approval of Auditors&#8217; Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ziv Haft, Certified Public
Accountants, Isr., BDO Member Firm, an independent registered public accounting firm, has served as our principal independent registered
public accounting firm for each of the two years ended December 31, 2024 and 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
information regarding fees paid by us to Ziv Haft, Certified Public Accountants, Isr., BDO Member Firm, an independent registered public
accounting firm, including audit services, for the years ended December 31, 2024 and 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 3pt; text-align: center; font-weight: bold"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 3pt; text-align: center; font-weight: bold"><sup>&#160;</sup></td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 3pt; text-align: center; font-weight: bold"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-size: 10pt">Audit fees <sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">135,500</td><td style="padding-bottom: 3pt; width: 1%; text-align: left"><sup>&#160;</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">136,000</td><td style="padding-bottom: 3pt; width: 1%; text-align: left"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Audit-related fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 3pt; text-align: left"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 3pt; text-align: left"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,500</td><td style="padding-bottom: 3pt; text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,500</td><td style="padding-bottom: 3pt; text-align: left"><sup>(3)</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">All other fees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 3pt; text-align: left"><sup>&#160;</sup></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 3pt; text-align: left"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">142,000</td><td style="padding-bottom: 3pt; text-align: left"><sup>&#160;</sup></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">138,500</td><td style="padding-bottom: 3pt; text-align: left"><sup>&#160;</sup></td></tr>
  </table><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Includes professional services
rendered in connection with the audit of our annual financial statements, review of our interim financial statements, tax returns and
professional services provided in connection with comfort letters, consents and review of documents filed with the SEC.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Includes professional services
rendered in connection with the fees which were required for a transfer pricing study.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Includes professional services
rendered in connection with a VAT audit.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Pre-Approval of Auditors&#8217; Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
audit committee charter provides that one of the audit committee&#8217;s duties is to pre-approve audit and non-audit services provided
to us by the independent registered public accounting firm. The audit committee shall also review and approve disclosures relating to
fees and non-audit services required to be included in our SEC reports. Subject to our board of directors and shareholders approval (if
and to the extent required by applicable law), the audit committee shall have the authority to approve all audit engagement fees and terms
and all non-audit engagements, as may be permissible, with the independent registered public accounting firm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">All
services provided by our auditors are approved in advance by our audit committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_068"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 D. EXEMPTIONS FROM THE LISTING STANDARDS
FOR AUDIT COMMITTEES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_069"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 E. PURCHASES OF EQUITY SECURITIES BY
THE ISSUER AND AFFILIATED PURCHASERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_070"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 F. CHANGE IN REGISTRANT&#8217;S CERTIFYING
ACCOUNTANT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_071"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 G. CORPORATE GOVERNANCE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Sarbanes-Oxley Act, as
well as related rules subsequently implemented by the SEC, require foreign private issuers, such as us, to comply with various corporate
governance practices. In addition, following the listing of the Ordinary Shares on Nasdaq, we will be required to comply with the Nasdaq
Stock Market Listing Rules. Under those rules, we may elect to follow certain corporate governance practices permitted under the Companies
Law in lieu of compliance with corresponding corporate governance requirements otherwise imposed by the Nasdaq Stock Market Listing Rules
for U.S. domestic issuers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with Israeli
law and practice and subject to the exemption set forth in Rule 5615 of the Nasdaq Stock Market Listing Rules, we have elected to follow
the provisions of the Companies Law, rather than the Nasdaq Stock Market Listing Rules, with respect to the following requirements:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Quorum</i>. While the Nasdaq Stock Market Listing Rules require that the quorum for purposes of any
meeting of the holders of a listed company&#8217;s common voting stock, as specified in the company&#8217;s bylaws, be no less than 33
1/3% of the company&#8217;s outstanding common voting stock, under Israeli law, a company is entitled to determine in its articles of
association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. The Companies Law provides
that a quorum of two or more shareholders holding at least 25% of the voting rights in person or by proxy is required for commencement
of business at a general meeting. However, the quorum set forth in our amended and restated articles of association with respect to an
adjourned meeting consists of at least any shareholders present in person or by proxy.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Nomination of our directors.</i> With the exception of directors elected by our board of directors
and external directors (if applicable), our directors are generally elected by an annual meeting of our shareholders for a term of office
that expires on the third annual general meeting following such election or re-election, such that each year the term of office of only
one class of directors will expire. The nominations for directors, which are presented to our shareholders by our board of directors,
are generally made by the board of directors itself, in accordance with the provisions of our amended and restated articles of association
and the Companies Law. Nominations need not be made by a nominating committee of our board of directors consisting solely of independent
directors, as required under the Nasdaq rules.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Compensation of officers.</i> Israeli law and our amended and restated articles of association do not
require that the independent members of our board of directors (or a compensation committee composed solely of independent members of
our board of directors) determine an executive officer&#8217;s compensation, as is generally required under the Nasdaq Stock Market Listing
Rules with respect to the chief executive officer and all other executive officers. Instead, compensation of executive officers is determined
and approved by our compensation committee and our board of directors, and in certain circumstances by our shareholders, either in consistency
with our amended and restated compensation policy for our office holders, or, in special circumstances in deviation therefrom, taking
into account certain considerations stated in the Companies Law (see &#8220;Item 6.C.Board Practices - Approval of Related Party Transactions
under Israeli Law&#8221; for additional information).</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Independent directors.</i> Israeli law does not require that a majority of the directors serving on
our board of directors be &#8220;independent,&#8221; as defined under Nasdaq Listing Rule 5605(a)(2), and rather requires we have at least
two external directors, if applicable, who meet the requirements of the Companies Law, as described above under &#8220;Management-Board
Practices-External Directors.&#8221; We are required, however, to ensure that all members of our Audit Committee are &#8220;independent&#8221;
under the applicable Nasdaq and SEC criteria for independence (as we cannot exempt ourselves from compliance with that SEC independence
requirement, despite our status as a foreign private issuer), and we must also ensure that a majority of the members of our Audit Committee
are &#8220;independent directors&#8221; as defined in the Companies Law. We have established an Audit Committee and appointed independent
directors compliant with applicable rules. Furthermore, Israeli law does not require, nor do our independent directors conduct, regularly
scheduled meetings at which only they are present, which the Nasdaq rules otherwise require.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Shareholder approval.</i> We will seek shareholder approval for all corporate actions requiring such
approval under the requirements of the Companies Law, rather than seeking approval for corporation actions in accordance with Nasdaq Listing
Rule 5635. In particular, under this Nasdaq listing rule, shareholder approval is generally required for: (i) an acquisition of shares/assets
of another company that involves the issuance of 20% or more of the acquirer&#8217;s shares or voting rights or if a director, officer
or 5% shareholder has greater than a 5% interest in the target company or the consideration to be received; (ii) the issuance of shares
leading to a change of control; (iii) adoption/amendment of equity compensation arrangements (although under the provisions of the Companies
Law there is no requirement for shareholder approval for the adoption/amendment of the equity compensation plan); and (iv) issuances of
20% or more of the shares or voting rights (including securities convertible into, or exercisable for, equity) of a listed company via
a private placement (and/or via sales by directors/officers/5% shareholders) if such equity is issued (or sold) at below the greater of
the book or market value of shares. By contrast, under the Companies Law, shareholder approval is required for, among other things: (i)
transactions with directors concerning the terms of their service or indemnification, exemption and insurance for their service (or for
any other position that they may hold at a company), for which approvals of the compensation committee, board of directors and shareholders
are all required, (ii) extraordinary transactions with controlling shareholders of publicly held companies, which require the special
approval, and (iii) terms of employment or other engagement of the controlling shareholder of us or such controlling shareholder&#8217;s
relative, which require special approval. In addition, under the Companies Law, a merger requires approval of the shareholders of each
of the merging companies.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Approval of Related Party Transactions</i>. All related party transactions are approved in accordance
with the requirements and procedures for approval of interested party acts and transaction as set forth in the Companies Law, which requires
the approval of the audit committee, or the compensation committee, as the case may be, the board of directors and shareholders, as may
be applicable, for specified transactions, rather than approval by the audit committee or other independent body of our board of directors
as required under the Nasdaq Stock Market Listing Rules (see &#8220;Management - Board Practices - Approval of Related Party Transactions
under Israeli Law&#8221; for additional information).</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Annual Shareholders Meeting. </i>As opposed to the Nasdaq listing Rule 5620(a), which mandates that
a listed company hold its annual shareholders meeting within one year of the company&#8217;s fiscal year-end, we are required, under the
Companies Law, to hold an annual shareholder meeting each calendar year and within 15 months of the last annual shareholders meeting.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><i>Distribution of periodic reports to shareholders; proxy solicitation. </i>As opposed to the Nasdaq
Stock Market Listing Rules, which require listed issuers to make such reports available to shareholders in one of a number of specific
manners, Israeli law does not require us to distribute periodic reports directly to shareholders, and the generally accepted business
practice in Israel is not to distribute such reports to shareholders but to make such reports available through a public website. In addition
to making such reports available on a public website, we currently make our audited financial statements available to our shareholders
at our offices and will only mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from
the SEC&#8217;s proxy solicitation rules.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_072"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 H. MINE SAFETY DISCLOSURE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_073"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS
THAT PREVENT INSPECTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_074"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 J. INSIDER TRADING POLICIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-15939">adopted</ix:nonNumeric> an insider
trading policy, or the Policy, governing the purchase, sale and other transactions in our securities that applies to our directors, senior
management, employees, and other covered persons, including immediate family members and entities controlled by any of the foregoing persons.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Policy prohibits, among
other things, insider trading and certain speculative transactions in our securities (including short sales, buying put and selling call
options and other hedging or derivative transactions in our securities) and establishes a regular blackout period schedule during which
directors, senior management, employees, and other covered persons may not trade in our securities, as well as certain pre-clearance procedures
that directors and senior management must observe prior to effecting any transaction in our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the Policy
is reasonably designed to promote compliance with applicable insider trading laws, rules and regulations, and listing standards applicable
to us. A copy of the Policy is filed as Exhibit 11.1 to this Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="D_075"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16 K. CYBERSECURITY.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board recognizes the critical
importance of maintaining the trust and confidence of our customers, clients, business partners and employees. <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="ixv-15940">The audit committee is
involved in oversight of our IT general controls and cybersecurity.</ix:nonNumeric> <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="ixv-15941">Our IT general controls cybersecurity policies, standards, processes
and practices are fully <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" id="ixv-15942">integrated</ix:nonNumeric> into our risk management approach.</ix:nonNumeric> In general, we seek to address IT general controls cybersecurity
risks through a comprehensive, cross-functional approach that is focused on preserving the confidentiality, security and availability
of the information that we collect and store by identifying, preventing and mitigating cybersecurity threats and effectively responding
to cybersecurity incidents when they occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="ixv-10552"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Management and Strategy</b></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the critical elements
of our overall risk management approach, our cybersecurity program is focused on the following key areas:</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_3" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Governance: As discussed in more detail under the heading &#8220;Governance,&#8221; the audit committee
oversees our cybersecurity risk management and interacts with the Company&#8217;s Sarbanes-Oxley Act, or SOX, advisor and the Company&#8217;s
Information Security advisor and other relevant members of management.</td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_4" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_3"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Collaborative Approach: The Company has implemented a comprehensive, cross-functional approach to identifying,
preventing and mitigating cybersecurity threats and incidents, while also implementing controls and procedures that provide for the prompt
escalation of certain cybersecurity incidents so that decisions regarding the public disclosure and reporting of such incidents can be
made by management in a timely manner.</td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_5" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_4"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Technical Safeguards: The Company deploys technical safeguards that are designed to protect the Company&#8217;s
information systems from cybersecurity threats, including firewalls, intrusion prevention and detection systems, anti-malware functionality
and access controls, which are evaluated and improved through vulnerability assessments and cybersecurity threat intelligence.</td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_6" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_5"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Recovery Planning: The Company has established and maintains comprehensive recovery plans that fully address
the Company&#8217;s response to a cybersecurity incident, and such plans are tested and evaluated on a regular basis.</td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_7" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_6"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Education and Awareness: The Company provides regular, mandatory training for personnel regarding cybersecurity
threats as a means to equip the Company&#8217;s personnel with effective tools to address cybersecurity threats, and to communicate the
Company&#8217;s evolving information security policies, standards, processes and practices.</td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We engage in the periodic
assessment and testing of our policies, standards, processes and practices that are designed to address cybersecurity threats and incidents.
These efforts include a wide range of activities, including audits, assessments, tabletop exercises, threat modeling, vulnerability evaluation,
and other exercises focused on evaluating the effectiveness of our cybersecurity measures and planning. We are engaged with a subcontractor
that monitors the IT system and cybersecurity, including centralized patch management as part of their routine job functions. We regularly
engage <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" id="ixv-15943">third parties</ix:nonNumeric> to perform assessments on our cybersecurity measures, including information security maturity assessments, audits
and independent reviews of our information security control environment and operating effectiveness. The results of such assessments,
audits and reviews are reported to the Board, and we adjust our cybersecurity policies, standards, processes and practices as necessary
based on the information provided by these assessments, audits and reviews.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="ixv-10614"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Governance</b></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_2" id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audit committee interacts
with the Company&#8217;s SOX advisor and the Company&#8217;s Information Security advisor and other relevant members of management. <span>The
Company&#8217;s Information</span> Security advisor <span>is responsible for assessing and managing cyber
risk management, informs senior management regarding the prevention, detection, mitigation, and remediation of cybersecurity incidents
and supervises such efforts. The Company&#8217;s Information</span> Security advisor <span>has experience
selecting, deploying, and operating cybersecurity technologies, initiatives, and processes, and relies on threat intelligence as well
as other information obtained from governmental, public or private sources.</span> The audit committee receives updates on IT general
controls, and a set of policies and procedures that govern how the Company&#8217;s IT systems operate and ensure the confidentiality,
integrity, and availability of data as well as on cybersecurity risks, including prevention of data theft, unauthorized access, operational
disruption, and data breaches. The audit committee also receives prompt and timely information regarding any cybersecurity incident that
meets established reporting thresholds, as well as ongoing updates regarding any such incident until it has been addressed. On an annual
basis, the audit committee discusses our approach to IT general controls and cybersecurity risk management with the Company&#8217;s SOX
advisor.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 19, 2025, <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" id="ixv-15944">we do
not believe that we have experienced any cybersecurity attack. Cybersecurity threats and cybersecurity incidents, if they occur, can materially
affect or are reasonably likely to affect the Company, including its business strategy, results of operations or financial condition.</ix:nonNumeric></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="D_076"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">PART III</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_077"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 17. FINANCIAL STATEMENTS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have elected to provide
financial statements and related information pursuant to Item 18.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_078"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 18. FINANCIAL STATEMENTS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements and
the related notes required by this Item are included in this annual report beginning on page F-1.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="D_079"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">ITEM 19. EXHIBITS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents are
filed as part of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; font-size: 10pt; width: 9%"><span style="font-size: 10pt"><b>Number</b></span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="text-align: justify; vertical-align: top; border-bottom: black 1.5pt solid; font-size: 10pt; width: 90%"><span style="font-size: 10pt"><b>Exhibit
    Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390024082340/ea021580201ex99-2_wearable.htm">Amended and Restated Articles of Association of Wearable Devices Ltd. (filed as Exhibit 99.2 to Form 6-K (File No. 001-41502) filed on September 26, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">2.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022054088/ea164883ex4-4_wearabledev.htm"><span style="font-size: 10pt">Form of Warrant (filed as Exhibit 4.4 to F-1 (File No. 333-262838) filed
    on September 8, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">2.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex4-1_wearable.htm"><span style="font-size: 10pt">Form of Underwriter&#8217;s Warrant (filed as Exhibit 4.1 to Form F-1 (File
    No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">2.3</span></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390024103113/ea022272201ex4-1_wearable.htm"><span style="font-size: 10pt">Form of Ordinary Warrant (filed as Exhibit 4.1 to Form 6-K (File No. 001-41502)
    filed on November 27, 2024 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">2.4</span></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390024103113/ea022272201ex4-2_wearable.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant (filed as Exhibit 4.2 to Form 6-K (File No.
    001-41502) filed on November 27, 2024 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">2.5</span></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390025008068/ea022911401ex4-1_wearable.htm"><span style="font-size: 10pt">Form of Warrant (filed as Exhibit 4.1 to Form 6-K (File No. 001-41502)
    filed on January 30, 2025 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">2.6</span></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390025008068/ea022911401ex4-2_wearable.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant (filed as Exhibit 4.2 to Form 6-K (File No.
    001-41502) filed on January 30, 2025 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">2.7*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><a href="ea023465401ex2-7_wearable.htm">Description of Securities.</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022012239/ea156798ex10-1_wearable.htm"><span style="font-size: 10pt">Form of Indemnification Agreement (filed as Exhibit 10.1 to Form F-1 (File
    No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022019279/ea158314ex4-3_wearable.htm"><span style="font-size: 10pt">Form of Warrant Agent Agreement (filed as Exhibit 4.3 to Form F-1 (File
    No. 333-262838) filed on September 8, 2022 and incorporated herein by reference ).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.3</span></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390025008068/ea022911401ex4-3_wearable.htm"><span style="font-size: 10pt">Form of Warrant Amendment Agreement (filed as Exhibit 4.3 to Form 6-K (File
    No. 001-41502) filed on January 30, 2025 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022008340/ea155863ex10-2_wearable.htm"><span style="font-size: 10pt">Wearable Devices Ltd. 2015 Share Option Plan (filed as Exhibit 10.2 to
    Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference ).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.5</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390023072128/ea184450ex10-1_wearable.htm"><span style="font-size: 10pt">First Amendment to Wearable Devices Ltd. 2015 Share Option Plan (filed
    as Exhibit 10.1 to Form 6-K (File No. 001-41502) filed on August 31, 2023 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.6</span></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390024071825/ea021201601ex10-1_wearable.htm"><span style="font-size: 10pt">Wearable Devices Ltd. 2024 Global Equity Incentive Plan (filed as Exhibit
    10.1 to Form 6-K (File No. 001-41502) filed on August 22, 2024 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.7</span></td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390024071825/ea021201601ex10-2_wearable.htm"><span style="font-size: 10pt">Wearable Devices Ltd. 2024 Employee Stock Purchase Plan (filed as Exhibit
    10.2 to Form 6-K (File No. 001-41502) filed on August 22, 2024 and incorporated herein by reference).</span></a></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.8#</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022018390/ea157448ex10-4_wearable.htm"><span style="font-size: 10pt">Agreement, dated July 16, 2020, by and between Wearable Devices Ltd. and
    the Israeli Innovation Authority (filed as Exhibit 10.4 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated
    herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.9</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390024082340/ea021580201ex99-1_wearable.htm"><span style="font-size: 10pt">Amended and Restated Compensation Policy for the Company&#8217;s Executive
    Officers and Directors (filed as Exhibit 99.1 to Form 6-K (File No. 001-41502) filed on September 26, 2024 and incorporated herein
    by reference).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.10</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022040341/ea163052ex10-6_wearabledev.htm"><span style="font-size: 10pt">Senior Credit Facility Agreement, dated July 4, 2022, by and between Wearable
    Devices Ltd. and L.I.A. Pure Capital Ltd (filed as Exhibit 10.6 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and
    incorporated herein by reference).</span></a></td></tr>

<tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.11</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022040341/ea163052ex10-8_wearabledev.htm"><span style="font-size: 10pt">First Addendum to Senior Agreement, dated July 19, 2022, by and between
    Wearable Devices Ltd. and L.I.A. Pure Capital Ltd. (filed as Exhibit 10.8 to Form F-1 (File No. 333-262838) filed on September 8,
    2022 and incorporated herein by reference).</span></a></td></tr>

<tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; width: 9%"><span style="font-size: 10pt">4.12</span></td>
    <td style="font-size: 10pt; width: 1%">&#160;</td>
    <td style="text-align: justify; font-size: 10pt; width: 90%"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390024050763/ea020750501ex10-1_wearable.htm">Standby Equity Purchase Agreement dated as of June 6, 2024 between the Company and YA II PN, Ltd. (filed as Exhibit 10.1 to Form 6-K (File No. 001-41502) filed on June 7, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">8.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390022008340/ea155863ex21-1_wearable.htm">List of Subsidiaries (filed as Exhibit 21.1 to Form F-1 (File No. 333-262838) filed on September 8, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">11.1*</span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify; font-size: 10pt"><a href="ea023465401ex11-1_wearable.htm"><span style="font-size: 10pt">Insider Trading Policy.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">12.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><a href="ea023465401ex12-1_wearable.htm">Certification of the Principal Executive Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934.</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">12.2*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><a href="ea023465401ex12-2_wearable.htm">Certification of the Principal Financial and Accounting Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934.</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">13.1%</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><a href="ea023465401ex13-1_wearable.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350.</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">13.2%</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><a href="ea023465401ex13-2_wearable.htm">Certification of the Principal Financial and Accounting Officer pursuant to 18 U.S.C. 1350.</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">15.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><a href="ea023465401ex15-1_wearable.htm"><span style="font-size: 10pt">Consent of Ziv Haft, Certified Public Accountants, Isr. BDO member firm,
    an independent registered public accounting firm.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">97.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1887673/000121390024023073/ea020095201ex97-1_wearable.htm">Clawback Policy (filed as Exhibit 97.1 to Form 20-F (File No. 001-41502) filed on March 15, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">101</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">The following financial information from the Registrant&#8217;s Annual
    Report on Form 20-F for the year ended December 31, 2024, formatted in Inline XBRL (eXtensible Business Reporting Language): (i)
    Consolidated Balance Sheets; (ii) Consolidated Statements of Comprehensive Loss; (iii) Statements of Changes in Shareholders&#8217;
    Equity (Deficit); (iv) Consolidated Statements of Cash Flows; and (v) Notes to Consolidated Financial Statements.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.25in"><span style="font-size: 10pt">*</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Filed herewith.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">%</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Furnished herewith</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">#</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-size: 10pt">Certain identified information in the exhibit has been excluded from the exhibit because it is both (i) not material and (ii) is the type that Wearable Devices Ltd. treats as private or confidential.</span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="D_080"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The registrant hereby certifies that it meets all
of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on Form
20-F filed on its behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 10pt"><b>Wearable Devices Ltd.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 36%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Date: March 20, 2025</span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt">/s/ Asher Dahan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-size: 10pt">Asher Dahan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 116; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="vertical-align: top; width: 89%">&#160;</td> <td style="vertical-align: bottom; width: 11%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report of Independent Registered Public Accounting Firm (BDO Ziv Haft: Tel Aviv, Israel: PCAOB ID#<ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-15945">1185</ix:nonNumeric>)</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr> <tr> <td style="vertical-align: top"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Comprehensive Loss</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr> <tr> <td style="vertical-align: top"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Changes in Shareholders&#8217; Equity</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: top"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr> <tr> <td style="vertical-align: top"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7 to F-28</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><img alt="" src="fin_001.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b><span style="text-decoration:underline">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shareholders and Board of Directors<br/>
of WEARABLE DEVICES LTD.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AuditorOpinionTextBlock-c0_cont_1" escape="true" name="dei:AuditorOpinionTextBlock" id="ixv-11202"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Consolidated Financial Statements</b></p></ix:nonNumeric><div>

</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_AuditorOpinionTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Wearable Devices Ltd. and its subsidiary (&#8220;the Company&#8221;) as of December&#160;31, 2024 and 2023, and the
related consolidated statements of comprehensive loss, changes in shareholders&#8217; equity and cash flows for each of the three&#160;years
in the period ended December 31, 2024, and the related notes (collectively, the &#8220;consolidated financial statements&#8221;). In
our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at
December&#160;31, 2024 and 2023, and the results of its operations and its cash flows for each of the three&#160;years in the period
ended December&#160;31, 2024, in conformity with accounting principles generally accepted in the United States of America.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Going Concern</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1.e to the consolidated financial
statements, the Company is still at its development stage, transitioning to production and at an early stage of generating revenues, therefore,
it has suffered recurring losses and negative cash flows from operations since inception as of December 31, 2024, the Company incurred
accumulated losses of $29.1 million. Further, as discussed in note 1.f, as of June 30, 2024, the Company was noncompliant with Nasdaq&#8217;s
requirements with respect to minimum stockholders&#8217; equity. The Company&#8217;s operations have been funded substantially through
issuance of shares and warrants, Israeli governmental grants and convertible promissory note. Considering the above, the Company&#8217;s
dependency on external funding for its operations raises a substantial doubt about the Company&#8217;s ability to continue as a going
concern. Management&#8217;s evaluation of the events and conditions and management&#8217;s plans regarding these matters are described
in Note 1.e. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements are the
responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.&#160;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were
we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an
understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the
Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to
assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made
by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide
a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 40%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ziv Haft</span></td> <td style="width: 60%">&#160;</td></tr> <tr style="vertical-align: top"> <td><ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-11250"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ziv Haft</span></ix:nonNumeric></td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified Public Accountants (Isr.)</span></td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BDO Member Firm</span></td> <td>&#160;</td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&#8217;s auditor since 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 19, 2025,<br/>
<ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-15946">Tel Aviv, Israel</ix:nonNumeric></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_006.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 2; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CONSOLIDATED BALANCE SHEETS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">U.S. dollars<br/> in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">Assets</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">CURRENT ASSETS:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-15947">3,089</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-15948">810</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Short-term bank deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositsAssetsCurrent" scale="3" unitRef="usd" id="ixv-15949">862</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositsAssetsCurrent" scale="3" unitRef="usd" id="ixv-15950">4,045</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Governmental grant receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivable" scale="3" unitRef="usd" id="ixv-15951">17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivable" scale="3" unitRef="usd" id="ixv-15952">108</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Other receivables and prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-15953">322</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-15954">757</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Inventories (Note 3)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FIFOInventoryAmount" scale="3" unitRef="usd" id="ixv-15955">1,226</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FIFOInventoryAmount" scale="3" unitRef="usd" id="ixv-15956">1,032</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">TOTAL CURRENT ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-15957">5,516</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-15958">6,752</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">NON-CURRENT ASSETS:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Long-term bank deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-0">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositsAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-15959">54</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Right-of-use assets (Note 5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-15960">330</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-15961">592</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Property and equipment, net (Note 4)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-15962">130</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-15963">194</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL NON-CURRENT ASSETS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd" id="ixv-15964">460</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd" id="ixv-15965">840</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">TOTAL ASSETS</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-15966">5,976</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-15967">7,592</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: center">Liabilities and Shareholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">CURRENT LIABILITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd" id="ixv-15968">157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" unitRef="usd" id="ixv-15969">410</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Advance payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AdvanceFromCustomers" scale="3" unitRef="usd" id="ixv-15970">83</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AdvanceFromCustomers" scale="3" unitRef="usd" id="ixv-15971">312</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Convertible promissory note (Note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="3" unitRef="usd" id="ixv-15972">770</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Accrued payroll and other employment related accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-15973">402</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-15974">579</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-15975">392</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-15976">190</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-15977">291</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-15978">297</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL CURRENT LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-15979">2,095</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-15980">1,788</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-15981">21</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-15982">278</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">TOTAL LIABILITIES</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-15983">2,116</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-15984">2,066</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">COMMITMENTS AND CONTINGENCIES <b style="font-style: normal; font-weight: normal">(Note 7)</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: left"><b>SHAREHOLDERS&#8217; EQUITY</b> (Note 10):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Ordinary shares <span style="-sec-ix-hidden: hidden-fact-4"><span style="-sec-ix-hidden: hidden-fact-5">no</span></span> par value: Authorized <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-15985"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-15986">50,000,000</ix:nonFraction></ix:nonFraction> as of December 31, 2024 and December 31, 2023; Issued and outstanding <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-15987"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-15988">707,463</ix:nonFraction></ix:nonFraction> shares as of December 31, 2024 and <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-15989"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-15990">254,843</ix:nonFraction></ix:nonFraction> shares as of December 31, 2023.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd" id="ixv-15991">67</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd" id="ixv-15992">57</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" unitRef="usd" id="ixv-15993">32,895</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" unitRef="usd" id="ixv-15994">26,692</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated losses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-15995">29,102</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-15996">21,223</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL SHAREHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-15997">3,860</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-15998">5,526</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-15999">5,976</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-16000">7,592</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
the consolidated financial statements.</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">U.S. dollars in thousands<br/>
 (except per share amounts)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-16001">522</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-16002">82</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-16003">45</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-16004">437</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-16005">62</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-16006">10</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">GROSS PROFIT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd" id="ixv-16007">85</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd" id="ixv-16008">20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd" id="ixv-16009">35</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.25in; padding-left: 0.375in; text-align: left">Research and development, net (Note 7. a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ResearchAndDevelopmentNet" scale="3" unitRef="usd" id="ixv-16010">2,964</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ResearchAndDevelopmentNet" scale="3" unitRef="usd" id="ixv-16011">3,316</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ResearchAndDevelopmentNet" scale="3" unitRef="usd" id="ixv-16012">2,271</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Sales and marketing expenses, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-16013">2,096</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-16014">2,008</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-16015">1,370</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-16016">2,845</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-16017">2,882</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-16018">1,948</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Initial public offering expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProspectiveInitialPublicOfferingExpenses" scale="3" unitRef="usd" id="ixv-16019">904</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">OPERATING LOSS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16020">7,820</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16021">8,186</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16022">6,458</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Financing income (expenses), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:FinancingIncomeExpensesNet" scale="3" sign="-" unitRef="usd" id="ixv-16023">52</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:FinancingIncomeExpensesNet" scale="3" unitRef="usd" id="ixv-16024">372</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:FinancingIncomeExpensesNet" scale="3" sign="-" unitRef="usd" id="ixv-16025">38</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">LOSS BEFORE TAX EXPENSES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-16026">7,872</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-16027">7,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-16028">6,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Tax expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-16029">7</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.25in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 4pt">NET LOSS AND TOTAL COMPREHENSIVE LOSS</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16030">7,879</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16031">7,814</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16032">6,496</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.25in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 4pt">Net loss per ordinary shares, basic and diluted *</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="1" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares"><ix:nonFraction contextRef="c0" decimals="1" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">24.2</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c6" decimals="1" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares"><ix:nonFraction contextRef="c6" decimals="1" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">38.4</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="1" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares"><ix:nonFraction contextRef="c7" decimals="1" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">42.4</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.25in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 4pt">Weighted average number of ordinary shares and pre-funded warrants
outstanding basic and diluted *</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" id="ix_7_fact" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">325,690</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" id="ix_8_fact" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" id="ix_9_fact" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">202,515</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" id="ix_10_fact" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" id="ix_11_fact" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">153,465</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">*</td> <td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:footnote id="ix_0_footnote" xml:lang="en-US">The share and per share information in these financial statements reflects the 1-for-20 reverse share split that became effective on October 10, 2024 and an additional 1-for-4 reverse share split of the Company&#8217;s issued and outstanding ordinary shares that became effective on March 17, 2025 (the &#8220;Reverse Share Splits&#8221;). See also Note 1c.</ix:footnote></p></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
the consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>




</div><div><a id="a_004"></a></div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217;
EQUITY</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ordinary shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><b>Additional</b></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number <br/> of shares**</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">paid-in<br/> capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated losses</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 40%; font-weight: bold">BALANCE AS OF DECEMBER 31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" id="ix_12_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">139,211</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16047">31</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16048">7,689</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-16049">6,913</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16050">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">CHANGES DURING THE YEAR 2022:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of $<ix:nonFraction contextRef="c7" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" unitRef="usd" id="ixv-16051">1.6</ix:nonFraction> million</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" id="ix_13_fact" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" scale="0" unitRef="shares">46,875</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" scale="3" unitRef="usd" id="ixv-16053">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" scale="3" unitRef="usd" id="ixv-16054">14,308</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" scale="3" unitRef="usd" id="ixv-16055">14,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Conversion of SAFEs (as defined in Note 10) into ordinary
    shares upon completion of initial public offering (Note 10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" id="ix_14_fact" name="wlds:ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" scale="0" unitRef="shares">1,477</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd" id="ixv-16057">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd" id="ixv-16058">399</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd" id="ixv-16059">400</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Issuance of ordinary shares as a result of exercise of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" id="ix_15_fact" name="wlds:StockIssuedDuringPeriodSharesStockWarrantsExercised" scale="0" unitRef="shares">500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="text-align: left">*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-16061">160</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-16062">160</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Exercise of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" id="ix_16_fact" name="wlds:StockIssuedDuringPeriodShareOfExerciseOfOptions" scale="0" unitRef="shares">58</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">-</div></td><td style="text-align: left">*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16064">790</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16065">790</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Comprehensive loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-16066">6,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-16067">6,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">BALANCE AS OF DECEMBER 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" id="ix_17_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">188,121</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16069">43</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16070">23,346</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-16071">13,409</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16072">9,980</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">CHANGES DURING THE YEAR 2023:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Shares issued in the public offering, net of issuance cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" id="ix_18_fact" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">55,556</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-16074">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-16075">1,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-16076">1,670</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Issuance of shares to April 2021 investors (Note 10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" id="ix_19_fact" name="wlds:StockIssuedDuringPeriodSharesInvestors" scale="0" unitRef="shares">2,114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueInvestors" scale="3" unitRef="usd" id="ixv-16078">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueInvestors" scale="3" sign="-" unitRef="usd" id="ixv-16079">1</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueInvestors" scale="3" unitRef="usd" id="ixv-16080">0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Exercise of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" id="ix_20_fact" name="wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" unitRef="shares">9,052</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-16082">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-16083">1,447</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-24">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-16084">1,449</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-25">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16085">241</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-26">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16086">241</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Comprehensive loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-16087">7,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-16088">7,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">BALANCE AS OF DECEMBER 31, 2023</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" id="ix_21_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">254,843</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16090">57</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16091">26,692</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-16092">21,223</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16093">5,526</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">CHANGES DURING THE YEAR 2024:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left">Issuance of shares associated with the SEPA (Note 1.d)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" id="ix_22_fact" name="wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" scale="0" unitRef="shares">307,175</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA" scale="3" unitRef="usd" id="ixv-16095">10</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA" scale="3" unitRef="usd" id="ixv-16096">4,343</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA" scale="3" unitRef="usd" id="ixv-16097">4,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issuance of units of ordinary shares pre-funded warrants and warrants under registered direct offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" id="ix_23_fact" name="wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" scale="0" unitRef="shares">127,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" scale="3" unitRef="usd" id="ixv-16099">1,578</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" scale="3" unitRef="usd" id="ixv-16100">1,578</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issuance of ordinary shares to service provider</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" id="ix_24_fact" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" unitRef="shares">9,765</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-16102">100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-16103">100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issuance of ordinary shares for the reverse split process</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" id="ix_25_fact" name="wlds:IssuanceOfOrdinarySharesForTheReverseSplitProcess" scale="0" unitRef="shares">8,180</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16105">182</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16106">182</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Comprehensive loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-16107">7,879</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-16108">7,879</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">BALANCE AS OF DECEMBER 31, 2024</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" id="ix_26_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">707,463</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16110">67</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16111">32,895</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-16112">29,102</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-16113">3,860</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td><ix:footnote id="ix_1_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represent an amount less than $500</span></ix:footnote></td></tr> </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">**</td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US">The share and per share information in these financial statements
reflects the Reverse Share Splits.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
the consolidated financial statements.</p><div>




</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>WEARABLE DEVICES LTD.
AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CONSOLIDATED STATEMENTS OF CASH FLOWS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">CASH FLOWS FROM OPERATING ACTIVITIES:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16115">7,879</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16116">7,814</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16117">6,496</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Adjustments required to reconcile net loss to net cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-16118">107</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-16119">68</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-16120">23</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Interest expenses on convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AccruedInterestOnConvertibleSecurities" scale="3" unitRef="usd" id="ixv-16121">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Accrued interest on deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AccruedInterestOnDeposits" scale="3" sign="-" unitRef="usd" id="ixv-16122">3</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AccruedInterestOnDeposits" scale="3" sign="-" unitRef="usd" id="ixv-16123">45</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Share-based compensation expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16124">182</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16125">241</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16126">790</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Unrealized gain from foreign currency derivative activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" sign="-" unitRef="usd" id="ixv-16127">68</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" unitRef="usd" id="ixv-16128">68</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Marketing expenses paid in ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:MarketingExpensesPaidInOrdinaryShares" scale="3" unitRef="usd" id="ixv-16129">100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Provision for inventory write-off</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWriteDown" scale="3" unitRef="usd" id="ixv-16130">75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in operating assets and liabilities items:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Decrease in accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd" id="ixv-16131">8</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Decrease (increase) in inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" unitRef="usd" id="ixv-16132">269</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" unitRef="usd" id="ixv-16133">1,026</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" sign="-" unitRef="usd" id="ixv-16134">5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Decrease (increase) in governmental grants receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseincreaseInGovernmentalGrantsReceivables" scale="3" sign="-" unitRef="usd" id="ixv-16135">91</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseincreaseInGovernmentalGrantsReceivables" scale="3" unitRef="usd" id="ixv-16136">54</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseincreaseInGovernmentalGrantsReceivables" scale="3" sign="-" unitRef="usd" id="ixv-16137">8</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Decrease (increase) in other receivables and prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" scale="3" sign="-" unitRef="usd" id="ixv-16138">357</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" scale="3" unitRef="usd" id="ixv-16139">136</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" scale="3" unitRef="usd" id="ixv-16140">496</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Increase (decrease) in advance payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseDecreaseInAdvancePayments" scale="3" sign="-" unitRef="usd" id="ixv-16141">228</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseDecreaseInAdvancePayments" scale="3" sign="-" unitRef="usd" id="ixv-16142">41</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:IncreaseDecreaseInAdvancePayments" scale="3" unitRef="usd" id="ixv-16143">79</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left">Increase (decrease) in deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" sign="-" unitRef="usd" id="ixv-16144">12</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" sign="-" unitRef="usd" id="ixv-16145">12</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Increase (decrease) in accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" sign="-" unitRef="usd" id="ixv-16146">253</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-16147">254</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" unitRef="usd" id="ixv-16148">84</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.375in; text-align: left">Increase (decrease) in accrued payroll and other employment related accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-16149">177</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-16150">163</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-16151">194</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-align: left">Increase in accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-16152">212</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-16153">36</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" unitRef="usd" id="ixv-16154">99</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-16155">7,613</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-16156">8,434</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-16157">5,714</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Purchase of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-16158">43</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-16159">194</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-16160">48</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Decrease (increase) in deposits, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseIncreaseInDepositsNet" scale="3" sign="-" unitRef="usd" id="ixv-16161">3,240</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:DecreaseIncreaseInDepositsNet" scale="3" unitRef="usd" id="ixv-16162">4,054</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Prepayments of leasing</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:PrepaymentsOfLeasing" scale="3" unitRef="usd" id="ixv-16163">18</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash provided by (used in) investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" unitRef="usd" id="ixv-16164">3,197</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-16165">4,248</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-16166">66</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds from issuance of shares issued in the public offering, net of issuance cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" scale="3" unitRef="usd" id="ixv-16167">1,578</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" scale="3" unitRef="usd" id="ixv-16168">1,670</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" scale="3" unitRef="usd" id="ixv-16169">14,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Proceeds from issuance of SAFEs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfSAFEs" scale="3" unitRef="usd" id="ixv-16170">500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Refund to SAFE investors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:RefundToSAFEInvestors" scale="3" unitRef="usd" id="ixv-16171">100</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Proceeds from credit line</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" unitRef="usd" id="ixv-16172">800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Repayment of credit line</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" unitRef="usd" id="ixv-16173">800</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Proceeds from issuance of ordinary shares as a result of exercise of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-16174">1,449</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" scale="3" unitRef="usd" id="ixv-16175">160</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds from issuance of ordinary shares associated with the SEPA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" unitRef="usd" id="ixv-16176">4,353</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Proceeds from issuance of convertible promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd" id="ixv-16177">1,920</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Repayment of convertible promissory note</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfConvertibleDebt" scale="3" unitRef="usd" id="ixv-16178">1,156</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-16179">6,695</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-16180">3,119</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-16181">14,879</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Net increase (decrease) in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" unitRef="usd" id="ixv-16182">2,279</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-16183">9,563</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" unitRef="usd" id="ixv-16184">9,099</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents at the beginning of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-16185">810</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-16186">10,373</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-16187">1,274</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Cash and cash equivalents at the end of year</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-16188">3,089</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-16189">810</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-16190">10,373</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline; text-align: left">Supplemental Disclosure:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-16191">49</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-16192">40</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest received</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InterestReceived" scale="3" sign="-" unitRef="usd" id="ixv-16193">144</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InterestReceived" scale="3" sign="-" unitRef="usd" id="ixv-16194">305</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Conversion of SAFEs to equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ConversionOfSAFEToEquity" scale="3" unitRef="usd" id="ixv-16195">400</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Right-of-use asset recognized against lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:RightofUseAssetRecognizedAgainstLeaseLiability" scale="3" unitRef="usd" id="ixv-16196">644</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:RightofUseAssetRecognizedAgainstLeaseLiability" scale="3" unitRef="usd" id="ixv-16197">229</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these financial statements.</p><div>




</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="ixv-13413"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - GENERAL:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wearable Devices Ltd. (the
    &#8220;Company&#8221;) was incorporated in Israel in March 2014. The Company develops&#160;and sells human-machine interface solutions
    for the smart wearables industry. In 2023, the Company started production of its B2C consumer product, the &#8220;Mudra Band&#8221;
    and started to generate revenues. The Company&#8217;s products are designated directly to end users and also designated to businesses
    in integration of its technology in their smart wearable devices. The Company&#8217;s ordinary shares and warrants began trading
    on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) on September 13, 2022, under the symbols &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221;
    respectively. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We qualify as an &#8220;emerging growth
company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the U.S.
Jumpstart Our Business Startups Act of 2012, and we may take advantage of certain exemptions, including exemptions from various reporting
requirements that are otherwise applicable to public traded entities that do not qualify as emerging growth companies. These exemptions
include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not being required to comply
    with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not being required to comply
    with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation
    or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements (i.e.,
    an auditor discussion and analysis).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We will remain an emerging growth
company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues exceed $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="wlds:AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" scale="9" unitRef="usd" id="ixv-16198">1.235</ix:nonFraction> billion; (ii)
the last day of the fiscal year following the fifth anniversary of the date of our initial public offering (i.e., December 31, 2027);
(iii) the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2&#160;under the&#160;Exchange Act,
which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented by warrants,
held by non-affiliates is at least $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="wlds:ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" scale="6" unitRef="usd" id="ixv-16199">700</ix:nonFraction> million as of the last business day of our most recently completed second fiscal quarter; or
(iv) the date on which we have issued more than $<ix:nonFraction contextRef="c0" decimals="-8" format="ixt:num-dot-decimal" name="wlds:IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" scale="9" unitRef="usd" id="ixv-16200">1.0</ix:nonFraction> billion in non-convertible debt securities during any three-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s revenues were derived from:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sales of B2C consumer product, the
&#8220;Mudra Band&#8221;.</p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sales of B2B Mudra
    development kits composed of multiple performance obligations including tangible parts (&#8220;Hardware&#8221;) and a limited period
    (generally one year) application programming interface (&#8220;API&#8221;) with no commercial rights, to enable the customer to evaluate
    the Company&#8217;s solution with its own products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sales of pilot transactions
    to evaluate the integration of the Company&#8217;s solution with the customer&#8217;s products composed of multiple performance obligations
    including Hardware, tailor-made software applications and technical support during the pilot period.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In 2024 and 2023, most of the Company&#8217;s
revenues were derived from the sales of Mudra Band to B2C customers. In 2022, all of the Company&#8217;s revenues were derived from the
sales of Mudra development kits. See also note 2.g.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">b.</p></td>
    <td style="padding-right: 3pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, the
Company established a wholly owned subsidiary in the United States of America for the purpose of marketing and distribution of its solutions
&#8211; Mudra Wearable, Inc. (the &#8220;Subsidiary&#8221;) &#8211; which commenced its operations in 2020. </p></td></tr>
  </table></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - GENERAL: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="padding-right: 3pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2024, the Company effected a one-for-twenty (<ix:nonNumeric contextRef="c31" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-16201">1-for-20</ix:nonNumeric>) reverse stock split of its ordinary share (the &#8220;October Reverse Split&#8221;). As a result of the October Reverse Split, every twenty (<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="wlds:ReverseStockSplitNumberOfSharesConverted" scale="0" unitRef="usdPershares" id="ixv-16202">20</ix:nonFraction>) shares either issued and outstanding were combined into&#160;<ix:nonFraction contextRef="c31" decimals="0" format="ixt-sec:numwordsen" name="wlds:ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" scale="0" unitRef="usdPershares" id="ixv-16203">one</ix:nonFraction>&#160;new ordinary share. All outstanding securities entitling their holders to purchase ordinary shares, including options and warrants were adjusted as a result of the October Reverse Split, as required by the terms of those securities. The October Reverse Split changed the par value per ordinary share from NIS <ix:nonFraction contextRef="c32" decimals="2" format="ixt:num-dot-decimal" name="wlds:ReverseSplitParValue" scale="0" unitRef="ilsPershares" id="ixv-16204">0.01</ix:nonFraction> to <ix:nonFraction contextRef="c32" decimals="0" format="ixt:fixed-zero" name="wlds:ReverseSplitParValue" scale="0" unitRef="usdPershares" id="ixv-16205">zero</ix:nonFraction> par value. On March 17, 2025, the Company effectuated an additional <ix:nonNumeric contextRef="c33" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-16206">1-for-4</ix:nonNumeric> reverse share split of its issued and outstanding ordinary shares (the &#8220;March Reverse Split&#8221; and, together with the October Reverse Split, the &#8220;Reverse Splits&#8221;). The March Reverse Split did not change the number of shares authorized for issuance. See also note 10.a below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All share amounts, share prices, and exercise prices have been adjusted retroactively within these financial statements to reflect the Reverse Splits.</p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td>
    <td style="padding-right: 3pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October
7, 2023, Hamas terrorists infiltrated Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian
and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel&#8217;s
border with the Gaza Strip and in other areas within the State of Israel. Following the attack, Israel&#8217;s security cabinet declared
war against Hamas and the Israeli military began to call-up reservists for active duty. As of March 18, 2025, the ceasefire that had been in place since January
2025 has ended, and hostilities have resumed.</p>
                                   <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the attack by Hamas on Israel&#8217;s
    southern border, Hezbollah, a terrorist organization in Lebanon, has also launched missile, rocket, and shooting attacks against
    Israeli military sites, troops, and Israeli towns in northern Israel. In response to these attacks, the Israeli army has carried
    out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon, and in October 2024, the Israeli military initiated
    a ground operation in Lebanon, primarily near the Israel-Lebanon border. As of the end of November 2024, Israel entered into a ceasefire
    agreement with Hezbollah, but there are no guarantees as to whether the agreement will hold or whether further hostilities will resume.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, many Israeli citizens are obligated
    to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of 40 (or older
    for certain reservists) and, in the event of a military conflict, may be called to active duty. As of March 19,2025, these events
    have had no material impact on the Company&#8217;s operations.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern:</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying consolidated financial
statements have been prepared assuming that the Company will continue as a going concern. To date, the Company is still at its development
stage and at an early stage of generating revenues. Therefore, the Company has suffered recurring losses from operations and negative
cash flows from operations since inception. In September 2022, the Company completed an initial public offering (&#8220;IPO&#8221;) and
listed its ordinary shares and warrants for trading on Nasdaq and raised net proceeds of $<ix:nonFraction contextRef="c34" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-16207">13.3</ix:nonFraction> million. In November 2023, the Company
completed a secondary offering and raised net proceeds of $<ix:nonFraction contextRef="c35" decimals="-5" format="ixt:num-dot-decimal" name="wlds:NetProceedsFromIssuanceSecondaryPublicOffering" scale="6" unitRef="usd" id="ixv-16208">1.7</ix:nonFraction> million. <span>In June 2024, the Company
entered into a </span>Standby Equity Purchase Agreement (the &#8220;SEPA&#8221;)<span>. During 2024, the
Company issued <ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" scale="0" unitRef="shares" id="ixv-16209">307,175</ix:nonFraction> ordinary shares pursuant to SEPA for net proceeds of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" scale="6" unitRef="usd" id="ixv-16210">4.4</ix:nonFraction> million. </span>In November 2024, the Company completed
a registered direct offering and raised net proceeds of $<ix:nonFraction contextRef="c36" decimals="-4" format="ixt:num-dot-decimal" name="wlds:ProceedsFromIssuanceRegisteredDirectOffering" scale="6" unitRef="usd" id="ixv-16211">1.58</ix:nonFraction> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2024, the
Company had incurred accumulated losses of $<ix:nonFraction contextRef="c4" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" unitRef="usd" id="ixv-16212">29</ix:nonFraction> million and expects to continue to fund its operations through fundings such as
issuance of convertible securities, ordinary shares and warrants and through Israeli governmental grants. There is no assurance that
such financing will be obtained. Considering the above, the Company&#8217;s dependency on external funding for our operations raises
a substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any
adjustments that might result from the outcome of these uncertainties.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - GENERAL: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;&#160;</p><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;25, 2022, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#8217;s minimum bid price requirement because the closing bid price of the ordinary shares was below $<ix:nonFraction contextRef="c37" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-16213">1.00</ix:nonFraction> per ordinary share for the previous 30 consecutive business days. On May 23, 2023, the Company received a notification letter from Nasdaq that the Company had been granted an additional 180-day compliance period, or until November 20, 2023, to regain compliance with Nasdaq&#8217;s minimum bid price rule. On June 9, 2023, the Company received a written notice from Nasdaq Stock Market LLC, indicating that it has regained compliance with the minimum bid price requirement. On October 24, 2023, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#8217;s minimum bid price requirement because the closing bid price of the ordinary shares was below $<ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-16214">1.00</ix:nonFraction> per ordinary share for the previous 30 consecutive business days. The Company was granted 180 calendar days, or until April&#160;22, 2024, to regain compliance with the minimum bid requirement. Since the Company did not regain compliance with the minimum bid price requirement by April 22, 2024, it applied for an additional 180-calendar day grace period. On April 23, 2024, Nasdaq granted the Company an additional 180-day compliance period, or until October 21, 2024, to regain compliance with Nasdaq&#8217;s minimum bid price rule. On October 10, 2024, the Reverse Share Split at the ratio of <ix:nonNumeric contextRef="c39" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-16215">1:20</ix:nonNumeric> became effective. As a result, the Company was informed by Nasdaq on October 28, 2024 that the Company had regained compliance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 16, 2025, the Company received a written notification from
Nasdaq, which stated that the Company was no longer in compliance with the minimum stockholders&#8217; equity requirement for continued
listing on Nasdaq, due to the Company&#8217;s failure to maintain a minimum of $<ix:nonFraction contextRef="c40" decimals="-5" format="ixt:num-dot-decimal" name="wlds:StockholdersEquityRequirementByStockExchanges" scale="6" unitRef="usd" id="ixv-16216">2.5</ix:nonFraction> million in stockholders&#8217; equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s stockholders&#8217; equity was approximately $<ix:nonFraction contextRef="c41" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" unitRef="usd" id="ixv-16217">1.7</ix:nonFraction>
million as of June 30, 2024. In accordance with Nasdaq rules, on February 5, 2025, the Company submitted a plan to regain compliance to
Nasdaq to explain the way the Company believes it has regained compliance with the minimum stockholders&#8217; equity requirement through
the SEPA it entered into with YA II PN, Ltd. (&#8220;YA&#8221;) on June 6, 2024, and the registered direct offering, completed on November
27, 2024. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance.
The notification letter has no immediate effect on the Company&#8217;s listing on Nasdaq, and during the grace period, as may be extended,
the Company&#8217;s ordinary shares and warrants will continue to trade on Nasdaq under the symbol &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221;
respectively.</p></td></tr> </table></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-13605"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying consolidated financial
statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;). The significant accounting policies followed in the preparation of the financial statements are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock" id="ixv-13611"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying consolidated financial
statements include the accounts of the Company and the Subsidiary. All intercompany transactions have been eliminated in consolidation.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-13625"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of the consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its estimates, judgments and assumptions.
Management bases its estimates, judgments and assumptions on historical experience and on various other factors that are believed to
be reasonable under the circumstances. Actual results could differ from those estimates.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="ixv-13640"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The currency of the primary economic
environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;USD&#8221;). The Company&#8217;s funding
and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-align: justify">&#160;</p>

<ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Transactions and balances originally
denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into USD using historical and
current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other items (stated below)
reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#8211; exchange rates at transaction
dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation etc.) &#8211; historical
exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_InventoryPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InventoryPolicyTextBlock" id="ixv-13658"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventories:</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation id="_InventoryPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories are composed of parts
of the Company&#8217;s products as well as completed products and are stated at the lower of cost or net realizable value. Inventory
cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably
predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase, and other costs
incurred in bringing the inventories to their present location and condition.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ixv-13673"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property and equipment</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock" id="ixv-13685"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated
at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#8239;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">Annual rates of depreciation are as follows:</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Furniture and leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c43" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-16218">7</ix:nonFraction>-<ix:nonFraction contextRef="c44" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-16219">15</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c45" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-16220">33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Electronic equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c46" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-16221">15</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Machines and molds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c47" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-16222">7</ix:nonFraction>-<ix:nonFraction contextRef="c48" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualRateOfDepreciation" scale="-2" unitRef="pure" id="ixv-16223">50</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock" id="ixv-13755"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>f.</b></span></td><td style="text-align: justify"><b>Leases</b></td>
</tr></table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_2" id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_3" id="_LesseeLeasesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#8217;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_4" id="_LesseeLeasesPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#8217;s incremental borrowing rate. The weighted-average&#160;rate applied was <ix:nonFraction contextRef="c42" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" unitRef="pure" id="ixv-16224">8</ix:nonFraction>%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_5" id="_LesseeLeasesPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has the option to extend some of its
lease agreements. In measuring the lease liability and the right-of-use asset, the Company took some of those options into account
since management believes that those options are reasonably certain to be exercised.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_6" id="_LesseeLeasesPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Leases with a lease term of <ix:nonNumeric contextRef="c4" format="ixt-sec:durmonth" name="us-gaap:LesseeFinanceLeaseRenewalTerm1" id="ixv-16225">12</ix:nonNumeric> months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.&#160;</p></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-13783"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue recognition </b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenue is recognized when (or as)
control of the promised goods or services is transferred to the customer, and in an amount that reflects the consideration the Company
is contractually due in exchange for those services or goods. The Company follows five steps to record revenue: (i) identify the contract
with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the
transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies its performance
obligations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company generates revenues from
the sales of B2C &#8220;Mudra Band&#8221;, sales of B2B &#8220;Mudra development kits&#8221; and sales of pilot transactions.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_4" id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The &#8220;Mudra Band&#8221;, is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#8220;Mudra Band&#8221; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point
in time indicating control has been transferred to the customer.&#160;&#160;</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_5" id="_RevenueRecognitionPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_6" id="_RevenueRecognitionPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_7" id="_RevenueRecognitionPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A pilot transaction has multiple performance
obligations, and it generally takes a few months but less than one year. Each Mudra development kit sale also has multiple performance
obligations.</p></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_8" id="_RevenueRecognitionPolicyTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The payment terms of the Mudra development
kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions are within the pilot period.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_9" id="_RevenueRecognitionPolicyTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In those transactions, each obligation-
Hardware and API (for Mudra development kit) and tailor-made software application and technical support (for a pilot transaction) - is
distinct and separately identifiable.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The amount allocated to the delivered
items is recognized upon delivery, the amount allocated to API is recognized over the API period and the amount allocated to technical
support is recognized over the service period (a pilot period).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="wlds_CostOfRevenuesPolicyTextBlock-c0_cont_1" escape="true" name="wlds:CostOfRevenuesPolicyTextBlock" id="ixv-13846"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of revenues</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="wlds_CostOfRevenuesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Costs are expensed as incurred. The primary components
of the cost of revenues include the cost of the product and outbound freight charges.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-13860"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>i.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research and development</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt">&#160;</p>

<ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Research and development expenses
consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as incurred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="wlds_GovernmentalGrantsPolicyTextBlock-c0_cont_1" escape="true" name="wlds:GovernmentalGrantsPolicyTextBlock" id="ixv-13874"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>j.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="wlds_GovernmentalGrantsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company receives royalty-bearing
grants from the Israeli government for approved research and development projects and marketing efforts. These grants are recognized
at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as provided by the relevant agreement
and included as a deduction from research and development or sales and marketing expenses, respectively.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock-c0_cont_1" escape="true" name="wlds:FinanceIncomeAndExpensesPolicyPolicyTextBlock" id="ixv-13888"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>k.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance income and expenses</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.55pt">&#160;</p>

<ix:continuation id="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Finance income is composed of interest
on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are composed of interest on senior
secured credit facility, bank charges and net currency exchange rates differences.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-13902"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>l.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-indent: 0.5in">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income taxes
in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred
taxes are determined utilizing the assets and liabilities method, which is based on the estimated future tax effects of the differences
between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed
using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets
is provided if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will
not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available
evidence, are not expected to be realized.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>







</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies ASC 740, which clarifies the accounting
and reporting for uncertainties with respect to income taxes. ASC 740 prescribes a comprehensive model for the financial statement recognition,
measurement, presentation, and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ixv-13947"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based compensation</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Share-based compensation expenses
related to employees&#8217; and consultants&#8217; options are measured at the grant date based on the fair value of the award and are
generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation expense on a
straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche is separately
expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes option
pricing model, which requires management to make certain assumptions of future expectations based on historical and current data include
the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="wlds_WarrantsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="wlds:WarrantsPolicyPolicyTextBlock" id="ixv-13962"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants and pre-funded warrants</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation id="wlds_WarrantsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The warrants&#8217; mechanism does
not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount of ordinary shares upon exercise.
Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional paid in capital), based on an
assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants are freestanding financial
instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity classification, including
whether the warrants are indexed to the Company&#8217;s own shares, among other conditions for equity classification.</p></ix:continuation>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="wlds_SeverancePolicyTextBlock-c0_cont_1" escape="true" name="wlds:SeverancePolicyTextBlock" id="ixv-13976"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Severance</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="wlds_SeverancePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Israeli labor law generally requires
payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. The Company&#8217;s
pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section 14 of the Israeli Severance Compensation
Act, 1963 (&#8220;section 14&#8221;), the Company&#8217;s employees are entitled to monthly deposits, at a rate of <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="wlds:RateOfMonthlySeverancePercentage" scale="-2" unitRef="pure" id="ixv-16226">8.33</ix:nonFraction>% of their monthly
salary, made in their name with insurance companies. Payments in accordance with section 14 relieve the Company from any future severance
payments in respect of those employees and, as such, the Company may only utilize the insurance policies for the purpose of paying severance
pay.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-13990"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>p.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted loss per share</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 80.55pt">&#160;</p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Basic and diluted loss per share is calculated
by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares and pre-funded warrants
outstanding during the financial year, adjusted for ordinary shares and pre-funded warrants issued during the year, if applicable.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><b>&#160;</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>







</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="ixv-14034"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
<tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements</b></span></td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company measures and discloses
fair value in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;), ASC 820, Fair Value Measurements and
Disclosures (&#8220;ASC 820&#8221;). ASC 820 defines fair value, establishes a framework and gives guidance regarding the methods
used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the
amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that
market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a
three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; ">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 1 &#8211; unadjusted quoted
prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement
date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; "><b>&#160;</b></p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 2 &#8211; pricing inputs are
other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration
with observable market data.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; "><b>&#160;</b></p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 3 &#8211; pricing inputs are
unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; "><b>&#160;</b></p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This hierarchy requires the Company
to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; ">&#160;</p>

<ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of cash is based on
its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and
liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-14066"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>r.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_2" id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains certain cash
balances in a well-known Israeli banks and U.S.-based bank.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_3" id="_ConcentrationRiskCreditRisk-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the years ended December 31, 2024 and 2023, the
Company partially hedged its foreign currency exchange risk.</p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Our derivative instruments primarily
include foreign currency forward agreements related to the NIS and associated with certain payroll payments. Our foreign currency forward
agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated as hedges for accounting
purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged item, are recorded within
our consolidated statements of loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-14086"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>s.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents:</b></span></td></tr> </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash equivalents are highly liquid
investments that are readily convertible into cash, with an original maturity of three months or less.</p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_SegmentReportingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="ixv-14100"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>t.</b></span></td><td><b>Segment Information</b></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:continuation id="_SegmentReportingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has a single operating and reportable segment. The Company&#8217;s chief operating decision maker, who is the Company&#8217;s Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;</p></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; ">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-14113"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
<tr style="vertical-align: top"> <td style="width: 0.25in"><b>&#160;</b></td> <td style="font-size: 10pt; width: 0.25in"><b>u.</b></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting Standards Adopted in 2024</b></span></td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2023, the FASB issued
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;). This ASU
expands public entities&#8217; segment disclosures by requiring disclosure of significant segment expenses that are regularly
provided to the chief operating decision maker (the &#8220;CODM&#8221;) and included within each reported measure of segment profit or loss, an amount and description of its
composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. All
disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. The ASU&#8217;s
amendments are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within
fiscal years beginning after December 15, 2024, with early adoption permitted. After evaluating the impact of this pronouncement on
the Company&#8217;s financial statements, the Company found that there is no impact on its financial statements.</p></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock-c0_cont_1" escape="true" name="wlds:AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" id="ixv-14154"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>v.</b></td><td style="text-align: justify"><b>ACCOUNTING STANDARDS ISSUED AND NOT YET ADOPTED IN 2024</b></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock-c0_cont_2" id="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2024, the FASB issued
ASU 2024-03, Income Statement &#8211; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures (Subtopic 220-40):
Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;), which requires the disaggregation of certain expense
captions into specified categories in disclosures within the notes to the consolidated financial statements to provide enhanced
transparency into the expense captions presented on the face of the statement of income and comprehensive income. ASU 2024-03 is
effective for annual reporting periods beginning after December 15, 2026, with early adoption permitted, and may be applied either
prospectively or retrospectively to financial statements issued for reporting periods after the effective date of ASU 2024-03 or
retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact
that the adoption of ASU 2024-03 will have on its related disclosures.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2024, the FASB issued ASU 2024-04, Induced Conversions
of Convertible Debt Instruments (&#8220;ASU 2024-04&#8221;). This new guidance is intended to improve the relevance and consistency in
application of the induced conversion guidance in Subtopic 470-20 for (a) convertible debt instruments with cash conversion features and
(b) debt instruments that are not currently convertible. ASU 2024-04 is effective for fiscal years beginning after December 15, 2026.
Early adoption is permitted. The Company does not plan to early adopt this standard. The Company is currently evaluating the effect of adoption of this standard
to its consolidated financial statements and disclosures.&#8195;</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:InventoryDisclosureTextBlock" id="ixv-14173"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 3 - INVENTORIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="ixv-14177"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cost:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Raw materials</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" unitRef="usd" id="ixv-16227">212</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" unitRef="usd" id="ixv-16228">514</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt">Work-in-progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" unitRef="usd" id="ixv-16229">103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" unitRef="usd" id="ixv-16230">206</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" unitRef="usd" id="ixv-16231">986</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" unitRef="usd" id="ixv-16232">312</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Provision for inventory write-off</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InventoryWriteoff" scale="3" unitRef="usd" id="ixv-16233">75</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FIFOInventoryAmount" scale="3" unitRef="usd" id="ixv-16234">1,226</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FIFOInventoryAmount" scale="3" unitRef="usd" id="ixv-16235">1,032</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-14260"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE</b>&#160; <b>4 - PROPERTY AND EQUIPMENT, net</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-14265"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cost:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16236">230</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16237">204</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Furniture and leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c51" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16238">38</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16239">38</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Electronic equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16240">20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16241">20</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Machines and molds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16242">86</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16243">72</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16244">374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-16245">334</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Less <span style="font-style: normal; font-weight: normal">-
    accumulated depreciation</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-16246">244</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-16247">140</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-16248">130</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-16249">194</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock" id="ixv-14367"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 5 - LEASES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has operating leases for
our office and vehicles. The Company&#8217;s leases have remaining terms of less than one year to approximately <ix:nonNumeric contextRef="c4" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="ixv-16250">2</ix:nonNumeric> years, some of which may include
options to extend the leases for up to <ix:nonNumeric contextRef="c0" name="us-gaap:LesseeOperatingLeaseOptionToExtend" id="ixv-16251">2 years</ix:nonNumeric>. The Company exercised the option to extend the lease for an additional one year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cash flows related to leases are classified as part of the cash used to operating activities in the cash flow statement.</p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 5 - LEASES (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation id="_LesseeOperatingLeasesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock" id="ixv-14403"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following table summarizes the classification
of operating lease right-of-use assets and liabilities in the Company&#8217;s Consolidated Balance Sheets as of December&#160;31, 2024
and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Right of use assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-16252">330</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-16253">592</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 0.2in">Short term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-16254">291</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-16255">297</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 7.3pt">Long term</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-16256">21</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-16257">278</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total lease liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-16258">312</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-16259">575</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="ixv-14486"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December&#160;31, 2024, the future minimum lease payments
under the Company&#8217;s operating lease liabilities are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S.&#160;dollars<br/> in&#160;thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd" id="ixv-16260">302</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" unitRef="usd" id="ixv-16261">22</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" unitRef="usd" id="ixv-16262">324</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" unitRef="usd" id="ixv-16263">12</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-16264">312</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less operating lease liabilities, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-16265">291</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Operating lease liabilities, non-current</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-16266">21</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total expenses under all operating leases were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" unitRef="usd" id="ixv-16267">288</ix:nonFraction> thousand,
$<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" unitRef="usd" id="ixv-16268">232</ix:nonFraction> thousand, and $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" unitRef="usd" id="ixv-16269">74</ix:nonFraction> thousand for the years ended December 31, 2024, 2023 and 2022, respectively.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock-c0_cont_1" escape="true" name="wlds:StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" id="ixv-14544"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 6 - STAND BY EQUITY PURCHASE AGREEMENT AND CONVERTIBLE
PROMISSORY NOTE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On June
6, 2024, the Company entered into the SEPA with YA, a fund managed by Yorkville Advisors Global, LP. Pursuant to the terms of the SEPA,
YA is committed to purchase up to the commitment amount, of the Company&#8217;s ordinary shares at any time during the three-year period
following the execution date of the SEPA. The purchase price of the ordinary shares sold to YA is equal to <ix:nonFraction contextRef="c57" decimals="2" format="ixt:num-dot-decimal" name="wlds:PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" scale="-2" unitRef="pure" id="ixv-16270">97</ix:nonFraction>% of the lowest volume weighted
average price (&#8220;VWAP&#8221;) of the ordinary shares during a pricing period of <ix:nonNumeric contextRef="c57" format="ixt-sec:duryear" name="wlds:CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" id="ixv-16271">3</ix:nonNumeric> consecutive trading days commencing on the trading
day of the delivery of advance notice by the Company. During the year ended December 31, 2024, the Company issued <ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" scale="0" unitRef="shares" id="ixv-16272">307,175</ix:nonFraction> ordinary shares
for gross proceeds of approximately $<ix:nonFraction contextRef="c25" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" unitRef="usd" id="ixv-16273">4.6</ix:nonFraction> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>According
to SEPA, the Company will have the sole right in its discretion to sell shares to YA from time to time by issuing advance notices to YA.
In addition, the Company also agreed to pay YA the commitment fee by issuance of the ordinary shares, equal to $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:NumberOfAmountIssuableAsCommitmentFee" scale="3" unitRef="usd" id="ixv-16274">100,000</ix:nonFraction>, or <ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="wlds:PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" scale="-2" unitRef="pure" id="ixv-16275">1.0</ix:nonFraction>% of the
aggregate amount available to be sold under the SEPA, as consideration for its irrevocable commitment to purchase ordinary shares under
SEPA. The Company and YA agreed to postpone the issuance of the Commitment Fee to YA. The Commitment Fee will be paid either by cash or
by the issuance to YA of such number of ordinary shares that is equal to the balance of the Commitment Fee divided by the average of the
daily VWAP of the ordinary shares during the <span style="-sec-ix-hidden: hidden-fact-72">three</span> trading days immediately prior to the payment date. The Company has also paid YA a
structuring fee in the amount of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:PaymentsForStructuringFee" scale="3" unitRef="usd" id="ixv-16276">10,000</ix:nonFraction>.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 6 - STAND BY EQUITY PURCHASE AGREEMENT AND CONVERTIBLE
PROMISSORY NOTE (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Subject
to certain conditions, according to the SEPA agreement, the Company may request pre-paid advances of the commitment amount, in an
amount up to $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="wlds:PrePaidAdvances" scale="6" unitRef="usd" id="ixv-16277">3</ix:nonFraction> million, which will be evidenced by one or more convertible promissory notes. In June 2024, the Company requested,
and received, an initial pre-paid advance of $<ix:nonFraction contextRef="c58" decimals="-6" format="ixt:num-dot-decimal" name="wlds:PrePaidAdvances" scale="6" unitRef="usd" id="ixv-16278">2</ix:nonFraction> million in connection with the execution of SEPA. Each convertible promissory note
will be discounted to <ix:nonFraction contextRef="c58" decimals="2" format="ixt:num-dot-decimal" name="wlds:PurchasePriceDiscount" scale="-2" unitRef="pure" id="ixv-16279">96</ix:nonFraction>% of the purchase price and be fully mature 12 months following its issuance and shall accrue interest on
the outstanding principal balance thereon at a rate of <ix:nonFraction contextRef="c59" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-16280">6</ix:nonFraction>% per annum, increasing to <ix:nonFraction contextRef="c60" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-16281">18</ix:nonFraction>% per annum upon an Event of Default (as
defined in the convertible promissory note). Beginning 60 days after the issuance of a convertible promissory note, the Company
shall pay to YA a monthly installment payment of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:MonthlyInstallmentPayment" scale="-2" unitRef="pure" id="ixv-16282">10</ix:nonFraction>% of the original principal amount of the convertible promissory note and accrued
interest, payable in cash or by submitting an advance notice, where YA will offset the amount due to be paid to us under such notice
against an equal amount of the monthly installment amount, at the Company&#8217;s option. If the Company elects to pay in cash, the
installment amount shall also include a payment premium in the amount of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:PrincipalAmountInstallmentPayment" scale="-2" unitRef="pure" id="ixv-16283">5</ix:nonFraction>% of the principal amount of the installment payment. Each
convertible promissory note will be convertible at a conversion price equal to $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockConvertibleConversionPriceIncrease" scale="0" unitRef="usdPershares" id="ixv-16284">4.00</ix:nonFraction> per ordinary share and contains customary
adjustments in the event of stock dividends, stock splits, reorganizations or similar events affecting the Company&#8217;s ordinary
shares and the conversion price. Each convertible promissory note will also contain anti-dilution provisions that provide that if
the Company issues ordinary shares, or securities convertible into or exercisable or exchange for, shares of ordinary shares at a
price per share that is less than the conversion price then in effect, then the conversion price of the convertible promissory note
upon each such issuance will be adjusted to the price equal to the consideration per share paid for such ordinary share or other
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The embedded
conversion option has not bifurcated due to the fixed nature of the conversion price, which is closely indexed to the Company&#8217;s
own shares. Additionally, there is no significant premium associated with the convertible promissory note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Moreover,
the Company retains the option to settle the debt in shares pursuant to the SEPA conditions. Given that the Company will incur an additional
cost, either in cash settlement or in shares settlement (in the form of discounted share price), the convertible promissory note will
bear a <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ConvertiblePromissoryNotePremiumPercentage" scale="-2" unitRef="pure" id="ixv-16285">5</ix:nonFraction>% premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The
convertible promissory note was recognized based on the amortized cost method and as of December 31, 2024, the convertible
promissory note, including accrued interest, amounted to approximately $<ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="3" unitRef="usd" id="ixv-16286">807</ix:nonFraction> thousand. As of
December 31, 2024, the convertible promissory note balance net is $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="3" unitRef="usd" id="ixv-16287">770</ix:nonFraction> thousand. In February 2025, the Company repaid the
entire balance of the convertible promissory note and the commitment fee.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-14614"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 7 - COMMITMENTS AND CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalties to the Israel Innovation Authority (&#8220;IIA&#8221;):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.4pt; text-indent: -0.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company receives royalty-bearing
grants from the IIA, for approved research and development projects. The programs include grants for: wages, materials, subcontractors
and miscellaneous. The Company was required to pay royalties at the rate of <ix:nonFraction contextRef="c62" decimals="2" format="ixt:num-dot-decimal" name="wlds:RoyaltiesRate" scale="-2" unitRef="pure" id="ixv-16288">3</ix:nonFraction>%-<ix:nonFraction contextRef="c63" decimals="3" format="ixt:num-dot-decimal" name="wlds:RoyaltiesRate" scale="-2" unitRef="pure" id="ixv-16289">3.5</ix:nonFraction>% on sales of products developed with the funds provided
by the IIA, up to an amount equal to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:GrantsReceivedEqualPercentageRate" scale="-2" unitRef="pure" id="ixv-16290">100</ix:nonFraction>% of the IIA research and development grants received, linked to the dollar including accrued
interest. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable to US Dollar deposits. However,
on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under such
directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024
the annual interest is calculated at a rate based on 12-month SOFR, or at an alternative rate published by the Bank of Israel plus <ix:nonFraction contextRef="c0" decimals="7" format="ixt:num-dot-decimal" name="wlds:AnnualAlternativeInterestPercentage" scale="-2" unitRef="pure" id="ixv-16291">0.71513</ix:nonFraction>%;
and, for grants approved on or following January 1, 2024 the annual interest shall be the higher of (i) the 12 months SOFR interest rate,
plus <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:AnnualInterestRate" scale="-2" unitRef="pure" id="ixv-16292">1</ix:nonFraction>%, or (ii) a fixed annual interest rate of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:FixedAnnualInterestRate" scale="-2" unitRef="pure" id="ixv-16293">4</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2018, two IIA programs
were completed, while the amounts received for them aggregated to $<ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AmountsReceivedAggregateAmount" scale="6" unitRef="usd" id="ixv-16294">1.224</ix:nonFraction> million. In addition, another IIA approved plan commenced on
May 1, 2020, and was completed on July 31, 2021, pursuant to which a total of $<ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AmountsReceivedAggregateAmount" scale="3" unitRef="usd" id="ixv-16295">627</ix:nonFraction> thousand was received. During January 2023, the IIA
approved an additional program to finance further development of the Company&#8217;s manufacturing process of its wearable neural interface
in Israel. The approved program is in amount of approximately $<ix:nonFraction contextRef="c66" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AmountOfDevelopmentProgram" scale="3" unitRef="usd" id="ixv-16296">900</ix:nonFraction> thousand (NIS <ix:nonFraction contextRef="c66" decimals="-5" format="ixt:num-dot-decimal" name="wlds:AmountOfDevelopmentProgram" scale="6" unitRef="ils" id="ixv-16297">3.1</ix:nonFraction> million), of which the IIA will finance <ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="wlds:PercentageOfFinancing" scale="-2" unitRef="pure" id="ixv-16298">60</ix:nonFraction>%; for
the years ended December 31, 2024 and 2023, the Company received $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:TotalCashReceivedFromTheIIA" scale="3" unitRef="usd" id="ixv-16299">180</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:TotalCashReceivedFromTheIIA" scale="3" unitRef="usd" id="ixv-16300">288</ix:nonFraction> thousand, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The terms of the grants under the Encouragement
of Research, Development and Technological Innovation in the Industry 1984 require that the manufacturing of products resulting from IIA-funded
programs be carried out in Israel, unless a prior written approval of the IIA is obtained (except for a transfer of up to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExceptTransferProductionRight" scale="-2" unitRef="pure" id="ixv-16301">10</ix:nonFraction>% of the production
rights, for which a notification to the IIA is sufficient). During December 2022, the Company received an approval from the IIA to transfer
some of its manufacturing activities abroad.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As a condition for obtaining approval
to manufacture outside Israel (or following a declaration that up to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ProductionTransferred" scale="-2" unitRef="pure" id="ixv-16302">10</ix:nonFraction>% of the production is transferred abroad), <ix:nonNumeric contextRef="c0" name="wlds:PayIncreasedRoyaltiesDescription" id="ixv-16303">the Company would be
required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate 3%-3.5%, and also the total
amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from the IIA, depending on the manufacturing
volume that is performed outside Israel (less royalties already paid to IIA).</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Research and development grants deducted
from research and development expenses amounted to $<ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ResearchAndDevelopmentGrantsDetection" scale="3" unitRef="usd" id="ixv-16304">92</ix:nonFraction> thousand, $<ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ResearchAndDevelopmentGrantsDetection" scale="3" unitRef="usd" id="ixv-16305">415</ix:nonFraction> thousand and <span style="-sec-ix-hidden: hidden-fact-73">nil</span> for the years ended December 31, 2024, 2023 and
2022, respectively. As of December 31, 2024, the maximum obligation with respect to the grants received from the IIA, contingent upon
entitled future sales, is $<ix:nonFraction contextRef="c70" decimals="-5" format="ixt:num-dot-decimal" name="wlds:MaximumObligatinAmount" scale="6" unitRef="usd" id="ixv-16306">2.4</ix:nonFraction> million plus interest which may be increased, depending on the manufacturing volume that is performed
outside Israel. The Company has obligations regarding know-how, technology, or products, not to transfer the information, rights thereon
and production rights which derive from the research and development, in whole or part, of its Mudra product and its Mudra Band product,
without the IIA Research Committee approval.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 7 - COMMITMENTS AND CONTINGENCIES: <span style="font-family: Times New Roman, Times, Serif; font-style: normal">(Cont.)</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalties to the Israeli Ministry of Economy and Industry (&#8220;IMEI&#8221;):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During 2020, the Company received a
grant from the IMEI, for approved marketing expenses amounting to $<ix:nonFraction contextRef="c71" decimals="-3" format="ixt:num-dot-decimal" name="wlds:GrantsReceivedFromTheIMEI" scale="3" unitRef="usd" id="ixv-16307">95</ix:nonFraction> thousand. The program includes participation in expenses for: consulting
for marketing, advertising and online marketing, flights to exhibitions and miscellaneous. &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the agreement with the IMEI,
if the export revenues in the defined target market increase by $<ix:nonFraction contextRef="c72" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenuesNetOfInterestExpense" scale="3" unitRef="usd" id="ixv-16308">311</ix:nonFraction> thousand compared to the base year, the Company would be required
to pay royalties at the rate of <ix:nonFraction contextRef="c72" decimals="2" format="ixt:num-dot-decimal" name="wlds:RoyaltiesRatePercentage" scale="-2" unitRef="pure" id="ixv-16309">3</ix:nonFraction>% of the increase, with the funds provided by the IMEI up to an amount equal to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:MarketingGrantReceived" scale="-2" unitRef="pure" id="ixv-16310">100</ix:nonFraction>% of the IMEI marketing
grant received, linked to the consumer price index (&#8220;CPI&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2024, the maximum
obligation with respect to the grant received from the IMEI, contingent upon entitled future sales, is $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivableCurrent" scale="3" unitRef="usd" id="ixv-16311">95</ix:nonFraction> thousand linked to the CPI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Commitments &#8211; Operating Leases:</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On July 1, 2018, the Company entered
into a lease agreement for a period which expired on September 30, 2022. The monthly lease payment totaled approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd" id="ixv-16312">5</ix:nonFraction> thousand.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">After September 30, 2022, the Company
stayed on the lease on a month-to-month basis. At the end of January 2023, the Company terminated this lease with 60 days&#8217; termination
notice that ended on March 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In January 2023, the Company entered into a new lease agreement in
Yokne&#8217;am Illit, Israel for a period which started on February 1, 2023, and expires on January 31, 2025, with an option to extend
the lease period by two additional lease periods, each for an additional 12 months. The Company exercised the option to extend the lease
for an additional one year. The Company&#8217;s monthly rent payment for this facility is approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd" id="ixv-16313">16</ix:nonFraction> thousand during the first
lease year and increased to approximately $<ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd" id="ixv-16314">20</ix:nonFraction> thousand during the second lease year. During the option lease periods, the lease payment
may be increased up to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:LeasePaymentIncreased" scale="-2" unitRef="pure" id="ixv-16315">10</ix:nonFraction>% as compared to the second lease year. The Company exercised the option and extended the lease for another year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Subsidiary, Mudra Wearable, leases
an office located in California. The lease is on a month-to-month basis for $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="wlds:LeaseMonthlyRentalPayments" scale="0" unitRef="usd" id="ixv-16316">495</ix:nonFraction> per month. Additionally, during 2022, the Company entered
into lease agreements to lease <ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="wlds:NumberOfVehicles" scale="0" unitRef="Vehicles" id="ixv-16317">5</ix:nonFraction> vehicles for a period of <ix:nonNumeric contextRef="c74" format="ixt-sec:duryear" name="wlds:LeaseAgreementsPeriod" id="ixv-16318">3</ix:nonNumeric> years.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-14719"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 8 - CONVERTIBLE SECURITIES &#8211; April 2021 investors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2022,
the Company&#160;received from Alpha Capital Anstalt (&#8220;Alpha&#8221;) the contractually required written consent to proceed with
the IPO (the &#8220;June 2022 Consent&#8221;) in exchange for a cash payment of $<ix:nonFraction contextRef="c75" decimals="-3" format="ixt:num-dot-decimal" name="wlds:CashPayment" scale="3" unitRef="usd" id="ixv-16319">300,000</ix:nonFraction> from the proceeds of the IPO, which was paid
on September 28, 2022, following the completion of the IPO. Pursuant to the share purchase agreements the Company entered into with certain
investors in April 2021 (the &#8220;April 2021 SPAs&#8221;), in the event of an initial public offering event or in a Dilutive Issuance
event (as defined below), reflecting a pre-money valuation of $<ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="wlds:PremoneyValuationAmount" scale="3" unitRef="usd" id="ixv-16320">26,400,000</ix:nonFraction>, or a lower one, then such investors shall receive additional
ordinary shares and additional shares underlying each warrant, based on <ix:nonFraction contextRef="c77" decimals="2" format="ixt:num-dot-decimal" name="wlds:WarrantPricePerSharePercentage" scale="-2" unitRef="pure" id="ixv-16321">80</ix:nonFraction>% of the price per share at the IPO (the &#8220;Discounted PPS&#8221;),
less the number of ordinary shares issued to them in the April 2021 financing, and the number of shares underlying each warrant shall
be increased assuming the exercise amount is divided by the Discounted PPS. Additionally, beginning on April 22, 2021 and until the earlier
of (i) the 90th calendar day after the expiration of the applicable lock-ups, following the IPO date (i.e. June 2023) or (ii) three years
from April 22, 2021, if the Company or its subsidiary shall issue any ordinary shares or equivalents of ordinary shares, in an equity
transaction other than an exempt issuance, entitling any person or entity to acquire ordinary shares at an effective price per share less
than the per share purchase price of $<ix:nonFraction contextRef="c78" decimals="2" format="ixt:num-dot-decimal" name="wlds:PurchasePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16322">180.00</ix:nonFraction> (subject to prior adjustment for reverse and forward stock splits and the like) (a &#8220;Dilutive
Issuance&#8221;), then, for no additional consideration, the Company shall immediately issue to the investors in the April 2021 financing
that number of additional ordinary shares equal to (a) the per share purchase price of $<ix:nonFraction contextRef="c79" decimals="2" format="ixt:num-dot-decimal" name="wlds:PurchasePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16323">180.00</ix:nonFraction> divided by amount actually paid in new
cash consideration by third parties for each ordinary share in the Dilutive Issuance less (b) the number of ordinary shares issued to
Alpha and other investors at the closing of the April 2021 financing pursuant to April 2021 SPAs. Pursuant to the June 2022 Consent, the
investor in the April 2021 financing waived their rights for such adjustments as of the date of the IPO and deferred such adjustments
(if any) to be effected on the 90th calendar day following the closing of the IPO.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 20, 2022, the Company&#8217;s
volume weighted average stock price was less than the exercise price of $<ix:nonFraction contextRef="c80" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-16324">160.00</ix:nonFraction> for the warrants. Accordingly, effective after the closing
of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date of the warrants), the warrants&#8217; exercise
price was adjusted pursuant to their terms to $<ix:nonFraction contextRef="c81" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-16325">160.00</ix:nonFraction> (the &#8220;Exercise Price Adjustment&#8221;). Following the Exercise Price Adjustment,
on February 16, 2023, the Company issued an aggregate of <ix:nonFraction contextRef="c82" decimals="0" format="ixt:num-dot-decimal" name="wlds:AggregateOrdinaryShares" scale="0" unitRef="shares" id="ixv-16326">2,114</ix:nonFraction> ordinary shares to the April 2021&#160;investors&#160;as a result of the
IPO.&#160;&#160;</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="wlds:CreditFacilityDisclosureTextBlock" id="ixv-14729"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 - CREDIT FACILITY </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On July 4, 2022, the Company
entered into a senior secured credit facility agreement with L.I.A. Pure Capital Ltd. (&#8220;Pure Capital&#8221;) to borrow from
time to time amounts until the closing of the IPO in an amount of up to $<ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherBorrowings" scale="3" unitRef="usd" id="ixv-16327">800</ix:nonFraction> thousand (the &#8220;Initial Credit&#8221;), which
Initial Credit could be increased, upon the request of the Company, to an amount not exceeding $<ix:nonFraction contextRef="c83" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" unitRef="usd" id="ixv-16328">1</ix:nonFraction> million (together with the Initial
Credit, the &#8220;Credit Facility&#8221;) in aggregate. The underlying outstanding amounts had priority in relation and senior to
any other debts owed by the Company to any third party, and were subject to a registered floating charge, for the benefit of Pure
Capital, against all of the Company&#8217;s assets. During July, August and September 2022, the Company received an aggregate of
$<ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AggregateAmount" scale="3" unitRef="usd" id="ixv-16329"><ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AggregateAmount" scale="3" unitRef="usd" id="ixv-16330"><ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="wlds:AggregateAmount" scale="3" unitRef="usd" id="ixv-16331">800</ix:nonFraction></ix:nonFraction></ix:nonFraction> thousand under the Credit Facility. The Credit Facility bore interest at the rate of <ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" unitRef="pure" id="ixv-16332">4</ix:nonFraction>% per annum. The outstanding amounts,
together with interest accrued and unpaid were due and payable on the earlier of (i) June 30, 2024, or (ii) upon receipt of a
certain financing transaction or in the event of certain customary events of default or a change of control. The Credit Facility was
fully repaid on September 19, 2022. The agreement indicates that the Company shall not assume any debt senior to the Credit Facility
during the term of the Credit Facility, unless Pure Capital has provided its advance written consent; and subject to applicable law,
any debt assumed by the Company during such term shall be deemed subordinated to any debt accrued under the agreement, if Pure
Capital had not provided its prior written consent; and without Pure Capital&#8217;s prior written consent, the Company shall not
pledge in favor of a third-party creditor or lender any of its assets or rights, including by a floating charge, until such time
that the Credit Facility, and any interest accrued thereon, has been repaid in full to Pure Capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, the Credit Facility
agreement requires the Company to retain Pure Capital for investor relations services and other related strategic services in
exchange for a monthly base fee of $<ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ServicesInExchangeForMonthlyBaseFee" scale="3" unitRef="usd" id="ixv-16333">35</ix:nonFraction> thousand, upon the closing of the IPO, under a <ix:nonNumeric contextRef="c87" format="ixt-sec:duryear" name="wlds:AggrementTerm" id="ixv-16334">3</ix:nonNumeric> year consulting agreement. If <ix:nonFraction contextRef="c87" decimals="2" format="ixt:num-dot-decimal" name="wlds:WarrantsIssuedPercentage" scale="-2" unitRef="pure" id="ixv-16335">70</ix:nonFraction>% or more of
the warrants (or other convertible securities) issued in connection with the IPO are exercised during the term of such instrument,
then the base monthly fee will immediately increase to $<ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="wlds:BaseMonthlyFeeImmediatelyIncreaseAmount" scale="3" unitRef="usd" id="ixv-16336">70</ix:nonFraction> thousand, which increase shall apply retroactively to the closing of the
IPO date. Total expenses for services rendered under Pure Capital agreement were
$<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ExpenseOnServiceRendering" scale="3" unitRef="usd" id="ixv-16337">420</ix:nonFraction> thousand, $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ExpenseOnServiceRendering" scale="3" unitRef="usd" id="ixv-16338">420</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:ExpenseOnServiceRendering" scale="3" unitRef="usd" id="ixv-16339">122</ix:nonFraction> thousand for the years ended December 31, 2024, 2023 and 2022, respectively.</p></ix:nonNumeric><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-14762"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="ixv-14778"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The share capital as of December 31, 2024 and 2023, is composed
of as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 4pt">Ordinary shares, NIS <ix:nonFraction contextRef="c135" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-16340"><ix:nonFraction contextRef="c136" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-16341">0.01</ix:nonFraction></ix:nonFraction> par value</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c135" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-16342">50,000,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c136" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-16343">50,000,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c135" decimals="INF" format="ixt:num-dot-decimal" name="wlds:NumberOfSharesIssuedAndOutstanding" scale="0" unitRef="shares" id="ixv-16344">707,463</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c136" decimals="INF" format="ixt:num-dot-decimal" name="wlds:NumberOfSharesIssuedAndOutstanding" scale="0" unitRef="shares" id="ixv-16345">254,843</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The ordinary shares entitle their holders:
to receive notices of, and to attend, general meetings where each ordinary share shall have one vote for all purposes; to share distributions
as may be declared by the Board of Directors of the Company and approved by the shareholders, if required; and, upon liquidation or dissolution
- to participate in the distribution of the assets of the Company after payment of all debts and other liabilities of the Company, in
accordance with the terms of the Company&#8217;s Articles of Association.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(1)</td><td style="text-align: justify"> In 2022, the Company issued <ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-16346">58</ix:nonFraction> ordinary shares, upon exercise of employees&#8217; options.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(2)</td><td style="text-align: justify">In September 2022, the Company completed its IPO whereby the Company issued and sold in connection with
the closing of the IPO <ix:nonFraction contextRef="c88" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-16347">46,875</ix:nonFraction> units, each consisting of <ix:nonFraction contextRef="c88" decimals="0" format="ixt-sec:numwordsen" name="wlds:NumberOfOrdinaryShares" scale="0" unitRef="shares" id="ixv-16348">one</ix:nonFraction> ordinary share and <ix:nonFraction contextRef="c89" decimals="0" format="ixt-sec:numwordsen" name="wlds:NumberOfWarrants" scale="0" unitRef="shares" id="ixv-16349">two</ix:nonFraction> warrants to purchase <ix:nonFraction contextRef="c89" decimals="0" format="ixt-sec:numwordsen" name="wlds:NumberOfOrdinaryShares" scale="0" unitRef="shares" id="ixv-16350">one</ix:nonFraction> ordinary share each. In addition,
the underwriter exercised its over-allotment option with respect to <ix:nonFraction contextRef="c90" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-16351">14,062</ix:nonFraction> warrants to purchase <ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-16352">14,062</ix:nonFraction> ordinary shares.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The warrants were exercisable immediately
upon issuance, at an exercise price of $<ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-16353">320.00</ix:nonFraction> per ordinary share and are exercisable until September 12, 2027. On September 16, 2022,
<ix:nonFraction contextRef="c93" decimals="0" format="ixt:num-dot-decimal" name="wlds:ExercisableWarrantsToShares" scale="0" unitRef="shares" id="ixv-16354">500</ix:nonFraction> warrants were exercised into <ix:nonFraction contextRef="c93" decimals="0" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" unitRef="shares" id="ixv-16355">500</ix:nonFraction> ordinary shares. On December 14, 2022, the exercise price of the warrants was adjusted to $<ix:nonFraction contextRef="c94" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-16356">160.00</ix:nonFraction>
per ordinary share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In connection with the IPO, the Company
received gross proceeds of approximately $<ix:nonFraction contextRef="c87" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-16357">16.0</ix:nonFraction> million, before deducting underwriting discounts and commissions and before offering expenses
($<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="wlds:UnderwritingNetProceed" scale="6" unitRef="usd" id="ixv-16358">14.9</ix:nonFraction> million net proceeds after deducting approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="wlds:UnderwritingDiscountsAndCommissions" scale="6" unitRef="usd" id="ixv-16359">1.1</ix:nonFraction> million of underwriting discounts and commissions and approximately $<ix:nonFraction contextRef="c87" decimals="-5" format="ixt:num-dot-decimal" name="wlds:ProceedAfterInitialPublicOfferingExpenses" scale="6" unitRef="usd" id="ixv-16360">13.3</ix:nonFraction>
million after other IPO expenses).&#160;</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(3)</td><td style="text-align: justify">During 2022, the Company entered into a simple agreement for future equity (the &#8220;SAFEs&#8221;) for
$<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:SAFEsAmount" scale="3" unitRef="usd" id="ixv-16361">500</ix:nonFraction> thousand with <ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="wlds:NumberOfInvestors" scale="0" unitRef="pure" id="ixv-16362">5</ix:nonFraction> investors, $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="wlds:InvestorAmount" scale="3" unitRef="usd" id="ixv-16363">100</ix:nonFraction> thousand each, of which $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" unitRef="usd" id="ixv-16364">400</ix:nonFraction> thousand were converted to <ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" unitRef="shares" id="ixv-16365">1,477</ix:nonFraction>&#160;ordinary shares and $<ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" unitRef="usd" id="ixv-16366">100</ix:nonFraction> thousand
of <ix:nonFraction contextRef="c95" decimals="0" format="ixt-sec:numwordsen" name="wlds:NumberOfInvestors" scale="0" unitRef="pure" id="ixv-16367">one</ix:nonFraction> investor were paid back in cash upon the closing of the IPO. Those&#160;SAFEs were not mandatorily redeemable, nor redeemable at
the option of the holder after a specified date, but in an Equity Financing (as defined in the SAFEs) which under current liquidity circumstances
constitutes a redemption event outside of the Company&#8217;s control. The Company issued to each SAFE investor a warrant to purchase
ordinary shares of the Company with an exercise price of $<ix:nonFraction contextRef="c15" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-16368">507.60</ix:nonFraction> per share in such offering for an aggregate amount of up to $<ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" scale="3" unitRef="usd" id="ixv-16369">25</ix:nonFraction> thousand
(exercisable for a total of <ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="wlds:ExercisableWarrantsToShares" scale="0" unitRef="shares" id="ixv-16370">197</ix:nonFraction> ordinary shares, until the earlier of: (i) eighteen (18) months from January 2022; or (ii) in a change
of control event, which generally covers (a) a transaction in which any person or group becomes the beneficial owner, directly or indirectly,
of more than <ix:nonFraction contextRef="c96" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" unitRef="pure" id="ixv-16371">50</ix:nonFraction>% of the Company&#8217;s outstanding voting securities with the right to vote for the election of members of the Company&#8217;s
Board of Directors, or (b) any reorganization, merger or consolidation of the Company, or (c) a sale, lease or other disposition of all
or substantially all of the Company&#8217;s assets).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(4)</td><td style="text-align: justify">During September 2022, investors exercised <ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="wlds:InvestorsExercisedWarrants" scale="0" unitRef="shares" id="ixv-16372">500</ix:nonFraction> warrants into ordinary shares.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(5)</td><td style="text-align: justify">In June 2023, <ix:nonFraction contextRef="c97" decimals="0" format="ixt:num-dot-decimal" name="wlds:ExercisableWarrantsToShares" scale="0" unitRef="shares" id="ixv-16373">9,052</ix:nonFraction> warrants were exercised into <ix:nonFraction contextRef="c97" decimals="0" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" unitRef="shares" id="ixv-16374">9,052</ix:nonFraction> ordinary shares at an exercise price of $<ix:nonFraction contextRef="c97" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16375">160.00</ix:nonFraction>
per ordinary share.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(6)</td><td style="text-align: justify">On November 13, 2023, the Company completed a public offering of its securities,
whereby the Company issued and sold <ix:nonFraction contextRef="c98" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-16376">55,556</ix:nonFraction> ordinary shares. The Company received gross proceeds of approximately $<ix:nonFraction contextRef="c98" decimals="-6" format="ixt:num-dot-decimal" name="wlds:GrossProceedsOfOrdinaryShares" scale="6" unitRef="usd" id="ixv-16377">2</ix:nonFraction> million, before deducting
underwriting discounts and commissions and before offering expenses ($<ix:nonFraction contextRef="c98" decimals="-5" format="ixt:num-dot-decimal" name="wlds:UnderwritingNetProceed" scale="6" unitRef="usd" id="ixv-16378">1.7</ix:nonFraction> million net proceeds after deducting underwriting discounts
and commissions and other expenses).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; ">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(7)</td><td style="text-align: justify">During 2024, the Company issued <ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" scale="0" unitRef="shares" id="ixv-16379">307,175</ix:nonFraction> ordinary shares pursuant to the SEPA for net proceeds of $<ix:nonFraction contextRef="c99" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" unitRef="usd" id="ixv-16380">4.4</ix:nonFraction> million (See also Note 6).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; ">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(8)</td><td><p style="text-align: justify; margin-top: 0; margin-bottom: 0">On November 27, 2024, the Company completed a registered direct offering and concurrent private placement, for the issuance and sale of <ix:nonFraction contextRef="c100" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-16381">63,000</ix:nonFraction> ordinary shares, <ix:nonFraction contextRef="c101" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuedAndSoldOrdinaryShares" scale="0" unitRef="shares" id="ixv-16382">142,500</ix:nonFraction> pre-funded warrants to purchase up to <ix:nonFraction contextRef="c102" decimals="0" format="ixt:num-dot-decimal" name="wlds:PreFundWarrant" scale="0" unitRef="shares" id="ixv-16383">142,500</ix:nonFraction> ordinary shares in the registered direct offering, and&#160;warrants to purchase up to <ix:nonFraction contextRef="c103" decimals="0" format="ixt:num-dot-decimal" name="wlds:PurchaseOfWarrants" scale="0" unitRef="shares" id="ixv-16384">205,500</ix:nonFraction> ordinary shares in the concurrent private placement&#160;at a combined purchase price of $<ix:nonFraction contextRef="c103" decimals="2" format="ixt:num-dot-decimal" name="wlds:CombinedPurchasePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16385">9.00</ix:nonFraction> per ordinary share. During December 2024, <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="wlds:PreFundedWarrantsToPurchase" scale="0" unitRef="shares" id="ixv-16386">64,500</ix:nonFraction> pre-funded warrants were exercised into <ix:nonFraction contextRef="c104" decimals="0" format="ixt:num-dot-decimal" name="wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants" scale="0" unitRef="shares" id="ixv-16387">64,500</ix:nonFraction> ordinary shares.</p> <p style="margin-top: 0; margin-bottom: 0">&#160;</p> <p style="text-align: justify; margin-top: 0; margin-bottom: 0">The warrants issued pursuant to the concurrent private placement have an&#160;exercise price of $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16388">10.00</ix:nonFraction> per ordinary share, are immediately exercisable and expire <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="ixv-16389">five years</ix:nonNumeric> following the date of issuance. The Company received gross proceeds of approximately $<ix:nonFraction contextRef="c105" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="6" unitRef="usd" id="ixv-16390">1.85</ix:nonFraction> million, before deducting underwriting discounts and commissions and before offering expenses ($<ix:nonFraction contextRef="c105" decimals="-4" format="ixt:num-dot-decimal" name="wlds:UnderwritingDiscountsAndCommissions" scale="6" unitRef="usd" id="ixv-16391">1.58</ix:nonFraction> million net proceeds after deducting underwriting discounts and commissions and other expenses). See also note 13.b.</p></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(9)</td><td style="text-align: justify">In December 2024, the Company issued <ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" unitRef="shares" id="ixv-16392">9,765</ix:nonFraction> ordinary shares to a service provider in return for marketing services.</td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in; "></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in; ">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based compensation</b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In 2015, the Company&#8217;s Board
of Directors adopted the 2015 Share Option Plan (the &#8220;2015 Plan&#8221;), with&#160;<ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16393">12,910</ix:nonFraction> options available for grant, and through
December 31, 2021, the Company&#8217;s Board of Directors approved, in the aggregate, an increase of&#160;<ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" unitRef="shares" id="ixv-16394">10,000</ix:nonFraction> options available for
grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that, there
are <ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16395">22,910</ix:nonFraction> ordinary shares reserved under the 2015 Plan (including those that were exercised into ordinary shares).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On December 15, 2022, the Company&#8217;s
Board of Directors approved an increase of&#160;a total of <ix:nonFraction contextRef="c109" decimals="0" format="ixt:num-dot-decimal" name="wlds:OptionsAvailableForGrant" scale="0" unitRef="shares" id="ixv-16396">5,308</ix:nonFraction> ordinary shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are <ix:nonFraction contextRef="c110" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16397">28,218</ix:nonFraction> ordinary
shares underlying options granted (including options that were exercised into ordinary shares) or reserved for future issuance under the
2015 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 23, 2023, the Company&#8217;s
Board of Directors approved an increase of&#160;a total of <ix:nonFraction contextRef="c111" decimals="0" format="ixt:num-dot-decimal" name="wlds:OptionsAvailableForGrant" scale="0" unitRef="shares" id="ixv-16398">11,639</ix:nonFraction> ordinary shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are <ix:nonFraction contextRef="c112" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16399">39,857</ix:nonFraction> ordinary
shares underlying options granted (including options that were exercised into ordinary shares) or reserved for future issuance under the
2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 15, 2024, the
Company&#8217;s Board of Directors approved the Company&#8217;s 2024 Global Equity Incentive Plan (the &#8220;Incentive
Plan&#8221;), which provides for the issuance of up to <ix:nonFraction contextRef="c113" decimals="0" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" scale="0" unitRef="shares" id="ixv-16400">57,132</ix:nonFraction> ordinary shares. The Incentive Plan is subject to the approval of the
Israeli Tax Authorities. In addition, the Incentive Plan includes an annex that governs the grants of awards to employees and other
service providers who are citizens or resident aliens of the United States, subject to the approval of the Company&#8217;s
shareholders. The Plan was approved at the shareholders meeting held on September 26, 2024. On December 20, 2024, the
Company&#8217;s Board of Directors approved an increase in the number of ordinary shares reserved for the Incentive Plan to
<ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-16401">141,492</ix:nonFraction>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Incentive Plan provides for the
grant of options, shares, restricted shares or restricted share units (&#8220;RSUs&#8221;) to employees, non-employee directors, consultants,
advisors, or service providers of the Company, as well as employees, non-employee directors, consultants, advisors, or service providers
of any affiliate of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 15, 2024, the
Company&#8217;s Board of Directors approved the Company&#8217;s 2024 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which
provides for the issuance of up to <ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" scale="0" unitRef="shares" id="ixv-16402">62,500</ix:nonFraction> ordinary shares and includes an annex that governs the grants of awards to employees who
are residents of the State of Israel. The ESPP is subject to the approval of the Company&#8217;s shareholders. The ESPP was approved
at the shareholders meeting held on September 26, 2024. Generally, all the Company&#8217;s employees will be eligible to participate
in the ESPP if they are employed by the Company, or employees of any participating subsidiary, provided that they have been employed
by the Company or subsidiary for more than five months in a calendar year. The ESPP permits participants to purchase ordinary shares
through payroll deductions in an amount equal to a whole percentage of from <ix:nonFraction contextRef="c116" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" scale="-2" unitRef="pure" id="ixv-16403">one</ix:nonFraction> to <ix:nonFraction contextRef="c117" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" scale="-2" unitRef="pure" id="ixv-16404">15</ix:nonFraction>% of their ESPP eligible compensation (or such
other limited established by the administrator in accordance with the terms of our ESPP) in an offering. The purchase price of the
shares will be determined by the Compensation Committee of the Board of Directors in accordance with the terms of the ESPP, but the
option price shall not be less than the lesser of 85 percent of the fair market value of the shares on the offering date, or <ix:nonFraction contextRef="c115" decimals="2" format="ixt:num-dot-decimal" name="wlds:FairMarketValueSharesPercentage" scale="-2" unitRef="pure" id="ixv-16405">85</ix:nonFraction>
percent of the fair market value of the shares on the exercise date., there have been no issuances under the ESPP as of December 31,
2024</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of March 19, 2025, the Company
had <ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-16406">9,208</ix:nonFraction> ordinary shares reserved for future issuance under the 2015 Plan.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Options to employees </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ixv-15002"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Below is a summary of the Company&#8217;s
options activity and related information with respect to options granted to employees during the years ended December 31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center"><b>Year ended <br/> December 31,</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center"><b>Year ended <br/> December 31,</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount<br/> of <br/> options</b> &#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted<br/> average <br/> exercise <br/> price</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount<br/> of <br/> options</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted <br/> average <br/> exercise<br/> price</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding - beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-16407">18,184</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c137" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16408">62.16</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c138" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-16409">12,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c138" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16410">45.04</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">**<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" id="ix_28_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">4,187</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c139" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16412">21.76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*<ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" id="ix_27_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">5,894</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c140" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16414">97.92</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expired or forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-16415">62</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c139" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16416">105.60</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-16417">62</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c140" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16418">53.12</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding - end of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-16419">22,309</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c141" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16420">54.48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-16421">18,184</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c137" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16422">62.16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exercisable at end of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c141" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-16423">18,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c141" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16424">46.56</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-16425">11,114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c137" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16426">48.96</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The weighted-average grant date fair value of stock-based
awards granted&#160;was $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-16427">21.76</ix:nonFraction>, $<ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-16428">97.92</ix:nonFraction> and $<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-16429">14.72</ix:nonFraction> per share during the years ended December 31, 2024, December 31,&#160;2023 and December
31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The options will expire at the earlier
of (i) <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-16430">ten years</ix:nonNumeric> from the date of grant or (ii) <ix:nonNumeric contextRef="c0" format="ixt-sec:durday" name="wlds:NumberOfDaysForTermination" id="ixv-16431">90</ix:nonNumeric> days following the termination of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 15, 2024, the Company&#8217;s Board
of Directors approved the allocation and / or grant of additional options to purchase up to <ix:nonFraction contextRef="c119" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" unitRef="shares" id="ixv-16432">2,187</ix:nonFraction> ordinary shares
to certain directors, officers and employees, with an exercise price of $<ix:nonFraction contextRef="c119" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16433">34.40</ix:nonFraction> per share. The options will expire at the earlier of (i)
<ix:nonNumeric contextRef="c119" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-16434">ten years</ix:nonNumeric> from the date of grant or (ii) <ix:nonNumeric contextRef="c119" format="ixt-sec:durday" name="wlds:NumberOfDaysForTermination" id="ixv-16435">90</ix:nonNumeric> days following the termination of respective employment or services. The fair value of each
option as of the grant date was $<ix:nonFraction contextRef="c119" decimals="2" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" scale="0" unitRef="usdPershares" id="ixv-16436">15.60</ix:nonFraction>, determined using the Black-Scholes option pricing model and the total expenses of approximately
$<ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OptionsExpenses" scale="3" unitRef="usd" id="ixv-16437">34</ix:nonFraction> thousand will be expensed over the option vesting periods of <ix:nonNumeric contextRef="c119" format="ixt-sec:durwordsen" name="wlds:VestingPeriods" id="ixv-16438">three years</ix:nonNumeric>. The options allocated to the Company&#8217;s Chief Executive
Officer and Chief Scientific Officer were also approved in the shareholders meeting held on September 26, 2024.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY: (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On December 25, 2024, the Company&#8217;s
Board of Directors approved the grant of additional options to purchase up to <ix:nonFraction contextRef="c120" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-16439">2,000</ix:nonFraction> ordinary shares to certain
employees, with an exercise price of $<ix:nonFraction contextRef="c121" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16440">7.63</ix:nonFraction> per share. The options will expire at the earlier of (i) <ix:nonNumeric contextRef="c121" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-16441">ten years</ix:nonNumeric> from the date of grant
or (ii) <ix:nonNumeric contextRef="c121" format="ixt-sec:durday" name="wlds:NumberOfDaysForTermination" id="ixv-16442">90</ix:nonNumeric> days following the termination of respective employment or services. The fair value of each option as of the grant date was
$<ix:nonFraction contextRef="c121" decimals="2" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" scale="0" unitRef="usdPershares" id="ixv-16443">4.32</ix:nonFraction>, determined using the Black-Scholes option pricing model and the total expenses of approximately $<ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OptionsExpenses" scale="3" unitRef="usd" id="ixv-16444">9</ix:nonFraction> thousand will be expensed over
the option vesting periods of <ix:nonNumeric contextRef="c121" format="ixt-sec:durwordsen" name="wlds:VestingPeriods" id="ixv-16445">three years</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ixv-15254"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following weighted-average assumptions
were used in determining the most recent fair values of stock options using the Black-Scholes valuation model:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected dividend yield</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-16446">0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected stock price volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" unitRef="pure" id="ixv-16447">55.0</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Risk free interest rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-16448">4.10</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected life of options</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" id="ixv-16449">6.25</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US">Including the grant of <ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-16451">1,500</ix:nonFraction> options to purchase up to <ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-16452">1,500</ix:nonFraction>
ordinary shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $<ix:nonFraction contextRef="c124" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16453">105.60</ix:nonFraction>
per share. The options will expire at the earlier of (i) <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-16454">ten years</ix:nonNumeric> from the date of grant or (ii) <ix:nonNumeric contextRef="c0" format="ixt-sec:durday" name="wlds:NumberOfDaysForTermination" id="ixv-16455">90</ix:nonNumeric> days following a termination of
employment or service. The fair value of each option as of the grant date was $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" scale="0" unitRef="usdPershares" id="ixv-16456">9.60</ix:nonFraction>, determined using the Black-Scholes option pricing
model and the total expenses of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OptionsExpenses" scale="3" unitRef="usd" id="ixv-16457">15</ix:nonFraction> thousand will be expensed over the option vesting periods of <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="wlds:VestingPeriods" id="ixv-16458">three years</ix:nonNumeric>.</ix:footnote></td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US">Including the grant of <ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-16460">1,250</ix:nonFraction> options to purchase up to <ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-16461">1,250</ix:nonFraction>
ordinary shares to the Company&#8217;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#8217;s shareholders
on September 26, 2024, with an exercise price of $<ix:nonFraction contextRef="c126" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16462">34.40</ix:nonFraction> per share. The options will expire at the earlier of (i) <ix:nonNumeric contextRef="c127" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-16463">ten years</ix:nonNumeric> from the date
of grant or (ii) <ix:nonNumeric contextRef="c127" format="ixt-sec:durday" name="wlds:NumberOfDaysForTermination" id="ixv-16464">90</ix:nonNumeric> days following a termination of employment or service. The fair value of each option as of the grant date was $<ix:nonFraction contextRef="c127" decimals="2" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" scale="0" unitRef="usdPershares" id="ixv-16465">15.60</ix:nonFraction>,
determined using the Black-Scholes option pricing model and the total expenses of $<ix:nonFraction contextRef="c127" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OptionsExpenses" scale="3" unitRef="usd" id="ixv-16466">19</ix:nonFraction> thousand will be expensed over the option vesting
periods of <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="wlds:VestingPeriods" id="ixv-16467">three years</ix:nonNumeric>.</ix:footnote></td>
</tr></table></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>



</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY (DEFICIT): (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Options to consultants </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="wlds:ScheduleOfOptionsToConsultantsTableTextBlock" id="ixv-15337"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s outstanding options
to consultants as of December 31, 2024 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Issuance date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In connection with</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No. of<br/> options<br/> issued</td> <td>&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No. of<br/> options<br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">2015</td><td style="width: 1%">&#160;</td> <td style="width: 22%; text-align: center"><ix:nonNumeric contextRef="c142" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" id="ixv-16468">Rendered services</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c142" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" unitRef="shares" id="ixv-16469">1,383</ix:nonFraction></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 1%">&#160;</td> <td style="white-space: nowrap; width: 9%; text-align: right"><ix:nonFraction contextRef="c143" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16470">0.24</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c143" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares" id="ixv-16471">1,383</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2017</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c144" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" id="ixv-16472">Rendered services</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c144" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" unitRef="shares" id="ixv-16473">461</ix:nonFraction></td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right"><ix:nonFraction contextRef="c145" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16474">0.24</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares" id="ixv-16475">461</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2021</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c146" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" id="ixv-16476">Rendered services</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c146" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" unitRef="shares" id="ixv-16477">863</ix:nonFraction></td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c147" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16478">0.24</ix:nonFraction>-</span>$<ix:nonFraction contextRef="c148" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-16479">180.00</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c149" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares" id="ixv-16480">863</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2023*</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c150" id="ix_29_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms">Rendered services</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c150" decimals="INF" format="ixt:num-dot-decimal" id="ix_30_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" unitRef="shares">1,250</ix:nonFraction></td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right"><ix:nonFraction contextRef="c151" decimals="2" format="ixt:num-dot-decimal" id="ix_31_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">43.68</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" id="ix_32_fact" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares">555</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US">On April 27, 2023, the Company&#8217;s Board of Directors approved
the additional grant of options to purchase up to <ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="wlds:IssuanceOfSharesOptions" scale="0" unitRef="shares" id="ixv-16486">1,250</ix:nonFraction> ordinary shares to a consultant, with an exercise price of $<ix:nonFraction contextRef="c129" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16487">43.68</ix:nonFraction> per share.
The options will expire at the earlier of (i) <ix:nonNumeric contextRef="c129" format="ixt-sec:durwordsen" name="wlds:TerminationPeriod" id="ixv-16488">ten years</ix:nonNumeric> from the date of grant or (ii) <ix:nonNumeric contextRef="c129" format="ixt-sec:durday" name="wlds:NumberOfDaysForTermination" id="ixv-16489">90</ix:nonNumeric> days following a termination of services. The
fair value of each option as of the grant date was $<ix:nonFraction contextRef="c129" decimals="2" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" scale="0" unitRef="usdPershares" id="ixv-16490">20.80</ix:nonFraction>, determined using the Black-Scholes option pricing model and the total expenses
of $<ix:nonFraction contextRef="c129" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OptionsExpenses" scale="3" unitRef="usd" id="ixv-16491">26</ix:nonFraction> thousand will be expensed over the option vesting periods of <ix:nonNumeric contextRef="c129" format="ixt-sec:durwordsen" name="wlds:VestingPeriods" id="ixv-16492">three years</ix:nonNumeric>.</ix:footnote></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> <b>RSUs to employees and consultants: </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">I<span>n
August 2024, the Company&#8217;s Board of Directors approved the Company&#8217;s
Incentive Plan, which provides for the issuance of up to <ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" scale="0" unitRef="shares" id="ixv-16493">57,132</ix:nonFraction> ordinary shares of the Company. On December 20, 2024, the Board
approved the increase of number of ordinary shares reserved under the Incentive Plan to <ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-16494">141,492</ix:nonFraction>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The
Incentive Plan provides for the grant of options, shares, restricted shares or  RSUs to employees,
non-employee directors, consultants, advisors, or service providers of the Company, as well as employees, non-employee directors, consultants,
advisors, or service providers of any affiliate of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On December 25, 2024, the Board </span>of Directors approved the
grant of <span><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" unitRef="shares" id="ixv-16495">131,375</ix:nonFraction> RSUs </span>to employees and consultants, which will be automatically exercised
into ordinary shares over a vesting period of between <ix:nonNumeric contextRef="c132" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ixv-16496">12</ix:nonNumeric> months to <ix:nonNumeric contextRef="c133" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ixv-16497">24</ix:nonNumeric> months, with the vesting starting on January 1, 2025. The unvested
RSUs will expire the termination of employment or service. The fair value of each RSU as of the grant date was $<ix:nonFraction contextRef="c131" decimals="2" format="ixt:num-dot-decimal" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" scale="0" unitRef="usdPershares" id="ixv-16498">7.12</ix:nonFraction>, determined using
the <ix:nonNumeric contextRef="c131" format="ixt-sec:durday" name="wlds:TerminationPeriod" id="ixv-16499">30</ix:nonNumeric> days&#8217; market price prior to the grant date, and the total expenses of $<ix:nonFraction contextRef="c131" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OptionsExpenses" scale="3" unitRef="usd" id="ixv-16500">934</ix:nonFraction> thousand will be expensed over the option vesting
periods.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="ixv-15453"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The share-based compensation expenses
are recognized in the following line items in the consolidated statements of comprehensive loss in the years ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c152" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16501">80</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16502">83</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c154" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16503">180</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sales and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c155" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16504">49</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c156" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16505">61</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c157" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16506">401</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">General and administrative expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c158" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16507">53</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c159" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16508">97</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c160" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16509">209</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16510">182</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16511">241</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-16512">790</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY (DEFICIT): (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="wlds:ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" id="ixv-15562"><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Equity Warrants to investors and associated with the
IPO and follow on fund raising, as of December 31, 2024:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number&#160;of warrants/ options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issuance date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise ratio</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Expiration date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Notes</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c161" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16513">98,261</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 14.5%; text-align: center">September 13, 2022</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c162" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares" id="ixv-16514">160.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 19.5%; text-align: left"><ix:nonNumeric contextRef="c162" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-16515">Each warrant is exercisable into 1 ordinary share</ix:nonNumeric></td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 19.5%; text-align: left"><ix:nonNumeric contextRef="c162" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-16516">5 years following the issuance date</ix:nonNumeric></td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 19.5%; text-align: left"><ix:nonNumeric contextRef="c162" id="ix_33_fact" name="wlds:ShareBasedCompensationArrangementNotes">Registered for trading (*)</ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td>&#160;</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td> <td style="text-align: center; vertical-align: top">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c163" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16518">2,344</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">September 15, 2022</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c164" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares" id="ixv-16519">424.80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c164" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-16520">Each warrant is exercisable into 1 ordinary share</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c164" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-16521">5 years following the issuance date</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c164" name="wlds:ShareBasedCompensationArrangementNotes" id="ixv-16522">Owned by underwriter</ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c165" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16523">295</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">September 15, 2022</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c166" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares" id="ixv-16524">338.40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c166" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-16525">Each warrant is exercisable into 1 ordinary share</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c166" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-16526">10 years following the issuance date</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c166" name="wlds:ShareBasedCompensationArrangementNotes" id="ixv-16527">Owned by the legal advisor</ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c167" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16528">205,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">November 27, 2024</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c168" decimals="2" format="ixt:num-dot-decimal" id="ix_34_fact" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares">10.00</ix:nonFraction></td><td style="text-align: left">(**)</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c168" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-16530">Each warrant is exercisable into 1 ordinary share</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c168" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-16531">5 years following the issuance date</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c168" name="wlds:ShareBasedCompensationArrangementNotes" id="ixv-16532">Owned by an investor</ix:nonNumeric></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c169" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-16533">78,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">November 27, 2024</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c170" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" unitRef="usdPershares" id="ixv-16534">0.0004</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c170" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" id="ixv-16535">Each pre funded warrant is exercisable into 1 ordinary share</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c170" name="wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" id="ixv-16536">Until exercised in full</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c170" name="wlds:ShareBasedCompensationArrangementNotes" id="ixv-16537">Owned by an investor</ix:nonNumeric></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">The warrants are exercisable at any time after their original
issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants will be exercisable, at the
option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement
registering the issuance of the ordinary shares underlying the warrants under the Securities Act of 1933, as amended, is effective and
available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary shares purchased
upon such exercise.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The exercise price per whole ordinary
share purchasable upon exercise of the warrants $<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePriceOfWarrants" scale="0" unitRef="usdPershares" id="ixv-16538">320.00</ix:nonFraction> per share (the &#8220;Initial Exercise Price&#8221;). The exercise price is subject
to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting ordinary shares and also upon any distributions of assets, including cash, stock or other property to the
Company&#8217;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until <ix:nonNumeric contextRef="c4" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="ixv-16539">two years</ix:nonNumeric> from the date of issuance
of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or
sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any ordinary shares or convertible security,
at an effective price per share less than the exercise price of the warrant then in effect, the exercise price of the warrant shall be
reduced to equal the effective price per share in such Dilutive Issuance;&#160;provided, however, that in no event shall the exercise
price of the warrant be reduced to an exercise price lower than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:WarrantBeReducedToAnExercisePricePercentage" scale="-2" unitRef="pure" id="ixv-16540">50</ix:nonFraction>% of the Initial Exercise Price. On the date that is 90 calendar days
immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the &#8220;Reset Price&#8221;),
provided that such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:InitialExercisePricePercentage" scale="-2" unitRef="pure" id="ixv-16541">50</ix:nonFraction>% of
the Initial Exercise Price of the warrants on the issuance date or (b) <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:WeightedAveragePricePercentage" scale="-2" unitRef="pure" id="ixv-16542">100</ix:nonFraction>% of the lowest volume weighted average price per ordinary share
occurring on any day between the initial exercise date of the warrants and 90 calendar days following the issuance date of the warrants.
The lowest Reset Price is $<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="wlds:LowestResetPrice" scale="0" unitRef="usdPershares" id="ixv-16543">160.00</ix:nonFraction>, which is <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wlds:InitialExercisePricesPercentage" scale="-2" unitRef="pure" id="ixv-16544">50</ix:nonFraction>% of the Initial Exercise Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(**)</td><td style="text-align: justify"><ix:footnote id="ix_7_footnote" xml:lang="en-US">On January 30, 2025, the exercise price of the warrants pursuant
to a November 2024 private placement was adjusted to $<ix:nonFraction contextRef="c134" decimals="2" format="ixt:num-dot-decimal" name="wlds:ExercisePricePerShare" scale="0" unitRef="usdPershares" id="ixv-16546">4.00</ix:nonFraction> per share following the closing of an additional offering.</ix:footnote></td>
</tr></table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WEARABLE DEVICES LTD. AND ITS SUBSIDIARY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</p><div>









</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY (DEFICIT):
(Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt">&#160;</p><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
per share</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-15729"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt">Loss per share has been calculated using the weighted average
number of ordinary shares and pre-funded warrants in issue during the relevant financial periods, the weighted average number of equity
shares in issue and profit for the period as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2024</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16547">7,879</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16548">7,814</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-16549">6,496</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Total number of ordinary shares and pre-funded warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesAndPrefundedWarrants" scale="0" unitRef="shares" id="ixv-16550">785,464</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesAndPrefundedWarrants" scale="0" unitRef="shares" id="ixv-16551">254,843</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="wlds:OrdinarySharesAndPrefundedWarrants" scale="0" unitRef="shares" id="ixv-16552">188,121</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Weighted average number of ordinary shares and pre-funded warrants</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-16553">325,690</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-16554">202,515</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-16555">153,465</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-78"><div style="-sec-ix-hidden: hidden-fact-80">Basic and diluted loss per share</div></div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-16556">24.2</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c6" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-16557">38.4</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-16558">42.4</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-15823"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 11 - TAXES ON INCOME:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is taxed under the Israeli law.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income of an Israeli company is subject to corporate tax. The corporate tax rate in Israel is&#160;<ix:nonFraction contextRef="c171" decimals="2" format="ixt:num-dot-decimal" name="wlds:CorporateTaxRatePercentage" scale="-2" unitRef="pure" id="ixv-16559">23</ix:nonFraction>%.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax assessments - In accordance with the Israeli Income Tax Ordinance, tax assessments of the Company through tax year 2019 are considered final.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carryforward tax losses of the Company as of December 31, 2024, amounted to approximately $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" unitRef="usd" id="ixv-16560">21.1</ix:nonFraction> million; however, a full valuation allowance of $<ix:nonFraction contextRef="c4" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" unitRef="usd" id="ixv-16561">4.85</ix:nonFraction> million was recorded against the potential future tax benefits.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Subsidiary is taxed under the U.S. tax law. The federal tax rate is <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-16562">21</ix:nonFraction>%.</span></td></tr> </table></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-15869"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 - RELATED PARTIES</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The employment expenses of the co-founders:
Asher Dahan (the Chairman of the Board of Directors and the Chief Executive Officer), Guy Wanger (President and Director) and Leeor Langer
(the Chief Technology Officer), for the years ended December 31, 2024, 2023 and 2022 amounted to approximately $<ix:nonFraction contextRef="c172" decimals="-3" format="ixt:num-dot-decimal" name="wlds:EmploymentExpenses" scale="3" unitRef="usd" id="ixv-16563">287</ix:nonFraction> thousand, $<ix:nonFraction contextRef="c173" decimals="-3" format="ixt:num-dot-decimal" name="wlds:EmploymentExpenses" scale="3" unitRef="usd" id="ixv-16564">293</ix:nonFraction> thousand,
and $<ix:nonFraction contextRef="c174" decimals="-3" format="ixt:num-dot-decimal" name="wlds:EmploymentExpenses" scale="3" unitRef="usd" id="ixv-16565">331</ix:nonFraction> thousand, respectively. On March 14, 2022, the Company&#8217;s shareholders meeting approved the increase of the monthly salary
of each of the Company&#8217;s co-founders to NIS&#160;<ix:nonFraction contextRef="c175" decimals="-3" format="ixt:num-dot-decimal" name="wlds:OfficerEmployeeMonthlySalary" scale="3" unitRef="ils" id="ixv-16566">70</ix:nonFraction>&#160;thousand (approximately $<ix:nonFraction contextRef="c175" decimals="-3" format="ixt:num-dot-decimal" name="wlds:RelatedPartyMonthlySalary" scale="3" unitRef="usd" id="ixv-16567">19</ix:nonFraction>&#160;thousand), plus social benefits and leased
car, and approved a one-time bonus equal to 6 monthly salaries, upon the closing of the IPO which was accomplished in September 2022.
In November 2024, the Company&#8217;s founders agreed to temporarily reduce their salaries.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-15877"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 13 - SUBSEQUENT EVENTS</b>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">a.</td><td style="text-align: justify">On January 30, 2025, the Company announced the closing of
&#8220;best efforts&#8221; public offering with a single institutional investor for the purchase and sale of <ix:nonFraction contextRef="c176" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-16568">86,250</ix:nonFraction> ordinary shares, <ix:nonFraction contextRef="c177" decimals="0" format="ixt:num-dot-decimal" name="wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" scale="0" unitRef="shares" id="ixv-16569">538,750</ix:nonFraction>
pre-funded warrants to purchase up to <ix:nonFraction contextRef="c178" decimals="0" format="ixt:num-dot-decimal" name="wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" scale="0" unitRef="shares" id="ixv-16570">538,750</ix:nonFraction> ordinary shares, and warrants to purchase up to <ix:nonFraction contextRef="c179" decimals="0" format="ixt:num-dot-decimal" name="wlds:SaleOfStockNumberOfShareIssuedInTransaction" scale="0" unitRef="shares" id="ixv-16571">625,000</ix:nonFraction> ordinary shares, at a combined
offering price of $<ix:nonFraction contextRef="c180" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-16572">4.00</ix:nonFraction> per share and accompanying warrant (the &#8220;Offering&#8221;). The Company received aggregate gross proceeds
of approximately $<ix:nonFraction contextRef="c134" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="6" unitRef="usd" id="ixv-16573">2.5</ix:nonFraction> million, before deducting placement agent fees and other offering expenses and assuming no exercise of the warrants.
The warrants have an exercise price of $<ix:nonFraction contextRef="c180" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-16574">4.00</ix:nonFraction> per share, are exercisable immediately and expire <ix:nonNumeric contextRef="c180" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="ixv-16575">five years</ix:nonNumeric> from the issuance date.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">b.</td><td style="text-align: justify">In connection with the Offering detailed in Note 12.a. the
Company also agreed to amend existing warrants that were previously issued on November 27, 2024 (see also Note 1.g.) to the investor
participating in the Offering to purchase up to <ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" scale="0" unitRef="shares" id="ixv-16576">205,500</ix:nonFraction> ordinary shares of the Company, with an exercise price of $<ix:nonFraction contextRef="c181" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-16577">10.00</ix:nonFraction> per share. Such
existing warrants have been amended to reduce the exercise price to $<ix:nonFraction contextRef="c100" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceDecrease" scale="0" unitRef="usdPershares" id="ixv-16578">4.00</ix:nonFraction> per share and now expire <ix:nonNumeric contextRef="c181" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="ixv-16579">five years</ix:nonNumeric> following the closing of
the Offering.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">c.</td><td style="text-align: justify"><ix:nonNumeric contextRef="c182" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-16580">On February 26, 2025, the Company&#8217;s shareholders meeting approved a reverse share split of the Company&#8217;s issued and outstanding ordinary shares at a ratio of up to 6:1</ix:nonNumeric>, to be effected, if effected, at the discretion of and on such date to be determined by the Board of Directors. On March 17, 2025, the Company effectuated the March <ix:nonNumeric contextRef="c183" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-16581">Reverse</ix:nonNumeric> Split. </td>
</tr></table></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-28</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c4" id="hidden-fact-0" name="us-gaap:DepositsAssetsNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-1" name="us-gaap:ConvertibleNotesPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-2" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-3" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-4" name="us-gaap:CommonStockNoParValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-5" name="us-gaap:CommonStockNoParValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-6" name="wlds:ProspectiveInitialPublicOfferingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-7" name="wlds:ProspectiveInitialPublicOfferingExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-8" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-9" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-10" name="wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-11" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-12" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-13" name="wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-14" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-15" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-16" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-17" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-18" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-19" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-20" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-21" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-22" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-23" name="wlds:StockIssuedDuringPeriodValueInvestors" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-24" name="wlds:StockIssuedDuringPeriodValueExerciseOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-25" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-26" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-27" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-28" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-29" name="wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-30" name="wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-31" name="wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-32" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-33" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-34" name="wlds:AccruedInterestOnConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-35" name="wlds:AccruedInterestOnConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-36" name="wlds:AccruedInterestOnDeposits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-37" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-38" name="wlds:MarketingExpensesPaidInOrdinaryShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-39" name="wlds:MarketingExpensesPaidInOrdinaryShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-40" name="us-gaap:InventoryWriteDown" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-41" name="us-gaap:InventoryWriteDown" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-42" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-43" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-44" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-45" name="wlds:DecreaseIncreaseInDepositsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-46" name="wlds:PrepaymentsOfLeasing" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-47" name="wlds:PrepaymentsOfLeasing" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-48" name="wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-49" name="wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-50" name="wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-51" name="wlds:ProceedsFromIssuanceOfSAFEs" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-52" name="wlds:ProceedsFromIssuanceOfSAFEs" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-53" name="wlds:RefundToSAFEInvestors" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-54" name="wlds:RefundToSAFEInvestors" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-55" name="us-gaap:ProceedsFromLinesOfCredit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-56" name="us-gaap:ProceedsFromLinesOfCredit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-57" name="us-gaap:RepaymentsOfLinesOfCredit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-58" name="us-gaap:RepaymentsOfLinesOfCredit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-59" name="wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-60" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-61" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-62" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-63" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-64" name="us-gaap:RepaymentsOfConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-65" name="us-gaap:RepaymentsOfConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-66" name="us-gaap:InterestPaidNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-67" name="wlds:InterestReceived" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-68" name="wlds:ConversionOfSAFEToEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-69" name="wlds:ConversionOfSAFEToEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-70" name="wlds:RightofUseAssetRecognizedAgainstLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-71" name="wlds:InventoryWriteoff" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" id="hidden-fact-72" name="wlds:CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice">P3Y</ix:nonNumeric>
<ix:nonFraction contextRef="c69" id="hidden-fact-73" name="wlds:ResearchAndDevelopmentGrantsDetection" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-74" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-75" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-76" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-77" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:footnote id="ix_6_footnote" xml:lang="en-US">The warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance. The warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement registering the issuance of the ordinary shares underlying the warrants under the Securities Act of 1933, as amended, is effective and available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary shares purchased upon such exercise. The exercise price per whole ordinary share purchasable upon exercise of the warrants $320.00 per share (the &#8220;Initial Exercise Price&#8221;). The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting ordinary shares and also upon any distributions of assets, including cash, stock or other property to the Company&#8217;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until two years from the date of issuance of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any ordinary shares or convertible security, at an effective price per share less than the exercise price of the warrant then in effect, the exercise price of the warrant shall be reduced to equal the effective price per share in such Dilutive Issuance; provided, however, that in no event shall the exercise price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the &#8220;Reset Price&#8221;), provided that such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted average price per ordinary share occurring on any day between the initial exercise date of the warrants and 90 calendar days following the issuance date of the warrants. The lowest Reset Price is $160.00, which is 50% of the Initial Exercise Price.</ix:footnote><!--Text not found in footnote sections assigned to Schedule of Issuance of Equity Warrants to Investors and Associate-->
<ix:nonFraction contextRef="c0" decimals="1" id="hidden-fact-78" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">24.2</ix:nonFraction>
<ix:nonFraction contextRef="c6" decimals="1" id="hidden-fact-79" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">38.4</ix:nonFraction>
<ix:nonFraction contextRef="c7" decimals="1" id="hidden-fact-80" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">42.4</ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-16666">0001887673</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-16667">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-16668">FY</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="wlds-20241231.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><ix:relationship xmlns="" fromRefs="ix_0_fact ix_1_fact ix_2_fact ix_3_fact ix_4_fact ix_5_fact ix_6_fact ix_7_fact ix_8_fact ix_9_fact ix_10_fact ix_11_fact" toRefs="ix_0_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-12 hidden-fact-14" toRefs="ix_1_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_12_fact ix_13_fact ix_14_fact ix_15_fact ix_16_fact ix_17_fact ix_18_fact ix_19_fact ix_20_fact ix_21_fact ix_22_fact ix_23_fact ix_24_fact ix_25_fact ix_26_fact" toRefs="ix_2_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_27_fact" toRefs="ix_3_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_28_fact" toRefs="ix_4_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_29_fact ix_30_fact ix_31_fact ix_32_fact" toRefs="ix_5_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_33_fact" toRefs="ix_6_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_34_fact" toRefs="ix_7_footnote"/>
<xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wlds:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wlds:WarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-10-01</xbrli:startDate>
    <xbrli:endDate>2024-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-17</xbrli:startDate>
    <xbrli:endDate>2025-03-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-01</xbrli:startDate>
    <xbrli:endDate>2023-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-01</xbrli:startDate>
    <xbrli:endDate>2024-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-10-24</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-10-10</xbrli:startDate>
    <xbrli:endDate>2024-10-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:LeaseLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MoldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MoldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MachinesAndMoldsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MachinesAndMoldsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-06</xbrli:startDate>
    <xbrli:endDate>2024-06-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-07-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-04-01</xbrli:startDate>
    <xbrli:endDate>2021-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-01</xbrli:startDate>
    <xbrli:endDate>2023-02-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-07-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-07-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-30</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-30</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxPQtRsMwMGseXt1qIodzzmaL/glMbImLWgeHF6ERfU0NGZNGGhBtuxC9Hos2B2CZStFQyEAt1gsw5LAjYSeWBYHmpgvOpAIsHYidrOMxKx7alFavI1Y4b+UJB9h3C7DUXDO4VAaMvWLWPuyXtsxVuJHCDwAtg2TqvU7JA2BQlnv+ax0DM42fP78=] CSR-->
  <xbrli:period>
    <xbrli:startDate>2022-09-30</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-16</xbrli:startDate>
    <xbrli:endDate>2022-09-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-13</xbrli:startDate>
    <xbrli:endDate>2023-11-13</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">wlds:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-27</xbrli:startDate>
    <xbrli:endDate>2024-11-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wlds:PreFundedWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-27</xbrli:startDate>
    <xbrli:endDate>2024-11-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2015-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-08-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-08-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoThousandTwentyFourGlobalEquityIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-08-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoThousandTwentyFousEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-08-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoThousandTwentyFousEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-08-15</xbrli:startDate>
    <xbrli:endDate>2024-08-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoThousandTwentyFousEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-08-15</xbrli:startDate>
    <xbrli:endDate>2024-08-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-08-15</xbrli:startDate>
    <xbrli:endDate>2024-08-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-25</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-25</xbrli:startDate>
    <xbrli:endDate>2024-12-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-30</xbrli:startDate>
    <xbrli:endDate>2023-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-09-26</xbrli:startDate>
    <xbrli:endDate>2024-09-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-04-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-01</xbrli:startDate>
    <xbrli:endDate>2023-04-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-25</xbrli:startDate>
    <xbrli:endDate>2024-12-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-25</xbrli:startDate>
    <xbrli:endDate>2024-12-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-25</xbrli:startDate>
    <xbrli:endDate>2024-12-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-30</xbrli:startDate>
    <xbrli:endDate>2025-01-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandFifteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2015-12-31</xbrli:startDate>
    <xbrli:endDate>2015-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandFifteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2015-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandSeventeenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2017-12-31</xbrli:startDate>
    <xbrli:endDate>2017-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandSeventeenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2017-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-31</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-31</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September132022Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September132022Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022OneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022OneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022TwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022TwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:NovemberTwoSevenTwoZeroTwoFourMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:NovemberTwoSevenTwoZeroTwoFourMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:NovemberTwoSevenTwoZeroTwoFourOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:NovemberTwoSevenTwoZeroTwoFourOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-03-01</xbrli:startDate>
    <xbrli:endDate>2022-03-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-30</xbrli:startDate>
    <xbrli:endDate>2025-01-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wlds:PreFundedWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wlds:PreFundedWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-30</xbrli:startDate>
    <xbrli:endDate>2025-01-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-06</xbrli:startDate>
    <xbrli:endDate>2025-02-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001887673</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-17</xbrli:startDate>
    <xbrli:endDate>2025-03-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="ilsPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="ils">
  <xbrli:measure>iso4217:ILS</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="Vehicles">
  <xbrli:measure>wlds:Vehicles</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.7
<SEQUENCE>2
<FILENAME>ea023465401ex2-7_wearable.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 2.7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF SHARE CAPITAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following description of the share capital
of Wearable Devices Ltd., or the Company, and the provisions of our amended and restated articles of association&nbsp;<FONT STYLE="background-color: white">and
Israeli law</FONT>&nbsp;are summaries, do not purport to be complete and is qualified in its entirety by reference to our articles of
association, Israeli law and any other documents referenced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Type and class of securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Ordinary Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 19, 2025, our authorized share capital
consists of 50,000,000 Ordinary Shares, no par value each, or the Ordinary Shares, of which 1,028,980 Ordinary Shares were issued and
outstanding as of such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All of our outstanding Ordinary Shares have been
validly issued, fully paid and non-assessable. Our Ordinary Shares are not redeemable and are not subject to any preemptive right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Ordinary Shares and warrants, or the Warrants,
were issued as part of our initial public offering and have been listed on the Nasdaq Capital Market under the symbol &ldquo;WLDS&rdquo;
and &ldquo;WLDSW,&rdquo; respectively, since September 13, 2022.&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Warrants and Options</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 19, 2025, we
have issued and outstanding Warrants to purchase an aggregate of 98,261 Ordinary Shares, with exercise price of $320.00 per Ordinary
Share. The Warrants are exercisable until September 12, 2027.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 19, 2025, we have issued: (i) options
to purchase an aggregate of 25,990 Ordinary Shares to certain employees, directors and consultants, under our 2015 Share Option Plan,
at a weighted average exercise price of $54.50 per Ordinary Share. An additional 9,208 Ordinary Shares are reserved for future issuance
under our 2015 Share Option Plan and 62,500 Ordinary Shares are reserved for future issuance under our 2024 Employee Stock Purchase Plan;
and (ii) RSUs convertible to 112,861 Ordinary Share to directors, employees and consultants under our 2024 Global Equity Incentive Plan.
An additional 10,117 Ordinary Shares are reserved for future issuance under the 2024 Global Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of March 19, 2025, in addition to the Warrants,
we have issued and outstanding: (i) warrants issued to the underwriter in our initial public offering to purchase up to 2,344 Ordinary
Shares at an exercise price of $424.80 per Ordinary Share, which became exercisable beginning on March 12, 2023 and will expire September
12, 2027; (ii) warrants to purchase up to 205,500 Ordinary Shares, exercisable for five years from January 2025 at an exercise price of
$4.00 per Ordinary Share; (iii) pre-funded warrants to purchase up to 400,000 Ordinary Shares, exercisable at any time at an exercise
price of $0.0004 per Ordinary Share; and (iv) warrants to purchase up to 625,000 Ordinary Shares, exercisable for five years from January
2025 at an exercise price of $4.00 per Ordinary Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Articles of Association</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our board of directors shall direct our policy
and shall supervise the performance of our Chief Executive Officer and his actions. Our board of directors may exercise all powers that
are not required under the Israeli Companies Law 5759-1999, or the Companies Law, or under our amended and restated articles of association
to be exercised or taken by our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Rights Attached to Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Ordinary Shares shall confer upon the holders
thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal right to attend and to vote at all of our general meetings, whether regular or special, with each Ordinary Share entitling the holder thereof, which attend the meeting and participate at the voting, either in person or by a proxy or by a written ballot, to one vote;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal right to participate in distribution of dividends, if any, whether payable in cash or in bonus shares, in distribution of assets or in any other distribution, on a per share pro rata basis; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal right to participate, upon our dissolution, in the distribution of our assets legally available for distribution, on a per share pro rata basis.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Election of Directors</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our amended and restated articles of association
provide for a staggered board of directors consisting of three classes of directors. Our directors are generally elected and/or re-elected
by the general meeting and, other than under certain exceptions, serve in office until the third annual general meeting after the general
meeting in which such director was appointed, in which such later annual general meeting the directors will be brought for re-election
or replacement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In each annual general meeting, the election or
re-election of directors following the expiration of the term of office of the directors of that class of directors will be for a term
of office that expires on the third annual general meeting following such election or re-election, such that each year the term of office
of only one class of directors will expire, and all other directors whose service term lapsed shall be deemed to have been re-elected
for a term until the next annual general meeting. The director deemed to be re-elected is generally the director that served the longest
period since its appointment or last re-election. If more than one director served the longest time, the board of directors will decide
which of such directors will be brought for re-election at the relevant general meeting.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Annual and Special Meetings</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Israeli law, we are required to hold
an annual general meeting of our shareholders once every calendar year, at such time and place which shall be determined by our board
of directors, that must be no later than 15 months after the date of the previous annual general meeting. All meetings other than the
annual general meeting of shareholders are referred to as special general meetings. Our board of directors may call special meetings whenever
it sees fit and upon the request of: (a) any two of our directors or such number of directors equal to one quarter of the directors then
at office; and/or (b) one or more shareholders holding, in the aggregate, (i) 5% or more of our outstanding issued shares and 1% of our
outstanding voting power or (ii) 5% or more of our outstanding voting power, or the Non Exempted Holding.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">However, under exemptions applicable to Israeli
companies whose securities are listed for trade on stock exchanges outside of Israel, or the Exemptions Regulations, the board of directors
of an Israeli company shall convene a special meeting at the request of one or more shareholders holding at least 10% of the issued and
outstanding share capital, and at least 1% of the voting rights in the company, or one or more shareholders holding at least 10% of the
voting rights in the company, provided that if the applicable law to companies incorporated in the country which the company is listed
for trade, establishes a right to demand convening of such a meeting for those holding a percentage of holdings lower than 10%, then the
Non Exempted Holding shall apply.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under Israeli law, one or more shareholders holding
at least 1% of the voting rights at the general meeting of shareholders may request that the board of directors include a matter on the
agenda of the general meeting of shareholders to be convened in the future, provided that it is appropriate to discuss such matter at
the general meeting of shareholders. However, under the Exemptions Regulations, one or more shareholders of an Israeli company whose shares
are listed outside of Israel, may request the company&rsquo;s board of directors to include a nomination of a candidate for a position
on the board of directors or the termination of a director, as an item on the agenda of a future general meeting, provided that the shareholder
holds at least 5% of the voting rights of the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the provisions of the Companies Law
and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of
record on a date to be decided by the board of directors, which may be between four and sixty days prior to the date of the meeting. Resolutions
regarding the following matters must be passed at a general meeting of our shareholders:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 48px">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendments to our amended and restated articles of association; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise of our board of directors&rsquo; powers by a general meeting if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment or termination of our auditors;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment of directors, including external directors (other than with respect to circumstances specified in our amended and restated articles of association); </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval of acts and transactions requiring general meeting approval pursuant to the provisions of the Companies Law (mainly certain related party transactions) and any other applicable law; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases or reductions of our authorized share capital; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a merger (as such term is defined in the Companies Law); and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dissolution of the Company by the court and voluntary dissolution of the Company in a regular or an expedited procedure.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Notices</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under our amended and restated articles of association,
we are not required to give notice to our registered shareholders pursuant to the Companies Law, unless otherwise required by law. The
provisions of the Companies Law and the regulations promulgated thereunder require that a notice of any annual or special shareholders
meeting be provided at least 14 or 21 (as applicable) days prior to the meeting, and if the agenda of the meeting includes the appointment
or removal of directors, the approval of transactions with office holders or interested or related parties, approval of the company&rsquo;s
general manager to serve as the chairman of the board of directors or an approval of a merger, notice must be provided at least 35 days
prior to the meeting&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;<B><I>Quorum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As permitted under the Companies Law, the quorum
required for our general meetings consists of at least two shareholders present in person, by proxy, written ballot or voting by means
of electronic voting system, who hold or represent between them at least 25% of the total outstanding voting rights. If within half an
hour of the time set forth for the general meeting a quorum is not present, the general meeting shall stand adjourned either (i) to the
same day of the following week, at the same hour and in the same place (ii) to such other date, time and place as prescribed in the notice
to the shareholders and in such adjourned meeting or (iii) to such day and at such time and place as the chairperson of the general meeting
shall determine (which may be earlier or later than the date pursuant to clause (i) above). If no quorum is present within half an hour
of the time arranged, any number of shareholders participating in the meeting, shall constitute a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If a special general meeting was summoned following
the request of a shareholder, and within half an hour a legal quorum shall not have been formed, the meeting shall be canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Adoption of Resolutions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our amended and restated articles of association
provide that resolutions amending provisions of the amended and restated articles of association related to the staggered board of directors
and the composition of the board of directors, as well as a resolution to dismiss a director, will require an affirmative vote of 70%
of the voting power represented at a general meeting and voting thereon. Other than that, and unless otherwise required under the Companies
Law and our amended and restated articles of association, all resolutions of the Company&rsquo;s shareholders require a simple majority
vote. A shareholder may vote in a general meeting in person, by proxy, by a written ballot.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Changing Rights Attached to Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise provided by the terms of the shares
and subject to any applicable law, any modification of rights attached to any class of shares must be adopted by the holders of a majority
of the shares of that class present a general meeting of the affected class or by a written consent of all the shareholders of the affected
class.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The enlargement of an existing class of shares
or the issuance of additional shares thereof, shall not be deemed to modify the rights attached to the previously issued shares of such
class or of any other class, unless otherwise provided by the terms of the shares.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Limitations on the Right to Own Securities
in Our Company</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no limitations on the right to own our
securities in our amended and restated articles of association. In certain circumstances the Warrants have restrictions upon the exercise
of such warrants if such exercise would result in the holders thereof owning more than 4.99% or 9.99% of our Ordinary Shares upon such
exercise, as further described below.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Provisions Restricting Change in Control
of Our Company</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our amended and restated articles of association
provide for a staggered board of directors, which mechanism may delay, defer or prevent a change of control of the Company&rsquo;s board
of directors. Other than that, there are no specific provisions of our amended and restated articles of association that would have an
effect of delaying, deferring or preventing a change in control of the Company or that would operate only with respect to a merger, acquisition
or corporate restructuring involving us. However, as described below, certain provisions of the Companies Law may have such effect.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law includes provisions that allow
a merger transaction and requires that each company that is a party to the merger have the transaction approved by its board of directors
and, unless certain requirements described under the Companies Law are met, a vote of the majority of shareholders, and, in the case of
the target company, also a majority vote of each class of its shares. For purposes of the shareholder vote of each party, unless a court
rules otherwise, the merger will not be deemed approved if shares representing a majority of the voting power present at the shareholders
meeting and which are not held by the other party to the merger (or by any person or group of persons acting in concert who holds 25%
or more of the voting power or the right to appoint 25% or more of the directors of the other party) vote against the merger. If, however,
the merger involves a merger with a company&rsquo;s own controlling shareholder or if the controlling shareholder has a personal interest
in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary transactions with
controlling shareholders. Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger
if it concludes that there exists a reasonable concern that as a result of the merger the surviving company will be unable to satisfy
the obligations of any of the parties to the merger, and may further give instructions to secure the rights of creditors. If the transaction
would have been approved by the shareholders of a merging company but for the separate approval of each class or the exclusion of the
votes of certain shareholders as provided above, a court may still approve the merger upon the petition of holders of at least 25% of
the voting rights of a company. For such petition to be granted, the court must find that the merger is fair and reasonable, taking into
account the value of the parties to the merger and the consideration offered to the shareholders. In addition, a merger may not be completed
unless at least (1) 50 days have passed from the time that the requisite proposals for approval of the merger were filed with the Israeli
Registrar of Companies by each merging company and (2) 30 days have passed since the merger was approved by the shareholders of each merging
company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The term &ldquo;Special Majority&rdquo; hereof
will be defined as described in section 275(a)(3) of the Companies Law as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at least a majority of the shares held by shareholders who are not controlling shareholders and do not have personal interest in the merger (excluding a personal interest that did not result from the shareholder&rsquo;s relationship with the controlling shareholder) have voted in favor of the proposal (shares held by abstaining shareholders shall not be considered); or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the total number of shares voted against the merger, does not exceed 2% of the aggregate voting rights of the company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law also provides that, subject to
certain exceptions, an acquisition of shares in an Israeli public company must be made by means of a &ldquo;special&rdquo; tender offer
if as a result of the acquisition (1) the purchaser would become a holder of 25% or more of the voting rights in the company, unless there
is already another holder of at least 25% or more of the voting rights in the company or (2) the purchaser would become a holder of 45%
or more of the voting rights in the company, unless there is already a holder of more than 45% of the voting rights in the company. These
requirements do not apply if, in general, the acquisition (1) was made in a private placement that received shareholders&rsquo; approval,
subject to certain conditions, (2) was from a holder of 25% or more of the voting rights in the company which resulted in the acquirer
becoming a holder of 25% or more of the voting rights in the company, or (3) was from a holder of more than 45% of the voting rights in
the company which resulted in the acquirer becoming a holder of more than 45% of the voting rights in the company. A &ldquo;special&rdquo;
tender offer must be extended to all shareholders. In general, a &ldquo;special&rdquo; tender offer may be consummated only if (1) at
least 5% of the voting power attached to the company&rsquo;s outstanding shares will be acquired by the offeror and (2) the offer is accepted
by a majority of the offerees who notified the company of their position in connection with such offer (excluding the offeror, controlling
shareholders, holders of 25% or more of the voting rights in the company or anyone on their behalf, or any person having a personal interest
in the acceptance of the tender offer). If a special tender offer is accepted, then the purchaser or any person or entity controlling
it or under common control with the purchaser or such controlling person or entity may not make a subsequent tender offer for the purchase
of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the
offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;However, under the Exemptions Regulations,
the aforesaid limitations regarding a special tender offer shall not apply if the law applicable to companies incorporated in the country
in which the foreign company is listed for trade includes restrictions on the acquisition of control of any portion of the company, or
that the acquisition of control requires the purchaser to conduct a tender offer to the company&rsquo;s shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, as a result of an acquisition of shares, the
acquirer will hold more than 90% of an Israeli company&rsquo;s outstanding shares or of certain class of shares, the acquisition must
be made by means of a tender offer for all of the outstanding shares, or for all of the outstanding shares of such class, as applicable.
In general, if less than 5% of the outstanding shares, or of applicable class, are not tendered in the tender offer and more than half
of the offerees who have no personal interest in the offer tendered their shares, all the shares that the acquirer offered to purchase
will be transferred to it by operation of law. However, a tender offer will also be accepted if the shareholders who do not accept the
offer hold less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares. Any shareholders
that was an offeree in such tender offer, whether such shareholder accepted the tender offer or not, may request, by petition to an Israeli
court, (i) appraisal rights in connection with a full tender offer, and (ii) that the fair value should be paid as determined by the court,
for a period of six months following the acceptance thereof. However, the acquirer is entitled to stipulate, under certain conditions,
that tendering shareholders will forfeit such appraisal rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Lastly, Israeli tax law treats some acquisitions,
such as stock-for-stock exchanges between an Israeli company and a foreign company, less favorably than U.S. tax laws. For example, Israeli
tax law may, under certain circumstances, subject a shareholder who exchanges his Ordinary Shares for shares in another corporation to
taxation prior to the sale of the shares received in such stock-for-stock swap.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Changes in Our Capital</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The general meeting may, by a simple majority vote
of the shareholders attending the general meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase our registered share capital by the creation of new shares from the existing class or a new class, as determined by the general meeting;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancel any registered share capital which have not been taken or agreed to be taken by any person;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 48px">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consolidate and divide all or any of our share capital into shares of larger nominal value than our existing shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 48px">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subdivide our existing shares or any of them, our share capital or any of it, into shares of smaller nominal value than is fixed; and</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 48px">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduce our share capital and any fund reserved for capital redemption in any manner, and with and subject to any incident authorized, and consent required, by the Companies Law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Exclusive Forum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our amended and restated articles of association
provide that unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United
States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities
Act&nbsp;of 1933, as amended, or the Securities Act and that any person or entity purchasing or otherwise acquiring any interest in any
security of the Company, shall be deemed to have notice of and consented to this exclusive forum provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Staggered Board</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our amended and restated articles of association
provide for a split of the board of directors into three classes with staggered three-year terms. At each annual general meeting of our
shareholders, the election or re-election of directors following the expiration of the term of office of the directors of that class of
directors will be for a term of office that expires on the third annual general meeting following such election or re-election, such that
each year the term of office of only one class of directors will expire. The director whom is to be retired and re-elected shall generally
be the director that served the longest period since its appointment or last re-election or, if more than one director served the longest
time, or if a director who is not to be re-elected agrees to be re-elected, the meeting of the board of directors which sets the date
and agenda for the annual general meeting (acting by a simple majority) will decide which of such directors will be brought for re-election
at the relevant general meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following summary of certain terms and provisions
of the Warrants and is subject to, and qualified in its entirety by, the provisions of the warrant agent agreement between us and VStock
Transfer, LLC, as warrant agent, and the form of Warrant, both of which are filed as exhibits to the Annual Report on Form 20-F for the
year ended December 31, 2024, or the Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Exercisability</I></B><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">The Warrants are exercisable at any time after
their original issuance and at any time up to the date that is five&nbsp;years after their original issuance. The Warrants will be exercisable,
at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice and, at any time a registration
statement registering the issuance of the Ordinary Shares underlying the Warrants under the Securities Act is effective and available
for the issuance of such shares, by payment in full in immediately available funds for the number of Ordinary Shares purchased upon such
exercise. If a registration statement registering the issuance of the Ordinary Shares underlying the Warrants under the Securities Act
is not effective or available the holder may, in its sole discretion, elect to exercise the Warrant through a cashless exercise, in which
case the holder would receive upon such exercise the net number of Ordinary Shares determined according to the formula set forth in the
Warrant. No fractional shares will be issued in connection with the exercise of a Warrant. In lieu of fractional shares, the Company will
pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Exercise Limitation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A holder will not have the right to exercise any
portion of the warrant if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of Ordinary
Shares outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the
terms of the Warrants. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided
that any increase in such percentage shall not be effective until 61&nbsp;days following notice from the holder to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Exercise Price</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The exercise price per
whole Ordinary Share purchasable upon exercise of the Warrants $320.00 per share. The exercise price is subject to appropriate adjustment
in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting
our Ordinary Shares and also upon any distributions of assets, including cash, stock or other property to our shareholders. Subject to
certain exemptions outlined in the Warrant, for a period until two years from the date of issuance of the Warrant, if the Company shall
sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or sell, enter into an agreement to sell
and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition the subsequently closes) any Ordinary Shares or convertible security, at an effective price per share
less than the exercise price of the Warrant then in effect, the exercise price of the Warrant shall be reduced to equal the effective
price per share in such Dilutive Issuance;&nbsp;provided, however, that in no event shall the exercise price of the Warrant be reduced
to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days immediately following the initial
issuance date of the Warrants, the exercise price of the Warrants will adjust to be equal to the Reset Price, provided that such value
is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of the Initial Exercise Price
of the Warrants on the issuance date or (b) 100% of the lowest volume weighted average price per Ordinary Share occurring on any day between
the initial exercise date of the Warrants and 90 calendar days following the issuance date of the Warrants. The lowest Reset Price is
$160.00, which is 50% of the Initial Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 20, 2022, the Company&rsquo;s volume
weighted average stock price was less than the exercise floor of $160.00 for the Warrants. Accordingly, effective after the closing of
trading on December 14, 2022 (the 90th calendar day immediately following the issuance date of the Warrants), the Warrants were adjusted
pursuant to their terms, including, but not limited to, to adjust the exercise price of the Warrants to $160.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Transferability</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to applicable laws, the Warrants may be
offered for sale, sold, transferred or assigned without the Company&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Warrant Agent</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Warrants were issued in registered form under
a warrant agent agreement between VStock Transfer, LLC, as warrant agent, and the Company. The Warrants were initially represented only
by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company, or DTC, and registered
in the name of Cede&nbsp;&amp; Co., a nominee of DTC, or as otherwise directed by DTC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Fundamental Transactions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event of a fundamental transaction, as described
in the Warrants and generally including any reorganization, recapitalization or reclassification of the Ordinary Shares, the sale, transfer
or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person,
the acquisition of more than 50% of the Company&rsquo;s outstanding Ordinary Shares, or any person or group becoming the beneficial owner
of 50% of the voting power represented by the Company&rsquo;s outstanding Ordinary Shares, the holders of the Warrants will be entitled
to receive upon exercise of the Warrants the kind and amount of securities, cash or other property that the holders would have received
had they exercised the Warrants immediately prior to such fundamental transaction without regard to any limitations on exercised contained
in the Warrants.&nbsp;The holders of the Warrants may also require the Company or any successor entity to purchase the Warrants from the
holders by paying to the holder an amount in cash (or other types or form of consideration in special circumstances listed in the Warrant)
equal to the Black Scholes value of the remaining unexercised portion of the Warrant on the date of the fundamental transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Home Country Practice</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For so long as any of the Warrants remains outstanding,
the Company will elect to follow home country practice in lieu of any rules and regulations of the trading market that would limit the
Company&rsquo;s ability to effect the provisions of the Warrants, including but not limited to shareholder approval rules related to the
issuance of securities or adjustment of terms of this Warrant for the benefit of warrant holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Rights as a Stockholder</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as otherwise provided in the Warrants or
by virtue of such holder&rsquo;s ownership of the Company&rsquo;s Ordinary Shares, the holder of a Warrant does not have the rights or
privileges of a holder of the Company&rsquo;s Ordinary Shares, including any voting rights, until the holder exercises the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Governing Law</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Warrants and the warrant agent agreement are
governed by New&nbsp;York law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>3
<FILENAME>ea023465401ex11-1_wearable.htm
<DESCRIPTION>INSIDER TRADING POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 11.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WEARABLE DEVICES LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INSIDER TRADING POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AND GUIDELINES WITH RESPECT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTAIN TRANSACTIONS IN COMPANY SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date: March 19, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Insider Trading Policy
(the &ldquo;<B>Policy</B>&rdquo;) provides guidelines to directors, officers, employees and other related persons of Wearable Devices
Ltd., an Israeli company (the &ldquo;<B>Company</B>&rdquo;), with respect to transactions in the Company&rsquo;s securities. The Company
has adopted this Policy in order to ensure compliance with securities laws and to avoid even the appearance of improper conduct by anyone
associated with the Company. Failure to comply with these procedures could result in a serious violation of the securities laws by you
and/or the Company and can result in both civil penalties and criminal fines and imprisonment. We have all worked hard to establish the
Company&rsquo;s reputation for integrity and ethical conduct, and we are all responsible for preserving and enhancing this reputation.
The appearance of insider trading can cause a substantial loss of confidence in the Company and its shares on the part of the public and
the securities markets. This could result in an adverse impact on the Company and its shareholders. Accordingly, avoiding the appearance
of engaging in share transactions on the basis of material undisclosed information can be as important as avoiding a transaction actually
based on such information. The Company has appointed its Chief Financial Officer, or in his or her absence, the Company&rsquo;s Chief
Executive Officer (the &ldquo;<B>Compliance Officer</B>,&rdquo; as the case may be), as the Company&rsquo;s Insider Trading Compliance
Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>I. <U>Applicability of Policy</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Policy applies to all
transactions in the Company&rsquo;s securities, including ordinary shares, options, warrants and any other securities the Company may
issue from time to time, such as preferred shares, notes and convertible debentures, as well as to derivative securities relating to the
Company&rsquo;s shares, whether or not issued by the Company, such as exchange-traded options and debt securities. It applies to all officers
of the Company, all members of the Company&rsquo;s Board of Directors, and all employees of, and consultants and contractors to, the Company
and its subsidiaries/branches who receive or have access to Material Nonpublic Information (as defined below) regarding the Company (collectively,
&ldquo;<B>Company Affiliated Persons</B>&rdquo;). Company Affiliated Persons, members of their immediate families (which include spouse
and minor children), members of their households, other family members living with them or who are supported by them, are sometimes referred
to in this Policy as &ldquo;<B>Insiders</B>&rdquo;. This Policy also applies to any trust or other estate in which an Insider has a substantial
beneficial interest or as to which he or she serves as trustee or in a similar fiduciary capacity, and to any trust, corporation, partnership
or other entity which the Insider controls, including venture capital partnerships. This Policy also applies to any person who receives
Material Nonpublic Information from any Insider.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any person who possesses Material
Nonpublic Information regarding the Company is an Insider for so long as the information is not publicly known. Any employee can be an
Insider from time to time, and would at those times be subject to this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Policy imposes additional
restrictions upon Insiders who have routine access to Material Nonpublic Information, referred to as &ldquo;<B>Access Insiders</B>.&rdquo;
Access Insiders are: (1)&nbsp;members of the board of directors, (2) the executive officers, (3) the controller, and (4) the investor
relations department of the Company. In addition, other employees of the Company who have routine access to Material Nonpublic Information
as determined by the Compliance Officer, who were notified that these additional restrictions apply to them shall also be Access Insiders
until otherwise determined by the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Company itself
must comply with securities laws applicable to its own securities trading activities, and must not engage in any transaction involving
a purchase or sale of its securities, including any offer to purchase or offer to sell or other disposition of its securities, when it
is in possession of Material Nonpublic Information concerning the Company, other than in compliance with applicable law, subject to the
policies and procedures adopted by the Company and the exceptions listed in Section XII of this Policy to the extent applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>II. <U>General Policy</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is the policy of the Company
to oppose the unauthorized disclosure of any nonpublic information acquired in the work-place and the misuse of Material Nonpublic Information
in securities trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>III. <U>Specific Policies</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.   <U>Trading
on Material Nonpublic Information</U>.</B> No Insider shall engage in any transaction involving a purchase or sale of the Company&rsquo;s
securities, including any offer to purchase or offer to sell or gift or other disposition of the Company&rsquo;s securities, during any
period commencing with the time that he or she first receives Material Nonpublic Information concerning the Company, and ending at the
close of business on the second Trading Day following the date of public disclosure of that information, or at such time as such nonpublic
information is no longer material. As used herein, the term &ldquo;<B>Trading Day</B>&rdquo; shall mean a day on which the Nasdaq Capital
Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.   <U>Tipping</U>.</B>
No Insider shall disclose (sometimes called a &ldquo;<B>Tip</B>&rdquo;) Material Nonpublic Information to any other person (including
family members) where such information may be used by such person to his or her profit by trading in the securities of companies to which
such information relates, nor shall such Insider or related person make recommendations or express opinions on the basis of Material Nonpublic
Information as to trading in the Company&rsquo;s securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.   <U>Confidentiality
of Nonpublic Information</U>.</B> Nonpublic information relating to the Company is the property of the Company and the unauthorized disclosure
of such information is forbidden. In the event any officer, director or employee of the Company receives any inquiry from outside the
Company, such as a stock analyst, for information (particularly financial results and/or projections) that may be Material Nonpublic Information,
the inquiry should be referred to the Compliance Officer, and to the other appropriate Company officers, as provided for in the Disclosure
Policy of the Company, if any, as may be in place from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IV. <U>Potential Criminal and Civil Liability
</U>&#9;<U>and/or Disciplinary Action</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.   <U>Liability
for Insider Trading</U>.</B> In the United States and many other countries, the personal consequences to an Insider of illegally trading
securities while in possession, or on the basis of, Material Nonpublic Information can be quite severe. In the United States there are
substantial civil penalties and criminal sanctions which may be assessed for insider trading. Civil penalties are a payment of a penalty
of up to three times the illicit windfall. In addition, Insiders may be subject to criminal fines of up to $5,000,000 and up to twenty
years in prison for engaging in transactions in the Company&rsquo;s securities at a time when they have knowledge of Material Nonpublic
Information regarding the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are located or engaged
in dealings outside the U.S., be aware that laws regarding insider trading and similar offenses differ from country to country. Employees
must abide by the laws in the country where located. However, you are required to comply with this Policy even if local law is less restrictive.
If a local law conflicts with this Policy, you must consult the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If securities transactions
ever become the subject of scrutiny, they are likely to be viewed after-the-fact with the benefit of hindsight. As a result, before engaging
in any transaction an Insider should carefully consider how the transaction may be construed in the bright light of hindsight. If you
have any questions or uncertainties about this Policy or a proposed transaction, please ask the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.   <U>Liability
for Tipping</U>.</B> Insiders may also be liable for improper transactions by any person (commonly referred to as a &ldquo;<B>Tippee&rdquo;</B>)
to whom they have disclosed Material Nonpublic Information or any person to whom the Tippee discloses such Material Nonpublic Information
regarding the Company or to whom they have made recommendations or expressed opinions on the basis of such information as to trading in
the Company&rsquo;s securities. The civil penalties and criminal sanctions for tipping by an Insider are the same as the ones for an Insider
conducting insider trading, even if the disclosing person did not profit from the trading. The U.S. Securities and Exchange Commission
(the &ldquo;<B>SEC</B>&rdquo;), the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;) and the stock exchanges use sophisticated
electronic surveillance techniques to uncover insider trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.   <U>Possible
Disciplinary Actions</U>.</B> The seriousness of securities law violations is reflected in the penalties and criminal sanctions such violations
carry. These violations may also create negative publicity for the Company and a director&rsquo;s resignation may be sought, or an officer
or other employee will be subject to possible Company disciplinary action including ineligibility for future participation in the Company&rsquo;s
equity incentive plans or termination of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>V. <U>Individual Responsibility</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Every Company Affiliated Person
has the individual responsibility to comply with this Policy against insider trading, regardless of whether the Company has recommended
a trading window to that person or any other Insiders of the Company. The guidelines set forth in this Policy are not intended to provide
a conclusive solution for all circumstances, and appropriate judgment should be exercised in connection with any trade in the Company&rsquo;s
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An Insider may, from time
to time, have to forego a proposed transaction in the Company&rsquo;s securities even if he or she planned to make the transaction before
learning of the Material Nonpublic Information and even though the Insider believes he or she may suffer an economic loss or forego anticipated
profit by waiting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VI. <U>Applicability of Policy to Inside Information
Regarding Other Companies</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Policy and the guidelines
described herein also apply to Material Nonpublic Information relating to other companies, including the Company&rsquo;s customers, vendors
or suppliers (&ldquo;<B>Business Partners</B>&rdquo;), when that information is obtained in the course of employment with, or other services
performed on behalf of, the Company. Civil penalties and criminal sanctions, and termination of employment, may result from trading on
inside information regarding the Company&rsquo;s Business Partners. All employees should treat Material Nonpublic Information about the
Company&rsquo;s Business Partners with the same care required with respect to information related directly to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">VII. <U>Dissemination of Company Information</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The prohibition of the disclosure
of Material Nonpublic Information applies to all contacts made within and outside the Company. Care should be taken to prevent the disclosure
of Material Nonpublic Information during all contact including phone calls and casual conversation. If in doubt about whether information
falls into the category of Material Nonpublic Information, then the information should not be disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to disclosure to any
third party, any officer, director or employee of the Company who is aware of any Material Nonpublic Information concerning the Company
that has not been disclosed to the public should report the intention to disclose such information promptly to the Compliance Officer
and obtain approval to do so, or otherwise act in accordance with the Company&rsquo;s Disclosure Policy, if any, as may be in place from
time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VIII. <U>Definition of Material Nonpublic Information</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Material Nonpublic Information
is information which is material, and that has not been disclosed or otherwise made available to the general public by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is not possible to define
all categories of material information. Generally, information should be regarded as material if a reasonable investor would consider
it important in making an investment decision regarding the purchase or sale of the Company&rsquo;s securities or the information, if
made public, would likely affect the market price of the Company&rsquo;s securities. Either positive or negative information may be material.
Information may be material even if it relates to future, speculative or contingent events and even if it is significant only when considered
in combination with publicly available information. Nonpublic information can be material even with respect to companies that do not have
publicly traded stock, such as those with outstanding bonds or bank loans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While it may be difficult
under this standard to determine whether particular information is material, there are various categories of information that are particularly
sensitive and, as a general rule, should always be considered material. If any Insider has questions as to the materiality of information,
he or she should contact the Compliance Officer for clarification. Examples of information which is deemed to be material include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Financial results;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Projections of future earnings or losses;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">News of a pending or proposed merger or acquisition;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">New product or project announcements of a significant nature;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0.25in; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Expansion or curtailment of operations or the gain or loss
of a substantial customer;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Changes in control of the Company or major changes in senior
management;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Significant new joint ventures, alliances, or strategic partnerships
or material developments in existing arrangements;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Impending bankruptcy or financial liquidity problems;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Significant product defects or modifications;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Significant pricing changes;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Events regarding the Company&rsquo;s securities (e.g. stock
splits, repurchases, or changes in dividend policy);</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Changes in auditors or auditor notification that the Company
may no longer rely on an audit report;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">A significant purchase or sale of assets or disposition of
a subsidiary or division;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">New equity or debt offerings, significant borrowings, or other
material financial transactions;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Significant litigation exposure due to actual or threatened
litigation;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Significant actions by regulatory bodies;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Receipt, cancellation or deferral of significant purchase
orders;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Cybersecurity risk and incidents;</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Proposed payment of a dividend; and</TD>
</TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Any of the above with respect to a subsidiary, or other affiliate
of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nonpublic information is information
that has not been previously disclosed to the general public and is otherwise not available to the general public. It is important to
note that information is not necessarily public merely because it has been discussed in the press, which will sometimes report rumors.
You should presume that information is nonpublic unless you can point to its official release by the Company in at least one of the following
ways:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">Information contained in publicly available documents filed
with securities regulatory authorities (e.g., filings with the SEC);</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">Issuance of press releases; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">Meetings with members of the press and the public.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75in 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>IX. Additional Circumstances Where No Exceptions
Apply</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are almost no exceptions
to the prohibition against insider trading. For example, it does not matter that the transactions in question may have been planned before
the Insider came into possession of the undisclosed material information, regardless of the economic loss that the person may believe
he or she might suffer as a consequence of not trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As noted above, the definition
of Insiders, to which this Policy applies, includes immediate family members of Company Affiliated Persons. Although immediate family
is narrowly defined, a Company Affiliated Person should be especially careful with respect to family members or to unrelated persons living
in the same household.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Finally, there are no limits
on the size of a transaction that will trigger insider trading liability; relatively small trades have in the past occasioned investigations
and lawsuits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>X. <U>Trading Window</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The period beginning two weeks
before the end of the last month of each calendar quarter and ending two Trading Days following the date of public disclosure of the financial
results for that quarter, is a particularly sensitive period of time for transactions in the Company&rsquo;s shares from the perspective
of compliance with applicable securities laws. This sensitivity is due to the fact that directors, officers and certain other employees
will, during that period, often possess Material Nonpublic Information about the expected financial results for the quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, to ensure compliance
with this Policy and applicable federal and state securities laws, it is the Company&rsquo;s policy that all directors, officers and employees
refrain from conducting transactions involving the Company&rsquo;s securities other than during the period (the &ldquo;<B>Trading Window</B>&rdquo;)
commencing at the close of business on the second Trading Day following the date of public disclosure of the financial results for a particular
fiscal quarter or year and continuing until the day that is two weeks before the last day of the last month of the next fiscal quarter.
As a courtesy to the persons subject to this Policy, the Company may provide advance notice before the Trading Window opens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Company
may also notify that directors, officers, selected employees and others are required to suspend trading because of developments known
to the Company and not yet disclosed to the public. In such event, such persons are advised not to engage in any transaction involving
the Company&rsquo;s securities during such period and should not disclose to others the fact of such suspension of trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose behind the self-imposed
Trading Window period is to help establish a diligent effort to avoid any improper transaction. It should be noted, however, that even
during the Trading Window, any person possessing Material Nonpublic Information concerning the Company may not attempt to &ldquo;beat
the market&rdquo; by trading simultaneously with, or shortly after, the official release of Material Nonpublic Information. Although there
is no fixed period for how long it takes the market to absorb information, out of prudence a person aware of Material Nonpublic Information
should refrain from any trading activity for at least two full Trading Days following its official release, whether or not the Company
has recommended a suspension of trading to that person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOTWITHSTANDING THESE TIMING
GUIDELINES, IT IS ILLEGAL FOR ANY PERSON TO TRADE WHILE IN POSSESSION OF MATERIAL NONPUBLIC INFORMATION, INCLUDING SITUATIONS IN WHICH
THE PERSON IS AWARE OF MAJOR DEVELOPMENTS THAT HAVE NOT YET BEEN PUBLICLY ANNOUNCED BY THE COMPANY. TRADING IN THE COMPANY&rsquo;S SECURITIES
DURING THE TRADING WINDOW SHOULD <U>NOT</U> BE CONSIDERED A &quot;SAFE HARBOR,&quot; AND ALL DIRECTORS, OFFICERS AND OTHER INSIDERS SHOULD
USE GOOD JUDGMENT AT ALL TIMES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>XI. <U>Inquiries</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All Insiders should review
this Policy carefully and contact the Compliance Officer if they have a concern that a contemplated transaction in the Company&rsquo;s
securities might not conform with this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>XII. <U>Certain Exceptions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Policy,
the Company considers that the exercise of share options for cash under the Company&rsquo;s share option plans or the purchase of shares
under employee purchase plans in effect at the time of the adoption of this Policy and that may be adopted in the future (but <U>not</U>
the sale of any such shares) is exempt from this Policy, since the other party to the transaction is the Company itself and the price
does not vary with the market but is fixed by the terms of the option agreement or the plan. Accordingly, cashless exercises of options
are subject to the Policy when they involve the sale of shares into the public marketplace.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">   </FONT><FONT STYLE="font-size: 10pt">The
restrictions set forth in this Policy shall not apply to sales made pursuant to a Qualified Plan. For purposes of this exception, a &ldquo;Qualified
Plan&rdquo; is a written plan for selling the Company&rsquo;s securities which meets each of the following requirements: (a) the plan
is adopted by the Insider during a Trading Window and when the Insider is not in possession of material non-public information; (b) the
plan is adhered to strictly by the Insider; (c) the plan either (i) specifies the amount of securities to be sold and the date on which
the securities are to be sold, (ii) includes a written formula or algorithm, or computer program, for determining the amount of securities
to be sold and the price at which and the date on which the securities are to be purchased or sold, or (iii) does not permit the Insider
to exercise any subsequent influence over how, when, or whether to effect sales; provided, in addition, that any other person who, pursuant
to the plan, does exercise such influence must not have been aware of the material non-public information when doing so; (d) the plan
includes a representation from the Insider adopting the plan that such Insider (i) is not aware of any material nonpublic information
about the Company or its securities and (ii) is adopting the plan in good faith and not as part of a plan or scheme to evade the prohibitions
of Rule 10b-5 under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;; (e) the plan provides that
trading under the plan cannot begin until the later of (i) 90 days after the adoption of the plan or (ii) two business days following
the disclosure of the Company&rsquo;s financial results in a Form 6-K or Form 20-F (such period being referred to as the &ldquo;cooling-off
period&rdquo;, but, in either case, not to exceed 120 days following the adoption of the plan, and provided that if the Insider is not
a director or officer of the Company, such cooling-off period shall be at least 30 days rather than the longer periods set forth above);
and (e) at the time it is adopted the plan conforms to all other requirements of Rule&nbsp;10b5-1 under the Exchange Act as then in effect.
Rule 10b5-1 provides an affirmative defense from insider trading liability under the U.S. federal securities laws for trading plans that
meet the above requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with Rule
10b5-1 under the Exchange Act, any change to the amount, price, or timing of the purchase or sale of securities underlying a Qualified
Plan constitutes termination of the Qualified Plan and the adoption of a new Qualified Plan, which triggers the cooling-off period described
above. No Insider may have more than one Qualified Plan for purchases or sales of securities on the open market during the same period.
In addition, no Insider may have more than one single-trade Qualified Plan during any 12-month period. A single-trade plan is one that
has the practical effect of requiring the purchase or sale of securities as a single transaction. With respect to overlapping Qualified
Plans, an Insider may have two separate plans provided (i) the later-commencing plan does not begin until all trades have been completed
under the first plan or the first plan expires without execution, and trading during the cooling-off period that would have applied if
the later-commencing plan was adopted on the date the earlier-commencing plan terminates and (ii) the separate plans satisfy all other
conditions applicable to Qualified Plans. With respect to overlapping Qualified Plans, an Insider may have separate plans for &ldquo;sell-to-cover&rdquo;
transactions in which an Insider instructs an agent to sell securities in order to satisfy tax withholding obligations at the time an
equity award vests. Any such additional plan must only authorize qualified &ldquo;sell-to-cover&rdquo; transactions. With respect to single-trade
Qualified Plans, an Insider may have a single-trade plan for &ldquo;sell-to-cover&rdquo; transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the above requirements,
a Qualified Plan shall be signed and dated by the Insider, and submitted to the Compliance Officer at least two (2) trading days before
it is filed with the broker who executes it. The Company shall have the right, at all time, to suspend purchases or sales under a Qualified
Plan, for instance in the event that the Company needs to comply with requirements by underwriters for &ldquo;lock-up&rdquo; agreements
in connection with an underwritten public offering of the Company&rsquo;s securities. Any cancellation, suspension, expansion or other
modification of a Qualified Plan by the Insider who established it must: (1) be in writing, signed and dated by such Insider, (2) be submitted
to the Compliance Officer within two (2) trading days after the cancellation, suspension, expansion or other modification was reduced
to writing, and (3) be made during a Trading Window, and when the Insider who established it has no Nonpublic Material Information about
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>XIII. <U>Additional Information for Directors,
Officers and Certain Employees with Routine Access to Material Nonpublic information</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Policy imposes additional restrictions upon
Access Insiders, because of their routine access to Material Nonpublic Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify"><B>Preclearance of trades:</B> The Company has determined that all Access Insiders should refrain from
trading in the Company&rsquo;s securities, even during the Trading Window, without first complying with the Company&rsquo;s &ldquo;preclearance&rdquo;
process. Each Access Insider should contact the Compliance Officer prior to commencing any trade, gift or other transaction in the Company&rsquo;s
securities. At the time of executing a trade in the Company&rsquo;s securities, such individuals will be responsible for verifying that
the Company has not imposed any restrictions on their ability to engage in transactions. If the individual has not completed the transaction
within ten (10) trading days of notification of the intention to trade, then the individual must again notify the Compliance Officer that
he or she intends to execute a transaction and re-verify the nonexistence of any restrictions on such trade. For the avoidance of doubt,
this paragraph shall not apply to a Qualified Plan, after it has been set up. Before each transaction in the Company&rsquo;s securities,
each officer and director should contact the Compliance Officer regarding compliance with Rule&nbsp;144 under the U.S. Securities Act
of 1933, as amended (&ldquo;<B>Rule 144</B>&rdquo;), which contains guidelines for the sale of privately issued shares and sales by affiliates
of the Company, if such sales are not covered by an effective registration statement, to the extent applicable.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify"><B>Rule 144 and Section 16 Matters for Directors and Officers: </B>Directors and principal officers of
the Company must also comply with Rule 144, or another applicable exemption from registration. The practical effect of Rule 144 is that
directors and officers who sell the Company&rsquo;s securities may be required to comply with a number of requirements including holding
period, volume limitation, manner of sale and SEC filing requirements. The Company may provide separate memoranda and other appropriate
materials to its directors and officers regarding compliance with Rule 144. In addition, if the Company is no longer considered a &ldquo;foreign
private issuer&rdquo;, the directors and officers who trade with Company securities have to report such transactions through the filing
of Form&nbsp;4s with the U.S. Securities and Exchange Commission. The Company will advise such persons if they are subject to the requirement
to file a Form 4.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>XIV. <U>Specific Requirements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<B>   <U>Speculative
Trading</U></B>. No Insider may engage in transactions of a speculative nature at any time. All Insiders are prohibited from short-selling
the Company&rsquo;s securities or engaging in transactions involving the Company&rsquo;s based derivative securities. A short sale, for
these purposes, means any transaction whereby one may benefit from a decline in the price of the Company&rsquo;s securities. &ldquo;<B>Derivative
Securities</B>&rdquo; are options, warrants, stock appreciation rights or similar rights whose value is derived from the value of an equity
security, such as the Company&rsquo;s common stock. This prohibition includes, but is not limited to, trading in the Company&rsquo;s based
put and call option contracts, transacting in straddles, hedging or monetization transaction with respect to the Company&rsquo;s securities,
and the like. In addition, no Insider shall engage in a transaction with respect to securities of the Company if he or she owns the security,
but does not deliver it against such sale (a &ldquo;short sale against the box&rdquo;) within twenty days thereafter, or does not within
five days after such sale deposit it in the mails or other usual channels of transportation. The above does not derogate from Insiders&rsquo;
right to hold and exercise options or other derivative securities granted under the Company&rsquo;s employee share option or equity incentive
plans as long as such exercise is not prohibited by this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.   <B><U>Margin
Accounts and Pledges</U></B>. Securities held in a margin account may be sold by the broker without the consent of the owner thereof if
such owner fails to meet a margin call. Similarly, securities pledged as collateral for a loan may be sold if the owner thereof defaults
on the loan. In case of an owner who is subject to this Policy, these sales may occur at a time when such person is aware of material,
non-public information or otherwise not permitted to trade such securities. Therefore, this policy prohibits holding any Company securities
in a margin account or pledging any Company securities as collateral for a loan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.   <B><U>Post-Termination
Transactions</U>.</B> If an Insider is aware of Material Nonpublic Information at the time such Insider&rsquo;s association with the Company
is terminated, whether by the Insider or the Company, the Insider may not trade in Company securities until such information is no longer
material or until two Trading Days after such information has become public. In addition, if the Company is not in a Trading Window at
the time such association with the Company is terminated, the Insider may not trade in Company securities until two Trading Days after
the next announcement of quarterly earnings or of the material, non-public information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.   <B><U>Ad
hoc Restrictions</U></B><I>. </I>The Compliance Officer has the authority to impose restrictions on trading in the Company&rsquo;s securities
by appropriate individuals at any time. In such event, the Compliance Officer will notify the affected individuals, either personally,
by email or by voicemail, to inform them of the restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.   <B><U>Open
Orders</U></B>. Any Insider who has placed a limit order or open instruction to buy or sell the Company&rsquo;s securities shall bear
responsibility for canceling such instructions immediately upon becoming in possession of Material Nonpublic Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>XV. <U>Acknowledgement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please sign the attached acknowledgement
form and return it to the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you have any questions
with respect to this Policy, please contact the Company&rsquo;s Compliance Officer, at alonmualem@wearabledevices.co.il.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>ACKNOWLEDGEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">I have received, read and understand the Insider Trading Policy and Guidelines with Respect to Certain Transactions in Company Securities of Wearable Devices Ltd., a copy of which is attached hereto, and agree to comply with the provisions thereof. </FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">Date: _______________</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify; layout-grid-mode: line"></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: justify; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: justify; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Name</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="text-align: justify; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Title</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>ea023465401ex12-1_wearable.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 12.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO EXCHANGE ACT RULE
13a-14(a) or 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher
Dahan, certify that:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this annual report on Form 20&ndash;F of Wearable Devices Ltd. (the &ldquo;company&rdquo;);</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15(d)-15(f)) for the company and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
the effectiveness of the company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
in this report any change in the company&rsquo;s internal control over financial reporting that occurred during the period covered by
the annual report that has materially affected, or is reasonably likely to materially affect, the company&rsquo;s internal control over
financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the company&rsquo;s auditors and the audit committee of the company&rsquo;s board of directors (or persons performing the
equivalent function):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the company&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
fraud, whether or not material, that involves management or other employees who have a significant role in the company&rsquo;s internal
control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 20, 2025</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>ea023465401ex12-2_wearable.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 12.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO EXCHANGE ACT RULE
13a-14(a) or 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon
Mualem, certify that:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this annual report on Form 20&ndash;F of Wearable Devices Ltd. (the &ldquo;company&rdquo;);</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the company and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
the effectiveness of the company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
in this report any change in the company&rsquo;s internal control over financial reporting that occurred during the period covered by
the annual report that has materially affected, or is reasonably likely to materially affect, the company&rsquo;s internal control over
financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the company&rsquo;s auditors and the audit committee of the company&rsquo;s board of directors (or persons performing the
equivalent function):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the company&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
fraud, whether or not material, that involves management or other employees who have a significant role in the company&rsquo;s internal
control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 20, 2025</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; white-space: nowrap; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Alon Mualem</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon Mualem</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>6
<FILENAME>ea023465401ex13-1_wearable.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 13.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C.&nbsp;Section 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2024 (the &ldquo;Report&rdquo;) by Wearable Devices Ltd. (the &ldquo;Company&rdquo;),
the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 20, 2025</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asher Dahan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>7
<FILENAME>ea023465401ex13-2_wearable.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 13.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C.&nbsp;Section 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2024 (the &ldquo;Report&rdquo;) by Wearable Devices Ltd. (the &ldquo;Company&rdquo;),
the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 20, 2025</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Alon Mualem</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon Mualem</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>8
<FILENAME>ea023465401ex15-1_wearable.htm
<DESCRIPTION>CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS, ISR. BDO MEMBER FIRM, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>Exhibit 15.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><IMG SRC="ex15-1_001.jpg" ALT="" STYLE="height: 50px; width: 110px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><U>Consent of Independent Registered
Public Accounting Firm</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wearable Devices Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation by reference
in the Registration Statements on Form S-8 (Files No. 333-284010, 333-269869 and 333-274343) and on Form F-3 (File No. 333-274841) of
Wearable Devices Ltd. of our report dated March 19, 2025, relating to the consolidated financial statements as of December 31, 2024 and
2023 and for each of the years in the three-year period ended December 31, 2024 which appears in this Form 20-F for the year ended December
31,2024. Our report contains an explanatory paragraph regarding the Company&rsquo;s ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">/s/ Ziv Haft</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 65%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Ziv Haft</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Certified Public Accountants (Isr.)</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>BDO Member Firm</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">March 20, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tel Aviv, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex15-1_002.jpg" ALT="" STYLE="height: 92px; width: 700px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>wlds-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 20 21:08:44 UTC 2025 -->
<xs:schema xmlns:wlds="http://www.wearabledevices.co.il/20241231" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2024" targetNamespace="http://www.wearabledevices.co.il/20241231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="wlds-20241231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wlds-20241231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wlds-20241231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wlds-20241231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet" id="wlds_r_ConsolidatedBalanceSheet">
        <link:definition>995301 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals" id="wlds_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement" id="wlds_r_ConsolidatedIncomeStatement">
        <link:definition>995303 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3" id="wlds_r_ShareholdersEquityType2or3">
        <link:definition>995304 - Statement - Consolidated Statements of Changes in Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals" id="wlds_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>995305 - Statement - Consolidated Statements of Changes in Shareholders&#8217; Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow" id="wlds_r_ConsolidatedCashFlow">
        <link:definition>995306 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/General" id="wlds_r_General">
        <link:definition>995307 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies" id="wlds_r_SignificantAccountingPolicies">
        <link:definition>995308 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/Inventories" id="wlds_r_Inventories">
        <link:definition>995309 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet" id="wlds_r_PropertyandEquipmentNet">
        <link:definition>995310 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/Leases" id="wlds_r_Leases">
        <link:definition>995311 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote" id="wlds_r_StandbyEquityPurchaseAgreementandConvertiblePromissoryNote">
        <link:definition>995312 - Disclosure - Stand by Equity Purchase Agreement and Convertible Promissory Note</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingencies" id="wlds_r_CommitmentsandContingencies">
        <link:definition>995313 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecurities" id="wlds_r_ConvertibleSecurities">
        <link:definition>995314 - Disclosure - Convertible Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/CreditFacility" id="wlds_r_CreditFacility">
        <link:definition>995315 - Disclosure - Credit Facility</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquity" id="wlds_r_ShareholdersEquity">
        <link:definition>995316 - Disclosure - Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/TaxesonIncome" id="wlds_r_TaxesonIncome">
        <link:definition>995317 - Disclosure - Taxes on Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/RelatedParties" id="wlds_r_RelatedParties">
        <link:definition>995318 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/SubsequentEvents" id="wlds_r_SubsequentEvents">
        <link:definition>995319 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy" id="wlds_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables" id="wlds_r_SignificantAccountingPoliciesTables">
        <link:definition>996001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/InventoriesTables" id="wlds_r_InventoriesTables">
        <link:definition>996002 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables" id="wlds_r_PropertyandEquipmentNetTables">
        <link:definition>996003 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/LeasesTables" id="wlds_r_LeasesTables">
        <link:definition>996004 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityTables" id="wlds_r_ShareholdersEquityTables">
        <link:definition>996005 - Disclosure - Shareholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/GeneralDetails" id="wlds_r_GeneralDetails">
        <link:definition>996006 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails" id="wlds_r_SignificantAccountingPoliciesDetails">
        <link:definition>996007 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable" id="wlds_r_ScheduleofAnnualRatesofDepreciationTable">
        <link:definition>996008 - Disclosure - Significant Accounting Policies - Schedule of Annual Rates of Depreciation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable" id="wlds_r_ScheduleofInventoriesTable">
        <link:definition>996009 - Disclosure - Inventories - Schedule of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable" id="wlds_r_ScheduleofPropertyandEquipmentNetTable">
        <link:definition>996010 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/LeasesDetails" id="wlds_r_LeasesDetails">
        <link:definition>996011 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" id="wlds_r_ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable">
        <link:definition>996012 - Disclosure - Leases - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable" id="wlds_r_ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable">
        <link:definition>996013 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails" id="wlds_r_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails">
        <link:definition>996014 - Disclosure - Stand by Equity Purchase Agreement and Convertible Promissory Note (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails" id="wlds_r_CommitmentsandContingenciesDetails">
        <link:definition>996015 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails" id="wlds_r_ConvertibleSecuritiesDetails">
        <link:definition>996016 - Disclosure - Convertible Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/CreditFacilityDetails" id="wlds_r_CreditFacilityDetails">
        <link:definition>996017 - Disclosure - Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDetails" id="wlds_r_ShareholdersEquityDetails">
        <link:definition>996018 - Disclosure - Shareholders&#8217; Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable" id="wlds_r_ScheduleofShareCapitalTable">
        <link:definition>996019 - Disclosure - Shareholders&#8217; Equity - Schedule of Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals" id="wlds_r_ScheduleofShareCapitalTable_Parentheticals">
        <link:definition>996020 - Disclosure - Shareholders&#8217; Equity - Schedule of Share Capital (Parentheticals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable" id="wlds_r_ScheduleofOptionsActivityTable">
        <link:definition>996021 - Disclosure - Shareholders&#8217; Equity - Schedule of Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable" id="wlds_r_ScheduleofWeightedAverageAssumptionsTable">
        <link:definition>996022 - Disclosure - Shareholders&#8217; Equity - Schedule of Weighted-Average Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable" id="wlds_r_ScheduleofOptionstoConsultantsTable">
        <link:definition>996023 - Disclosure - Shareholders&#8217; Equity - Schedule of Options to Consultants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxPQtRsMwMGseXt1qIodzzmaL/glMbImLWgeHF6ERfU0NGZNGGhBtuxC9Hos2B2CZStFQyEAt1gsw5LAjYSeWBYHmpgvOpAIsHYidrOMxKx7alFavI1Y4b+UJB9h3C7DUXDO4VAaMvWLWPuyXtsxVuJFBUYWfOw7tdJXsW+ldIqtIXPKSVHnHwSM=] CSR-->
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable" id="wlds_r_ScheduleofShareBasedCompensationExpensesTable">
        <link:definition>996024 - Disclosure - Shareholders&#8217; Equity - Schedule of Share-Based Compensation Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" id="wlds_r_ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable">
        <link:definition>996025 - Disclosure - Shareholders&#8217; Equity - Schedule of Issuance of Equity Warrants to Investors and Associate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable" id="wlds_r_ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable">
        <link:definition>996026 - Disclosure - Shareholders&#8217; Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals" id="wlds_r_ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals">
        <link:definition>996027 - Disclosure - Shareholders&#8217; Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Parentheticals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails" id="wlds_r_TaxesonIncomeDetails">
        <link:definition>996028 - Disclosure - Taxes on Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/RelatedPartiesDetails" id="wlds_r_RelatedPartiesDetails">
        <link:definition>996029 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/SubsequentEventsDetails" id="wlds_r_SubsequentEventsDetails">
        <link:definition>996030 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wearabledevices.co.il/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:element name="ScheduleOfAnnualRatesOfDepreciationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentNetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfPropertyAndEquipmentNetAbstract"/>
  <xs:element name="ScheduleOfShareCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfShareCapitalAbstract"/>
  <xs:element name="ScheduleOfOptionsActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfOptionsActivityAbstract"/>
  <xs:element name="ScheduleOfOptionsToConsultantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfOptionsToConsultantsAbstract"/>
  <xs:element name="ScheduleOfShareBasedCompensationExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfShareBasedCompensationExpensesAbstract"/>
  <xs:element name="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract"/>
  <xs:element name="ChangesDuringTheYear2022Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ChangesDuringTheYear2022Abstract"/>
  <xs:element name="ChangesDuringTheYear2023Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ChangesDuringTheYear2023Abstract"/>
  <xs:element name="ChangesDuringTheYear2024Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ChangesDuringTheYear2024Abstract"/>
  <xs:element name="AdvanceFromCustomers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AdvanceFromCustomers"/>
  <xs:element name="ResearchAndDevelopmentNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ResearchAndDevelopmentNet"/>
  <xs:element name="ProspectiveInitialPublicOfferingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProspectiveInitialPublicOfferingExpenses"/>
  <xs:element name="FinancingIncomeExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_FinancingIncomeExpensesNet"/>
  <xs:element name="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet"/>
  <xs:element name="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares"/>
  <xs:element name="ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
  <xs:element name="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
  <xs:element name="StockIssuedDuringPeriodSharesStockWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised"/>
  <xs:element name="StockIssuedDuringPeriodShareOfExerciseOfOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions"/>
  <xs:element name="StockIssuedDuringPeriodValueInvestors" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodValueInvestors"/>
  <xs:element name="StockIssuedDuringPeriodSharesInvestors" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodSharesInvestors"/>
  <xs:element name="StockIssuedDuringPeriodValueExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
  <xs:element name="StockIssuedDuringPeriodSharesExerciseOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
  <xs:element name="StockIssuedDuringPeriodValueAssociatedWithTheSEPA" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA"/>
  <xs:element name="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
  <xs:element name="IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering"/>
  <xs:element name="IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares"/>
  <xs:element name="IssuanceOfOrdinarySharesForTheReverseSplitProcess" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess"/>
  <xs:element name="AccruedInterestOnConvertibleSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AccruedInterestOnConvertibleSecurities"/>
  <xs:element name="AccruedInterestOnDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AccruedInterestOnDeposits"/>
  <xs:element name="MarketingExpensesPaidInOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_MarketingExpensesPaidInOrdinaryShares"/>
  <xs:element name="DecreaseincreaseInGovernmentalGrantsReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
  <xs:element name="DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses"/>
  <xs:element name="IncreaseDecreaseInAdvancePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IncreaseDecreaseInAdvancePayments"/>
  <xs:element name="DecreaseIncreaseInDepositsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_DecreaseIncreaseInDepositsNet"/>
  <xs:element name="PrepaymentsOfLeasing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_PrepaymentsOfLeasing"/>
  <xs:element name="ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
  <xs:element name="ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses"/>
  <xs:element name="ProceedsFromIssuanceOfSAFEs" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfSAFEs"/>
  <xs:element name="RefundToSAFEInvestors" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_RefundToSAFEInvestors"/>
  <xs:element name="ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
  <xs:element name="InterestReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_InterestReceived"/>
  <xs:element name="ConversionOfSAFEToEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConversionOfSAFEToEquity"/>
  <xs:element name="RightofUseAssetRecognizedAgainstLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_RightofUseAssetRecognizedAgainstLeaseLiability"/>
  <xs:element name="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock"/>
  <xs:element name="CreditFacilityDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CreditFacilityDisclosureTextBlock"/>
  <xs:element name="CostOfRevenuesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CostOfRevenuesPolicyTextBlock"/>
  <xs:element name="GovernmentalGrantsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_GovernmentalGrantsPolicyTextBlock"/>
  <xs:element name="FinanceIncomeAndExpensesPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock"/>
  <xs:element name="WarrantsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantsPolicyPolicyTextBlock"/>
  <xs:element name="SeverancePolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_SeverancePolicyTextBlock"/>
  <xs:element name="AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock"/>
  <xs:element name="ScheduleOfAnnualRatesOfDepreciationTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock"/>
  <xs:element name="ScheduleOfOptionsToConsultantsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfOptionsToConsultantsTableTextBlock"/>
  <xs:element name="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock"/>
  <xs:element name="SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable"/>
  <xs:element name="AnnualRateOfDepreciation" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualRateOfDepreciation"/>
  <xs:element name="InventoryWriteoff" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_InventoryWriteoff"/>
  <xs:element name="ShareholdersEquityScheduleofShareCapitalDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable"/>
  <xs:element name="NumberOfSharesIssuedAndOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_NumberOfSharesIssuedAndOutstanding"/>
  <xs:element name="ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable"/>
  <xs:element name="ShareholdersEquityScheduleofOptionsActivityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions"/>
  <xs:element name="ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable"/>
  <xs:element name="ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate"/>
  <xs:element name="ShareBasedCompensationArrangementNotes" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementNotes"/>
  <xs:element name="OrdinarySharesAndPrefundedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharesAndPrefundedWarrants"/>
  <xs:element name="GeneralDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_GeneralDetailsTable"/>
  <xs:element name="AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany"/>
  <xs:element name="ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus"/>
  <xs:element name="IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue"/>
  <xs:element name="ReverseStockSplitNumberOfSharesConverted" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ReverseStockSplitNumberOfSharesConverted"/>
  <xs:element name="ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted"/>
  <xs:element name="ReverseSplitParValue" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_ReverseSplitParValue"/>
  <xs:element name="NetProceedsFromIssuanceSecondaryPublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_NetProceedsFromIssuanceSecondaryPublicOffering"/>
  <xs:element name="IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement"/>
  <xs:element name="ProceedsFromIssuanceRegisteredDirectOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedsFromIssuanceRegisteredDirectOffering"/>
  <xs:element name="StockholdersEquityRequirementByStockExchanges" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_StockholdersEquityRequirementByStockExchanges"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="RateOfMonthlySeverancePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_RateOfMonthlySeverancePercentage"/>
  <xs:element name="StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable"/>
  <xs:element name="PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice"/>
  <xs:element name="CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice"/>
  <xs:element name="NumberOfAmountIssuableAsCommitmentFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_NumberOfAmountIssuableAsCommitmentFee"/>
  <xs:element name="PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement"/>
  <xs:element name="CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice"/>
  <xs:element name="PaymentsForStructuringFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_PaymentsForStructuringFee"/>
  <xs:element name="PrePaidAdvances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_PrePaidAdvances"/>
  <xs:element name="PurchasePriceDiscount" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_PurchasePriceDiscount"/>
  <xs:element name="MonthlyInstallmentPayment" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_MonthlyInstallmentPayment"/>
  <xs:element name="PrincipalAmountInstallmentPayment" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_PrincipalAmountInstallmentPayment"/>
  <xs:element name="ConvertiblePromissoryNotePremiumPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertiblePromissoryNotePremiumPercentage"/>
  <xs:element name="CommitmentsandContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_CommitmentsandContingenciesDetailsTable"/>
  <xs:element name="RoyaltiesRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_RoyaltiesRate"/>
  <xs:element name="GrantsReceivedEqualPercentageRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_GrantsReceivedEqualPercentageRate"/>
  <xs:element name="AnnualAlternativeInterestPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualAlternativeInterestPercentage"/>
  <xs:element name="AnnualInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualInterestRate"/>
  <xs:element name="FixedAnnualInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_FixedAnnualInterestRate"/>
  <xs:element name="AmountsReceivedAggregateAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AmountsReceivedAggregateAmount"/>
  <xs:element name="AmountOfDevelopmentProgram" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AmountOfDevelopmentProgram"/>
  <xs:element name="PercentageOfFinancing" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_PercentageOfFinancing"/>
  <xs:element name="TotalCashReceivedFromTheIIA" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_TotalCashReceivedFromTheIIA"/>
  <xs:element name="ExceptTransferProductionRight" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExceptTransferProductionRight"/>
  <xs:element name="ProductionTransferred" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProductionTransferred"/>
  <xs:element name="PayIncreasedRoyaltiesDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_PayIncreasedRoyaltiesDescription"/>
  <xs:element name="ResearchAndDevelopmentGrantsDetection" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ResearchAndDevelopmentGrantsDetection"/>
  <xs:element name="MaximumObligatinAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_MaximumObligatinAmount"/>
  <xs:element name="GrantsReceivedFromTheIMEI" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_GrantsReceivedFromTheIMEI"/>
  <xs:element name="RoyaltiesRatePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_RoyaltiesRatePercentage"/>
  <xs:element name="MarketingGrantReceived" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_MarketingGrantReceived"/>
  <xs:element name="LeasePaymentIncreased" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_LeasePaymentIncreased"/>
  <xs:element name="LeaseMonthlyRentalPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_LeaseMonthlyRentalPayments"/>
  <xs:element name="NumberOfVehicles" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_NumberOfVehicles"/>
  <xs:element name="LeaseAgreementsPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_LeaseAgreementsPeriod"/>
  <xs:element name="ConvertibleSecuritiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ConvertibleSecuritiesDetailsTable"/>
  <xs:element name="CashPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_CashPayment"/>
  <xs:element name="PremoneyValuationAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_PremoneyValuationAmount"/>
  <xs:element name="WarrantPricePerSharePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantPricePerSharePercentage"/>
  <xs:element name="PurchasePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_PurchasePricePerShare"/>
  <xs:element name="AggregateOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AggregateOrdinaryShares"/>
  <xs:element name="CreditFacilityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_CreditFacilityDetailsTable"/>
  <xs:element name="AggregateAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_AggregateAmount"/>
  <xs:element name="ServicesInExchangeForMonthlyBaseFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ServicesInExchangeForMonthlyBaseFee"/>
  <xs:element name="AggrementTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AggrementTerm"/>
  <xs:element name="WarrantsIssuedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantsIssuedPercentage"/>
  <xs:element name="BaseMonthlyFeeImmediatelyIncreaseAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount"/>
  <xs:element name="ExpenseOnServiceRendering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExpenseOnServiceRendering"/>
  <xs:element name="ShareholdersEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_ShareholdersEquityDetailsTable"/>
  <xs:element name="NumberOfOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_NumberOfOrdinaryShares"/>
  <xs:element name="NumberOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_NumberOfWarrants"/>
  <xs:element name="ExercisableWarrantsToShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExercisableWarrantsToShares"/>
  <xs:element name="UnderwritingNetProceed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnderwritingNetProceed"/>
  <xs:element name="UnderwritingDiscountsAndCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_UnderwritingDiscountsAndCommissions"/>
  <xs:element name="ProceedAfterInitialPublicOfferingExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_ProceedAfterInitialPublicOfferingExpenses"/>
  <xs:element name="SAFEsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_SAFEsAmount"/>
  <xs:element name="NumberOfInvestors" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_NumberOfInvestors"/>
  <xs:element name="InvestorAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_InvestorAmount"/>
  <xs:element name="InvestorsExercisedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_InvestorsExercisedWarrants"/>
  <xs:element name="ExercisePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExercisePricePerShare"/>
  <xs:element name="GrossProceedsOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_GrossProceedsOfOrdinaryShares"/>
  <xs:element name="IssuedAndSoldOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuedAndSoldOrdinaryShares"/>
  <xs:element name="PreFundWarrant" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_PreFundWarrant"/>
  <xs:element name="PurchaseOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_PurchaseOfWarrants"/>
  <xs:element name="CombinedPurchasePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_CombinedPurchasePricePerShare"/>
  <xs:element name="PreFundedWarrantsToPurchase" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_PreFundedWarrantsToPurchase"/>
  <xs:element name="OptionsAvailableForGrant" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_OptionsAvailableForGrant"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP"/>
  <xs:element name="FairMarketValueSharesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_FairMarketValueSharesPercentage"/>
  <xs:element name="TerminationPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TerminationPeriod"/>
  <xs:element name="NumberOfDaysForTermination" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_NumberOfDaysForTermination"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate"/>
  <xs:element name="OptionsExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_OptionsExpenses"/>
  <xs:element name="VestingPeriods" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_VestingPeriods"/>
  <xs:element name="IssuanceOfSharesOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_IssuanceOfSharesOptions"/>
  <xs:element name="ExercisePriceOfWarrants" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_ExercisePriceOfWarrants"/>
  <xs:element name="WarrantBeReducedToAnExercisePricePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantBeReducedToAnExercisePricePercentage"/>
  <xs:element name="InitialExercisePricePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_InitialExercisePricePercentage"/>
  <xs:element name="WeightedAveragePricePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WeightedAveragePricePercentage"/>
  <xs:element name="LowestResetPrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_LowestResetPrice"/>
  <xs:element name="InitialExercisePricesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_InitialExercisePricesPercentage"/>
  <xs:element name="TaxesonIncomeDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_TaxesonIncomeDetailsTable"/>
  <xs:element name="CorporateTaxRatePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CorporateTaxRatePercentage"/>
  <xs:element name="RelatedPartiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_RelatedPartiesDetailsTable"/>
  <xs:element name="EmploymentExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_EmploymentExpenses"/>
  <xs:element name="OfficerEmployeeMonthlySalary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wlds_OfficerEmployeeMonthlySalary"/>
  <xs:element name="RelatedPartyMonthlySalary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wlds_RelatedPartyMonthlySalary"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wlds_SubsequentEventsDetailsTable"/>
  <xs:element name="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight"/>
  <xs:element name="SaleOfStockNumberOfShareIssuedInTransaction" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_SaleOfStockNumberOfShareIssuedInTransaction"/>
  <xs:element name="AsherDahanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AsherDahanMember"/>
  <xs:element name="CofoundersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CofoundersMember"/>
  <xs:element name="ComputersAndSoftwareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ComputersAndSoftwareMember"/>
  <xs:element name="ConvertiblePromissoryNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertiblePromissoryNoteMember"/>
  <xs:element name="ConvertibleSecuritiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertibleSecuritiesMember"/>
  <xs:element name="ElectronicEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ElectronicEquipmentMember"/>
  <xs:element name="IIAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IIAMember"/>
  <xs:element name="IMEIMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_IMEIMember"/>
  <xs:element name="LeaseLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_LeaseLiabilityMember"/>
  <xs:element name="MachinesAndMoldsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_MachinesAndMoldsMember"/>
  <xs:element name="MoldMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_MoldMember"/>
  <xs:element name="NovemberTwoSevenTwoZeroTwoFourMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_NovemberTwoSevenTwoZeroTwoFourMember"/>
  <xs:element name="NovemberTwoSevenTwoZeroTwoFourOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember"/>
  <xs:element name="OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember"/>
  <xs:element name="OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember"/>
  <xs:element name="OrdinarySharesNoParValuePerShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_OrdinarySharesNoParValuePerShareMember"/>
  <xs:element name="PreFundedWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_PreFundedWarrantsMember"/>
  <xs:element name="September132022Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_September132022Member"/>
  <xs:element name="September152022OneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_September152022OneMember"/>
  <xs:element name="September152022TwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_September152022TwoMember"/>
  <xs:element name="StandbyEquityPurchaseAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StandbyEquityPurchaseAgreementMember"/>
  <xs:element name="TwoThousandFifteenMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandFifteenMember"/>
  <xs:element name="TwoThousandSeventeenMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandSeventeenMember"/>
  <xs:element name="TwoThousandTwentyFourGlobalEquityIncentivePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember"/>
  <xs:element name="TwoThousandTwentyFousEmployeeStockPurchasePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember"/>
  <xs:element name="TwoThousandTwentyThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandTwentyThreeMember"/>
  <xs:element name="TwoThousandTwentyoneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoThousandTwentyoneMember"/>
  <xs:element name="TwoZeroOneFiveMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_TwoZeroOneFiveMember"/>
  <xs:element name="WarrantsToPurchaseOrdinarySharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_WarrantsToPurchaseOrdinarySharesMember"/>
  <xs:element name="AnnualRatesOfDepreciationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_AnnualRatesOfDepreciationAbstract"/>
  <xs:element name="ConvertibleSecuritiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ConvertibleSecuritiesLineItems"/>
  <xs:element name="CreditFacilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_CreditFacilityAbstract"/>
  <xs:element name="ScheduleOfAnnualRatesOfDepreciationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfAnnualRatesOfDepreciationLineItems"/>
  <xs:element name="ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract"/>
  <xs:element name="SignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_SignificantAccountingPoliciesLineItems"/>
  <xs:element name="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract"/>
  <xs:element name="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wlds_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>wlds-20241231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 20 21:08:44 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedBalanceSheet" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedIncomeStatement" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedCashFlow" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofInventoriesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofPropertyandEquipmentNetTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"/>
  <calculationLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_GrantsReceivable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FIFOInventoryAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_FIFOInventoryAmount" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_AdvanceFromCustomers" xlink:href="wlds-20241231.xsd#wlds_AdvanceFromCustomers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="wlds_AdvanceFromCustomers" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_ResearchAndDevelopmentNet" xlink:href="wlds-20241231.xsd#wlds_ResearchAndDevelopmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="wlds_ResearchAndDevelopmentNet" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SellingAndMarketingExpense" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:href="wlds-20241231.xsd#wlds_ProspectiveInitialPublicOfferingExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_FinancingIncomeExpensesNet" xlink:href="wlds-20241231.xsd#wlds_FinancingIncomeExpensesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="wlds_FinancingIncomeExpensesNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnConvertibleSecurities" xlink:href="wlds-20241231.xsd#wlds_AccruedInterestOnConvertibleSecurities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_AccruedInterestOnConvertibleSecurities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnDeposits" xlink:href="wlds-20241231.xsd#wlds_AccruedInterestOnDeposits"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxPQtRsMwMGseXt1qIodzzmaL/glMbImLWgeHF6ERfU0NGZNGGhBtuxC9Hos2B2CZStFQyEAt1gsw5LAjYSeWBYHmpgvOpAIsHYidrOMxKx7alFavI1Y4b+UJB9h3C7DUXDO4VAaMvWLWPuyXtsxVuJERK5PbM3CjW7TfPHxLW3COLsUm6CaXuOY=] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_AccruedInterestOnDeposits" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_MarketingExpensesPaidInOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_MarketingExpensesPaidInOrdinaryShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_MarketingExpensesPaidInOrdinaryShares" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryWriteDown" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePayments" xlink:href="wlds-20241231.xsd#wlds_IncreaseDecreaseInAdvancePayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_IncreaseDecreaseInAdvancePayments" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:href="wlds-20241231.xsd#wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" xlink:href="wlds-20241231.xsd#wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" order="17" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseIncreaseInDepositsNet" xlink:href="wlds-20241231.xsd#wlds_DecreaseIncreaseInDepositsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="wlds_DecreaseIncreaseInDepositsNet" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wlds_PrepaymentsOfLeasing" xlink:href="wlds-20241231.xsd#wlds_PrepaymentsOfLeasing"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="wlds_PrepaymentsOfLeasing" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfSAFEs"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_RefundToSAFEInvestors" xlink:href="wlds-20241231.xsd#wlds_RefundToSAFEInvestors"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wlds_RefundToSAFEInvestors" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FIFOInventoryAmount"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="wlds_InventoryWriteoff" xlink:href="wlds-20241231.xsd#wlds_InventoryWriteoff"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="wlds_InventoryWriteoff" order="4" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>wlds-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 20 21:08:44 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedBalanceSheet" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedIncomeStatement" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquityType2or3" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedCashFlow" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_General" roleURI="http://www.wearabledevices.co.il/role/General"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SignificantAccountingPolicies" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_Inventories" roleURI="http://www.wearabledevices.co.il/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_PropertyandEquipmentNet" roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_Leases" roleURI="http://www.wearabledevices.co.il/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_StandbyEquityPurchaseAgreementandConvertiblePromissoryNote" roleURI="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_CommitmentsandContingencies" roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConvertibleSecurities" roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecurities"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_CreditFacility" roleURI="http://www.wearabledevices.co.il/role/CreditFacility"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquity" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_TaxesonIncome" roleURI="http://www.wearabledevices.co.il/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_RelatedParties" roleURI="http://www.wearabledevices.co.il/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SubsequentEvents" roleURI="http://www.wearabledevices.co.il/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_AccountingPoliciesByPolicy" roleURI="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SignificantAccountingPoliciesTables" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_InventoriesTables" roleURI="http://www.wearabledevices.co.il/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_PropertyandEquipmentNetTables" roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_LeasesTables" roleURI="http://www.wearabledevices.co.il/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquityTables" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofAnnualRatesofDepreciationTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofInventoriesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofPropertyandEquipmentNetTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofShareCapitalTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofShareCapitalTable_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofOptionsActivityTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofWeightedAverageAssumptionsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofOptionstoConsultantsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofShareBasedCompensationExpensesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_GeneralDetails" roleURI="http://www.wearabledevices.co.il/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SignificantAccountingPoliciesDetails" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_LeasesDetails" roleURI="http://www.wearabledevices.co.il/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails" roleURI="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_CommitmentsandContingenciesDetails" roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConvertibleSecuritiesDetails" roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_CreditFacilityDetails" roleURI="http://www.wearabledevices.co.il/role/CreditFacilityDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquityDetails" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_TaxesonIncomeDetails" roleURI="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_RelatedPartiesDetails" roleURI="http://www.wearabledevices.co.il/role/RelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SubsequentEventsDetails" roleURI="http://www.wearabledevices.co.il/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#DocumentAndEntityInformation" roleURI="http://www.wearabledevices.co.il/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_DepositsAssetsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_GrantsReceivable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FIFOInventoryAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_FIFOInventoryAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AdvanceFromCustomers" xlink:href="wlds-20241231.xsd#wlds_AdvanceFromCustomers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="wlds_AdvanceFromCustomers" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockValue" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="25" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockNoParValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ResearchAndDevelopmentNet" xlink:href="wlds-20241231.xsd#wlds_ResearchAndDevelopmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="wlds_ResearchAndDevelopmentNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:href="wlds-20241231.xsd#wlds_ProspectiveInitialPublicOfferingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_FinancingIncomeExpensesNet" xlink:href="wlds-20241231.xsd#wlds_FinancingIncomeExpensesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="wlds_FinancingIncomeExpensesNet" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="wlds-20241231.xsd#wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesInvestors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_StockIssuedDuringPeriodSharesInvestors" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueInvestors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_StockIssuedDuringPeriodValueInvestors" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess" order="24" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_Depreciation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnConvertibleSecurities" xlink:href="wlds-20241231.xsd#wlds_AccruedInterestOnConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_AccruedInterestOnConvertibleSecurities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnDeposits" xlink:href="wlds-20241231.xsd#wlds_AccruedInterestOnDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_AccruedInterestOnDeposits" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MarketingExpensesPaidInOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_MarketingExpensesPaidInOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_MarketingExpensesPaidInOrdinaryShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_InventoryWriteDown" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:href="wlds-20241231.xsd#wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" xlink:href="wlds-20241231.xsd#wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePayments" xlink:href="wlds-20241231.xsd#wlds_IncreaseDecreaseInAdvancePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_IncreaseDecreaseInAdvancePayments" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseIncreaseInDepositsNet" xlink:href="wlds-20241231.xsd#wlds_DecreaseIncreaseInDepositsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_DecreaseIncreaseInDepositsNet" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PrepaymentsOfLeasing" xlink:href="wlds-20241231.xsd#wlds_PrepaymentsOfLeasing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_PrepaymentsOfLeasing" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfSAFEs"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RefundToSAFEInvestors" xlink:href="wlds-20241231.xsd#wlds_RefundToSAFEInvestors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_RefundToSAFEInvestors" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_InterestPaidNet" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestReceived" xlink:href="wlds-20241231.xsd#wlds_InterestReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_InterestReceived" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfSAFEToEquity" xlink:href="wlds-20241231.xsd#wlds_ConversionOfSAFEToEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_ConversionOfSAFEToEquity" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:href="wlds-20241231.xsd#wlds_RightofUseAssetRecognizedAgainstLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" order="38" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/General" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/Inventories" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/Leases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" xlink:to="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/CommitmentsandContingencies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ConvertibleSecurities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/CreditFacility" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityAbstract" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityAbstract"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityDisclosureTextBlock" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_CreditFacilityAbstract" xlink:to="wlds_CreditFacilityDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquity" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/TaxesonIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/RelatedParties" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CostOfRevenuesPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_CostOfRevenuesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_CostOfRevenuesPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_GovernmentalGrantsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_GovernmentalGrantsPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsPolicyPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_WarrantsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_WarrantsPolicyPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_SeverancePolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_SeverancePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_SeverancePolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/InventoriesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/LeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfOptionsToConsultantsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationLineItems" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationLineItems" xlink:to="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:to="srt_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:href="wlds-20241231.xsd#wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ComputersAndSoftwareMember" xlink:href="wlds-20241231.xsd#wlds_ComputersAndSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_ComputersAndSoftwareMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ElectronicEquipmentMember" xlink:href="wlds-20241231.xsd#wlds_ElectronicEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_ElectronicEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MoldMember" xlink:href="wlds-20241231.xsd#wlds_MoldMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_MoldMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualRateOfDepreciation" xlink:href="wlds-20241231.xsd#wlds_AnnualRateOfDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationLineItems" xlink:to="wlds_AnnualRateOfDepreciation" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InventoryWriteoff" xlink:href="wlds-20241231.xsd#wlds_InventoryWriteoff"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="wlds_InventoryWriteoff" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FIFOInventoryAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_FIFOInventoryAmount" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ComputersAndSoftwareMember" xlink:href="wlds-20241231.xsd#wlds_ComputersAndSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_ComputersAndSoftwareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:href="wlds-20241231.xsd#wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ElectronicEquipmentMember" xlink:href="wlds-20241231.xsd#wlds_ElectronicEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_ElectronicEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MachinesAndMoldsMember" xlink:href="wlds-20241231.xsd#wlds_MachinesAndMoldsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="wlds_MachinesAndMoldsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding" xlink:href="wlds-20241231.xsd#wlds_NumberOfSharesIssuedAndOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="wlds_NumberOfSharesIssuedAndOutstanding" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:to="us-gaap_AwardDateAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:to="srt_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandFifteenMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandFifteenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="wlds_TwoThousandFifteenMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandSeventeenMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandSeventeenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="wlds_TwoThousandSeventeenMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyoneMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyoneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="wlds_TwoThousandTwentyoneMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyThreeMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="wlds_TwoThousandTwentyThreeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_September132022Member" xlink:href="wlds-20241231.xsd#wlds_September132022Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_September132022Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022OneMember" xlink:href="wlds-20241231.xsd#wlds_September152022OneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_September152022OneMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022TwoMember" xlink:href="wlds-20241231.xsd#wlds_September152022TwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_September152022TwoMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NovemberTwoSevenTwoZeroTwoFourMember" xlink:href="wlds-20241231.xsd#wlds_NovemberTwoSevenTwoZeroTwoFourMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_NovemberTwoSevenTwoZeroTwoFourMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember" xlink:href="wlds-20241231.xsd#wlds_NovemberTwoSevenTwoZeroTwoFourOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementNotes" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="wlds_ShareBasedCompensationArrangementNotes" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesAndPrefundedWarrants" xlink:href="wlds-20241231.xsd#wlds_OrdinarySharesAndPrefundedWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="wlds_OrdinarySharesAndPrefundedWarrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals" xlink:type="extended">
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxPQtRsMwMGseXt1qIodzzmaL/glMbImLWgeHF6ERfU0NGZNGGhBtuxC9Hos2B2CZStFQyEAt1gsw5LAjYSeWBYHmpgvOpAIsHYidrOMxKx7alFavI1Y4b+UJB9h3C7DUXDO4VAaMvWLWPuyXtsxVuJGWqoYCIwzOVdBUq8ccAPtXk0dPuAOTKS0=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/GeneralDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_GeneralDetailsTable" xlink:href="wlds-20241231.xsd#wlds_GeneralDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_GeneralDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_GeneralDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_GeneralDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" xlink:href="wlds-20241231.xsd#wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" xlink:href="wlds-20241231.xsd#wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ReverseStockSplitNumberOfSharesConverted" xlink:href="wlds-20241231.xsd#wlds_ReverseStockSplitNumberOfSharesConverted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_ReverseStockSplitNumberOfSharesConverted" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" xlink:href="wlds-20241231.xsd#wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ReverseSplitParValue" xlink:href="wlds-20241231.xsd#wlds_ReverseSplitParValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_ReverseSplitParValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:href="wlds-20241231.xsd#wlds_NetProceedsFromIssuanceSecondaryPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceRegisteredDirectOffering" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceRegisteredDirectOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_ProceedsFromIssuanceRegisteredDirectOffering" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockholdersEquityRequirementByStockExchanges" xlink:href="wlds-20241231.xsd#wlds_StockholdersEquityRequirementByStockExchanges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="wlds_StockholdersEquityRequirementByStockExchanges" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockholdersEquity" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesLineItems" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_SignificantAccountingPoliciesLineItems" xlink:to="wlds_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseLiabilityMember" xlink:href="wlds-20241231.xsd#wlds_LeaseLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wlds_LeaseLiabilityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DebtWeightedAverageInterestRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RateOfMonthlySeverancePercentage" xlink:href="wlds-20241231.xsd#wlds_RateOfMonthlySeverancePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_SignificantAccountingPoliciesLineItems" xlink:to="wlds_RateOfMonthlySeverancePercentage" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/LeasesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseExpense" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:href="wlds-20241231.xsd#wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:to="srt_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertiblePromissoryNoteMember" xlink:href="wlds-20241231.xsd#wlds_ConvertiblePromissoryNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wlds_ConvertiblePromissoryNoteMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfAmountIssuableAsCommitmentFee" xlink:href="wlds-20241231.xsd#wlds_NumberOfAmountIssuableAsCommitmentFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_NumberOfAmountIssuableAsCommitmentFee" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" xlink:href="wlds-20241231.xsd#wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PaymentsForStructuringFee" xlink:href="wlds-20241231.xsd#wlds_PaymentsForStructuringFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_PaymentsForStructuringFee" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PrePaidAdvances" xlink:href="wlds-20241231.xsd#wlds_PrePaidAdvances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_PrePaidAdvances" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchasePriceDiscount" xlink:href="wlds-20241231.xsd#wlds_PurchasePriceDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_PurchasePriceDiscount" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MonthlyInstallmentPayment" xlink:href="wlds-20241231.xsd#wlds_MonthlyInstallmentPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_MonthlyInstallmentPayment" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PrincipalAmountInstallmentPayment" xlink:href="wlds-20241231.xsd#wlds_PrincipalAmountInstallmentPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_PrincipalAmountInstallmentPayment" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertiblePromissoryNotePremiumPercentage" xlink:href="wlds-20241231.xsd#wlds_ConvertiblePromissoryNotePremiumPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_ConvertiblePromissoryNotePremiumPercentage" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_CommitmentsandContingenciesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_CommitmentsandContingenciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_CommitmentsandContingenciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="srt_StatementScenarioAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_OtherCommitmentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="srt_RangeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IIAMember" xlink:href="wlds-20241231.xsd#wlds_IIAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="wlds_IIAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IMEIMember" xlink:href="wlds-20241231.xsd#wlds_IMEIMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="wlds_IMEIMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAgreementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LeaseAgreementsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RoyaltiesRate" xlink:href="wlds-20241231.xsd#wlds_RoyaltiesRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_RoyaltiesRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GrantsReceivedEqualPercentageRate" xlink:href="wlds-20241231.xsd#wlds_GrantsReceivedEqualPercentageRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_GrantsReceivedEqualPercentageRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualAlternativeInterestPercentage" xlink:href="wlds-20241231.xsd#wlds_AnnualAlternativeInterestPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_AnnualAlternativeInterestPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualInterestRate" xlink:href="wlds-20241231.xsd#wlds_AnnualInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_AnnualInterestRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_FixedAnnualInterestRate" xlink:href="wlds-20241231.xsd#wlds_FixedAnnualInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_FixedAnnualInterestRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AmountsReceivedAggregateAmount" xlink:href="wlds-20241231.xsd#wlds_AmountsReceivedAggregateAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_AmountsReceivedAggregateAmount" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AmountOfDevelopmentProgram" xlink:href="wlds-20241231.xsd#wlds_AmountOfDevelopmentProgram"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_AmountOfDevelopmentProgram" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PercentageOfFinancing" xlink:href="wlds-20241231.xsd#wlds_PercentageOfFinancing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_PercentageOfFinancing" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TotalCashReceivedFromTheIIA" xlink:href="wlds-20241231.xsd#wlds_TotalCashReceivedFromTheIIA"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_TotalCashReceivedFromTheIIA" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExceptTransferProductionRight" xlink:href="wlds-20241231.xsd#wlds_ExceptTransferProductionRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_ExceptTransferProductionRight" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProductionTransferred" xlink:href="wlds-20241231.xsd#wlds_ProductionTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_ProductionTransferred" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PayIncreasedRoyaltiesDescription" xlink:href="wlds-20241231.xsd#wlds_PayIncreasedRoyaltiesDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_PayIncreasedRoyaltiesDescription" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection" xlink:href="wlds-20241231.xsd#wlds_ResearchAndDevelopmentGrantsDetection"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_ResearchAndDevelopmentGrantsDetection" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MaximumObligatinAmount" xlink:href="wlds-20241231.xsd#wlds_MaximumObligatinAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_MaximumObligatinAmount" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GrantsReceivedFromTheIMEI" xlink:href="wlds-20241231.xsd#wlds_GrantsReceivedFromTheIMEI"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_GrantsReceivedFromTheIMEI" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesNetOfInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesNetOfInterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RevenuesNetOfInterestExpense" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RoyaltiesRatePercentage" xlink:href="wlds-20241231.xsd#wlds_RoyaltiesRatePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_RoyaltiesRatePercentage" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_MarketingGrantReceived" xlink:href="wlds-20241231.xsd#wlds_MarketingGrantReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_MarketingGrantReceived" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_GrantsReceivableCurrent" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseCost" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PaymentsForRent" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LeasePaymentIncreased" xlink:href="wlds-20241231.xsd#wlds_LeasePaymentIncreased"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_LeasePaymentIncreased" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseMonthlyRentalPayments" xlink:href="wlds-20241231.xsd#wlds_LeaseMonthlyRentalPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_LeaseMonthlyRentalPayments" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfVehicles" xlink:href="wlds-20241231.xsd#wlds_NumberOfVehicles"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_NumberOfVehicles" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseAgreementsPeriod" xlink:href="wlds-20241231.xsd#wlds_LeaseAgreementsPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="wlds_LeaseAgreementsPeriod" order="24" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesLineItems" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_ConvertibleSecuritiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ConvertibleSecuritiesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ConvertibleSecuritiesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesMember" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wlds_ConvertibleSecuritiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CashPayment" xlink:href="wlds-20241231.xsd#wlds_CashPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_CashPayment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PremoneyValuationAmount" xlink:href="wlds-20241231.xsd#wlds_PremoneyValuationAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_PremoneyValuationAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantPricePerSharePercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantPricePerSharePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_WarrantPricePerSharePercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchasePricePerShare" xlink:href="wlds-20241231.xsd#wlds_PurchasePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_PurchasePricePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AggregateOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_AggregateOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_AggregateOrdinaryShares" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/CreditFacilityDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_CreditFacilityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_CreditFacilityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_OtherBorrowings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AggregateAmount" xlink:href="wlds-20241231.xsd#wlds_AggregateAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_AggregateAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:href="wlds-20241231.xsd#wlds_ServicesInExchangeForMonthlyBaseFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_ServicesInExchangeForMonthlyBaseFee" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AggrementTerm" xlink:href="wlds-20241231.xsd#wlds_AggrementTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_AggrementTerm" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsIssuedPercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantsIssuedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_WarrantsIssuedPercentage" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:href="wlds-20241231.xsd#wlds_BaseMonthlyFeeImmediatelyIncreaseAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExpenseOnServiceRendering" xlink:href="wlds-20241231.xsd#wlds_ExpenseOnServiceRendering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="wlds_ExpenseOnServiceRendering" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_ShareholdersEquityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="srt_ShareRepurchaseProgramAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="srt_ShareRepurchaseProgramDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ShareRepurchaseProgramDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="srt_ShareRepurchaseProgramDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="srt_RangeAxis" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoZeroOneFiveMember" xlink:href="wlds-20241231.xsd#wlds_TwoZeroOneFiveMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="wlds_TwoZeroOneFiveMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PreFundedWarrantsMember" xlink:href="wlds-20241231.xsd#wlds_PreFundedWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="wlds_PreFundedWarrantsMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wlds_TwoZeroOneFiveMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StandbyEquityPurchaseAgreementMember" xlink:href="wlds-20241231.xsd#wlds_StandbyEquityPurchaseAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ShareRepurchaseProgramDomain" xlink:to="wlds_StandbyEquityPurchaseAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:to="us-gaap_InvestorMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_NumberOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_NumberOfOrdinaryShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfWarrants" xlink:href="wlds-20241231.xsd#wlds_NumberOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_NumberOfWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisableWarrantsToShares" xlink:href="wlds-20241231.xsd#wlds_ExercisableWarrantsToShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_ExercisableWarrantsToShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_UnderwritingNetProceed" xlink:href="wlds-20241231.xsd#wlds_UnderwritingNetProceed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_UnderwritingNetProceed" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_UnderwritingDiscountsAndCommissions" xlink:href="wlds-20241231.xsd#wlds_UnderwritingDiscountsAndCommissions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_UnderwritingDiscountsAndCommissions" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedAfterInitialPublicOfferingExpenses" xlink:href="wlds-20241231.xsd#wlds_ProceedAfterInitialPublicOfferingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_ProceedAfterInitialPublicOfferingExpenses" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_SAFEsAmount" xlink:href="wlds-20241231.xsd#wlds_SAFEsAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_SAFEsAmount" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfInvestors" xlink:href="wlds-20241231.xsd#wlds_NumberOfInvestors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_NumberOfInvestors" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InvestorAmount" xlink:href="wlds-20241231.xsd#wlds_InvestorAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_InvestorAmount" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_Cash" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InvestorsExercisedWarrants" xlink:href="wlds-20241231.xsd#wlds_InvestorsExercisedWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_InvestorsExercisedWarrants" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePricePerShare" xlink:href="wlds-20241231.xsd#wlds_ExercisePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_ExercisePricePerShare" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_GrossProceedsOfOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_GrossProceedsOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_GrossProceedsOfOrdinaryShares" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuedAndSoldOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_IssuedAndSoldOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_IssuedAndSoldOrdinaryShares" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PreFundWarrant" xlink:href="wlds-20241231.xsd#wlds_PreFundWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_PreFundWarrant" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchaseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_PurchaseOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_PurchaseOfWarrants" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CombinedPurchasePricePerShare" xlink:href="wlds-20241231.xsd#wlds_CombinedPurchasePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_CombinedPurchasePricePerShare" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PreFundedWarrantsToPurchase" xlink:href="wlds-20241231.xsd#wlds_PreFundedWarrantsToPurchase"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_PreFundedWarrantsToPurchase" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OptionsAvailableForGrant" xlink:href="wlds-20241231.xsd#wlds_OptionsAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_OptionsAvailableForGrant" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_FairMarketValueSharesPercentage" xlink:href="wlds-20241231.xsd#wlds_FairMarketValueSharesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_FairMarketValueSharesPercentage" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_TerminationPeriod" xlink:href="wlds-20241231.xsd#wlds_TerminationPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_TerminationPeriod" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfDaysForTermination" xlink:href="wlds-20241231.xsd#wlds_NumberOfDaysForTermination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_NumberOfDaysForTermination" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" order="44" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OptionsExpenses" xlink:href="wlds-20241231.xsd#wlds_OptionsExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_OptionsExpenses" order="45" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_VestingPeriods" xlink:href="wlds-20241231.xsd#wlds_VestingPeriods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_VestingPeriods" order="46" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesOptions" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_IssuanceOfSharesOptions" order="47" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="48" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="49" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePriceOfWarrants" xlink:href="wlds-20241231.xsd#wlds_ExercisePriceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_ExercisePriceOfWarrants" order="50" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="51" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantBeReducedToAnExercisePricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_WarrantBeReducedToAnExercisePricePercentage" order="52" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InitialExercisePricePercentage" xlink:href="wlds-20241231.xsd#wlds_InitialExercisePricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_InitialExercisePricePercentage" order="53" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WeightedAveragePricePercentage" xlink:href="wlds-20241231.xsd#wlds_WeightedAveragePricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_WeightedAveragePricePercentage" order="54" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_LowestResetPrice" xlink:href="wlds-20241231.xsd#wlds_LowestResetPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_LowestResetPrice" order="55" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_InitialExercisePricesPercentage" xlink:href="wlds-20241231.xsd#wlds_InitialExercisePricesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="wlds_InitialExercisePricesPercentage" order="56" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_TaxesonIncomeDetailsTable" xlink:href="wlds-20241231.xsd#wlds_TaxesonIncomeDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="wlds_TaxesonIncomeDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CorporateTaxRatePercentage" xlink:href="wlds-20241231.xsd#wlds_CorporateTaxRatePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="wlds_CorporateTaxRatePercentage" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/RelatedPartiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_RelatedPartiesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_RelatedPartiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_RelatedPartiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_RelatedPartiesDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_RelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_CofoundersMember" xlink:href="wlds-20241231.xsd#wlds_CofoundersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wlds_CofoundersMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_AsherDahanMember" xlink:href="wlds-20241231.xsd#wlds_AsherDahanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="wlds_AsherDahanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_EmploymentExpenses" xlink:href="wlds-20241231.xsd#wlds_EmploymentExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_EmploymentExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficerEmployeeMonthlySalary" xlink:href="wlds-20241231.xsd#wlds_OfficerEmployeeMonthlySalary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_OfficerEmployeeMonthlySalary" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_RelatedPartyMonthlySalary" xlink:href="wlds-20241231.xsd#wlds_RelatedPartyMonthlySalary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wlds_RelatedPartyMonthlySalary" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <loc xlink:type="locator" xlink:label="wlds_SubsequentEventsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="wlds_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SubsequentEventsDetailsTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SubsequentEventsDetailsTable" xlink:to="srt_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wlds_SubsequentEventsDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_PreFundedWarrantsMember" xlink:href="wlds-20241231.xsd#wlds_PreFundedWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="wlds_PreFundedWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" xlink:href="wlds-20241231.xsd#wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_SaleOfStockNumberOfShareIssuedInTransaction" xlink:href="wlds-20241231.xsd#wlds_SaleOfStockNumberOfShareIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="wlds_SaleOfStockNumberOfShareIssuedInTransaction" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.wearabledevices.co.il/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesNoParValuePerShareMember" xlink:href="wlds-20241231.xsd#wlds_OrdinarySharesNoParValuePerShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wlds_OrdinarySharesNoParValuePerShareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsToPurchaseOrdinarySharesMember" xlink:href="wlds-20241231.xsd#wlds_WarrantsToPurchaseOrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wlds_WarrantsToPurchaseOrdinarySharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorOpinionTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="38" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>wlds-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 20 21:08:44 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">TOTAL CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">TOTAL NON-CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">TOTAL CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">GROSS PROFIT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">OPERATING LOSS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">LOSS BEFORE TAX EXPENSES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET LOSS AND TOTAL COMPREHENSIVE LOSS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Loss for the period (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents at the beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash and cash equivalents at the end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">General [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNetAbstract_lbl" xml:lang="en-US">Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryNetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FIFOInventoryAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FIFOInventoryAmount_lbl" xml:lang="en-US">Inventories, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_FIFOInventoryAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FIFOInventoryAmount_lbl0" xml:lang="en-US">Inventories (Note 3)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_FIFOInventoryAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property and Equipment, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Total property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property and equipment, net (Note 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:to="wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Total operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US">Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total future minimum lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract_lbl" xml:lang="en-US">Stand by Equity Purchase Agreement and Convertible Promissory Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" xlink:to="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract_lbl" xml:lang="en-US">Convertible Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityAbstract" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CreditFacilityAbstract_lbl" xml:lang="en-US">Credit Facility [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityAbstract" xlink:to="wlds_CreditFacilityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Shareholders&#8217; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsActivityAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfOptionsActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfOptionsActivityAbstract_lbl" xml:lang="en-US">Schedule of Options Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsActivityAbstract" xlink:to="wlds_ScheduleOfOptionsActivityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding - beginning, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Outstanding - end, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding - beginning, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding - end, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US">Schedule of Weighted Average Assumptions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xml:lang="en-US">Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Taxes on Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Parties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositsAssetsCurrent_lbl" xml:lang="en-US">Short-term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivable_lbl" xml:lang="en-US">Governmental grant receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Other receivables and prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Long-term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets (Note 5)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Right of use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AdvanceFromCustomers" xlink:href="wlds-20241231.xsd#wlds_AdvanceFromCustomers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AdvanceFromCustomers_lbl" xml:lang="en-US">Advance payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AdvanceFromCustomers" xlink:to="wlds_AdvanceFromCustomers_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Convertible promissory note (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl0" xml:lang="en-US">Convertible promissory note balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll and other employment related accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl0" xml:lang="en-US">Short term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US">Less operating lease liabilities, current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Long term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US">Operating lease liabilities, non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY (Note 10):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary shares no par value: Authorized 50,000,000 as of December 31, 2024 and December 31, 2023; Issued and outstanding 707,463 shares as of December 31, 2024 and 254,843 shares as of December 31, 2023.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockNoParValue_lbl" xml:lang="en-US">Ordinary shares, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares, authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Ordinary shares, Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Ordinary shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_FinancingIncomeExpensesNet" xlink:href="wlds-20241231.xsd#wlds_FinancingIncomeExpensesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_FinancingIncomeExpensesNet_lbl" xml:lang="en-US">Financing income (expenses), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinancingIncomeExpensesNet" xlink:to="wlds_FinancingIncomeExpensesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per ordinary shares, basic (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Basic loss per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net loss per ordinary shares, diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of ordinary shares and pre-funded warrants outstanding basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted average number of ordinary shares and pre-funded warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of ordinary shares and pre-funded warrants outstanding diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2022Abstract" xlink:href="wlds-20241231.xsd#wlds_ChangesDuringTheYear2022Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ChangesDuringTheYear2022Abstract_lbl" xml:lang="en-US">CHANGES DURING THE YEAR 2022:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_ChangesDuringTheYear2022Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl" xml:lang="en-US">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of $1.6 million</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl" xml:lang="en-US">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of $1.6 million (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Units of ordinary shares and warrants issued, issuance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Conversion of SAFEs (as defined in Note 10) into ordinary shares upon completion of initial public offering (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="wlds-20241231.xsd#wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl" xml:lang="en-US">Conversion of SAFEs (as defined in Note 10) into ordinary shares upon completion of initial public offering (Note 10) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl" xml:lang="en-US">Issuance of ordinary shares as a result of exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl" xml:lang="en-US">Issuance of ordinary shares as a result of exercise of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:to="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions_lbl" xml:lang="en-US">Exercise of options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions" xlink:to="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share based compensation expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2023Abstract" xlink:href="wlds-20241231.xsd#wlds_ChangesDuringTheYear2023Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ChangesDuringTheYear2023Abstract_lbl" xml:lang="en-US">CHANGES DURING THE YEAR 2023:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="wlds_ChangesDuringTheYear2023Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Shares issued in the public offering, net of issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Shares issued in the public offering, net of issuance cost (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Issued and sold ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueInvestors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors_lbl" xml:lang="en-US">Issuance of shares to April 2021 investors (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueInvestors" xlink:to="wlds_StockIssuedDuringPeriodValueInvestors_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesInvestors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors_lbl" xml:lang="en-US">Issuance of shares to April 2021 investors (Note 10) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:to="wlds_StockIssuedDuringPeriodSharesInvestors_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl0" xml:lang="en-US">Exercised ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ChangesDuringTheYear2024Abstract" xlink:href="wlds-20241231.xsd#wlds_ChangesDuringTheYear2024Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ChangesDuringTheYear2024Abstract_lbl" xml:lang="en-US">CHANGES DURING THE YEAR 2024:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2024Abstract" xlink:to="wlds_ChangesDuringTheYear2024Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA_lbl" xml:lang="en-US">Issuance of shares associated with the SEPA (Note 1.d)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA" xlink:to="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl" xml:lang="en-US">Issuance of shares associated with the SEPA (Note 1.d) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl0" xml:lang="en-US">Ordinary shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl1" xml:lang="en-US">Issuance of shares associated with the SEPA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl1"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering_lbl" xml:lang="en-US">Issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares_lbl" xml:lang="en-US">Issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of ordinary shares to service provider</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of ordinary shares to service provider (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0" xml:lang="en-US">Issuance of ordinary shares to service provider</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess_lbl" xml:lang="en-US">Issuance of ordinary shares for the reverse split process (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess" xlink:to="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments required to reconcile net loss to net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnConvertibleSecurities" xlink:href="wlds-20241231.xsd#wlds_AccruedInterestOnConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AccruedInterestOnConvertibleSecurities_lbl" xml:lang="en-US">Interest expenses on convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnConvertibleSecurities" xlink:to="wlds_AccruedInterestOnConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AccruedInterestOnDeposits" xlink:href="wlds-20241231.xsd#wlds_AccruedInterestOnDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AccruedInterestOnDeposits_lbl" xml:lang="en-US">Accrued interest on deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnDeposits" xlink:to="wlds_AccruedInterestOnDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MarketingExpensesPaidInOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_MarketingExpensesPaidInOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MarketingExpensesPaidInOrdinaryShares_lbl" xml:lang="en-US">Marketing expenses paid in ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingExpensesPaidInOrdinaryShares" xlink:to="wlds_MarketingExpensesPaidInOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Provision for inventory write-off</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities items:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IncreaseDecreaseInAdvancePayments" xlink:href="wlds-20241231.xsd#wlds_IncreaseDecreaseInAdvancePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IncreaseDecreaseInAdvancePayments_lbl" xml:lang="en-US">Increase (decrease) in advance payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePayments" xlink:to="wlds_IncreaseDecreaseInAdvancePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Increase (decrease) in deferred revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Increase (decrease) in accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Increase (decrease) in accrued payroll and other employment related accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Increase in accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl" xml:lang="en-US">Proceeds from issuance of shares issued in the public offering, net of issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses_lbl" xml:lang="en-US">Proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfSAFEs"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs_lbl" xml:lang="en-US">Proceeds from issuance of SAFEs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSAFEs" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from credit line</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl" xml:lang="en-US">Proceeds from issuance of ordinary shares as a result of exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of ordinary shares associated with the SEPA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Gross proceeds from issuance of common stock (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US">Proceeds from ordinary shares (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from issuance of convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Disclosure:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InterestReceived" xlink:href="wlds-20241231.xsd#wlds_InterestReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InterestReceived_lbl" xml:lang="en-US">Interest received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestReceived" xlink:to="wlds_InterestReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConversionOfSAFEToEquity" xlink:href="wlds-20241231.xsd#wlds_ConversionOfSAFEToEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConversionOfSAFEToEquity_lbl" xml:lang="en-US">Conversion of SAFEs to equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEToEquity" xlink:to="wlds_ConversionOfSAFEToEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:href="wlds-20241231.xsd#wlds_RightofUseAssetRecognizedAgainstLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl" xml:lang="en-US">Right-of-use asset recognized against lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:to="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ResearchAndDevelopmentNet" xlink:href="wlds-20241231.xsd#wlds_ResearchAndDevelopmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_ResearchAndDevelopmentNet_lbl" xml:lang="en-US">Research and development, net (Note 7. a)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentNet" xlink:to="wlds_ResearchAndDevelopmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:href="wlds-20241231.xsd#wlds_ProspectiveInitialPublicOfferingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses_lbl" xml:lang="en-US">Initial public offering expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Tax expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xml:lang="en-US">Unrealized gain from foreign currency derivative activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Decrease in accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Decrease (increase) in inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:href="wlds-20241231.xsd#wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl" xml:lang="en-US">Decrease (increase) in governmental grants receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" xlink:href="wlds-20241231.xsd#wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses_lbl" xml:lang="en-US">Decrease (increase) in other receivables and prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" xlink:to="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_DecreaseIncreaseInDepositsNet" xlink:href="wlds-20241231.xsd#wlds_DecreaseIncreaseInDepositsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_DecreaseIncreaseInDepositsNet_lbl" xml:lang="en-US">Decrease (increase) in deposits, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseIncreaseInDepositsNet" xlink:to="wlds_DecreaseIncreaseInDepositsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PrepaymentsOfLeasing" xlink:href="wlds-20241231.xsd#wlds_PrepaymentsOfLeasing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_PrepaymentsOfLeasing_lbl" xml:lang="en-US">Prepayments of leasing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrepaymentsOfLeasing" xlink:to="wlds_PrepaymentsOfLeasing_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RefundToSAFEInvestors" xlink:href="wlds-20241231.xsd#wlds_RefundToSAFEInvestors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_RefundToSAFEInvestors_lbl" xml:lang="en-US">Refund to SAFE investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RefundToSAFEInvestors" xlink:to="wlds_RefundToSAFEInvestors_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Repayment of credit line</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl" xml:lang="en-US">Repayment of convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="us-gaap_RepaymentsOfConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesNoParValuePerShareMember" xlink:href="wlds-20241231.xsd#wlds_OrdinarySharesNoParValuePerShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharesNoParValuePerShareMember_lbl" xml:lang="en-US">Ordinary Shares, no par value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesNoParValuePerShareMember" xlink:to="wlds_OrdinarySharesNoParValuePerShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsToPurchaseOrdinarySharesMember" xlink:href="wlds-20241231.xsd#wlds_WarrantsToPurchaseOrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantsToPurchaseOrdinarySharesMember_lbl" xml:lang="en-US">Warrants to Purchase Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsToPurchaseOrdinarySharesMember" xlink:to="wlds_WarrantsToPurchaseOrdinarySharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl" xml:lang="en-US">Schedule of Annual Rates of Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualRateOfDepreciation" xlink:href="wlds-20241231.xsd#wlds_AnnualRateOfDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AnnualRateOfDepreciation_lbl" xml:lang="en-US">Annual rates of depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRateOfDepreciation" xlink:to="wlds_AnnualRateOfDepreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LIFOMethodRelatedItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LIFOMethodRelatedItemsAbstract_lbl" xml:lang="en-US">Cost:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:to="us-gaap_LIFOMethodRelatedItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US">Raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US">Work-in-progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US">Finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less - accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock_lbl" xml:lang="en-US">Stand by equity purchase agreement and convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" xlink:to="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">CONVERTIBLE SECURITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityDisclosureTextBlock" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CreditFacilityDisclosureTextBlock_lbl" xml:lang="en-US">CREDIT FACILITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityDisclosureTextBlock" xlink:to="wlds_CreditFacilityDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding" xlink:href="wlds-20241231.xsd#wlds_NumberOfSharesIssuedAndOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding_lbl" xml:lang="en-US">Ordinary shares, Issued and outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfSharesIssuedAndOutstanding" xlink:to="wlds_NumberOfSharesIssuedAndOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Options Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Expired or forfeited, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable at end, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable at end, Weighted average exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted-Average Assumptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Expected stock price volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl" xml:lang="en-US">Expected life of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfOptionsToConsultantsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl" xml:lang="en-US">Schedule of Options to Consultants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:to="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl" xml:lang="en-US">In connection with</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">No. of options issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">No. of options exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl" xml:lang="en-US">Schedule of Issuance of Equity Warrants to Investors and Associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Number of warrants to purchase Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0" xml:lang="en-US">Options available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Exercise price for each warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl" xml:lang="en-US">Exercise ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl" xml:lang="en-US">Expiration date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementNotes" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementNotes_lbl" xml:lang="en-US">Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementNotes" xlink:to="wlds_ShareBasedCompensationArrangementNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OrdinarySharesAndPrefundedWarrants" xlink:href="wlds-20241231.xsd#wlds_OrdinarySharesAndPrefundedWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OrdinarySharesAndPrefundedWarrants_lbl" xml:lang="en-US">Total number of ordinary shares and pre-funded warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesAndPrefundedWarrants" xlink:to="wlds_OrdinarySharesAndPrefundedWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES ON INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InventoryWriteoff" xlink:href="wlds-20241231.xsd#wlds_InventoryWriteoff"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wlds_InventoryWriteoff_lbl" xml:lang="en-US">Provision for inventory write-off</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InventoryWriteoff" xlink:to="wlds_InventoryWriteoff_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Expired or forfeited, Amount of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:href="wlds-20241231.xsd#wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember_lbl" xml:lang="en-US">Furniture and Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:to="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ComputersAndSoftwareMember" xlink:href="wlds-20241231.xsd#wlds_ComputersAndSoftwareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ComputersAndSoftwareMember_lbl" xml:lang="en-US">Computers and Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ComputersAndSoftwareMember" xlink:to="wlds_ComputersAndSoftwareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ElectronicEquipmentMember" xlink:href="wlds-20241231.xsd#wlds_ElectronicEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ElectronicEquipmentMember_lbl" xml:lang="en-US">Electronic Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ElectronicEquipmentMember" xlink:to="wlds_ElectronicEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MoldMember" xlink:href="wlds-20241231.xsd#wlds_MoldMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MoldMember_lbl" xml:lang="en-US">Machines and molds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MoldMember" xlink:to="wlds_MoldMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:href="wlds-20241231.xsd#wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember_lbl" xml:lang="en-US">Furniture and Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:to="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MachinesAndMoldsMember" xlink:href="wlds-20241231.xsd#wlds_MachinesAndMoldsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MachinesAndMoldsMember_lbl" xml:lang="en-US">Machines and Molds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MachinesAndMoldsMember" xlink:to="wlds_MachinesAndMoldsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandFifteenMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandFifteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandFifteenMember_lbl" xml:lang="en-US">2015 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandFifteenMember" xlink:to="wlds_TwoThousandFifteenMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandSeventeenMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandSeventeenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandSeventeenMember_lbl" xml:lang="en-US">2017 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandSeventeenMember" xlink:to="wlds_TwoThousandSeventeenMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyoneMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyoneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandTwentyoneMember_lbl" xml:lang="en-US">2021 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyoneMember" xlink:to="wlds_TwoThousandTwentyoneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyThreeMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandTwentyThreeMember_lbl" xml:lang="en-US">2023 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyThreeMember" xlink:to="wlds_TwoThousandTwentyThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Sales and Marketing Expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_September132022Member" xlink:href="wlds-20241231.xsd#wlds_September132022Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_September132022Member_lbl" xml:lang="en-US">September 13, 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September132022Member" xlink:to="wlds_September132022Member_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022OneMember" xlink:href="wlds-20241231.xsd#wlds_September152022OneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_September152022OneMember_lbl" xml:lang="en-US">September 15, 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022OneMember" xlink:to="wlds_September152022OneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_September152022TwoMember" xlink:href="wlds-20241231.xsd#wlds_September152022TwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_September152022TwoMember_lbl" xml:lang="en-US">September 15, 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022TwoMember" xlink:to="wlds_September152022TwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NovemberTwoSevenTwoZeroTwoFourMember" xlink:href="wlds-20241231.xsd#wlds_NovemberTwoSevenTwoZeroTwoFourMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NovemberTwoSevenTwoZeroTwoFourMember_lbl" xml:lang="en-US">November 27, 2024 Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NovemberTwoSevenTwoZeroTwoFourMember" xlink:to="wlds_NovemberTwoSevenTwoZeroTwoFourMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember" xlink:href="wlds-20241231.xsd#wlds_NovemberTwoSevenTwoZeroTwoFourOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember_lbl" xml:lang="en-US">November 27, 2024 Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember" xlink:to="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsAxis_lbl" xml:lang="en-US">Other Commitments [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_lbl" xml:lang="en-US">Partner Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ShareRepurchaseProgramAxis_lbl" xml:lang="en-US">Share Repurchase Program [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="srt_ShareRepurchaseProgramAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" xlink:href="wlds-20241231.xsd#wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany_lbl" xml:lang="en-US">Gross revenue limit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" xlink:to="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" xlink:href="wlds-20241231.xsd#wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus_lbl" xml:lang="en-US">Value of ordinary shares and warrants held by non-affiliates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" xlink:to="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue_lbl" xml:lang="en-US">Value of non-convertible debt securities issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" xlink:to="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl0" xml:lang="en-US">Reverse share split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ReverseStockSplitNumberOfSharesConverted" xlink:href="wlds-20241231.xsd#wlds_ReverseStockSplitNumberOfSharesConverted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ReverseStockSplitNumberOfSharesConverted_lbl" xml:lang="en-US">Reverse stock split, shares issued and outstanding (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseStockSplitNumberOfSharesConverted" xlink:to="wlds_ReverseStockSplitNumberOfSharesConverted_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" xlink:href="wlds-20241231.xsd#wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted_lbl" xml:lang="en-US">Number of shares combined in reverse split (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" xlink:to="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ReverseSplitParValue" xlink:href="wlds-20241231.xsd#wlds_ReverseSplitParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ReverseSplitParValue_lbl" xml:lang="en-US">Reverse split par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseSplitParValue" xlink:to="wlds_ReverseSplitParValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Net proceeds from issuance of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Gross proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:href="wlds-20241231.xsd#wlds_NetProceedsFromIssuanceSecondaryPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl" xml:lang="en-US">Net proceeds from secondary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:to="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement_lbl" xml:lang="en-US">SEPA for net proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" xlink:to="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedsFromIssuanceRegisteredDirectOffering" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceRegisteredDirectOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedsFromIssuanceRegisteredDirectOffering_lbl" xml:lang="en-US">Net proceeds from registered direct offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceRegisteredDirectOffering" xlink:to="wlds_ProceedsFromIssuanceRegisteredDirectOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Ordinary share price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StockholdersEquityRequirementByStockExchanges" xlink:href="wlds-20241231.xsd#wlds_StockholdersEquityRequirementByStockExchanges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StockholdersEquityRequirementByStockExchanges_lbl" xml:lang="en-US">Stockholders equity requirement by stock exchanges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockholdersEquityRequirementByStockExchanges" xlink:to="wlds_StockholdersEquityRequirementByStockExchanges_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtWeightedAverageInterestRate_lbl" xml:lang="en-US">Weighted average interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtWeightedAverageInterestRate" xlink:to="us-gaap_DebtWeightedAverageInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl" xml:lang="en-US">Lease term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RateOfMonthlySeverancePercentage" xlink:href="wlds-20241231.xsd#wlds_RateOfMonthlySeverancePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RateOfMonthlySeverancePercentage_lbl" xml:lang="en-US">Rate of monthly severance, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RateOfMonthlySeverancePercentage" xlink:to="wlds_RateOfMonthlySeverancePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US">Leases remaining terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xml:lang="en-US">Leases extend term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Total operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice_lbl" xml:lang="en-US">Purchase price of shares, percentage on lowest VWAP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" xlink:to="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice_lbl" xml:lang="en-US">Purchase price calculation of shares, pricing period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" xlink:to="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfAmountIssuableAsCommitmentFee" xlink:href="wlds-20241231.xsd#wlds_NumberOfAmountIssuableAsCommitmentFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NumberOfAmountIssuableAsCommitmentFee_lbl" xml:lang="en-US">Number of amount issuable as commitment fee (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfAmountIssuableAsCommitmentFee" xlink:to="wlds_NumberOfAmountIssuableAsCommitmentFee_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" xlink:href="wlds-20241231.xsd#wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement_lbl" xml:lang="en-US">Percentage of aggregate amount available to be sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" xlink:to="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice_lbl" xml:lang="en-US">Number of trading days for calculating average VWAP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" xlink:to="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PaymentsForStructuringFee" xlink:href="wlds-20241231.xsd#wlds_PaymentsForStructuringFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PaymentsForStructuringFee_lbl" xml:lang="en-US">Structuring fee paid (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PaymentsForStructuringFee" xlink:to="wlds_PaymentsForStructuringFee_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PrePaidAdvances" xlink:href="wlds-20241231.xsd#wlds_PrePaidAdvances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PrePaidAdvances_lbl" xml:lang="en-US">Pre-paid advances of commitment amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrePaidAdvances" xlink:to="wlds_PrePaidAdvances_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchasePriceDiscount" xlink:href="wlds-20241231.xsd#wlds_PurchasePriceDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PurchasePriceDiscount_lbl" xml:lang="en-US">Discounted of purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePriceDiscount" xlink:to="wlds_PurchasePriceDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Percentage of interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MonthlyInstallmentPayment" xlink:href="wlds-20241231.xsd#wlds_MonthlyInstallmentPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MonthlyInstallmentPayment_lbl" xml:lang="en-US">Monthly installment payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MonthlyInstallmentPayment" xlink:to="wlds_MonthlyInstallmentPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PrincipalAmountInstallmentPayment" xlink:href="wlds-20241231.xsd#wlds_PrincipalAmountInstallmentPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PrincipalAmountInstallmentPayment_lbl" xml:lang="en-US">Principal amount of installment payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrincipalAmountInstallmentPayment" xlink:to="wlds_PrincipalAmountInstallmentPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl" xml:lang="en-US">Conversion price per ordinary share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertiblePromissoryNotePremiumPercentage" xlink:href="wlds-20241231.xsd#wlds_ConvertiblePromissoryNotePremiumPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConvertiblePromissoryNotePremiumPercentage_lbl" xml:lang="en-US">Convertible promissory note premium percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertiblePromissoryNotePremiumPercentage" xlink:to="wlds_ConvertiblePromissoryNotePremiumPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Promissory note including accrued interest (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RoyaltiesRate" xlink:href="wlds-20241231.xsd#wlds_RoyaltiesRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RoyaltiesRate_lbl" xml:lang="en-US">Royalties rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRate" xlink:to="wlds_RoyaltiesRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GrantsReceivedEqualPercentageRate" xlink:href="wlds-20241231.xsd#wlds_GrantsReceivedEqualPercentageRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GrantsReceivedEqualPercentageRate_lbl" xml:lang="en-US">Grants received equal percentage rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedEqualPercentageRate" xlink:to="wlds_GrantsReceivedEqualPercentageRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualAlternativeInterestPercentage" xlink:href="wlds-20241231.xsd#wlds_AnnualAlternativeInterestPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AnnualAlternativeInterestPercentage_lbl" xml:lang="en-US">Annual alternative interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualAlternativeInterestPercentage" xlink:to="wlds_AnnualAlternativeInterestPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualInterestRate" xlink:href="wlds-20241231.xsd#wlds_AnnualInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AnnualInterestRate_lbl" xml:lang="en-US">Annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualInterestRate" xlink:to="wlds_AnnualInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_FixedAnnualInterestRate" xlink:href="wlds-20241231.xsd#wlds_FixedAnnualInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_FixedAnnualInterestRate_lbl" xml:lang="en-US">Fixed annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FixedAnnualInterestRate" xlink:to="wlds_FixedAnnualInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AmountsReceivedAggregateAmount" xlink:href="wlds-20241231.xsd#wlds_AmountsReceivedAggregateAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AmountsReceivedAggregateAmount_lbl" xml:lang="en-US">Amounts received aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountsReceivedAggregateAmount" xlink:to="wlds_AmountsReceivedAggregateAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AmountOfDevelopmentProgram" xlink:href="wlds-20241231.xsd#wlds_AmountOfDevelopmentProgram"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AmountOfDevelopmentProgram_lbl" xml:lang="en-US">Approved development program</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountOfDevelopmentProgram" xlink:to="wlds_AmountOfDevelopmentProgram_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PercentageOfFinancing" xlink:href="wlds-20241231.xsd#wlds_PercentageOfFinancing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PercentageOfFinancing_lbl" xml:lang="en-US">Financing rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfFinancing" xlink:to="wlds_PercentageOfFinancing_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TotalCashReceivedFromTheIIA" xlink:href="wlds-20241231.xsd#wlds_TotalCashReceivedFromTheIIA"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TotalCashReceivedFromTheIIA_lbl" xml:lang="en-US">Total cash received from the IIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalCashReceivedFromTheIIA" xlink:to="wlds_TotalCashReceivedFromTheIIA_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExceptTransferProductionRight" xlink:href="wlds-20241231.xsd#wlds_ExceptTransferProductionRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExceptTransferProductionRight_lbl" xml:lang="en-US">Except transfer production right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExceptTransferProductionRight" xlink:to="wlds_ExceptTransferProductionRight_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProductionTransferred" xlink:href="wlds-20241231.xsd#wlds_ProductionTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProductionTransferred_lbl" xml:lang="en-US">Production transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProductionTransferred" xlink:to="wlds_ProductionTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PayIncreasedRoyaltiesDescription" xlink:href="wlds-20241231.xsd#wlds_PayIncreasedRoyaltiesDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PayIncreasedRoyaltiesDescription_lbl" xml:lang="en-US">Pay increased royalties, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PayIncreasedRoyaltiesDescription" xlink:to="wlds_PayIncreasedRoyaltiesDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection" xlink:href="wlds-20241231.xsd#wlds_ResearchAndDevelopmentGrantsDetection"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection_lbl" xml:lang="en-US">Research and development grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentGrantsDetection" xlink:to="wlds_ResearchAndDevelopmentGrantsDetection_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MaximumObligatinAmount" xlink:href="wlds-20241231.xsd#wlds_MaximumObligatinAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MaximumObligatinAmount_lbl" xml:lang="en-US">Maximum obligatin amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MaximumObligatinAmount" xlink:to="wlds_MaximumObligatinAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GrantsReceivedFromTheIMEI" xlink:href="wlds-20241231.xsd#wlds_GrantsReceivedFromTheIMEI"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GrantsReceivedFromTheIMEI_lbl" xml:lang="en-US">Grants received from the IMEI</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedFromTheIMEI" xlink:to="wlds_GrantsReceivedFromTheIMEI_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesNetOfInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesNetOfInterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenuesNetOfInterestExpense_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesNetOfInterestExpense" xlink:to="us-gaap_RevenuesNetOfInterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RoyaltiesRatePercentage" xlink:href="wlds-20241231.xsd#wlds_RoyaltiesRatePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RoyaltiesRatePercentage_lbl" xml:lang="en-US">Royalties rate percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRatePercentage" xlink:to="wlds_RoyaltiesRatePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_MarketingGrantReceived" xlink:href="wlds-20241231.xsd#wlds_MarketingGrantReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_MarketingGrantReceived_lbl" xml:lang="en-US">Marketing grant received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingGrantReceived" xlink:to="wlds_MarketingGrantReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US">Maximum obligation amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Monthly lease payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Rent payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LeasePaymentIncreased" xlink:href="wlds-20241231.xsd#wlds_LeasePaymentIncreased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LeasePaymentIncreased_lbl" xml:lang="en-US">Lease payment increased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeasePaymentIncreased" xlink:to="wlds_LeasePaymentIncreased_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseMonthlyRentalPayments" xlink:href="wlds-20241231.xsd#wlds_LeaseMonthlyRentalPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LeaseMonthlyRentalPayments_lbl" xml:lang="en-US">Lease monthly payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseMonthlyRentalPayments" xlink:to="wlds_LeaseMonthlyRentalPayments_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfVehicles" xlink:href="wlds-20241231.xsd#wlds_NumberOfVehicles"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NumberOfVehicles_lbl" xml:lang="en-US">Number of vehicles (in Vehicles)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfVehicles" xlink:to="wlds_NumberOfVehicles_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseAgreementsPeriod" xlink:href="wlds-20241231.xsd#wlds_LeaseAgreementsPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LeaseAgreementsPeriod_lbl" xml:lang="en-US">Lease agreements period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreementsPeriod" xlink:to="wlds_LeaseAgreementsPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CashPayment" xlink:href="wlds-20241231.xsd#wlds_CashPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CashPayment_lbl" xml:lang="en-US">Cash payment (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CashPayment" xlink:to="wlds_CashPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PremoneyValuationAmount" xlink:href="wlds-20241231.xsd#wlds_PremoneyValuationAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PremoneyValuationAmount_lbl" xml:lang="en-US">Pre-money valuation amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PremoneyValuationAmount" xlink:to="wlds_PremoneyValuationAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantPricePerSharePercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantPricePerSharePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantPricePerSharePercentage_lbl" xml:lang="en-US">Warrant price per share percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantPricePerSharePercentage" xlink:to="wlds_WarrantPricePerSharePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchasePricePerShare" xlink:href="wlds-20241231.xsd#wlds_PurchasePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PurchasePricePerShare_lbl" xml:lang="en-US">Purchase price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePricePerShare" xlink:to="wlds_PurchasePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Exercise price range (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1"/>
    <loc xlink:type="locator" xlink:label="wlds_AggregateOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_AggregateOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AggregateOrdinaryShares_lbl" xml:lang="en-US">Aggregate ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateOrdinaryShares" xlink:to="wlds_AggregateOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherBorrowings_lbl" xml:lang="en-US">Initial credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Credit facility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AggregateAmount" xlink:href="wlds-20241231.xsd#wlds_AggregateAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AggregateAmount_lbl" xml:lang="en-US">Aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateAmount" xlink:to="wlds_AggregateAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl" xml:lang="en-US">Credit facility bore interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:href="wlds-20241231.xsd#wlds_ServicesInExchangeForMonthlyBaseFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee_lbl" xml:lang="en-US">Services in exchange for monthly base fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:to="wlds_ServicesInExchangeForMonthlyBaseFee_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AggrementTerm" xlink:href="wlds-20241231.xsd#wlds_AggrementTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AggrementTerm_lbl" xml:lang="en-US">Agreement term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggrementTerm" xlink:to="wlds_AggrementTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsIssuedPercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantsIssuedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantsIssuedPercentage_lbl" xml:lang="en-US">Warrants issued percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsIssuedPercentage" xlink:to="wlds_WarrantsIssuedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:href="wlds-20241231.xsd#wlds_BaseMonthlyFeeImmediatelyIncreaseAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl" xml:lang="en-US">Base monthly fee immediately increase amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:to="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExpenseOnServiceRendering" xlink:href="wlds-20241231.xsd#wlds_ExpenseOnServiceRendering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExpenseOnServiceRendering_lbl" xml:lang="en-US">Total expense on service</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExpenseOnServiceRendering" xlink:to="wlds_ExpenseOnServiceRendering_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_NumberOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NumberOfOrdinaryShares_lbl" xml:lang="en-US">Number of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfOrdinaryShares" xlink:to="wlds_NumberOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfWarrants" xlink:href="wlds-20241231.xsd#wlds_NumberOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NumberOfWarrants_lbl" xml:lang="en-US">Number of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfWarrants" xlink:to="wlds_NumberOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants to purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisableWarrantsToShares" xlink:href="wlds-20241231.xsd#wlds_ExercisableWarrantsToShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExercisableWarrantsToShares_lbl" xml:lang="en-US">Exercised warrants to shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisableWarrantsToShares" xlink:to="wlds_ExercisableWarrantsToShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnderwritingNetProceed" xlink:href="wlds-20241231.xsd#wlds_UnderwritingNetProceed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnderwritingNetProceed_lbl" xml:lang="en-US">Underwriting net proceed (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingNetProceed" xlink:to="wlds_UnderwritingNetProceed_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_UnderwritingDiscountsAndCommissions" xlink:href="wlds-20241231.xsd#wlds_UnderwritingDiscountsAndCommissions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_UnderwritingDiscountsAndCommissions_lbl" xml:lang="en-US">Underwriting discounts and commissions (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingDiscountsAndCommissions" xlink:to="wlds_UnderwritingDiscountsAndCommissions_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ProceedAfterInitialPublicOfferingExpenses" xlink:href="wlds-20241231.xsd#wlds_ProceedAfterInitialPublicOfferingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ProceedAfterInitialPublicOfferingExpenses_lbl" xml:lang="en-US">Proceed after initial public offering expenses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedAfterInitialPublicOfferingExpenses" xlink:to="wlds_ProceedAfterInitialPublicOfferingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SAFEsAmount" xlink:href="wlds-20241231.xsd#wlds_SAFEsAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_SAFEsAmount_lbl" xml:lang="en-US">SAFEs amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SAFEsAmount" xlink:to="wlds_SAFEsAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfInvestors" xlink:href="wlds-20241231.xsd#wlds_NumberOfInvestors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NumberOfInvestors_lbl" xml:lang="en-US">Number of investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfInvestors" xlink:to="wlds_NumberOfInvestors_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InvestorAmount" xlink:href="wlds-20241231.xsd#wlds_InvestorAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InvestorAmount_lbl" xml:lang="en-US">Investor amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorAmount" xlink:to="wlds_InvestorAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Converted amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Shares converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xml:lang="en-US">Aggregate amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Outstanding voting securities percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InvestorsExercisedWarrants" xlink:href="wlds-20241231.xsd#wlds_InvestorsExercisedWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InvestorsExercisedWarrants_lbl" xml:lang="en-US">Investors exercised warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorsExercisedWarrants" xlink:to="wlds_InvestorsExercisedWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePricePerShare" xlink:href="wlds-20241231.xsd#wlds_ExercisePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExercisePricePerShare_lbl" xml:lang="en-US">Exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePricePerShare" xlink:to="wlds_ExercisePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GrossProceedsOfOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_GrossProceedsOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GrossProceedsOfOrdinaryShares_lbl" xml:lang="en-US">Gross proceeds of ordinary shares (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossProceedsOfOrdinaryShares" xlink:to="wlds_GrossProceedsOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuedAndSoldOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_IssuedAndSoldOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuedAndSoldOrdinaryShares_lbl" xml:lang="en-US">Issued and sold ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuedAndSoldOrdinaryShares" xlink:to="wlds_IssuedAndSoldOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PreFundWarrant" xlink:href="wlds-20241231.xsd#wlds_PreFundWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PreFundWarrant_lbl" xml:lang="en-US">Pre fund warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PreFundWarrant" xlink:to="wlds_PreFundWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PurchaseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_PurchaseOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PurchaseOfWarrants_lbl" xml:lang="en-US">Purchase of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchaseOfWarrants" xlink:to="wlds_PurchaseOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CombinedPurchasePricePerShare" xlink:href="wlds-20241231.xsd#wlds_CombinedPurchasePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CombinedPurchasePricePerShare_lbl" xml:lang="en-US">Combined purchase price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CombinedPurchasePricePerShare" xlink:to="wlds_CombinedPurchasePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PreFundedWarrantsToPurchase" xlink:href="wlds-20241231.xsd#wlds_PreFundedWarrantsToPurchase"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PreFundedWarrantsToPurchase_lbl" xml:lang="en-US">Pre-funded warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PreFundedWarrantsToPurchase" xlink:to="wlds_PreFundedWarrantsToPurchase_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Expire from the date of issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceed amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Options to ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OptionsAvailableForGrant" xlink:href="wlds-20241231.xsd#wlds_OptionsAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OptionsAvailableForGrant_lbl" xml:lang="en-US">Options available for grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsAvailableForGrant" xlink:to="wlds_OptionsAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan_lbl" xml:lang="en-US">Issuance of ordinary shares under incentive plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Ordinary shares reserved for future issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP_lbl" xml:lang="en-US">Issuance of ordinary shares under ESPP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage_lbl" xml:lang="en-US">Compensation percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_FairMarketValueSharesPercentage" xlink:href="wlds-20241231.xsd#wlds_FairMarketValueSharesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_FairMarketValueSharesPercentage_lbl" xml:lang="en-US">Fair market value shares percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FairMarketValueSharesPercentage" xlink:to="wlds_FairMarketValueSharesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Granted weighted average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TerminationPeriod" xlink:href="wlds-20241231.xsd#wlds_TerminationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TerminationPeriod_lbl" xml:lang="en-US">Termination period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TerminationPeriod" xlink:to="wlds_TerminationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_NumberOfDaysForTermination" xlink:href="wlds-20241231.xsd#wlds_NumberOfDaysForTermination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_NumberOfDaysForTermination_lbl" xml:lang="en-US">Number of days for termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfDaysForTermination" xlink:to="wlds_NumberOfDaysForTermination_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl" xml:lang="en-US">Fair value option grant date (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OptionsExpenses" xlink:href="wlds-20241231.xsd#wlds_OptionsExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OptionsExpenses_lbl" xml:lang="en-US">Option expenses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsExpenses" xlink:to="wlds_OptionsExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_VestingPeriods" xlink:href="wlds-20241231.xsd#wlds_VestingPeriods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_VestingPeriods_lbl" xml:lang="en-US">Vesting periods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_VestingPeriods" xlink:to="wlds_VestingPeriods_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IssuanceOfSharesOptions" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IssuanceOfSharesOptions_lbl" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesOptions" xlink:to="wlds_IssuanceOfSharesOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Granted shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ExercisePriceOfWarrants" xlink:href="wlds-20241231.xsd#wlds_ExercisePriceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ExercisePriceOfWarrants_lbl" xml:lang="en-US">Exercise of warrants (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrants" xlink:to="wlds_ExercisePriceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrant period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0" xml:lang="en-US">Warrant expire</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantBeReducedToAnExercisePricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl" xml:lang="en-US">Warrant be reduced to an exercise price percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:to="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InitialExercisePricePercentage" xlink:href="wlds-20241231.xsd#wlds_InitialExercisePricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InitialExercisePricePercentage_lbl" xml:lang="en-US">Initial exercise price percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricePercentage" xlink:to="wlds_InitialExercisePricePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WeightedAveragePricePercentage" xlink:href="wlds-20241231.xsd#wlds_WeightedAveragePricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WeightedAveragePricePercentage_lbl" xml:lang="en-US">Weighted average price percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WeightedAveragePricePercentage" xlink:to="wlds_WeightedAveragePricePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LowestResetPrice" xlink:href="wlds-20241231.xsd#wlds_LowestResetPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LowestResetPrice_lbl" xml:lang="en-US">Lowest reset price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LowestResetPrice" xlink:to="wlds_LowestResetPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_InitialExercisePricesPercentage" xlink:href="wlds-20241231.xsd#wlds_InitialExercisePricesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_InitialExercisePricesPercentage_lbl" xml:lang="en-US">Initial exercise price percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricesPercentage" xlink:to="wlds_InitialExercisePricesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CorporateTaxRatePercentage" xlink:href="wlds-20241231.xsd#wlds_CorporateTaxRatePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CorporateTaxRatePercentage_lbl" xml:lang="en-US">Corporate tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CorporateTaxRatePercentage" xlink:to="wlds_CorporateTaxRatePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Carryforward tax losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_EmploymentExpenses" xlink:href="wlds-20241231.xsd#wlds_EmploymentExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_EmploymentExpenses_lbl" xml:lang="en-US">Employment expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmploymentExpenses" xlink:to="wlds_EmploymentExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_OfficerEmployeeMonthlySalary" xlink:href="wlds-20241231.xsd#wlds_OfficerEmployeeMonthlySalary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_OfficerEmployeeMonthlySalary_lbl" xml:lang="en-US">Officer employee monthly salary (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficerEmployeeMonthlySalary" xlink:to="wlds_OfficerEmployeeMonthlySalary_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RelatedPartyMonthlySalary" xlink:href="wlds-20241231.xsd#wlds_RelatedPartyMonthlySalary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_RelatedPartyMonthlySalary_lbl" xml:lang="en-US">Monthly salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RelatedPartyMonthlySalary" xlink:to="wlds_RelatedPartyMonthlySalary_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" xlink:href="wlds-20241231.xsd#wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight_lbl" xml:lang="en-US">Warrants to purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" xlink:to="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SaleOfStockNumberOfShareIssuedInTransaction" xlink:href="wlds-20241231.xsd#wlds_SaleOfStockNumberOfShareIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_SaleOfStockNumberOfShareIssuedInTransaction_lbl" xml:lang="en-US">Number of shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SaleOfStockNumberOfShareIssuedInTransaction" xlink:to="wlds_SaleOfStockNumberOfShareIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Aggregate gross proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl" xml:lang="en-US">Exercise price reduce (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CostOfRevenuesPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_CostOfRevenuesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CostOfRevenuesPolicyTextBlock_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostOfRevenuesPolicyTextBlock" xlink:to="wlds_CostOfRevenuesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_GovernmentalGrantsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock_lbl" xml:lang="en-US">Governmental grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GovernmentalGrantsPolicyTextBlock" xlink:to="wlds_GovernmentalGrantsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl" xml:lang="en-US">Finance income and expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:to="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_WarrantsPolicyPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_WarrantsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_WarrantsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Warrants and pre-funded warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsPolicyPolicyTextBlock" xlink:to="wlds_WarrantsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SeverancePolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_SeverancePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_SeverancePolicyTextBlock_lbl" xml:lang="en-US">Severance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SeverancePolicyTextBlock" xlink:to="wlds_SeverancePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Accounting Standards Adopted in 2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock_lbl" xml:lang="en-US">ACCOUNTING STANDARDS ISSUED AND NOT YET ADOPTED IN 2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" xlink:to="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_LeaseLiabilityMember" xlink:href="wlds-20241231.xsd#wlds_LeaseLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_LeaseLiabilityMember_lbl" xml:lang="en-US">Lease Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseLiabilityMember" xlink:to="wlds_LeaseLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertiblePromissoryNoteMember" xlink:href="wlds-20241231.xsd#wlds_ConvertiblePromissoryNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Convertible Promissory Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertiblePromissoryNoteMember" xlink:to="wlds_ConvertiblePromissoryNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IIAMember" xlink:href="wlds-20241231.xsd#wlds_IIAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IIAMember_lbl" xml:lang="en-US">IIA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IIAMember" xlink:to="wlds_IIAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_IMEIMember" xlink:href="wlds-20241231.xsd#wlds_IMEIMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_IMEIMember_lbl" xml:lang="en-US">IMEI [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IMEIMember" xlink:to="wlds_IMEIMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAgreementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseAgreementsMember_lbl" xml:lang="en-US">Lease Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAgreementsMember" xlink:to="us-gaap_LeaseAgreementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesMember" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_ConvertibleSecuritiesMember_lbl" xml:lang="en-US">Convertible Security Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecuritiesMember" xlink:to="wlds_ConvertibleSecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxPQtRsMwMGseXt1qIodzzmaL/glMbImLWgeHF6ERfU0NGZNGGhBtuxC9Hos2B2CZStFQyEAt1gsw5LAjYSeWBYHmpgvOpAIsHYidrOMxKx7alFavI1Y4b+UJB9h3C7DUXDO4VAaMvWLWPuyXtsxVuJHUWMz22/FX3fkfTzCG73RAAjXA8WzPyb4=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StandbyEquityPurchaseAgreementMember" xlink:href="wlds-20241231.xsd#wlds_StandbyEquityPurchaseAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_StandbyEquityPurchaseAgreementMember_lbl" xml:lang="en-US">Standby Equity Purchase Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StandbyEquityPurchaseAgreementMember" xlink:to="wlds_StandbyEquityPurchaseAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_PreFundedWarrantsMember" xlink:href="wlds-20241231.xsd#wlds_PreFundedWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_PreFundedWarrantsMember_lbl" xml:lang="en-US">Pre Funded Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PreFundedWarrantsMember" xlink:to="wlds_PreFundedWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoZeroOneFiveMember" xlink:href="wlds-20241231.xsd#wlds_TwoZeroOneFiveMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoZeroOneFiveMember_lbl" xml:lang="en-US">2015 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoZeroOneFiveMember" xlink:to="wlds_TwoZeroOneFiveMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember_lbl" xml:lang="en-US">2024 Global Equity Incentive Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember" xlink:to="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember_lbl" xml:lang="en-US">2024 Employee Stock Purchase Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember" xlink:to="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IL_lbl" xml:lang="en-US">Israeli [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CofoundersMember" xlink:href="wlds-20241231.xsd#wlds_CofoundersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_CofoundersMember_lbl" xml:lang="en-US">Co-founders [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CofoundersMember" xlink:to="wlds_CofoundersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_AsherDahanMember" xlink:href="wlds-20241231.xsd#wlds_AsherDahanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wlds_AsherDahanMember_lbl" xml:lang="en-US">Asher Dahan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AsherDahanMember" xlink:to="wlds_AsherDahanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies - Schedule of Annual Rates of Depreciation (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:to="wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationLineItems" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationLineItems_lbl" xml:lang="en-US">Schedule of Annual Rates of Depreciation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationLineItems" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Schedule of Property and Equipment Net [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Share Capital (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable" xlink:to="wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xml:lang="en-US">Schedule of Share Capital [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Share Capital (Parentheticals) (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" xlink:to="wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Options Activity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable" xlink:to="wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems_lbl" xml:lang="en-US">Schedule of Options Activity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateDomain_lbl" xml:lang="en-US">Award Date [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateDomain" xlink:to="us-gaap_AwardDateDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Options to Consultants (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:to="wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Statement of Income Location, Balance [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Expenses [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Issuance of Equity Warrants to Investors and Associate (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" xlink:to="wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl0" xml:lang="en-US">Schedule of Equity Warrants to Investors and Associated with the IPO [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_GeneralDetailsTable" xlink:href="wlds-20241231.xsd#wlds_GeneralDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GeneralDetailsTable_lbl" xml:lang="en-US">General (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GeneralDetailsTable" xlink:to="wlds_GeneralDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">General [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SignificantAccountingPoliciesDetailsTable" xlink:to="wlds_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SignificantAccountingPoliciesLineItems" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US">Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SignificantAccountingPoliciesLineItems" xlink:to="wlds_SignificantAccountingPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:href="wlds-20241231.xsd#wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable_lbl" xml:lang="en-US">Stand by Equity Purchase Agreement and Convertible Promissory Note (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:to="wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems_lbl" xml:lang="en-US">Stand by Equity Purchase Agreement and Convertible Promissory Note [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsDomain_lbl" xml:lang="en-US">Other Commitments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsDomain" xlink:to="us-gaap_OtherCommitmentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CommitmentsandContingenciesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_CommitmentsandContingenciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CommitmentsandContingenciesDetailsTable_lbl" xml:lang="en-US">Commitments and Contingencies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CommitmentsandContingenciesDetailsTable" xlink:to="wlds_CommitmentsandContingenciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertibleSecuritiesDetailsTable_lbl" xml:lang="en-US">Convertible Securities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecuritiesDetailsTable" xlink:to="wlds_ConvertibleSecuritiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ConvertibleSecuritiesLineItems" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertibleSecuritiesLineItems_lbl" xml:lang="en-US">Convertible Securities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecuritiesLineItems" xlink:to="wlds_ConvertibleSecuritiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_CreditFacilityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CreditFacilityDetailsTable_lbl" xml:lang="en-US">Credit Facility (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityDetailsTable" xlink:to="wlds_CreditFacilityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Credit Facility [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ShareRepurchaseProgramDomain_lbl" xml:lang="en-US">Share Repurchase Program [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ShareRepurchaseProgramDomain" xlink:to="srt_ShareRepurchaseProgramDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title and Position [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_lbl" xml:lang="en-US">Partner Type of Partners&apos; Capital Account, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_ShareholdersEquityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareholdersEquityDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareholdersEquityDetailsTable" xlink:to="wlds_ShareholdersEquityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Shareholders&#8217; Equity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_TaxesonIncomeDetailsTable" xlink:href="wlds-20241231.xsd#wlds_TaxesonIncomeDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TaxesonIncomeDetailsTable_lbl" xml:lang="en-US">Taxes on Income (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TaxesonIncomeDetailsTable" xlink:to="wlds_TaxesonIncomeDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl" xml:lang="en-US">Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US">Investment, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related and Nonrelated Parties [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_RelatedPartiesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_RelatedPartiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RelatedPartiesDetailsTable_lbl" xml:lang="en-US">Related Parties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RelatedPartiesDetailsTable" xlink:to="wlds_RelatedPartiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Parties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US">Financial Instruments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wlds_SubsequentEventsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SubsequentEventsDetailsTable" xlink:to="wlds_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Events [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock_lbl0" xml:lang="en-US">The policy representing the accounting standard issued and not yet adopted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" xlink:to="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AccruedInterestOnConvertibleSecurities_lbl0" xml:lang="en-US">Amount of accrued interest on convertible securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnConvertibleSecurities" xlink:to="wlds_AccruedInterestOnConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AccruedInterestOnDeposits_lbl0" xml:lang="en-US">Represent the amount of accrued interest on deposit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnDeposits" xlink:to="wlds_AccruedInterestOnDeposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AdvanceFromCustomers_lbl0" xml:lang="en-US">It represent advances from customers.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AdvanceFromCustomers" xlink:to="wlds_AdvanceFromCustomers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AggregateAmount_lbl0" xml:lang="en-US">An aggregate amount or score is made up of several smaller amounts or scores added together.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateAmount" xlink:to="wlds_AggregateAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AggregateOrdinaryShares_lbl0" xml:lang="en-US">Number of shares of aggregate ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateOrdinaryShares" xlink:to="wlds_AggregateOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AggrementTerm_lbl0" xml:lang="en-US">Aggrement term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggrementTerm" xlink:to="wlds_AggrementTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AmountOfDevelopmentProgram_lbl0" xml:lang="en-US">The amount of development program.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountOfDevelopmentProgram" xlink:to="wlds_AmountOfDevelopmentProgram_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AmountsReceivedAggregateAmount_lbl0" xml:lang="en-US">The amounts received aggregate amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountsReceivedAggregateAmount" xlink:to="wlds_AmountsReceivedAggregateAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualAlternativeInterestPercentage_lbl0" xml:lang="en-US">The percentage as an alternative annual interest rate published by bank of israel.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualAlternativeInterestPercentage" xlink:to="wlds_AnnualAlternativeInterestPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany_lbl0" xml:lang="en-US">Annual gross revenue limit to remain as an emerging growth company.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" xlink:to="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualInterestRate_lbl0" xml:lang="en-US">Annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualInterestRate" xlink:to="wlds_AnnualInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualRateOfDepreciation_lbl0" xml:lang="en-US">The percentage of annual rate of depreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRateOfDepreciation" xlink:to="wlds_AnnualRateOfDepreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl0" xml:lang="en-US">The amount of base monthly fee immediately increase amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:to="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice_lbl0" xml:lang="en-US">Calculation of purchase price of shares, period for considering lowest volume weighted average price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" xlink:to="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice_lbl0" xml:lang="en-US">Calculation of shares using commitment fee payable, number days considered for the volume weighted average price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" xlink:to="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CashPayment_lbl0" xml:lang="en-US">Cash payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CashPayment" xlink:to="wlds_CashPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight_lbl0" xml:lang="en-US">Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into one shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" xlink:to="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CombinedPurchasePricePerShare_lbl0" xml:lang="en-US">Combined purchase price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CombinedPurchasePricePerShare" xlink:to="wlds_CombinedPurchasePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConversionOfSAFEToEquity_lbl0" xml:lang="en-US">The amount of conversion of SAFE to equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEToEquity" xlink:to="wlds_ConversionOfSAFEToEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl0" xml:lang="en-US">Conversion of SAFEs into ordinary shares upon completion of initial public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ConvertiblePromissoryNotePremiumPercentage_lbl0" xml:lang="en-US">Convertible promissory note premium percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertiblePromissoryNotePremiumPercentage" xlink:to="wlds_ConvertiblePromissoryNotePremiumPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CorporateTaxRatePercentage_lbl0" xml:lang="en-US">Percentage of the corporate tax rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CorporateTaxRatePercentage" xlink:to="wlds_CorporateTaxRatePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CostOfRevenuesPolicyTextBlock_lbl0" xml:lang="en-US">Policy of cost of revenue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostOfRevenuesPolicyTextBlock" xlink:to="wlds_CostOfRevenuesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_CreditFacilityDisclosureTextBlock_lbl0" xml:lang="en-US">The entire disclosure for credit facility.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityDisclosureTextBlock" xlink:to="wlds_CreditFacilityDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_DecreaseIncreaseInDepositsNet_lbl0" xml:lang="en-US">Represent the amount of decrease (Increase) in deposits, net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseIncreaseInDepositsNet" xlink:to="wlds_DecreaseIncreaseInDepositsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses_lbl0" xml:lang="en-US">Decrease (increase) in other receivables and prepaid expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" xlink:to="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl0" xml:lang="en-US">Amount of decrease (increase) in governmental grants receivables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_EmploymentExpenses_lbl0" xml:lang="en-US">Represent the amount of expense on employment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmploymentExpenses" xlink:to="wlds_EmploymentExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExceptTransferProductionRight_lbl0" xml:lang="en-US">Except transfer production right.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExceptTransferProductionRight" xlink:to="wlds_ExceptTransferProductionRight_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExercisableWarrantsToShares_lbl0" xml:lang="en-US">Exercisable warrants to shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisableWarrantsToShares" xlink:to="wlds_ExercisableWarrantsToShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExercisePriceOfWarrants_lbl0" xml:lang="en-US">Per share or per unit amount of exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrants" xlink:to="wlds_ExercisePriceOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExercisePricePerShare_lbl0" xml:lang="en-US">Exercise price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePricePerShare" xlink:to="wlds_ExercisePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ExpenseOnServiceRendering_lbl0" xml:lang="en-US">Represent the amount of expense on service rendering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExpenseOnServiceRendering" xlink:to="wlds_ExpenseOnServiceRendering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_FairMarketValueSharesPercentage_lbl0" xml:lang="en-US">The minimum that an option price can reach in relation to the market share price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FairMarketValueSharesPercentage" xlink:to="wlds_FairMarketValueSharesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for finance income and expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:to="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_FinancingIncomeExpensesNet_lbl0" xml:lang="en-US">Represent the amount of finance income (Loss), net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinancingIncomeExpensesNet" xlink:to="wlds_FinancingIncomeExpensesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_FixedAnnualInterestRate_lbl0" xml:lang="en-US">Fixed annual interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FixedAnnualInterestRate" xlink:to="wlds_FixedAnnualInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for governmental grants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GovernmentalGrantsPolicyTextBlock" xlink:to="wlds_GovernmentalGrantsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_GrantsReceivedFromTheIMEI_lbl0" xml:lang="en-US">Grants received from the IMEI.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedFromTheIMEI" xlink:to="wlds_GrantsReceivedFromTheIMEI_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_GrossProceedsOfOrdinaryShares_lbl0" xml:lang="en-US">Gross proceeds of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossProceedsOfOrdinaryShares" xlink:to="wlds_GrossProceedsOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IncreaseDecreaseInAdvancePayments_lbl0" xml:lang="en-US">The increase (decrease) during the reporting period in advance payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePayments" xlink:to="wlds_IncreaseDecreaseInAdvancePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InitialExercisePricePercentage_lbl0" xml:lang="en-US">Initial exercise price percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricePercentage" xlink:to="wlds_InitialExercisePricePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InitialExercisePricesPercentage_lbl0" xml:lang="en-US">Initial exercise price percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricesPercentage" xlink:to="wlds_InitialExercisePricesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InterestReceived_lbl0" xml:lang="en-US">Represent the amount of interest received.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestReceived" xlink:to="wlds_InterestReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InventoryWriteoff_lbl0" xml:lang="en-US">Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InventoryWriteoff" xlink:to="wlds_InventoryWriteoff_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InvestorAmount_lbl0" xml:lang="en-US">The amount of Investor.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorAmount" xlink:to="wlds_InvestorAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_InvestorsExercisedWarrants_lbl0" xml:lang="en-US">Shares of investors exercised warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorsExercisedWarrants" xlink:to="wlds_InvestorsExercisedWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue_lbl0" xml:lang="en-US">Issuance of non-convertible debt securities to become large accelerated status, value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" xlink:to="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl0" xml:lang="en-US">Value of stock issued during the period upon the conversion of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess_lbl0" xml:lang="en-US">Round up in the number of shares during the period as a result of a reverse stock split.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess" xlink:to="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl2" xml:lang="en-US">Issuance of shares associated with standby equity purchase agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfSharesOptions_lbl0" xml:lang="en-US">Issuance of share options provides financial incentives for investors; or performance incentives for shareholders who are active in the operations of the company&apos;s business.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesOptions" xlink:to="wlds_IssuanceOfSharesOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement_lbl0" xml:lang="en-US">Value of shares issued to investors associated with the SEPA.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" xlink:to="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl0" xml:lang="en-US">Amount of issuance of units of ordinary shares and warrants in connection with the initial public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl0" xml:lang="en-US">Issuance of units of ordinary shares and warrants in connection with the initial public offering shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering_lbl0" xml:lang="en-US">Represent the value of issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares_lbl0" xml:lang="en-US">Issuance of units of ordinary shares pre-funded warrants and warrants under registered direct offering, shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_IssuedAndSoldOrdinaryShares_lbl0" xml:lang="en-US">Number of pre-funded warrants to purchase ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuedAndSoldOrdinaryShares" xlink:to="wlds_IssuedAndSoldOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_LeaseAgreementsPeriod_lbl0" xml:lang="en-US">Lease agreements period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreementsPeriod" xlink:to="wlds_LeaseAgreementsPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_LeaseMonthlyRentalPayments_lbl0" xml:lang="en-US">Represents the amount of lease monthly rental payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseMonthlyRentalPayments" xlink:to="wlds_LeaseMonthlyRentalPayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_LeasePaymentIncreased_lbl0" xml:lang="en-US">Lease payment increased.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeasePaymentIncreased" xlink:to="wlds_LeasePaymentIncreased_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_LowestResetPrice_lbl0" xml:lang="en-US">Lowest reset price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LowestResetPrice" xlink:to="wlds_LowestResetPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_MarketingExpensesPaidInOrdinaryShares_lbl0" xml:lang="en-US">Marketing expenses paid in ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingExpensesPaidInOrdinaryShares" xlink:to="wlds_MarketingExpensesPaidInOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_MarketingGrantReceived_lbl0" xml:lang="en-US">Marketing grant received percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingGrantReceived" xlink:to="wlds_MarketingGrantReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_MaximumObligatinAmount_lbl0" xml:lang="en-US">Maximum obligatin amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MaximumObligatinAmount" xlink:to="wlds_MaximumObligatinAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_MonthlyInstallmentPayment_lbl0" xml:lang="en-US">Percentage of monthly installment payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MonthlyInstallmentPayment" xlink:to="wlds_MonthlyInstallmentPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl0" xml:lang="en-US">The cash inflow associated with the amount received from entity&apos;s secondary offering of stock to the public.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:to="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NumberOfAmountIssuableAsCommitmentFee_lbl0" xml:lang="en-US">Number of amount issuable as commitment fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfAmountIssuableAsCommitmentFee" xlink:to="wlds_NumberOfAmountIssuableAsCommitmentFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NumberOfDaysForTermination_lbl0" xml:lang="en-US">Number of days from termination to expiration of the options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfDaysForTermination" xlink:to="wlds_NumberOfDaysForTermination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NumberOfInvestors_lbl0" xml:lang="en-US">Represents the number of investors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfInvestors" xlink:to="wlds_NumberOfInvestors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NumberOfOrdinaryShares_lbl0" xml:lang="en-US">Number of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfOrdinaryShares" xlink:to="wlds_NumberOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding_lbl0" xml:lang="en-US">Number of shares Issued and outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfSharesIssuedAndOutstanding" xlink:to="wlds_NumberOfSharesIssuedAndOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NumberOfVehicles_lbl0" xml:lang="en-US">Represent the number of vehicles.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfVehicles" xlink:to="wlds_NumberOfVehicles_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_NumberOfWarrants_lbl0" xml:lang="en-US">Number of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfWarrants" xlink:to="wlds_NumberOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OfficerEmployeeMonthlySalary_lbl0" xml:lang="en-US">The amount of officer employee monthly salary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficerEmployeeMonthlySalary" xlink:to="wlds_OfficerEmployeeMonthlySalary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OptionsAvailableForGrant_lbl0" xml:lang="en-US">Total available options for grant,</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsAvailableForGrant" xlink:to="wlds_OptionsAvailableForGrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OptionsExpenses_lbl0" xml:lang="en-US">The total expenses in thousand will be expensed over the option vesting periods.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsExpenses" xlink:to="wlds_OptionsExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_OrdinarySharesAndPrefundedWarrants_lbl0" xml:lang="en-US">Total number of Ordinary Shares and pre-funded warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesAndPrefundedWarrants" xlink:to="wlds_OrdinarySharesAndPrefundedWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PayIncreasedRoyaltiesDescription_lbl0" xml:lang="en-US">Pay increased royalties, description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PayIncreasedRoyaltiesDescription" xlink:to="wlds_PayIncreasedRoyaltiesDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PaymentsForStructuringFee_lbl0" xml:lang="en-US">Cash outflow for the structuring fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PaymentsForStructuringFee" xlink:to="wlds_PaymentsForStructuringFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement_lbl0" xml:lang="en-US">Percentage of aggregate amount of shares available to be sold, to be transferred under agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" xlink:to="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PercentageOfFinancing_lbl0" xml:lang="en-US">The percentage of financing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfFinancing" xlink:to="wlds_PercentageOfFinancing_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PreFundWarrant_lbl0" xml:lang="en-US">Number of pre-funded warrants to purchase ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PreFundWarrant" xlink:to="wlds_PreFundWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PreFundedWarrantsToPurchase_lbl0" xml:lang="en-US">Represents the share of pre-funded warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PreFundedWarrantsToPurchase" xlink:to="wlds_PreFundedWarrantsToPurchase_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PrePaidAdvances_lbl0" xml:lang="en-US">Represent the amount of prepaid advances.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrePaidAdvances" xlink:to="wlds_PrePaidAdvances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PremoneyValuationAmount_lbl0" xml:lang="en-US">The amount of pre money valuation amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PremoneyValuationAmount" xlink:to="wlds_PremoneyValuationAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PrepaymentsOfLeasing_lbl0" xml:lang="en-US">The amount of prepayments of leasing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrepaymentsOfLeasing" xlink:to="wlds_PrepaymentsOfLeasing_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PrincipalAmountInstallmentPayment_lbl0" xml:lang="en-US">The percentage of principal amount installment payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrincipalAmountInstallmentPayment" xlink:to="wlds_PrincipalAmountInstallmentPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedAfterInitialPublicOfferingExpenses_lbl0" xml:lang="en-US">Proceed after initial public offering expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedAfterInitialPublicOfferingExpenses" xlink:to="wlds_ProceedAfterInitialPublicOfferingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl0" xml:lang="en-US">Amount of proceeds from issuance of ordinary shares as a result of exercise of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs_lbl0" xml:lang="en-US">The cash inflow from the SAFE investor.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSAFEs" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl0" xml:lang="en-US">Represent the amount of proceeds from issuance of shares issued in the public offering, net of issuance cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses_lbl0" xml:lang="en-US">Represent the amount of proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProceedsFromIssuanceRegisteredDirectOffering_lbl0" xml:lang="en-US">The cash inflow associated with the amount received from entity&apos;s registered direct offering of stock to the public.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceRegisteredDirectOffering" xlink:to="wlds_ProceedsFromIssuanceRegisteredDirectOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProductionTransferred_lbl0" xml:lang="en-US">Production transferred.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProductionTransferred" xlink:to="wlds_ProductionTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses_lbl0" xml:lang="en-US">Amount of initial public offering (IPO) refers to the process of offering shares of a private corporation to the public in a new stock issuance for the first time.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PurchaseOfWarrants_lbl0" xml:lang="en-US">The number of warrants to purchase ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchaseOfWarrants" xlink:to="wlds_PurchaseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PurchasePriceDiscount_lbl0" xml:lang="en-US">Percentage of convertible promissory note purchase price discount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePriceDiscount" xlink:to="wlds_PurchasePriceDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice_lbl0" xml:lang="en-US">Purchase price of shares, percentage on lowest volume weighted average price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" xlink:to="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_PurchasePricePerShare_lbl0" xml:lang="en-US">Purchase price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePricePerShare" xlink:to="wlds_PurchasePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RateOfMonthlySeverancePercentage_lbl0" xml:lang="en-US">The percentage of severance  monthly deposits rate can take their monthly salary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RateOfMonthlySeverancePercentage" xlink:to="wlds_RateOfMonthlySeverancePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RefundToSAFEInvestors_lbl0" xml:lang="en-US">Amount of refund to SAFE investors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RefundToSAFEInvestors" xlink:to="wlds_RefundToSAFEInvestors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RelatedPartyMonthlySalary_lbl0" xml:lang="en-US">The amount of related party monthly salary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RelatedPartyMonthlySalary" xlink:to="wlds_RelatedPartyMonthlySalary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection_lbl0" xml:lang="en-US">The amount of grants detection from the value of research and development expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentGrantsDetection" xlink:to="wlds_ResearchAndDevelopmentGrantsDetection_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ResearchAndDevelopmentNet_lbl0" xml:lang="en-US">The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity&apos;s use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentNet" xlink:to="wlds_ResearchAndDevelopmentNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ReverseSplitParValue_lbl0" xml:lang="en-US">The new par value after the reverse split.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseSplitParValue" xlink:to="wlds_ReverseSplitParValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ReverseStockSplitNumberOfSharesConverted_lbl0" xml:lang="en-US">Describe the number of shares that will become one share after the reverse split.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseStockSplitNumberOfSharesConverted" xlink:to="wlds_ReverseStockSplitNumberOfSharesConverted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted_lbl0" xml:lang="en-US">Reverse stock split, number of shares issued for each share or lot converted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" xlink:to="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl0" xml:lang="en-US">The amount is right-of use asset recognized against lease liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:to="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RoyaltiesRate_lbl0" xml:lang="en-US">Percentage of royalties rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRate" xlink:to="wlds_RoyaltiesRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_RoyaltiesRatePercentage_lbl0" xml:lang="en-US">Royalties rate percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRatePercentage" xlink:to="wlds_RoyaltiesRatePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_SAFEsAmount_lbl0" xml:lang="en-US">The amount of SAFEs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SAFEsAmount" xlink:to="wlds_SAFEsAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_SaleOfStockNumberOfShareIssuedInTransaction_lbl0" xml:lang="en-US">Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into one shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SaleOfStockNumberOfShareIssuedInTransaction" xlink:to="wlds_SaleOfStockNumberOfShareIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of annual rates of depreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of the change in Issuance of equity warrants to investors and associat.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of stock options issued to consultants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:to="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee_lbl0" xml:lang="en-US">The amount of services in exchange for monthly base fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:to="wlds_ServicesInExchangeForMonthlyBaseFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_SeverancePolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for severance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SeverancePolicyTextBlock" xlink:to="wlds_SeverancePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl0" xml:lang="en-US">Expected life of options in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl0" xml:lang="en-US">The fair value option granted date during the reporting period as calculated by applying the disclosed option pricing methodology.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP_lbl0" xml:lang="en-US">The maximum amount of ordinary shares that can be issued according to the company&apos;s 2024 employee stock purchase plan (&quot;ESPP&quot;) approved by the board of directors and subject to the approval of the shareholders&apos; meeting.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan_lbl0" xml:lang="en-US">Share based compensation arrangement by share based payment award number of ordinary shares issued under incentive plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl0" xml:lang="en-US">Description of exercise ratio.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl0" xml:lang="en-US">Description of Expiration date&#xd;    &#xd;
.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ShareBasedCompensationArrangementNotes_lbl0" xml:lang="en-US">Description of Notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementNotes" xlink:to="wlds_ShareBasedCompensationArrangementNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock_lbl0" xml:lang="en-US">Stand by equity purchase agreement and convertible promissory note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" xlink:to="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions_lbl0" xml:lang="en-US">Represent the shares of exercise of options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions" xlink:to="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl1" xml:lang="en-US">Shares issued from the exercise of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors_lbl0" xml:lang="en-US">Shares issued to investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:to="wlds_StockIssuedDuringPeriodSharesInvestors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl0" xml:lang="en-US">Stock issued during period shares stock warrants exercised.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:to="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA_lbl0" xml:lang="en-US">Represent the value of issuance of shares associated with the SEPA.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA" xlink:to="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl0" xml:lang="en-US">Represent the value of stock issued during the period from the exercise of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors_lbl0" xml:lang="en-US">Represent the value of stock issued during the period to investors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueInvestors" xlink:to="wlds_StockIssuedDuringPeriodValueInvestors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_StockholdersEquityRequirementByStockExchanges_lbl0" xml:lang="en-US">Stockholders equity requirement by stock exchanges.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockholdersEquityRequirementByStockExchanges" xlink:to="wlds_StockholdersEquityRequirementByStockExchanges_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_TerminationPeriod_lbl0" xml:lang="en-US">Termination period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TerminationPeriod" xlink:to="wlds_TerminationPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_TotalCashReceivedFromTheIIA_lbl0" xml:lang="en-US">Total cash received from the IIA.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalCashReceivedFromTheIIA" xlink:to="wlds_TotalCashReceivedFromTheIIA_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_UnderwritingDiscountsAndCommissions_lbl0" xml:lang="en-US">It represent underwriting discounts and commissions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingDiscountsAndCommissions" xlink:to="wlds_UnderwritingDiscountsAndCommissions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_UnderwritingNetProceed_lbl0" xml:lang="en-US">Amount of net proceeds after deducting.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingNetProceed" xlink:to="wlds_UnderwritingNetProceed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus_lbl0" xml:lang="en-US">Value of ordinary shares held by non-affiliates to become large accelerated status.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" xlink:to="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_VestingPeriods_lbl0" xml:lang="en-US">Expensed over vesting periods.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_VestingPeriods" xlink:to="wlds_VestingPeriods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl0" xml:lang="en-US">Warrant be reduced to an exercise price percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:to="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantPricePerSharePercentage_lbl0" xml:lang="en-US">Percentage of warrant price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantPricePerSharePercentage" xlink:to="wlds_WarrantPricePerSharePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantsIssuedPercentage_lbl0" xml:lang="en-US">The warrants issued percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsIssuedPercentage" xlink:to="wlds_WarrantsIssuedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WarrantsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsPolicyPolicyTextBlock" xlink:to="wlds_WarrantsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_WeightedAveragePricePercentage_lbl0" xml:lang="en-US">Weighted average price percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WeightedAveragePricePercentage" xlink:to="wlds_WeightedAveragePricePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ComputersAndSoftwareMember_lbl0" xml:lang="en-US">Collection of computer and software.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ComputersAndSoftwareMember" xlink:to="wlds_ComputersAndSoftwareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_ElectronicEquipmentMember_lbl0" xml:lang="en-US">Collection of Electronic equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ElectronicEquipmentMember" xlink:to="wlds_ElectronicEquipmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_AnnualRatesOfDepreciationAbstract" xlink:href="wlds-20241231.xsd#wlds_AnnualRatesOfDepreciationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wlds_AnnualRatesOfDepreciationAbstract_lbl" xml:lang="en-US">Annual rates of depreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRatesOfDepreciationAbstract" xlink:to="wlds_AnnualRatesOfDepreciationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl1" xml:lang="en-US">Convertible Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl1" xml:lang="en-US">Stockholders&apos; Equity, Reverse Stock Split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoZeroOneFiveMember_lbl0" xml:lang="en-US">Two Zero One Five Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoZeroOneFiveMember" xlink:to="wlds_TwoZeroOneFiveMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtWeightedAverageInterestRate_lbl0" xml:lang="en-US">Debt, Weighted Average Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtWeightedAverageInterestRate" xlink:to="us-gaap_DebtWeightedAverageInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl0" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl0" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl0" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NumberOfAmountIssuableAsCommitmentFee_lbl1" xml:lang="en-US">Number Of Amount Issuable As Commitment Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfAmountIssuableAsCommitmentFee" xlink:to="wlds_NumberOfAmountIssuableAsCommitmentFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnderwritingDiscountsAndCommissions_lbl1" xml:lang="en-US">Underwriting Discounts And Commissions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingDiscountsAndCommissions" xlink:to="wlds_UnderwritingDiscountsAndCommissions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember_lbl0" xml:lang="en-US">Office Furniture And Equipment And Leasehold Improvements Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:to="wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandSeventeenMember_lbl0" xml:lang="en-US">Two Thousand Seventeen Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandSeventeenMember" xlink:to="wlds_TwoThousandSeventeenMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl1" xml:lang="en-US">Conversion Of SAFEs Into Ordinary Shares Upon Completion Of Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ServicesInExchangeForMonthlyBaseFee_lbl1" xml:lang="en-US">Services In Exchange For Monthly Base Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ServicesInExchangeForMonthlyBaseFee" xlink:to="wlds_ServicesInExchangeForMonthlyBaseFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue_lbl1" xml:lang="en-US">Issuance Of Nonconvertible Debt Securities To Become Large Accelerated Status Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" xlink:to="wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement_lbl1" xml:lang="en-US">Issuance Of Shares Value Associated With Standby Equity Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" xlink:to="wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage_lbl0" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PrincipalAmountInstallmentPayment_lbl1" xml:lang="en-US">Principal Amount Installment Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrincipalAmountInstallmentPayment" xlink:to="wlds_PrincipalAmountInstallmentPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RoyaltiesRatePercentage_lbl1" xml:lang="en-US">Royalties Rate Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRatePercentage" xlink:to="wlds_RoyaltiesRatePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NumberOfVehicles_lbl1" xml:lang="en-US">Number Of Vehicles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfVehicles" xlink:to="wlds_NumberOfVehicles_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl0" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl1" xml:lang="en-US">Decreaseincrease In Governmental Grants Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseincreaseInGovernmentalGrantsReceivables" xlink:to="wlds_DecreaseincreaseInGovernmentalGrantsReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering_lbl1" xml:lang="en-US">Issuance Of Units Of Ordinary Shares Pre Funded Warrants And Warrants Under Registered Direct Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl0" xml:lang="en-US">Board of Directors Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PayIncreasedRoyaltiesDescription_lbl1" xml:lang="en-US">Pay Increased Royalties Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PayIncreasedRoyaltiesDescription" xlink:to="wlds_PayIncreasedRoyaltiesDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CombinedPurchasePricePerShare_lbl1" xml:lang="en-US">Combined Purchase Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CombinedPurchasePricePerShare" xlink:to="wlds_CombinedPurchasePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl0" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ResearchAndDevelopmentNet_lbl1" xml:lang="en-US">Research And Development Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentNet" xlink:to="wlds_ResearchAndDevelopmentNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GrossProceedsOfOrdinaryShares_lbl1" xml:lang="en-US">Gross Proceeds Of Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrossProceedsOfOrdinaryShares" xlink:to="wlds_GrossProceedsOfOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_EmploymentExpenses_lbl1" xml:lang="en-US">Employment Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_EmploymentExpenses" xlink:to="wlds_EmploymentExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ComputersAndSoftwareMember_lbl1" xml:lang="en-US">Computers And Software Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ComputersAndSoftwareMember" xlink:to="wlds_ComputersAndSoftwareMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl0" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MaximumObligatinAmount_lbl1" xml:lang="en-US">Maximum Obligatin Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MaximumObligatinAmount" xlink:to="wlds_MaximumObligatinAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl1" xml:lang="en-US">Net Proceeds From Issuance Secondary Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NetProceedsFromIssuanceSecondaryPublicOffering" xlink:to="wlds_NetProceedsFromIssuanceSecondaryPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantPricePerSharePercentage_lbl1" xml:lang="en-US">Warrant Price Per Share Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantPricePerSharePercentage" xlink:to="wlds_WarrantPricePerSharePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandTwentyThreeMember_lbl0" xml:lang="en-US">Two Thousand Twenty Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyThreeMember" xlink:to="wlds_TwoThousandTwentyThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl0" xml:lang="en-US">Common Stock, Convertible, Conversion Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LeaseMonthlyRentalPayments_lbl1" xml:lang="en-US">Lease Monthly Rental Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseMonthlyRentalPayments" xlink:to="wlds_LeaseMonthlyRentalPayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl1" xml:lang="en-US">Stock Issued During Period Value Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl0" xml:lang="en-US">Inventory Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement_lbl1" xml:lang="en-US">Percentage Of Aggregate Amount Of Shares Available To Be Sold To Be Transferred Under Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" xlink:to="wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExpenseOnServiceRendering_lbl1" xml:lang="en-US">Expense On Service Rendering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExpenseOnServiceRendering" xlink:to="wlds_ExpenseOnServiceRendering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl2" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PreFundedWarrantsToPurchase_lbl1" xml:lang="en-US">Pre Funded Warrants To Purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PreFundedWarrantsToPurchase" xlink:to="wlds_PreFundedWarrantsToPurchase_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExercisePricePerShare_lbl1" xml:lang="en-US">Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePricePerShare" xlink:to="wlds_ExercisePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl0" xml:lang="en-US">Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfSAFEs_lbl1" xml:lang="en-US">Proceeds From Issuance Of SAFEs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSAFEs" xlink:to="wlds_ProceedsFromIssuanceOfSAFEs_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAgreementsMember_lbl0" xml:lang="en-US">Lease Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAgreementsMember" xlink:to="us-gaap_LeaseAgreementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl1" xml:lang="en-US">Issuance Of Ordinary Shares As AResult Of Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AdvanceFromCustomers_lbl1" xml:lang="en-US">Advance From Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AdvanceFromCustomers" xlink:to="wlds_AdvanceFromCustomers_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfShareBasedCompensationExpensesAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfShareBasedCompensationExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfShareBasedCompensationExpensesAbstract_lbl" xml:lang="en-US">Schedule Of Share Based Compensation Expenses Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfShareBasedCompensationExpensesAbstract" xlink:to="wlds_ScheduleOfShareBasedCompensationExpensesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceRegisteredDirectOffering_lbl1" xml:lang="en-US">Proceeds From Issuance Registered Direct Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceRegisteredDirectOffering" xlink:to="wlds_ProceedsFromIssuanceRegisteredDirectOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl3" xml:lang="en-US">Issuance Of Shares Associated With Standby Equity Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:to="wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice_lbl1" xml:lang="en-US">Purchase Price Of Shares Percentage On Lowest Volume Weighted Average Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" xlink:to="wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantsIssuedPercentage_lbl1" xml:lang="en-US">Warrants Issued Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsIssuedPercentage" xlink:to="wlds_WarrantsIssuedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl0" xml:lang="en-US">Conversion of Stock, Amount Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl0" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SAFEsAmount_lbl1" xml:lang="en-US">SAFEs Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SAFEsAmount" xlink:to="wlds_SAFEsAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember_lbl0" xml:lang="en-US">Office Furniture Machines Leasehold Improvements And Electronic Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:to="wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SeverancePolicyTextBlock_lbl1" xml:lang="en-US">Severance Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SeverancePolicyTextBlock" xlink:to="wlds_SeverancePolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl0" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ResearchAndDevelopmentGrantsDetection_lbl1" xml:lang="en-US">Research And Development Grants Detection</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ResearchAndDevelopmentGrantsDetection" xlink:to="wlds_ResearchAndDevelopmentGrantsDetection_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Options To Consultants Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsTableTextBlock" xlink:to="wlds_ScheduleOfOptionsToConsultantsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember_lbl0" xml:lang="en-US">Two Thousand Twenty Four Global Equity Incentive Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember" xlink:to="wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ReverseSplitParValue_lbl1" xml:lang="en-US">Reverse Split Par Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseSplitParValue" xlink:to="wlds_ReverseSplitParValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CostOfRevenuesPolicyTextBlock_lbl1" xml:lang="en-US">Cost Of Revenues Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CostOfRevenuesPolicyTextBlock" xlink:to="wlds_CostOfRevenuesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl0" xml:lang="en-US">Chief Executive Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Issuance Of Equity Warrants To Investors And Associat Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AsherDahanMember_lbl0" xml:lang="en-US">Asher Dahan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AsherDahanMember" xlink:to="wlds_AsherDahanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AmountsReceivedAggregateAmount_lbl1" xml:lang="en-US">Amounts Received Aggregate Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountsReceivedAggregateAmount" xlink:to="wlds_AmountsReceivedAggregateAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConversionOfSAFEToEquity_lbl1" xml:lang="en-US">Conversion Of SAFETo Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConversionOfSAFEToEquity" xlink:to="wlds_ConversionOfSAFEToEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl0" xml:lang="en-US">Investor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl2" xml:lang="en-US">Stock Issued During Period Shares Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProspectiveInitialPublicOfferingExpenses_lbl1" xml:lang="en-US">Prospective Initial Public Offering Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProspectiveInitialPublicOfferingExpenses" xlink:to="wlds_ProspectiveInitialPublicOfferingExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InventoryWriteoff_lbl1" xml:lang="en-US">Inventory Writeoff</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InventoryWriteoff" xlink:to="wlds_InventoryWriteoff_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExceptTransferProductionRight_lbl1" xml:lang="en-US">Except Transfer Production Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExceptTransferProductionRight" xlink:to="wlds_ExceptTransferProductionRight_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses_lbl1" xml:lang="en-US">Proceeds From Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net Of Issuance Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" xlink:to="wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AccruedInterestOnConvertibleSecurities_lbl1" xml:lang="en-US">Accrued Interest On Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnConvertibleSecurities" xlink:to="wlds_AccruedInterestOnConvertibleSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CashPayment_lbl1" xml:lang="en-US">Cash Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CashPayment" xlink:to="wlds_CashPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantsToPurchaseOrdinarySharesMember_lbl0" xml:lang="en-US">Warrants To Purchase Ordinary Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsToPurchaseOrdinarySharesMember" xlink:to="wlds_WarrantsToPurchaseOrdinarySharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses_lbl1" xml:lang="en-US">Decrease Increase In Other Receivables And Prepaid Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" xlink:to="wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl3" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember_lbl0" xml:lang="en-US">November Two Seven Two Zero Two Four One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember" xlink:to="wlds_NovemberTwoSevenTwoZeroTwoFourOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TerminationPeriod_lbl1" xml:lang="en-US">Termination Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TerminationPeriod" xlink:to="wlds_TerminationPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl0" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuedAndSoldOrdinaryShares_lbl1" xml:lang="en-US">Issued And Sold Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuedAndSoldOrdinaryShares" xlink:to="wlds_IssuedAndSoldOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RateOfMonthlySeverancePercentage_lbl1" xml:lang="en-US">Rate Of Monthly Severance Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RateOfMonthlySeverancePercentage" xlink:to="wlds_RateOfMonthlySeverancePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharesNoParValuePerShareMember_lbl0" xml:lang="en-US">Ordinary Shares No Par Value Per Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesNoParValuePerShareMember" xlink:to="wlds_OrdinarySharesNoParValuePerShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertibleSecuritiesMember_lbl0" xml:lang="en-US">Convertible Securities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertibleSecuritiesMember" xlink:to="wlds_ConvertibleSecuritiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NumberOfInvestors_lbl1" xml:lang="en-US">Number Of Investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfInvestors" xlink:to="wlds_NumberOfInvestors_lbl1"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract_lbl" xml:lang="en-US">Schedule Of Annual Rates Of Depreciation Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl1" xml:lang="en-US">Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_September152022TwoMember_lbl0" xml:lang="en-US">September152022 Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022TwoMember" xlink:to="wlds_September152022TwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl0" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl0" xml:lang="en-US">Inventory Write-down</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl0" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExercisePriceOfWarrants_lbl1" xml:lang="en-US">Exercise Price Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisePriceOfWarrants" xlink:to="wlds_ExercisePriceOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantsPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Warrants Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantsPolicyPolicyTextBlock" xlink:to="wlds_WarrantsPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl0" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RoyaltiesRate_lbl1" xml:lang="en-US">Royalties Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RoyaltiesRate" xlink:to="wlds_RoyaltiesRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl0" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ChangesDuringTheYear2024Abstract_lbl0" xml:lang="en-US">Changes During The Year2024 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2024Abstract" xlink:to="wlds_ChangesDuringTheYear2024Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MonthlyInstallmentPayment_lbl1" xml:lang="en-US">Monthly Installment Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MonthlyInstallmentPayment" xlink:to="wlds_MonthlyInstallmentPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GovernmentalGrantsPolicyTextBlock_lbl1" xml:lang="en-US">Governmental Grants Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GovernmentalGrantsPolicyTextBlock" xlink:to="wlds_GovernmentalGrantsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNoParValue_lbl0" xml:lang="en-US">Common Stock, No Par Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_September132022Member_lbl0" xml:lang="en-US">September132022 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September132022Member" xlink:to="wlds_September132022Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl0" xml:lang="en-US">Temporary Equity, Aggregate Amount of Redemption Requirement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MachinesAndMoldsMember_lbl0" xml:lang="en-US">Machines And Molds Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MachinesAndMoldsMember" xlink:to="wlds_MachinesAndMoldsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany_lbl1" xml:lang="en-US">Annual Gross Revenue Limit To Remain As An Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" xlink:to="wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl1" xml:lang="en-US">Base Monthly Fee Immediately Increase Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:to="wlds_BaseMonthlyFeeImmediatelyIncreaseAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InitialExercisePricesPercentage_lbl1" xml:lang="en-US">Initial Exercise Prices Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricesPercentage" xlink:to="wlds_InitialExercisePricesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IMEIMember_lbl0" xml:lang="en-US">IMEIMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IMEIMember" xlink:to="wlds_IMEIMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NovemberTwoSevenTwoZeroTwoFourMember_lbl0" xml:lang="en-US">November Two Seven Two Zero Two Four Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NovemberTwoSevenTwoZeroTwoFourMember" xlink:to="wlds_NovemberTwoSevenTwoZeroTwoFourMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions_lbl1" xml:lang="en-US">Stock Issued During Period Share Of Exercise Of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions" xlink:to="wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NumberOfSharesIssuedAndOutstanding_lbl1" xml:lang="en-US">Number Of Shares Issued And Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfSharesIssuedAndOutstanding" xlink:to="wlds_NumberOfSharesIssuedAndOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Disclosure [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NumberOfDaysForTermination_lbl1" xml:lang="en-US">Number Of Days For Termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfDaysForTermination" xlink:to="wlds_NumberOfDaysForTermination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PaymentsForStructuringFee_lbl1" xml:lang="en-US">Payments For Structuring Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PaymentsForStructuringFee" xlink:to="wlds_PaymentsForStructuringFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Ordinary Shares Issued Under Incentive Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl1" xml:lang="en-US">Stock Issued During Period Shares Stock Warrants Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:to="wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualRateOfDepreciation_lbl1" xml:lang="en-US">Annual Rate Of Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRateOfDepreciation" xlink:to="wlds_AnnualRateOfDepreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodValueInvestors_lbl1" xml:lang="en-US">Stock Issued During Period Value Investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueInvestors" xlink:to="wlds_StockIssuedDuringPeriodValueInvestors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate During Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_FairMarketValueSharesPercentage_lbl1" xml:lang="en-US">Fair Market Value Shares Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FairMarketValueSharesPercentage" xlink:to="wlds_FairMarketValueSharesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedAfterInitialPublicOfferingExpenses_lbl1" xml:lang="en-US">Proceed After Initial Public Offering Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedAfterInitialPublicOfferingExpenses" xlink:to="wlds_ProceedAfterInitialPublicOfferingExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandFifteenMember_lbl0" xml:lang="en-US">Two Thousand Fifteen Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandFifteenMember" xlink:to="wlds_TwoThousandFifteenMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl0" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OptionsAvailableForGrant_lbl1" xml:lang="en-US">Options Available For Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsAvailableForGrant" xlink:to="wlds_OptionsAvailableForGrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CorporateTaxRatePercentage_lbl1" xml:lang="en-US">Corporate Tax Rate Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CorporateTaxRatePercentage" xlink:to="wlds_CorporateTaxRatePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TotalCashReceivedFromTheIIA_lbl1" xml:lang="en-US">Total Cash Received From The IIA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TotalCashReceivedFromTheIIA" xlink:to="wlds_TotalCashReceivedFromTheIIA_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PreFundWarrant_lbl1" xml:lang="en-US">Pre Fund Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PreFundWarrant" xlink:to="wlds_PreFundWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl0" xml:lang="en-US">Lessee, Finance Lease, Renewal Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract_lbl" xml:lang="en-US">Schedule Of Issuance Of Equity Warrants To Investors And Associate Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" xlink:to="wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ReverseStockSplitNumberOfSharesConverted_lbl1" xml:lang="en-US">Reverse Stock Split Number Of Shares Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseStockSplitNumberOfSharesConverted" xlink:to="wlds_ReverseStockSplitNumberOfSharesConverted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Option Grant Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_FinancingIncomeExpensesNet_lbl1" xml:lang="en-US">Financing Income Expenses Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinancingIncomeExpensesNet" xlink:to="wlds_FinancingIncomeExpensesNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StandbyEquityPurchaseAgreementMember_lbl0" xml:lang="en-US">Standby Equity Purchase Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StandbyEquityPurchaseAgreementMember" xlink:to="wlds_StandbyEquityPurchaseAgreementMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InvestorsExercisedWarrants_lbl1" xml:lang="en-US">Investors Exercised Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorsExercisedWarrants" xlink:to="wlds_InvestorsExercisedWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InitialExercisePricePercentage_lbl1" xml:lang="en-US">Initial Exercise Price Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InitialExercisePricePercentage" xlink:to="wlds_InitialExercisePricePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Ordinary Shares Issued Under ESPP</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PurchaseOfWarrants_lbl1" xml:lang="en-US">Purchase Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchaseOfWarrants" xlink:to="wlds_PurchaseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GrantsReceivedFromTheIMEI_lbl1" xml:lang="en-US">Grants Received From The IMEI</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedFromTheIMEI" xlink:to="wlds_GrantsReceivedFromTheIMEI_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MarketingGrantReceived_lbl1" xml:lang="en-US">Marketing Grant Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingGrantReceived" xlink:to="wlds_MarketingGrantReceived_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PrepaymentsOfLeasing_lbl1" xml:lang="en-US">Prepayments Of Leasing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrepaymentsOfLeasing" xlink:to="wlds_PrepaymentsOfLeasing_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PercentageOfFinancing_lbl1" xml:lang="en-US">Percentage Of Financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PercentageOfFinancing" xlink:to="wlds_PercentageOfFinancing_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementNotes_lbl1" xml:lang="en-US">Share Based Compensation Arrangement Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementNotes" xlink:to="wlds_ShareBasedCompensationArrangementNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfSharesOptions_lbl1" xml:lang="en-US">Issuance Of Shares Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfSharesOptions" xlink:to="wlds_IssuanceOfSharesOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl1" xml:lang="en-US">Proceeds From Issuance Of Shares Issued In The Public Offering Net Of Issuance Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:to="wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PrePaidAdvances_lbl1" xml:lang="en-US">Pre Paid Advances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PrePaidAdvances" xlink:to="wlds_PrePaidAdvances_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandTwentyoneMember_lbl0" xml:lang="en-US">Two Thousand Twentyone Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyoneMember" xlink:to="wlds_TwoThousandTwentyoneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LeasePaymentIncreased_lbl1" xml:lang="en-US">Lease Payment Increased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeasePaymentIncreased" xlink:to="wlds_LeasePaymentIncreased_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted_lbl1" xml:lang="en-US">Reverse Stock Split Number Of Shares Issued For Each Share Or Lot Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" xlink:to="wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl1" xml:lang="en-US">Proceeds From Issuance Of Ordinary Shares As AResult Of Exercise Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:to="wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl0" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA_lbl1" xml:lang="en-US">Stock Issued During Period Value Associated With The SEPA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA" xlink:to="wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfConvertibleDebt_lbl0" xml:lang="en-US">Repayments of Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfConvertibleDebt" xlink:to="us-gaap_RepaymentsOfConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ProductionTransferred_lbl1" xml:lang="en-US">Production Transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ProductionTransferred" xlink:to="wlds_ProductionTransferred_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AggrementTerm_lbl1" xml:lang="en-US">Aggrement Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggrementTerm" xlink:to="wlds_AggrementTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl0" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl0" xml:lang="en-US">Proceeds from Lines of Credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl0" xml:lang="en-US">Conversion of Stock, Shares Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PremoneyValuationAmount_lbl1" xml:lang="en-US">Premoney Valuation Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PremoneyValuationAmount" xlink:to="wlds_PremoneyValuationAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl1" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl1" xml:lang="en-US">Warrant Be Reduced To An Exercise Price Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WarrantBeReducedToAnExercisePricePercentage" xlink:to="wlds_WarrantBeReducedToAnExercisePricePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember_lbl0" xml:lang="en-US">Two Thousand Twenty Fous Employee Stock Purchase Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember" xlink:to="wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl0" xml:lang="en-US">Accounts Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LeaseLiabilityMember_lbl0" xml:lang="en-US">Lease Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseLiabilityMember" xlink:to="wlds_LeaseLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice_lbl1" xml:lang="en-US">Calculation Of Purchase Price Of Shares Period For Considering Lowest Volume Weighted Average Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" xlink:to="wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_VestingPeriods_lbl1" xml:lang="en-US">Vesting Periods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_VestingPeriods" xlink:to="wlds_VestingPeriods_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FIFOInventoryAmount_lbl1" xml:lang="en-US">FIFO Inventory Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FIFOInventoryAmount" xlink:to="us-gaap_FIFOInventoryAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LIFOMethodRelatedItemsAbstract_lbl0" xml:lang="en-US">LIFO Method Related Items [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:to="us-gaap_LIFOMethodRelatedItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_FixedAnnualInterestRate_lbl1" xml:lang="en-US">Fixed Annual Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FixedAnnualInterestRate" xlink:to="wlds_FixedAnnualInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MarketingExpensesPaidInOrdinaryShares_lbl1" xml:lang="en-US">Marketing Expenses Paid In Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MarketingExpensesPaidInOrdinaryShares" xlink:to="wlds_MarketingExpensesPaidInOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_September152022OneMember_lbl0" xml:lang="en-US">September152022 One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_September152022OneMember" xlink:to="wlds_September152022OneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock_lbl1" xml:lang="en-US">Accounting Standards Issued And Not Yet Adopted In2024 Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" xlink:to="wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RelatedPartyMonthlySalary_lbl1" xml:lang="en-US">Related Party Monthly Salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RelatedPartyMonthlySalary" xlink:to="wlds_RelatedPartyMonthlySalary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AccruedInterestOnDeposits_lbl1" xml:lang="en-US">Accrued Interest On Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AccruedInterestOnDeposits" xlink:to="wlds_AccruedInterestOnDeposits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Exercise Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio_lbl1"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl0" xml:lang="en-US">Selling and Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Finance Income And Expenses Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:to="wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_UnderwritingNetProceed_lbl1" xml:lang="en-US">Underwriting Net Proceed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_UnderwritingNetProceed" xlink:to="wlds_UnderwritingNetProceed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ChangesDuringTheYear2023Abstract_lbl0" xml:lang="en-US">Changes During The Year2023 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2023Abstract" xlink:to="wlds_ChangesDuringTheYear2023Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NumberOfOrdinaryShares_lbl1" xml:lang="en-US">Number Of Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfOrdinaryShares" xlink:to="wlds_NumberOfOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl2" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl1" xml:lang="en-US">Rightof Use Asset Recognized Against Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RightofUseAssetRecognizedAgainstLeaseLiability" xlink:to="wlds_RightofUseAssetRecognizedAgainstLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares_lbl1" xml:lang="en-US">Issuance Of Units Of Ordinary Shares Pre Funded Warrants And Warrants Under Registered Direct Offering Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl0" xml:lang="en-US">Repayments of Lines of Credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_RefundToSAFEInvestors_lbl1" xml:lang="en-US">Refund To SAFEInvestors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_RefundToSAFEInvestors" xlink:to="wlds_RefundToSAFEInvestors_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IIAMember_lbl0" xml:lang="en-US">IIAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IIAMember" xlink:to="wlds_IIAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock_lbl1" xml:lang="en-US">Stand By Equity Purchase Agreement And Convertible Promissory Note Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" xlink:to="wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Expected Life Of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:to="wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OptionsExpenses_lbl1" xml:lang="en-US">Options Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OptionsExpenses" xlink:to="wlds_OptionsExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ChangesDuringTheYear2022Abstract_lbl0" xml:lang="en-US">Changes During The Year2022 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ChangesDuringTheYear2022Abstract" xlink:to="wlds_ChangesDuringTheYear2022Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl1" xml:lang="en-US">Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:to="wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CreditFacilityDisclosureTextBlock_lbl1" xml:lang="en-US">Credit Facility Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CreditFacilityDisclosureTextBlock" xlink:to="wlds_CreditFacilityDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl0" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AmountOfDevelopmentProgram_lbl1" xml:lang="en-US">Amount Of Development Program</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AmountOfDevelopmentProgram" xlink:to="wlds_AmountOfDevelopmentProgram_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherBorrowings_lbl0" xml:lang="en-US">Other Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice_lbl1" xml:lang="en-US">Calculation Of Shares Using Commitment Fee Payable Number Days Considered For The Volume Weighted Average Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" xlink:to="wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LowestResetPrice_lbl1" xml:lang="en-US">Lowest Reset Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LowestResetPrice" xlink:to="wlds_LowestResetPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_CofoundersMember_lbl0" xml:lang="en-US">Cofounders Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_CofoundersMember" xlink:to="wlds_CofoundersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfOptionsToConsultantsAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfOptionsToConsultantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfOptionsToConsultantsAbstract_lbl" xml:lang="en-US">Schedule Of Options To Consultants Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfOptionsToConsultantsAbstract" xlink:to="wlds_ScheduleOfOptionsToConsultantsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus_lbl1" xml:lang="en-US">Value Of Ordinary Shares Held By Non Affiliates To Become Large Accelerated Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" xlink:to="wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfShareCapitalAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfShareCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfShareCapitalAbstract_lbl" xml:lang="en-US">Schedule Of Share Capital Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfShareCapitalAbstract" xlink:to="wlds_ScheduleOfShareCapitalAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AggregateAmount_lbl1" xml:lang="en-US">Aggregate Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateAmount" xlink:to="wlds_AggregateAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl0" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualInterestRate_lbl1" xml:lang="en-US">Annual Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualInterestRate" xlink:to="wlds_AnnualInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl0" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OfficerEmployeeMonthlySalary_lbl1" xml:lang="en-US">Officer Employee Monthly Salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OfficerEmployeeMonthlySalary" xlink:to="wlds_OfficerEmployeeMonthlySalary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_DecreaseIncreaseInDepositsNet_lbl1" xml:lang="en-US">Decrease Increase In Deposits Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_DecreaseIncreaseInDepositsNet" xlink:to="wlds_DecreaseIncreaseInDepositsNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PreFundedWarrantsMember_lbl0" xml:lang="en-US">Pre Funded Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PreFundedWarrantsMember" xlink:to="wlds_PreFundedWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_OrdinarySharesAndPrefundedWarrants_lbl1" xml:lang="en-US">Ordinary Shares And Prefunded Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_OrdinarySharesAndPrefundedWarrants" xlink:to="wlds_OrdinarySharesAndPrefundedWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertiblePromissoryNotePremiumPercentage_lbl1" xml:lang="en-US">Convertible Promissory Note Premium Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertiblePromissoryNotePremiumPercentage" xlink:to="wlds_ConvertiblePromissoryNotePremiumPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InterestReceived_lbl1" xml:lang="en-US">Interest Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InterestReceived" xlink:to="wlds_InterestReceived_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl0" xml:lang="en-US">Sale of Stock, Consideration Received Per Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PurchasePriceDiscount_lbl1" xml:lang="en-US">Purchase Price Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePriceDiscount" xlink:to="wlds_PurchasePriceDiscount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockIssuedDuringPeriodSharesInvestors_lbl1" xml:lang="en-US">Stock Issued During Period Shares Investors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockIssuedDuringPeriodSharesInvestors" xlink:to="wlds_StockIssuedDuringPeriodSharesInvestors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl0" xml:lang="en-US">Operating Lease, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl0" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ElectronicEquipmentMember_lbl1" xml:lang="en-US">Electronic Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ElectronicEquipmentMember" xlink:to="wlds_ElectronicEquipmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl0" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_InvestorAmount_lbl1" xml:lang="en-US">Investor Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_InvestorAmount" xlink:to="wlds_InvestorAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_NumberOfWarrants_lbl1" xml:lang="en-US">Number Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_NumberOfWarrants" xlink:to="wlds_NumberOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivableCurrent_lbl0" xml:lang="en-US">Grants Receivable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess_lbl1" xml:lang="en-US">Issuance Of Ordinary Shares For The Reverse Split Process</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess" xlink:to="wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight_lbl1" xml:lang="en-US">Class Of Warrant Or Right Number Of Securities Called By Warrant Or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" xlink:to="wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AggregateOrdinaryShares_lbl1" xml:lang="en-US">Aggregate Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AggregateOrdinaryShares" xlink:to="wlds_AggregateOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl0" xml:lang="en-US">ISRAEL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_GrantsReceivedEqualPercentageRate_lbl0" xml:lang="en-US">Grants Received Equal Percentage Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_GrantsReceivedEqualPercentageRate" xlink:to="wlds_GrantsReceivedEqualPercentageRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_WeightedAveragePricePercentage_lbl1" xml:lang="en-US">Weighted Average Price Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_WeightedAveragePricePercentage" xlink:to="wlds_WeightedAveragePricePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivable_lbl0" xml:lang="en-US">Grants Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_SaleOfStockNumberOfShareIssuedInTransaction_lbl1" xml:lang="en-US">Sale Of Stock Number Of Share Issued In Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_SaleOfStockNumberOfShareIssuedInTransaction" xlink:to="wlds_SaleOfStockNumberOfShareIssuedInTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Annual Rates Of Depreciation Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:to="wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ExercisableWarrantsToShares_lbl1" xml:lang="en-US">Exercisable Warrants To Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ExercisableWarrantsToShares" xlink:to="wlds_ExercisableWarrantsToShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl0" xml:lang="en-US">Deposits Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_StockholdersEquityRequirementByStockExchanges_lbl1" xml:lang="en-US">Stockholders Equity Requirement By Stock Exchanges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_StockholdersEquityRequirementByStockExchanges" xlink:to="wlds_StockholdersEquityRequirementByStockExchanges_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_LeaseAgreementsPeriod_lbl1" xml:lang="en-US">Lease Agreements Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_LeaseAgreementsPeriod" xlink:to="wlds_LeaseAgreementsPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ConvertiblePromissoryNoteMember_lbl0" xml:lang="en-US">Convertible Promissory Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ConvertiblePromissoryNoteMember" xlink:to="wlds_ConvertiblePromissoryNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl0" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Decrease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl2" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl2"/>
    <loc xlink:type="locator" xlink:label="wlds_ScheduleOfPropertyAndEquipmentNetAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfPropertyAndEquipmentNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_ScheduleOfPropertyAndEquipmentNetAbstract_lbl" xml:lang="en-US">Schedule Of Property And Equipment Net Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_ScheduleOfPropertyAndEquipmentNetAbstract" xlink:to="wlds_ScheduleOfPropertyAndEquipmentNetAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_MoldMember_lbl0" xml:lang="en-US">Mold Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_MoldMember" xlink:to="wlds_MoldMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_PurchasePricePerShare_lbl1" xml:lang="en-US">Purchase Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_PurchasePricePerShare" xlink:to="wlds_PurchasePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualRatesOfDepreciationAbstract_lbl0" xml:lang="en-US">Annual Rates Of Depreciation Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualRatesOfDepreciationAbstract" xlink:to="wlds_AnnualRatesOfDepreciationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsCurrent_lbl0" xml:lang="en-US">Deposits Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesNetOfInterestExpense_lbl0" xml:lang="en-US">Revenues, Net of Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesNetOfInterestExpense" xlink:to="us-gaap_RevenuesNetOfInterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl0" xml:lang="en-US">Assets, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_IncreaseDecreaseInAdvancePayments_lbl1" xml:lang="en-US">Increase Decrease In Advance Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_IncreaseDecreaseInAdvancePayments" xlink:to="wlds_IncreaseDecreaseInAdvancePayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wlds_AnnualAlternativeInterestPercentage_lbl1" xml:lang="en-US">Annual Alternative Interest Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wlds_AnnualAlternativeInterestPercentage" xlink:to="wlds_AnnualAlternativeInterestPercentage_lbl1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>wlds-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 20 21:08:44 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedBalanceSheet" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedIncomeStatement" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquityType2or3" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConsolidatedCashFlow" roleURI="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_General" roleURI="http://www.wearabledevices.co.il/role/General"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SignificantAccountingPolicies" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_Inventories" roleURI="http://www.wearabledevices.co.il/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_PropertyandEquipmentNet" roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_Leases" roleURI="http://www.wearabledevices.co.il/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_StandbyEquityPurchaseAgreementandConvertiblePromissoryNote" roleURI="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_CommitmentsandContingencies" roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConvertibleSecurities" roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecurities"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_CreditFacility" roleURI="http://www.wearabledevices.co.il/role/CreditFacility"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquity" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_TaxesonIncome" roleURI="http://www.wearabledevices.co.il/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_RelatedParties" roleURI="http://www.wearabledevices.co.il/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SubsequentEvents" roleURI="http://www.wearabledevices.co.il/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_AccountingPoliciesByPolicy" roleURI="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SignificantAccountingPoliciesTables" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_InventoriesTables" roleURI="http://www.wearabledevices.co.il/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_PropertyandEquipmentNetTables" roleURI="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_LeasesTables" roleURI="http://www.wearabledevices.co.il/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquityTables" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofAnnualRatesofDepreciationTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofInventoriesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofPropertyandEquipmentNetTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofShareCapitalTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofShareCapitalTable_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofOptionsActivityTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofWeightedAverageAssumptionsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofOptionstoConsultantsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofShareBasedCompensationExpensesTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable" roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals" roleURI="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_GeneralDetails" roleURI="http://www.wearabledevices.co.il/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SignificantAccountingPoliciesDetails" roleURI="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_LeasesDetails" roleURI="http://www.wearabledevices.co.il/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails" roleURI="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_CommitmentsandContingenciesDetails" roleURI="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ConvertibleSecuritiesDetails" roleURI="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_CreditFacilityDetails" roleURI="http://www.wearabledevices.co.il/role/CreditFacilityDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_ShareholdersEquityDetails" roleURI="http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_TaxesonIncomeDetails" roleURI="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_RelatedPartiesDetails" roleURI="http://www.wearabledevices.co.il/role/RelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wlds-20241231.xsd#wlds_r_SubsequentEventsDetails" roleURI="http://www.wearabledevices.co.il/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#cover" roleURI="http://xbrl.sec.gov/dei/role/document/Cover"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#ai" roleURI="http://xbrl.sec.gov/dei/role/document/AuditInformation"/>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_GrantsReceivable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FIFOInventoryAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_FIFOInventoryAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Assets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvanceFromCustomers" xlink:href="wlds-20241231.xsd#wlds_AdvanceFromCustomers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="AdvanceFromCustomers" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockNoParValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ResearchAndDevelopmentNet" xlink:href="wlds-20241231.xsd#wlds_ResearchAndDevelopmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="ResearchAndDevelopmentNet" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProspectiveInitialPublicOfferingExpenses" xlink:href="wlds-20241231.xsd#wlds_ProspectiveInitialPublicOfferingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="ProspectiveInitialPublicOfferingExpenses" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="FinancingIncomeExpensesNet" xlink:href="wlds-20241231.xsd#wlds_FinancingIncomeExpensesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="FinancingIncomeExpensesNet" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesDuringTheYear2022Abstract" xlink:href="wlds-20241231.xsd#wlds_ChangesDuringTheYear2022Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ChangesDuringTheYear2022Abstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="wlds-20241231.xsd#wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="StockIssuedDuringPeriodSharesStockWarrantsExercised" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodShareOfExerciseOfOptions" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="StockIssuedDuringPeriodShareOfExerciseOfOptions" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueInvestors" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueInvestors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="StockIssuedDuringPeriodValueInvestors" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesInvestors" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesInvestors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="StockIssuedDuringPeriodSharesInvestors" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="StockIssuedDuringPeriodValueExerciseOfWarrants" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="StockIssuedDuringPeriodSharesExerciseOfWarrants" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueAssociatedWithTheSEPA" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="StockIssuedDuringPeriodValueAssociatedWithTheSEPA" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfOrdinarySharesForTheReverseSplitProcess" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="IssuanceOfOrdinarySharesForTheReverseSplitProcess" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_ShareBasedCompensation" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_StockholdersEquity_0" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesDuringTheYear2022Abstract" xlink:to="us-gaap_SharesOutstanding_0" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccruedInterestOnConvertibleSecurities" xlink:href="wlds-20241231.xsd#wlds_AccruedInterestOnConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccruedInterestOnConvertibleSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccruedInterestOnDeposits" xlink:href="wlds-20241231.xsd#wlds_AccruedInterestOnDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccruedInterestOnDeposits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="MarketingExpensesPaidInOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_MarketingExpensesPaidInOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="MarketingExpensesPaidInOrdinaryShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseincreaseInGovernmentalGrantsReceivables" xlink:href="wlds-20241231.xsd#wlds_DecreaseincreaseInGovernmentalGrantsReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="DecreaseincreaseInGovernmentalGrantsReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" xlink:href="wlds-20241231.xsd#wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInAdvancePayments" xlink:href="wlds-20241231.xsd#wlds_IncreaseDecreaseInAdvancePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAdvancePayments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseIncreaseInDepositsNet" xlink:href="wlds-20241231.xsd#wlds_DecreaseIncreaseInDepositsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="DecreaseIncreaseInDepositsNet" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaymentsOfLeasing" xlink:href="wlds-20241231.xsd#wlds_PrepaymentsOfLeasing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PrepaymentsOfLeasing" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfSAFEs" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfSAFEs"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfSAFEs" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RefundToSAFEInvestors" xlink:href="wlds-20241231.xsd#wlds_RefundToSAFEInvestors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RefundToSAFEInvestors" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfConvertibleDebt" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestReceived" xlink:href="wlds-20241231.xsd#wlds_InterestReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="InterestReceived" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfSAFEToEquity" xlink:href="wlds-20241231.xsd#wlds_ConversionOfSAFEToEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="ConversionOfSAFEToEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RightofUseAssetRecognizedAgainstLeaseLiability" xlink:href="wlds-20241231.xsd#wlds_RightofUseAssetRecognizedAgainstLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="RightofUseAssetRecognizedAgainstLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/General" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/Inventories" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/PropertyandEquipmentNet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/Leases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" xlink:to="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/CommitmentsandContingencies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ConvertibleSecurities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/CreditFacility" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="CreditFacilityAbstract" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityAbstract"/>
    <loc xlink:type="locator" xlink:label="CreditFacilityDisclosureTextBlock" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAbstract" xlink:to="CreditFacilityDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquity" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/TaxesonIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/RelatedParties" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CostOfRevenuesPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_CostOfRevenuesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="CostOfRevenuesPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentalGrantsPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_GovernmentalGrantsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="GovernmentalGrantsPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinanceIncomeAndExpensesPolicyPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="FinanceIncomeAndExpensesPolicyPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsPolicyPolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_WarrantsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="WarrantsPolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeverancePolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_SeverancePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SeverancePolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" xlink:href="wlds-20241231.xsd#wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfAnnualRatesOfDepreciationTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfAnnualRatesOfDepreciationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/InventoriesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/LeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionsToConsultantsTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfOptionsToConsultantsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ScheduleOfOptionsToConsultantsTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfAnnualRatesOfDepreciationAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfAnnualRatesOfDepreciationLineItems" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfAnnualRatesOfDepreciationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAnnualRatesOfDepreciationAbstract" xlink:to="SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" xlink:href="wlds-20241231.xsd#wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ComputersAndSoftwareMember" xlink:href="wlds-20241231.xsd#wlds_ComputersAndSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ComputersAndSoftwareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ElectronicEquipmentMember" xlink:href="wlds-20241231.xsd#wlds_ElectronicEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ElectronicEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MoldMember" xlink:href="wlds-20241231.xsd#wlds_MoldMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="MoldMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable" xlink:to="ScheduleOfAnnualRatesOfDepreciationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AnnualRateOfDepreciation" xlink:href="wlds-20241231.xsd#wlds_AnnualRateOfDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAnnualRatesOfDepreciationLineItems" xlink:to="AnnualRateOfDepreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LIFOMethodRelatedItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryNetAbstract" xlink:to="us-gaap_LIFOMethodRelatedItemsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoryWriteoff" xlink:href="wlds-20241231.xsd#wlds_InventoryWriteoff"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:to="InventoryWriteoff" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FIFOInventoryAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LIFOMethodRelatedItemsAbstract" xlink:to="us-gaap_FIFOInventoryAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentNetAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfPropertyAndEquipmentNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentNetAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ComputersAndSoftwareMember" xlink:href="wlds-20241231.xsd#wlds_ComputersAndSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ComputersAndSoftwareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" xlink:href="wlds-20241231.xsd#wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ElectronicEquipmentMember" xlink:href="wlds-20241231.xsd#wlds_ElectronicEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="ElectronicEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MachinesAndMoldsMember" xlink:href="wlds-20241231.xsd#wlds_MachinesAndMoldsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="MachinesAndMoldsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareCapitalAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofShareCapitalDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareCapitalAbstract" xlink:to="ShareholdersEquityScheduleofShareCapitalDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofShareCapitalDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofShareCapitalDetailsTable" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesIssuedAndOutstanding" xlink:href="wlds-20241231.xsd#wlds_NumberOfSharesIssuedAndOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="NumberOfSharesIssuedAndOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareCapitalAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfShareCapitalAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareCapitalAbstract" xlink:to="ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionsActivityAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfOptionsActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofOptionsActivityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsActivityAbstract" xlink:to="ShareholdersEquityScheduleofOptionsActivityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofOptionsActivityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofOptionsActivityDetailsTable" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionsToConsultantsAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfOptionsToConsultantsAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionsToConsultantsAbstract" xlink:to="ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:to="us-gaap_AwardDateAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoThousandFifteenMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandFifteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoThousandFifteenMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandSeventeenMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandSeventeenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoThousandSeventeenMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyoneMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyoneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoThousandTwentyoneMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyThreeMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoThousandTwentyThreeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedCompensationExpensesAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfShareBasedCompensationExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationExpensesAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYE9rliDcrbWhjsc3i7BCl/DvlJVwr+JR0O2nYady5Se133BDWCF8ON/Jzif84CehHV5r9vMQwYxPQtRsMwMGseXt1qIodzzmaL/glMbImLWgeHF6ERfU0NGZNGGhBtuxC9Hos2B2CZStFQyEAt1gsw5LAjYSeWBYHmpgvOpAIsHYidrOMxKx7alFavI1Y4b+UJB9h3C7DUXDO4VAaMvWLWPuyXtsxVuJHA4ms8rxVPzNVwyeSWiSNbZmJv/2AX9ak=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" xlink:href="wlds-20241231.xsd#wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract" xlink:to="ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="September132022Member" xlink:href="wlds-20241231.xsd#wlds_September132022Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="September132022Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="September152022OneMember" xlink:href="wlds-20241231.xsd#wlds_September152022OneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="September152022OneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="September152022TwoMember" xlink:href="wlds-20241231.xsd#wlds_September152022TwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="September152022TwoMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NovemberTwoSevenTwoZeroTwoFourMember" xlink:href="wlds-20241231.xsd#wlds_NovemberTwoSevenTwoZeroTwoFourMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="NovemberTwoSevenTwoZeroTwoFourMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NovemberTwoSevenTwoZeroTwoFourOneMember" xlink:href="wlds-20241231.xsd#wlds_NovemberTwoSevenTwoZeroTwoFourOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="NovemberTwoSevenTwoZeroTwoFourOneMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementNotes" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementNotes" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesAndPrefundedWarrants" xlink:href="wlds-20241231.xsd#wlds_OrdinarySharesAndPrefundedWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="OrdinarySharesAndPrefundedWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/GeneralDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralDetailsTable" xlink:href="wlds-20241231.xsd#wlds_GeneralDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="GeneralDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" xlink:href="wlds-20241231.xsd#wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" xlink:href="wlds-20241231.xsd#wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitNumberOfSharesConverted" xlink:href="wlds-20241231.xsd#wlds_ReverseStockSplitNumberOfSharesConverted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="ReverseStockSplitNumberOfSharesConverted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" xlink:href="wlds-20241231.xsd#wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReverseSplitParValue" xlink:href="wlds-20241231.xsd#wlds_ReverseSplitParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="ReverseSplitParValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetProceedsFromIssuanceSecondaryPublicOffering" xlink:href="wlds-20241231.xsd#wlds_NetProceedsFromIssuanceSecondaryPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="NetProceedsFromIssuanceSecondaryPublicOffering" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceRegisteredDirectOffering" xlink:href="wlds-20241231.xsd#wlds_ProceedsFromIssuanceRegisteredDirectOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="ProceedsFromIssuanceRegisteredDirectOffering" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockholdersEquityRequirementByStockExchanges" xlink:href="wlds-20241231.xsd#wlds_StockholdersEquityRequirementByStockExchanges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="StockholdersEquityRequirementByStockExchanges" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockholdersEquity" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesLineItems" xlink:href="wlds-20241231.xsd#wlds_SignificantAccountingPoliciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LeaseLiabilityMember" xlink:href="wlds-20241231.xsd#wlds_LeaseLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="LeaseLiabilityMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="SignificantAccountingPoliciesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DebtWeightedAverageInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RateOfMonthlySeverancePercentage" xlink:href="wlds-20241231.xsd#wlds_RateOfMonthlySeverancePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesLineItems" xlink:to="RateOfMonthlySeverancePercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/LeasesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:href="wlds-20241231.xsd#wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable"/>
    <loc xlink:type="locator" xlink:label="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:href="wlds-20241231.xsd#wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract" xlink:to="StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNoteMember" xlink:href="wlds-20241231.xsd#wlds_ConvertiblePromissoryNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertiblePromissoryNoteMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable" xlink:to="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfAmountIssuableAsCommitmentFee" xlink:href="wlds-20241231.xsd#wlds_NumberOfAmountIssuableAsCommitmentFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="NumberOfAmountIssuableAsCommitmentFee" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" xlink:href="wlds-20241231.xsd#wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" xlink:href="wlds-20241231.xsd#wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentsForStructuringFee" xlink:href="wlds-20241231.xsd#wlds_PaymentsForStructuringFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="PaymentsForStructuringFee" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrePaidAdvances" xlink:href="wlds-20241231.xsd#wlds_PrePaidAdvances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="PrePaidAdvances" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasePriceDiscount" xlink:href="wlds-20241231.xsd#wlds_PurchasePriceDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="PurchasePriceDiscount" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MonthlyInstallmentPayment" xlink:href="wlds-20241231.xsd#wlds_MonthlyInstallmentPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="MonthlyInstallmentPayment" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrincipalAmountInstallmentPayment" xlink:href="wlds-20241231.xsd#wlds_PrincipalAmountInstallmentPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="PrincipalAmountInstallmentPayment" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNotePremiumPercentage" xlink:href="wlds-20241231.xsd#wlds_ConvertiblePromissoryNotePremiumPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="ConvertiblePromissoryNotePremiumPercentage" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_CommitmentsandContingenciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingenciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_OtherCommitmentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="IIAMember" xlink:href="wlds-20241231.xsd#wlds_IIAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="IIAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IMEIMember" xlink:href="wlds-20241231.xsd#wlds_IMEIMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="IMEIMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="srt_RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_VehiclesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseAgreementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_LeaseAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_OtherCommitmentsLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RoyaltiesRate" xlink:href="wlds-20241231.xsd#wlds_RoyaltiesRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="RoyaltiesRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantsReceivedEqualPercentageRate" xlink:href="wlds-20241231.xsd#wlds_GrantsReceivedEqualPercentageRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="GrantsReceivedEqualPercentageRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AnnualAlternativeInterestPercentage" xlink:href="wlds-20241231.xsd#wlds_AnnualAlternativeInterestPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="AnnualAlternativeInterestPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AnnualInterestRate" xlink:href="wlds-20241231.xsd#wlds_AnnualInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="AnnualInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FixedAnnualInterestRate" xlink:href="wlds-20241231.xsd#wlds_FixedAnnualInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="FixedAnnualInterestRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmountsReceivedAggregateAmount" xlink:href="wlds-20241231.xsd#wlds_AmountsReceivedAggregateAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="AmountsReceivedAggregateAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmountOfDevelopmentProgram" xlink:href="wlds-20241231.xsd#wlds_AmountOfDevelopmentProgram"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="AmountOfDevelopmentProgram" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfFinancing" xlink:href="wlds-20241231.xsd#wlds_PercentageOfFinancing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="PercentageOfFinancing" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalCashReceivedFromTheIIA" xlink:href="wlds-20241231.xsd#wlds_TotalCashReceivedFromTheIIA"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="TotalCashReceivedFromTheIIA" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExceptTransferProductionRight" xlink:href="wlds-20241231.xsd#wlds_ExceptTransferProductionRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="ExceptTransferProductionRight" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProductionTransferred" xlink:href="wlds-20241231.xsd#wlds_ProductionTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="ProductionTransferred" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PayIncreasedRoyaltiesDescription" xlink:href="wlds-20241231.xsd#wlds_PayIncreasedRoyaltiesDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="PayIncreasedRoyaltiesDescription" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ResearchAndDevelopmentGrantsDetection" xlink:href="wlds-20241231.xsd#wlds_ResearchAndDevelopmentGrantsDetection"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="ResearchAndDevelopmentGrantsDetection" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaximumObligatinAmount" xlink:href="wlds-20241231.xsd#wlds_MaximumObligatinAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="MaximumObligatinAmount" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantsReceivedFromTheIMEI" xlink:href="wlds-20241231.xsd#wlds_GrantsReceivedFromTheIMEI"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="GrantsReceivedFromTheIMEI" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesNetOfInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesNetOfInterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_RevenuesNetOfInterestExpense" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltiesRatePercentage" xlink:href="wlds-20241231.xsd#wlds_RoyaltiesRatePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="RoyaltiesRatePercentage" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketingGrantReceived" xlink:href="wlds-20241231.xsd#wlds_MarketingGrantReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="MarketingGrantReceived" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_GrantsReceivableCurrent" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LeaseCost" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PaymentsForRent" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeasePaymentIncreased" xlink:href="wlds-20241231.xsd#wlds_LeasePaymentIncreased"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="LeasePaymentIncreased" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseMonthlyRentalPayments" xlink:href="wlds-20241231.xsd#wlds_LeaseMonthlyRentalPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="LeaseMonthlyRentalPayments" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfVehicles" xlink:href="wlds-20241231.xsd#wlds_NumberOfVehicles"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="NumberOfVehicles" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseAgreementsPeriod" xlink:href="wlds-20241231.xsd#wlds_LeaseAgreementsPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="LeaseAgreementsPeriod" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSecuritiesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSecuritiesLineItems" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract" xlink:to="ConvertibleSecuritiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSecuritiesMember" xlink:href="wlds-20241231.xsd#wlds_ConvertibleSecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleSecuritiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesDetailsTable" xlink:to="ConvertibleSecuritiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CashPayment" xlink:href="wlds-20241231.xsd#wlds_CashPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="CashPayment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PremoneyValuationAmount" xlink:href="wlds-20241231.xsd#wlds_PremoneyValuationAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="PremoneyValuationAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantPricePerSharePercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantPricePerSharePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="WarrantPricePerSharePercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasePricePerShare" xlink:href="wlds-20241231.xsd#wlds_PurchasePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="PurchasePricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_AggregateOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleSecuritiesLineItems" xlink:to="AggregateOrdinaryShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/CreditFacilityDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="CreditFacilityAbstract" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityAbstract"/>
    <loc xlink:type="locator" xlink:label="CreditFacilityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_CreditFacilityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAbstract" xlink:to="CreditFacilityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDetailsTable" xlink:to="us-gaap_LineOfCreditFacilityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_OtherBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateAmount" xlink:href="wlds-20241231.xsd#wlds_AggregateAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="AggregateAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ServicesInExchangeForMonthlyBaseFee" xlink:href="wlds-20241231.xsd#wlds_ServicesInExchangeForMonthlyBaseFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="ServicesInExchangeForMonthlyBaseFee" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggrementTerm" xlink:href="wlds-20241231.xsd#wlds_AggrementTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="AggrementTerm" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsIssuedPercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantsIssuedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="WarrantsIssuedPercentage" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BaseMonthlyFeeImmediatelyIncreaseAmount" xlink:href="wlds-20241231.xsd#wlds_BaseMonthlyFeeImmediatelyIncreaseAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="BaseMonthlyFeeImmediatelyIncreaseAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpenseOnServiceRendering" xlink:href="wlds-20241231.xsd#wlds_ExpenseOnServiceRendering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="ExpenseOnServiceRendering" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/ShareholdersEquityDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsTable" xlink:href="wlds-20241231.xsd#wlds_ShareholdersEquityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ShareholdersEquityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="srt_ShareRepurchaseProgramAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="srt_ShareRepurchaseProgramDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="StandbyEquityPurchaseAgreementMember" xlink:href="wlds-20241231.xsd#wlds_StandbyEquityPurchaseAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ShareRepurchaseProgramAxis" xlink:to="StandbyEquityPurchaseAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_DirectorMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_ChiefExecutiveOfficerMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="us-gaap_InvestorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoZeroOneFiveMember" xlink:href="wlds-20241231.xsd#wlds_TwoZeroOneFiveMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="TwoZeroOneFiveMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyFourGlobalEquityIncentivePlanMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwoThousandTwentyFourGlobalEquityIncentivePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyFousEmployeeStockPurchasePlanMember" xlink:href="wlds-20241231.xsd#wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwoThousandTwentyFousEmployeeStockPurchasePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoZeroOneFiveMember_0" xlink:href="wlds-20241231.xsd#wlds_TwoZeroOneFiveMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwoZeroOneFiveMember_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="srt_RangeAxis" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantsMember" xlink:href="wlds-20241231.xsd#wlds_PreFundedWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PreFundedWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_ClassOfStockLineItems" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_NumberOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="NumberOfOrdinaryShares" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfWarrants" xlink:href="wlds-20241231.xsd#wlds_NumberOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="NumberOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisableWarrantsToShares" xlink:href="wlds-20241231.xsd#wlds_ExercisableWarrantsToShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ExercisableWarrantsToShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesExerciseOfWarrants" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritingNetProceed" xlink:href="wlds-20241231.xsd#wlds_UnderwritingNetProceed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="UnderwritingNetProceed" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritingDiscountsAndCommissions" xlink:href="wlds-20241231.xsd#wlds_UnderwritingDiscountsAndCommissions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="UnderwritingDiscountsAndCommissions" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedAfterInitialPublicOfferingExpenses" xlink:href="wlds-20241231.xsd#wlds_ProceedAfterInitialPublicOfferingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ProceedAfterInitialPublicOfferingExpenses" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SAFEsAmount" xlink:href="wlds-20241231.xsd#wlds_SAFEsAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="SAFEsAmount" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfInvestors" xlink:href="wlds-20241231.xsd#wlds_NumberOfInvestors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="NumberOfInvestors" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestorAmount" xlink:href="wlds-20241231.xsd#wlds_InvestorAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="InvestorAmount" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_Cash" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestorsExercisedWarrants" xlink:href="wlds-20241231.xsd#wlds_InvestorsExercisedWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="InvestorsExercisedWarrants" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePricePerShare" xlink:href="wlds-20241231.xsd#wlds_ExercisePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ExercisePricePerShare" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossProceedsOfOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_GrossProceedsOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="GrossProceedsOfOrdinaryShares" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement" order="23.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="24.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedAndSoldOrdinaryShares" xlink:href="wlds-20241231.xsd#wlds_IssuedAndSoldOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="IssuedAndSoldOrdinaryShares" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreFundWarrant" xlink:href="wlds-20241231.xsd#wlds_PreFundWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PreFundWarrant" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseOfWarrants" xlink:href="wlds-20241231.xsd#wlds_PurchaseOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PurchaseOfWarrants" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CombinedPurchasePricePerShare" xlink:href="wlds-20241231.xsd#wlds_CombinedPurchasePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="CombinedPurchasePricePerShare" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantsToPurchase" xlink:href="wlds-20241231.xsd#wlds_PreFundedWarrantsToPurchase"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PreFundedWarrantsToPurchase" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsAvailableForGrant" xlink:href="wlds-20241231.xsd#wlds_OptionsAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="OptionsAvailableForGrant" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairMarketValueSharesPercentage" xlink:href="wlds-20241231.xsd#wlds_FairMarketValueSharesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="FairMarketValueSharesPercentage" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="41.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TerminationPeriod" xlink:href="wlds-20241231.xsd#wlds_TerminationPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="TerminationPeriod" order="42.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfDaysForTermination" xlink:href="wlds-20241231.xsd#wlds_NumberOfDaysForTermination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="NumberOfDaysForTermination" order="43.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" xlink:href="wlds-20241231.xsd#wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate" order="44.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsExpenses" xlink:href="wlds-20241231.xsd#wlds_OptionsExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="OptionsExpenses" order="45.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VestingPeriods" xlink:href="wlds-20241231.xsd#wlds_VestingPeriods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="VestingPeriods" order="46.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfSharesOptions" xlink:href="wlds-20241231.xsd#wlds_IssuanceOfSharesOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="IssuanceOfSharesOptions" order="47.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="48.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="49.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceOfWarrants" xlink:href="wlds-20241231.xsd#wlds_ExercisePriceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="ExercisePriceOfWarrants" order="50.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="51.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantBeReducedToAnExercisePricePercentage" xlink:href="wlds-20241231.xsd#wlds_WarrantBeReducedToAnExercisePricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="WarrantBeReducedToAnExercisePricePercentage" order="52.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialExercisePricePercentage" xlink:href="wlds-20241231.xsd#wlds_InitialExercisePricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="InitialExercisePricePercentage" order="53.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAveragePricePercentage" xlink:href="wlds-20241231.xsd#wlds_WeightedAveragePricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="WeightedAveragePricePercentage" order="54.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LowestResetPrice" xlink:href="wlds-20241231.xsd#wlds_LowestResetPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="LowestResetPrice" order="55.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialExercisePricesPercentage" xlink:href="wlds-20241231.xsd#wlds_InitialExercisePricesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="InitialExercisePricesPercentage" order="56.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/TaxesonIncomeDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsTable" xlink:href="wlds-20241231.xsd#wlds_TaxesonIncomeDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="TaxesonIncomeDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="us-gaap_IncomeTaxContingencyLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CorporateTaxRatePercentage" xlink:href="wlds-20241231.xsd#wlds_CorporateTaxRatePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="CorporateTaxRatePercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/RelatedPartiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsTable" xlink:href="wlds-20241231.xsd#wlds_RelatedPartiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CofoundersMember" xlink:href="wlds-20241231.xsd#wlds_CofoundersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="CofoundersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AsherDahanMember" xlink:href="wlds-20241231.xsd#wlds_AsherDahanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AsherDahanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EmploymentExpenses" xlink:href="wlds-20241231.xsd#wlds_EmploymentExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="EmploymentExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfficerEmployeeMonthlySalary" xlink:href="wlds-20241231.xsd#wlds_OfficerEmployeeMonthlySalary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="OfficerEmployeeMonthlySalary" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyMonthlySalary" xlink:href="wlds-20241231.xsd#wlds_RelatedPartyMonthlySalary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="RelatedPartyMonthlySalary" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.wearabledevices.co.il/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="wlds-20241231.xsd#wlds_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantsMember" xlink:href="wlds-20241231.xsd#wlds_PreFundedWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PreFundedWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" xlink:href="wlds-20241231.xsd#wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfStockNumberOfShareIssuedInTransaction" xlink:href="wlds-20241231.xsd#wlds_SaleOfStockNumberOfShareIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="SaleOfStockNumberOfShareIssuedInTransaction" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/Cover" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityListingsTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_NameChangeEventTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NameChangeEventTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_NameChangeEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="14.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:href="wlds-20241231.xsd#wlds_OrdinarySharesNoParValuePerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OrdinarySharesNoParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsToPurchaseOrdinarySharesMember" xlink:href="wlds-20241231.xsd#wlds_WarrantsToPurchaseOrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="WarrantsToPurchaseOrdinarySharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/AuditInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:href="wlds-20241231.xsd#wlds_OrdinarySharesNoParValuePerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OrdinarySharesNoParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsToPurchaseOrdinarySharesMember" xlink:href="wlds-20241231.xsd#wlds_WarrantsToPurchaseOrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="WarrantsToPurchaseOrdinarySharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorTable_0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorTable_0" xlink:to="dei_EntityAddressesAddressTypeAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex15-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex15-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !( )T# 2(  A$! Q$!_\0
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M[$^O8?F/-IT)U*GLUN>C4K1A#VCV.@\1_$O0/#LTELTK7=Y'PT-O@[3SPS=
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M2B0.+EOF]/D/^>O\LC@/A]X@L?#7B9K_ %(NMNL+Q@QKN()Z #TX/^1\O?\
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MJV\/33\SWGX4:3'IW@J&Y"@37SM,Y]@=JC\ /U[=!W!S@X(![9KE?AM/'/\
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M,-L02>5F ]>G'^?Y#_#KQ&2P$-MR>2)A[]./\_R/:5?Y0_L_*_\ G_\ BO\
M(]!;QUX= ;_B8KD#/W&_P_3_  .!O'7AT!O^)BN0,_<;_#]/\#CSYOAUXCW,
M##;$$GE9@/7IQ_G^2-\.O$A+#RK;ENHF'OTX_P _R/:5?Y0_L_*_^?\ ^*_R
M/0F\=>'0&_XF*Y S]QO\/T_P.!O'7AT!O^)BN0,_<;_#]/\  X\^;X=>(LL/
M)MCDG)$X]^G'3V_EV&^'7B/<P,-L02>5F ]>G'^?Y'M*O\H?V?E?_/[\5_D>
M@MXZ\.@-_P 3%<@9^XW^'Z?X'"2>-_#9#!K^,[1NYC)_I[?YP<>?O\.O$9+
M0VW)Y(F'OTX_S_(;X=>(]S PVQ!)Y68#UZ<?Y_D>UK?RA_9^5O\ Y??BO\CT
M#_A./#<:LJ:@@"C.!&<?R]NG^!PK>.O#HW?\3%<J,_<;W]OT_P #CSY_AUXC
M)8"&VY/)$P]^G'^?Y#?#KQ%EAY-L<DY(G'OTXZ>W\NQ[6M_*']GY7_S^_%?Y
M'I5CXKT;4[T65E>K)<,I8+M/3!.?T_SSC:[UYMX2\&ZSH_B>*]O(X/)4.&*2
MYQD'! X_S^GI-;TW)J\E8\;'4J%*KRX>7-&VX4445H<(4444 %%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex15-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex15-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "9!(8# 2(  A$! Q$!_\0
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M%%% !1110 4444 %%%% !1110 4449H **3-+0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%)FEH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSRZO!J+K'<G4%C6-%;'E&-B."..G.: /9LU1U;5[/1+![W4)A%"I SC)8GH
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MPN3]@CW3MV SV QSZYJ*YUSQ+'X4THW$EU8WSZLMIYLT(5Y(BV%9E/!.",T
M>HYHS7F5QK&J^%-6\0V9U*XU&.#2_ML+79!*/D#L/N\YQ4GAK5-<_MK2FVZ[
M=VE[%F\>\M\11OMRK1D=%[?E0!W&L:_I>@0)-JE[':QR-M1GS@GKVJ33-8T_
M6;7[3IMY%=0YQNC;./KZ5Q_Q(%PUSX8%H(6N3J:B(3@^66QQNQSBL?3]2O/"
MUWXO^V6L!UCR%OO]$_U)!&U0 1D$'DYH ]5S1FO-O#>IZXVM:6X_MRZM+R)C
M?/>V^V)&VY5HR.BYXI_AB\N[S2;_ %[5O$%Y';V4]S$(U(\M5!P&(QEB.V:
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MDEG)+J3Q2&!L<A2"4;T/8T^_MSX>UGQ/INGW%RMJVA278629G*RCC<"3G/-
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M;56M//BUV*&P%_.&L#;H6?YSGY\Y&3STK$UAV;0_$V]V8#Q&H&YLX&\<<]*
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M\2)HPY92K'."K%3@]QP<&JDFM3P:Q;V5Q:(L=RYCB>.<.^0"V63 P,#KD]J
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MV9L]2MEN+<L&,;$XR.AXJ+2/#VD:!&\>E6$-JK_>\L<M]2>:9?:PT4]I;64
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MLW#2%(MV7RY)W$C(]JT_$%G?RP65I86GG6*M_I,2SB(L@&%3)[$]?88KH**
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MK=Q1B@#F-%TZ]6RFMKNSFLIY5#37T=RKRROW.<<#T'0"K5_X<%W#;_\ $RU
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MXEDOFU34&M_(0#=,OS$.Q*D;?NX(_,U'8^'F&LPWW]FI91VN]DB%R9-[L,#
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MF1Z3&=.B,9D260_>XQ@M]W\Z3P\Z7-EX8TVV207MG</-=(8R/LZX<,K<<9+
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M20*7/H >M)<ZA9V6P7=W! 7^Z)9 N[Z9/-(+F==:(]SX1;1A,JR&U$/F8XR
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M9P"2>@Q[TQ79S>G^$/[.U9IDCT^6W,[3B26WS.I8D[0W3J>O6MS3YKZ:ZO\
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MU71I;_PPVE1S+'-Y:*LC#*[E(()'ID5LXS534KU=-TVXO70NL$9D*CJ<<X%
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MVEW*^$O#UO'9N)HI[9YHT7!7'WB?ZU=L-*_XK?6-1N+/AHX!;SNN>BG=M/\
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M=$D@T^[EU.UM%6-!;K+%NV@%) >GUKO\48YS2&F1VQD^S1>:BI)L&Y5Z XY
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M.+(Q[7@"%FVXV@_Q?6DTS1/L&MZ)+;V MXTTYXYV1  &^0X;WSFNOQ1BBP7
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04 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>fin_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fin_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S ' # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#],_AY_P %
M"OVNM>_;?\/?#/7?B@MQX#N?VD]3^']YX='@_P 'A5\+CQEKVC?V*NLCP[P1
MH"@JPQ("!A\Y-?MO_P %'O%_Q,^&O[%_[0WQ<^#'C:7P%\1OAC\-]1^(OA_Q
M/;^&=&\1M$/ P7Q%JVBIHVOB2&5O%6AV\OAO^_&TJ.K*5 F_ES^$2A/^"C'A
M)<[@G[6VK+GN0OQ)U\9_'&:_I_\ ^"I*-_P[L_;+)N<)_P ,]?$W"\8X\/S
M\^H)!Z#Z"OF?"'$XC-.(8K'3CG,'Q=2H^^KQ=.=>A#V/*]XSC-T^6VBETMI_
M5WT].$N'N",+P#_JAE,,BEG7A(L5-<-17#[EB$I*55M)7FY1UJ7L]>DKG\=_
MPS_X*X?\%H/CKXDN?"_P9^)7C/XI^*+;1?[8O?#_ ,/_ ("_#/Q-JECI/_09
M_L30/AL?E]NY]:]0\8?\%$_^"_GP@T"X\>?$RP^-7@GP=H&#K'B#QO\ LK^#
M--\,:?Z?VWK?_"MQC!SC& .W/7S;_@@3\=_@[^S[^V)\0O&_QN^(?@SX3>$+
MO]GSQ-HUEX@\9ZQ%X<T^]U;_ (3?P 5TI?/(CS%_8>MR#=N)VY56.T'^DC]M
MW_@L%^P'X2_9[^)6B>'_ (S_  _^.GB;QA\.?%?@_P ._#3X9WD?C.36]4UW
M1=<T../7-:3[1X7T/0,[DED\4S0(5S\L@( _OGC/$87(^.*/#>4^"G#&>Y+.
M/#:G-\-5FTJL:?MI*M"$J49/FG)RE->]%2E9M6_R+X8H5\SX2J\19OXA\29)
MG,'6Y:<N)(24G3YW",H2G=J;C"+7+>7,]TSR?_@C]_P6,U;]MCQ+J_[/GQ]\
M/>'_  W\==%T#4/$WAW5/"MNUAX;^(_AK1I%_MMXM%?<_A_7O"[F-)H#(L/E
M?/$(V#"7F_\ @O1^U_\ M:?L8)^SCXP_9S^, \!Z3X[O?'?AOQ?X4N_ O@[Q
M1IE_JNAIH.LZ+K*:SXA\/.T&TZPZ,B$(2&.2S25^3_\ P;L_LK_%?Q3^UGI_
M[4U_HNMZ+\(OA)X/\;:-9>*-5M=4TW3_ ![X]\=:.= AT/0O-9%UX>&= UC7
M/$/C%G95,K>%T5@W3[H_X.EB#\._V.<-N/\ PL3XODGZ^"]#QS^&?QKX#$Y!
MPGAO'W*N'LGRB$LEJ5(NKPNY1G&%25"M4JTK7ER*G.,$XW7(I-6B]#[2AQ%Q
M%BO!'-LVQ>:S>;KF4:NO-**J*,9W27-*4?>YMI.SUW/S<^'7_!1W_@O)\9O#
M/_";?"6^^*_Q2\'F\U+1U\5>"?V9/!?B3PS_ &IH)!UK1QK7A_X<8!5L>I5@
M0#GK/I/_  7'_P""K7[./CBWT7]H32[#6&"L;KX>_&#X*'X;ZC?Z<W&[1=7T
M#PYX2\0LPY*M)'*5(!QQ7[M_\&W1;_AW=$H'!^.OQ=.['3,^BY&?H,XS]*_5
MO]J3]E#X-_M>_#/6/A1\:?!^G>(_#NIVNI&RNY[.%?$?AC5) \*>*_!VN-#)
M+X?UZ)W25)H!'(QVAP8UD25<0>(?!.6<8YOPSG'A5PK')LHQ4L/*I3YX55!2
M]ESSGO*O!RE*RE!*W[MJ5F^/)>"^+<UX1RGB7*>/N)O[8E3514Y-.FURN3II
M/_EVK<J;4E:S>S3^5?\ @G5_P5#^!_\ P4&\%:A<>&4N? 7Q?\'V,=Q\2/A7
MXDOH;W5-$L':.)-:T36B$C\1>!KB1E6#Q-%&D3RL(RJ$H#]W?%_XL?#_ . W
MPV\6_%OXH>(M/\&^ ?!FCMK'B+Q!JI(CT_35/SEB,D<D)M"LP/&TX++_ )S'
MP-\5>/O^":__  4:TC[1JMT=7_9^_:"U/X8^/#:9&G>+/ 7]M#0?'# 8RI\5
M>'<>* >"K;>0<5^W?_!SA^T1K<^M? #]EC0]3NK/PO/X9U3XX>.;*TN0%UW4
M5UD:%X$&L!02J^%CH?C;Q-V!*("%55(Y.(O [ +Q&X1RKAW,$N#N.J/^LZDK
MRG3PUH5<12YVI.T8J,8-M<WN\TI.+YO2R;Q<QBX(XJS3-U_PNY!5_P!6DFN6
M52LI.,)N-U[SJ)RE[MKZVU/'OVG?^#B#]I?XQ>/5^'?[#GPKM_ .@:EJXT3P
M;JNK^$I/B5\;O'6.0^A>!&;_ (1;0)!V\.,OC&7&0&4,5KBY/CC_ ,''_@K2
ME^)FJZ5^T\/#UG:'6+FSN?@_\,_$A&F '(UGP./#7_"3J54'('A '&<< D?J
MQ_P;T?L5^"_AE^S?I'[6WB7P]I>H_%KXZ7/B4>'?$5W:YU7PK\,M&UJ30-"T
M31HVMR=!_P"$I;0M4\3>+_+N 9WE\/QLF;=%?^D1BP;@ +D#<7(SG& !D#GC
MI[=A6'$/'G _!.<YEPUPCX?\+Y]E&22^KU*O$T)5*U:=/W:C52*TYIQJV<VD
MYM/D@DD;<.\&<6<593'B3B+BSB7(LVSM*=./#LE"$*;UIN4=59+D;MHTI*[=
MS^0/]B7_ (..O%/_  EFC_#K]O/P?H=OI-U>KH__  NWX?Z-JWAW4?">I@C!
M^*?@8LW_ !(3GYO$_A+:0 /^*(ZLO]:VC^(-(\2:+8Z_HE[IVLZ/K-CIFM:5
MJVF7*W^GW^F:RI;1M7TJ3YT*2*R."N$ZL&../Y O^#C[]C/P3X+O? 7[9/PY
M\/:9HVK>._%G_"M/C3;Z9;II]GX@\32Z7<ZWX%\:&*.)436C'X?UGPQXLG\U
MWG4^'!(J20,\GWE_P;A?M$^)?BG^R#XO^#OB*_NM1O?V=_B,/#7AV[N@IV^!
MO&FCKX@T+1<;26/AG7CKL;L2<*B*F"<GFX^X5X2S;@7*_$O@W+7DBJ5/8\4\
M+Q?/3IUI<T%*E=2LO:.-HJ5I0E3?+'WK]/!?%7$65<79IP!Q=F4LYE9OACB:
M4;3E&*7NU-FY.-U*Z^)2/RU^$?/_  4G\(Y_Z/$U?_U9?B&OZ@_^"J'_ "CH
M_;-';_AGSXG_ /IDFK^7WX0D'_@I#X2(.0?VP]6((Z$?\+*U_FOZEO\ @HQX
M/\4>._V%/VK/ _@CP]K7B_Q9XO\ @GX^\,^&O"OA^R_M+5-<U?6=$DAT?2-'
MTG)1F<N%P54G#G+ _)_*_@Q.-//HSDU&$.,*52<KJ*4(8BA.4KWBE:,)/F;4
M5:[DDFU_J[^TABY8;PLC'62^C_2A9:\LWSI*26J;;6EE*US^&'_@DA^Q%\-/
MV^/VD?%_P6^,>N>-O#GAG0OA!XC\?V5W\/KW1=-U+^T]&\:^'= 4G_A(/#GB
MWC&O @ Y.-H!8XK^@GQY_P &Q7[,UUHUR?AI^T#\;O"'B%;(M9W?BNT\%^.O
M#3Z@!R^K:#%X;\*2R ,0H4^+(V)( 4\;OR__ &2/'GP*_P""*/C_ %#Q]\?/
M%>J?%_\ :W\8>'M2\ >(OV=/@G>>$K_PU\&?#.L:YH'B!3\4_BEK<L'AMO'_
M )F@:$7\*^%6">%8@\922"<.WZ)>)_\ @Z)^$J:-?#P=^R7\4-0UT69-G9^*
M_'7@[3+ '&!_;$GAUO%GEXR<D*S,3P5'%?WEQGF?BWQ!Q5]>\-5Q-+A+V=&G
M3<E2A3E*$8QE.+K<KE2E*[]IK"5+6'-&TI?XP<&Y=X:Y7P[/"<=?ZOO.'*I*
M*7MI2UYI03<+QY]5IO?LTT?CE\)OVM?VR/\ @C[^U[J_P,\8?$76O&WP[^$7
MCO2O#/Q&^%5YXBUGQ)\-O%/@/7O[!U[^W/ NB^(/^2?^(/\ A'-=7Q-X*'A1
MEW;O+\>JZDU^M'_!SU=V7B3X4?L2:_IDHFL-5\7_ !.N[6Y&"/[,UKP?X)._
M([R1NA)[9QVX_"'P'\/_ -IK_@L%^VYXJ\06/ATW>O\ Q9\=Z5K?Q4\6^'[/
M5Q\-O@QX"1-!T+!UXE5'_"*>'-"'AGP4"P\8^,V ;@+D?TS?\%W/V0/BC^T;
MX0_8R^'?PGL=&TW0?ASK/Q1OO'?Q+\;ZM_PC/PU^%/@;0_ VA:6?&'Q,\9\M
MHGAX1@Y"!F=HY>I1L=O$<^'\@\4/"K,,U?#V3\7QHSGQ=.G)2I<RR*,U*NZ7
M/%UZE3GY8PE*3E*5U->RYIX?I\19IP-XA8'!PDLDUCPLG&:]WGDO=4M7'D47
MJDKM-<OO,]6_X-P/^4<T('('QW^+O(R,@OHHY![#C@]SQS7[WSSPP0NV<_95
MR,G(&1GC]!VQG/2OXROV2_\ @KW^QE_P3-^$MK^RK\)M#^-G[3=CH6K^)?$_
MB;XP:7:>$/!O@KQ5XZUP[]=C\#Z+K<__  D4?P_+$#P>_B;?O"B/S952.1?+
M?VS_ /@XM^,7QQ\%>(/A9^SI\-/^%&Z3XGLAHVM?$/Q#XBB\1?$MM/UI&5M,
M\$?\(\B>&O#\KQ_*?%!;QBF%5416'S?C_$/A;QMQIQQFV<X+*G3R3/>*)U(5
MZZA2C[.=7F4G"=6-514$JJC.G"\>5/DDW&/Z)P[XE<+\+\#Y9D^)S)SSS)>&
M5'DA"<VZT8S2CS1C*+DZC4=Y.RO=Z7_*O]N+7HOV@_\ @H_^T/-X"SK</Q&_
M:GU'PQX0N])Y&OG_ (3+0/ >A?V'\HR#_8N0<#(Y Z ?IS_P<H^!=3\+_M8_
M 'Q+-]HN='\0?LYZ=X:L[M>^I^"/&WB!M;)ZG+1Z[H#GL-V!7I__  1!_P""
M3GQ/U'XJ>!OVR?VBO!NI^"OA]\.I(O$?P8\$^*K*33_$WCCQNY*:%XUUK0U4
MOH'AWPF0OB3P6VX#Q5XOD^TRD10[6_>;_@K;_P $^[?]OW]G6W\*>%;W3]#^
M,_PPUI?&7PMU_4P]EIM]JKLD>L^#-=9$9AX>\5J8S)NVK'XMT+PS-(PCB=J_
M6,[\1^',B\3/#S)\'F/M,HX'X8APEQ)6@X5(JI6C*A5E&47)<L)*"JSA)V=T
MO@FX_!9/P%G^><#\69QB\L<<WSZJ^)Z49+D<E&4ZD%R:>]):QCRW:L[*^K?^
M"(WC?PY\1/\ @F=^S4FCRV=S<>#?#^I>#/$%J"6-GXD\$^,-<C<2+A2KRG^R
M_$B %EVZTCDY.P?K<8269",VS8/7@  X(P1G\^3Q7^=A^Q9^WC^U-_P1_P#C
M)XN^%_Q$^%NN)X:US5_MGQ&^!?C\)X<U4:EHC1F7QAX&UTK\NNS>'(U$GB9/
M^$O\&^-%"&-TECCE3]Z-=_X.>?V5(/![7WA7X%?'36_&YM R^%-8L_!WAO2U
MU/NG_":IXD\4@* #M9O"4AR23GI7X[QKX1\55.+,US#AG+GG^29[5GB*-:C*
MG4485I3KQNXU.5**JM<TGR3BH-23;O\ HO!?BEP]'AW+,#Q'F$LDSC)(JG.G
M*G47/[-<FB]F[J48I.+5T].B-;_@Y@\=Z%H7[&OPO^'<]R'\4>.OV@_#>L:/
M;':SKI?@?PCXA.O:KE3C$1UG0XB#DYUL9.0<^0_\&NOA/5;3X4?M;>.)X+C_
M (1[7_B)\,_"NCW9QNOM6\$>#=:US7&4^P\<:*#@C<2!FOPP^(GCK]M;_@M?
M^U/83>'/"%WKFH6]L_AKPAX6TW4-;?X1? KP/-(7.LZ[XY<DG+MCQEXD3;XP
M\8*$A@CCC2/P.G]TG["O[*'@;]B+]G#P'\!?"TJZU=>%;%=9\8>*C:1Z<?%W
MCO7)"OC'Q@0Y1@\DK,L:L,Q^%H_#\0=PBE_J^-7@^ ?!K*?#?$YC3J\99[B(
M\2UE3G"HL/!W<5-QE+6')3CRNRD^:27+%,\?A2GB^,_$[,^.L,FLCR2+ITW.
M+A&HVFKQ<HQCJI2D^6_+?6US^9SX(_"WQ)??MH>(_C,(-/\ "'P9^"_[2WBK
MQ=\0?B1XJNV\/>'=!TKP_P#$CQ!_Q)!KD@_XJ#Q#&N ?#7AH*@=D$K!G /\
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MTNY>&7#VKW?O<G-9O6^K7Q)7/N__ (>F?L'#@?'CP\!V T?Q7C_TP#^0IO\
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E "T444 %&!Z"BBBR[+[E_D 8 Z "DP/0?E110&^O7OU^_<__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !' '8# 2(  A$! Q$!_\0
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M7$6WC^^U&2Z_LSPI?WD%M<26YE65%#,A /7ZUJZ7XW\/ZM?1V5E>M)-)]U3
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+@4ZBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &Y F\# 2(  A$! Q$!_\0
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M_ ],<>G'I5*@!22S%F))/))I*** "BBB@ HHHH **** "BBB@ HHHH ****
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M'N:EI(J,F]T0T445)84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU@@?:=I.-W;- "45?TVR>\$\8@=PR'9(HSM<<_K5 @J<,I5AU!&"* "BBB@
MHHI2C*JLRD*WW2>AH 2BM&RL)KNPN=ML[$+YD<@'IU%=WX0\.:#?^#GN;JUC
MFN6<B>>23!MN>FWJ!CG- 'F=%23K&ES*D3;XE=@C>HSP:CH **** "BG1QO-
M(L<:%W;@*HY-:EGI0DG\@*;NZQDP1-A4'^TW^% &3D45UB165LAGCA@WK<+;
MW4T:>8D QDLB\]>F?:LO7H(T^QSK''%-.C&1(U*JP#85PIZ;ASB@#'HHHZG
M&30 45H0Z8=R_:F=6;E8(UW2M^';\:-5M8[6XC@2%HI@O[V+?O*GMD^N.HH
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M&$K+)CYN?E' J'Q?9^$5U'69;;5M1DU'[3*1"]J A?><C=GI[TFC?\EJM_\
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MVR)@6TDD08C!?N36)3WFEE5%DD9U084$YP*90 4444 ;>F2Q)I3--$SO%,3
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M@BC1114E!1110 4444 %&**[#PW-8VFBM)<,GSRR&0EQ\H5/E#*>6#%CT]*
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M>Y#X(:.?^8K=_P#?*T[_ (4?H_\ T%;S_OE:7L9C^MTNYX717NO_  H[1_\
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MC^TE_P">9_.O>/\ AGK0_P#H,WW_ 'PM'_#/.A_]!F^_[X6CG0^4\'_M)?\
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MB=A?&*XC:W>9#&NTJR_P^X]ZR<D/D?0Z934RL,XSSZ5REAK5X]W9+*5GCNB
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M<VL(3<+>-V>VN&E@?D@-\W*N>XKKJAEK86BBBD,*^?OVC/\ D*Z'_P!<'_\
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MQ2*$Q2XHHH ,48IVT[=V#MZ9QQ49FC!P6% #L48IHFC/1A3NHR.E Q,44M%
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M%5YIRW$D-C9R&)(48@,1U8XZFN&\V7_GK)_WV:1HJ>A]B;T_YZ)_WT*-Z?\
M/1/^^A7QYYLO_/63_OLT[S9?^>LG_?9I6*Y#[##I_P ]$_[Z%*&4G"LI/H"*
M^/!++_SUD_[[-3VM_>65PL]K=SPS*<JZ2$$4<H^4^OJ"RK]YE7ZD"N)\/^,;
MB\^%\GB&Y0/=VT+A_1W7@'^5?/VH:QJ.L7DE[?7DTT\AR27.![ =A24;C1];
M^9'_ ,]$_P"^A2^9'_ST3_OH5\?B23_GK)_WV:422?\ /63_ +[-'(.Y]?\
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MZ.+#9DU&=N>GR_+3)V=BI>:[JE^9_/O9C',Q+1[N.3T^E4!2"EH*L>S^%_\
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MZ'_UP?\ ]"KZ KY__:,_Y"NA_P#7!_\ T*N2&YTSV/$:***W, HHHH ****
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M&ZMHA<?NG%H9E!$@4%6([>QJU,]_"D96Y@9G<(O[OKG\:S[W-'Y%RW>:&_\
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MN.%<U\1/^2>:W_U[_P!172BN9^(G_)/-;_Z]_P"HJ7L7#XD><_L_?\?.N_\
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M\S,I?#>F!)D\N0K+RX,A/.<Y'H:T[>WCMD*1@A6;<<GO3Z44K%78ZN;^(?\
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ML7_"]I/^@&G_ '^/^%'_  O:3_H!I_W^/^%>.T4O:S[C^K4NQ['_ ,+WD_Z
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MG,UU.V68]!Z #L!6?1322"X4444Q!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 45/13 @HJ>B@""BIZ* (**GHH @HJ>B@""BIZ* (**GHH @HJ>B@""BIZ*
M (**GHH @HJ>B@""BIZ* (**GHH @HJ>B@""BIZ* (**GHH @HJ>B@""BIZ*
M (**GHH @HJ?O10!!14]% $%%3T4 045/10!!14]% $%%3T4 045/10!!14]
M% $%%3T4 045-2T 045/10!!14]% $%%3T4 045/10!!14]% $%%3T4 045/
410!!14]% $%%3T4 045/10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #? 5 # 2(  A$! Q$!_\0
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MA@^:C*TGHSOJ*0'-+7GGM!1110 4444 5[W_ (\9_P#</\JL"J][_P >4_\
MN'^56!1T%U"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% $3$*A). .YK@M7U$ZC?-("?*3Y8Q[>OXUT/B"YF:#[%:@M
M)*,OM/*I_P#7Z5S8TN^'_+LWYC_&NW#12?-(\;'5F_<C\RBMI;?9%M/L\7V9
M<8AVC8,'(X^O-5-0T&WU&#R$:.VC:1I9 EM$^]SU;YU.&]QS6X-,O1_R[/\
MF*D&FWG_ #[O^8KT&X/=H\I.I%W5S'31-,\FSCDL()A91K' 94#%%7IR>O3/
MUJ\UG:RI.DEO$R7!S,K(")#@#YO7@#\JNC3[K_G@_P"E.%C=_P#/!_TI<T.Z
M$Y5'W,U]+T^2XDN'L;9II5"R2&,;G QP3WZ#\A4QM;=IO.:",R%Q)O*C.X#
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MT@NI-1@$$^1$X.[?CKC'/'?T[UA7>D:EIES ;1S>QR:M#=Q^>V&5RCB3<57
M4X4YQU)S3?[-U;3]<TJY@MK>:ZEGO;F9 S)#$75 %WA2>W4@9.:PYY=CI]G3
M>J9L7/B%8KV6&".">)=/6^28SA4<&39C=@@#'.:T6U;3TU![!KN+[6BEWBSD
MJ ,\]AQS@\XKF'\'WT5J8(KBW<RZ:]I)NW*%<S&7*]?ERQ&.P K773-5MFU2
MVLIK>.&_FEN$N]Q$L#NO=,8;! P<CCMQ24I=4)PI]&/G\5:/#91WBW:26S7*
MVSR+QY3,"06!Y P/3O5C^V[.-+J>YGMX;6!HPLOF[M^]0P^7&03G@<D]:PH/
M#.JQ22W>^W%V+NWN8XI+J696\I64AI&&X;MWH<5;FT/4GOGU)?LANEO(;M(6
M9O+8K#Y;*6QD'DD'!Z#BCFEV$X4]DS2F\0:/;V<%W+J, MY\^4X)._'7&!GC
MOZ=ZF;6--6ZM[;[;"9[E0\**=V]3T/'&#V)ZUE:?H-Y::E;WUP\/F--=W%Q'
M&3M5I@@"ID<@;>2<9))J"Q\/:I9?V2L!@MY;:***YN8YW_>QJ23&8MNUA@X!
MR",FGS2[$\D.YU-%+@^E&#Z5L8&QHMYM)MW/'\-;G%<;&S1R*Z\%3FNJLKD7
M-LKCKCFO-Q-.SYEU/9P5:ZY'TV+E%%%<IZ97O?\ CRG_ -P_RJP*I7[JMK(I
M/S.I51W8GL*NBCH+J%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!*Q-=OOL]OY$9_>R\?1>Y_I6M+*D,3R.<*HR3[5Q5W<O>73S/Q
MN^Z/0=A6]"GS2N]D<6+K>SA9;LD!TX 9L3GV<TX-IW_/E_X^:J"G"O1Y/ZN>
M+<M;M/\ ^?,_]]FG!M/_ .?,_P#?1JJ*44<GG^(7\BV&L/\ GT/_ 'T:4-8_
M\^A_[Z-5>@R:2.1)8UDC=71AE64Y!'J#WJ.1=POY%T/8?\^I_P"^S2^99?\
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M,4F?[@P6_GBK%% %:&XCG#;"<J<,K#!4^XJQ59/^0E+_ -<4_FU6: %HHHH
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# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "" G # 2(  A$! Q$!_\0
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MHHJA<!I;J.!9'C787<H<$X( &?Q/Y4 7Z*I6+O);GS&+,KNFX_Q ,0#^E7:
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MC /X>]:E(1F@#.NX!=I%/;R!+A/FBE'((/8^JG_Z_:I;JV^UV;0D['(!5A_
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M,(B'"93 <]VQTQZ?C6Z%"C ' Z8IP^M!%-R;W9$816R'4444BPHHHH ****
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MPU#_ ,!S3:[$)]S5HK*_MH?] _4/_ <T?VT/^@?J'_@.:5F/F1J45E_VT/\
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M%9?]M#_H'ZA_X#FC^VA_T#]0_P# <T6#F1J45E_VT/\ H'ZA_P" YH_MH?\
M0/U#_P !S18.9&I167_;0_Z!^H?^ YI%UC)P-/O\_P#7#'\S2Y0YBW-.D5W!
M"5):4,01VVC_ .O5JLNTAGDNVN[N,1N5\N./.=BYR<GIDG'3T%:G2AZ#3;%H
MHHH&)56[NUL[5YW5F5,9 ZXSC-6JAG@2X@DAD&4=2K#U!H6^HGL345BQW-W8
M1B*ZMKBXV?*DT"[]X[$C.0?7M4W]M#_H'ZA_X#FG87-W-2BLO^VA_P! _4/_
M  '-']M#_H'ZA_X#FBP<R-2BLO\ MH?] _4/_ <T?VT/^@?J'_@.:+!S(U**
MS/[:'_0/U#_P'- UE<\V-^/<VYHL',C3HJG#>03V_G1RJT8SENF,=<YZ8]ZK
M'6X6^:&VNYXSTDBA)4_0]Z+!S(U:*R_[:'_0/U#_ ,!S1_;0_P"@?J'_ (#F
MBP<R-2BLO^VA_P! _4/_  '-']M#_H'ZA_X#FBP<R-6DK+_MH?\ 0/U#_P !
MS1_;0_Z!^H?^ YI68<R-.J\5T);J>WVD&';ENQR,U2_M:612L.G7C2$<"2/R
MU_$D\5-I]J]M"S3.'GE<R2,.A8]A[   ?2G:P7N]#1HHHI%!1110!6M+I;RV
MCG12JN,X/458K%'GZ;/+L@DGM9&,@$>"T;'DC'<$\\=,U/\ VR/^?#4/_ <T
MVNQ"?<U**RO[:'_0/U#_ ,!S1_;0_P"@?J'_ (#FE9CYD:E%9?\ ;0_Z!^H?
M^ YH_MH?] _4/_ <T6#F1JT5E?VT/^@?J'_@.:/[:'_0/U#_ ,!S19AS(U**
MH6NH0W3.J%E=/O1R JZ_4'M[U'-JT,4KQ)'/<,G#B",OM/H3TS[46=Q\R-.B
MLO\ MH?] _4/_ <T?VT/^@?J'_@.:=A<R-2BLO\ MH?] _4/_ <T?VT/^@?J
M'_@.:+!S(U**R_[:'_0/U#_P'-']M#_H'ZA_X#FBP<R-6JDERL=U#;E26E#,
M".P7'7\Q50:P2<#3]0S_ -<,?S-+96]Q)=/>7:!'*[(XP<^6G7D]R3U^@H"]
M]C5HHHI%!1110 4444 %%%% !1110 450U&^MM-M&N;J410J0"Q!/)( &!R<
MD@5#;ZQ874#S6TYE59!$X1&+(Q( #+C*]1U'3GI0!JT444 %,8!@00"#P0>]
M,GGBMH6FGD6.-1EG8X J:@1@:;9/#J=PL@8P6IV6H(X56&XX^F=H]ABMXBL^
M]U.RTM5>\G$8D;:BX+,Y]%49)_ 4^SOH-1@\^V<O$25R5*D$'!!! (H;N)*R
M+U%%5X)XKJ".>"19(I%#(ZG(8'H0:"BQ1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !115>[N[>QM9+FZF2&",;G=S@ 4 6**S[#5+34T=[
M25G$;;7#(R%3C/(8 UH4 %%49KZWMUF+R9: !I%12[*#T^49/-7J "BBB@#
MO[%GU2%8QBVN\_:E X;9R/SZ'U K<4 +BEQFJ5Y?VVG6[7%Y,L40(&YSW/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "@ D$# 2(  A$! Q$!_\0
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M*GA^5&#?:(W=7W*74GGGD\]>?TIUGX?EMEN=]UN,T93A<!,G/'MS0!N;(R.
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M]"0,#]* -.BFE0>M)L7TH ?13-B^E&Q?2@!]%,V+Z4;%]* 'T4S8OI1L7TH
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M_6N,[ 7[[5DWMMJ,EV[02,(B!\N_'/;']:UE^^U4Y]5M+:<PR.3(J[B%&<4
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M>G[ES]X5PXW^*=N#_ACZ9)T7ZTN]?[P_.DDZ+]:XSL!?OM5>;4;6"4QRR[7
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M]S]:?10 S+?W/UHRW]S]:?FB@!F6_N?K1EO[GZT^B@!F6_N?K1EO[GZT^C-
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M@ZK(P+ ?4T[S8_[Z_G0 )$L<21+G:JA1SV%'E+Z4>;'_ 'U_.CS8_P"^OYT
M'E+Z54DO;.*5HWE"NIQBK?FQ_P!]?SK.DTVTEG>9Y&+LV<[N@]![4 3I>6<D
MD<:RJ6?.P#OCK5KRD]*H)IMFD\<PD)>,DKEN!GFK_FQ_WU_.@ \I?2CRE]*/
M-C_OK^='FQ_WU_.@ \I?2HIW@@CWRG" ]:E\V/\ OK^=5[J&&[B,3RE5R"=K
M8S[&@"-;^Q;[LR')./?C^53P207,(DB;<AZ&J2:9:1$;'( ;<%W=.V/IS5NU
MBM[.W6"$J$7U.<T 3^6OI1Y2^E'FQ_WU_.CS8_[Z_G0 >4OI1Y2^E'FQ_P!]
M?SH\V/\ OK^= %22]LHI6CDE574\@T1WME)*L2RJ7)P!TY]ZAFTVTFG>9Y&:
M1SG);H,8Q]*(=-LX95E$C,X;<2S9R?>@#1\M/2CRE]*!+'C[Z_G1YL?]]?SH
M /*7TH\I?2CS8_[Z_G1YL?\ ?7\Z (IY(;>/S)3M0=Z@&H6+?=G')QD9Q4EW
M'#=Q>4TI52<G:1S]:JKIEHDBNLK#;R!NX]OYT 7H7AN(5EB8-&PX/K4GE)Z5
M!:QP6MNL,;@JN<9-3^;'_?7\Z #RE]*/*7TH\V/^^OYT>;'_ 'U_.@ \I?2J
MDE_912/$\H5EX(/\ZM^;'_?7\ZSY]/M9IGE>1BS'GYN,>GTH FCO+.21460%
MF;:!@]:M>6OI5"&PM8)8Y1*S,A)&YL\FKXE3'WU_.@ \I?2EQ@8%)YL?]]?S
4I#+'_?7\Z *-%'F)_>'YT4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !2 G # 2(  A$! Q$!_\0
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M\Z1D8^CD_6@#I:*YK3O$T][K<6G_ &(M'(+AC<*0H7RI?+QM)S]3[CCTZ6@
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M?_X1R=(QA[=W\N)&#+A7*QLA8X'7Y@1]*NZ9H\MA?-*\JN@1E#8.^3<0<O\
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M26.:87TLD\D;D MDD[,=N@&*@A36(]2>YB\QHY(X@4F0#<1&_)_NG=M!QZT
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M\NY21QW'&,CO5O7+R6PTI[B QB19(US(<+@NH.3V&">>U7_*CW!MB[@, XY
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M(;#,^X*Q&W'RX##GV-=&NRYMU+K&Z.H.,[E/T]13RBGJHZYZ4H4*  , =A3
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MTH$<J/$NH6[2R7MBL<<=H)-BGEY-X4L#V3YACO@$U:;Q%<$PI'IH9Y$C)#7
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M)P,9- #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Wearable Devices Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001887673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5 Ha-Tnufa Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Yokne&#8217;am Illit<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Israel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2066736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">707,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wlds_OrdinarySharesNoParValuePerShareMember', window );">Ordinary Shares, no par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WLDS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wlds_WarrantsToPurchaseOrdinarySharesMember', window );">Warrants to Purchase Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to Purchase Ordinary Shares<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WLDSW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Asher Dahan<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">asher.dahan@wearabledevices.co.il<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5 Ha-Tnufa Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Yokne&#8217;am Illit<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Israel<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2066736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPhoneFaxNumbersLineItems', window );"><strong>Entity Phone Fax Numbers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">4.6185670<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityContactPersonnelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityContactPersonnelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPhoneFaxNumbersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPhoneFaxNumbersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wlds_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wlds_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wlds_WarrantsToPurchaseOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wlds_WarrantsToPurchaseOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorTable', window );"><strong>Auditor [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ziv Haft<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel Aviv, Israel<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Consolidated Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Wearable Devices Ltd. and its subsidiary (&#8220;the Company&#8221;) as of December&#160;31, 2024 and 2023, and the
related consolidated statements of comprehensive loss, changes in shareholders&#8217; equity and cash flows for each of the three&#160;years
in the period ended December 31, 2024, and the related notes (collectively, the &#8220;consolidated financial statements&#8221;). In
our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at
December&#160;31, 2024 and 2023, and the results of its operations and its cash flows for each of the three&#160;years in the period
ended December&#160;31, 2024, in conformity with accounting principles generally accepted in the United States of America.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,089<span></span>
</td>
<td class="nump">$ 810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short-term bank deposits</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">4,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Governmental grant receivable</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other receivables and prepaid expenses</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FIFOInventoryAmount', window );">Inventories (Note 3)</a></td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">5,516<span></span>
</td>
<td class="nump">6,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Long-term bank deposits</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets (Note 5)</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net (Note 4)</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">TOTAL NON-CURRENT ASSETS</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">840<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">5,976<span></span>
</td>
<td class="nump">7,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AdvanceFromCustomers', window );">Advance payments</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note (Note 6)</a></td>
<td class="nump">770<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and other employment related accruals</a></td>
<td class="nump">402<span></span>
</td>
<td class="nump">579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">2,095<span></span>
</td>
<td class="nump">1,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">2,116<span></span>
</td>
<td class="nump">2,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY (Note 10):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares no par value: Authorized 50,000,000 as of December 31, 2024 and December 31, 2023; Issued and outstanding 707,463 shares as of December 31, 2024 and 254,843 shares as of December 31, 2023.</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">32,895<span></span>
</td>
<td class="nump">26,692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated losses</a></td>
<td class="num">(29,102)<span></span>
</td>
<td class="num">(21,223)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="nump">3,860<span></span>
</td>
<td class="nump">5,526<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 5,976<span></span>
</td>
<td class="nump">$ 7,592<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FIFOInventoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FIFOInventoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AdvanceFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent advances from customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AdvanceFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Ordinary shares, par value (in Dollars per share)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="nump">707,463<span></span>
</td>
<td class="nump">254,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, outstanding</a></td>
<td class="nump">707,463<span></span>
</td>
<td class="nump">254,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(437)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ResearchAndDevelopmentNet', window );">Research and development, net (Note 7. a)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,964)<span></span>
</td>
<td class="num">(3,316)<span></span>
</td>
<td class="num">(2,271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expenses, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,096)<span></span>
</td>
<td class="num">(2,008)<span></span>
</td>
<td class="num">(1,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,845)<span></span>
</td>
<td class="num">(2,882)<span></span>
</td>
<td class="num">(1,948)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProspectiveInitialPublicOfferingExpenses', window );">Initial public offering expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(904)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">OPERATING LOSS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,820)<span></span>
</td>
<td class="num">(8,186)<span></span>
</td>
<td class="num">(6,458)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_FinancingIncomeExpensesNet', window );">Financing income (expenses), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(52)<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">LOSS BEFORE TAX EXPENSES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,872)<span></span>
</td>
<td class="num">(7,814)<span></span>
</td>
<td class="num">(6,496)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS AND TOTAL COMPREHENSIVE LOSS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (7,879)<span></span>
</td>
<td class="num">$ (7,814)<span></span>
</td>
<td class="num">$ (6,496)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per ordinary shares, basic (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (24.2)<span></span>
</td>
<td class="num">$ (38.4)<span></span>
</td>
<td class="num">$ (42.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per ordinary shares, diluted (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (24.2)<span></span>
</td>
<td class="num">$ (38.4)<span></span>
</td>
<td class="num">$ (42.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of ordinary shares and pre-funded warrants outstanding basic (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">325,690<span></span>
</td>
<td class="nump">202,515<span></span>
</td>
<td class="nump">153,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares and pre-funded warrants outstanding diluted (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">325,690<span></span>
</td>
<td class="nump">202,515<span></span>
</td>
<td class="nump">153,465<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The share and per share information in these financial statements reflects the 1-for-20 reverse share split that became effective on October 10, 2024 and an additional 1-for-4 reverse share split of the Company&#8217;s issued and outstanding ordinary shares that became effective on March 17, 2025 (the &#8220;Reverse Share Splits&#8221;). See also Note 1c.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_FinancingIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of finance income (Loss), net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_FinancingIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProspectiveInitialPublicOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of initial public offering (IPO) refers to the process of offering shares of a private corporation to the public in a new stock issuance for the first time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProspectiveInitialPublicOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ResearchAndDevelopmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ResearchAndDevelopmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Ordinary shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated losses</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 31<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 7,689<span></span>
</td>
<td class="num">$ (6,913)<span></span>
</td>
<td class="nump">$ 807<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">139,211<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ChangesDuringTheYear2022Abstract', window );"><strong>CHANGES DURING THE YEAR 2022:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet', window );">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of $1.6 million</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,308<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares', window );">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of $1.6 million (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,875<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Conversion of SAFEs (as defined in Note 10) into ordinary shares upon completion of initial public offering (Note 10)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">399<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering', window );">Conversion of SAFEs (as defined in Note 10) into ordinary shares upon completion of initial public offering (Note 10) (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,477<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants', window );">Issuance of ordinary shares as a result of exercise of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">160<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised', window );">Issuance of ordinary shares as a result of exercise of warrants (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions', window );">Exercise of options (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">58<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">790<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(6,496)<span></span>
</td>
<td class="num">(6,496)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,346<span></span>
</td>
<td class="num">(13,409)<span></span>
</td>
<td class="nump">9,980<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">188,121<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ChangesDuringTheYear2022Abstract', window );"><strong>CHANGES DURING THE YEAR 2022:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued in the public offering, net of issuance cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,659<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued in the public offering, net of issuance cost (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">55,556<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodValueInvestors', window );">Issuance of shares to April 2021 investors (Note 10)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesInvestors', window );">Issuance of shares to April 2021 investors (Note 10) (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,114<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Exercise of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,447<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercise of warrants (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,052<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">241<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(7,814)<span></span>
</td>
<td class="num">(7,814)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,692<span></span>
</td>
<td class="num">(21,223)<span></span>
</td>
<td class="nump">5,526<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">254,843<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ChangesDuringTheYear2022Abstract', window );"><strong>CHANGES DURING THE YEAR 2022:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA', window );">Issuance of shares associated with the SEPA (Note 1.d)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,343<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement', window );">Issuance of shares associated with the SEPA (Note 1.d) (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">307,175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering', window );">Issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,578<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares', window );">Issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">127,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of ordinary shares to service provider</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of ordinary shares to service provider (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess', window );">Issuance of ordinary shares for the reverse split process (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,879)<span></span>
</td>
<td class="num">(7,879)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 67<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 32,895<span></span>
</td>
<td class="num">$ (29,102)<span></span>
</td>
<td class="nump">$ 3,860<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">707,463<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The share and per share information in these financial statements
reflects the Reverse Share Splits.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represent an amount less than $500</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ChangesDuringTheYear2022Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ChangesDuringTheYear2022Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of SAFEs into ordinary shares upon completion of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Round up in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of shares associated with standby equity purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance of units of ordinary shares and warrants in connection with the initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of units of ordinary shares and warrants in connection with the initial public offering shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the value of issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of units of ordinary shares pre-funded warrants and warrants under registered direct offering, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the shares of exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued from the exercise of warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodSharesInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued to investors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodSharesInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the value of issuance of shares associated with the SEPA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodValueExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the value of stock issued during the period from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodValueExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodValueInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the value of stock issued during the period to investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodValueInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; Equity (Parentheticals)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Units of ordinary shares and warrants issued, issuance expenses</a></td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,879)<span></span>
</td>
<td class="num">$ (7,814)<span></span>
</td>
<td class="num">$ (6,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AccruedInterestOnConvertibleSecurities', window );">Interest expenses on convertible promissory note</a></td>
<td class="nump">4<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AccruedInterestOnDeposits', window );">Accrued interest on deposits</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized gain from foreign currency derivative activities</a></td>
<td class="nump">68<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_MarketingExpensesPaidInOrdinaryShares', window );">Marketing expenses paid in ordinary shares</a></td>
<td class="nump">100<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for inventory write-off</a></td>
<td class="nump">75<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease in accounts receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Decrease (increase) in inventories</a></td>
<td class="num">(269)<span></span>
</td>
<td class="num">(1,026)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_DecreaseincreaseInGovernmentalGrantsReceivables', window );">Decrease (increase) in governmental grants receivables</a></td>
<td class="nump">91<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses', window );">Decrease (increase) in other receivables and prepaid expenses</a></td>
<td class="nump">357<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="num">(496)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IncreaseDecreaseInAdvancePayments', window );">Increase (decrease) in advance payments</a></td>
<td class="num">(228)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Increase (decrease) in deferred revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase (decrease) in accounts payable</a></td>
<td class="num">(253)<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Increase (decrease) in accrued payroll and other employment related accruals</a></td>
<td class="num">(177)<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Increase in accrued expenses</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(7,613)<span></span>
</td>
<td class="num">(8,434)<span></span>
</td>
<td class="num">(5,714)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_DecreaseIncreaseInDepositsNet', window );">Decrease (increase) in deposits, net</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="num">(4,054)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PrepaymentsOfLeasing', window );">Prepayments of leasing</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">3,197<span></span>
</td>
<td class="num">(4,248)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost', window );">Proceeds from issuance of shares issued in the public offering, net of issuance cost</a></td>
<td class="nump">1,578<span></span>
</td>
<td class="nump">1,670<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses', window );">Proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfSAFEs', window );">Proceeds from issuance of SAFEs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RefundToSAFEInvestors', window );">Refund to SAFE investors</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from credit line</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit line</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants', window );">Proceeds from issuance of ordinary shares as a result of exercise of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,449<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of ordinary shares associated with the SEPA</a></td>
<td class="nump">4,353<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible promissory note</a></td>
<td class="nump">1,920<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayment of convertible promissory note</a></td>
<td class="num">(1,156)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">6,695<span></span>
</td>
<td class="nump">3,119<span></span>
</td>
<td class="nump">14,879<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">2,279<span></span>
</td>
<td class="num">(9,563)<span></span>
</td>
<td class="nump">9,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the beginning of year</a></td>
<td class="nump">810<span></span>
</td>
<td class="nump">10,373<span></span>
</td>
<td class="nump">1,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the end of year</a></td>
<td class="nump">3,089<span></span>
</td>
<td class="nump">810<span></span>
</td>
<td class="nump">10,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">49<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InterestReceived', window );">Interest received</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(305)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConversionOfSAFEToEquity', window );">Conversion of SAFEs to equity</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RightofUseAssetRecognizedAgainstLeaseLiability', window );">Right-of-use asset recognized against lease liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 644<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AccruedInterestOnConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued interest on convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AccruedInterestOnConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AccruedInterestOnDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of accrued interest on deposit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AccruedInterestOnDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConversionOfSAFEToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of conversion of SAFE to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConversionOfSAFEToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_DecreaseIncreaseInDepositsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of decrease (Increase) in deposits, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_DecreaseIncreaseInDepositsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease (increase) in other receivables and prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_DecreaseincreaseInGovernmentalGrantsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease (increase) in governmental grants receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_DecreaseincreaseInGovernmentalGrantsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IncreaseDecreaseInAdvancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in advance payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IncreaseDecreaseInAdvancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of interest received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_MarketingExpensesPaidInOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketing expenses paid in ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_MarketingExpensesPaidInOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PrepaymentsOfLeasing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of prepayments of leasing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PrepaymentsOfLeasing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of proceeds from issuance of ordinary shares as a result of exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfSAFEs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the SAFE investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfSAFEs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of proceeds from issuance of shares issued in the public offering, net of issuance cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RefundToSAFEInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of refund to SAFE investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RefundToSAFEInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RightofUseAssetRecognizedAgainstLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is right-of use asset recognized against lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RightofUseAssetRecognizedAgainstLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - GENERAL:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wearable Devices Ltd. (the
    &#8220;Company&#8221;) was incorporated in Israel in March 2014. The Company develops&#160;and sells human-machine interface solutions
    for the smart wearables industry. In 2023, the Company started production of its B2C consumer product, the &#8220;Mudra Band&#8221;
    and started to generate revenues. The Company&#8217;s products are designated directly to end users and also designated to businesses
    in integration of its technology in their smart wearable devices. The Company&#8217;s ordinary shares and warrants began trading
    on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) on September 13, 2022, under the symbols &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221;
    respectively. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We qualify as an &#8220;emerging growth
company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the U.S.
Jumpstart Our Business Startups Act of 2012, and we may take advantage of certain exemptions, including exemptions from various reporting
requirements that are otherwise applicable to public traded entities that do not qualify as emerging growth companies. These exemptions
include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not being required to comply
    with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not being required to comply
    with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation
    or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements (i.e.,
    an auditor discussion and analysis).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We will remain an emerging growth
company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues exceed $1.235 billion; (ii)
the last day of the fiscal year following the fifth anniversary of the date of our initial public offering (i.e., December 31, 2027);
(iii) the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2&#160;under the&#160;Exchange Act,
which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented by warrants,
held by non-affiliates is at least $700 million as of the last business day of our most recently completed second fiscal quarter; or
(iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any three-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s revenues were derived from:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sales of B2C consumer product, the
&#8220;Mudra Band&#8221;.</p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sales of B2B Mudra
    development kits composed of multiple performance obligations including tangible parts (&#8220;Hardware&#8221;) and a limited period
    (generally one year) application programming interface (&#8220;API&#8221;) with no commercial rights, to enable the customer to evaluate
    the Company&#8217;s solution with its own products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The sales of pilot transactions
    to evaluate the integration of the Company&#8217;s solution with the customer&#8217;s products composed of multiple performance obligations
    including Hardware, tailor-made software applications and technical support during the pilot period.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In 2024 and 2023, most of the Company&#8217;s
revenues were derived from the sales of Mudra Band to B2C customers. In 2022, all of the Company&#8217;s revenues were derived from the
sales of Mudra development kits. See also note 2.g.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">b.</p></td>
    <td style="padding-right: 3pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, the
Company established a wholly owned subsidiary in the United States of America for the purpose of marketing and distribution of its solutions
&#8211; Mudra Wearable, Inc. (the &#8220;Subsidiary&#8221;) &#8211; which commenced its operations in 2020. </p></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="padding-right: 3pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2024, the Company effected a one-for-twenty (1-for-20) reverse stock split of its ordinary share (the &#8220;October Reverse Split&#8221;). As a result of the October Reverse Split, every twenty (20) shares either issued and outstanding were combined into&#160;one&#160;new ordinary share. All outstanding securities entitling their holders to purchase ordinary shares, including options and warrants were adjusted as a result of the October Reverse Split, as required by the terms of those securities. The October Reverse Split changed the par value per ordinary share from NIS 0.01 to zero par value. On March 17, 2025, the Company effectuated an additional 1-for-4 reverse share split of its issued and outstanding ordinary shares (the &#8220;March Reverse Split&#8221; and, together with the October Reverse Split, the &#8220;Reverse Splits&#8221;). The March Reverse Split did not change the number of shares authorized for issuance. See also note 10.a below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All share amounts, share prices, and exercise prices have been adjusted retroactively within these financial statements to reflect the Reverse Splits.</p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td>
    <td style="padding-right: 3pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October
7, 2023, Hamas terrorists infiltrated Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian
and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel&#8217;s
border with the Gaza Strip and in other areas within the State of Israel. Following the attack, Israel&#8217;s security cabinet declared
war against Hamas and the Israeli military began to call-up reservists for active duty. As of March 18, 2025, the ceasefire that had been in place since January
2025 has ended, and hostilities have resumed.</p>
                                   <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the attack by Hamas on Israel&#8217;s
    southern border, Hezbollah, a terrorist organization in Lebanon, has also launched missile, rocket, and shooting attacks against
    Israeli military sites, troops, and Israeli towns in northern Israel. In response to these attacks, the Israeli army has carried
    out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon, and in October 2024, the Israeli military initiated
    a ground operation in Lebanon, primarily near the Israel-Lebanon border. As of the end of November 2024, Israel entered into a ceasefire
    agreement with Hezbollah, but there are no guarantees as to whether the agreement will hold or whether further hostilities will resume.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, many Israeli citizens are obligated
    to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of 40 (or older
    for certain reservists) and, in the event of a military conflict, may be called to active duty. As of March 19,2025, these events
    have had no material impact on the Company&#8217;s operations.</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern:</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying consolidated financial
statements have been prepared assuming that the Company will continue as a going concern. To date, the Company is still at its development
stage and at an early stage of generating revenues. Therefore, the Company has suffered recurring losses from operations and negative
cash flows from operations since inception. In September 2022, the Company completed an initial public offering (&#8220;IPO&#8221;) and
listed its ordinary shares and warrants for trading on Nasdaq and raised net proceeds of $13.3 million. In November 2023, the Company
completed a secondary offering and raised net proceeds of $1.7 million. <span>In June 2024, the Company
entered into a </span>Standby Equity Purchase Agreement (the &#8220;SEPA&#8221;)<span>. During 2024, the
Company issued 307,175 ordinary shares pursuant to SEPA for net proceeds of $4.4 million. </span>In November 2024, the Company completed
a registered direct offering and raised net proceeds of $1.58 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2024, the
Company had incurred accumulated losses of $29 million and expects to continue to fund its operations through fundings such as
issuance of convertible securities, ordinary shares and warrants and through Israeli governmental grants. There is no assurance that
such financing will be obtained. Considering the above, the Company&#8217;s dependency on external funding for our operations raises
a substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any
adjustments that might result from the outcome of these uncertainties.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td> <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;25, 2022, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#8217;s minimum bid price requirement because the closing bid price of the ordinary shares was below $1.00 per ordinary share for the previous 30 consecutive business days. On May 23, 2023, the Company received a notification letter from Nasdaq that the Company had been granted an additional 180-day compliance period, or until November 20, 2023, to regain compliance with Nasdaq&#8217;s minimum bid price rule. On June 9, 2023, the Company received a written notice from Nasdaq Stock Market LLC, indicating that it has regained compliance with the minimum bid price requirement. On October 24, 2023, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#8217;s minimum bid price requirement because the closing bid price of the ordinary shares was below $1.00 per ordinary share for the previous 30 consecutive business days. The Company was granted 180 calendar days, or until April&#160;22, 2024, to regain compliance with the minimum bid requirement. Since the Company did not regain compliance with the minimum bid price requirement by April 22, 2024, it applied for an additional 180-calendar day grace period. On April 23, 2024, Nasdaq granted the Company an additional 180-day compliance period, or until October 21, 2024, to regain compliance with Nasdaq&#8217;s minimum bid price rule. On October 10, 2024, the Reverse Share Split at the ratio of 1:20 became effective. As a result, the Company was informed by Nasdaq on October 28, 2024 that the Company had regained compliance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 16, 2025, the Company received a written notification from
Nasdaq, which stated that the Company was no longer in compliance with the minimum stockholders&#8217; equity requirement for continued
listing on Nasdaq, due to the Company&#8217;s failure to maintain a minimum of $2.5 million in stockholders&#8217; equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s stockholders&#8217; equity was approximately $1.7
million as of June 30, 2024. In accordance with Nasdaq rules, on February 5, 2025, the Company submitted a plan to regain compliance to
Nasdaq to explain the way the Company believes it has regained compliance with the minimum stockholders&#8217; equity requirement through
the SEPA it entered into with YA II PN, Ltd. (&#8220;YA&#8221;) on June 6, 2024, and the registered direct offering, completed on November
27, 2024. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance.
The notification letter has no immediate effect on the Company&#8217;s listing on Nasdaq, and during the grace period, as may be extended,
the Company&#8217;s ordinary shares and warrants will continue to trade on Nasdaq under the symbol &#8220;WLDS&#8221; and &#8220;WLDSW,&#8221;
respectively.</p></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying consolidated financial
statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;). The significant accounting policies followed in the preparation of the financial statements are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying consolidated financial
statements include the accounts of the Company and the Subsidiary. All intercompany transactions have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of the consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its estimates, judgments and assumptions.
Management bases its estimates, judgments and assumptions on historical experience and on various other factors that are believed to
be reasonable under the circumstances. Actual results could differ from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The currency of the primary economic
environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;USD&#8221;). The Company&#8217;s funding
and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Transactions and balances originally
denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into USD using historical and
current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other items (stated below)
reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#8211; exchange rates at transaction
dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation etc.) &#8211; historical
exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventories:</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories are composed of parts
of the Company&#8217;s products as well as completed products and are stated at the lower of cost or net realizable value. Inventory
cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably
predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase, and other costs
incurred in bringing the inventories to their present location and condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property and equipment</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated
at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#8239;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">Annual rates of depreciation are as follows:</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Furniture and leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Electronic equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Machines and molds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-50</span></td><td style="text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>f.</b></span></td><td style="text-align: justify"><b>Leases</b></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#8217;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#8217;s incremental borrowing rate. The weighted-average&#160;rate applied was 8%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has the option to extend some of its
lease agreements. In measuring the lease liability and the right-of-use asset, the Company took some of those options into account
since management believes that those options are reasonably certain to be exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Leases with a lease term of 12 months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue recognition </b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenue is recognized when (or as)
control of the promised goods or services is transferred to the customer, and in an amount that reflects the consideration the Company
is contractually due in exchange for those services or goods. The Company follows five steps to record revenue: (i) identify the contract
with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the
transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies its performance
obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company generates revenues from
the sales of B2C &#8220;Mudra Band&#8221;, sales of B2B &#8220;Mudra development kits&#8221; and sales of pilot transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The &#8220;Mudra Band&#8221;, is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#8220;Mudra Band&#8221; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point
in time indicating control has been transferred to the customer.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A pilot transaction has multiple performance
obligations, and it generally takes a few months but less than one year. Each Mudra development kit sale also has multiple performance
obligations.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The payment terms of the Mudra development
kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions are within the pilot period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In those transactions, each obligation-
Hardware and API (for Mudra development kit) and tailor-made software application and technical support (for a pilot transaction) - is
distinct and separately identifiable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The amount allocated to the delivered
items is recognized upon delivery, the amount allocated to API is recognized over the API period and the amount allocated to technical
support is recognized over the service period (a pilot period).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of revenues</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Costs are expensed as incurred. The primary components
of the cost of revenues include the cost of the product and outbound freight charges.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>i.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research and development</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Research and development expenses
consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>j.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company receives royalty-bearing
grants from the Israeli government for approved research and development projects and marketing efforts. These grants are recognized
at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as provided by the relevant agreement
and included as a deduction from research and development or sales and marketing expenses, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>k.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance income and expenses</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Finance income is composed of interest
on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are composed of interest on senior
secured credit facility, bank charges and net currency exchange rates differences.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>l.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income taxes
in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred
taxes are determined utilizing the assets and liabilities method, which is based on the estimated future tax effects of the differences
between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed
using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets
is provided if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will
not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available
evidence, are not expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies ASC 740, which clarifies the accounting
and reporting for uncertainties with respect to income taxes. ASC 740 prescribes a comprehensive model for the financial statement recognition,
measurement, presentation, and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based compensation</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Share-based compensation expenses
related to employees&#8217; and consultants&#8217; options are measured at the grant date based on the fair value of the award and are
generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation expense on a
straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche is separately
expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes option
pricing model, which requires management to make certain assumptions of future expectations based on historical and current data include
the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants and pre-funded warrants</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The warrants&#8217; mechanism does
not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount of ordinary shares upon exercise.
Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional paid in capital), based on an
assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants are freestanding financial
instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity classification, including
whether the warrants are indexed to the Company&#8217;s own shares, among other conditions for equity classification.</p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Severance</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Israeli labor law generally requires
payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. The Company&#8217;s
pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section 14 of the Israeli Severance Compensation
Act, 1963 (&#8220;section 14&#8221;), the Company&#8217;s employees are entitled to monthly deposits, at a rate of 8.33% of their monthly
salary, made in their name with insurance companies. Payments in accordance with section 14 relieve the Company from any future severance
payments in respect of those employees and, as such, the Company may only utilize the insurance policies for the purpose of paying severance
pay.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>p.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted loss per share</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 80.55pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Basic and diluted loss per share is calculated
by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares and pre-funded warrants
outstanding during the financial year, adjusted for ordinary shares and pre-funded warrants issued during the year, if applicable.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
<tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements</b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company measures and discloses
fair value in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;), ASC 820, Fair Value Measurements and
Disclosures (&#8220;ASC 820&#8221;). ASC 820 defines fair value, establishes a framework and gives guidance regarding the methods
used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the
amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that
market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a
three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 1 &#8211; unadjusted quoted
prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; "><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 2 &#8211; pricing inputs are
other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration
with observable market data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; "><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 3 &#8211; pricing inputs are
unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; "><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This hierarchy requires the Company
to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of cash is based on
its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and
liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>r.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains certain cash
balances in a well-known Israeli banks and U.S.-based bank.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the years ended December 31, 2024 and 2023, the
Company partially hedged its foreign currency exchange risk.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Our derivative instruments primarily
include foreign currency forward agreements related to the NIS and associated with certain payroll payments. Our foreign currency forward
agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated as hedges for accounting
purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged item, are recorded within
our consolidated statements of loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>s.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents:</b></span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash equivalents are highly liquid
investments that are readily convertible into cash, with an original maturity of three months or less.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>t.</b></span></td><td><b>Segment Information</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has a single operating and reportable segment. The Company&#8217;s chief operating decision maker, who is the Company&#8217;s Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; ">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
<tr style="vertical-align: top"> <td style="width: 0.25in"><b>&#160;</b></td> <td style="font-size: 10pt; width: 0.25in"><b>u.</b></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting Standards Adopted in 2024</b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2023, the FASB issued
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;). This ASU
expands public entities&#8217; segment disclosures by requiring disclosure of significant segment expenses that are regularly
provided to the chief operating decision maker (the &#8220;CODM&#8221;) and included within each reported measure of segment profit or loss, an amount and description of its
composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. All
disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. The ASU&#8217;s
amendments are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within
fiscal years beginning after December 15, 2024, with early adoption permitted. After evaluating the impact of this pronouncement on
the Company&#8217;s financial statements, the Company found that there is no impact on its financial statements.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>v.</b></td><td style="text-align: justify"><b>ACCOUNTING STANDARDS ISSUED AND NOT YET ADOPTED IN 2024</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2024, the FASB issued
ASU 2024-03, Income Statement &#8211; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures (Subtopic 220-40):
Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;), which requires the disaggregation of certain expense
captions into specified categories in disclosures within the notes to the consolidated financial statements to provide enhanced
transparency into the expense captions presented on the face of the statement of income and comprehensive income. ASU 2024-03 is
effective for annual reporting periods beginning after December 15, 2026, with early adoption permitted, and may be applied either
prospectively or retrospectively to financial statements issued for reporting periods after the effective date of ASU 2024-03 or
retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact
that the adoption of ASU 2024-03 will have on its related disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2024, the FASB issued ASU 2024-04, Induced Conversions
of Convertible Debt Instruments (&#8220;ASU 2024-04&#8221;). This new guidance is intended to improve the relevance and consistency in
application of the induced conversion guidance in Subtopic 470-20 for (a) convertible debt instruments with cash conversion features and
(b) debt instruments that are not currently convertible. ASU 2024-04 is effective for fiscal years beginning after December 15, 2026.
Early adoption is permitted. The Company does not plan to early adopt this standard. The Company is currently evaluating the effect of adoption of this standard
to its consolidated financial statements and disclosures.&#8195;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 3 - INVENTORIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cost:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Raw materials</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">212</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">514</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt">Work-in-progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">206</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">986</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">312</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Provision for inventory write-off</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(75</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,226</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,032</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE</b>&#160; <b>4 - PROPERTY AND EQUIPMENT, net</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cost:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">230</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">204</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Furniture and leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Electronic equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Machines and molds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">86</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">374</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">334</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Less <span style="font-style: normal; font-weight: normal">-
    accumulated depreciation</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">244</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">140</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">130</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">194</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 5 - LEASES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has operating leases for
our office and vehicles. The Company&#8217;s leases have remaining terms of less than one year to approximately 2 years, some of which may include
options to extend the leases for up to 2 years. The Company exercised the option to extend the lease for an additional one year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cash flows related to leases are classified as part of the cash used to operating activities in the cash flow statement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following table summarizes the classification
of operating lease right-of-use assets and liabilities in the Company&#8217;s Consolidated Balance Sheets as of December&#160;31, 2024
and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Right of use assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">330</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">592</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 0.2in">Short term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">297</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 7.3pt">Long term</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">278</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total lease liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">312</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">575</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December&#160;31, 2024, the future minimum lease payments
under the Company&#8217;s operating lease liabilities are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S.&#160;dollars<br/> in&#160;thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">302</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">324</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less operating lease liabilities, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(291</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Operating lease liabilities, non-current</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">21</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total expenses under all operating leases were $288 thousand,
$232 thousand, and $74 thousand for the years ended December 31, 2024, 2023 and 2022, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stand by Equity Purchase Agreement and Convertible Promissory Note<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract', window );"><strong>Stand by Equity Purchase Agreement and Convertible Promissory Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock', window );">Stand by equity purchase agreement and convertible promissory note</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 6 - STAND BY EQUITY PURCHASE AGREEMENT AND CONVERTIBLE
PROMISSORY NOTE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On June
6, 2024, the Company entered into the SEPA with YA, a fund managed by Yorkville Advisors Global, LP. Pursuant to the terms of the SEPA,
YA is committed to purchase up to the commitment amount, of the Company&#8217;s ordinary shares at any time during the three-year period
following the execution date of the SEPA. The purchase price of the ordinary shares sold to YA is equal to 97% of the lowest volume weighted
average price (&#8220;VWAP&#8221;) of the ordinary shares during a pricing period of 3 consecutive trading days commencing on the trading
day of the delivery of advance notice by the Company. During the year ended December 31, 2024, the Company issued 307,175 ordinary shares
for gross proceeds of approximately $4.6 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>According
to SEPA, the Company will have the sole right in its discretion to sell shares to YA from time to time by issuing advance notices to YA.
In addition, the Company also agreed to pay YA the commitment fee by issuance of the ordinary shares, equal to $100,000, or 1.0% of the
aggregate amount available to be sold under the SEPA, as consideration for its irrevocable commitment to purchase ordinary shares under
SEPA. The Company and YA agreed to postpone the issuance of the Commitment Fee to YA. The Commitment Fee will be paid either by cash or
by the issuance to YA of such number of ordinary shares that is equal to the balance of the Commitment Fee divided by the average of the
daily VWAP of the ordinary shares during the <span style="-sec-ix-hidden: hidden-fact-72">three</span> trading days immediately prior to the payment date. The Company has also paid YA a
structuring fee in the amount of $10,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Subject
to certain conditions, according to the SEPA agreement, the Company may request pre-paid advances of the commitment amount, in an
amount up to $3 million, which will be evidenced by one or more convertible promissory notes. In June 2024, the Company requested,
and received, an initial pre-paid advance of $2 million in connection with the execution of SEPA. Each convertible promissory note
will be discounted to 96% of the purchase price and be fully mature 12 months following its issuance and shall accrue interest on
the outstanding principal balance thereon at a rate of 6% per annum, increasing to 18% per annum upon an Event of Default (as
defined in the convertible promissory note). Beginning 60 days after the issuance of a convertible promissory note, the Company
shall pay to YA a monthly installment payment of 10% of the original principal amount of the convertible promissory note and accrued
interest, payable in cash or by submitting an advance notice, where YA will offset the amount due to be paid to us under such notice
against an equal amount of the monthly installment amount, at the Company&#8217;s option. If the Company elects to pay in cash, the
installment amount shall also include a payment premium in the amount of 5% of the principal amount of the installment payment. Each
convertible promissory note will be convertible at a conversion price equal to $4.00 per ordinary share and contains customary
adjustments in the event of stock dividends, stock splits, reorganizations or similar events affecting the Company&#8217;s ordinary
shares and the conversion price. Each convertible promissory note will also contain anti-dilution provisions that provide that if
the Company issues ordinary shares, or securities convertible into or exercisable or exchange for, shares of ordinary shares at a
price per share that is less than the conversion price then in effect, then the conversion price of the convertible promissory note
upon each such issuance will be adjusted to the price equal to the consideration per share paid for such ordinary share or other
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The embedded
conversion option has not bifurcated due to the fixed nature of the conversion price, which is closely indexed to the Company&#8217;s
own shares. Additionally, there is no significant premium associated with the convertible promissory note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>Moreover,
the Company retains the option to settle the debt in shares pursuant to the SEPA conditions. Given that the Company will incur an additional
cost, either in cash settlement or in shares settlement (in the form of discounted share price), the convertible promissory note will
bear a 5% premium.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The
convertible promissory note was recognized based on the amortized cost method and as of December 31, 2024, the convertible
promissory note, including accrued interest, amounted to approximately $807 thousand. As of
December 31, 2024, the convertible promissory note balance net is $770 thousand. In February 2025, the Company repaid the
entire balance of the convertible promissory note and the commitment fee.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stand by equity purchase agreement and convertible promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 7 - COMMITMENTS AND CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalties to the Israel Innovation Authority (&#8220;IIA&#8221;):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.4pt; text-indent: -0.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company receives royalty-bearing
grants from the IIA, for approved research and development projects. The programs include grants for: wages, materials, subcontractors
and miscellaneous. The Company was required to pay royalties at the rate of 3%-3.5% on sales of products developed with the funds provided
by the IIA, up to an amount equal to 100% of the IIA research and development grants received, linked to the dollar including accrued
interest. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable to US Dollar deposits. However,
on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under such
directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024
the annual interest is calculated at a rate based on 12-month SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%;
and, for grants approved on or following January 1, 2024 the annual interest shall be the higher of (i) the 12 months SOFR interest rate,
plus 1%, or (ii) a fixed annual interest rate of 4%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2018, two IIA programs
were completed, while the amounts received for them aggregated to $1.224 million. In addition, another IIA approved plan commenced on
May 1, 2020, and was completed on July 31, 2021, pursuant to which a total of $627 thousand was received. During January 2023, the IIA
approved an additional program to finance further development of the Company&#8217;s manufacturing process of its wearable neural interface
in Israel. The approved program is in amount of approximately $900 thousand (NIS 3.1 million), of which the IIA will finance 60%; for
the years ended December 31, 2024 and 2023, the Company received $180 thousand and $288 thousand, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The terms of the grants under the Encouragement
of Research, Development and Technological Innovation in the Industry 1984 require that the manufacturing of products resulting from IIA-funded
programs be carried out in Israel, unless a prior written approval of the IIA is obtained (except for a transfer of up to 10% of the production
rights, for which a notification to the IIA is sufficient). During December 2022, the Company received an approval from the IIA to transfer
some of its manufacturing activities abroad.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As a condition for obtaining approval
to manufacture outside Israel (or following a declaration that up to 10% of the production is transferred abroad), the Company would be
required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate 3%-3.5%, and also the total
amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from the IIA, depending on the manufacturing
volume that is performed outside Israel (less royalties already paid to IIA).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Research and development grants deducted
from research and development expenses amounted to $92 thousand, $415 thousand and <span style="-sec-ix-hidden: hidden-fact-73">nil</span> for the years ended December 31, 2024, 2023 and
2022, respectively. As of December 31, 2024, the maximum obligation with respect to the grants received from the IIA, contingent upon
entitled future sales, is $2.4 million plus interest which may be increased, depending on the manufacturing volume that is performed
outside Israel. The Company has obligations regarding know-how, technology, or products, not to transfer the information, rights thereon
and production rights which derive from the research and development, in whole or part, of its Mudra product and its Mudra Band product,
without the IIA Research Committee approval.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalties to the Israeli Ministry of Economy and Industry (&#8220;IMEI&#8221;):</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During 2020, the Company received a
grant from the IMEI, for approved marketing expenses amounting to $95 thousand. The program includes participation in expenses for: consulting
for marketing, advertising and online marketing, flights to exhibitions and miscellaneous. &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the agreement with the IMEI,
if the export revenues in the defined target market increase by $311 thousand compared to the base year, the Company would be required
to pay royalties at the rate of 3% of the increase, with the funds provided by the IMEI up to an amount equal to 100% of the IMEI marketing
grant received, linked to the consumer price index (&#8220;CPI&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2024, the maximum
obligation with respect to the grant received from the IMEI, contingent upon entitled future sales, is $95 thousand linked to the CPI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Commitments &#8211; Operating Leases:</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On July 1, 2018, the Company entered
into a lease agreement for a period which expired on September 30, 2022. The monthly lease payment totaled approximately $5 thousand.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">After September 30, 2022, the Company
stayed on the lease on a month-to-month basis. At the end of January 2023, the Company terminated this lease with 60 days&#8217; termination
notice that ended on March 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In January 2023, the Company entered into a new lease agreement in
Yokne&#8217;am Illit, Israel for a period which started on February 1, 2023, and expires on January 31, 2025, with an option to extend
the lease period by two additional lease periods, each for an additional 12 months. The Company exercised the option to extend the lease
for an additional one year. The Company&#8217;s monthly rent payment for this facility is approximately $16 thousand during the first
lease year and increased to approximately $20 thousand during the second lease year. During the option lease periods, the lease payment
may be increased up to 10% as compared to the second lease year. The Company exercised the option and extended the lease for another year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Subsidiary, Mudra Wearable, leases
an office located in California. The lease is on a month-to-month basis for $495 per month. Additionally, during 2022, the Company entered
into lease agreements to lease 5 vehicles for a period of 3 years.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract', window );"><strong>Convertible Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CONVERTIBLE SECURITIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 8 - CONVERTIBLE SECURITIES &#8211; April 2021 investors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In June 2022,
the Company&#160;received from Alpha Capital Anstalt (&#8220;Alpha&#8221;) the contractually required written consent to proceed with
the IPO (the &#8220;June 2022 Consent&#8221;) in exchange for a cash payment of $300,000 from the proceeds of the IPO, which was paid
on September 28, 2022, following the completion of the IPO. Pursuant to the share purchase agreements the Company entered into with certain
investors in April 2021 (the &#8220;April 2021 SPAs&#8221;), in the event of an initial public offering event or in a Dilutive Issuance
event (as defined below), reflecting a pre-money valuation of $26,400,000, or a lower one, then such investors shall receive additional
ordinary shares and additional shares underlying each warrant, based on 80% of the price per share at the IPO (the &#8220;Discounted PPS&#8221;),
less the number of ordinary shares issued to them in the April 2021 financing, and the number of shares underlying each warrant shall
be increased assuming the exercise amount is divided by the Discounted PPS. Additionally, beginning on April 22, 2021 and until the earlier
of (i) the 90th calendar day after the expiration of the applicable lock-ups, following the IPO date (i.e. June 2023) or (ii) three years
from April 22, 2021, if the Company or its subsidiary shall issue any ordinary shares or equivalents of ordinary shares, in an equity
transaction other than an exempt issuance, entitling any person or entity to acquire ordinary shares at an effective price per share less
than the per share purchase price of $180.00 (subject to prior adjustment for reverse and forward stock splits and the like) (a &#8220;Dilutive
Issuance&#8221;), then, for no additional consideration, the Company shall immediately issue to the investors in the April 2021 financing
that number of additional ordinary shares equal to (a) the per share purchase price of $180.00 divided by amount actually paid in new
cash consideration by third parties for each ordinary share in the Dilutive Issuance less (b) the number of ordinary shares issued to
Alpha and other investors at the closing of the April 2021 financing pursuant to April 2021 SPAs. Pursuant to the June 2022 Consent, the
investor in the April 2021 financing waived their rights for such adjustments as of the date of the IPO and deferred such adjustments
(if any) to be effected on the 90th calendar day following the closing of the IPO.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 20, 2022, the Company&#8217;s
volume weighted average stock price was less than the exercise price of $160.00 for the warrants. Accordingly, effective after the closing
of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date of the warrants), the warrants&#8217; exercise
price was adjusted pursuant to their terms to $160.00 (the &#8220;Exercise Price Adjustment&#8221;). Following the Exercise Price Adjustment,
on February 16, 2023, the Company issued an aggregate of 2,114 ordinary shares to the April 2021&#160;investors&#160;as a result of the
IPO.&#160;&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CreditFacilityAbstract', window );"><strong>Credit Facility [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CreditFacilityDisclosureTextBlock', window );">CREDIT FACILITY</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 - CREDIT FACILITY </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On July 4, 2022, the Company
entered into a senior secured credit facility agreement with L.I.A. Pure Capital Ltd. (&#8220;Pure Capital&#8221;) to borrow from
time to time amounts until the closing of the IPO in an amount of up to $800 thousand (the &#8220;Initial Credit&#8221;), which
Initial Credit could be increased, upon the request of the Company, to an amount not exceeding $1 million (together with the Initial
Credit, the &#8220;Credit Facility&#8221;) in aggregate. The underlying outstanding amounts had priority in relation and senior to
any other debts owed by the Company to any third party, and were subject to a registered floating charge, for the benefit of Pure
Capital, against all of the Company&#8217;s assets. During July, August and September 2022, the Company received an aggregate of
$800 thousand under the Credit Facility. The Credit Facility bore interest at the rate of 4% per annum. The outstanding amounts,
together with interest accrued and unpaid were due and payable on the earlier of (i) June 30, 2024, or (ii) upon receipt of a
certain financing transaction or in the event of certain customary events of default or a change of control. The Credit Facility was
fully repaid on September 19, 2022. The agreement indicates that the Company shall not assume any debt senior to the Credit Facility
during the term of the Credit Facility, unless Pure Capital has provided its advance written consent; and subject to applicable law,
any debt assumed by the Company during such term shall be deemed subordinated to any debt accrued under the agreement, if Pure
Capital had not provided its prior written consent; and without Pure Capital&#8217;s prior written consent, the Company shall not
pledge in favor of a third-party creditor or lender any of its assets or rights, including by a floating charge, until such time
that the Credit Facility, and any interest accrued thereon, has been repaid in full to Pure Capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, the Credit Facility
agreement requires the Company to retain Pure Capital for investor relations services and other related strategic services in
exchange for a monthly base fee of $35 thousand, upon the closing of the IPO, under a 3 year consulting agreement. If 70% or more of
the warrants (or other convertible securities) issued in connection with the IPO are exercised during the term of such instrument,
then the base monthly fee will immediately increase to $70 thousand, which increase shall apply retroactively to the closing of the
IPO date. Total expenses for services rendered under Pure Capital agreement were
$420 thousand, $420 thousand and $122 thousand for the years ended December 31, 2024, 2023 and 2022, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CreditFacilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CreditFacilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CreditFacilityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CreditFacilityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders&#8217; Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 10 - SHAREHOLDERS&#8217; EQUITY:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share capital</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The share capital as of December 31, 2024 and 2023, is composed
of as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 4pt">Ordinary shares, NIS 0.01 par value</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">50,000,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">50,000,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">707,463</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">254,843</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The ordinary shares entitle their holders:
to receive notices of, and to attend, general meetings where each ordinary share shall have one vote for all purposes; to share distributions
as may be declared by the Board of Directors of the Company and approved by the shareholders, if required; and, upon liquidation or dissolution
- to participate in the distribution of the assets of the Company after payment of all debts and other liabilities of the Company, in
accordance with the terms of the Company&#8217;s Articles of Association.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(1)</td><td style="text-align: justify"> In 2022, the Company issued 58 ordinary shares, upon exercise of employees&#8217; options.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(2)</td><td style="text-align: justify">In September 2022, the Company completed its IPO whereby the Company issued and sold in connection with
the closing of the IPO 46,875 units, each consisting of one ordinary share and two warrants to purchase one ordinary share each. In addition,
the underwriter exercised its over-allotment option with respect to 14,062 warrants to purchase 14,062 ordinary shares.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The warrants were exercisable immediately
upon issuance, at an exercise price of $320.00 per ordinary share and are exercisable until September 12, 2027. On September 16, 2022,
500 warrants were exercised into 500 ordinary shares. On December 14, 2022, the exercise price of the warrants was adjusted to $160.00
per ordinary share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In connection with the IPO, the Company
received gross proceeds of approximately $16.0 million, before deducting underwriting discounts and commissions and before offering expenses
($14.9 million net proceeds after deducting approximately $1.1 million of underwriting discounts and commissions and approximately $13.3
million after other IPO expenses).&#160;</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(3)</td><td style="text-align: justify">During 2022, the Company entered into a simple agreement for future equity (the &#8220;SAFEs&#8221;) for
$500 thousand with 5 investors, $100 thousand each, of which $400 thousand were converted to 1,477&#160;ordinary shares and $100 thousand
of one investor were paid back in cash upon the closing of the IPO. Those&#160;SAFEs were not mandatorily redeemable, nor redeemable at
the option of the holder after a specified date, but in an Equity Financing (as defined in the SAFEs) which under current liquidity circumstances
constitutes a redemption event outside of the Company&#8217;s control. The Company issued to each SAFE investor a warrant to purchase
ordinary shares of the Company with an exercise price of $507.60 per share in such offering for an aggregate amount of up to $25 thousand
(exercisable for a total of 197 ordinary shares, until the earlier of: (i) eighteen (18) months from January 2022; or (ii) in a change
of control event, which generally covers (a) a transaction in which any person or group becomes the beneficial owner, directly or indirectly,
of more than 50% of the Company&#8217;s outstanding voting securities with the right to vote for the election of members of the Company&#8217;s
Board of Directors, or (b) any reorganization, merger or consolidation of the Company, or (c) a sale, lease or other disposition of all
or substantially all of the Company&#8217;s assets).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(4)</td><td style="text-align: justify">During September 2022, investors exercised 500 warrants into ordinary shares.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(5)</td><td style="text-align: justify">In June 2023, 9,052 warrants were exercised into 9,052 ordinary shares at an exercise price of $160.00
per ordinary share.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(6)</td><td style="text-align: justify">On November 13, 2023, the Company completed a public offering of its securities,
whereby the Company issued and sold 55,556 ordinary shares. The Company received gross proceeds of approximately $2 million, before deducting
underwriting discounts and commissions and before offering expenses ($1.7 million net proceeds after deducting underwriting discounts
and commissions and other expenses).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; ">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(7)</td><td style="text-align: justify">During 2024, the Company issued 307,175 ordinary shares pursuant to the SEPA for net proceeds of $4.4 million (See also Note 6).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; ">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(8)</td><td><p style="text-align: justify; margin-top: 0; margin-bottom: 0">On November 27, 2024, the Company completed a registered direct offering and concurrent private placement, for the issuance and sale of 63,000 ordinary shares, 142,500 pre-funded warrants to purchase up to 142,500 ordinary shares in the registered direct offering, and&#160;warrants to purchase up to 205,500 ordinary shares in the concurrent private placement&#160;at a combined purchase price of $9.00 per ordinary share. During December 2024, 64,500 pre-funded warrants were exercised into 64,500 ordinary shares.</p> <p style="margin-top: 0; margin-bottom: 0">&#160;</p> <p style="text-align: justify; margin-top: 0; margin-bottom: 0">The warrants issued pursuant to the concurrent private placement have an&#160;exercise price of $10.00 per ordinary share, are immediately exercisable and expire five years following the date of issuance. The Company received gross proceeds of approximately $1.85 million, before deducting underwriting discounts and commissions and before offering expenses ($1.58 million net proceeds after deducting underwriting discounts and commissions and other expenses). See also note 13.b.</p></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">(9)</td><td style="text-align: justify">In December 2024, the Company issued 9,765 ordinary shares to a service provider in return for marketing services.</td></tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based compensation</b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In 2015, the Company&#8217;s Board
of Directors adopted the 2015 Share Option Plan (the &#8220;2015 Plan&#8221;), with&#160;12,910 options available for grant, and through
December 31, 2021, the Company&#8217;s Board of Directors approved, in the aggregate, an increase of&#160;10,000 options available for
grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that, there
are 22,910 ordinary shares reserved under the 2015 Plan (including those that were exercised into ordinary shares).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On December 15, 2022, the Company&#8217;s
Board of Directors approved an increase of&#160;a total of 5,308 ordinary shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are 28,218 ordinary
shares underlying options granted (including options that were exercised into ordinary shares) or reserved for future issuance under the
2015 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 23, 2023, the Company&#8217;s
Board of Directors approved an increase of&#160;a total of 11,639 ordinary shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are 39,857 ordinary
shares underlying options granted (including options that were exercised into ordinary shares) or reserved for future issuance under the
2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 15, 2024, the
Company&#8217;s Board of Directors approved the Company&#8217;s 2024 Global Equity Incentive Plan (the &#8220;Incentive
Plan&#8221;), which provides for the issuance of up to 57,132 ordinary shares. The Incentive Plan is subject to the approval of the
Israeli Tax Authorities. In addition, the Incentive Plan includes an annex that governs the grants of awards to employees and other
service providers who are citizens or resident aliens of the United States, subject to the approval of the Company&#8217;s
shareholders. The Plan was approved at the shareholders meeting held on September 26, 2024. On December 20, 2024, the
Company&#8217;s Board of Directors approved an increase in the number of ordinary shares reserved for the Incentive Plan to
141,492.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Incentive Plan provides for the
grant of options, shares, restricted shares or restricted share units (&#8220;RSUs&#8221;) to employees, non-employee directors, consultants,
advisors, or service providers of the Company, as well as employees, non-employee directors, consultants, advisors, or service providers
of any affiliate of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 15, 2024, the
Company&#8217;s Board of Directors approved the Company&#8217;s 2024 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which
provides for the issuance of up to 62,500 ordinary shares and includes an annex that governs the grants of awards to employees who
are residents of the State of Israel. The ESPP is subject to the approval of the Company&#8217;s shareholders. The ESPP was approved
at the shareholders meeting held on September 26, 2024. Generally, all the Company&#8217;s employees will be eligible to participate
in the ESPP if they are employed by the Company, or employees of any participating subsidiary, provided that they have been employed
by the Company or subsidiary for more than five months in a calendar year. The ESPP permits participants to purchase ordinary shares
through payroll deductions in an amount equal to a whole percentage of from one to 15% of their ESPP eligible compensation (or such
other limited established by the administrator in accordance with the terms of our ESPP) in an offering. The purchase price of the
shares will be determined by the Compensation Committee of the Board of Directors in accordance with the terms of the ESPP, but the
option price shall not be less than the lesser of 85 percent of the fair market value of the shares on the offering date, or 85
percent of the fair market value of the shares on the exercise date., there have been no issuances under the ESPP as of December 31,
2024</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of March 19, 2025, the Company
had 9,208 ordinary shares reserved for future issuance under the 2015 Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Options to employees </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Below is a summary of the Company&#8217;s
options activity and related information with respect to options granted to employees during the years ended December 31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center"><b>Year ended <br/> December 31,</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center"><b>Year ended <br/> December 31,</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount<br/> of <br/> options</b> &#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted<br/> average <br/> exercise <br/> price</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount<br/> of <br/> options</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted <br/> average <br/> exercise<br/> price</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding - beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">18,184</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">62.16</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">12,353</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45.04</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">**4,187</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">21.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*5,894</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">97.92</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expired or forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(62</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">105.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(62</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">53.12</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding - end of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">54.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">62.16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exercisable at end of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">46.56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">48.96</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The weighted-average grant date fair value of stock-based
awards granted&#160;was $21.76, $97.92 and $14.72 per share during the years ended December 31, 2024, December 31,&#160;2023 and December
31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The options will expire at the earlier
of (i) ten years from the date of grant or (ii) 90 days following the termination of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 15, 2024, the Company&#8217;s Board
of Directors approved the allocation and / or grant of additional options to purchase up to 2,187 ordinary shares
to certain directors, officers and employees, with an exercise price of $34.40 per share. The options will expire at the earlier of (i)
ten years from the date of grant or (ii) 90 days following the termination of respective employment or services. The fair value of each
option as of the grant date was $15.60, determined using the Black-Scholes option pricing model and the total expenses of approximately
$34 thousand will be expensed over the option vesting periods of three years. The options allocated to the Company&#8217;s Chief Executive
Officer and Chief Scientific Officer were also approved in the shareholders meeting held on September 26, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On December 25, 2024, the Company&#8217;s
Board of Directors approved the grant of additional options to purchase up to 2,000 ordinary shares to certain
employees, with an exercise price of $7.63 per share. The options will expire at the earlier of (i) ten years from the date of grant
or (ii) 90 days following the termination of respective employment or services. The fair value of each option as of the grant date was
$4.32, determined using the Black-Scholes option pricing model and the total expenses of approximately $9 thousand will be expensed over
the option vesting periods of three years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following weighted-average assumptions
were used in determining the most recent fair values of stock options using the Black-Scholes valuation model:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected dividend yield</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected stock price volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">55.0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Risk free interest rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.10</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected life of options</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6.25</td><td style="text-align: left">&#160;</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Including the grant of 1,500 options to purchase up to 1,500
ordinary shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $105.60
per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of
employment or service. The fair value of each option as of the grant date was $9.60, determined using the Black-Scholes option pricing
model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify">Including the grant of 1,250 options to purchase up to 1,250
ordinary shares to the Company&#8217;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#8217;s shareholders
on September 26, 2024, with an exercise price of $34.40 per share. The options will expire at the earlier of (i) ten years from the date
of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $15.60,
determined using the Black-Scholes option pricing model and the total expenses of $19 thousand will be expensed over the option vesting
periods of three years.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Options to consultants </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s outstanding options
to consultants as of December 31, 2024 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Issuance date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In connection with</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No. of<br/> options<br/> issued</td> <td>&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No. of<br/> options<br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">2015</td><td style="width: 1%">&#160;</td> <td style="width: 22%; text-align: center">Rendered services</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,383</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 1%">&#160;</td> <td style="white-space: nowrap; width: 9%; text-align: right">0.24</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,383</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2017</td><td>&#160;</td> <td style="text-align: center">Rendered services</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">461</td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right">0.24</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">461</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2021</td><td>&#160;</td> <td style="text-align: center">Rendered services</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">863</td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.24-</span>$180.00</p></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">863</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2023*</td><td>&#160;</td> <td style="text-align: center">Rendered services</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,250</td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right">43.68</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">555</td><td style="text-align: left">&#160;</td></tr> </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify">On April 27, 2023, the Company&#8217;s Board of Directors approved
the additional grant of options to purchase up to 1,250 ordinary shares to a consultant, with an exercise price of $43.68 per share.
The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The
fair value of each option as of the grant date was $20.80, determined using the Black-Scholes option pricing model and the total expenses
of $26 thousand will be expensed over the option vesting periods of three years.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> <b>RSUs to employees and consultants: </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">I<span>n
August 2024, the Company&#8217;s Board of Directors approved the Company&#8217;s
Incentive Plan, which provides for the issuance of up to 57,132 ordinary shares of the Company. On December 20, 2024, the Board
approved the increase of number of ordinary shares reserved under the Incentive Plan to 141,492.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>The
Incentive Plan provides for the grant of options, shares, restricted shares or  RSUs to employees,
non-employee directors, consultants, advisors, or service providers of the Company, as well as employees, non-employee directors, consultants,
advisors, or service providers of any affiliate of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span>On December 25, 2024, the Board </span>of Directors approved the
grant of <span>131,375 RSUs </span>to employees and consultants, which will be automatically exercised
into ordinary shares over a vesting period of between 12 months to 24 months, with the vesting starting on January 1, 2025. The unvested
RSUs will expire the termination of employment or service. The fair value of each RSU as of the grant date was $7.12, determined using
the 30 days&#8217; market price prior to the grant date, and the total expenses of $934 thousand will be expensed over the option vesting
periods.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The share-based compensation expenses
are recognized in the following line items in the consolidated statements of comprehensive loss in the years ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">80</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">180</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sales and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">401</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">General and administrative expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">53</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">97</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">209</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">182</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">241</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">790</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Equity Warrants to investors and associated with the
IPO and follow on fund raising, as of December 31, 2024:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number&#160;of warrants/ options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issuance date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise ratio</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Expiration date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Notes</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">98,261</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 14.5%; text-align: center">September 13, 2022</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">160.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 19.5%; text-align: left">Each warrant is exercisable into 1 ordinary share</td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 19.5%; text-align: left">5 years following the issuance date</td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 19.5%; text-align: left">Registered for trading (*)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td>&#160;</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td> <td style="text-align: center; vertical-align: top">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">&#160;</td><td style="text-align: right">2,344</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">September 15, 2022</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">424.80</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">Each warrant is exercisable into 1 ordinary share</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">5 years following the issuance date</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Owned by underwriter</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right">295</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">September 15, 2022</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">338.40</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">Each warrant is exercisable into 1 ordinary share</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">10 years following the issuance date</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Owned by the legal advisor</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">&#160;</td><td style="text-align: right">205,500</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">November 27, 2024</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">(**)</td><td>&#160;</td> <td style="text-align: left">Each warrant is exercisable into 1 ordinary share</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">5 years following the issuance date</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Owned by an investor</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right">78,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">November 27, 2024</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.0004</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">Each pre funded warrant is exercisable into 1 ordinary share</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Until exercised in full</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Owned by an investor</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">The warrants are exercisable at any time after their original
issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants will be exercisable, at the
option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement
registering the issuance of the ordinary shares underlying the warrants under the Securities Act of 1933, as amended, is effective and
available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary shares purchased
upon such exercise.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The exercise price per whole ordinary
share purchasable upon exercise of the warrants $320.00 per share (the &#8220;Initial Exercise Price&#8221;). The exercise price is subject
to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting ordinary shares and also upon any distributions of assets, including cash, stock or other property to the
Company&#8217;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until two years from the date of issuance
of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or
sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any ordinary shares or convertible security,
at an effective price per share less than the exercise price of the warrant then in effect, the exercise price of the warrant shall be
reduced to equal the effective price per share in such Dilutive Issuance;&#160;provided, however, that in no event shall the exercise
price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days
immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the &#8220;Reset Price&#8221;),
provided that such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of
the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted average price per ordinary share
occurring on any day between the initial exercise date of the warrants and 90 calendar days following the issuance date of the warrants.
The lowest Reset Price is $160.00, which is 50% of the Initial Exercise Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(**)</td><td style="text-align: justify">On January 30, 2025, the exercise price of the warrants pursuant
to a November 2024 private placement was adjusted to $4.00 per share following the closing of an additional offering.</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
per share</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt">Loss per share has been calculated using the weighted average
number of ordinary shares and pre-funded warrants in issue during the relevant financial periods, the weighted average number of equity
shares in issue and profit for the period as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2024</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(7,879</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(7,814</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(6,496</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Total number of ordinary shares and pre-funded warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">785,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254,843</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">188,121</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Weighted average number of ordinary shares and pre-funded warrants</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">325,690</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">202,515</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">153,465</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-78"><div style="-sec-ix-hidden: hidden-fact-80">Basic and diluted loss per share</div></div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(24.2</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(38.4</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(42.4</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 11 - TAXES ON INCOME:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is taxed under the Israeli law.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income of an Israeli company is subject to corporate tax. The corporate tax rate in Israel is&#160;23%.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax assessments - In accordance with the Israeli Income Tax Ordinance, tax assessments of the Company through tax year 2019 are considered final.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carryforward tax losses of the Company as of December 31, 2024, amounted to approximately $21.1 million; however, a full valuation allowance of $4.85 million was recorded against the potential future tax benefits.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Subsidiary is taxed under the U.S. tax law. The federal tax rate is 21%.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Parties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 - RELATED PARTIES</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The employment expenses of the co-founders:
Asher Dahan (the Chairman of the Board of Directors and the Chief Executive Officer), Guy Wanger (President and Director) and Leeor Langer
(the Chief Technology Officer), for the years ended December 31, 2024, 2023 and 2022 amounted to approximately $287 thousand, $293 thousand,
and $331 thousand, respectively. On March 14, 2022, the Company&#8217;s shareholders meeting approved the increase of the monthly salary
of each of the Company&#8217;s co-founders to NIS&#160;70&#160;thousand (approximately $19&#160;thousand), plus social benefits and leased
car, and approved a one-time bonus equal to 6 monthly salaries, upon the closing of the IPO which was accomplished in September 2022.
In November 2024, the Company&#8217;s founders agreed to temporarily reduce their salaries.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 13 - SUBSEQUENT EVENTS</b>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">a.</td><td style="text-align: justify">On January 30, 2025, the Company announced the closing of
&#8220;best efforts&#8221; public offering with a single institutional investor for the purchase and sale of 86,250 ordinary shares, 538,750
pre-funded warrants to purchase up to 538,750 ordinary shares, and warrants to purchase up to 625,000 ordinary shares, at a combined
offering price of $4.00 per share and accompanying warrant (the &#8220;Offering&#8221;). The Company received aggregate gross proceeds
of approximately $2.5 million, before deducting placement agent fees and other offering expenses and assuming no exercise of the warrants.
The warrants have an exercise price of $4.00 per share, are exercisable immediately and expire five years from the issuance date.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">b.</td><td style="text-align: justify">In connection with the Offering detailed in Note 12.a. the
Company also agreed to amend existing warrants that were previously issued on November 27, 2024 (see also Note 1.g.) to the investor
participating in the Offering to purchase up to 205,500 ordinary shares of the Company, with an exercise price of $10.00 per share. Such
existing warrants have been amended to reduce the exercise price to $4.00 per share and now expire five years following the closing of
the Offering.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">c.</td><td style="text-align: justify">On February 26, 2025, the Company&#8217;s shareholders meeting approved a reverse share split of the Company&#8217;s issued and outstanding ordinary shares at a ratio of up to 6:1, to be effected, if effected, at the discretion of and on such date to be determined by the Board of Directors. On March 17, 2025, the Company effectuated the March Reverse Split. </td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (7,879)<span></span>
</td>
<td class="num">$ (7,814)<span></span>
</td>
<td class="num">$ (6,496)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risk Management and Strategy</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the critical elements
of our overall risk management approach, our cybersecurity program is focused on the following key areas:</p><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Governance: As discussed in more detail under the heading &#8220;Governance,&#8221; the audit committee
oversees our cybersecurity risk management and interacts with the Company&#8217;s Sarbanes-Oxley Act, or SOX, advisor and the Company&#8217;s
Information Security advisor and other relevant members of management.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Collaborative Approach: The Company has implemented a comprehensive, cross-functional approach to identifying,
preventing and mitigating cybersecurity threats and incidents, while also implementing controls and procedures that provide for the prompt
escalation of certain cybersecurity incidents so that decisions regarding the public disclosure and reporting of such incidents can be
made by management in a timely manner.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Technical Safeguards: The Company deploys technical safeguards that are designed to protect the Company&#8217;s
information systems from cybersecurity threats, including firewalls, intrusion prevention and detection systems, anti-malware functionality
and access controls, which are evaluated and improved through vulnerability assessments and cybersecurity threat intelligence.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Recovery Planning: The Company has established and maintains comprehensive recovery plans that fully address
the Company&#8217;s response to a cybersecurity incident, and such plans are tested and evaluated on a regular basis.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Education and Awareness: The Company provides regular, mandatory training for personnel regarding cybersecurity
threats as a means to equip the Company&#8217;s personnel with effective tools to address cybersecurity threats, and to communicate the
Company&#8217;s evolving information security policies, standards, processes and practices.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We engage in the periodic
assessment and testing of our policies, standards, processes and practices that are designed to address cybersecurity threats and incidents.
These efforts include a wide range of activities, including audits, assessments, tabletop exercises, threat modeling, vulnerability evaluation,
and other exercises focused on evaluating the effectiveness of our cybersecurity measures and planning. We are engaged with a subcontractor
that monitors the IT system and cybersecurity, including centralized patch management as part of their routine job functions. We regularly
engage third parties to perform assessments on our cybersecurity measures, including information security maturity assessments, audits
and independent reviews of our information security control environment and operating effectiveness. The results of such assessments,
audits and reviews are reported to the Board, and we adjust our cybersecurity policies, standards, processes and practices as necessary
based on the information provided by these assessments, audits and reviews.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Governance</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The audit committee interacts
with the Company&#8217;s SOX advisor and the Company&#8217;s Information Security advisor and other relevant members of management. <span>The
Company&#8217;s Information</span> Security advisor <span>is responsible for assessing and managing cyber
risk management, informs senior management regarding the prevention, detection, mitigation, and remediation of cybersecurity incidents
and supervises such efforts. The Company&#8217;s Information</span> Security advisor <span>has experience
selecting, deploying, and operating cybersecurity technologies, initiatives, and processes, and relies on threat intelligence as well
as other information obtained from governmental, public or private sources.</span> The audit committee receives updates on IT general
controls, and a set of policies and procedures that govern how the Company&#8217;s IT systems operate and ensure the confidentiality,
integrity, and availability of data as well as on cybersecurity risks, including prevention of data theft, unauthorized access, operational
disruption, and data breaches. The audit committee also receives prompt and timely information regarding any cybersecurity incident that
meets established reporting thresholds, as well as ongoing updates regarding any such incident until it has been addressed. On an annual
basis, the audit committee discusses our approach to IT general controls and cybersecurity risk management with the Company&#8217;s SOX
advisor.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of March 19, 2025, we do
not believe that we have experienced any cybersecurity attack. Cybersecurity threats and cybersecurity incidents, if they occur, can materially
affect or are reasonably likely to affect the Company, including its business strategy, results of operations or financial condition.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">Our IT general controls cybersecurity policies, standards, processes
and practices are fully integrated into our risk management approach.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The audit committee is
involved in oversight of our IT general controls and cybersecurity.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying consolidated financial
statements include the accounts of the Company and the Subsidiary. All intercompany transactions have been eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of the consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its estimates, judgments and assumptions.
Management bases its estimates, judgments and assumptions on historical experience and on various other factors that are believed to
be reasonable under the circumstances. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currency</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The currency of the primary economic
environment in which the operations of the Company are conducted is the U.S. dollar (&#8220;USD&#8221;). The Company&#8217;s funding
and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Transactions and balances originally
denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into USD using historical and
current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other items (stated below)
reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#8211; exchange rates at transaction
dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation etc.) &#8211; historical
exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inventories:</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories are composed of parts
of the Company&#8217;s products as well as completed products and are stated at the lower of cost or net realizable value. Inventory
cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably
predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase, and other costs
incurred in bringing the inventories to their present location and condition.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>e.</b></span></td> <td style="padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property and equipment</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated
at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#8239;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">Annual rates of depreciation are as follows:</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Furniture and leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Electronic equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Machines and molds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-50</span></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>f.</b></span></td><td style="text-align: justify"><b>Leases</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#8217;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#8217;s incremental borrowing rate. The weighted-average&#160;rate applied was 8%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has the option to extend some of its
lease agreements. In measuring the lease liability and the right-of-use asset, the Company took some of those options into account
since management believes that those options are reasonably certain to be exercised.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Leases with a lease term of 12 months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>g.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue recognition </b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenue is recognized when (or as)
control of the promised goods or services is transferred to the customer, and in an amount that reflects the consideration the Company
is contractually due in exchange for those services or goods. The Company follows five steps to record revenue: (i) identify the contract
with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the
transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies its performance
obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company generates revenues from
the sales of B2C &#8220;Mudra Band&#8221;, sales of B2B &#8220;Mudra development kits&#8221; and sales of pilot transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The &#8220;Mudra Band&#8221;, is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#8220;Mudra Band&#8221; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point
in time indicating control has been transferred to the customer.&#160;&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A pilot transaction has multiple performance
obligations, and it generally takes a few months but less than one year. Each Mudra development kit sale also has multiple performance
obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The payment terms of the Mudra development
kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions are within the pilot period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In those transactions, each obligation-
Hardware and API (for Mudra development kit) and tailor-made software application and technical support (for a pilot transaction) - is
distinct and separately identifiable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The amount allocated to the delivered
items is recognized upon delivery, the amount allocated to API is recognized over the API period and the amount allocated to technical
support is recognized over the service period (a pilot period).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CostOfRevenuesPolicyTextBlock', window );">Cost of revenues</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>h.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost of revenues</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Costs are expensed as incurred. The primary components
of the cost of revenues include the cost of the product and outbound freight charges.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>i.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research and development</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Research and development expenses
consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GovernmentalGrantsPolicyTextBlock', window );">Governmental grants</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>j.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company receives royalty-bearing
grants from the Israeli government for approved research and development projects and marketing efforts. These grants are recognized
at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as provided by the relevant agreement
and included as a deduction from research and development or sales and marketing expenses, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock', window );">Finance income and expenses</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>k.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Finance income and expenses</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Finance income is composed of interest
on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are composed of interest on senior
secured credit facility, bank charges and net currency exchange rates differences.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>l.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income taxes</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company accounts for income taxes
in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Deferred
taxes are determined utilizing the assets and liabilities method, which is based on the estimated future tax effects of the differences
between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed
using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets
is provided if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will
not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available
evidence, are not expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company applies ASC 740, which clarifies the accounting
and reporting for uncertainties with respect to income taxes. ASC 740 prescribes a comprehensive model for the financial statement recognition,
measurement, presentation, and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share based compensation</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-based compensation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Share-based compensation expenses
related to employees&#8217; and consultants&#8217; options are measured at the grant date based on the fair value of the award and are
generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation expense on a
straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche is separately
expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes option
pricing model, which requires management to make certain assumptions of future expectations based on historical and current data include
the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantsPolicyPolicyTextBlock', window );">Warrants and pre-funded warrants</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>m.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants and pre-funded warrants</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The warrants&#8217; mechanism does
not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount of ordinary shares upon exercise.
Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional paid in capital), based on an
assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants are freestanding financial
instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity classification, including
whether the warrants are indexed to the Company&#8217;s own shares, among other conditions for equity classification.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SeverancePolicyTextBlock', window );">Severance</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Severance</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Israeli labor law generally requires
payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. The Company&#8217;s
pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section 14 of the Israeli Severance Compensation
Act, 1963 (&#8220;section 14&#8221;), the Company&#8217;s employees are entitled to monthly deposits, at a rate of 8.33% of their monthly
salary, made in their name with insurance companies. Payments in accordance with section 14 relieve the Company from any future severance
payments in respect of those employees and, as such, the Company may only utilize the insurance policies for the purpose of paying severance
pay.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and diluted loss per share</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>p.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted loss per share</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Basic and diluted loss per share is calculated
by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares and pre-funded warrants
outstanding during the financial year, adjusted for ordinary shares and pre-funded warrants issued during the year, if applicable.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
<tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value Measurements</b></span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company measures and discloses
fair value in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;), ASC 820, Fair Value Measurements and
Disclosures (&#8220;ASC 820&#8221;). ASC 820 defines fair value, establishes a framework and gives guidance regarding the methods
used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the
amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that
market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a
three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 1 &#8211; unadjusted quoted
prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement
date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 2 &#8211; pricing inputs are
other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration
with observable market data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 3 &#8211; pricing inputs are
unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This hierarchy requires the Company
to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of cash is based on
its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and
liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>r.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company maintains certain cash
balances in a well-known Israeli banks and U.S.-based bank.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the years ended December 31, 2024 and 2023, the
Company partially hedged its foreign currency exchange risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Our derivative instruments primarily
include foreign currency forward agreements related to the NIS and associated with certain payroll payments. Our foreign currency forward
agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated as hedges for accounting
purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged item, are recorded within
our consolidated statements of loss.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>s.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents:</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash equivalents are highly liquid
investments that are readily convertible into cash, with an original maturity of three months or less.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>t.</b></span></td><td><b>Segment Information</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has a single operating and reportable segment. The Company&#8217;s chief operating decision maker, who is the Company&#8217;s Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Adopted in 2024</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
<tr style="vertical-align: top"> <td style="width: 0.25in"><b>&#160;</b></td> <td style="font-size: 10pt; width: 0.25in"><b>u.</b></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting Standards Adopted in 2024</b></span></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2023, the FASB issued
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;). This ASU
expands public entities&#8217; segment disclosures by requiring disclosure of significant segment expenses that are regularly
provided to the chief operating decision maker (the &#8220;CODM&#8221;) and included within each reported measure of segment profit or loss, an amount and description of its
composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. All
disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. The ASU&#8217;s
amendments are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within
fiscal years beginning after December 15, 2024, with early adoption permitted. After evaluating the impact of this pronouncement on
the Company&#8217;s financial statements, the Company found that there is no impact on its financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock', window );">ACCOUNTING STANDARDS ISSUED AND NOT YET ADOPTED IN 2024</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>v.</b></td><td style="text-align: justify"><b>ACCOUNTING STANDARDS ISSUED AND NOT YET ADOPTED IN 2024</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2024, the FASB issued
ASU 2024-03, Income Statement &#8211; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures (Subtopic 220-40):
Disaggregation of Income Statement Expenses (&#8220;ASU 2024-03&#8221;), which requires the disaggregation of certain expense
captions into specified categories in disclosures within the notes to the consolidated financial statements to provide enhanced
transparency into the expense captions presented on the face of the statement of income and comprehensive income. ASU 2024-03 is
effective for annual reporting periods beginning after December 15, 2026, with early adoption permitted, and may be applied either
prospectively or retrospectively to financial statements issued for reporting periods after the effective date of ASU 2024-03 or
retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact
that the adoption of ASU 2024-03 will have on its related disclosures.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2024, the FASB issued ASU 2024-04, Induced Conversions
of Convertible Debt Instruments (&#8220;ASU 2024-04&#8221;). This new guidance is intended to improve the relevance and consistency in
application of the induced conversion guidance in Subtopic 470-20 for (a) convertible debt instruments with cash conversion features and
(b) debt instruments that are not currently convertible. ASU 2024-04 is effective for fiscal years beginning after December 15, 2026.
Early adoption is permitted. The Company does not plan to early adopt this standard. The Company is currently evaluating the effect of adoption of this standard
to its consolidated financial statements and disclosures.&#8195;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The policy representing the accounting standard issued and not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CostOfRevenuesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policy of cost of revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CostOfRevenuesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finance income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GovernmentalGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for governmental grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GovernmentalGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_SeverancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for severance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_SeverancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock', window );">Schedule of Annual Rates of Depreciation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated
at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#8239;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">Annual rates of depreciation are as follows:</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Furniture and leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 88%; text-align: left">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Electronic equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Machines and molds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-50</span></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of annual rates of depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cost:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Raw materials</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">212</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">514</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt">Work-in-progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">206</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">986</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">312</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Provision for inventory write-off</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(75</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,226</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,032</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment Net</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Cost:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">230</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">204</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Furniture and leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Electronic equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Machines and molds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">86</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">374</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">334</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Less <span style="font-style: normal; font-weight: normal">-
    accumulated depreciation</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">244</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">140</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">130</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">194</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following table summarizes the classification
of operating lease right-of-use assets and liabilities in the Company&#8217;s Consolidated Balance Sheets as of December&#160;31, 2024
and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 9pt">Right of use assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">330</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">592</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 0.2in">Short term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">291</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">297</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 7.3pt">Long term</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">278</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total lease liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">312</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">575</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">At December&#160;31, 2024, the future minimum lease payments
under the Company&#8217;s operating lease liabilities are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Year ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S.&#160;dollars<br/> in&#160;thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">302</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">324</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Less operating lease liabilities, current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(291</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Operating lease liabilities, non-current</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">21</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481440/840-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481418/840-10-55-40<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders&#8217; Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Share Capital</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The share capital as of December 31, 2024 and 2023, is composed
of as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 4pt">Ordinary shares, NIS 0.01 par value</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">50,000,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">50,000,000</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">707,463</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">254,843</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Below is a summary of the Company&#8217;s
options activity and related information with respect to options granted to employees during the years ended December 31, 2024 and 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center"><b>Year ended <br/> December 31,</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center"><b>Year ended <br/> December 31,</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2024</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount<br/> of <br/> options</b> &#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted<br/> average <br/> exercise <br/> price</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Amount<br/> of <br/> options</b></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Weighted <br/> average <br/> exercise<br/> price</b> &#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Outstanding - beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">18,184</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">62.16</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">12,353</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45.04</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">**4,187</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">21.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">*5,894</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">97.92</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expired or forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(62</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">105.60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(62</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">53.12</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Outstanding - end of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">54.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">62.16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exercisable at end of year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">46.56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">48.96</td><td style="text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Including the grant of 1,500 options to purchase up to 1,500
ordinary shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $105.60
per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of
employment or service. The fair value of each option as of the grant date was $9.60, determined using the Black-Scholes option pricing
model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify">Including the grant of 1,250 options to purchase up to 1,250
ordinary shares to the Company&#8217;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#8217;s shareholders
on September 26, 2024, with an exercise price of $34.40 per share. The options will expire at the earlier of (i) ten years from the date
of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $15.60,
determined using the Black-Scholes option pricing model and the total expenses of $19 thousand will be expensed over the option vesting
periods of three years.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of weighted-Average Assumptions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following weighted-average assumptions
were used in determining the most recent fair values of stock options using the Black-Scholes valuation model:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected dividend yield</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected stock price volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">55.0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Risk free interest rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.10</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt">Expected life of options</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6.25</td><td style="text-align: left">&#160;</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Including the grant of 1,500 options to purchase up to 1,500
ordinary shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $105.60
per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of
employment or service. The fair value of each option as of the grant date was $9.60, determined using the Black-Scholes option pricing
model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</td>
</tr></table>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify">Including the grant of 1,250 options to purchase up to 1,250
ordinary shares to the Company&#8217;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#8217;s shareholders
on September 26, 2024, with an exercise price of $34.40 per share. The options will expire at the earlier of (i) ten years from the date
of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $15.60,
determined using the Black-Scholes option pricing model and the total expenses of $19 thousand will be expensed over the option vesting
periods of three years.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfOptionsToConsultantsTableTextBlock', window );">Schedule of Options to Consultants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company&#8217;s outstanding options
to consultants as of December 31, 2024 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Issuance date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">In connection with</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No. of<br/> options<br/> issued</td> <td>&#160;</td> <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">No. of<br/> options<br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">2015</td><td style="width: 1%">&#160;</td> <td style="width: 22%; text-align: center">Rendered services</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,383</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 1%">&#160;</td> <td style="white-space: nowrap; width: 9%; text-align: right">0.24</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,383</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2017</td><td>&#160;</td> <td style="text-align: center">Rendered services</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">461</td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right">0.24</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">461</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2021</td><td>&#160;</td> <td style="text-align: center">Rendered services</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">863</td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.24-</span>$180.00</p></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">863</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2023*</td><td>&#160;</td> <td style="text-align: center">Rendered services</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,250</td> <td>&#160;</td> <td style="text-align: left">$</td> <td>&#160;</td> <td style="white-space: nowrap; text-align: right">43.68</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">555</td><td style="text-align: left">&#160;</td></tr> </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify">On April 27, 2023, the Company&#8217;s Board of Directors approved
the additional grant of options to purchase up to 1,250 ordinary shares to a consultant, with an exercise price of $43.68 per share.
The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The
fair value of each option as of the grant date was $20.80, determined using the Black-Scholes option pricing model and the total expenses
of $26 thousand will be expensed over the option vesting periods of three years.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The share-based compensation expenses
are recognized in the following line items in the consolidated statements of comprehensive loss in the years ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">U.S. dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">80</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">180</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sales and marketing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">401</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">General and administrative expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">53</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">97</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">209</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">182</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">241</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">790</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock', window );">Schedule of Issuance of Equity Warrants to Investors and Associate</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Equity Warrants to investors and associated with the
IPO and follow on fund raising, as of December 31, 2024:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number&#160;of warrants/ options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issuance date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise ratio</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Expiration date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Notes</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">98,261</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 14.5%; text-align: center">September 13, 2022</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">160.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 19.5%; text-align: left">Each warrant is exercisable into 1 ordinary share</td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 19.5%; text-align: left">5 years following the issuance date</td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 19.5%; text-align: left">Registered for trading (*)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td>&#160;</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">&#160;</td><td>&#160;</td> <td style="text-align: center; vertical-align: top">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">&#160;</td><td style="text-align: right">2,344</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">September 15, 2022</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">424.80</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">Each warrant is exercisable into 1 ordinary share</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">5 years following the issuance date</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Owned by underwriter</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right">295</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">September 15, 2022</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">338.40</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">Each warrant is exercisable into 1 ordinary share</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">10 years following the issuance date</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Owned by the legal advisor</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">&#160;</td><td style="text-align: right">205,500</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">November 27, 2024</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">(**)</td><td>&#160;</td> <td style="text-align: left">Each warrant is exercisable into 1 ordinary share</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">5 years following the issuance date</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Owned by an investor</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">&#160;</td><td style="text-align: right">78,000</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">November 27, 2024</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">0.0004</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">Each pre funded warrant is exercisable into 1 ordinary share</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Until exercised in full</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Owned by an investor</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">The warrants are exercisable at any time after their original
issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants will be exercisable, at the
option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement
registering the issuance of the ordinary shares underlying the warrants under the Securities Act of 1933, as amended, is effective and
available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary shares purchased
upon such exercise.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The exercise price per whole ordinary
share purchasable upon exercise of the warrants $320.00 per share (the &#8220;Initial Exercise Price&#8221;). The exercise price is subject
to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting ordinary shares and also upon any distributions of assets, including cash, stock or other property to the
Company&#8217;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until two years from the date of issuance
of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or
sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any ordinary shares or convertible security,
at an effective price per share less than the exercise price of the warrant then in effect, the exercise price of the warrant shall be
reduced to equal the effective price per share in such Dilutive Issuance;&#160;provided, however, that in no event shall the exercise
price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days
immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the &#8220;Reset Price&#8221;),
provided that such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of
the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted average price per ordinary share
occurring on any day between the initial exercise date of the warrants and 90 calendar days following the issuance date of the warrants.
The lowest Reset Price is $160.00, which is 50% of the Initial Exercise Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(**)</td><td style="text-align: justify">On January 30, 2025, the exercise price of the warrants pursuant
to a November 2024 private placement was adjusted to $4.00 per share following the closing of an additional offering.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt">Loss per share has been calculated using the weighted average
number of ordinary shares and pre-funded warrants in issue during the relevant financial periods, the weighted average number of equity
shares in issue and profit for the period as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2024</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2022</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(7,879</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(7,814</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(6,496</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Total number of ordinary shares and pre-funded warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">785,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254,843</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">188,121</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Weighted average number of ordinary shares and pre-funded warrants</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">325,690</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">202,515</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">153,465</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-78"><div style="-sec-ix-hidden: hidden-fact-80">Basic and diluted loss per share</div></div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(24.2</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(38.4</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(42.4</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in Issuance of equity warrants to investors and associat.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfOptionsToConsultantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of stock options issued to consultants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfOptionsToConsultantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>General (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 17, 2025</div></th>
<th class="th"><div>Feb. 06, 2025</div></th>
<th class="th"><div>Oct. 10, 2024</div></th>
<th class="th">
<div>Nov. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 16, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2024 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 24, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 25, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany', window );">Gross revenue limit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus', window );">Value of ordinary shares and warrants held by non-affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue', window );">Value of non-convertible debt securities issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NetProceedsFromIssuanceSecondaryPublicOffering', window );">Net proceeds from secondary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement', window );">SEPA for net proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 5,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split, description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1:20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ReverseStockSplitNumberOfSharesConverted', window );">Reverse stock split, shares issued and outstanding (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted', window );">Number of shares combined in reverse split (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ReverseSplitParValue', window );">Reverse split par value | (per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from issuance of ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement', window );">Ordinary shares issued (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedsFromIssuanceRegisteredDirectOffering', window );">Net proceeds from registered direct offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary share price (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split, description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Reverse<span></span>
</td>
<td class="text">On February 26, 2025, the Company&#8217;s shareholders meeting approved a reverse share split of the Company&#8217;s issued and outstanding ordinary shares at a ratio of up to 6:1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Ordinary Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split, description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">1-for-4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockholdersEquityRequirementByStockExchanges', window );">Stockholders equity requirement by stock exchanges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="17"></td></tr>
<tr><td colspan="17"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The share and per share information in these financial statements
reflects the Reverse Share Splits.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual gross revenue limit to remain as an emerging growth company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of non-convertible debt securities to become large accelerated status, value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of shares associated with standby equity purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued to investors associated with the SEPA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NetProceedsFromIssuanceSecondaryPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's secondary offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NetProceedsFromIssuanceSecondaryPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedsFromIssuanceRegisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's registered direct offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedsFromIssuanceRegisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ReverseSplitParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The new par value after the reverse split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ReverseSplitParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ReverseStockSplitNumberOfSharesConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describe the number of shares that will become one share after the reverse split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ReverseStockSplitNumberOfSharesConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse stock split, number of shares issued for each share or lot converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockholdersEquityRequirementByStockExchanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholders equity requirement by stock exchanges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockholdersEquityRequirementByStockExchanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of ordinary shares held by non-affiliates to become large accelerated status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRenewalTerm1', window );">Lease term</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RateOfMonthlySeverancePercentage', window );">Rate of monthly severance, percentage</a></td>
<td class="nump">8.33%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wlds_LeaseLiabilityMember', window );">Lease Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RateOfMonthlySeverancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of severance  monthly deposits rate can take their monthly salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RateOfMonthlySeverancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wlds_LeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wlds_LeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Annual Rates of Depreciation (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember', window );">Computers and Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfAnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rates of depreciation</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember', window );">Electronic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfAnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rates of depreciation</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Furniture and Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfAnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rates of depreciation</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Machines and molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfAnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rates of depreciation</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Furniture and Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfAnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rates of depreciation</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Machines and molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ScheduleOfAnnualRatesOfDepreciationLineItems', window );"><strong>Schedule of Annual Rates of Depreciation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualRateOfDepreciation', window );">Annual rates of depreciation</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualRateOfDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of annual rate of depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualRateOfDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ScheduleOfAnnualRatesOfDepreciationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ScheduleOfAnnualRatesOfDepreciationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Schedule of Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LIFOMethodRelatedItemsAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 212<span></span>
</td>
<td class="nump">$ 514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-progress</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">986<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InventoryWriteoff', window );">Provision for inventory write-off</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FIFOInventoryAmount', window );">Inventories, net</a></td>
<td class="nump">$ 1,226<span></span>
</td>
<td class="nump">$ 1,032<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FIFOInventoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FIFOInventoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LIFOMethodRelatedItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LIFOMethodRelatedItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InventoryWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InventoryWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Schedule of Property and Equipment Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property and Equipment Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 374<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember', window );">Computers and Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property and Equipment Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember', window );">Furniture and Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property and Equipment Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember', window );">Electronic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property and Equipment Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MachinesAndMoldsMember', window );">Machines and Molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property and Equipment Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ComputersAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_ElectronicEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MachinesAndMoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=wlds_MachinesAndMoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Leases remaining terms</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Leases extend term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Total operating leases</a></td>
<td class="nump">$ 288<span></span>
</td>
<td class="nump">$ 232<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">$ 330<span></span>
</td>
<td class="nump">$ 592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short term</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long term</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">312<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less operating lease liabilities, current</a></td>
<td class="num">(291)<span></span>
</td>
<td class="num">(297)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stand by Equity Purchase Agreement and Convertible Promissory Note (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 06, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems', window );"><strong>Stand by Equity Purchase Agreement and Convertible Promissory Note [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice', window );">Purchase price of shares, percentage on lowest VWAP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice', window );">Purchase price calculation of shares, pricing period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock (in Dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,353<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfAmountIssuableAsCommitmentFee', window );">Number of amount issuable as commitment fee (in Dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement', window );">Percentage of aggregate amount available to be sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice', window );">Number of trading days for calculating average VWAP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PaymentsForStructuringFee', window );">Structuring fee paid (in Dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PrePaidAdvances', window );">Pre-paid advances of commitment amount (in Dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PurchasePriceDiscount', window );">Discounted of purchase price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_MonthlyInstallmentPayment', window );">Monthly installment payment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PrincipalAmountInstallmentPayment', window );">Principal amount of installment payment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockConvertibleConversionPriceIncrease', window );">Conversion price per ordinary share (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertiblePromissoryNotePremiumPercentage', window );">Convertible promissory note premium percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible promissory note balance (in Dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 770<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wlds_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems', window );"><strong>Stand by Equity Purchase Agreement and Convertible Promissory Note [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Promissory note including accrued interest (in Dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Convertible Promissory Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems', window );"><strong>Stand by Equity Purchase Agreement and Convertible Promissory Note [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Percentage of interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Convertible Promissory Note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems', window );"><strong>Stand by Equity Purchase Agreement and Convertible Promissory Note [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Percentage of interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems', window );"><strong>Stand by Equity Purchase Agreement and Convertible Promissory Note [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement', window );">Ordinary shares issued (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock (in Dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The share and per share information in these financial statements
reflects the Reverse Share Splits.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockConvertibleConversionPriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockConvertibleConversionPriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Calculation of purchase price of shares, period for considering lowest volume weighted average price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Calculation of shares using commitment fee payable, number days considered for the volume weighted average price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConvertiblePromissoryNotePremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible promissory note premium percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConvertiblePromissoryNotePremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of shares associated with standby equity purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_MonthlyInstallmentPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of monthly installment payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_MonthlyInstallmentPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NumberOfAmountIssuableAsCommitmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of amount issuable as commitment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NumberOfAmountIssuableAsCommitmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PaymentsForStructuringFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow for the structuring fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PaymentsForStructuringFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate amount of shares available to be sold, to be transferred under agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PrePaidAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of prepaid advances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PrePaidAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PrincipalAmountInstallmentPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of principal amount installment payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PrincipalAmountInstallmentPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PurchasePriceDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of convertible promissory note purchase price discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PurchasePriceDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of shares, percentage on lowest volume weighted average price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wlds_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wlds_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> &#8362; in Millions</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Vehicles</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2023 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GrantsReceivedEqualPercentageRate', window );">Grants received equal percentage rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualAlternativeInterestPercentage', window );">Annual alternative interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.71513%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AnnualInterestRate', window );">Annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_FixedAnnualInterestRate', window );">Fixed annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AmountsReceivedAggregateAmount', window );">Amounts received aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 627,000<span></span>
</td>
<td class="nump">$ 1,224,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AmountOfDevelopmentProgram', window );">Approved development program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">&#8362; 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PercentageOfFinancing', window );">Financing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TotalCashReceivedFromTheIIA', window );">Total cash received from the IIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="nump">$ 288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExceptTransferProductionRight', window );">Except transfer production right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProductionTransferred', window );">Production transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PayIncreasedRoyaltiesDescription', window );">Pay increased royalties, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company would be
required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate 3%-3.5%, and also the total
amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from the IIA, depending on the manufacturing
volume that is performed outside Israel (less royalties already paid to IIA).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_MarketingGrantReceived', window );">Marketing grant received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Maximum obligation amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Monthly lease payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_LeasePaymentIncreased', window );">Lease payment increased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_LeaseMonthlyRentalPayments', window );">Lease monthly payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member] | Lease Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfVehicles', window );">Number of vehicles (in Vehicles) | Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_LeaseAgreementsPeriod', window );">Lease agreements period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RoyaltiesRate', window );">Royalties rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RoyaltiesRate', window );">Royalties rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=wlds_IIAMember', window );">IIA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ResearchAndDevelopmentGrantsDetection', window );">Research and development grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,000<span></span>
</td>
<td class="nump">$ 415,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=wlds_IMEIMember', window );">IMEI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_MaximumObligatinAmount', window );">Maximum obligatin amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GrantsReceivedFromTheIMEI', window );">Grants received from the IMEI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesNetOfInterestExpense', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 311,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RoyaltiesRatePercentage', window );">Royalties rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent payment</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesNetOfInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesNetOfInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AmountOfDevelopmentProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of development program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AmountOfDevelopmentProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AmountsReceivedAggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts received aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AmountsReceivedAggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualAlternativeInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage as an alternative annual interest rate published by bank of israel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualAlternativeInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AnnualInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual interest rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AnnualInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExceptTransferProductionRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Except transfer production right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExceptTransferProductionRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_FixedAnnualInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed annual interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_FixedAnnualInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GrantsReceivedEqualPercentageRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GrantsReceivedEqualPercentageRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GrantsReceivedFromTheIMEI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grants received from the IMEI.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GrantsReceivedFromTheIMEI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_LeaseAgreementsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease agreements period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_LeaseAgreementsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_LeaseMonthlyRentalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of lease monthly rental payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_LeaseMonthlyRentalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_LeasePaymentIncreased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease payment increased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_LeasePaymentIncreased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_MarketingGrantReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketing grant received percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_MarketingGrantReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_MaximumObligatinAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum obligatin amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_MaximumObligatinAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NumberOfVehicles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of vehicles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NumberOfVehicles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PayIncreasedRoyaltiesDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pay increased royalties, description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PayIncreasedRoyaltiesDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PercentageOfFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PercentageOfFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProductionTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Production transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProductionTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ResearchAndDevelopmentGrantsDetection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of grants detection from the value of research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ResearchAndDevelopmentGrantsDetection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RoyaltiesRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalties rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RoyaltiesRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RoyaltiesRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalties rate percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RoyaltiesRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_TotalCashReceivedFromTheIIA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cash received from the IIA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_TotalCashReceivedFromTheIIA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=wlds_IIAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=wlds_IIAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=wlds_IMEIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=wlds_IMEIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Securities (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 16, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Nov. 27, 2024</div></th>
<th class="th"><div>Dec. 14, 2022</div></th>
<th class="th"><div>Sep. 20, 2022</div></th>
<th class="th"><div>Apr. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertibleSecuritiesLineItems', window );"><strong>Convertible Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CashPayment', window );">Cash payment (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PremoneyValuationAmount', window );">Pre-money valuation amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantPricePerSharePercentage', window );">Warrant price per share percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PurchasePricePerShare', window );">Purchase price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wlds_ConvertibleSecuritiesMember', window );">Convertible Security Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertibleSecuritiesLineItems', window );"><strong>Convertible Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AggregateOrdinaryShares', window );">Aggregate ordinary shares (in Shares)</a></td>
<td class="nump">2,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ConvertibleSecuritiesLineItems', window );"><strong>Convertible Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AggregateOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of aggregate ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AggregateOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ConvertibleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ConvertibleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PremoneyValuationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of pre money valuation amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PremoneyValuationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PurchasePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PurchasePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantPricePerSharePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of warrant price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantPricePerSharePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wlds_ConvertibleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wlds_ConvertibleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jul. 04, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Initial credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AggregateAmount', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Credit facility bore interest</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExpenseOnServiceRendering', window );">Total expense on service</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ServicesInExchangeForMonthlyBaseFee', window );">Services in exchange for monthly base fee</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_AggrementTerm', window );">Agreement term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantsIssuedPercentage', window );">Warrants issued percentage</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_BaseMonthlyFeeImmediatelyIncreaseAmount', window );">Base monthly fee immediately increase amount</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An aggregate amount or score is made up of several smaller amounts or scores added together.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_AggrementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggrement term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_AggrementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_BaseMonthlyFeeImmediatelyIncreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of base monthly fee immediately increase amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_BaseMonthlyFeeImmediatelyIncreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExpenseOnServiceRendering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of expense on service rendering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExpenseOnServiceRendering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ServicesInExchangeForMonthlyBaseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of services in exchange for monthly base fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ServicesInExchangeForMonthlyBaseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantsIssuedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The warrants issued percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantsIssuedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 30, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 25, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 27, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 26, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 15, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 13, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 16, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 27, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 20, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 23, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 15, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 14, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 20, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">707,463<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">254,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issued and sold ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfOrdinaryShares', window );">Number of ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfWarrants', window );">Number of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisableWarrantsToShares', window );">Exercised warrants to shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercised ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">64,500<span></span>
</td>
<td class="nump">9,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_UnderwritingNetProceed', window );">Underwriting net proceed (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_UnderwritingDiscountsAndCommissions', window );">Underwriting discounts and commissions (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SAFEsAmount', window );">SAFEs amount (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfInvestors', window );">Number of investors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InvestorAmount', window );">Investor amount (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Converted amount (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Shares converted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Aggregate amount (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InvestorsExercisedWarrants', window );">Investors exercised warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisePricePerShare', window );">Exercise price per share (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.4<span></span>
</td>
<td class="nump">$ 105.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 43.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_GrossProceedsOfOrdinaryShares', window );">Gross proceeds of ordinary shares (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from ordinary shares (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PreFundedWarrantsToPurchase', window );">Pre-funded warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expire from the date of issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options available for grant</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Options to ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan', window );">Issuance of ordinary shares under incentive plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Ordinary shares reserved for future issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted weighted average exercise price (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 97.92<span></span>
</td>
<td class="nump">$ 14.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TerminationPeriod', window );">Termination period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfDaysForTermination', window );">Number of days for termination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate', window );">Fair value option grant date (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OptionsExpenses', window );">Option expenses (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_VestingPeriods', window );">Vesting periods</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesOptions', window );">Ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisePriceOfWarrants', window );">Exercise of warrants (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WarrantBeReducedToAnExercisePricePercentage', window );">Warrant be reduced to an exercise price percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InitialExercisePricePercentage', window );">Initial exercise price percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_WeightedAveragePricePercentage', window );">Weighted average price percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_LowestResetPrice', window );">Lowest reset price (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_InitialExercisePricesPercentage', window );">Initial exercise price percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=wlds_PreFundedWarrantsMember', window );">Pre Funded Warrants [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuedAndSoldOrdinaryShares', window );">Issued and sold ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember', window );">2024 Global Equity Incentive Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan', window );">Issuance of ordinary shares under incentive plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember', window );">2024 Employee Stock Purchase Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP', window );">Issuance of ordinary shares under ESPP</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_FairMarketValueSharesPercentage', window );">Fair market value shares percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember', window );">2024 Employee Stock Purchase Plan [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage', window );">Compensation percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember', window );">2024 Employee Stock Purchase Plan [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage', window );">Compensation percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=wlds_TwoZeroOneFiveMember', window );">2015 Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Ordinary shares reserved for future issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issued and sold ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">55,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 507.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisableWarrantsToShares', window );">Exercised warrants to shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercised ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement', window );">Issuance of shares associated with the SEPA</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from ordinary shares (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PreFundWarrant', window );">Pre fund warrant</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of ordinary shares to service provider</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_TwoZeroOneFiveMember', window );">2015 Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options available for grant</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,857<span></span>
</td>
<td class="nump">28,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Options to ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TerminationPeriod', window );">Termination period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate', window );">Fair value option grant date (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OptionsExpenses', window );">Option expenses (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of Individually Immaterial Business Acquisitions [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Outstanding voting securities percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisePricePerShare', window );">Exercise price per share (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_InvestorMember', window );">Investor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfInvestors', window );">Number of investors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OptionsAvailableForGrant', window );">Options available for grant</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,639<span></span>
</td>
<td class="nump">5,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesOptions', window );">Ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member] | Ordinary Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesOptions', window );">Ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ExercisePricePerShare', window );">Exercise price per share (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_TerminationPeriod', window );">Termination period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfDaysForTermination', window );">Number of days for termination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate', window );">Fair value option grant date (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OptionsExpenses', window );">Option expenses (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_IssuanceOfSharesOptions', window );">Ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=wlds_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from ordinary shares (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issued and sold ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfOrdinaryShares', window );">Number of ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price range (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ProceedAfterInitialPublicOfferingExpenses', window );">Proceed after initial public offering expenses (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issued and sold ordinary shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_UnderwritingDiscountsAndCommissions', window );">Underwriting discounts and commissions (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,580<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_PurchaseOfWarrants', window );">Purchase of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CombinedPurchasePricePerShare', window );">Combined purchase price per share (in Dollars per share) | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceed amount (in Dollars) | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,850<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="27"></td></tr>
<tr><td colspan="27"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The share and per share information in these financial statements
reflects the Reverse Share Splits.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitment made to pay deferred cash remuneration expressed as a percentage of the individual's base salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CombinedPurchasePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Combined purchase price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CombinedPurchasePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExercisableWarrantsToShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercisable warrants to shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExercisableWarrantsToShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_FairMarketValueSharesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum that an option price can reach in relation to the market share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_FairMarketValueSharesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_GrossProceedsOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_GrossProceedsOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InitialExercisePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial exercise price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InitialExercisePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InitialExercisePricesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial exercise price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InitialExercisePricesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InvestorAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InvestorAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_InvestorsExercisedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of investors exercised warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_InvestorsExercisedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of shares associated with standby equity purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuanceOfSharesOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of share options provides financial incentives for investors; or performance incentives for shareholders who are active in the operations of the company's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuanceOfSharesOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_IssuedAndSoldOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pre-funded warrants to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_IssuedAndSoldOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_LowestResetPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lowest reset price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_LowestResetPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NumberOfDaysForTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of days from termination to expiration of the options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NumberOfDaysForTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NumberOfInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of investors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NumberOfInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NumberOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NumberOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OptionsAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total available options for grant,</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OptionsAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OptionsExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expenses in thousand will be expensed over the option vesting periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OptionsExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PreFundWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pre-funded warrants to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PreFundWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PreFundedWarrantsToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the share of pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PreFundedWarrantsToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ProceedAfterInitialPublicOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceed after initial public offering expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ProceedAfterInitialPublicOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_PurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_PurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_SAFEsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of SAFEs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_SAFEsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value option granted date during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of ordinary shares that can be issued according to the company's 2024 employee stock purchase plan ("ESPP") approved by the board of directors and subject to the approval of the shareholders' meeting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award number of ordinary shares issued under incentive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued from the exercise of warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_TerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_TerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_UnderwritingDiscountsAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent underwriting discounts and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_UnderwritingDiscountsAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_UnderwritingNetProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net proceeds after deducting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_UnderwritingNetProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_VestingPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expensed over vesting periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_VestingPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WarrantBeReducedToAnExercisePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant be reduced to an exercise price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WarrantBeReducedToAnExercisePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_WeightedAveragePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_WeightedAveragePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=wlds_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=wlds_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=wlds_TwoZeroOneFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=wlds_TwoZeroOneFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_TwoZeroOneFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_TwoZeroOneFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=wlds_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=wlds_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Share Capital (Details) - Ordinary Shares [Member] - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Share Capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_NumberOfSharesIssuedAndOutstanding', window );">Ordinary shares, Issued and outstanding</a></td>
<td class="nump">707,463<span></span>
</td>
<td class="nump">254,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_NumberOfSharesIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares Issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_NumberOfSharesIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Share Capital (Parentheticals) (Details) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Share Capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Options Activity (Details) - Stock Options [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems', window );"><strong>Schedule of Options Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding - beginning, Amount of options</a></td>
<td class="nump">18,184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding - beginning, Weighted average exercise price</a></td>
<td class="nump">$ 62.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 45.04<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted, Amount of options</a></td>
<td class="nump">4,187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,894<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, Weighted average exercise price</a></td>
<td class="nump">$ 21.76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 97.92<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised, Amount of options</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted average exercise price</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Expired or forfeited, Amount of options</a></td>
<td class="num">(62)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(62)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Expired or forfeited, Weighted average exercise price</a></td>
<td class="nump">$ 105.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 53.12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding - end, Amount of options</a></td>
<td class="nump">22,309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Outstanding - end, Weighted average exercise price</a></td>
<td class="nump">$ 54.48<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 62.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end, Amount of options</a></td>
<td class="nump">18,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,114<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Exercisable at end, Weighted average exercise price</a></td>
<td class="nump">$ 46.56<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 48.96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Including the grant of 1,250 options to purchase up to 1,250
ordinary shares to the Company&#8217;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#8217;s shareholders
on September 26, 2024, with an exercise price of $34.40 per share. The options will expire at the earlier of (i) ten years from the date
of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $15.60,
determined using the Black-Scholes option pricing model and the total expenses of $19 thousand will be expensed over the option vesting
periods of three years.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Including the grant of 1,500 options to purchase up to 1,500
ordinary shares to directors, as approved by the Company&#8217;s shareholders on November 30, 2023, with an exercise price of $105.60
per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of
employment or service. The fair value of each option as of the grant date was $9.60, determined using the Black-Scholes option pricing
model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Weighted-Average Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Schedule of Weighted Average Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions', window );">Expected life of options</a></td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected life of options in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Options to Consultants (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandFifteenMember', window );">2015 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">In connection with</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Rendered services<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">No. of options issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">No. of options exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandSeventeenMember', window );">2017 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">In connection with</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Rendered services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">No. of options issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">No. of options exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyoneMember', window );">2021 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">In connection with</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Rendered services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">No. of options issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">No. of options exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyoneMember', window );">2021 [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyoneMember', window );">2021 [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyThreeMember', window );">2023 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">In connection with</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">Rendered services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">No. of options issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">No. of options exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 43.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On April 27, 2023, the Company&#8217;s Board of Directors approved
the additional grant of options to purchase up to 1,250 ordinary shares to a consultant, with an exercise price of $43.68 per share.
The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The
fair value of each option as of the grant date was $20.80, determined using the Black-Scholes option pricing model and the total expenses
of $26 thousand will be expensed over the option vesting periods of three years.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=wlds_TwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=wlds_TwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=wlds_TwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=wlds_TwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=wlds_TwoThousandTwentyoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=wlds_TwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=wlds_TwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Share-Based Compensation Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Schedule of Share-Based Compensation Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Schedule of Share-Based Compensation Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and Marketing Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Schedule of Share-Based Compensation Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Schedule of Share-Based Compensation Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expenses</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Issuance of Equity Warrants to Investors and Associate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_September132022Member', window );">September 13, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Schedule of Equity Warrants to Investors and Associated with the IPO [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants to purchase Ordinary Shares | shares</a></td>
<td class="nump">98,261<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price for each warrant | $ / shares</a></td>
<td class="nump">$ 160<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each warrant is exercisable into 1 ordinary share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">5 years following the issuance date<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Registered for trading (*)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_September152022OneMember', window );">September 15, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Schedule of Equity Warrants to Investors and Associated with the IPO [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants to purchase Ordinary Shares | shares</a></td>
<td class="nump">2,344<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price for each warrant | $ / shares</a></td>
<td class="nump">$ 424.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each warrant is exercisable into 1 ordinary share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">5 years following the issuance date<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Owned by underwriter<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_September152022TwoMember', window );">September 15, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Schedule of Equity Warrants to Investors and Associated with the IPO [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants to purchase Ordinary Shares | shares</a></td>
<td class="nump">295<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price for each warrant | $ / shares</a></td>
<td class="nump">$ 338.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each warrant is exercisable into 1 ordinary share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">10 years following the issuance date<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Owned by the legal advisor<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_NovemberTwoSevenTwoZeroTwoFourMember', window );">November 27, 2024 Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Schedule of Equity Warrants to Investors and Associated with the IPO [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants to purchase Ordinary Shares | shares</a></td>
<td class="nump">205,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price for each warrant | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each warrant is exercisable into 1 ordinary share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">5 years following the issuance date<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Owned by an investor<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wlds_NovemberTwoSevenTwoZeroTwoFourOneMember', window );">November 27, 2024 Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Schedule of Equity Warrants to Investors and Associated with the IPO [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of warrants to purchase Ordinary Shares | shares</a></td>
<td class="nump">78,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price for each warrant | $ / shares</a></td>
<td class="nump">$ 0.0004<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio', window );">Exercise ratio</a></td>
<td class="text">Each pre funded warrant is exercisable into 1 ordinary share<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate', window );">Expiration date</a></td>
<td class="text">Until exercised in full<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ShareBasedCompensationArrangementNotes', window );">Notes</a></td>
<td class="text">Owned by an investor<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance. The warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement registering the issuance of the ordinary shares underlying the warrants under the Securities Act of 1933, as amended, is effective and available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary shares purchased upon such exercise. The exercise price per whole ordinary share purchasable upon exercise of the warrants $320.00 per share (the &#8220;Initial Exercise Price&#8221;). The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting ordinary shares and also upon any distributions of assets, including cash, stock or other property to the Company&#8217;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until two years from the date of issuance of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any ordinary shares or convertible security, at an effective price per share less than the exercise price of the warrant then in effect, the exercise price of the warrant shall be reduced to equal the effective price per share in such Dilutive Issuance; provided, however, that in no event shall the exercise price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the &#8220;Reset Price&#8221;), provided that such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted average price per ordinary share occurring on any day between the initial exercise date of the warrants and 90 calendar days following the issuance date of the warrants. The lowest Reset Price is $160.00, which is 50% of the Initial Exercise Price.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On January 30, 2025, the exercise price of the warrants pursuant
to a November 2024 private placement was adjusted to $4.00 per share following the closing of an additional offering.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of exercise ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of Expiration date


.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ShareBasedCompensationArrangementNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of Notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ShareBasedCompensationArrangementNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_September132022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_September132022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_September152022OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_September152022OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_September152022TwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_September152022TwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_NovemberTwoSevenTwoZeroTwoFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_NovemberTwoSevenTwoZeroTwoFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wlds_NovemberTwoSevenTwoZeroTwoFourOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wlds_NovemberTwoSevenTwoZeroTwoFourOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the period (in Dollars)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (7,879)<span></span>
</td>
<td class="num">$ (7,814)<span></span>
</td>
<td class="num">$ (6,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OrdinarySharesAndPrefundedWarrants', window );">Total number of ordinary shares and pre-funded warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">785,464<span></span>
</td>
<td class="nump">254,843<span></span>
</td>
<td class="nump">188,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of ordinary shares and pre-funded warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">325,690<span></span>
</td>
<td class="nump">202,515<span></span>
</td>
<td class="nump">153,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per share (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (24.2)<span></span>
</td>
<td class="num">$ (38.4)<span></span>
</td>
<td class="num">$ (42.4)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The share and per share information in these financial statements reflects the 1-for-20 reverse share split that became effective on October 10, 2024 and an additional 1-for-4 reverse share split of the Company&#8217;s issued and outstanding ordinary shares that became effective on March 17, 2025 (the &#8220;Reverse Share Splits&#8221;). See also Note 1c.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OrdinarySharesAndPrefundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of Ordinary Shares and pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OrdinarySharesAndPrefundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Parentheticals) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (24.2)<span></span>
</td>
<td class="num">$ (38.4)<span></span>
</td>
<td class="num">$ (42.4)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The share and per share information in these financial statements reflects the 1-for-20 reverse share split that became effective on October 10, 2024 and an additional 1-for-4 reverse share split of the Company&#8217;s issued and outstanding ordinary shares that became effective on March 17, 2025 (the &#8220;Reverse Share Splits&#8221;). See also Note 1c.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carryforward tax losses</a></td>
<td class="nump">$ 21,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 4,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israeli [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_CorporateTaxRatePercentage', window );">Corporate tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_CorporateTaxRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the corporate tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_CorporateTaxRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details)<br> &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 14, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_OfficerEmployeeMonthlySalary', window );">Officer employee monthly salary (in New Shekels) | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_RelatedPartyMonthlySalary', window );">Monthly salary</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wlds_CofoundersMember', window );">Co-founders [Member] | Asher Dahan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_EmploymentExpenses', window );">Employment expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 293<span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_EmploymentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of expense on employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_EmploymentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_OfficerEmployeeMonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of officer employee monthly salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_OfficerEmployeeMonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_RelatedPartyMonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of related party monthly salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_RelatedPartyMonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wlds_CofoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wlds_CofoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wlds_AsherDahanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wlds_AsherDahanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th"><div>Mar. 17, 2025</div></th>
<th class="th"><div>Feb. 06, 2025</div></th>
<th class="th"><div>Jan. 30, 2025</div></th>
<th class="th"><div>Nov. 27, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 14, 2022</div></th>
<th class="th"><div>Sep. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight', window );">Warrants to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceDecrease', window );">Exercise price reduce (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Aggregate gross proceeds (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse share split</a></td>
<td class="text">Reverse<span></span>
</td>
<td class="text">On February 26, 2025, the Company&#8217;s shareholders meeting approved a reverse share split of the Company&#8217;s issued and outstanding ordinary shares at a ratio of up to 6:1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Pre Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight', window );">Warrants to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_SaleOfStockNumberOfShareIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Subsequent Event [Member] | Pre Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight', window );">Warrants to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">538,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into one shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wlds_SaleOfStockNumberOfShareIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into one shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wlds_SaleOfStockNumberOfShareIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wlds_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=wlds_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=wlds_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>79
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( %J*=%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( %J*=%KD#$3@\P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%.PS ,AE\%Y=XZ31F"J.L%Q DD)":!N$6)
MMT4T3908M7M[VK!U('@ CK'_?/XLN=%!:A_Q*?J D2RFB]%U?9(ZK-F>*$B
MI/?H5"JG1#\UMSXZ1=,S[B H_:YV"(+S*W!(RBA2, .+L!!9VQ@M=41%/A[Q
M1B_X\!&[##,:L$.'/26HR@I8.T\,A[%KX R88831I:\"FH68JW]B<P?8,3DF
MNZ2&82B'.N>F'2IX?7QXSNL6MD^D>HW3KV0E'0*NV6GR2WU[M[EGK>!B5?"Z
M$'PC*EE=R\N;M]GUA]]9V'ECM_9_&:_$-^.38-O K[MH/P%02P,$%     @
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M3@H\W/[O#;#"Q([A[8N_ 5!+ P04    " !:BG1:R=5:$60'  #6)@  &
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M7W%0@:(##,N6DSA+; -VLJ(!VBUHTA58L0\T=;*(4*1*4G;\[WND9,7!',V
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M%EB0)<X3\4"??Y!=0+[R-Z<)+_Z#YYVMTP+SG N:[AI+!6F<E9_X]VX@#AI
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M)B7+],\5)3'E"@#?EPQ(EP]J@*H=/OX/4$L#!!0    ( %J*=%H[+>&,3PD
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MIN%VGV6X5Z@5ZHUO1X)<-=)T-3O<#AU_UQ7Z/_5N7#PQO>&20.#:FD:CJXL
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M0YC8N(5$685K;'96EKR]^SS_O'A-EGP#JUFR9)?:O*ZTU4_@*@1T[ AX+T7
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M  !W+P  &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;.U:77/;-M:^YZ_
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M!],MAC%LOW':'7-NKG590A#B>92<]V2E((.4?"A@JT2HD&,N<=@Q?UE*?%'
MNM&/,(<CH[@<PFVPA')XO=(H/ :))>L:T4AG.-?!-*(N5_#*#]/Q[.RQF$,P
MB/P<9^CC[/ A_?8+4X*'DN#AEP6'0*W)@02?<4E!=0%_DQ"ZAJVQ/N:.62R4
MI0V" 5%M\P"+D;I<'#_/($I4F#?BF ("S!7,!.<D:"NE!0C(/ =)#05XH?'7
M863[U"*%I[/YR6P NV^_Y"M98Q-"JRP8;FW:LA FSTGVH(Y<+BDD(0HX<EF
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M- C2;16SJ%D7=3N:P0/<_-,8 "+V3@FUA]0,&X[%CUN]4)!VM&?1@ *@W9+
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MX,1G>&P/X"/P?UBHLKZL6T_[0-' ];/7E>8%<'M?%P@YBBE*G+DW32_;,%_
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MH*DW;6,Z/#O<1_P0-C1#:=D:PH#UCJ0A$M2-N<"2"BYEX]43TN(*Q;1]."P
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ML0Q9R;?7;S^P*9^K]Q,S!+T-1JU2$-K4@I!$P\@N.3 9>*!@%1T[Z06JD_'
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M_2UK#;0NWQ*V'(G09&LTE#@1XT!6.(9P<^6PJ 5^%6M>0;XNN73P"4+\(?[
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M_>YD'-:MNG]QNO2?Y+5V]('WCQG=J-"P >VG6KO]"SMH[VB+_P%02P,$%
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M@( FY-=6BGHV>C?25IJ$85-Y1[,*]P @)M4+1*&&)N%?T5R/% H;6QPL1+>
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M*PG-U5^5ME (>"SE.EI" $G/JEM(%V8FQ@=OQOWC P&$G,SQ'/>@759!U]H
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M[TW!EPOTD,K2 CR?&>/K'W1 \YWH_']02P,$%     @ 6HIT6B-)N>34!@
MNA   !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&ULE5AM;]LV$/ZN7W'P
MNL$!5%MVO"QK7@ G3;$,VVHT;?=AV =:.MML*%$CJ3C^][LC)5E*G&#[$DL4
M[_VYY\B<;[6YMQM$!X^Y*NS%8.-<^6X\MND&<V%'NL2"OJRTR86C5[,>V]*@
MR+Q0KL;3)#D9YT(6@\MSO[8PE^>Z<DH6N#!@JSP79G>%2F\O!I-!L_!)KC>.
M%\:7YZ58XQVZ+^7"T-NXU9+)' LK=0$&5Q>#^>3=U8SW^PU?)6YMYQDXDJ76
M]_QRFUT,$G8(%::.-0CZ><!K5(H5D1O_U#H'K4D6[#XWVC_XV"F6I;!XK=6?
M,G.;B\'I #)<B4JY3WK["];Q_,CZ4JVL_PO;L/=X-H"TLD[GM3!YD,LB_(K'
M.@\=@=/D!8%I+3#U?@=#WLOWPHG+<Z.W8'@W:>,''ZJ7)N=DP46Y<X:^2I)S
ME]>Z>$#CY%(AW&%:&>DDVO.Q(]V\8YS6>JZ"GND+>B93^%T7;F/AIL@PZRL8
MDU.M9]/&LZOIJQK?8SJ"XTD,TV0Z>T7?<1OIL==W_+\BA;_F2^L,@>/O0T$'
ME;/#*KEAWME2I'@QH(ZP:!YP</G#=Y.3Y.P5AV>MP[/7M%]>?_SCZ\VGS[=7
MO]W W<WUET^WGV]O[@YY^:J>PU[^\?'S#9S"6SAL!7[X[G0ZF9S!O#12<0DF
M("E_A$=CX;: 7ZL">7D:1VZ#<*WS4A0[:M,4J<LR6!F=PUR5&P'7HI1.*)@7
MEGX<#%GW-#GS7_WSY.P(6$M*".)25$(IUO5/)0WIVE*I'!;\V6+AP&DHC4Z1
M/TFW\0[<+C["D!]JY:U_Y)J7:@W) O QW8ABC4"D!@)283=0BEW.RO4*WAPG
M29PD20B"E=;F+'^MK<6PW<AT UMA259F$5','98.\R4:F)[&(3MD0A'QR6)=
M1YB7"CT?[56-8%$96XD0&B_:C3!DM3+DIT40:X/(WEGH)IL6D/,C"Q+C3$!*
M "<BCO:EHF@[)>QFJ+-\MYC;)C\QB_ V?*C3(0I:HF:A$I;54LF4%E=H.*1Z
MCV$9 >^EJIACX=9R-"E&X?N04D1$2;#,8,EC@(P0]WIB)B6"THMO<UW@#AZ$
MJD23GC?3DW@62A&#KQ3)4G)I9\PN%C1*J +[8"EM2C48!)%EDE4)%6F3R8)F
M3DBLI9"RSN=FM2+F,FKG Q.^M,9046)/^QF9A=/D^Z9NE+V4_I([H5C"P2$<
MOI<VU145*H/%XJY-<J30AF(6E0<,:7WJI*0LDEB 1-Z4I5,VRBAEF=R-?4!]
M;:_'%%(5+9'4IC3,.3Y!]O(&J/B()I6,O9S=)V<@DP\RXQ+N_(Y^9".8M_E4
M.TH9KF51L#;=(G :![_961*D)6])&"711.3S4 8>^#EA+ N%128,9&('8D50
MKQTKI1'=#A)E2: 4S.M*I_=OJ](^;3NN2B8<DH41CEKR.CYB6 VE-TLM!CMR
MQD:!NWH^4U>L>KW'F*=VM-72RDS652/P^:)!V-$O)TDPH3UP6,X>*+CO/&HV
MWN5V$3%A844XNV@RS>&+L.$1\])Y4]QE,1.!Y./6VALF3%J6,6%]QP@2J>?2
M9TX1:EDA];,_'3U#-<,T\G8]YMOUEIJ" #?KY#09$6<.*27?2%M@:<EMFWVC
M<XPG5^9;0Z1@&%B$ GHG0&9 [9O>@Z4Z.MMB6<E[/"+RV+=2H)>HH9<]93$9
MQ%Y[H;N-S1.#,!OP$O<*6)<KSY'*YY#F32A=S< ]!GVI[S@SKM-S'<M/$TU%
MI552/A1'_SF7G8ZKV[ =CCQRV+4"MY&?7[U00X]*RFPIC#_F<&X\ ?0=:Z)[
M1MV^\C!<'OU7DHK"L.?B!;3N,UA38ZJT]82P>C&AG(MV$#X94,^GY+,9[RO<
M#K_7*D<\Z(\I]%T2)/GH'G+D)\H>L>1\._0]@>RGM@^5QAH:GL%/Y:*AY,FY
M.V)GB69#BX4I<ICBGAP4^LGRIX2/O1-&TIPP.JCVI[:?SFSTH%65(VS]I82Y
MG7J.[EAUHP6@\<FE'D-U?[>DWT'BB4<BIX9WU..#BC%/4X^%-;/]GD#V1%U'
MP+Q.5);5HX!.]<'_R2SX'Z;E\W1T.[.?FH;W>@5I' MDT+[6"6DCB_:AAV)1
M;LH^K @/%$)N^;4)OSO1;YHD+;RJ>5OSAHY&\*'G[XL",9\9/^#25-Q0DQ.?
MD.,^3=7]Q<2_IE/@N@YY&D\FLV?-6/?%P3,[1TS<:^FV6N<L\J Z=%$9=^Z3
M.9JUOS5;\.,^7"W;U?9B/@_WT?WV<*O_71@Z"##05B2:C'[Z<1#:K7EQNO2W
MTZ5V=-?UCQL41&2\@;ZOM';-"QMH_UUQ^2]02P,$%     @ 6HIT6F<)=2*1
M!@  +@\  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&ULC5=M;QLW$OZN
M7S%0W<(%5+W9J=/X!7"<!.=#>C&2] Z'PWV@=F<E7KGDEN1:UK^_9\A=O=AJ
MT"_2\F6&,\\\,T->K9W_/:R8(SW5QH;KX2K&YLUD$HH5URJ,7<,6*Y7SM8H8
M^N4D-)Y5F81J,YE/IS]/:J7M\.8JS3WXFRO71J,M/W@*;5TKOWG+QJVOA[-A
M/_%9+U=1)B8W5XU:\A>.OS4/'J/)5DNI:[9!.TN>J^OA[>S-VW/9GS;\4_,Z
M['V3>+)P[G<9W)?7PZD8Q(:+*!H4_A[YCHT113#CCT[G<'ND".Y_]]H_)-_A
MRT(%OG/F7[J,J^OAZR&57*G6Q,]N_3?N_'DE^@IG0OJE==X[OQA2T8;HZDX8
M%M3:YG_UU.&P)_!Z^B<"\TY@GNS.!R4KWZFH;JZ\6Y.7W= F'\G5) WCM)6@
M?(D>JQIR\>;.<ZDC?5"%-CINKB812F5I4G0*WF8%\S]1,)O3K\[&5:#WMN3R
M4,$$UFQ-FO<FO9U_4^,[+L9T-AO1?#H__X:^LZV+9TG?V5]SD?YSNPC1@P[_
M/>9MUG5^7)>DR)O0J(*OA\B!P/Z1AS<_?#?[>7KY#4O/MY:>?TO[S=WG]^_N
MO]*'V[O[C_=?_WW,O&\K^,>GK^_I%_J)GFFB3Y;^WIH-G2=4YR.**Z8[5S?*
M;@9L(P,CTC8Z4A38:H>\Y:*5V2+#5_7PJ:5G1EI&,#6NZ./X?GP[I@?LI3O5
MZ*@,?8SEF$Y_^.[U?#Z]W%])4[/+'PD'+9P7>"KOZD%$GLM<^E>U:VT,A!]M
MDJ&%<4';);DJ#>\?/L%64K;;*O-M(_(GKZ=3;'%M4+:D4]G<67%O==0P+9.A
MMV-$ZY4N5H/#52I<:TI:,$Z!]\CY<H0#4$-$H><_6@ZQ-Z8#<23'[RRR+A(_
M%0QUL/MDAM0U1JK0:71+AIS/Z"5W\N&#?'@.36?U,^INX1/OEXC#4D4>TU<(
MM$@^;S8)I3:&"/_EN\=RI4IJ/,(J$=123HW*51$X=0&/;@!'R"7K2EY S*U!
M@,5FW]'LITQI#YW*1_@N6M;@$&K[XG^HMVD3#EGJD*E5&8?S8%"Q4G[)(ZKD
M0&A=L.5*)S2%*(..*%"Y1$<!S,J89U +"K.+RT J!$9'HG>M%]5"\!'=MLM6
MQ&#1%VXBUPMX\X+SL*U@M(,RQ:R'$@<-#BF48,V"AZ'(J#\O+>"TD$9\%AMB
M)DS63.??4P-ERMJVSN)'(C4:'!)DIZPH?)OL%:L:I3O$RY;37*,V:F&@,[.4
ME3<:2G#NJ?X1V%BFLVFNJ2,"^*<:TXG4"8HFA4 -"O81P%.EK;*%&(92:8/*
M/11RNM/_R#GQ>H'<J]#7\U*0M:X[BIB2R-ME J) O_#.'(=PK<*@:HV1$"4O
M<>PND+-?<@'+LKM2I %B 9P#C.M@[R,=5D(A24CPI97Z@DFA]X[WQP(\*#.K
M9 DAJ+<D/-R&PF -AW!8 %<J(-W<HRZEK (,53X"3J8U$C"R%0AP>KS,^;>7
M-$UCX(@$TJCU:+"U-=O^(AD[(T-;K+*5V5N4KE*02;J=!\& 3=FG;E;8\6G'
M\"V:(]*'V9C*AR!XX%.J)\<]$NJ"W/2\]J>T/2HW.AZS06.X7$I.H0$]NL1G
ME6O/3ZGV=.U)5CP93LZD*E9EW%.)D#4OU[,PDI)NVI1Q@%*]+$RYZV1 T8T&
M.SX]#[PX*D>]2%')7G9VE&BP8+8]E<4+4%OBL(_,F&Y+J$:"P>O-Z"@;=U27
M_J-]8OI!4?:<\O" AU5*V$<8)PAT-3^0W%MT 17B0J[W:5'X$J5<+76QVZ3M
M *TL9V^54KF6"Q\R5*[#5'%*ZI.S5]NRN=<M7[;N44<Y16>T09E*#$"52$6P
M]W),]Q5=3+^7R-525%&917ZM/,H1(GHJ$4^60_P1-4A+SJ0["Y#D@!Z)C$F7
M&MEANT? KNGB#J&@EY_8%QH=GH[D>V*!="'?IKP0$[);R?,>!D%@C?Y.ND;*
M:>!G-MNK0[J67$SWL$E7CMUZYKHDOI0\%,;\4#&;OC =0C@0R\O<]YW$F)_P
M0 N(4Y4N;5W0?$J%;7X?L&+O!H<M@Y/S^;YY!\/$D)/9?+Z;Z3NWQ"Z0'%,2
MKNRY/O?7]O1[EJ1S[P5A&^X<&Q^[*D_VWC U(Q7EI1;D*F9C?LYL9[>/P=O\
M!MIMSR_)7Y')B!K*0071Z?CBU3"G?S^(KDDOHH6+Z%GI<X4'+7O9@/7*N=@/
MY(#M$_GF_U!+ P04    " !:BG1:[.B7*&P7   ]40  &0   'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6S5/&F3VS:6W_$K4#V>J6X7K18I4H>OJK;323PU
MB;UN>U-36_L!$B&)8XI42*K;G5^_[P# 0Y1:=NS9W:K$+9(@\/#N"WQ^EQ>?
MRK76E?R\2;/RQ=FZJK9/+R_+Q5IO5#G(MSJ#)\N\V*@*+HO59;DMM(KII4UZ
M&0R'X\N-2K*SE\_IWKOBY?-\5Z5)IM\5LMQM-JJX?Z73_.[%F7]F;[Q/5NL*
M;UR^?+Y5*WVCJX_;=P5<7;I9XF2CLS+),UGHY8NS*__IJQ#'TX#_3/1=V?@M
M<2?S//^$%V_B%V=#!$BG>E'A# K^W.K7.DUQ(@#C=S/GF5L27VS^MK/_2'N'
MO<Q5J5_GZ6])7*U?G$W/9*R7:I=6[_.[G[793X3S+?*TI'_E'8\=!6=RL2NK
M?&->!@@V2<9_U6>#A\8+T^&!%P+S0D!P\T($Y0^J4B^?%_F=+' TS(8_:*OT
M-@"79$B4FZJ IPF\5[V\6:M"K_,TUD7YM[], W_R3%[_ODNJ^^>7%<R/HRX7
M9JY7/%=P8"X_D+_D6;4NY746Z[@]P24 YJ ++'2O@J,S_J 7 SGR/1D,@_#(
M?".WVQ'--_KBW<K_NIJ750%,\M]]&^=IP_YI47">EENUT"_.0#)*7=SJLY=_
M^XL_'CX[ G3H@ Z/S?[RYN>K]]<_O_W'#]?O;QS0__'QS8=_]D%Z?*Y?WWZX
MEOY0/I&'9WTJU$ 2IN1";9-*I?+#6LNR=4>5,E]*H(_>S'7A:"15%N./D2>3
M4B[RS38O=2Q@*+RPS%/0 >53\>N.7H*[-&DIKG;5.B^2/W0LWY3E#O[@/*!#
MR@I^)-E*M%8Z[4*\+>!5T#1F%4_^^N9&#@=#7VY5(6]5NM,R&GK#(?W?_#D9
M3KQP/))!%'K3<$3[S]NS29U5295J6:UU4DC#5$]%E8.N6FA0-3++JV2A$5$>
M[0<>J:K26>S)E<YT 6C<@-S"]DIYM]: 7:T6Z\Y"^&^:RK6""?-,R]N\TH#)
M0N+=[:Y !)?/<&X>'B? QLE\ASJO%(#UC;J7<[BO%RD\C^7\'D&6KW)5Q$3#
M!."M\H((BD]> ]54=D\@J^VVR&_KM\J&  &)E[!7$!^8]AD.]^1N"YHV3>!>
MK$CK J  49FG!)!X@H "]@$QR5;!3I*,YFU";>%09:FK?:B6%9!WJ^[!,E3X
M$/$0ZSF,))Z!L05 H.9)FE2)[KX/0&="+1: 9)4M-&C;:DW/8=9-=["1BU)>
M(< I3W8%NUDDM+N!./<OY)L,.3[P6F FS,;1M,LW!D?ZLRX62:EQ1KW9IOF]
MUDXEY5NB'DP?T/0W>ELQ6^\OA#*6Z@K62@ %;]Z]958R].J @Q@"6L2(]D6>
M9<8T(A($#E^D>0GL:-& LX5C;SJ)Y"Z#Z3UF4'BS!'J9@<B4'98E9K_+Y9TJ
M"I4!6$CT7;%8JU+WC<=9![A1%<<)0N01-#NP(L5=D2#!+;YXF\"2Q1,@?%XQ
M%VS=-H ARRUL"Y?T0V\X#OJA,,\ZQ!F0I+L7[D@F>64U!UE/-AL= ^UU>B^(
MC(A7Y",0\ JV79-U6X#H(WH>C0)0.4.Y186WCR;566$'6B5M$-P/2+%.!O)M
MDP_\L<>\("*8NQ=@1%4&6\8!>]N$R9RJ!%0T^&I_!U4+):!15/PO<$PT*;1'
M8.1@>V)_>T30#I-9KFJQL##Z,I:K(B]+6#A?:!V3L)'^^9QL".6XV& (7E":
M(H^ 5@,]B)HMWBV(&QW#X 6HE$6^RXQ> #'9 +%0K.C:O)LOE[K T?HSN+F@
M2<7Y(S\<S.PB,@._V '$NJ=>KPO=P'?O >Q? $UWHM%@).Q,O"CK-11("^D%
MJ(?1A?QA1_#O*P80#%U8)E"R3%!/2+4JM":A01NRW%4[Y!AV@<[Q==1!P?#9
MS=6/UZ2/ O_9!8X5CY"1P$SO2H28J!G!Y+>Z1./A =3-YRC2'F+A;IV RG@4
MMEY&-@76 "DV;.1[X62R9V)Q;&M:8?2-799GVJH$"*H6GTBMJ7+-*K9?H:&(
M@\F4M$%^'^PT6,D,+!;X((!_P!K@",71@V=%XQJDG#2343AF5K:'AE" := _
MR3*!C<&,, 58-00,M(-Q-7^$368+!.L<I E""'#28FL)":X+@S9B(0@#B@(I
MQG859U@DQ6*W0><(_ N!^AA\D5V%*"-H-PR?OB7M"&Y4$NM#M@W>KHH\9=77
ML1= &=+X"%2-=&7505.CBB[Q.G:;&*9?0T;#R6#,&I(5(Z"BW*$G9*63_!U
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MG7?FI4;VZVFSLZI.<5)Z2WP<W QD#*NKPKS+DER*]\!>E%2FO@M]J]-\2ZZ
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M\+U=^Q0F*413K7>\%C-MVWOI*-G3OH2 =II59$L%8TA2M?6N)]K]8X1U3HT
M]$>9PS$"=^<HSI:P(F^L1*;1-G1QE*Q59=(\ZL(@5AQ&[-[VC&QT\,0'=/UA
M32>D'F#@-D]WF[J/0MHR4\US;6$2^0*/CI%"-UJ;OE-3W6&+49-2K7:D/3!1
MU73)?]11[4S ^3*SB0Y"S8%9FV>!.P_SIR ?&YC4G@\WY9SH))ZR!^S($C?\
M9O29]T_8[7V+(VP[!FTT-#Z%H+)6B=AVTXG%0/X#PO.ZK$27C1E!CW(/&.![
ML>.&J#I#UR6^..PY(=GZ3B@FF5'UC1Z90J?Z%A7)DK^; "";Q)S7NVS#8>,/
M6]A>0#<YKYXOD\HY><8@-[]2U>B^VL^,'WDX.O8P$(32SK+G$V\ZF<D+^N&'
M^&/LA;.QO! ?*)?YY9B<3",O'(?N$U;^=.KY@2]^.XRM4Z<> 3>/0>A@.U[D
M1Q#\CF"I2+Q29;(P+F!* 4;:9I]SB-*QW>L<0V3\&P;XM^\;:9>-3]K1V7_\
M<!]^K )<)OZZG;OKO@UXQ9_$JX?SAP5_404$7*AGE_#J<#")SMCYL!=5OJ4/
MY,WSJLHW]'.M%7AY. ">+_.\LA>X@/MBXLO_ 5!+ P04    " !:BG1:B:@&
M-S\#  #T!@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6R-54UOVS@0
MO?=7#-1V3ZEDR4Z:36T#B9NB/N0#==I=8+&'D32RN*5$E:2B^-]W2-F*4[C&
M7FQ^S'OS9D@^33NEOYN2R,)3)6LS"TIKFXLH,EE)%9I0-53S3J%TA9:G>AV9
M1A/F'E3)*!F-SJ(*11W,IW[M7L^GJK52U'2OP;15A7IS15)ULR .=@M?Q+JT
M;B&:3QM<TXKLU^9>\RP:6')146V$JD%3,0LNXXNKB8OW =\$=69O#*Z25*GO
M;K+,9\'("2))F74,R'^/M" I'1'+^+'E#(:4#K@_WK%_\K5S+2D:6BCYE\AM
M.0O. \BIP%;:+ZK[3-MZ3AU?IJ3QO]#UL<G[ ++66%5MP:R@$G7_CT_;/NP!
MSD>_ 21;0.)U]XF\RH]H<3[5J@/MHIG-#7RI'LWB1.T.964U[PK&V?D#/I$!
M;L^RSE1%T\@RJ=N*LBW!54^0_(8@3N!&U;8T<%WGE+\DB%C-("G92;I*CC)^
MI"R$<7P"R2B9'.$;#R6./=_X_Y4(_URFQFJ^#O\>JK;GFASF<D_DPC28T2S@
M-V!(/U(P_^-U?#;Z<$3I9% Z.<8^?[C\^WH%=[>PO%W<W5P?DG><X/;NX1KB
M&-[!+U07KS"$AY)@H:H&ZPT( Y;[DD/+IZ;!\M;2:"0I0&(70AKNVJ4*P'K8
MS)[QIDW_X[<%5O&J;I1&2XZT3_1B"?Q [&@<.AF_#5_Q0?/I !I#QO!3MX:E
M+]U;97B.=4;\'&SY0MY6EL/=Z5S4+NK$)]FG8=5VKUQ;:M6N2Q^V(=1\M^(_
M ;73R0;#+>!6%$PF0\A#6*#6&W:\#G7N,5(Y[E]9T:_P?:4JY2;N[NP)8*7:
MVC(E]P:;1JLGP09"<@-ODCB,^2%+R9[T 4K5T2-I1D#12@F/*%OL[4JR7_H.
M<(HWD_#\=(>"CO-J<AWB#+AFYS76ZVJ4Y>(%2B:SK>Y;GU)-A6#G!NI/9M6F
M7+%@"SYT"[Z&J[ OV5T#%U\0[S'G\SGRZ<5OPT,7/MISHHKTVONMX29S.WI3
M&E8'2[_LG>PYO/\>W*!><V4@J6#H*'Q_&H#N/;:?6-5X7TN599?TPY(_2Z1=
M .\7BMNQG;@$PX=N_A-02P,$%     @ 6HIT6I2):$*L P  RP<  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C N>&ULC551C]HX$'[G5XS2JMI*+(% E^T6
MD&"A=TC;701[UX?3/9AD0JPZ=FH["_S[&SN0I2N*[B7QV#/??#.>&0^V2O\P
M&:*%72ZD&0:9M<5=&)HXPYR9EBI0TDFJ=,XLB7H3FD(C2[Q1+L*HW;X)<\9E
M,!KXO84>#51I!9>XT&#*/&=Z/T&AML.@$QPWEGR36;<1C@8%V^ *[5_%0I,4
MUB@)SU$:KB1H3(?!N',WZ3E]K_ WQZTY68.+9*W4#R?,DV'0=H108&P= J/?
M"]ZC$ Z(:/P\8 :U2V=XNCZB?_6Q4RQK9O!>B>\\L=DPN T@P925PB[5]D\\
MQ//)X<5*&/^%;:4;]0.(2V-5?C F!CF7U9_M#GDX,;AM_\8@.AA$GG?ER+.<
M,LM& ZVVH)TVH;F%#]5;$SDNW:6LK*933G9VM$3!+":P8-IR-(/0$J@["N,#
MP*0"B'X#T(G@FY(V,S"3"2:_ H3$IJ84'2E-HHN(4XQ;T.TT(6I'O0MXW3K$
MKL?K_K\0X9_QVEA-Y?#ON6@KK-YY+-<B=Z9@,0X#Z@&#^@6#T8=WG9OVEPM,
M>S73WB7TT7+V,'Z>36$Q7C[/9ZMS]"X#/#X]SX!NY!K>0,%SAH!Y(=2>.LH"
M[JBK#25#I6#I*%;7J2KI K6Y:XRIG#1,6<8D7+G3^XQQZ@!YU)XHIA,G3+FF
M[E+: ),)5*H<4YCM,"Y=N\%3FO(8]<<F_%'NX3N3&X*^6E#N>.*(.+LCRD<O
M/2 J#0]>LW'UBOF,<2:54)O]"2A-)>]VCXQ(H*M H/K!?$UNCC7DOUT/3HL(
M6$ZANHJP"EA1:+7CU-XH]O ^NNT3GBH-*3=)_-Q]%1L.X'VWVSG1H#@*](-%
M[%OP).$;TW$&G<IGU*QRHO*"R?V'=[=1I__%@,F8QDP)EVW(J7.YW%1$7K#*
M(I<Q35B#QX3GKL.(GV&")F>#=I&1F\/I6_R3RW0A/LY7T&_7I.'J3<R=S_49
M9;00)3%4,6<"UB@QY;:Z7>$()8V8Z::7:\(,E,1K2Z,:UDJ2-?XLR9@\W_Q*
MG)JO"65!L]B7G%#&!7X(8KYX@FW&*:HM(X=Q3$$)3I684#9@A86M+M6EM=68
M2W@DY\>=WOE$UUE@&XW5?1-*H31Q(5(:DS)&9\EUS;!UKH_#DP&;H][X9\0E
MFNJHFK7U;OU2C:L!_:I>/7-4(!LN#:4S)=-VJ_\I %T]'95@5>'']5I9&OY^
MF=%KB]HIT'FJE#T*SD']?H_^ U!+ P04    " !:BG1:$:PM_=8$  #M"@
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MBP]'[SY\[$7[F-7+4 =5X,.F4+GS!!2(VEA5(;6]B%L 'UG8RQ?O)Y/QQT[
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M\Y^FXO/>MA$38""0; %4E7$WFB58CEU3?^==A5E+ZZ(9$G$8HKXUB@S>AE@
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MDH$+Z1@?C:6Z=$\C22T^K6NT4COGR%%'MEN>U(D^Z87".38+BHY)#AG#58P
MJT/''Y6_DW[QAX#T'&)'US1@H"7%M@8719O0&R<N?F?> -B^^G?%HN\\D; 2
M" ,.4X[=1?6894PS+KQRAK*,*VN(;7/VG7Y]A!-4<AFQ1%U2W)%!' "1F<."
MF/;$K$CDAO=%9Z= X(X$:RWO//A(GG/[0%>8KL+FQ;J#C?N!F$]3'1EEBF(*
M7MT>.+*E(;@FP.B9E;(]V<#\%)@_*LX<DH4]0\\8DS&\2^H$4] Y? A2]K6)
M.+X!@('5N$,VP=G^QID#--^-O$4D(9;JWH."1=LP*@"AJ$B:L0XR%6\1AP]J
M/$NO+&W]763PD3C\3-X_I,[WIL_\]"Y3NH6M!AEU@_XC38$Q^005M63K/3C[
MO@VB21-\PT]PL$'HEEU9.F3" 4G<STGF"2#V7GRZ%D<H1H.L.F;8*&$=<[*1
MA8H9!<+Z2<ZH4?FZHJ2W;;>8U^)IY?XVCL4)B$@&<0@H8<Z1E!<_K ZP3R0,
MR;QWCM^[LJ":06LRSOMV\4B'^1./??<F0@9T!P:\AS\Q<U/TO$^*WWGF=WY@
M/@<Q_)Q'LG. QV/)MEG2 #$;Q8.7+H?H/><@&!R=X@ 87$]%?V[ZPG9AM+0)
MKO^2U*8H@URI*J:.\_YT:47=_^C@(QD82G6VS0+.H.@;M5'NS2/WY@^@:0O6
MP_G71!D&N3@ZU0$N:C31PVL<_L''4!E9;> +\U27.T['[\")E1/_1[#+L01A
MVX7'<+5QAA5SE>!/2CM]Z!C'.!M[4V:C#22O?T4UJ%Q*8076H!D6S1]H0Q%_
M3L7 ]'U7JC1B!U/O9-GL3A; :BQ2NF<#M+FV1H+1@!C 3\AIO2UE6M'/'S@D
M^/U/Y4L;# &I@+:$X0U[$;#-;CD?#$> 1" >\4FOZ(G&L"G9TI"K=S-T4M-<
M%@B9?Z!W ZX%@ OE=?,UU]"E9>A0<,K*N7!UA_U"(4V2<<!%BNBP08%I+C+T
MQ*6#'$ PPKZORX$@AIU:YIA4Q;ZAV7CCT+MNW2UMDAB4KA_I'+J=BI%E^K^Y
M\H&OE?FT3$;."+[63D+:BJM2&!1CFH>!6K_83S!.<I89&>?Z4!@Y^*)C)\4R
MM#B*B565KDUF54Z)MQRK50TV7+B<+,0#M]Z6$H%8>@MT] JZW$ZAJ.%B[!QC
M+])LO!GIFIG7R&\'#NY'.I%*Q$1QWBZ ]PU;J-PZ>0KC!/S1%,1;BI>29KJ;
M!G@C$91?4C' (:!8/[@,=8-GYZ<3'R$Y.K[@"CY&2L;@L[&GXDIQ")(QV7BJ
M27VS;>#$_O9!Q'"G4JA.<8"I>^8BEJJ6+5658"$T5&2^G,]-CCA;J.9>.= ?
M.YADY JCQ&^N.>A@ U72M./@(^8)<6 I[VW<N)O+]6!XJ<:*7!93UO@,2R/*
M?^[ V(+S.]S>Y2(5Q,3)=@AO&*LP,N%>*,*P&-$Y1?:&BNMR"4V\+8R?@B'5
MRXEC+@'.)B3'B0UW )UIDPJ?KC MHPD?;D#3@36WB'@I<L$<)L6UUC408"')
ME7+Z!(!4EF6&([@GJN1 "^7;9=;9'@]2S^B4"A= S!+T'-,4$C&R<PH.Y"+]
MF.O&LX (;*D;CKPG49C"_K*X/Y^0[9U*E\R@AE0QL,+I@!?8O 3G3#FC)C97
MQI8BW_&&NMM6+E%. D;JZD\/*X")9D_]*E0QR8U>4"R9=S*SFQI"AI"K&6C7
M2S.ADRQA]\078B27^\D[<H<@JAAP,Y!*/"5?P!V)$-56OF<D81E_KZMD%R[C
M,&YU8]?:;+QM[69-/79TFL@&X,'!GMOQJ0Y8X,U4T!HG^VL<_B&@78]CL;RS
MV9;U3K'QG#U[Z1-C6*1 ..2_3FLI_3H9 2?.%'6LX5)JTRV>28AP"U\AR&+Z
M(=8*?$A'+:APCOO!79*T@.?NT.1B?XD+]?;2/ 0$[2 C2-&RH<I$ *T+M=(5
M5?O<#KK4<,V(=N54!'@!QNO$D[54$OV SQ;XKS%HS]>$:6* G@UQ@0^JN\ON
M)F-#[C[/:5% J_FMK^CQ645C_Z:4^>W)3;ZN*4%+#V68PL8'2&>]Z1AK"O;J
MUVE077HGR-KG,M]!0KK=?,)W\X$820^3*2\===?5K;AE).YI$A^YJX%?#G<5
MFBQG(79:E:YD;+2]/8'X5D4$9QYH'9O%WK'9>//8']27X)PSZ.H)9@ZI:&L.
M1V4_TE(&RO_06EQ+=A^\#F\48DUM-Z*HP0J@+\$"/-:708Z2G"3F7ES"5N32
MKGU>"!N=\-!L2H!):J@<T;EF@^CM0KN71=-DV:'[0=,,:#4*$7JW%MQ!DDVR
M'PR>4!@AV$R:+G0%FMQRF? ((S)IV-46W'(%<K:5FEO^Y59#.'N<.MPJ0R]N
MK7?P/2P5F^-E"\#'Z(:#AU6K"<^ZA%J<PN>!+8(EZB+K;@'8AH*(W=4%-VCX
MFQ#)1B;4>S+<>!(*T,"=P25H*(*=T+E "LP<0IXR#T/C2N[\*RL?@H*#E&L0
MMF\Q7]AO<JCO*W?4$Y0"M)X-]]&Y]K>1]4=U,;;&S<9[XVX0B>*Y#"K=C_3#
MU>!Q_:0AEP$0#6OG\CY)I7L[F?G<,[8GA9'PI4N@@AYJ@(<EP\'@B/$X&?!2
M7!+:"?AWWW?N#:[C:[=1_\O^D61;=T&.<\(I-?VNG+RFU*_ -A?8#K7F@+OG
MY]V-IZGXU!K;2G8!UMV<FYU[4?/\B1R[3/QO=H$5S]G/3\]"J!:G\-':9%"R
M EQANY.D<*AJ@85HEPN84 L,M\\ 5<^G9V<_.?+ 0[JG,^ _ 71*P7/R'WZM
MY,8%J''K?*>(]^Y;D@8BVH07AJMJ'9M&P(+^8-<8CB+;)I,F49*[4Q&W7174
M^(P9JZZYW,!9UGAB',<J9['[1Q>LZ;8UVYI[;V%M-$$=8D;U,/8ISL8;%=\
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M]"\=T)6M<+LZAB$1T%'%Q37 X=Z#BJ5E5Z^>W_$JGU21>LDFTBS8)Q74]CA
M5_HQ@=[)AZ?;88_@FD3IXIRRH,>4]1R3KMCV-!]O>QJ,]2^*>NO>\+#_0BDG
M;N/3MM/A+$)O9NPT_H#7CM%5!>\D,+O@DC09WZ.=GYV</IL$:?T<"O?NZNW\
M^>GQ"W&=7F(&O?T<)=2/',Y"A"72UY%H;";XFOF4P+9=E'CC&5.P.I:/G>AW
M,@8+CVOIL#N5^Q2#^Z&AZRJQ1*NVE(;>!>"Z0_PE@E%E$D=-O%IR^?'J?6@A
MZO3B.9!.Q=+PJB 79W#V?N4;$9>Z\8YFDER=XH8];'W8>IR%%R6Y98R+-O'5
M&WXZZJWV]["P9733X1I5>?:-2OH^B(0:CQ#P,CR^""M+^-PI_'"G4'+&''-C
MT[Y[CI-"O?/U5PB=Z3MD[&#>4'*0\'6Q"1Z'6X?0;/G;W/TEEG15VN8NFVF3
MZCM=_XDP;O9DXO0CY1Y7QZUW\/]HJG/GT!2*F9"%*Y=O,2IJ&KIM0>.<I0VO
M?@!;Z!/UW+Q4U=B-P@%DE0U9\2%#V4WE+ZD/V^<Q.(ZNZK!8Q;!T8)I1%QM[
M!N?C/8,7EY<?OW[X<OWA5W'SY>+#U<7GJQMQ?7/S]>V5@(_BP\<OXG_>?A$7
M5Q\_?8'OKC\<MHL_T%YX![S^,0KZ]O/\H/T\/SD%X7'-@^%^:<B,1(/:O5[J
M!OC'WKH^$K"B<K7"+"L)3<>HWK2+AFWR_/3D',QRUGL:9&>/CK?>!/9L,I(=
M\\R]O@QN+NS/[:,$9U6S7*;WJ;'.Q.5SO'6QXG>8Z*ICB)(<!J![%>^2/>C]
MX<$0+U1K=. %7Y6$.(N"C)"O\1TY@;KX-JG03)2'L"#VC%$O;F@=[G:<\0]3
MD? .K\?T[)![6T@X<&]$'C(83Q\P&/XN -ZN"_?WE49]1B\6^[71@G=>>U'N
MXHN/^F_MXTK-DH;T*68ZB9MAB_X5>2D/:I,-K$<M(,XN8_8J3!M/0O<;51/#
MTT')6$?C=A[L[1JRF%E(T@;.]:C$3DQ^9Z.S=SY8341S^K#")W.>H\+S>R4N
M*:0AS(EW9BZ3".=*+1#^)[TD>RIXWH-%E;J/M19-FL5I!WY3"F*P]$Y [H75
M(6[2@RR]]N7$7#MJ\T!MLDPE@F4Y?W9Z,C\EJ3B2QYUXK<#=I!D)SAQ@1)C,
MZKO4*)5VM#C>'Q:@&#4-A;--EDKU[)R2?QT]^T?.^.DT>]M5*VU35YS*&K8R
M$57;DM]-DR@D.V7KX/;WRZCK<J;FH2B=G<DRG]5\T AVVU7M%(1G]O.3P9>[
M/D[>S[M19D5O(:8W+58-OZHW?!O>='S![_>-C_-KDM]+L\)D7JF6,/1T^@P<
ML>$W#_,'$!UZV^^B;IIZ0W^N(>!7!A^ WY<UV'KW 1<([W]^_?]02P,$%
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M,GFL @  P 4  !D   !X;"]W;W)K<VAE971S+W-H965T,C@N>&ULG53;;M-
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MAT.[-PXAJXU59>M,#$HNFR?[UN;A1QR2UB'QO)N#/,L/S++E7*L#:+>;T-S
MA^J]B1R7KB@;JVF5DY]=WB&%9.#LD6T%FO-Y9 G4+459"[!N )+_ !@G<*^D
MW1OX2>:8OP:(B$U'*3E26B>#B!\P&T$ZOH D3JX&\-(NQ-3CI<,A_K':&JM)
M!7^>"K*!N#H-X6[&S%0LPT5(TC>HOV*X?/MF?!V_'R!XU1&\&D)?;NBFY;5
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MV>WDY"3%M!&>)W%O-&0G@W \H56346^2!&]^%U4F 5NP.<2?^8^G2UGAF:J
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M4,V%:AY4\Z%:@-*JP;FK$9+%-4*_=&E!3*X_K:=3&YC0$B"HID(U#:KI4,V
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M!E-[VG13H)L.JMH7Q95"6V)]<VW?--#.P,Z72N&AXQ9H7\GL&5!+ P04
M" !:BG1:KN+%QVL#   1$   &0   'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6R]6%UOVC 4_2M6)DV;M#5QH-!V@-2O:96*5!5M>ZCVX"878C6V4]N!3MJ/
MG^V$A%;4&JS  \2)[_&YUR<^N@P60CZH#$"C)Y9S-0PRK8N3,%1)!HRH U$
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M %P9X/,U8_)^H [']<<0[P]02P,$%     @ 6HIT6N+I4RZD @  O@@  !D
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M'9)!3E=</XK-=VC]A(8O%5S97[)I<SV'I"NE1=F"44')JN:?OK9UV (,AD<
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MKB(T*)O+I FTJ.T\7@B-T]TN"[Q_09H$?)X+H=\",^*[&SWY#U!+ P04
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M]CVE4ZOUF-<'31E T71A&T?),3M*UU$:)7*2]5#-T3_FV]M0],V9>@L+2?-
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M<O^*RJ&Q^J(2U$MV9_\"4$L#!!0    ( %J*=%J&G3!9"0L  ,J    9
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M+"O7=V0'SUG^O7HYD_\#4$L#!!0    ( %J*=%JRU<6AM@0  + B   9
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MB@+R_C.EXG!1!&@.J<S^ U!+ P04    " !:BG1:+94Q;JT$  #O(0  &0
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MS4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(M1+4&U%-4R5,M1K4 UN291FT\
M(&YW K"IANN]U-ITWYD A,OC[M\G=]?E=/:WOYQ+XMD_!>7?CZ/Y+^%?]N*^
M@C$O[V>'YP)H91RJ*:BFHIJ&:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$
M:C&J):B6HEJ&:CFJ%:@FRRQW27&[<X%-!5VONH+.F,T>EV?CC:^%V6)&($SJ
M*^FJQ<9S %)3>@?*OWI2?[_B3D5'U5!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4
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MP4D!VJF':@JJJ:BFK;3M58K^F;A_:7<='=1 -1/5+%2S4<U!-1?5/%3S42U
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M<+$=.UUGMW#/UIDV"VX<E70-"] _RKG$F=NJI"R'0C%1$ FKL7/3'4U"@[>
MGPRV:F],3)*E$$]F,DO'CF<, 8=$&P6*CPU,@',CA#:>&TVG?:4A[H]WZE]L
M=LRRI HF@O]BJ<[&SM A*:QHQ?6]V'Z%)D_/Z"6"*_M/M@W6<TA2*2WRAHP.
M<E;43_K2U&&/T U/$/R&X)]+"!I"8(/6SFRL*=4TCJ38$FG0J&8&MC:6C6E8
M84YQH27N,N3I>)%1"9G@*4AU>3'TNX-K\OFY8OJ5?"(+_&;2B@,1*V*!9$)+
MIBDG'Z:@*>/J(Z*^RY05^ 74$$4>[B!?@GS$+657(E>C4_,^-VE<W=:N_!.N
MII!T2-"](K[GAT?HD_/IP2'=Q?JT1?+;(OE6+SA5I)-U>/B&4#+3D*O'8S%K
MW?"XKKFA(U72!,8.7D$%<@-.?'G1[7O7QT+_)[&#$@1M"8*_J<?M(=='>D5N
M*IT)R7Y#>BQW+=:S8J:1;.*>5_\B=[.?Z0S@@=^P]1O^F]^94A6DA!8IP6:F
M- Y8L3[F/7QG:> -PG[PQOE[F-\+AV'PQK>[=S=-7[RC<LT*13BLD.AU!J@@
MZUY33[0H[75="HV7WPXS;,\@#0#W5T+HW<1T@+;AQW\ 4$L#!!0    ( %J*
M=%KAQ S)50(  # &   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;*U5
M74_;,!3]*U=&0DR".A^E($@CC7;3D(9646U[0'MPD]O&PHF#[;3P[V<[(6JE
M=NL#+XFO?<_)/<?V3;*1ZED7B 9>2U'I,2F,J6\HU5F!)=,#66-E5Y92E<S8
M4*VHKA6RW(-*0:,@&-&2\8JDB9^;J321C1&\PID"W90E4V]W*.1F3$+R/O'(
M5X5Q$S1-:K;".9J?]4S9B/8L.2^QTEQ6H' Y)I_#F\G0Y?N$7QPW>FL,3LE"
MRF<7W.=C$KB"4&!F' .SKS5.4 A'9,MXZ3A)_TD'W!Z_LW_UVJV6!=,XD>(W
MSTTQ)M<$<ERR1IA'N?F&G9Y+QY=)H?T3-EUN0"!KM)%E![85E+QJW^RU\V$+
M$ X/ *(.$!T+B#M [(6VE7E94V98FBBY >6R+9L;>&\\VJKAE=O%N5%VE5N<
M2><%4UA(D:/2IR?747AU"U]>&F[>X +F]LSDC4"02_"),&$U-TS V<Q&E2G0
M\(P)_0G.IF@8=Z,+L#SQ*+H%"MJ!=$*-K=1]CV9=57=M5=&!JJ:8#2 .SR$*
MHN$>^.1X>+P+I]:?WJ2H-RGR?,,#?#]4SBM[QEL3-#P]8+E ]6>?L'\RN3MY
MHVN6X9C82Z=1K9&DIR?A*+C=)_.#R'9$Q[WHV+/'AT[&P<U_^FY3X=Y@J?=:
M$'^D!1]$MF/!L+=@>-R^M^?X'&JF8,U$@_MDMUS7GLLUSW4:#((PH>MM.?])
M:LND6_?9]=('IE:\TB!P:6'!X.J2@&K[4QL86?LKOI#&-@P_+&Q+1^42[/I2
M2O,>N*[1_R32OU!+ P04    " !:BG1:S%.(NI\%  #2%   &0   'AL+W=O
M<FMS:&5E=',O<VAE970T-BYX;6RM6%EOVS@0?O>O(-R@:(%4I^4C30SDZFZ!
M[;9H=K</11]H:6P)D425I.SXW^^0DN6+5ARW>8@ESL%OOAF1'%XN&'\4,8 D
M3UF:BZMN+&5Q8=LBC"&CPF(%Y"B9,IY1B:]\9HN" XVT49;:GN/T[8PF>7=\
MJ<>^\/$E*V6:Y/"%$U%F&>7+&TC9XJKK=E<#7Y-9+-6 /;XLZ P>0/Y;?.'X
M9C=>HB2#7"0L)QRF5]UK]^+>'2@#K?%? @NQ\4Q4*!/&'M7+Q^BJZRA$D$(H
ME0N*/W.XA315GA#'S]IIMYE3&6X^K[Q_T,%C,!,JX):EWY)(QE?=89=$,*5E
M*K^RQ9]0!Q0H?R%+A?Y/%K6NTR5A*23+:F-$D"5Y]4N?:B(V#-S^ 0.O-O!V
M#?P#!GYMX.\:] X8]&J#WK$S!+6!#MVN8M?$W5%)QY><+0A7VNA-/6CVM37R
ME>2J4!XD1VF"=G+\$%,.,4LCX.+UJZ'G#MZ3^Y]E(I?D'7G LHS*% B;DL^%
M2JP@URJS2OSF#B1-4O%6*4H6/C8JWS]!-@'^ P5GQ"9"32$N;8EPU:1V6$.[
MJ:!Y!Z"Y'OG$<AD+<I]'$&T[L#'.)EAO%>R-U^KQ#D*+^.XY\1RO9P!T=[RY
MWP+';[CWM3__$/=M]'[_"[7)1PF9^&'BKG+=,[M6R\N%*&@(5UU</P3P.73'
MKU^Y?>>]*>[?Y&R+A5[#0J_-^_AS*86D>93D,RR8"<R2/,?G<W*=L3*7BAQ6
MD6.BH?(=:-]J49R/W:$[Q.3.-^,S:'E^X#=:6\"#!GAP&O!O>G6"B- Y<%QM
M"3P!#Q,!I.!)"*8PJIE<?P-AW[/<_DX<!K5>8#D]<R#])I!^:R!_<)HCW",9
M[^]QV7.'@VV@M^T3?G=-)7VW[SD8CG92>?^,9^]'2TD.&D(&QQ%R0B8'^RGR
M7&NPFTF#VFA@C3QS)H<-\&$K\/L:WK&Y;/5F_NZ)*7._[F<KW%$3[NC8<$_(
M5*OO%P3_ZWZV@G>=]=;M/!-^D7 ,F7&")\8I),=_Q+7GS6_M7=_;J=%GE+91
M;QPXW!-0GY"_>I[!YJKN!-;NEU:K;7UJ@6^YAP+QUH%X+UC_(3^:>V^/5L_S
MG=$N[GVU[:UM&_;ZT.&V[N8FV*>0[QM8[5F]X6X4!KWMG6T[C/6IP6T_-M3?
M/IW@^8G*E]!O.C(XP[WB-ZCAWR'ZUX<&M_W48,)]"O^FHT#?"O:JWZ0WM$:'
M^%=GANV1]:;IMN^:N*M_S,.TU)4E8R SM8VJ;+CG7N"L<D(D(T7)PQC;.U(6
MZE7+.XRC)3:K=<.@!,K++<L*FB_KYD20VSB!*4$:PU+UF.3S=(H<<8(E7<L>
MP@1RF>#P2GA.J""T*#B;(\N3I=&QV&B%.MC#/D A=2-#O'[5,IQC<R9CG&DG
M02K&,Q^KWR$%JFM'%OD'YUC%O$C2%(W4RJ>RKJ8'RM,$M='V3?*62,C)$L<$
MF7*6:8V(2NB@N.:1HQXJCAP4+%&-I=CE*ZXI&G/L#:ENO=$ LB)E2VSGM97:
M<Q!D!6A*$T[F-"TU:*!A7&-4#.'(.F]J=K+ T3,7%U7GO!-!-0TR6(I5CF]2
M&CZ^PTZ&I9BRVI4B12ED+()4)T:I2B:I)@%R 7JR,W>$$E8*I:(IFL!* 3<(
M_!BT8>UU#D*BUPY2G+"H1LL!*MHL//H=++_ :2\_E)O*+\)TA9)Q\>+Z(8CW
M;U36Y>,[5<O86CYZZW(ZO[M^R GUT_G-]3-2Y4->7#Z=Y\LG>'GYD /E8SJ1
MV1OW*AGPF;[0$B14NTS57C6CU:79C7=QJZ^*=L?599IA_,Z[N#?I7[M]-.@;
M)8/5O=R>Y.):^[+74*O;OD^48V\J2 I3A.U8 ]P3>'6!5KU(5N@;H@F3DF7Z
M,0:*=:P44#YE3*Y>U 3-->;X?U!+ P04    " !:BG1:T 7K^J,"  !^!@
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M;,U:6W/;N!5^[Z_ :-,=IZ-:(BC9LF-[)G&R4W>:32;N=A\R>8!(2,*&)!@
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MGW^:T>#\!7GSI1!F2_Y*[J%HXB+A1"[(G=8%RR)[7 [XG2G%,J.)D>0N6W,
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MO#X#3TAY02-M@5_;CB"]'@O?QWI!(W*!7^4.\E[/O'>;#)IPOB4%//RIC1)
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M:Z_;2_> 20DC8/#+R*"=X"(, 0[ AB6AYX:VV18+;G^&=%E8,Y'8[-DWM3M
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M+W-H965T-3$N>&ULK5=-;]LX$/TK [4H$J"QOF4YL0TDMA>[P+8-XF1[*/9
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M0@?@\S5'P>V-GJ#[ IG^!U!+ P04    " !:BG1:78-L)(,#  !U"0  &0
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MX '44WDGM.4W*%E!@<F",R1@/?6NPZO9Q.RW&YX+J.31&)E(5IR_&F.13;W
M" ("J3((6/]V< .$&" MXWN-Z364QO%X?$"_M;'K6%98P@TG7XM,Y5-O[*$,
MUGA+U#VO/D,=S]#@I9Q(^T65VSO0C.E6*DYK9VW3@KD_WM?G<.0012<<HMHA
MLKH=D54YQPHGL> 5$F:W1C,#&ZKUUN(*9I+RH(1>+;2?2A[Q'B32Q[-@*:>
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ML'2D RJI/^-L3[BR1IJZT7)I;PQP5JH7:R4Y/LW03_KWD%,)";FC7&8@R$4
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M@K6,95O-$JAEM-:[Y5*P)56,+ 67VDZ"SQE;R%V/=3K+S.UK+2C-JVF3W:6
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M(RXT\H#2/"C-A]("*"V$TB(4K6W")O)PS'<1])@ FTF]W0?-.FK:[J [+6?
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !:BG1:(K;,/GP$  !*)   #P
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M[D9#A9OG+1X?RFV=ZR#FICL8:A%63&#%O%@SV+:ESN'LN?A;EM)D2K1WUB/
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M_#,T[Z$\DV6V<*+YZ5[+I>-F87U=E^4,ROXU'ZW,#Y_"'#[C>?<?4$L#!!0
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MI]ZYG'8I7WN^UWC]_Z2ZG,]-U\M?EM\[1S?4!>< /S<\?@%02P,$%     @
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M'/)9]Y7"Y!-02P$"% ,4    " !:BG1:1L=-2)4   #-    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %J*=%KD#$3@
M\P   "L"   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( %J*=%J97)PC$ 8  )PG   3              "  >4!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 6HIT6LG56A%D!P  UB8
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M965T-2YX;6Q02P$"% ,4    " !:BG1:.RWAC$\)  #R/@  &
M    @($3(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @
M6HIT6FY$O$5O @  $P4  !@              ("!F"P  'AL+W=O<FMS:&5E
M=',O<VAE970W+GAM;%!+ 0(4 Q0    ( %J*=%H;WZ5?QPD  *(T   8
M          " @3TO  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M    " !:BG1:Z=4T\XP1  !W+P  &               @($Z.0  >&PO=V]R
M:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 6HIT6H44<#16&P  *4X
M !D              ("!_$H  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q0
M2P$"% ,4    " !:BG1:8'EG_H<"  !7!0  &0              @(&)9@
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( %J*=%H@. H&
MNP(  -$%   9              " @4=I  !X;"]W;W)K<VAE971S+W-H965T
M,3(N>&UL4$L! A0#%     @ 6HIT6M[<&V(V!   KPD  !D
M ("!.6P  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " !:
MBG1:X!6@ 1 )  !&%P  &0              @(&F<   >&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( %J*=%JG=P]8?0H  #,:   9
M          " @>UY  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#
M%     @ 6HIT6B-)N>34!@  NA   !D              ("!H80  'AL+W=O
M<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " !:BG1:9PEU(I$&   N
M#P  &0              @(&LBP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM
M;%!+ 0(4 Q0    ( %J*=%KLZ)<H;!<  #U1   9              " @722
M  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ 6HIT6HFH
M!C<_ P  ] 8  !D              ("!%ZH  'AL+W=O<FMS:&5E=',O<VAE
M970Q.2YX;6Q02P$"% ,4    " !:BG1:E(EH0JP#  #+!P  &0
M    @(&-K0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (
M %J*=%H1K"W]U@0  .T*   9              " @7"Q  !X;"]W;W)K<VAE
M971S+W-H965T,C$N>&UL4$L! A0#%     @ 6HIT6BW[!JAD @  A08  !D
M             ("!?;8  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"
M% ,4    " !:BG1:/*4S.!$"  #=!   &0              @($8N0  >&PO
M=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( %J*=%IN]\P7_0@
M .\9   9              " @6"[  !X;"]W;W)K<VAE971S+W-H965T,C0N
M>&UL4$L! A0#%     @ 6HIT6J&B=[>U'   "UH  !D              ("!
ME,0  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !:BG1:
MQ*R]MM,"   >!@  &0              @(& X0  >&PO=V]R:W-H965T<R]S
M:&5E=#(V+GAM;%!+ 0(4 Q0    ( %J*=%HPZJ96@P(  %<%   9
M      " @8KD  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%
M  @ 6HIT6D3@,GFL @  P 4  !D              ("!1.<  'AL+W=O<FMS
M:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !:BG1:>EW5570#  "&"
M&0              @($GZ@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+
M 0(4 Q0    ( %J*=%IK_G*I,@T  %DL   9              " @=+M  !X
M;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ 6HIT6E B.NR)
M"P  JY$  !D              ("!._L  'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6Q02P$"% ,4    " !:BG1:Z =@4HX"   Q!P  &0
M@('[!@$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( %J*
M=%JNXL7':P,  !$0   9              " @< ) 0!X;"]W;W)K<VAE971S
M+W-H965T,S,N>&UL4$L! A0#%     @ 6HIT6ER51)NE @  D <  !D
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M=#,X+GAM;%!+ 0(4 Q0    ( %J*=%HF@K4 F <  +X[   9
M  " @>T< 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @
M6HIT6H:=,%D)"P  RH   !D              ("!O"0! 'AL+W=O<FMS:&5E
M=',O<VAE970T,"YX;6Q02P$"% ,4    " !:BG1:LM7%H;8$  "P(@  &0
M            @('\+P$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4
M Q0    ( %J*=%HME3%NK00  .\A   9              " @>DT 0!X;"]W
M;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ 6HIT6G33GGX -0
M^D8$ !D              ("!S3D! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6Q02P$"% ,4    " !:BG1:$,NP,V0"  #\!0  &0              @($$
M;P$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( %J*=%KA
MQ S)50(  # &   9              " @9]Q 0!X;"]W;W)K<VAE971S+W-H
M965T-#4N>&UL4$L! A0#%     @ 6HIT6LQ3B+J?!0  TA0  !D
M     ("!*W0! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %J*=%I^]T5Y/ 0  (T,   9              "
M@7Z1 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ 6HIT
M6EV#;"2# P  =0D  !D              ("!\94! 'AL+W=O<FMS:&5E=',O
M<VAE970U,BYX;6Q02P$"% ,4    " !:BG1:<=>Y')\"  !;!P  &0
M        @(&KF0$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0
M   ( %J*=%J,3@4!= ,  "X0   9              " @8&< 0!X;"]W;W)K
M<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ 6HIT6L(";$Q[!@  <$
M !D              ("!+* ! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q0
M2P$"% ,4    " !:BG1:+\?P^'$#   W%P  #0              @ '>I@$
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( %J*=%J7BKL<P    !,"   +
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4!08     /P _ # 1   EM $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>184</ContextCount>
  <ElementCount>379</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>57</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995300 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995301 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995303 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995304 - Statement - Consolidated Statements of Changes in Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995305 - Statement - Consolidated Statements of Changes in Shareholders??? Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995306 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995307 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995308 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Stand by Equity Purchase Agreement and Convertible Promissory Note</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote</Role>
      <ShortName>Stand by Equity Purchase Agreement and Convertible Promissory Note</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Convertible Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConvertibleSecurities</Role>
      <ShortName>Convertible Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995315 - Disclosure - Credit Facility</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/CreditFacility</Role>
      <ShortName>Credit Facility</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995316 - Disclosure - Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquity</Role>
      <ShortName>Shareholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995317 - Disclosure - Taxes on Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/TaxesonIncome</Role>
      <ShortName>Taxes on Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995318 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995319 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/SignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/Inventories</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/PropertyandEquipmentNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/Leases</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Shareholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996006 - Disclosure - General (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/GeneralDetails</Role>
      <ShortName>General (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/General</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Significant Accounting Policies - Schedule of Annual Rates of Depreciation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable</Role>
      <ShortName>Significant Accounting Policies - Schedule of Annual Rates of Depreciation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Inventories - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable</Role>
      <ShortName>Inventories - Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable</Role>
      <ShortName>Property and Equipment, Net - Schedule of Property and Equipment Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/LeasesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Leases - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable</Role>
      <ShortName>Leases - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable</Role>
      <ShortName>Leases - Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Stand by Equity Purchase Agreement and Convertible Promissory Note (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails</Role>
      <ShortName>Stand by Equity Purchase Agreement and Convertible Promissory Note (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/CommitmentsandContingencies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Convertible Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails</Role>
      <ShortName>Convertible Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ConvertibleSecurities</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Credit Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/CreditFacilityDetails</Role>
      <ShortName>Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/CreditFacility</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Shareholders??? Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ShareholdersEquityDetails</Role>
      <ShortName>Shareholders??? Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/ShareholdersEquityTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Shareholders??? Equity - Schedule of Share Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Share Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>996020 - Disclosure - Shareholders??? Equity - Schedule of Share Capital (Parentheticals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals</Role>
      <ShortName>Shareholders??? Equity - Schedule of Share Capital (Parentheticals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Shareholders??? Equity - Schedule of Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Shareholders??? Equity - Schedule of Weighted-Average Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Weighted-Average Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Shareholders??? Equity - Schedule of Options to Consultants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Options to Consultants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Shareholders??? Equity - Schedule of Share-Based Compensation Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Share-Based Compensation Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Shareholders??? Equity - Schedule of Issuance of Equity Warrants to Investors and Associate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Issuance of Equity Warrants to Investors and Associate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Shareholders??? Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Shareholders??? Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Parentheticals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals</Role>
      <ShortName>Shareholders??? Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Parentheticals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>996028 - Disclosure - Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/TaxesonIncomeDetails</Role>
      <ShortName>Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/TaxesonIncome</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>996029 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/RelatedParties</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="ea0234654-20f_wearable.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>996030 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wearabledevices.co.il/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wearabledevices.co.il/role/SubsequentEvents</ParentRole>
      <Position>55</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="ea0234654-20f_wearable.htm">ea0234654-20f_wearable.htm</File>
    <File>wlds-20241231.xsd</File>
    <File>wlds-20241231_cal.xml</File>
    <File>wlds-20241231_def.xml</File>
    <File>wlds-20241231_lab.xml</File>
    <File>wlds-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fin_001.jpg</File>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="464">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="7">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="50">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>86
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0234654-20f_wearable.htm": {
   "nsprefix": "wlds",
   "nsuri": "http://www.wearabledevices.co.il/20241231",
   "dts": {
    "inline": {
     "local": [
      "ea0234654-20f_wearable.htm"
     ]
    },
    "schema": {
     "local": [
      "wlds-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "wlds-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "wlds-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "wlds-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wlds-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 232,
   "keyCustom": 147,
   "axisStandard": 24,
   "axisCustom": 0,
   "memberStandard": 25,
   "memberCustom": 29,
   "hidden": {
    "total": 84,
    "http://fasb.org/us-gaap/2024": 48,
    "http://www.wearabledevices.co.il/20241231": 33,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 184,
   "entityCount": 1,
   "segmentCount": 57,
   "elementCount": 777,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 464,
    "http://xbrl.sec.gov/dei/2024": 50,
    "http://xbrl.sec.gov/cyd/2024": 7,
    "http://xbrl.sec.gov/ecd/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation",
     "longName": "995300 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
     "longName": "995301 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "995302 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement",
     "longName": "995303 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3",
     "longName": "995304 - Statement - Consolidated Statements of Changes in Shareholders\u2019 Equity",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c8",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c9",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals",
     "longName": "995305 - Statement - Consolidated Statements of Changes in Shareholders\u2019 Equity (Parentheticals)",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 Equity (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c7",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow",
     "longName": "995306 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.wearabledevices.co.il/role/General",
     "longName": "995307 - Disclosure - General",
     "shortName": "General",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.wearabledevices.co.il/role/SignificantAccountingPolicies",
     "longName": "995308 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.wearabledevices.co.il/role/Inventories",
     "longName": "995309 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.wearabledevices.co.il/role/PropertyandEquipmentNet",
     "longName": "995310 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.wearabledevices.co.il/role/Leases",
     "longName": "995311 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote",
     "longName": "995312 - Disclosure - Stand by Equity Purchase Agreement and Convertible Promissory Note",
     "shortName": "Stand by Equity Purchase Agreement and Convertible Promissory Note",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.wearabledevices.co.il/role/CommitmentsandContingencies",
     "longName": "995313 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.wearabledevices.co.il/role/ConvertibleSecurities",
     "longName": "995314 - Disclosure - Convertible Securities",
     "shortName": "Convertible Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.wearabledevices.co.il/role/CreditFacility",
     "longName": "995315 - Disclosure - Credit Facility",
     "shortName": "Credit Facility",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:CreditFacilityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:CreditFacilityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquity",
     "longName": "995316 - Disclosure - Shareholders\u2019 Equity",
     "shortName": "Shareholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.wearabledevices.co.il/role/TaxesonIncome",
     "longName": "995317 - Disclosure - Taxes on Income",
     "shortName": "Taxes on Income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.wearabledevices.co.il/role/RelatedParties",
     "longName": "995318 - Disclosure - Related Parties",
     "shortName": "Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.wearabledevices.co.il/role/SubsequentEvents",
     "longName": "995319 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables",
     "longName": "996001 - Disclosure - Significant Accounting Policies (Tables)",
     "shortName": "Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.wearabledevices.co.il/role/InventoriesTables",
     "longName": "996002 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables",
     "longName": "996003 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.wearabledevices.co.il/role/LeasesTables",
     "longName": "996004 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityTables",
     "longName": "996005 - Disclosure - Shareholders\u2019 Equity (Tables)",
     "shortName": "Shareholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.wearabledevices.co.il/role/GeneralDetails",
     "longName": "996006 - Disclosure - General (Details)",
     "shortName": "General (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails",
     "longName": "996007 - Disclosure - Significant Accounting Policies (Details)",
     "shortName": "Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeFinanceLeaseRenewalTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeFinanceLeaseRenewalTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
     "longName": "996008 - Disclosure - Significant Accounting Policies - Schedule of Annual Rates of Depreciation (Details)",
     "shortName": "Significant Accounting Policies - Schedule of Annual Rates of Depreciation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c45",
      "name": "wlds:AnnualRateOfDepreciation",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c45",
      "name": "wlds:AnnualRateOfDepreciation",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable",
     "longName": "996009 - Disclosure - Inventories - Schedule of Inventories (Details)",
     "shortName": "Inventories - Schedule of Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable",
     "longName": "996010 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment Net (Details)",
     "shortName": "Property and Equipment, Net - Schedule of Property and Equipment Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.wearabledevices.co.il/role/LeasesDetails",
     "longName": "996011 - Disclosure - Leases (Details)",
     "shortName": "Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable",
     "longName": "996012 - Disclosure - Leases - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities (Details)",
     "shortName": "Leases - Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable",
     "longName": "996013 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails",
     "longName": "996014 - Disclosure - Stand by Equity Purchase Agreement and Convertible Promissory Note (Details)",
     "shortName": "Stand by Equity Purchase Agreement and Convertible Promissory Note (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c57",
      "name": "wlds:PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "wlds:StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c57",
      "name": "wlds:PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "wlds:StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
     "longName": "996015 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wlds:GrantsReceivedEqualPercentageRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:GrantsReceivedEqualPercentageRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
     "longName": "996016 - Disclosure - Convertible Securities (Details)",
     "shortName": "Convertible Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c75",
      "name": "wlds:CashPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c75",
      "name": "wlds:CashPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.wearabledevices.co.il/role/CreditFacilityDetails",
     "longName": "996017 - Disclosure - Credit Facility (Details)",
     "shortName": "Credit Facility (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c83",
      "name": "us-gaap:OtherBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "wlds:CreditFacilityDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c83",
      "name": "us-gaap:OtherBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "wlds:CreditFacilityDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
     "longName": "996018 - Disclosure - Shareholders\u2019 Equity (Details)",
     "shortName": "Shareholders\u2019 Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c100",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable",
     "longName": "996019 - Disclosure - Shareholders\u2019 Equity - Schedule of Share Capital (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Share Capital (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals",
     "longName": "996020 - Disclosure - Shareholders\u2019 Equity - Schedule of Share Capital (Parentheticals) (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Share Capital (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ilsPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c135",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ilsPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable",
     "longName": "996021 - Disclosure - Shareholders\u2019 Equity - Schedule of Options Activity (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Options Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c137",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c138",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable",
     "longName": "996022 - Disclosure - Shareholders\u2019 Equity - Schedule of Weighted-Average Assumptions (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Weighted-Average Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
     "longName": "996023 - Disclosure - Shareholders\u2019 Equity - Schedule of Options to Consultants (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Options to Consultants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c142",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "wlds:ScheduleOfOptionsToConsultantsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c142",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "wlds:ScheduleOfOptionsToConsultantsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable",
     "longName": "996024 - Disclosure - Shareholders\u2019 Equity - Schedule of Share-Based Compensation Expenses (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Share-Based Compensation Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c152",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable",
     "longName": "996025 - Disclosure - Shareholders\u2019 Equity - Schedule of Issuance of Equity Warrants to Investors and Associate (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Issuance of Equity Warrants to Investors and Associate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c161",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "wlds:ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c161",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "wlds:ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable",
     "longName": "996026 - Disclosure - Shareholders\u2019 Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wlds:OrdinarySharesAndPrefundedWarrants",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals",
     "longName": "996027 - Disclosure - Shareholders\u2019 Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Parentheticals) (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareDiluted",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "1",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R53": {
     "role": "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails",
     "longName": "996028 - Disclosure - Taxes on Income (Details)",
     "shortName": "Taxes on Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.wearabledevices.co.il/role/RelatedPartiesDetails",
     "longName": "996029 - Disclosure - Related Parties (Details)",
     "shortName": "Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c175",
      "name": "wlds:OfficerEmployeeMonthlySalary",
      "unitRef": "ils",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c175",
      "name": "wlds:OfficerEmployeeMonthlySalary",
      "unitRef": "ils",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.wearabledevices.co.il/role/SubsequentEventsDetails",
     "longName": "996030 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c181",
      "name": "wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c181",
      "name": "wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0234654-20f_wearable.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCOUNTING STANDARDS ISSUED AND NOT YET ADOPTED IN 2024",
        "documentation": "The policy representing the accounting standard issued and not yet adopted.",
        "label": "Accounting Standards Issued And Not Yet Adopted In2024 Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r726"
     ]
    },
    "wlds_AccruedInterestOnConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AccruedInterestOnConvertibleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expenses on convertible promissory note",
        "documentation": "Amount of accrued interest on convertible securities.",
        "label": "Accrued Interest On Convertible Securities"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AccruedInterestOnDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AccruedInterestOnDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest on deposits",
        "documentation": "Represent the amount of accrued interest on deposit.",
        "label": "Accrued Interest On Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less - accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r124",
      "r537"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r63",
      "r129",
      "r532",
      "r555",
      "r556"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r904",
      "r905",
      "r906",
      "r908",
      "r972",
      "r1032"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments required to reconcile net loss to net cash used in operating activities",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AdvanceFromCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AdvanceFromCustomers",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance payments",
        "documentation": "It represent advances from customers.",
        "label": "Advance From Customers"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AggregateAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount",
        "documentation": "An aggregate amount or score is made up of several smaller amounts or scores added together.",
        "label": "Aggregate Amount"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AggregateOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AggregateOrdinaryShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate ordinary shares (in Shares)",
        "documentation": "Number of shares of aggregate ordinary shares.",
        "label": "Aggregate Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AggrementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AggrementTerm",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreement term",
        "documentation": "Aggrement term",
        "label": "Aggrement Term"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r786",
      "r802",
      "r837"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r778",
      "r789",
      "r805",
      "r840"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r806",
      "r832",
      "r841",
      "r845",
      "r853"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AmountOfDevelopmentProgram": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AmountOfDevelopmentProgram",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approved development program",
        "documentation": "The amount of development program.",
        "label": "Amount Of Development Program"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AmountsReceivedAggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AmountsReceivedAggregateAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts received aggregate amount",
        "documentation": "The amounts received aggregate amount.",
        "label": "Amounts Received Aggregate Amount"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AnnualAlternativeInterestPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AnnualAlternativeInterestPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual alternative interest percentage",
        "documentation": "The percentage as an alternative annual interest rate published by bank of israel.",
        "label": "Annual Alternative Interest Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross revenue limit",
        "documentation": "Annual gross revenue limit to remain as an emerging growth company.",
        "label": "Annual Gross Revenue Limit To Remain As An Emerging Growth Company"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "wlds_AnnualInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AnnualInterestRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual interest rate",
        "documentation": "Annual interest rate",
        "label": "Annual Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AnnualRateOfDepreciation": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AnnualRateOfDepreciation",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual rates of depreciation",
        "documentation": "The percentage of annual rate of depreciation.",
        "label": "Annual Rate Of Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_AsherDahanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "AsherDahanMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asher Dahan [Member]",
        "label": "Asher Dahan Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r98",
      "r125",
      "r151",
      "r179",
      "r183",
      "r195",
      "r196",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r405",
      "r407",
      "r425",
      "r527",
      "r611",
      "r695",
      "r696",
      "r726",
      "r748",
      "r937",
      "r938",
      "r992"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL CURRENT ASSETS",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r131",
      "r151",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r405",
      "r407",
      "r425",
      "r726",
      "r937",
      "r938",
      "r992"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL NON-CURRENT ASSETS",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r405",
      "r407",
      "r425",
      "r937",
      "r938",
      "r992"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NON-CURRENT ASSETS:",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r764",
      "r782"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r764",
      "r782"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r764",
      "r782"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "wlds_BaseMonthlyFeeImmediatelyIncreaseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "BaseMonthlyFeeImmediatelyIncreaseAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base monthly fee immediately increase amount",
        "documentation": "The amount of base monthly fee immediately increase amount.",
        "label": "Base Monthly Fee Immediately Increase Amount"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Board of Directors [Member]",
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r402",
      "r707",
      "r708"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r37",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r402",
      "r707",
      "r708"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding voting securities percentage",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r764",
      "r782"
     ]
    },
    "wlds_CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price calculation of shares, pricing period",
        "documentation": "Calculation of purchase price of shares, period for considering lowest volume weighted average price.",
        "label": "Calculation Of Purchase Price Of Shares Period For Considering Lowest Volume Weighted Average Price"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of trading days for calculating average VWAP",
        "documentation": "Calculation of shares using commitment fee payable, number days considered for the volume weighted average price.",
        "label": "Calculation Of Shares Using Commitment Fee Payable Number Days Considered For The Volume Weighted Average Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash (in Dollars)",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r530",
      "r583",
      "r606",
      "r726",
      "r748",
      "r895"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r122",
      "r682"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at the beginning of year",
        "periodEndLabel": "Cash and cash equivalents at the end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r71",
      "r147"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r71"
     ]
    },
    "wlds_CashPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CashPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment (in Dollars)",
        "documentation": "Cash payment.",
        "label": "Cash Payment"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "wlds_ChangesDuringTheYear2022Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ChangesDuringTheYear2022Abstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CHANGES DURING THE YEAR 2022:",
        "label": "Changes During The Year2022 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer [Member]",
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r126",
      "r127",
      "r128",
      "r151",
      "r171",
      "r172",
      "r174",
      "r176",
      "r181",
      "r182",
      "r236",
      "r277",
      "r279",
      "r280",
      "r281",
      "r284",
      "r285",
      "r314",
      "r315",
      "r318",
      "r321",
      "r328",
      "r425",
      "r562",
      "r563",
      "r564",
      "r565",
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r584",
      "r598",
      "r621",
      "r643",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r882",
      "r901",
      "r909"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r181",
      "r314",
      "r315",
      "r316",
      "r318",
      "r321",
      "r326",
      "r328",
      "r562",
      "r563",
      "r564",
      "r565",
      "r705",
      "r882",
      "r901"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price",
        "verboseLabel": "Exercise price range (in Dollars per share)",
        "netLabel": "Exercise price (in Dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "wlds_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to purchase",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into one shares.",
        "label": "Class Of Warrant Or Right Number Of Securities Called By Warrant Or Right"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to purchase",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "wlds_CofoundersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CofoundersMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-founders [Member]",
        "label": "Cofounders Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CombinedPurchasePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CombinedPurchasePricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Combined purchase price per share (in Dollars per share)",
        "documentation": "Combined purchase price per share.",
        "label": "Combined Purchase Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES (Note 7)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r91",
      "r529",
      "r597"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r269",
      "r270",
      "r667",
      "r930",
      "r935"
     ]
    },
    "wlds_CommitmentsandContingenciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CommitmentsandContingenciesDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares reserved for future issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_CommonStockConvertibleConversionPriceIncrease": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockConvertibleConversionPriceIncrease",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price per ordinary share (in Dollars per share)",
        "label": "Common Stock, Convertible, Conversion Price, Increase",
        "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "verboseLabel": "Ordinary Shares [Member]",
        "netLabel": "Common Stock [Member]",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r738",
      "r739",
      "r740",
      "r742",
      "r743",
      "r744",
      "r745",
      "r904",
      "r905",
      "r908",
      "r972",
      "r1029",
      "r1032"
     ]
    },
    "us-gaap_CommonStockNoParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockNoParValue",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in Dollars per share)",
        "label": "Common Stock, No Par Value",
        "documentation": "Face amount per share of no-par value common stock."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, authorized",
        "verboseLabel": "Ordinary shares, Authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r598"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, issued",
        "verboseLabel": "Ordinary shares issued",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, outstanding",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r54",
      "r598",
      "r617",
      "r1032",
      "r1033"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares no par value: Authorized 50,000,000 as of December 31, 2024 and December 31, 2023; Issued and outstanding 707,463 shares as of December 31, 2024 and 254,843 shares as of December 31, 2023.",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r531",
      "r726"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r133",
      "r135",
      "r141",
      "r523",
      "r543",
      "r544"
     ]
    },
    "wlds_ComputersAndSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ComputersAndSoftwareMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computers and Software [Member]",
        "documentation": "Collection of computer and software.",
        "label": "Computers And Software Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r109"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r687"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConversionOfSAFEToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ConversionOfSAFEToEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of SAFEs to equity",
        "documentation": "The amount of conversion of SAFE to equity.",
        "label": "Conversion Of SAFETo Equity"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of SAFEs (as defined in Note 10) into ordinary shares upon completion of initial public offering (Note 10) (in Shares)",
        "documentation": "Conversion of SAFEs into ordinary shares upon completion of initial public offering.",
        "label": "Conversion Of SAFEs Into Ordinary Shares Upon Completion Of Initial Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted amount (in Dollars)",
        "label": "Conversion of Stock, Amount Converted",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares converted",
        "label": "Conversion of Stock, Shares Converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible promissory note (Note 6)",
        "verboseLabel": "Convertible promissory note balance (in Dollars)",
        "label": "Convertible Notes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "wlds_ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Note [Member]",
        "label": "Convertible Promissory Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertiblePromissoryNotePremiumPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ConvertiblePromissoryNotePremiumPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible promissory note premium percentage",
        "documentation": "Convertible promissory note premium percentage.",
        "label": "Convertible Promissory Note Premium Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertibleSecuritiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ConvertibleSecuritiesDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Securities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertibleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ConvertibleSecuritiesLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Securities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ConvertibleSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ConvertibleSecuritiesMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Security Agreements [Member]",
        "label": "Convertible Securities Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CorporateTaxRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CorporateTaxRatePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate tax rate",
        "documentation": "Percentage of the corporate tax rate.",
        "label": "Corporate Tax Rate Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of revenues",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r151",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r425",
      "r695",
      "r937"
     ]
    },
    "wlds_CostOfRevenuesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CostOfRevenuesPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues",
        "documentation": "Policy of cost of revenue.",
        "label": "Cost Of Revenues Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CreditFacilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CreditFacilityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CreditFacilityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CreditFacilityDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_CreditFacilityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "CreditFacilityDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacility"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CREDIT FACILITY",
        "documentation": "The entire disclosure for credit facility.",
        "label": "Credit Facility Disclosure Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]",
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r863"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Board of Directors Oversight [Text Block]",
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r863"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]",
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r859"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes Integrated [Flag]",
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r860"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes Integrated [Text Block]",
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r860"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r766",
      "r858"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r766",
      "r858"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r766",
      "r858"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Third Party Engaged [Flag]",
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r861"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r770",
      "r862"
     ]
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CONVERTIBLE SECURITIES",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r149",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r275",
      "r276",
      "r286",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r302",
      "r309",
      "r310",
      "r312",
      "r434"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r44",
      "r45",
      "r89",
      "r90",
      "r153",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r724",
      "r902",
      "r931",
      "r932",
      "r933",
      "r982",
      "r983"
     ]
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory note including accrued interest (in Dollars)",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period."
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of interest rate",
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r305",
      "r982"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails",
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r153",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r724",
      "r902",
      "r931",
      "r932",
      "r933",
      "r982",
      "r983"
     ]
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtWeightedAverageInterestRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average interest rate",
        "label": "Debt, Weighted Average Interest Rate",
        "documentation": "Weighted average interest rate of debt outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_DecreaseIncreaseInDepositsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "DecreaseIncreaseInDepositsNet",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease (increase) in deposits, net",
        "documentation": "Represent the amount of decrease (Increase) in deposits, net.",
        "label": "Decrease Increase In Deposits Net"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease (increase) in other receivables and prepaid expenses",
        "documentation": "Decrease (increase) in other receivables and prepaid expenses.",
        "label": "Decrease Increase In Other Receivables And Prepaid Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_DecreaseincreaseInGovernmentalGrantsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "DecreaseincreaseInGovernmentalGrantsReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease (increase) in governmental grants receivables",
        "documentation": "Amount of decrease (increase) in governmental grants receivables.",
        "label": "Decreaseincrease In Governmental Grants Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation percentage",
        "label": "Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage",
        "documentation": "Commitment made to pay deferred cash remuneration expressed as a percentage of the individual's base salary."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Options Activity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r795",
      "r809"
     ]
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term bank deposits",
        "label": "Deposits Assets, Current",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term bank deposits",
        "label": "Deposits Assets, Noncurrent",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r27"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Director [Member]",
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r916",
      "r1030"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r795",
      "r809"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r764",
      "r782"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r764",
      "r782",
      "r833"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r764",
      "r782",
      "r833"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r753"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement",
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per ordinary shares, basic (in Dollars per share)",
        "verboseLabel": "Basic loss per share (in Dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r169",
      "r171",
      "r174",
      "r175",
      "r176",
      "r178",
      "r400",
      "r404",
      "r418",
      "r419",
      "r524",
      "r545",
      "r690"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasicAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement",
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per ordinary shares, diluted (in Dollars per share)",
        "verboseLabel": "Diluted loss per share",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r171",
      "r174",
      "r175",
      "r176",
      "r178",
      "r400",
      "r404",
      "r418",
      "r419",
      "r524",
      "r545",
      "r690"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic and diluted loss per share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r177"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r377",
      "r390",
      "r713"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "wlds_ElectronicEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ElectronicEquipmentMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Electronic Equipment [Member]",
        "documentation": "Collection of Electronic equipment.",
        "label": "Electronic Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll and other employment related accruals",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Expenses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock Options [Member]",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_EmploymentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "EmploymentExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employment expenses",
        "documentation": "Represent the amount of expense on employment.",
        "label": "Employment Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r782"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r117",
      "r137",
      "r138",
      "r139",
      "r154",
      "r155",
      "r156",
      "r158",
      "r163",
      "r165",
      "r167",
      "r180",
      "r237",
      "r238",
      "r260",
      "r330",
      "r388",
      "r389",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r404",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r417",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r437",
      "r446",
      "r541",
      "r551",
      "r552",
      "r553",
      "r571",
      "r643"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r396",
      "r884",
      "r885",
      "r886",
      "r968",
      "r969",
      "r970",
      "r971"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r786",
      "r802",
      "r837"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r772",
      "r783",
      "r799",
      "r834"
     ]
    },
    "wlds_ExceptTransferProductionRight": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ExceptTransferProductionRight",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Except transfer production right",
        "documentation": "Except transfer production right.",
        "label": "Except Transfer Production Right"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "wlds_ExercisableWarrantsToShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ExercisableWarrantsToShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised warrants to shares",
        "documentation": "Exercisable warrants to shares.",
        "label": "Exercisable Warrants To Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ExercisePriceOfWarrants": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ExercisePriceOfWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants (in Dollars per share)",
        "documentation": "Per share or per unit amount of exercise price.",
        "label": "Exercise Price Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ExercisePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ExercisePricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price per share (in Dollars per share)",
        "documentation": "Exercise price per share.",
        "label": "Exercise Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "wlds_ExpenseOnServiceRendering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ExpenseOnServiceRendering",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total expense on service",
        "documentation": "Represent the amount of expense on service rendering.",
        "label": "Expense On Service Rendering"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FIFOInventoryAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FIFOInventoryAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inventories, net",
        "terseLabel": "Inventories (Note 3)",
        "label": "FIFO Inventory Amount",
        "documentation": "The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods."
       }
      }
     },
     "auth_ref": [
      "r683"
     ]
    },
    "wlds_FairMarketValueSharesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "FairMarketValueSharesPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair market value shares percentage",
        "documentation": "The minimum that an option price can reach in relation to the market share price.",
        "label": "Fair Market Value Shares Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_FinanceIncomeAndExpensesPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "FinanceIncomeAndExpensesPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance income and expenses",
        "documentation": "Disclosure of accounting policy for finance income and expenses.",
        "label": "Finance Income And Expenses Policy Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r311",
      "r326",
      "r415",
      "r424",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r542",
      "r699",
      "r714",
      "r715",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r727",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r917",
      "r918",
      "r919",
      "r920",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978"
     ]
    },
    "wlds_FinancingIncomeExpensesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "FinancingIncomeExpensesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing income (expenses), net",
        "documentation": "Represent the amount of finance income (Loss), net.",
        "label": "Financing Income Expenses Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257",
      "r258",
      "r259",
      "r491",
      "r492",
      "r679"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257",
      "r258",
      "r259",
      "r679"
     ]
    },
    "wlds_FixedAnnualInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "FixedAnnualInterestRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed annual interest rate",
        "documentation": "Fixed annual interest rate.",
        "label": "Fixed Annual Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized gain from foreign currency derivative activities",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r619",
      "r746",
      "r980",
      "r981",
      "r1031"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r806",
      "r841"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r806",
      "r841"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r806",
      "r841"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r806",
      "r841"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r806",
      "r841"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r763",
      "r793"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "General and administrative expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r623"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative Expenses [Member]",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "wlds_GeneralDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "GeneralDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_GovernmentalGrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "GovernmentalGrantsPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Governmental grants",
        "documentation": "Disclosure of accounting policy for governmental grants.",
        "label": "Governmental Grants Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrantsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Governmental grant receivable",
        "label": "Grants Receivable",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_GrantsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrantsReceivableCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum obligation amount",
        "label": "Grants Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "wlds_GrantsReceivedEqualPercentageRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "GrantsReceivedEqualPercentageRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants received equal percentage rate",
        "label": "Grants Received Equal Percentage Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_GrantsReceivedFromTheIMEI": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "GrantsReceivedFromTheIMEI",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants received from the IMEI",
        "documentation": "Grants received from the IMEI.",
        "label": "Grants Received From The IMEI"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_GrossProceedsOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "GrossProceedsOfOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds of ordinary shares (in Dollars)",
        "documentation": "Gross proceeds of ordinary shares.",
        "label": "Gross Proceeds Of Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "GROSS PROFIT",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r66",
      "r97",
      "r151",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r425",
      "r692",
      "r695",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r937"
     ]
    },
    "wlds_IIAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IIAMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IIA [Member]",
        "label": "IIAMember"
       }
      }
     },
     "auth_ref": []
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "IL",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Israeli [Member]",
        "label": "ISRAEL"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IMEIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IMEIMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IMEI [Member]",
        "label": "IMEIMember"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPO [Member]",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r764",
      "r782"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "LOSS BEFORE TAX EXPENSES",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r93",
      "r97",
      "r525",
      "r539",
      "r692",
      "r695",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r267",
      "r268",
      "r421",
      "r422",
      "r423",
      "r548",
      "r550",
      "r628",
      "r679",
      "r716",
      "r1001"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r268",
      "r421",
      "r422",
      "r423",
      "r548",
      "r550",
      "r628",
      "r679",
      "r716",
      "r1001"
     ]
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TAXES ON INCOME",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r373",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r385",
      "r391",
      "r393",
      "r394",
      "r395",
      "r567",
      "r713"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax expenses",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r115",
      "r166",
      "r167",
      "r179",
      "r186",
      "r196",
      "r376",
      "r377",
      "r392",
      "r546",
      "r713"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r374",
      "r375",
      "r381",
      "r382",
      "r384",
      "r387",
      "r561"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease in accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "wlds_IncreaseDecreaseInAdvancePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IncreaseDecreaseInAdvancePayments",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in advance payments",
        "documentation": "The increase (decrease) during the reporting period in advance payments.",
        "label": "Increase Decrease In Advance Payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in deferred revenues",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r900"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in accrued payroll and other employment related accruals",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease (increase) in inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities items:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r806",
      "r832",
      "r841",
      "r845",
      "r853"
     ]
    },
    "wlds_InitialExercisePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "InitialExercisePricePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial exercise price percentage",
        "documentation": "Initial exercise price percentage.",
        "label": "Initial Exercise Price Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_InitialExercisePricesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "InitialExercisePricesPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial exercise price percentage",
        "documentation": "Initial exercise price percentage.",
        "label": "Initial Exercise Prices Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r857"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r857"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r857"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r145",
      "r146"
     ]
    },
    "wlds_InterestReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "InterestReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest received",
        "documentation": "Represent the amount of interest received.",
        "label": "Interest Received"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVENTORIES",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": "us-gaap_FIFOInventoryAmount",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r684"
     ]
    },
    "us-gaap_InventoryNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r121",
      "r130",
      "r247",
      "r248",
      "r250",
      "r489",
      "r688"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": "us-gaap_FIFOInventoryAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r686"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": "us-gaap_FIFOInventoryAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work-in-progress",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r685"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for inventory write-off",
        "label": "Inventory Write-down",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "wlds_InventoryWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "InventoryWriteoff",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable": {
       "parentTag": "us-gaap_FIFOInventoryAmount",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for inventory write-off",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Writeoff"
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r797",
      "r798"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "wlds_InvestorAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "InvestorAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor amount (in Dollars)",
        "documentation": "The amount of Investor.",
        "label": "Investor Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestorMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor [Member]",
        "label": "Investor [Member]",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r988",
      "r989"
     ]
    },
    "wlds_InvestorsExercisedWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "InvestorsExercisedWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investors exercised warrants",
        "documentation": "Shares of investors exercised warrants.",
        "label": "Investors Exercised Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of non-convertible debt securities issued",
        "documentation": "Issuance of non-convertible debt securities to become large accelerated status, value.",
        "label": "Issuance Of Nonconvertible Debt Securities To Become Large Accelerated Status Value"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares as a result of exercise of warrants",
        "documentation": "Value of stock issued during the period upon the conversion of warrants.",
        "label": "Issuance Of Ordinary Shares As AResult Of Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfOrdinarySharesForTheReverseSplitProcess": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfOrdinarySharesForTheReverseSplitProcess",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares for the reverse split process (in Shares)",
        "documentation": "Round up in the number of shares during the period as a result of a reverse stock split.",
        "label": "Issuance Of Ordinary Shares For The Reverse Split Process"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares associated with the SEPA (Note 1.d) (in Shares)",
        "verboseLabel": "Ordinary shares issued (in Shares)",
        "netLabel": "Issuance of shares associated with the SEPA",
        "documentation": "Issuance of shares associated with standby equity purchase agreement.",
        "label": "Issuance Of Shares Associated With Standby Equity Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfSharesOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfSharesOptions",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "documentation": "Issuance of share options provides financial incentives for investors; or performance incentives for shareholders who are active in the operations of the company's business.",
        "label": "Issuance Of Shares Options"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEPA for net proceeds",
        "documentation": "Value of shares issued to investors associated with the SEPA.",
        "label": "Issuance Of Shares Value Associated With Standby Equity Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of $1.6 million",
        "documentation": "Amount of issuance of units of ordinary shares and warrants in connection with the initial public offering.",
        "label": "Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses of $1.6 million (in Shares)",
        "documentation": "Issuance of units of ordinary shares and warrants in connection with the initial public offering shares.",
        "label": "Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering",
        "documentation": "Represent the value of issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering.",
        "label": "Issuance Of Units Of Ordinary Shares Pre Funded Warrants And Warrants Under Registered Direct Offering"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of units of ordinary shares pre funded warrants and warrants under registered direct offering (in Shares)",
        "documentation": "Issuance of units of ordinary shares pre-funded warrants and warrants under registered direct offering, shares.",
        "label": "Issuance Of Units Of Ordinary Shares Pre Funded Warrants And Warrants Under Registered Direct Offering Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_IssuedAndSoldOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "IssuedAndSoldOrdinaryShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued and sold ordinary shares",
        "documentation": "Number of pre-funded warrants to purchase ordinary shares.",
        "label": "Issued And Sold Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LIFOMethodRelatedItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LIFOMethodRelatedItemsAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost:",
        "label": "LIFO Method Related Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseAgreementsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Agreements [Member]",
        "label": "Lease Agreements [Member]",
        "documentation": "Contractual agreement that stipulates the lessee pay the lessor for use of an asset."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929"
     ]
    },
    "wlds_LeaseAgreementsPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "LeaseAgreementsPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease agreements period",
        "documentation": "Lease agreements period.",
        "label": "Lease Agreements Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly lease payment",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r725"
     ]
    },
    "wlds_LeaseLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "LeaseLiabilityMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Liability [Member]",
        "label": "Lease Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_LeaseMonthlyRentalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "LeaseMonthlyRentalPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease monthly payment",
        "documentation": "Represents the amount of lease monthly rental payment.",
        "label": "Lease Monthly Rental Payments"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_LeasePaymentIncreased": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "LeasePaymentIncreased",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease payment increased",
        "documentation": "Lease payment increased.",
        "label": "Lease Payment Increased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "us-gaap_LesseeFinanceLeaseRenewalTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeFinanceLeaseRenewalTerm1",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term",
        "label": "Lessee, Finance Lease, Renewal Term",
        "documentation": "Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases extend term",
        "label": "Lessee, Operating Lease, Option to Extend",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases remaining terms",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r985"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r44",
      "r45",
      "r46",
      "r49",
      "r50",
      "r51",
      "r52",
      "r151",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r406",
      "r407",
      "r408",
      "r425",
      "r596",
      "r691",
      "r748",
      "r937",
      "r992",
      "r993"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r92",
      "r534",
      "r726",
      "r903",
      "r921",
      "r979"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL CURRENT LIABILITIES",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r120",
      "r151",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r406",
      "r407",
      "r408",
      "r425",
      "r726",
      "r937",
      "r992",
      "r993"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility bore interest",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "documentation": "The effective interest rate at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r48"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r902",
      "r936"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r48"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_LowestResetPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "LowestResetPrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lowest reset price (in Dollars per share)",
        "documentation": "Lowest reset price.",
        "label": "Lowest Reset Price"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_MachinesAndMoldsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "MachinesAndMoldsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machines and Molds [Member]",
        "label": "Machines And Molds Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_MarketingExpensesPaidInOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "MarketingExpensesPaidInOrdinaryShares",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketing expenses paid in ordinary shares",
        "documentation": "Marketing expenses paid in ordinary shares.",
        "label": "Marketing Expenses Paid In Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_MarketingGrantReceived": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "MarketingGrantReceived",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketing grant received",
        "documentation": "Marketing grant received percentage.",
        "label": "Marketing Grant Received"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum [Member]",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r274",
      "r333",
      "r371",
      "r420",
      "r487",
      "r547",
      "r549",
      "r557",
      "r588",
      "r589",
      "r651",
      "r653",
      "r655",
      "r656",
      "r658",
      "r677",
      "r678",
      "r698",
      "r705",
      "r709",
      "r717",
      "r718",
      "r722",
      "r723",
      "r736",
      "r939",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999"
     ]
    },
    "wlds_MaximumObligatinAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "MaximumObligatinAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum obligatin amount",
        "documentation": "Maximum obligatin amount.",
        "label": "Maximum Obligatin Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum [Member]",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r274",
      "r333",
      "r371",
      "r420",
      "r487",
      "r547",
      "r549",
      "r557",
      "r588",
      "r589",
      "r651",
      "r653",
      "r655",
      "r656",
      "r658",
      "r677",
      "r678",
      "r698",
      "r705",
      "r709",
      "r717",
      "r718",
      "r722",
      "r736",
      "r939",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "wlds_MoldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "MoldMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machines and molds [Member]",
        "label": "Mold Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_MonthlyInstallmentPayment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "MonthlyInstallmentPayment",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly installment payment",
        "documentation": "Percentage of monthly installment payment.",
        "label": "Monthly Installment Payment"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow",
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement",
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET LOSS AND TOTAL COMPREHENSIVE LOSS",
        "verboseLabel": "Net loss",
        "netLabel": "Loss for the period (in Dollars)",
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r73",
      "r94",
      "r118",
      "r132",
      "r134",
      "r139",
      "r151",
      "r157",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r166",
      "r167",
      "r173",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r400",
      "r404",
      "r419",
      "r425",
      "r540",
      "r620",
      "r641",
      "r642",
      "r746",
      "r937"
     ]
    },
    "wlds_NetProceedsFromIssuanceSecondaryPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NetProceedsFromIssuanceSecondaryPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from secondary",
        "documentation": "The cash inflow associated with the amount received from entity's secondary offering of stock to the public.",
        "label": "Net Proceeds From Issuance Secondary Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Adopted in 2024",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r797",
      "r798"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r806",
      "r832",
      "r841"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "wlds_NovemberTwoSevenTwoZeroTwoFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NovemberTwoSevenTwoZeroTwoFourMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "November 27, 2024 Member]",
        "label": "November Two Seven Two Zero Two Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NovemberTwoSevenTwoZeroTwoFourOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NovemberTwoSevenTwoZeroTwoFourOneMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "November 27, 2024 Member]",
        "label": "November Two Seven Two Zero Two Four One Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NumberOfAmountIssuableAsCommitmentFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NumberOfAmountIssuableAsCommitmentFee",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of amount issuable as commitment fee (in Dollars)",
        "documentation": "Number of amount issuable as commitment fee.",
        "label": "Number Of Amount Issuable As Commitment Fee"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NumberOfDaysForTermination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NumberOfDaysForTermination",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of days for termination",
        "documentation": "Number of days from termination to expiration of the options.",
        "label": "Number Of Days For Termination"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NumberOfInvestors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NumberOfInvestors",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of investors",
        "documentation": "Represents the number of investors.",
        "label": "Number Of Investors"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NumberOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NumberOfOrdinaryShares",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of ordinary shares",
        "documentation": "Number of ordinary shares.",
        "label": "Number Of Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NumberOfSharesIssuedAndOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NumberOfSharesIssuedAndOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, Issued and outstanding",
        "documentation": "Number of shares Issued and outstanding.",
        "label": "Number Of Shares Issued And Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NumberOfVehicles": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NumberOfVehicles",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of vehicles (in Vehicles)",
        "documentation": "Represent the number of vehicles.",
        "label": "Number Of Vehicles"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_NumberOfWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "NumberOfWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants",
        "documentation": "Number of warrants.",
        "label": "Number Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and Leasehold Improvements [Member]",
        "label": "Office Furniture And Equipment And Leasehold Improvements Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and Leasehold Improvements [Member]",
        "label": "Office Furniture Machines Leasehold Improvements And Electronic Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OfficerEmployeeMonthlySalary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "OfficerEmployeeMonthlySalary",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Officer employee monthly salary (in New Shekels)",
        "documentation": "The amount of officer employee monthly salary.",
        "label": "Officer Employee Monthly Salary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "OPERATING LOSS",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r692",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total operating leases",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Future Minimum Lease Payments Under Operating Lease Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable",
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease liabilities",
        "terseLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable",
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Short term",
        "negatedLabel": "Less operating lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable",
      "http://www.wearabledevices.co.il/role/ScheduleofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Long term",
        "netLabel": "Operating lease liabilities, non-current",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofClassificationofOperatingLeaseRightofUseAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets (Note 5)",
        "verboseLabel": "Right of use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities",
        "label": "Lessee, Operating Lease, Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r102",
      "r103"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carryforward tax losses",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "wlds_OptionsAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "OptionsAvailableForGrant",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options available for grant",
        "documentation": "Total available options for grant,",
        "label": "Options Available For Grant"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OptionsExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "OptionsExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option expenses (in Dollars)",
        "documentation": "The total expenses in thousand will be expensed over the option vesting periods.",
        "label": "Options Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharesAndPrefundedWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "OrdinarySharesAndPrefundedWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total number of ordinary shares and pre-funded warrants",
        "documentation": "Total number of Ordinary Shares and pre-funded warrants.",
        "label": "Ordinary Shares And Prefunded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_OrdinarySharesNoParValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, no par value per share",
        "label": "Ordinary Shares No Par Value Per Share Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GENERAL",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r87",
      "r558",
      "r559"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial credit",
        "label": "Other Borrowings",
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90"
     ]
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Domain]",
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r788",
      "r804",
      "r839"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r780",
      "r791",
      "r807",
      "r842"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r780",
      "r791",
      "r807",
      "r842"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option [Member]",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PartnerTypeOfPartnersCapitalAccountAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partner Type [Axis]",
        "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r574"
     ]
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partner Type of Partners' Capital Account, Name [Domain]",
        "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r574"
     ]
    },
    "wlds_PayIncreasedRoyaltiesDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PayIncreasedRoyaltiesDescription",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay increased royalties, description",
        "documentation": "Pay increased royalties, description.",
        "label": "Pay Increased Royalties Description"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent payment",
        "label": "Payments for Rent",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "wlds_PaymentsForStructuringFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PaymentsForStructuringFee",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Structuring fee paid (in Dollars)",
        "documentation": "Cash outflow for the structuring fee.",
        "label": "Payments For Structuring Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Units of ordinary shares and warrants issued, issuance expenses",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "wlds_PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of aggregate amount available to be sold",
        "documentation": "Percentage of aggregate amount of shares available to be sold, to be transferred under agreement.",
        "label": "Percentage Of Aggregate Amount Of Shares Available To Be Sold To Be Transferred Under Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PercentageOfFinancing": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PercentageOfFinancing",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing rate",
        "documentation": "The percentage of financing.",
        "label": "Percentage Of Financing"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "wlds_PreFundWarrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PreFundWarrant",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre fund warrant",
        "documentation": "Number of pre-funded warrants to purchase ordinary shares.",
        "label": "Pre Fund Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Funded Warrants [Member]",
        "label": "Pre Funded Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PreFundedWarrantsToPurchase": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PreFundedWarrantsToPurchase",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded warrants",
        "documentation": "Represents the share of pre-funded warrants.",
        "label": "Pre Funded Warrants To Purchase"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PrePaidAdvances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PrePaidAdvances",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-paid advances of commitment amount (in Dollars)",
        "documentation": "Represent the amount of prepaid advances.",
        "label": "Pre Paid Advances"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PremoneyValuationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PremoneyValuationAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-money valuation amount (in Dollars)",
        "documentation": "The amount of pre money valuation amount.",
        "label": "Premoney Valuation Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables and prepaid expenses",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "wlds_PrepaymentsOfLeasing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PrepaymentsOfLeasing",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepayments of leasing",
        "documentation": "The amount of prepayments of leasing.",
        "label": "Prepayments Of Leasing"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PrincipalAmountInstallmentPayment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PrincipalAmountInstallmentPayment",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount of installment payment",
        "documentation": "The percentage of principal amount installment payment.",
        "label": "Principal Amount Installment Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement [Member]",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ProceedAfterInitialPublicOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ProceedAfterInitialPublicOfferingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceed after initial public offering expenses (in Dollars)",
        "documentation": "Proceed after initial public offering expenses.",
        "label": "Proceed After Initial Public Offering Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of convertible promissory note",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from issuance of ordinary shares",
        "verboseLabel": "Gross proceeds (in Dollars)",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of ordinary shares associated with the SEPA",
        "verboseLabel": "Gross proceeds from issuance of common stock (in Dollars)",
        "netLabel": "Proceeds from ordinary shares (in Dollars)",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "wlds_ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of ordinary shares as a result of exercise of warrants",
        "documentation": "Amount of proceeds from issuance of ordinary shares as a result of exercise of warrants.",
        "label": "Proceeds From Issuance Of Ordinary Shares As AResult Of Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceed amount (in Dollars)",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "wlds_ProceedsFromIssuanceOfSAFEs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ProceedsFromIssuanceOfSAFEs",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of SAFEs",
        "documentation": "The cash inflow from the SAFE investor.",
        "label": "Proceeds From Issuance Of SAFEs"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of shares issued in the public offering, net of issuance cost",
        "documentation": "Represent the amount of proceeds from issuance of shares issued in the public offering, net of issuance cost",
        "label": "Proceeds From Issuance Of Shares Issued In The Public Offering Net Of Issuance Cost"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses",
        "documentation": "Represent the amount of proceeds from issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance expenses.",
        "label": "Proceeds From Issuance Of Units Of Ordinary Shares And Warrants In Connection With The Initial Public Offering Net Of Issuance Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ProceedsFromIssuanceRegisteredDirectOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ProceedsFromIssuanceRegisteredDirectOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from registered direct offering",
        "documentation": "The cash inflow associated with the amount received from entity's registered direct offering of stock to the public.",
        "label": "Proceeds From Issuance Registered Direct Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from credit line",
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r902"
     ]
    },
    "wlds_ProductionTransferred": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ProductionTransferred",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Production transferred",
        "documentation": "Production transferred.",
        "label": "Production Transferred"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r444"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/PropertyandEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PROPERTY AND EQUIPMENT, net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r110",
      "r113",
      "r114"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r123",
      "r538"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total property and equipment, net",
        "terseLabel": "Property and equipment, net (Note 4)",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r444",
      "r526",
      "r538",
      "r726"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r110",
      "r113",
      "r536"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/PropertyandEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r444"
     ]
    },
    "wlds_ProspectiveInitialPublicOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ProspectiveInitialPublicOfferingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Initial public offering expenses",
        "documentation": "Amount of initial public offering (IPO) refers to the process of offering shares of a private corporation to the public in a new stock issuance for the first time.",
        "label": "Prospective Initial Public Offering Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PurchaseOfWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PurchaseOfWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of warrants",
        "documentation": "The number of warrants to purchase ordinary shares.",
        "label": "Purchase Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PurchasePriceDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PurchasePriceDiscount",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discounted of purchase price",
        "documentation": "Percentage of convertible promissory note purchase price discount.",
        "label": "Purchase Price Discount"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price of shares, percentage on lowest VWAP",
        "documentation": "Purchase price of shares, percentage on lowest volume weighted average price.",
        "label": "Purchase Price Of Shares Percentage On Lowest Volume Weighted Average Price"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_PurchasePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "PurchasePricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price per share",
        "documentation": "Purchase price per share.",
        "label": "Purchase Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r274",
      "r331",
      "r333",
      "r363",
      "r364",
      "r365",
      "r371",
      "r420",
      "r462",
      "r471",
      "r487",
      "r547",
      "r549",
      "r557",
      "r588",
      "r589",
      "r651",
      "r653",
      "r655",
      "r656",
      "r658",
      "r677",
      "r678",
      "r698",
      "r705",
      "r709",
      "r717",
      "r718",
      "r722",
      "r723",
      "r736",
      "r740",
      "r934",
      "r939",
      "r975",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails",
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r274",
      "r331",
      "r333",
      "r363",
      "r364",
      "r365",
      "r371",
      "r420",
      "r462",
      "r471",
      "r487",
      "r547",
      "r549",
      "r557",
      "r588",
      "r589",
      "r651",
      "r653",
      "r655",
      "r656",
      "r658",
      "r677",
      "r678",
      "r698",
      "r705",
      "r709",
      "r717",
      "r718",
      "r722",
      "r723",
      "r736",
      "r740",
      "r934",
      "r939",
      "r975",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999"
     ]
    },
    "wlds_RateOfMonthlySeverancePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "RateOfMonthlySeverancePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate of monthly severance, percentage",
        "documentation": "The percentage of severance  monthly deposits rate can take their monthly salary.",
        "label": "Rate Of Monthly Severance Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r772",
      "r783",
      "r799",
      "r834"
     ]
    },
    "wlds_RefundToSAFEInvestors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "RefundToSAFEInvestors",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Refund to SAFE investors",
        "documentation": "Amount of refund to SAFE investors.",
        "label": "Refund To SAFEInvestors"
       }
      }
     },
     "auth_ref": []
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "wlds_RelatedPartiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "RelatedPartiesDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r332",
      "r450",
      "r451",
      "r528",
      "r535",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r616",
      "r618",
      "r650"
     ]
    },
    "wlds_RelatedPartyMonthlySalary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "RelatedPartyMonthlySalary",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly salary",
        "documentation": "The amount of related party monthly salary.",
        "label": "Related Party Monthly Salary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r624",
      "r625",
      "r628"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r332",
      "r450",
      "r451",
      "r528",
      "r535",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r616",
      "r618",
      "r650",
      "r991"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RELATED PARTIES",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r448",
      "r449",
      "r451",
      "r452",
      "r568",
      "r569",
      "r570",
      "r626",
      "r627",
      "r628",
      "r647",
      "r649"
     ]
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfConvertibleDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of convertible promissory note",
        "label": "Repayments of Convertible Debt",
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of credit line",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r902"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expenses [Member]",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "wlds_ResearchAndDevelopmentGrantsDetection": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ResearchAndDevelopmentGrantsDetection",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development grants",
        "documentation": "The amount of grants detection from the value of research and development expenses.",
        "label": "Research And Development Grants Detection"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ResearchAndDevelopmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ResearchAndDevelopmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development, net (Note 7. a)",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Net"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r784",
      "r800",
      "r835"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r774",
      "r785",
      "r801",
      "r836"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r781",
      "r792",
      "r808",
      "r843"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs) [Member]",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r82",
      "r533",
      "r554",
      "r556",
      "r566",
      "r599",
      "r726"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r154",
      "r155",
      "r156",
      "r158",
      "r163",
      "r165",
      "r167",
      "r237",
      "r238",
      "r260",
      "r388",
      "r389",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r404",
      "r409",
      "r411",
      "r412",
      "r414",
      "r417",
      "r435",
      "r437",
      "r551",
      "r553",
      "r571",
      "r1032"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r680",
      "r689"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r140",
      "r151",
      "r179",
      "r184",
      "r185",
      "r194",
      "r196",
      "r198",
      "r199",
      "r201",
      "r236",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r425",
      "r525",
      "r695",
      "r937"
     ]
    },
    "us-gaap_RevenuesNetOfInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesNetOfInterestExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues, Net of Interest Expense",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r179",
      "r184",
      "r185",
      "r194",
      "r196",
      "r198",
      "r199",
      "r201"
     ]
    },
    "wlds_ReverseSplitParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ReverseSplitParValue",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse split par value",
        "documentation": "The new par value after the reverse split.",
        "label": "Reverse Split Par Value"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ReverseStockSplitNumberOfSharesConverted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ReverseStockSplitNumberOfSharesConverted",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse stock split, shares issued and outstanding (in Dollars per share)",
        "documentation": "Describe the number of shares that will become one share after the reverse split.",
        "label": "Reverse Stock Split Number Of Shares Converted"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares combined in reverse split (in Dollars per share)",
        "documentation": "Reverse stock split, number of shares issued for each share or lot converted.",
        "label": "Reverse Stock Split Number Of Shares Issued For Each Share Or Lot Converted"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_RightofUseAssetRecognizedAgainstLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "RightofUseAssetRecognizedAgainstLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use asset recognized against lease liability",
        "documentation": "The amount is right-of use asset recognized against lease liability.",
        "label": "Rightof Use Asset Recognized Against Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_RoyaltiesRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "RoyaltiesRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties rate",
        "documentation": "Percentage of royalties rate.",
        "label": "Royalties Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_RoyaltiesRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "RoyaltiesRatePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties rate percentage",
        "documentation": "Royalties rate percentage.",
        "label": "Royalties Rate Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "wlds_SAFEsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "SAFEsAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SAFEs amount (in Dollars)",
        "documentation": "The amount of SAFEs.",
        "label": "SAFEs Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate gross proceeds (in Dollars)",
        "label": "Sale of Stock, Consideration Received Per Transaction",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SaleOfStockNumberOfShareIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "SaleOfStockNumberOfShareIssuedInTransaction",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into one shares.",
        "label": "Sale Of Stock Number Of Share Issued In Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (in Dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r334",
      "r907"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r334",
      "r883",
      "r907"
     ]
    },
    "wlds_ScheduleOfAnnualRatesOfDepreciationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfAnnualRatesOfDepreciationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Annual Rates Of Depreciation Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfAnnualRatesOfDepreciationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfAnnualRatesOfDepreciationLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Annual Rates of Depreciation [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfAnnualRatesOfDepreciationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfAnnualRatesOfDepreciationTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Annual Rates of Depreciation",
        "documentation": "Tabular disclosure of annual rates of depreciation.",
        "label": "Schedule Of Annual Rates Of Depreciation Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCapitalizationEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCapitalizationEquityLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Capital [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfClassificationOfOperatingLeaseRightofUseAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Classification of Operating Lease Right-of-Use Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Number of Ordinary Shares and Pre-funded Warrants",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Expenses",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r396",
      "r884",
      "r885",
      "r886",
      "r968",
      "r969",
      "r970",
      "r971"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventories",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r60",
      "r61",
      "r62"
     ]
    },
    "wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Issuance of Equity Warrants to Investors and Associate",
        "documentation": "Tabular disclosure of the change in Issuance of equity warrants to investors and associat.",
        "label": "Schedule Of Issuance Of Equity Warrants To Investors And Associat Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociateAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Issuance Of Equity Warrants To Investors And Associate Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfOptionsActivityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfOptionsActivityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Options Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfOptionsToConsultantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfOptionsToConsultantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Options To Consultants Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfOptionsToConsultantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfOptionsToConsultantsTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Options to Consultants",
        "documentation": "Tabular disclosure of stock options issued to consultants.",
        "label": "Schedule Of Options To Consultants Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ScheduleOfPropertyAndEquipmentNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfPropertyAndEquipmentNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property And Equipment Net Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofPropertyandEquipmentNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r444"
     ]
    },
    "wlds_ScheduleOfShareBasedCompensationExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfShareBasedCompensationExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Based Compensation Expenses Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Options Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r85"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of weighted-Average Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "wlds_ScheduleOfShareCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ScheduleOfShareCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Capital Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Capital",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r585",
      "r586",
      "r587",
      "r652",
      "r654",
      "r657",
      "r659",
      "r666",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r681",
      "r706",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r737",
      "r740",
      "r941",
      "r1000",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r197",
      "r199",
      "r693",
      "r694",
      "r697"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sales and marketing expenses, net",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and Marketing Expenses [Member]",
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "wlds_September132022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "September132022Member",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "September 13, 2022 [Member]",
        "label": "September132022 Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_September152022OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "September152022OneMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "September 15, 2022 [Member]",
        "label": "September152022 One Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_September152022TwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "September152022TwoMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "September 15, 2022 [Member]",
        "label": "September152022 Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series of Individually Immaterial Business Acquisitions [Member]",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "wlds_ServicesInExchangeForMonthlyBaseFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ServicesInExchangeForMonthlyBaseFee",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Services in exchange for monthly base fee",
        "documentation": "The amount of services in exchange for monthly base fee.",
        "label": "Services In Exchange For Monthly Base Fee"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SeverancePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "SeverancePolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance",
        "documentation": "Disclosure of accounting policy for severance.",
        "label": "Severance Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow",
      "http://www.wearabledevices.co.il/role/ScheduleofShareBasedCompensationExpensesTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Share based compensation expenses",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life of options",
        "documentation": "Expected life of options in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Expected Life Of Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Assumptions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected stock price volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value option grant date (in Dollars per share)",
        "documentation": "The fair value option granted date during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Option Grant Date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable",
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Schedule of Equity Warrants to Investors and Associated with the IPO [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options to ordinary shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares under ESPP",
        "documentation": "The maximum amount of ordinary shares that can be issued according to the company's 2024 employee stock purchase plan (\"ESPP\") approved by the board of directors and subject to the approval of the shareholders' meeting.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Ordinary Shares Issued Under ESPP"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares under incentive plan",
        "documentation": "Share based compensation arrangement by share based payment award number of ordinary shares issued under incentive plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Ordinary Shares Issued Under Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants to purchase Ordinary Shares",
        "verboseLabel": "Options available for grant",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end, Amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding - beginning, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expired or forfeited, Amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted weighted average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding - beginning, Amount of options",
        "periodEndLabel": "Outstanding - end, Amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding - end, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In connection with",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms",
        "documentation": "Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No. of options issued",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise ratio",
        "documentation": "Description of exercise ratio.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Exercise Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration date",
        "documentation": "Description of Expiration date\r    \r   \n.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Expiration Date"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareBasedCompensationArrangementNotes": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareBasedCompensationArrangementNotes",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes",
        "documentation": "Description of Notes.",
        "label": "Share Based Compensation Arrangement Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expired or forfeited, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Weighted average exercise price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r341",
      "r360",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price for each warrant",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No. of options exercisable",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "srt_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program [Axis]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "srt_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program [Domain]"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expire from the date of issuance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "wlds_ShareholdersEquityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareholdersEquityDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareholdersEquityScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofIssuanceofEquityWarrantstoInvestorsandAssociateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Issuance of Equity Warrants to Investors and Associate (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityScheduleofOptionsActivityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareholdersEquityScheduleofOptionsActivityDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Options Activity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareholdersEquityScheduleofOptionstoConsultantsDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Options to Consultants (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityScheduleofShareCapitalDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareholdersEquityScheduleofShareCapitalDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Share Capital (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ShareholdersEquityScheduleofShareCapitalParentheticalsDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Share Capital (Parentheticals) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary share price (in Dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in Shares)",
        "periodEndLabel": "Balance (in Shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "SignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "SignificantAccountingPoliciesScheduleofAnnualRatesofDepreciationDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofAnnualRatesofDepreciationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies - Schedule of Annual Rates of Depreciation (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r148"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stand by Equity Purchase Agreement and Convertible Promissory Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stand by Equity Purchase Agreement and Convertible Promissory Note [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNote"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stand by equity purchase agreement and convertible promissory note",
        "documentation": "Stand by equity purchase agreement and convertible promissory note.",
        "label": "Stand By Equity Purchase Agreement And Convertible Promissory Note Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StandbyEquityPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StandbyEquityPurchaseAgreementMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standby Equity Purchase Agreement [Member]",
        "label": "Standby Equity Purchase Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stand by Equity Purchase Agreement and Convertible Promissory Note (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable",
      "http://www.wearabledevices.co.il/role/ScheduleofShareCapitalTable_Parentheticals",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r126",
      "r127",
      "r128",
      "r151",
      "r171",
      "r172",
      "r174",
      "r176",
      "r181",
      "r182",
      "r236",
      "r277",
      "r279",
      "r280",
      "r281",
      "r284",
      "r285",
      "r314",
      "r315",
      "r318",
      "r321",
      "r328",
      "r425",
      "r562",
      "r563",
      "r564",
      "r565",
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r584",
      "r598",
      "r621",
      "r643",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r882",
      "r901",
      "r909"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3",
      "http://www.wearabledevices.co.il/role/StandbyEquityPurchaseAgreementandConvertiblePromissoryNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r54",
      "r57",
      "r58",
      "r117",
      "r137",
      "r138",
      "r139",
      "r154",
      "r155",
      "r156",
      "r158",
      "r163",
      "r165",
      "r167",
      "r180",
      "r237",
      "r238",
      "r260",
      "r330",
      "r388",
      "r389",
      "r397",
      "r398",
      "r399",
      "r401",
      "r403",
      "r404",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r417",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r435",
      "r437",
      "r446",
      "r541",
      "r551",
      "r552",
      "r553",
      "r571",
      "r643"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r199",
      "r200",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r585",
      "r586",
      "r587",
      "r652",
      "r654",
      "r657",
      "r659",
      "r666",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r681",
      "r706",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r737",
      "r740",
      "r941",
      "r1000",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r180",
      "r437",
      "r490",
      "r560",
      "r584",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r598",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r607",
      "r608",
      "r609",
      "r610",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r618",
      "r622",
      "r623",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r643",
      "r741"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r334",
      "r883",
      "r887",
      "r907"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r180",
      "r202",
      "r437",
      "r490",
      "r560",
      "r584",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r598",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r607",
      "r608",
      "r609",
      "r610",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r618",
      "r622",
      "r623",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r643",
      "r741"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r787",
      "r803",
      "r838"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodShareOfExerciseOfOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StockIssuedDuringPeriodShareOfExerciseOfOptions",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options (in Shares)",
        "documentation": "Represent the shares of exercise of options.",
        "label": "Stock Issued During Period Share Of Exercise Of Options"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodSharesExerciseOfWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrants",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants (in Shares)",
        "verboseLabel": "Exercised ordinary shares",
        "documentation": "Shares issued from the exercise of warrants",
        "label": "Stock Issued During Period Shares Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodSharesInvestors": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StockIssuedDuringPeriodSharesInvestors",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares to April 2021 investors (Note 10) (in Shares)",
        "documentation": "Shares issued to investors",
        "label": "Stock Issued During Period Shares Investors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares to service provider (in Shares)",
        "verboseLabel": "Issuance of ordinary shares to service provider",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in the public offering, net of issuance cost (in Shares)",
        "verboseLabel": "Issued and sold ordinary shares",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r53",
      "r54",
      "r82",
      "r562",
      "r643",
      "r661"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised, Amount of options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r53",
      "r54",
      "r82",
      "r347"
     ]
    },
    "wlds_StockIssuedDuringPeriodSharesStockWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StockIssuedDuringPeriodSharesStockWarrantsExercised",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares as a result of exercise of warrants (in Shares)",
        "documentation": "Stock issued during period shares stock warrants exercised.",
        "label": "Stock Issued During Period Shares Stock Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodValueAssociatedWithTheSEPA": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StockIssuedDuringPeriodValueAssociatedWithTheSEPA",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares associated with the SEPA (Note 1.d)",
        "documentation": "Represent the value of issuance of shares associated with the SEPA.",
        "label": "Stock Issued During Period Value Associated With The SEPA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodValueExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants",
        "documentation": "Represent the value of stock issued during the period from the exercise of warrants.",
        "label": "Stock Issued During Period Value Exercise Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_StockIssuedDuringPeriodValueInvestors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StockIssuedDuringPeriodValueInvestors",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares to April 2021 investors (Note 10)",
        "documentation": "Represent the value of stock issued during the period to investors.",
        "label": "Stock Issued During Period Value Investors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares to service provider",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in the public offering, net of issuance cost",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r53",
      "r54",
      "r82",
      "r571",
      "r643",
      "r661",
      "r747"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of SAFEs (as defined in Note 10) into ordinary shares upon completion of initial public offering (Note 10)",
        "label": "Stock Issued During Period, Value, Other",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r54",
      "r57",
      "r58",
      "r82"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet",
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "terseLabel": "Stockholders\u2019 equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r57",
      "r58",
      "r75",
      "r600",
      "r617",
      "r644",
      "r645",
      "r726",
      "r748",
      "r903",
      "r921",
      "r979",
      "r1032"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY (Note 10):",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r150",
      "r313",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r330",
      "r416",
      "r646",
      "r648",
      "r665"
     ]
    },
    "wlds_StockholdersEquityRequirementByStockExchanges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "StockholdersEquityRequirementByStockExchanges",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders equity requirement by stock exchanges",
        "documentation": "Stockholders equity requirement by stock exchanges.",
        "label": "Stockholders Equity Requirement By Stock Exchanges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse stock split, description",
        "verboseLabel": "Reverse share split",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r454"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Member]",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r454"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r454"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r454"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_SubsequentEventsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "SubsequentEventsDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUBSEQUENT EVENTS",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r455"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails",
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure:",
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "wlds_TaxesonIncomeDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TaxesonIncomeDetailsTable",
     "presentation": [
      "http://www.wearabledevices.co.il/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount (in Dollars)",
        "label": "Temporary Equity, Aggregate Amount of Redemption Requirement",
        "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TerminationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TerminationPeriod",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination period",
        "documentation": "Termination period.",
        "label": "Termination Period"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r916",
      "r990"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TotalCashReceivedFromTheIIA": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TotalCashReceivedFromTheIIA",
     "crdr": "credit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash received from the IIA",
        "documentation": "Total cash received from the IIA.",
        "label": "Total Cash Received From The IIA"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r311",
      "r326",
      "r415",
      "r424",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r542",
      "r714",
      "r715",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r727",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r917",
      "r918",
      "r919",
      "r920",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "wlds_TwoThousandFifteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TwoThousandFifteenMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 [Member]",
        "label": "Two Thousand Fifteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandSeventeenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TwoThousandSeventeenMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 [Member]",
        "label": "Two Thousand Seventeen Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandTwentyFourGlobalEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TwoThousandTwentyFourGlobalEquityIncentivePlanMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Global Equity Incentive Plan [Member]",
        "label": "Two Thousand Twenty Four Global Equity Incentive Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandTwentyFousEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TwoThousandTwentyFousEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Employee Stock Purchase Plan [Member]",
        "label": "Two Thousand Twenty Fous Employee Stock Purchase Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TwoThousandTwentyThreeMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 [Member]",
        "label": "Two Thousand Twenty Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoThousandTwentyoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TwoThousandTwentyoneMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ScheduleofOptionstoConsultantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 [Member]",
        "label": "Two Thousand Twentyone Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_TwoZeroOneFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "TwoZeroOneFiveMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015 Plan [Member]",
        "label": "Two Zero One Five Member"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_UnderwritingDiscountsAndCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "UnderwritingDiscountsAndCommissions",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discounts and commissions (in Dollars)",
        "documentation": "It represent underwriting discounts and commissions.",
        "label": "Underwriting Discounts And Commissions"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_UnderwritingNetProceed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "UnderwritingNetProceed",
     "crdr": "debit",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting net proceed (in Dollars)",
        "documentation": "Amount of net proceeds after deducting.",
        "label": "Underwriting Net Proceed"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r107",
      "r108",
      "r111",
      "r112"
     ]
    },
    "wlds_ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus",
     "presentation": [
      "http://www.wearabledevices.co.il/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of ordinary shares and warrants held by non-affiliates",
        "documentation": "Value of ordinary shares held by non-affiliates to become large accelerated status.",
        "label": "Value Of Ordinary Shares Held By Non Affiliates To Become Large Accelerated Status"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles [Member]",
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "wlds_VestingPeriods": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "VestingPeriods",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting periods",
        "documentation": "Expensed over vesting periods.",
        "label": "Vesting Periods"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "wlds_WarrantBeReducedToAnExercisePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "WarrantBeReducedToAnExercisePricePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant be reduced to an exercise price percentage",
        "documentation": "Warrant be reduced to an exercise price percentage.",
        "label": "Warrant Be Reduced To An Exercise Price Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantExercisePriceDecrease": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantExercisePriceDecrease",
     "presentation": [
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price reduce (in Dollars per share)",
        "label": "Warrant, Exercise Price, Decrease",
        "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant [Member]",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r738",
      "r739",
      "r742",
      "r743",
      "r744",
      "r745"
     ]
    },
    "wlds_WarrantPricePerSharePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "WarrantPricePerSharePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConvertibleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant price per share percentage",
        "documentation": "Percentage of warrant price per share.",
        "label": "Warrant Price Per Share Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails",
      "http://www.wearabledevices.co.il/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant period",
        "verboseLabel": "Warrant expire",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r974",
      "r975",
      "r976"
     ]
    },
    "wlds_WarrantsIssuedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "WarrantsIssuedPercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/CreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued percentage",
        "documentation": "The warrants issued percentage.",
        "label": "Warrants Issued Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_WarrantsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "WarrantsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wearabledevices.co.il/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and pre-funded warrants",
        "documentation": "Disclosure of accounting policy for warrants.",
        "label": "Warrants Policy Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wlds_WarrantsToPurchaseOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "WarrantsToPurchaseOrdinarySharesMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to Purchase Ordinary Shares",
        "label": "Warrants To Purchase Ordinary Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares and pre-funded warrants outstanding diluted (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r176"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ConsolidatedIncomeStatement",
      "http://www.wearabledevices.co.il/role/ScheduleofWeightedAverageNumberofOrdinarySharesandPrefundedWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares and pre-funded warrants outstanding basic (in Shares)",
        "verboseLabel": "Weighted average number of ordinary shares and pre-funded warrants",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r176"
     ]
    },
    "wlds_WeightedAveragePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wearabledevices.co.il/20241231",
     "localname": "WeightedAveragePricePercentage",
     "presentation": [
      "http://www.wearabledevices.co.il/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average price percentage",
        "documentation": "Weighted average price percentage.",
        "label": "Weighted Average Price Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-4"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481440/840-10-50-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Subparagraph": "(Note 3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481418/840-10-55-40"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481501/840-20-50-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481501/840-20-50-2"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-6"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>87
<FILENAME>0001213900-25-025602-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-025602-xbrl.zip
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M<2W]L1380 ]VWBS<<QH/ML/NXO=NU=8UFB(8KB-6TJ6.+!!CL!^;X_(A!^?
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M/9*ZQ[SC0CTOY!(L^JE]&4+V<Y2)_57.T)5&ZI<#[ M$4#Z*;4WPX/!(9,1
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M]W1[Y0(X^ZO6)@&&YYNR"'EPPT$/@(.B&/])EBRRB0P3QXIEBU?A9X&<T&0
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M<(:9V3(H43(%HR]RILY!NB]T@5(^PM)IAL7'%+G^@NJ;F_Y_4KKWB,,^[%.
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M\21B?(^%1N69N9L7>5HCIN>AK(-Y0 ;1?<'IYB@9(7"7J&L%D91?1SRB4BI
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M!9FM&2?#Q2UKPN?[7B8AR]I%1669#Y*H69P3^I&>(%79J!KKX;:*NXBIBL9
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MICE6VQ6(; 4[MAV:_&NC+U*O7Y]87FZ;!@>O+\%$ YXPU(W<E"WV!+I+$@6
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MBB$E ]7=IA&$5^;I 4UP:'H@OZ(]W=27W2]UR1ZZG3;9[(^)-XZY.?JFR=D
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MPIH0?BTDTXWWG8Z3/Y8: 06;7WE3Q+W!%,P2'0/.#P<\2MA^SFH$_>!RB ;
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MN$T96N6HP>?4?K*@'0!5L"J7"3S:L>IX_'VA;WD@R_ @;FU_P]PZ0QA)Y7I
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M',*I(]Z^%>H!7?S"WBT7LM-DJE-5,X3NXV*/*G5M.' ;'1$R)]8PA,,BR)6
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MJ<:%GAFYV0$@_8]RQ7R"2'(%$(ZBN:AI#VQ'T9O@TA'/G[[U*Y;$WG6*1Q#
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MW;R1L'+G?^%>MSAUKWL ]]^'=25_)[#.9V>PSA2L\_0,UOG];0M&^#?!&ES
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MD"2#R'<E U=$GW*$^T2<T%4Q2(FW.;#:$-?C^>)"8!+7L!#F RD&1LH9M;8
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MW&BG\C^X34G58W1RH_,[/?+9HS\%>:2\ZE):V40-@"C._3,U&$9=6Z4:1#A
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M#'(J&#JSY@M<9_S*P?O:Z!,:X3NT;U.-:[IB:4G1P]VWVQO'3I*\?D*^&_@
MR,[I*3 :2*;FPPR,ZBEG-%[B7SJD7Y@Q@WZ//,D5ND>2+=%)JW8$<5-O2OY"
M'>X7<Z+9GX]] #T.C&Q;ECWIJ4F9"X/M*_ M$P:^[';9 7=V5N]<!?GT7 69
M5D&>G*L@OX>-@'I RC@GM6Z?15NW8*UK2OPHO$F'=JD4->/FPOE?5*DY*7Q7
MNO><\L\Z*'!L.AIQ/^<X>&^K95\C04E0FN^_Z0L+22EI)%H.:454A^FVXD;_
M&+<BW[%J+VO.5NT.ZZZ\6,;_&?^XHTO#=!3U%93RTC#Z%F$S=$'CZ=*LMVA
MN]=0OBY7U;)M.0G_3=V\KM8O&L$9._,+7E 6 A5V<QR0\9&YX2N?&R#;IL^
MV\&:AY5LER(#6/]<J:XIS)I:!MNK!J%L0, J@6KZY30=*1\G +DI7&8'0:F\
MV":0T>-B==U21I$9FPO3G,*_Z@P@(2!T71="[;-:@!S7$=NKRJDL]^)+7F_7
M*"*?^):67?]\:BK3S.U;Q$VXSTF9()#Y97U]4GDY^;39;"@BNVU?W:I@:NKO
MHHK1824W!@;^58-O(ERV="%E.<,^ XPG;<HX]^BPY*9T(UXE$RUUJ%3G<".5
M%@O+]"A+F@_,)55)28Y:@K85L?>Y^Z7#FG#HRME2@=< ?=1N#Y*A94X"EB75
M7\O9I.3*J=FC$A3=;*L* 2(Q1$W6T+]&][UK90C:GLZN@TGAA"*\IWQ\/I[1
M6.*EH)8D  )@WCHY9\ DR RSQ\&E,@FD!93'D1S"<DL0,C=S,0RXV-*;RUK1
M*;/?MW4^OR?647M#HV^BZ)KZ@S9'P0(Z!!5M884GSS_I[34GKQ7G]RU6;OS,
MP/L!,QPG',X'?<8TZ%^VA:5:(FX@E3$\]"W5565G!4E6-0I1HS].+T2%PB<Y
M.T6*?\MJN*VJ)F.2X'N0F\2I!\#EE6H?+G=K55DV&%>$'"<:;P2FA]:QO,(A
M+N 0=XQ '^>2O%^>&I=K^H@6W/,)6&[C=EK3;N<7U>/P[6ZLD)YJ=18^H-):
M@#^)D'1BZ]'++LZ;<,(:A2!"[M\%0P[M%0ISVZ!IS#12E=+6!7 +H0=-ZX \
MKDNM![ZQXBJ;'<0N+)Q?:]^G!1LR+4F,KQ=62-XV*:MQ0E@U3!*^A=[[?;>[
M7O$+H1?$'HVS %$*9./1KX!#X'P1GO:% VWIJ4I3MFF)"NPP3=$A.<6I\#SQ
M=-#0I+X[KW&^"8Q8,N(?XX?06R*[P9^M<JY62'Q2TT:YHN/]9XZ5E.JZ.>R6
MW&UEM29E-T^DK$O\=[RY]SA,R5&!]Z1@6#7I12>,4:D 8[CJR;/BT5R)&XW;
M<EONI>S*$1)36!M^)#M1!PW_\AQ]4J\C]7%4VP9J(Y:$K4Q1=,YEY_ '68G,
M5]U$^-HL%'$ZDX-HYP(/Y#I>5.#W_6#<1KC:MDOI:+YIMS<>^N %NN^P=P"=
MY&8\WG$G4KV4VYW?8]PG&C?D!:>+[SL65[KC,KK[95;OT!8>K1@5U)8@R5>O
M[<>D1\$"0[R*U!ZS*?0T;U)C*J2-:)$:HEOPD\=-Q4B0?\35EX->ZEOC2OYH
M8Z"6R.&-EN9.I?/O2H5GMSAE]YXKV)E2TDZ;#I)64!4\TH%W@37M6D@F6W$O
M->SLZ;;'T@WY%F+":><1T+5S^>E\LRU,8]?FC(FBV9!P47)=$?8A_4!O31:N
M.(?)4Y@=3?6&FU1B &_D,'9OS&8XF $Z\VZY-#E;P5"!7QV8OXE)2$5G.X51
M=)D!,&GNEE/DCPF'!O@>:@O1"J&4\XK<0\89I_HIO7)T7%OTH#'4:/Y2N"^/
M67G:V N$TS?&D0RL:YN*KR9=-9E]FT7NU?7ST?$\&:UDM*5V$T=F5R(WL$VY
MJMS&XQ@W6EX_1+=#+L\N;.0\FHHS)J,(E1OYJQWO9-76&56&IXT?AMV!-?)3
M<HQ7O'4TOM$$H4(  BJ?CG.H]LXUB\_.-8MIS>+IN6;Q.]@(\;8"4+-+PR2H
MD,)<')0Z.=R3'G;NY*%^4_=<A$=""&B?"0ES4^AEFLC4#IP*JAOG>14W@D!T
MIZIDQ-'B<)8>J)\ )A+R\N^N\P^A5[7:#YPXCX&32D2EOEIP)!4&%>-D()5B
MQO+,V36#,^$SX/ZY:GF*$3D@I[,UV.U/IK&0ZK2@-=ZQU,_?G5SZWZG0GV<7
M[JJ2QY.^;^]XN<7TY4X^M*OV!Q:E"P9%Y9>N)%#IVJ9>]>E@EMM*?M4A!AVZ
MVYU/0TM<4&N7Q N2&8UF2@G 0XS&-#_:MYN!8F99((7CY&;O-JKEQ',8>W:Q
MB7>6'EI+*8H]IS&\[$B03GM-2V=X=JL3FO9,?X_URU*K[KL+]YVTV+Q[@G(9
MO0+=Q.P'?=U)'"Y2*022+ _#]1UU1*:M\8^5!Q@X7?\;";;<AA1"3*U'G)FL
M4J=4U@8^58V@:PL1@,W8J:'S.5&<IHFF8W8&-@#<(JV:"KF./9EVBEZ!],NK
M=LU?1&4E75<[YCQCP-MMV[W&:J,Z53%2"3"F(J21Z97-ZJRSZR0L'SPX/1?A
MGM\^@L0NQ >D*K%9F2_,+*$<P+MZT"<W)U(IHPX*EW4:7\O Y.JS-;8&(IW<
M!4H_N55;G[)N<E3Z7^-IX=OP(:D_L^:PH3%&;-<KYJ'MDD;Y$,0>,L($M_)C
MX\*\(X7G5\,N[[:M=,B2=I#]-;>]&' ;$AEW/S\3'GC@(B9E[>3(SCYU7:Y%
M%F''5''&[I%VGO&8)UF<E!DX,8LH >?I+NC"6/4WM2AHR,B@"'>53]#4G)C%
M/34H-)OM[!\M&GE&G(:;MSD%T82HUB<W&R,SE2?)2&%6$H+UW6'/6KB>M(I_
MZ:U#H/\XHQ)/QS3?(:T6S\]H=-QP2[0@@FO0@GFTMU392_EQ9<#DEHC^T $B
MGW0@I7DOT:'.=B HJTCR8P%>=8.=U7*^<)32/P<_:1!?\%)1K4(0(GS:8*JY
ML]5UBI0^3/(?.EEL'C7%"@B::JW]=5;JI84*/@_,H1/TQ[@5YH0)4$" [A5V
M*\J%[SZ>SCQIH)*&76WMR4<776[P@$*E#&C%;>TJ;K0<I.G/'C?3],=ZX2D]
M3@<8E9Q<%K)' QY04C$^IWLK+N2;^ MA6UY%_WI=BY&7?):[AW"8.3<K;UF0
M$2RA@[8#Z59OI1'G (@+14!4'@B//Z6^E^%:=4B8X8?SZ=J36M+9 1H T,FA
M=(24+\WS0I1+J>M&8DD]Y_CX,]8[)Y!"91&Y'B.E4:V#E//;VZ9:2^5)CFN9
M!91DIL6)+"23[ =_U6BS)R.@D'':>"IQ0K"QH4:H60&ZC@T3?<'T)+V[T93O
MJF%>#C"1 7Y;=O'D??R,V/D?/RWR05+8BY--)L=-%X4*U($</>J!4 5;UMO4
M98O13Z7R#V+86B&!V(V[9<2G$)?17/.Y'TS C)4SMGCZQ^*\P9C&+YE"X&^J
M\OIX\6I'@<_S733Y50GN))I3*!FVD\\%_+UJ2B#RXL^_JO9#A0+SXX_Q"X^+
MF1F_1J/W#0^Q'!D"]UJR\\B&1)HS.9FR%+,IGY0U<<F)R*SN?)5',UAYG-V^
MRJ&FQZ 8NY$DR"/4!:>+/=4"9?&8[6 R7K ,]RFM5SJRB__!HSK,'-6+MQW5
MA:+%?"J,44^6'+3^'>&7;)MI;M#H/8*%SN<H;D9J85K<CX8;PWY)^)I';CO
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M=-ZA5U'?-)E9Z!X?0D*VO\ Y7"Y^(K0 , A0+U:BDQ3JT\+R'F6PZ+H6E4&
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M@&E4V'Z:*"DIU3_FI!30#FQS-$_T;I>++]2/%$0S5 D?SR1>M+NY*BU.)ET
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MQV3*J+^4C&(-EH2RHA#=9\_V]O[9&Z4!9NQG?%H"3<<U+ (,6G4HH]/+B90
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M PR30=$_M U56 .>)4F<A!K8ELNV4] O85^'CAF>(&K%E"MT^1N0!M_P,<;
M QYZD5X"5R1&OJ!M#_!AOK4C)KE%9-5=56&LB<+8+R92$O"-"XT8 0Q5K3@1
M:V*C[D7Q"R@6" /P(4P2>4)Y>>WE5*U6E'ZQBQ<$@:W$*9YOW*1+X-51QE^,
M!U(L-B2^<4@!"F$>VS4S6>&5.9CET+/0PS[>2N,#8MC2,W=S6+>WC1ML/NL3
M/;34@);H$0Y-7 6*CA$OTE>6U;$5PCF)/2E(=GV?WDRR*61+F2@"=UE&9?0
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M&7XR2CLP"Q% :S#N;^+. \#'OI!732\7WZ1_R;Z4U:G!F)]@ $*VV:Q3CVR
M!,T=_;%";4^P-"=+AA_I*_0($),>";)YA#2SVRA^2+G<[47<:S'B" 7GQ$(V
M!NPY\HGS>>JYZYRA 1TFD5%<T.V1UGK=@IL+"(G^&I0>()B3/T@JNRJ[%?Z1
M*4)[J@X>1&72$YT)?)"W U! -3;#,21.*NG;X"U"LN@[TDC0"V5G0]& S7Z3
M8S'P+HU^<P8"4:0T1PI12?S@_[/WMDUN6U>V\'?\"I1OYBFG"NRT6I8MV1-7
M2;(=:R:R=27%NO-I"B0/240@P !@MYE?_^RU7\X+R&Y)MB6W3%;=.TG4)'@
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M&\O"-#B,WJB/L+/&[]<:?TG\'EFY#^ MI"_8?$"\NUGM>M;+84LPK&$IXVU
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M5\%&>6*.\DU4H@Y4*.GLXF"RT@TR _#H/Y'Q/&QQ_"(GCS8P (<PT837$CG
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M1,UO^&6:S5)N^F?)$:VLM\A$NXO?KHR 43Q1=A'[I2>63>3)^*J1OBY?[HC
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M1<[SZ.(1GQZ/+A['E):WL(#PFS2O5/G@!BO! XD>A)@)G 8_MPS$&<PY#6^
MS>=SC1  \:PL8.@C\KXO\T^K/^>;LF)P:,MCW@R.R!,(OO!1;[O9JA2V:"FO
M/6GZ324P"\?$3!H#A?UL*'(%)<N%8IX@_/W3BM9 )U,T4D&)\U9F3 ,FV.BA
M+2C5(/'3 !-\^/PO/ST'#=,<R.<B2V1O4AW(P=4IX6M=;LB5]'_.M_3N,29*
MZ3"/MY84W;'7.T-/2NKNC/[DB-/'6'A)?FGD\0R&#=>;9OC^*\M6U*]\81M!
M^+@:H!5^N[2O\L>A(_A'9+I5%JUCQ^7^$RTR_^M"U\%TWWJG^.TQ-)LUH7Y\
M$=$R4*#R&J<8'R+FUO?^_!XV[!MWR^^W3=\)VW#_A&W8QS9<G+ -M\?@WQ%*
M')U/_BCO,STZ3J7_H\WW]DX?89-^Y3PE3CI(6=!!<\TY$V40_@^^^($R.NLT
M^_,7A0G.J-*)HFA!3%%-T="5\G],F$+#>LB:F?")>.V:#BPHDU-8HJ.X!!T6
M,H]_6G?-6?YP,3BIX8?QK7R#:*N(QL P?**\&#&[Q/XX:M*F#Y+LE#D/RL#-
MMQ:^)"FR/;\BJ+?C8^,?+20'Q\"(QFFV"M%[&IQ>-=.J?RQ4:$-WP"8PFX9Q
M:FA*O*' <0!Y6VP7I2XXX8;:>P$FZIDN0@.9$/@H+"'P2\<S-95G.VO2=S:*
MP_;BKR6+M\6?2(,L'>')[-7'9G4XE+IUJ?#):7X IRF^XQNQ%BZV_'<U[#E.
M3>:TVN*G>"ZK,N)(&%TD_Y2KM%V]RYH2U=HDB?NS+^JVC5 FA0MY;EPN W$E
M;&3J(0&,Z_<'@4U1)R"3>G_H!CQ\]L2601N/)>W]C<ZCNV'FX*NT:7FHFA0Y
MLG W019I$&11UK01VZ-4RVVN^JJTUD0?$3LRT2)W#)LE.9ZUER#@++!FRLHD
M[4W3NK/\R<!7KDM(.,F9\%_;QF47YW?N:P;*G4EZ3^EK4E^(#NC%^7G^&NZ$
M>R%3#/A1N \F8.[3))+!]%\;>FG\=Z9>I,7%&2OK]YE>29E)+8!+D0+QN'6^
MZ,,6J5+Y ZM6@7(#KGQ?$49E*7HR !X\;-R@)**1PB&.FJF;E0@T<,:3V]D.
M%80K4-XM)RA?,Z>$D%%8#<8$N\9U\.S:Z5Q?![^5H?@'3U8>GY*5T[E[S;D+
M.C_I-CU,P3;^"!RW@[2Z:LU5&70.@)?QK+0-2J<CT@*3,8EM#%$KXD3Q,6&X
M>0R044I$;:N*J)]:]Z$#!M3%Y]*Q*7O3L77*L*_]\<R<C9QU [A,Z.LOW(9N
M:,H'S\5=^:G.H>\,EKR92_F9'BG7R9_N?O; \YYLNTX$O'CCZ=A]*8AF0(VJ
M?D:YR2#7@]K0GRX>/+AU1\]I.WZP[?CWJGDML>]#\)^@'TMV,M8%THT:;5'#
M5]R\5P'%>%1OW="V"LFC(SK ,C*@.KHY;SNU[7W*&@H._!X;HLT'RP;(GM]8
M#WI2?"O90Y\9F>?:"2DY8@+H'JRJC>QM^=7,!W&>FYTIT]^T!?'P> O2)KI^
M"Y9#M /]BL/U_G3G%F[!WX2<^S^KKU^9G)7/H,Q?0SG@]?MKR=Z:<,B'K'S#
MXO9;[!<TKDR!0[81JW '3IXYF<QF)<F?4B %=AX=0KF6,>84:!VM9__.C^D_
MTS%]\? _)@5)@16J>$_%E5+@7(<P\E0W)45.:S>O2H$(=N6\8IEO2 IEK.E@
M'XYHC45ZAWZ6D=/@.#:,L5D[XQE-ZVC6=@:%\07$:]'*"H6ACWDN@LQS$1@)
MCZ*4T%=MFT!Z?"(E..(] 1'*VF.ER(B>JDGYPM^6I0C(D''/I4E0<>$)M01A
MI"Z%]"*0^D>7%57QSKE)^;,+W-Q[W^G:H336P05<_K]0U>L:F0&4G1+]NFP7
MKI"A"$BWM/9%0-Y#E=;>5A*!9&OE@U&D[Z:LUSF4N!K]6860<DT/,BRZ@XU\
M =\#E/36[9/;H>7XX(0MV,<6W#UA"WZUEN-[A4$^UM2K8E([;/%7Y#LX\8+(
M$OF+8P1'/B$?S+D8DZEB;IR]-*CZ!AM*I_!DTW)_>S3L8)T93GJYA\QS'AQR
M-/U61]PT^_$S7IV+TV"=&YEV;3D/XGVIXC&W<'Y\04?#8TLMBS2C8GTJ>HMR
MN9%><DBH9<3[QQ?WI1L* H0B?]C,N[::Y_?/SN-_%@MIYLCJ[_!?,O[+$16X
MPZ2WO?=CVQX_)C/*!E0-XS^9S'E6E[P[K+AIM QB>%S89-"Q03CQ);0(>L>#
MA$HVREI-2O(4(S&AKZT$F$&$"&,XS6#TG!EDWPPZ.]\'_IL@>W2%"++!_*/"
M "%S1+3W)2&*+Q114/D;/=/U'<^6N$91Q$.HG[)0W0<^26[M<S'@GC\IUJ+C
M9S"=S'<U]RD_*F67V?\[DW_P(!T+32(?3T5XH@L\>9F2L8>A.44Y0!C,_S5N
M__?#=EZU?DJ/=2YG&$BA7:=2[^#J9; /=]\77IZ0"[-)9\=^-B_7;;S B/;
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M\-FSOVE)JF>/_8V;^2.)'HW<- >S@;P59Z0_ILI4B4"#4#^YJ +5$I*J7[?
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MBI[K"SU:W\<2/B:+?25%-@D'3$J@M-Y.9L;!H5KB>J/92XLF*&6SZJ!7PA,
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MI.J WR6_2><+/ A@(F.>#\ZKK 4I]6Z492TAXIO> M+3=M<L-!(FSG7.,TN
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M##&-[&[9SKWNH=Z>)K.YNS2UF?XG]./QWY^]^7_=W@"=7>%O#]JUU[!@5@@
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M.7Q^7W7+Z7^_O5)QO_L(E8I?=?QW\7\6\3B6FK&OPSF1NWR*"M@?E C[LR?
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M/)3-F&*55?@B\(SD0T.32%<GB?)3,XG?19Y=E5-C#I#[LQBA[Q[=3W!>2O1
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MC7/@?0CME#NJT]:9^#_A;/X2C$+E6BC\+;!:^]M\3,GK71LI2D"8';3?$W.
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M]?^(BVD9)K,%S5F_]W(;.J(2,)GX*QU!Y_*X^ +-% OZ-S0?=2XZ@9_$DXC
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MC=V=8RO>^4E6X(Q6X+/=4]9/%*HJ":\D_+"]D2@;B?*H$J7UQ#DG3=7 ].1
M(/8OC2Z@750752QM*^Y$G>!69U07UZ2:"AP]:H;"^03&LU\;>!%1M4^Q? _^
MY%J7Z11<F2N.['YM.UD-KH@ERLOKN?B!G<$0=DU\2,[4><TV32!UNZE<Z# L
MF$5:([WY71+FMK#*7 (GN>9J$9>$YVL!"&[DQT9^/+3\8.H(BIDO<I/=[^3E
M5W/^-=D1W+1$:9^.(MM):BG_M=_2'5TL)FP,8)VS EX\$F1RF>$[D=4J+N8,
MTR%(7K4L[N:H;([*(QX5ROLAADR;I<7"H2)+1RUAD.J"%(LA2GMFVG+-6+Y?
M<:L32D_P>*W52QBR8E>!=( ]?!_Q54;P5,6\I:A'*QF1UC VIVMSNA[^=-FV
MHV&"T:4CIW!Z$B$>EQ!4I')3/>+A 9NRI$038D6L>YN6%*%7L6EX;RF$98P;
MLHNT, VO>C6E<VP.RN:@//1!N2*7:EL. WN2&&^'MQ"=IH2<0EZ3/A;XYEJC
M#>[\B%%*I(+1Q478RQM2*+@N%5UP>+6INO%TF]WS>?F10CH?Z^1N*LJ/)3;&
MBY'"\!>C12%\?+EV%1)9]T@1[* 1BS,NU839 V![O=YKV7<K-Y?7X.;2)2@4
M:2>A.B>N]Z'.9:I'J94D%4)$0U_(3 -M1LN/26DI2J+#NU6XT %MV*4]&N#:
M#FICK>.,MX.''F[@H75X:'\##_V!#\ 24"3Q[7"6<E5NCZ9<JZJ(2E4)IYPZ
M%1@,HZ'CQVB#3XC80TFG<W\I?UOY)L]/7M-E*SGCG-N]U5"0UF'JF:CJ6^9-
M+>)SVY*?#0/Q--_N!EJPT7GO7^<U!*5BN=FZ0!Y=X%G)B>B!V!I,2I%'M3DY
MOU)\+<J!$Z47HA(%+F392A 17D+SZ&W?[^/[O7:%N2'/WU*Y-HZ8S5E[\+.V
MY* T' WRFG!R&U9T5\Y%P][IA!6TT<F4P-J7*LAAWZ;>;OJAQ9E,^8(J-XR<
M./*RXAH.XXP-!C>:03S'%O\04PE#0YMSMCEGCW_.B(+#=_@&B9>'_E4[(IX$
MD6]U$Y$&"+;VCC;46Y/Y-_[-S;EXI'.AQ#L!/IEJG\P0QT\3^%A0(9%B-U(^
M"RO64\(WY@Z#.3,JJ6#"6.(&PI^#F6Q6<1]%<"D/%G@[C2+,B9%*5(;!VH]S
MR6MA\PU[R-TPE0 "#UUHV'V[#HKXX:ZF<$"3:)A0D6 J#7"M(#>.EKHD[@?3
M4&0Z^ZES[V?TZ2;-B?5[3KRQS)?FOX,)QCG_1"8QRCM*K?,VJ76-^02V Z$Q
MLVZ&8;60:J:UN2GD=%7RY\2]&ZB<.<J"P];M&XL((. SK90EUWZ"B"HD*J"R
MSE8*'<$[S866Y1HH:W0Z*\AG*F^N\U(?$]V$2FD*[!2TEAHSM"!$YE5GX]-<
M&XH60I%?J6($L%'8I61OK(Y_G"1VRE##6STJ1-#HLC*KRUMC=&VYK=SWW*(>
M*9;?^CU+QIB\%Q=Z>YM2(C6F4KOH@FA?Z(<SQ(K3T*+')L:32A.QJJ10:<89
MQ#JE/:^<#+Z1VDNRP'3V;P4@9)+PK-(GBM27LO ,8=?*=:54C$Z%YO UZFB3
M$K82WR^[O<D/?LT$8"'SH-'))NJ!IBY)6:/)(AV9&HQ-SWG--;%BA2[$F*H*
M5Q/[:T-*47-5%W_+I6UE)5$5(M/ $V06AK%L>RZJBSV!IEQ=7!2+J.#*D!&L
M_4Q>SW7^BJ@H6 [.PC%QFL&LIX)0L:KY1?/05%%IFHZ7'A9:K,,[U06J^M7T
M4W]K=UN5U(LT7 ;#_"#/3( 7)S7)B@7=\.VM>5M[4@/3;!-3(DO'6,;59TK8
M(27/18Q=P3_YOM%Y*<H4<//<A7=UL.U?8K#2C_ _DD;LN4L)$[Y0#/[5!="0
M.NOW=%,R%%P7SE[,Q:GDPTX*ETT%WU8VG^7-]CNI1(V.,9KVRU@6$V<"!T#7
MKJG*C#]MZHI]TA^IEM9CWT2O[1# YMKYQFL')&'EXJ'K1H/\)'^_3A-C:B(V
M4,@L8^WP;L?:X;>Q=C#AMDOD0>_%^ZZ,RT49-:!;C&[KM5/@=/R34#A[FP;'
MA(1,>BO$A4U<@6H27 ;&PGVI5ZV+B^KM#$4)OT#R5.9A/%9<&S7:NF4K$1=5
M.E&J@^#R4V/N71Y+XJ*HQ@V90&4&UU^XS;3D%H&=1='H (A$H ]KOU 5D<<+
M D.9EXRC)!X*QS;UQ-06V1 ]W [S<[3!_-0Q/[L;S,\/?  VK#-/9RT^"N%#
M_<I!KWKA\)^&_E6.7Z4*?Q7HE)L$KZ"&:N<M%:W+E8HH4/,>N:YNP=L=H.40
M4FXJ6H!H<DVB/)>P )J8=I7-P Y,B)W%^>EL+3AWO.6IRKAD^A09K509-/5+
MJOTS9X5)"@,EUY2GIR9HJ4923.,Y3ZR@W!S_'-ZY?)5Z+3ZYS79NW,ZJ*+(3
M]2F6A'VV.!6SL2Z(N\-;MZC3%0X^;;^H.2CPYR"UI&P'(SE,&3@J45ZI#<?N
M"\YT)GO8?1.Z'N1+T,E1VF')J2Q=V$HZZ<U2-V?D7V2A))^RUBI>"-QYA HW
MK<,7>]N2ED-.J_ BCWAS!ER)A*8JS',LPR.?RW:&#\2G0O 0\TM/>X9H4E^2
M^R '.UK*6EU 8R7U[U>*0N@O:%22'.1O[6^3)<3$Z\,HC28QOMWN?M"P*%S=
MT.GR6I\BM$/&"QLOVR(&K^(D<2@2*PF6+@NAJ=#1YCJE$V)%?QV41@442,?$
MT[F8\"IV%UU%+/&9=;[A!$KQ2'G956B\8*W8#.9N"0M3>DCB"'8^J->2__&]
M:4]:RR/P*6.%QS/5)H(V+*0I:EJ[DV1R8LP&U\;QDK$'5N(>L5),2NZA31>C
M;D4W<T45!.!7KL1HVS 6E.Y%7$K>(;HE67"J&)3'W<+1JHW5-&!5(4L39MFU
M9*J.SK67$4TSB-X23].NTAP2(2G&%<=PV?"E";L3-JK.[38N4G/:S06#'*C.
MV:]?ENXM:=]RNN@I?E@L<L6=,(YFJ2Y5X$LIDAE8!272G<Q#_6IC.>"KU1=$
M&L4W^)+.UETZGC5-$@P@'5',E$E8]Z4QAXD:>Y,\S<@QA+RK0;.\M=-N40/&
MRAT[.-5>46+D_T+8WD;H\U=AGCE''+BVBV@1O(YZ_HN.?UI*8"LI,IWR[F0P
M0)<8Y=/4M3PNOE@8@L!#+)0^Z*:$&?8ZFRN74H.KS)[7B:GJI;M4"0-9E;AD
MSC>)%1NPW?V#[<@E/EZ,1!<MOH &5025.FIH<:!-74SMRN&>KC)IE];09W&#
MJ=YLYT?9SK6B@/:N-((^4Z"=:DZ>V'YQ5C'=C77(=O<TG@F5^&:K;[;ZHVQU
M)N^'S8LNNF%47D61JD%9:.U,J["20N!QV2>7)%0#+M!?<H&NOS%TNY(7Q^VQ
M$J5Y4*I5!1QT#%I7NEY .<V)W0_F<X[P9V^DK,7M:BEDQFZS2053(NY04$B+
M,$%]>#%'. :2+-E34"W!N3F7FW/Y*.=RGA5RGUQSV@%H6+BUZ:6TRL[%4FK\
M%'H2P2B3(]62E.,WO$)EGH=<;TU5]H-[+Q^A&L?0)W@0,XI&83%M[LLFZ6=S
M:A[EU#!KEW'7NRYR23*5.N1RCRDSI-'Z"-RKSRK[XAP]08J0PT\URR]J=@]8
MA)?JM^3(X]]XIG.ZST66ZE]7ZE!?P>DN&E\3CJ8Q3(7RL:"SP01$V*7X%8[Y
M?_6]'%,D+J/P@J<>&L7Y:#%#*"WF#;+_5AAQ3=(N3$P2A9>V$Q)ZLN%I6LVQ
M2%XF.^!@/#I@0:2C> Y6QL:3LY&@#T +IV+!"/B;*\'@:/D% >8$K\YB$XOS
M9 Q9!)'3X,IF0?;_L_>FS6UC2;KP]_,K$!7M&]($S!8ERY;*,Q6ALN4JS759
MOI9JZNU/$R )2FB# !N+9/6O?W,[&Q9JL7;CQHUIET@"9\L\N3SY9)ID7XV#
MT6/%8"FDCN-ZBI+*..,(@]WT*V','JSS04H>C]=L#C47GGQKH"6<6S5.4N%X
MHO\VEO5*X[Y*%B9O0."!X?0/I_]!3K]-Q'LF8=0=Q3<9:.76!&.]T47#*A(D
MN8V*2K8>80J85D2RZOP\8WN9_%TLC^% #HU $Y/99^)/N;H&_Y5DT71:F\)@
M_),[IDEL<4Y^&,B8U9WU2(,<#G+X$'*(G+N+>D&FF52SG\5<2R^N+MXP^E()
M!?KVDN1!#3&;X10_^"FF( 2<8(HX"KED9P#GKBE*GE(XX5K5-CL;0[5-N]KF
MU5!M\X0%X/)XFH%(]4&^N&.W%VP@Z%MR!\4SIFI83V/K]:JK;;E"8[+FO:T1
MK"[.;#8 1H"^:C'.=>V#=&:_%"&-ZMZGFY?V-B4)9!6X%'--?.[Z6[+AL3!
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MKJVW: 6L)9>OIG.%)=FU)/6'ZMXG'4>^-%L'>R?JW=#5SP[@1BW ^T):?8W
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M67J3F9.&2"34QK_&/"K\N4@PJ%97DO$DFNJ4"B7!L_J*ZY1>$(@$J2+D6EB
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M=-BPMNX!&57*VO\>E !KMXNRHA?7)=4DXX/9R9<L*/^[A1\0RD-3EH@."7=
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MD76#$-UUB-YUF+_+,3'=>1#:H&-!C3X:^&LGY,9\VAAL4A.&,URAD4S_[>>
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MC.XIP.Q?7DT4&<%39HAI-B]%CWU5^^&AQN_Q36)/M3#Y[ EJ?ZC3(\R76.]
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MYNVMZMS;9VH^W-/HKP7]V!V@'VWHQ];SAWX\,=%I6-Z[3\GRWA\QV#LX/,]
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M_YP4?X?7_NJH=?D3@A%F5YEIY[0ZQO8\5L^:I_>S3NCVWNS\=CSX=TL#UA5
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M[;P*QSOMIEJ/;!><8[.SM=')5WFU$9MA7F=TC IUR?RY'0/\YK^CK,9!;&[
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M IU8/$KS&K$67'J&MU;CJ78;GD;2Y7KYI%=/*9_T;J0.*)HK%93[WY9P#OG
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M(G[YH::<^2KQO ?3>1#/03P'\;RY ZW+=J74>CN\HN.<10O;)1Z9 R/JGH$
M..-.JVO$TSIU@AZ<%)QNW]R<5H-*&%3"CZ@2KNI-7UT/W,B+-I: ND^IO\P0
M4(/4WP]4ZV:3N1:Z_?6 ;F^AVW<WGC^Z_6D+UG"=/JWK5%O8MQ64NOE=IP:G
M=Q#)023O-"9U,^F\KY#4@*\<Q//IB*?(9$ X;D)K.9YHAYQNW8&<JMO$7MWU
M+?K8ZI.N5WIU!VTI[FYJ[Y'UA%N><.E5/K0Z>.@I'*/(*BQWHKXQ695>( .?
M::Q(?\3^@+Q?7E-DU G2H;,,O,YMV,>/BK.\CHK,7"@,>)K-L<'%IPSG;CZ-
MXYE#+UA&::S)<DSWQ6](7VAJ46QO3_RBG@-\$X?%/051F4D-5FF)+7^-LJ_V
M)\2;2+UBE>ZU6(%2+2.>]BCX7;>@3!&1SITIX4?(1DE=LH6UL,U*VUS.DO@6
M)W&0+)9Y*<T49TAER3CWLSC@EZJHHC:)%6S>0,/Z\#*C\G.,PIXF2SSK9SG3
M4G8S34]0HK*7]AB:@V8.<%,PIG"S_3O.Z*M3[*9<8)*)R%HCJBC" LE*^#;/
MHX(?H!\JC86UJ'("B3IF(AGF!0UR8>OG&X77^34+M75Y=1RDT;FALSJJI/:1
M!_6#5$(_J0Y$^R.ENV,^:7'\S\3L4O++4Y^)7PG-_=^6FA"!&?*9R9;4!-Q&
M55)Q7V[BUXWQGUF47I0)"VJ:8H-4IJWGL+3T'Y=.Z'1MNKH,;FRXBHC2774K
MM%'PC[R&*SBOTQD]N$ZKX(*:S9UG]+9H=I:4\"S<$.GIC:^#Z5'E=',\\!KZ
M^9)43)V"/H,!U'0R0Q5ANR681E3R#=C\-6E%:D!>8,L\R\ZKU1'^BG08W-<Y
M.(Y4PXTLST[;9&TLA-9T@1?A!_^LX;$SMGA&]W_"ON<T38Q<3)[4J&4O4#NA
MGX#7INYAB#?2;SG87AGYMN ;GA31HKS_&79)/M9//WF[Z+LFT<'CX*HPL0T,
M68.VT#&&L.A6# W]U*.0D/K%OC=*RURAA4WV>&L(YO6F%3GV<4M*=FGXE>(,
M=8T0C*IZ2B@<RZ_&RAB3]VBG);HQ?:C$L-,\,<A$@=04AM6\QL&S%HZ1HKQB
M=28=VZ=U68KJGT0E!V$R6'L<ANMZL'/!Y.G<J=UMFOU/T'#8TU-1ZVO/N<#+
MI%@6<169]NKH";)/ FX@V'EU$7';4!D6Z?>Z.LT%^41TZ4PC3Y^?)?$Y]JZ'
MIY:EQ2[9V2CX"VQP20J5=LZ?J7O)<7FN7#4\-QC US@C;G=8 MA%F!7LWSRF
M!T2IN8"FL>;MP1_&WTXC//1GL5R+"FZYDAJ9Z&-GU<PC\+ &7?(D+"&7([YI
M$L$#DY9-5 :.0=1G#?$O[]L<NLST>3H&1,,C>%K6#PS^MQB.(2CL=SJR'J I
M=&0N'G/!/,S\AHA0<PK:8K4V (9I3G@;TPOW-C;9$I2RT(FZROU:2-QD<^N%
M$V@D X&L!KS!4.CI>\OH@LP/#!N* 7*A2 . U,,W2VVX4!0UPN0MF"+(BK7/
M-S^J"!![^_?C>'J:Y6E^@BDV]UMKH'#DHL8X)79.6]?=5<SM.8%YI' 3/X(+
M],<^D+J0\81,8#X,'%W.6G%Q?7#HS#HGE6XM.93Q"=U#WN&E(S@*_J0;1C^T
M89J&="[Y1WB/DK7HG!A.1\*@-+E*S]@TJ5(R!P,Z6,0QAE$SDP^P=@(8"63=
M_QRL)>OX7>SSY^4HDTSQ6][BR5]+X&MD\4N" VU&6-#H)-;=#-%B-ZW^<(WB
M;W$Q3<2XO69\\Y'<, ]\/5X+<OIF@)RV(:?C 7+Z8XC*]PW^8W2N='9T/T/6
M2T>Q'60S> UX,VM@7L;E>AALO]G<?3G>?;W[> S+P1%&1QCV,;C)/H:.$6IL
M/"13*[GIC/ZE_TQX6\A!,7"[@Q)-4 ZLJ D\;8X7(@Y&W]G\$";4%?OW\?1[
M'LX/GI_^C0;C<(ZFC6N$-3?4F%]LJS6-M)=BI(5.(')WXT6@"3#%AF)71$DN
M&@U%Y,_U:'Q=;P7&A0V2@C2/,IB,MF'9D^D:JW56]' QG$-6;U*-@KV.WZCV
M;Y"9DU9$6Z:Q]8'.3_,2H2DPS&09I83-.$,0&R7D3V!\F9D7$X:;P8$TS>K[
MB:0\M>-_5R%#WUG1F@L\DD6.8 T\=?A?&,@_BY)4Q_&[U-E USR ?A\AZ!=.
M,BS+OR,=HF8_MB3O7=>0$W-Y1?#?(CDY911<[?T=7=ZO67[^\C0_USH<Q:(N
MN7T")W# "DCS)=L<F$@ZP[R0-D'XS7P+*,S/DN;$][TD9:@[\L)WX"=3:>*+
MOV)=J7-890W_1\9)/:GG25%6UN,>:F4&N7S\<DE)%Y4FBP0#3M,\FU$6"6\;
MD(HT)CO H%$Q%H9A!V[(CG&UN*H+"Y=-Z0-M='5=3]1O>I",03(>O63$TO54
MZ6--Q-[+>I(F4[A'P$$E $>!]PW9R[B]B*C^%_;.@/NN)@#M&3D,1<S71WEO
M)5J#UWEU="D\/IDD*3*KH@UA(@<V([W"*944/P;EX4#@7^LEMD]88E0"01^<
MQSXQ4# \'8)* 3]T4E<8^T<&:[)+P.)'?DD$Z!.<?UG$YE&FP$!K6,RU[MEG
MB?US<+PW!/GO<?"P"^I7?68(]H=U;1QX^A*7(/9HI6)G$6N8#E'+QS,)2@LJ
ME!RS6SJL2)!-,?@QE1=@W4,R3]!6DO0=[6S$&#L04X[BD!@>['$.CM1+&M-Y
M..&C 4JA7N*-LK/]0CLE\&O,9^KV-(HN(##'ZB(F#-DLAO<MDLR^H=##G>J.
M+B'=0+IR33M$4OF$+RKRBR@E-)Q1)@6<RJR&OW#\M=*1*UW)A.Z:Q(1*J;/@
M"[&,BS-J)B$.%X+@R#W*4TK5H_:*"J^XB'04!JMP[(@\RN<A_X>5$M=]DRT(
MYE3&K>S*,AS/SL8',6#Q25#0&L#@MT8;+W"MMT:\V&;"<$,G*0,6X%\%;QGM
M$&KU(EY&R0R;;9W$%/<C(S?*E+3'(D1B7%:85\;G'$ZKG.@*MZGF=(NA$/I;
ME-T%(PM14E2CPD,$I6_PDN/-EZ#]X1T?#WX]_-+ ;/YY%+S/4\QLSV+">I4C
M93 7\./NM^.$R&0IJ3EA,*.>0 C,<+!=?%H(#&H7%*V=V0R1D0+Y7";2SD2.
M*PU2<NJ*G&'S\-"6I=DE+3L%9 G.=H$OTQ6[8]V@ >Y%Z]_G=55BLP>!HL&=
M.*]PXAY5E=*_Q8<W-@DW](JK3UQY\+=#O+#1OW=J>;\0& U&?'3XX0L?9JQV
M"V#1X,L13EXQW,4LNDRV4;>W3.L25->;\?9XZP4Y1:&K'\Q2<963C10VEZEK
MJN4I@D8G1+L7G,(,X%C F]<$/C#>#&BB)4W"_JR@N=' QB]"@SB(P/7[1A56
M_ELT^N?5BT< H1DN,0PHX_U@<.'N748X<Q!*L#(+!R -CZGG$0/U7"5O]#FK
M/&NZZN,)9VL9%]@KS$.6!#0(K#^=\Y&S+R!?2><@4)J3F39C-33+Q?/0=8B:
MP36CC>K_T]CEC/:I7#R\GK>B.QQAX0M\^3E^>1I3G6K;G@9-1$:WLQYU07_F
MF\>NC3_V$)\KXY?E)4<1;ES,$(&> NVBC%;5G5_Y U_A@EJG@F3R'OS=P?&?
MY6F]D+T#76:77P_(ZI:H%(5QA\F JQWJ!XRH2-1CBG?FLHQ_#O2_&M&1J\^_
M.XZB@F!%*(6C,C\)NL2&*F@5SBGJS-665X'Z_.$=B/_A W'8W/YF5*3C5;)<
M%BV#;['+C9$)/5Y8-5S]__II\Z<5#^P"%%T^GR_Z[/_GI/C[+UKNR6R6/T7!
MY[C !X+#S7^!:9)WU9QEYY1X=[VQ>K.D\,M5-A!F Z,_*7)0!GBD\N+GH#B9
MK&UNO HWMW;"S>WM]?8FRSG;V7G1%03[D^S_[8T7S:GHX_FB>T>:W^IZMCO'
MUD]V&S^A',9/OXPW-WI'TO6.%]==PO8"M1^J*49A6<@7V+7+LVHQKKH"7=/>
M;DW[%N9ZD^/2?NVNK )"$^YX&;8VKK\,=Q*W_-'MN(.Y:E_^EUSXX&+49>AA
M\JU=X0#O:^)!,>YOBZ_$&#F.(313[?<1--I8,?#@\0L=Z+8 ;!P)&#P'\PYC
MYO+Y1-AYMICI5M;8V/8*4ZL(]6(FJ"'<')*7^X6\V""?8'25W3,B@]%%3ARX
MU\:DV+MB.7)@1)E;*IN1F5CE%3E&9^ 6D94LA802T&&;#=U_L279(RSUT]DH
M=,WF+&<T$@&-QALF0N0MHII&:(DPI(=&?G*";G<5=ZQH@G6.\0*.L8UI>PX"
MG05>%+T2*PSP/5/!@48O%DC";W!VI6]3D]MQ*@B^W)2USN(IG! Z"!GAK6S<
M18(>W($XX\(YG8*4(\-!)4%J^4O2-,ZK4S@7T5ENMS>+V4#GJ6*(@_*=&).7
MB8Z"0\L?1HVDQN.PO6"XGYI\!&ME<$+S"]IK.B#+G$8>64&9.2?7AA%E\]B6
MC28@1E*G"@MQ$>!)YJ_@P9["4S :&1>Q76+CS& <Q1XBY4M<YY%@ZA7V6D(B
M\(=7PN-Y2.)QR+[K1Z.#XS_:GL.2*FK<8ZM8-LQ78(SF^;J6PP@7QE$8JV%G
MU?#*HDF11V;1Y@4,^3POONK3T'F.1NH#GV/]A[+[J2%ZH!1&G7FV*$::>L)K
MB^A;LJ@7SA:G2<29)%P-#O&.MV4I3IT 8RF1%A-.B:;3HHYG'-W*B?"AK.*(
M.GG#Y3P$66YS$M<JZM@9BCK:11V;0U''($C?%ZW4.+Y&N+%+MYML00JOPW";
M)EAP+B52V=IDQ#NV$67$9\.?.DP;3'!%?H+>)-0P.5+@C=!M-['MIA\4!J<Z
M(].X74TJ+OZ&?'X:%-".N"JLWCOIM#O]U)=W]^/<]=5OEA6OI*HG)T=_G.99
M)@ O26WA4U]*KLU8K^ZZMF*WUA@Q>\& 9GVW,],@/!IFAZ:W)3"BI!M?E$[H
MU\E58EYPAD8K8D;G<>S>RFXN9SK-.==$"!TT$>$37132MW,FDDH)(%H/R1^&
M&N_)GH+3]419$]M):\FHG/)/3-\ZYKCU#,HKNP:NH0#3J1*P7LSGRN%X]/E
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MEH8UH031$GP@.J,(81.:!>E=GB$#+![M7QU"WM]L3:B<US\S<HF/*@W6VUO
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MC/2O('21J&V#U_*;JJ<_*%!9\!=(Y5"F71 ;C&!B4*LD'VA&,GRVJQ15,N3
M&R(%D$KHN I]9]P=C2V-F?Q!C%TR[<@8J?J>>*,!;SPFC':8,!*%>SH5]#%C
MM&]3H.(CPYH@;H+5 Y=7U/NL[/2J_LVAK8T3/!N)].%Q]$X4-B=H3KK>(Q25
M1GFE-;,#9:YD\".)<"I1P6NT). #JV0L'&27R2!I(F.)D3BD(<)D'?DJPNK
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M"#.J4E]5[E+W6=$"!B<*>U;U$^(V@PW/J"75Y-4Y1K@G?Q:#4)R(.,0,]O(
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MX$'JL(U\RT<-64Q#5O:TMC+SU8*NY\>@:T+0-?^6@ZY)LEQ4!>=(/=W)6=E
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MPUQM4V\.)<_R#M>YW@NWB%<JQ6N^NVJVFZ=@=V74QA"1M3/XQ:./$9<;GV^
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M]4_<8K5J=QWA?K7-JWJKT[CYDULQ(T3L'M7I4-1I9K.;#:C3)RCF:MTW6]P
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MV&BF[.'RDP>RX::XRWQW,SF$N69S0W+KS+)VB?O&0&N)V$.^@X:6C[4UP7@
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MRH]DU -[8_0JF>]S.PC8:Y^/*N)DP/:%$T97:7 R,ORW/I^;SPP^0>8^<A.
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MM(JWMLHJY9?UKW[*55K%MUIEE0K+>D/S5FDOO*'T-:2KGX?S/[C%P_G@!W,
MIS\;(3\L5EA[T8X,&:[4@=TE0+/MC(%@Z>]OV'I%/('\'.-%YN>OW%_@'D[T
M&K=\EPLEN&<^<L)?D_1T.OA$J\8_+]CA%ZCR2#G2?*J1?H057V2<A5(V*>AT
M/"T7]&E2KF)A)_JVS$B+F]&W8C6;Y(P=]6U![RSE*I9VHF_+C+2\&7TK%;:A
M;]OU,S?C2GS#+T&3'CYV()KC*P445%X_[EB@1S'TV5E_C&Q5+Y;O6^XH,/36
M/F_-]TA_H,_O0"-4OI*H\G(=:K0,=[@*S;[8HPOUJ-G$H,\7&?3$:"?V[\20
MBX5RIG*1H@55"FWZ&1ET*TNM:G6WJKC<H"\VK(J%7"%3SB<5%!Q5<>'RX]2K
MFD^^DVU-%Y<<=?+];'W*F"\7,Z7*=I0Q'4^U_HP-D2_+02U$8II^#!%.TQG<
MI\DDIK/</3XM_(!:!?$JV3R3?*%IH:U_CX.1W7^=0AH,E+-IYTBZWO>\$3!Q
M:U$/\9L3\\? ^>!8($'FGGUM$X>WX.H#-T\Q]]DN[0/8,$CUQP*62-AM^JSO
ML"[_ ?B]\V?\:V>%')(?^8%\=C!T[!'_@#4R'UB7[QF3]?N$6S?Y"YK=D0?.
M9SZG=2BT7-,*.XO1@TN)S^4^*[S[BHC(1;N#P+23NU#&W=NIH_J"! 'Y<QQ3
MV7P'[X"'%W*_ML0H<&>;;1A%@'_*_WJ:Y6O!I>D$GDF-;KM9W+5R$03WM-QY
ML7VW*B/PS"WV,Y+&'S"__D(,\*4C WP" WSIR "_K&H;TWC>2\D\[UMP$';'
M_KZ$69W%"?^Y=O>)C[UQE]2HQY"->G;9"&,I7^Q(*)^2G;FR?G+F6(/VE,C"
MU,3?J[%\)YYN#UKG6-JNB[YRY?$M_; =OGD[+-BS#XF-;(H-D,+3#=Q$?G*X
M)M#>^/O<V/3;H<6O(0/[WL]W/G0\E41.+D4':EKQ6!OJO9W]^E9[N4;";V+N
M'6]M2[W;#A"[.\K6U7NBM,W>$UM=\6U0V I7N20]Y=BP/]9N:W=7=;.&5XGK
M^E7]R\=ZRRSF,4XUT4%H'ZGEJ\L%W9/A-(LE _+%BTPA/Y]W\(V0^%=7(6!;
MKJ=F"3HF_S0"OMB!@*L <Z]4YQ<C'(Z,9V.A\BLQ5LZ4\GR\>ND"\.H7^?E-
MY&=*90*KMH_:G,]O7YW+N9/+:FY^G=P^]?\X@OR/@WEK@]DG%S@5D9>,HE]_
M;0&;5^=SW?RS7FN!%USXL(<"/@[F.)A=UB2E#_?2.!I!,+8@6^KU\?0.IH&#
M)2(8[N7<G7 9>18O]N@)@1EV,H,H]5K@S[3EBR1; /SR;PO4+I87\E/NK5=$
M#33[Z+'(:4([G;"4L3++8\GS>V1VLG[1'-B.PW_8L![-]N *R]VMHP4@2,@D
M!=/L?X75;_9EBHENW#6W]TTL?,.]4LO^C:]ZYRF9CO*.C>B[,Z_HI4JF>GZ8
MG6JBTE^$_6HCPD[G?Q>Y-B_3B&$/Q%T\0'&7N+A+F>)2;/[;$7E*E@UH$[-G
M_" ;(:;;H:Z425?R\T,]A^/;)SCRG@MP2E@Q?O"W:S?UP'QG!7RY^K;+>N!6
M$)(R=PH 04\Y(3@0X8B,A[C@@Z'#1N))4_P.T=Z)/VU_CHKT!W5I\J .Y<==
M&I!>@PLIJJ1?N72NE'":_42UG!TXSY3.ER$SVOW&7^I0C@2U&H@DOAZ#D.ZY
MJ+P>0BV;W+GUTVWD<R[ PQ3>,D?LFH57/;DL7JQJ G=_7.;?_'&YYG6_X'>!
MW*J]&+<7#=;ORQ/79/Y_)O]A[."-E_U@?M<.\*/R]KP_)C+]852>/(RFK#T=
M0_A'Z2W5A1!Z,\^=\LH:L/N=7UA@Y__]X*Q]S$F.><=!K85JW^S+]6[VI0:D
M,@,5B+94#E\)BF_>_&]:$0KK4(3]N0J=7-:U8\ ;(B7M(9X"E<5. 5T!FC3K
MV2? X4=*2OMT *0=='GO#%;:D4_OU+7O(Y_>,6L_O-S$9K>P3\\>+.[)80"&
MN0'6#6]8IF>'MK;[1Z>\N8N_8&]BO2M-(=*=\MQ6GB<RPNR'S-*N]K(<U(?C
M[JUCL<OK6.S]<>F2H]N#H<^>N%R 5P"J,N*S.[B>#1.F]V=KYYC6"A2FI\B.
M(ILBLNEATI]-9'- T:45;';$*!&3]QWC5_..]6,Q='2ELJG>)F]VX58Y:]>W
M;N>[[TFS=I3HO.*HPKRY'2[[&K^M+Q6[229X7+"FJEK-Y OS\YM'HKR$I=I.
MD44%<FGS*UB.*T0KM$H#DR57Z)R[BH5BIEA:W"*_W56:XP&MG*->H2SL'-)2
MQ4PI=^P)E&I+[: 2];QP<GF1N:C.CR^LP)JY#T&'5<MEBL=RF>-@WL)@=IX&
M4:RCQ)DZO^2EZP6;[@T_VRY?+'=O2*80GPG^N6,O^*<YV=YRIER>[P/M8Q ]
MOS(9P!3,W*3D9AY[I8,MZ"BL7.B_'@D"[CY3*1\\YK2P"/)L]\N_\K5K/:M?
MP=4_?SMIJ2@V5?)>>V9MZ-L.L@;Q\^J9!2//#_:D.F+)8^EB04!J0TY[=FN(
M3#Y%4]%]W%%+'4FSQ(;[:5)J,_=3=8^+'V9'&)8ZCY837XJ(P\5R<MR7=N*%
MPT+ +G,8K7GG5',GEX=3_U#?MZ*&Y<Z00F[!,V0&G#GI,+G(Y,I)33CW?T=L
MYC!9$@U>Y:[M88IQ,X?*LF(L8FEG:7]+.].>+HM@K'>O!!LY79;5@1+IP-NN
M,C_"E-/MH_V#_6\N8K0\<K5:AF[:>WNM2;W:^U<JL;$ T0J+75G'8N\R.7$$
M(;\]>&CJ/3Z]J.@HLBDBFUZK\[.);$Z ;!7"X+6!6:OGP(A=31&C/8*0UW"2
MKF_=JIM:MWVZBBP,4R[.F_WAPL *RY68%Y+[+2\&4RZ42YGJ$02[W%)M![%W
MD3NY+,\/11U7B%9H96ZN)58HSS=2)5.YF!][_7E6:8Z/M$JAUJHPY0L(D^<S
MA<+B=N]GA"GOH#3CHLAM7J9<V CN'_T@8S>U6"G"1=/[EVWUVTGQF^26EWLS
MJ3UW<&> S4NSP>9'E=B\2JRS0]VD_4G FEE!X'5M;$NIN@*TZ_<U"3;+]@ZB
M/5)AN2++0F$6N;ZD1Y,2 N+H-MQG'E[I%+D?^]TG*V"U1Y\QZ%PP\Y93S)UG
M\BGH\P^G-]@"2[*N1&IT-3I/#)0UW6D.T.'YF)VW(OV-I+%7D'[EY+*4*::X
MY!_0 J2-64]G'#J@R<[2MHW@9E90MG-4MO(:E6V?O+K9!_O4AD!#GYWU^;"8
MUA<HTB0(_N:;/GNT ^Y-\8_U;)]U1ZI&:J=H@B4/^,6[Y]S[[ :E))$Z6AN)
MKR"AEA+0-<I'DO2G:*"3+YQGW@!M<O&P^HLL?Q9N2E7263% E6?*YP=/LEH\
M+'[]I0^S76I+/I=;C[;L2U^[^.DU\LR ^<\V_^O0]YYM+J]#/(]*BU?GTN]O
M/+]-\Y\'8C^O[&^+MK06X["J(Y<Z8-*41TY?^IFF .C8WX"7<5A529LJD%Y2
M!XKKT('#N?7$CPLN?(QE^@P:<#$S&#KV"$X.+L"=UCXM>W D-'29UM"!ZPJ_
M+;=HYFV8^#W->^;!4<WD4_#Q[&CG[0M6_SB.E<:Q<Q:8[5>9S/_@GC/W'*)+
MM71!03X'68+JWI8O'LX"[J;Z)Y^KK&/]]MOO>8,E(^F@9F\=T7^4PE$**9&+
M^T!5GL]1=<?YXD2K/VUUQRK'XOK6K;JI==MCBOG2O+D=+C:V4%TNIE!90^W&
M>>X\4ZH<:S>66JJMX)CS^=S)9>58NY%VA5;F"EUBA?(GE\5"IGHQ/W/S\ZS2
M[(.TN'*\??G:C3STC2Y<9/*YQ6MM?L;:C<V5V4Q?H2+?49EJBJ;$*S#,OQ]9
M7!Z8T+HT#$/DJH9),09"J)/;PMVH')=FQQZPP+QC+V;+&UANAGZ1,=O,M_N_
MF@/+?[3=LY$WY%X/C$G\0HXSIZO#4 Y"C $'QE_J.&)Z>'B+<:4?@X3'Y0!/
M+M2BZSF.-0S8!U/^I/X4#*TN?Q>,[<>O)Y>SW$ ^+?Q '(F7RQ)EW6^ J]<'
M?-:W!K;S^F'>D/&S@?U?1C/$KKWP+%IW>"/J:M_S1BX@W"4_Z5_R-R?FCX'S
MP;% 9LP]^]I>YV!:C'OP =<%DS_0&GAC_I/#@L </?%?_ VQ86*TVB O0[6+
M*UU<YR):,ZDSDQJS7H5)H;3)6A53G=F:$]V?_QX'([O_RB\4">K$=>E] N"3
MU"QIG__][W$#D?BN)!TJS-*ASA.CW"1B+H?,%_^R73*&8#2)FCY@9M]V+;=K
M6PX?@S7"TH+ \%G?8=U1@'E-D=TST5DW,<D79!.4QD"MF:,TBZXOKB.HUZ2%
MFVZ2-O,V$*O5A7R.Y;YR!3)AZH%)<N8"';%'GXMQ:/F 8S5 =/QHPML[%KTD
M23JK#7Z_S/HVQS#Y]O]S=F;>V,SI?3#OK4=N]MOL/V/F=KEU*_]J(EB!O]\\
M.Q/?0_^$OJI!/O27YPL);Z_ [^:%7DZ64J@DL:42QLV9/GLY[U_-SNN0S[GF
M6P]V]U?SCGLN))L[#\10UK_T7GX+!03"5:*9)JH'GUG?SQX8MQ#\N4.4N3[<
M2L)P0:0G$P?"I%XEOUP?+\PC7,P5MO'24I^V#? _%II=ZZ\<I.Q^>V]=[F"
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M W$[X77.A$9FG='%)R__WA\$AO62PVVZ8BL=;LJX-X_7C[AZP]M5^5AVYB>
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MD>$JOCZ-VL(T\#8]J05#F0?5:>^A.F50G?8>JO.B9=^C=EX3M;/RME75:3\
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M6=+U)'#OT#*0/:M9\?'!1W\BVV9%FPP5-</)2_H#^6"M7(VDI7<5$9W A1P
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MX#G#84\NY="\Q<T2^VR5V+530MW6*0&8]P^V;@C2D#<4;H2\3\8#)$!2 1A
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MH_<;A8[1V!4VFD$SM[[09_1/(,>.OL+<L.DC08,(WY.:'D$.H)6?T U$-[0
MTKQ(.G5 3V;&FG1.SC1GR1>#'T:11^#-\7N]<&W>UM )?=_^L E&#4S9U0-[
MZMHU2%LDHQSC'P4*U=A4="S^KFX([I/%[(2'>T$,"5YY5*^\V^AA['.\-"S0
M#C*,KD!Z[_!S@9LF14\@/,2_PP44@\M#C /\/OQ73!V\L'N";P,W9)8F@')
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M[\"%D,&KDCP^SG;$%!KK%]L7Q)+UT6E^9W3V:.H4O^3AF%G2N=L7&&L$*+S
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M;I4FJMOQ\SP-(MX\'M]91]][YT<Q@* )&(Z5?2=7.+- A?0XIX=E'&)WRKC
M(GP",XO2,O>644HG0YL$.#!V$WX"9966!$<2/DHS=WI>6D#'58T[H=/V@F@9
MQ732B1_S,/Q:%LTC^L&;,NK@)RPZ(F28$YKV"1N\F;^DC8EC[R+-/M-R9W[&
M6Z?R@O DRGE=W4[S$#.U* M9PI0 C.BNG],"!#Q%IQ?0M'IC>_SC!4V3R51
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M_>"SM]=_3G#FM.$A@7!2'Y$7X>[)ZT<T:PL DTSYGW<GBA"'H%PPU"Y0/[?
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M%MQ6(L8Y-IXH7HEHUI G68DMHJ+D/BGUCHX8NBZW6MG!O<P^5X>LOV@R\'0
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MLT18R_G7M+JO(,_%BTR :\["/A 8E@&#T@N?6.7FJP.4GE\R :YC"%&6AAC
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M9K>49SZ:^A:57ZOT[>L?4$L#!!0    ( %J*=%H#G 2=9RL  +#Q   =
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M,7^>UK-(?]%EDE:H&8+ZB(__[<G>SC:<( OM]M-P0"]M1Z?>_B&1(^^3&&I
M(<M\YMRC>3R[&9GSO1W;YSKRENYYM)%N1@7S\7!PT7K!RX>'W2,77DET62O0
M?D&B9\52D^H,*G!2%R7O$U0&FJQF<<=R!V79WL[N 3<C.RGZF,%,0>K4D8*!
MXL& W'6F2S75?3QQL+]]$+)$)!QQ!*,?CU-L%43>8;RW\U/OD07_ZO(,>IF
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MTL9+";-'- Z[J!P\Q-_:CCK>ILQAS5?0@8/M=K^YYD?::Q>1D4ZR^$O&I)'
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M!,KU]'Y"N;Z?,^LC'LGWX[B"#0,;! N.YN.MI,B*\CGJ@;66"Q,"+04%WG#
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MZ(=1 ?]^ZG<<2_C3X?Q"+G!G#3_)!>K+%Z^0:HE9*']4%G][/#IG!1=+IRA
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MW6OU\6^RD(Y]_SE[6DN@>RA1<Z9-?P!KJ\/P*B<V%;*OGA^W=G(\'AS1?#P
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M83CM9PQJOJN]L:0S1I3L.R7]_,_S[ZINN;,A4T;/7GX=FI5:U^0"B3FMKEQ
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M MB6G! P-<W]77TQ+6,)J< D2U@\$3*HNGX$&]J9^XY?^BDZ4_WJ&3ZT,L6
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M*:BH=B=#^_5BVW?84I'_R8X\_F'\>6?+4++W-GY[B/OY/P!02P,$%     @
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M-+:TMKUO[^C\\%MO7_\ :_#C$'MB<FIZ9O839VY^Y<OJVOK&YM;VSG<7"$#
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M -P^A=%D0/[_\+^#%J;5Y?;]8R(+)<MHWX1WEEM<H3*'Y*C-KEA;\4=MU<]
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M"3Y6K:&3@28=5/A2!O+.E*@&PF@C?)X>09L1G+C+3%&9.0:A?DI7XS&Y%.H
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MK) DGI:F,2F.-PL@8\?H/=9(^!!U38@AT76%,#.C44::@/?>C:G?!%&;+ON
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M]UAGAQ"M+75Z#(/[6IV86F2+=Q8$*TZ<5V4YG+NN&9N++:X>< KR=H.KO,Y
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MU]<98D (&J34"XU>$]O7KO#*N)+?O_SC37S>N\A5.]C=8[+F"K D)=@1:S!
M[617_? 4]0HW!U\U/F=72?Q=;7=:A8;@E:'L<D?IS0X_*+"9R,BI7I?R6]Q
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M0?+<VM?#\LW-*5<&%-V^*O AV8AAO!#@_+JIX[<'P[5-8OB5@\P1V':&<I;
MGE\U]K9$%!Q&N)8S/1(D IT6-?5)B; Y>+-#:[=2#),YH'AK #.=[5=*XTSL
M_ Z+3L_^]D)WPLJK)BU")J&40BLOXFP_HBZPK^3'0?J/S=P'$H>7.2QUC9C1
M^4BU;:'0!<*BL++\=*W96>_2K+9KA^SNA[\#[7=3JT4[8?.1GXT%!.'(;=%
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MY1'3VF:DZPX\%/)>!1'J3XU^K+J]Z$S1R]ZH%\O3_]A]#61ZO?B2SX"5+DF
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M&(7@@2C[K-T=EB?_A"@;HUI9Z*KJC"(RV/]%J /7OHYSX0/0Y=7EYW<>,J9
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M0EDHD T#\&\*"O']/'EAU/H27)U)Y<RWX_?>9EV;TBZW?G:5I*]/^ 8CS>,
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M@K,I_VT.F-VUN#V /3A+A,ET)EUG_MD=!+G;":._AW(ME6ML101@J'%=K5^
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M!R2P!OP7 M@;NXM%<ID"'T7 F\'6*#YL*6&WR=O,DE5F-],AEP;(6H0<TUO
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MCP&H8*DQ&+*.)?HFT@=&:I8ZT?>_$H?!20"\NIXC6@4U;PW,TE\U>?U,98#
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MI(K[D?'NB\%*.KZ3+*Y^^D]T.P16YIFI&N93;0!M]1TC<$G7+Y0_)_<]*:,
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M+ZY^Y<O- 2P;&_#'CF8ISZ3,7,X5%Y9%=>F#80[^&(P*C6O/XY&*>"(U U&
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M5!LYN6P=T[:Z?B S3JG!DU4V<2VC[QY.V#W+09F& 9;1<=(T_708BA&EL;5
M9'2^T'\^C>N=Y;'*ZN[= :5[[X7C)F*.T)I2 ,D@\8*"TM+,UI_*<GS5^E9K
M=F0BV2<S")5L!;M?=Q^M-Z>="=\:6,MK2]Q9('3*K YT5TB55OI/(YQ>A7_Q
MR#PN [KD0G]:.A6IV%S);\!;(KGF4QG O(5NUW['4%7!'G,[MRA*BYO47-0
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M*41NJ+8!!E/8?W=' *K?_'M539(W/XE9JAXS]54+/WNKVOA<N42Q]2-(3W9
MI)M2]XU1QZ0,;=6/[N%<N.Z[/L,J]I?.QK7SWI08_+B5PPR75*<J%2KA#_IA
MUR]FP%_>AQBTX*O$+_>7M$9S>")B@P9Q(MS<S;JW^)1OHO7%3$5$;O"1G(OG
M'D0???.IT>.(.WZ8T$DW:\-[U\SBH8*KBD:5R/VL5+KGGI;#SV5?B]>TZ!O\
M9\S4"M:+DVT'D4)-JQ'VX^&[\V-[]GY.6-^Y]!1M@Y+ 96?&!02)TC@M2TPF
M&5VG2Z\.#>\O1;O,F0B^J JSF#I8(7<0-=UQ'!M]$?Z;8$$+/9W('IE\N3W6
M-/$<Z&AJX:H)IPS^'U!+ P04    " !:BG1:] J,D]0V   #.   #0   &EM
M86=E7S P-BYJ<&?-MV54&TST_QD(;L7=@UMQ"$XI[NX4*QXL6*"T2.%! PGN
M;L5=VU)<BE,D2('@6J"%4@IL?_^S\F9?[.ZKO7/FU;UGSGS.]\K,T\K3%H!4
M2TU3#8"!@0&P_[< 3VL %0 >#@XN#C8>+BXN/CX> 1$E,1$A(1$=.<4S2B9Z
M%F8F>D9&5@XA;E9V 1 C(X\4KX"PB+BX. LW6%Y:5$Y(3%ST?P[!P,/')R(D
MHB4FIA5E8V03_7]M3_T ,CR $:8O$(,=@$F& 23#>!H"L   &-@8_\L _[MA
M8 *QL'%P\? )"/\%M),",#& 0$PL(#8V%M8_;_@_/P"+#)N<3409A\+0 9?=
MCU(T$E&"!WK1_(7*:.X'AYBC?Q0^ 34-+1T])Q<W#R^?N(2DE#181N6EJIJZ
MAJ:6L8FIF;F%I963\VL75S=W#VA 8%!P""PT^GU,[']Q\0G(M/2,S*SLG-S2
MLO**RJKJF@\MK6WM'9U=W3T#@T/#(Z-CXQ/S"XO?EI975E';.^C=O?V#PZ/C
MRZOKG[]N;G_?_?D?+@P $./_L/];+K)_7)A86$ LW/_APL ,_I\ ,BQL-A$<
M<F5#7 <_"G;12#S*%XB2YB_X(#&C'U2._G,$U!SBVYR7_X/VO\C^GX%%_7\B
M^S_!_B\N%( (B/%//" 90!%P^X>G>O_Z3;Q<<F'00NO;H(,./U0$1VG7Y#MZ
M;5>76QG46K7[?BQ'V[1^^I LTZY?/RL);-C#XG?\*_5O$K(MB3ZN<A-U?2[B
MA[!S58#/G$U%2G+][CQ[SZ?WPPJ<ED;4Y'SCS,\R26 <I.KUVBR)VW#M['/[
MK*^:A=(9I*_' FVCN3,G4[P,<'55*6,C:,3-@@J@@L,CQ2V2+Z6XQ-&E9\8I
MBTO)'.<FI3NG PE[%*/4OA,.GVR1>34.F*)X)I9OFD:YN;D9B6Y_UH*&;USW
M)3L]Z6BP&3]L_\V_& 4?"\N[(P-,S(B8^5N[/4L8Q8 0<JVU50K9"!"=P^A7
M\-%R;LFSY+-R9%@E0\"O]H276!ALB+V0FT*_;^J=;W8B9%#\6<S@A0+#[?:/
M.?I9'\N2-5Z<SU4K2G'[(T;"0\TV,VJ&:RT>*GEV$TDN^_PCZ)@L:H%1Z@:A
M!M@H/H9Q>G[>7958C=7(6\R2^7WD@69KH7&/)JNZ$[R\FBOC5[--8U9VMRJE
M,0=/@\+,R,B9>-L]?]VRN3Y1=_R01^WG#'_)M"N2AYD*!1^&H?Z'3!QWD&@\
M>WAYLX65Z2 _U1?@]_G_N6'.?)^1,[UI0P69]MKA()!Y(S)'.V9D9W"/23=@
M$6"HZGJ\+(H:])[MF+\545MWW1.,UNREHNV6!;U(X,_LNC2YV1254?E"VL9L
ME0/?4G9V&?>"/#)"IO5"CG32:DJ[12X)U3RA?'=?@P'Q5Z\7:^S[S_NW];&B
MUQ@3EA;:?TMXQJ-;8X/A5$8NK%B.8PW%T/SM_SP 2Z5=*W]MJR7JZU)<65#.
MGZUA=67$!R\KZ#I25Q@^&<YL@*1K/='UO)NK(,N-<W9+*B4#9=^@$JP#;G=&
M9Q)16#%)8<(!YV5F$7.1Q)]1L;7A5FA4] 77%8Z%<X2:T@%7#]YKS2VXV[21
M*E'5(AE"Z5EIZVYW1N!O096W>_6%+[K.Z904:^H)S'F':V$Q5#$['_UM@;I1
M^\];4T2W'5R[-IHQL)!!UZ@:%GI43.RF6R[A'61)A8'4C)>.D(_9'QH]1GN4
M[Y+#;:KJW^.:A.Y>.)L:+ICX/I;JB*TDMX0@Q,SQPKCJ-!))*'CC7BD:NR83
M'7W-@^O-V.HD3S/I&S[:54P"3]BKNDPE]LC\ YF<E!@2:?.G>M$\AF_.N'7@
MCNX@\;/5.%+"IF(\-=I4LRO19,DPG3OG[)FK:^""S$\2R.8[<<#=7UE33=S!
M$A?-?.(DC$O=@D-3X[3L#=8((;BI,EOHQ@KGM9#O>C(!4N958^[,+_G^"S%(
MHOSDBV>#6 3.:#D7J%)%/ K/L^>&["*=2>]R@N)B_).H,O3]\5D*Q PN;4A#
M@N_MIJA?7R]A(IMUDVS8-B(TOLAMT0,.JQN\9T9RO6XZR&THL#KMWT3OD^W=
M8(XV"?9?'&/K; HNF'VU$UVOKTD?/A#G$%)&Z<\RBRDQ+)HQ1^Y0+B5_M1:1
M[VM1?YZ)_Q*U9T+QL .0OJV? /#4/2CL6Y[_HMWUJA-[KPR/=BS:UW5^ @SH
MRGWB^CCG$"5X4ZYQ):)X'(3#07+6A086[]Y,Z.UI"0E]/:INL!L<,;"Q*)^W
MUGNA#K31B</RNRO1^N6%WA\_26AZ?-Z<7'^K*I4EMX_UIHH;EL3H/6XTV,"+
M#* TEX+L\)_,$*Y[-!V1AY>"F<B_AT#N;6I\LCC06(CE:/BWER%S6UW)5<E"
M]0K#-_$5+48OG34,TKJB $QJ8OFSN*]5H10AFQ/46=3TT>6.+IO-#;0OUIQ!
M@K.^X?<F\[]']1*G7+13V+!Z7?$DQ^8:#DP/P #F8F#TD1(3,=64+EJ61\!;
MJ+*])^7T"I(IM=)09N_;[[T+8=UROC<KK ^=_?WV^.;;CTD,I.1HA_(PUUDU
MFH:KM"?7Q-B)L_1%: ;6LF)=2+X;ZE0RB_KKDJ[7@K8,YA39.I5_634'^EA5
M1*RTM)N!A>&_5J3U/7Y)+G=.98* (H)<86/:'_P+*/^L0KTVY%M]PZ*EDM6<
MF>^M*)?IIGP9?BS6%A+_Z-\5,Z@F_BG@"?%:X/Q*T9U@*=4FDMP\TG(7EB=X
M B_*T-YA(;-U-S_Q]*'4S3:RO2B\+G=V.MQ]< -6E';7RPXM;)[XN3\!' 49
MH[:3!U)+WM2\Z8-P*QJ?2_\\<@.4MO[,R_%VZA'MV,DR4NMS(B !U!-HKM>H
M#J_&4)KSA^UX3D*@IFT6I=1+U)]@4$KXUS<M#^H3,@$<%*C_57JIO_NMC[(Z
M4>]A<,+*.)@TKKVJUW9>VO@6U"I4H9VK-JSFA=<F3ST767E%)#EFPNJHX: !
MSC"EH1*VRDTO9.*S6Z+@K=KES'S-L4SX\-E4KWJ08Z04K!G["6!!@%CNM)II
MF^7NX#+Z(5OM&L_XVDBWQ#R?!( K%RR.\?JG/+WV2]D70\B^(SX=DUHPYYA]
M*+D^$^^56ZY!>P_<(J*C.]]&IYYM92;5W]\O2FGLT$,VG&]?4&3+B?G [#M]
M!U5^?M9&)^@0!UM%*"8(!:EH^KB^M NA1941F/AC3(L5ANY$<(43*@N<0^H7
M!2ZG)^K;S5[>UT?X/E-,EF^#T E1P]CCM(DG[6)A"KM)PM9I(^_X2F#;)[VC
MN6JYK#--C"(,';$,K2E9F=/"8==3DOK$MNF9(@')#"V?\%F;:4=(2-:=@'13
M@(#8D/34^6*V8%(+7_FWZ3]4 ,I89*GJH?NXL=[SO([6;3S'.<>BYBX ]![0
M_0O=R4+"^H(@_:ANU+<5,;4NCH!B@A[%O^''WW_]?O<3NUX3GPQL9LK**!;
MO%]]M-2RMN[QC#V"JTN4&SQQ9OA K%SC;BZU_$]@ZGV<I#4T1G:J\D;TT2.L
MO$.\>B%C.6LW09*>.L^C67YCW>A['=)&?&Y\SS7,AQ7P=C^,/-0TKXCD$+HR
MB'6)@2D7*\K]>M](.RD:R<"=$"/.WR4XKBFXVV,Q,33/.I#E/QT::D\B&U##
M-2\T74!5_E8YFE63L'/#AC$FO'OWE_2,C6-.]MU?B=+FA[\<F:HQ4E]7E<I)
M*8JR,HQ'_702!T.! P,\AFCG*XNZ4^6[6SCT-AJI?"RFUSMWOM_;62!TY614
MY=L/:)(#"(<PA(5^,_^QL=A!?3,9(KB$OZ2!-OQH@MEU%X>%B(X*#Z_&O+@1
M@D]=.VPD:6CK:8N]')YUE4O5E B:)F12H(&O(D"PC;R#:6<7SI[;<3DS<1GB
MG[[6:YH<HFL<D=G4;+& +\1)OQB:?](-B__V/G"1F_2ZLU-;9^I:2Y&J^OX$
M !<3GSP![G VWBW3/*J5S"GN JN> ,MM[_[@U9RSN2[LQ^"[NN5@<->,\#$0
MNA?/02 Y?35EG2\Y'#J:#!1BLXRU&UU]%&?;KH?)AI"EC-1WV22XQAI9PEI*
M<+?UIC%4_V[HLN(3 .]L?\WH-I'C4@VHA;YHB6YS8@+O'A1N?4N?JTHXQR"+
ME0T+"7IQK!#@3[(/HO4Z6.ZN=-%_B*S(D_6D\":B/I]7I_/WM?8%'R"N.U]9
MU;+$!N!1Q24YB"9-R3*ZB#'C<]\G)YE,EFUP=0H5]T0[:KP/$:D!$9'@=KZ:
M;E6/?4Y6@.Y1]1'N2<IWW?]R-"(5OJF.6^@&5!9G(B=LZS4Q0:ZFX4Y+FYFL
ME">A9?7 9U9G<AH6XM45:M8".+@U#1 YJ4"FKZWQK&G0S*O=Z='I\S(6(:E"
M\&Y0E<KV9*_OA!#2>;VQPP;!2]OO+0W E)[QT0(<8<6]L@\43%Z#3LM[BMD]
M 5+"]/_\_>\)\(+*6F^VLN5C@ED.DQ/6^9=-3:7>=QNT8[5_VMLZ#=;J6,FS
M1,96I>]4G.<S1])SC76S3NC1&G/P!E3!]/>VAH&U S91#()AL4X0-U9"[P=K
M?5B5O@_$%[*'T+ 4R3?3V63*#.OF<%\L2V[L<A[O];Y.\AO8(D+,>+@XCV]O
MD-7_C5NX]9-&8-I(.DA+HZ!7213]:)QZR]&*+P)/@->Y@K?>=)>2.[L\=N"?
MAO.ET;K=VB<YXU&"PV9BI#/G_[WD4\-=YLKS++T3M>Z]DRTU]Y^D'<_IZ9PE
MBOQ5C(>>%^<'1],HBT,%]O:[!;8SM!JT&;=P6$GR%S-#25(\Q44M*T<[DIT8
MN!0#G*L="OW2DO[,ZY9^'-19Z#.2*Y5.S.Y7L "_W; NFO_ 0JSG_'DUH*EB
MHB4Y6I'7"XWE*_)E])4'H/ 5\>_PTYA:97HEI"87N5&7.[0W%1H[3EN?%QA+
MNX0BEQPHP8Q&EC&Z_FAX]T@V/B_R7V?PU8X:49<Y/P.;4^3R/E8XWWE.V:3#
MF_F^#X=DZ9(D=U*D_D\ '?MP-XRK)\#8-\@3P,[_W:&V57L19UM]HTH )8S7
M^S*M,)C:2/HO,5>%$Q3&61-[^H71GSH#,_IC$"+I48*_IASUIN/LT:G1<:$Q
MN:DGI&@R79M4%".+CKGO%XA*CPFH&B5>2+5&K[)[0=&QI)P*A$9':- =&5C]
M?NL9B-4F9)BK,:_<Q?^>('_+F8@\9-KOR$PPH+>K[<@12I/#*HLV&VA-FSQ?
M0_P$8E9_91E$B5I'.5[-JA,(1+D810F_?&TM1TI[);.?GROY'\4P^]I:2LO
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MD134!@6+N_86C;HSYYST!BV2*RGDF]7[7[F9CVQ]<D28Q-K;I+0]'[]O+8R
M2$^'/G@&ZW4B%_1C\2W$BK]\&6/\R:)7% ,PG7^'?@*8/P$:2YX I4L%0M%5
MVD&W/ACW*EI<HKBLYX2MRR5V>(<>N@HH"Z%?^!P&U.Z#)3.&S>K7.%DF;=U]
M'1IGWE.M\623V,2IM.2*6H8K\[5ZYG:OD*(- 9Z$\ES'@SJ>&O1'U*M_[P@!
M)9(D8N.$<-[+WTXJUF%>Q0ZNE+YW48[%<?"]C>@H%>?K8W?!OS+CU;!Y&8G/
MV0P3BB+2 OT'P-]Y\G](/(8+\\*(Q/I2O+/(6UO?,R!5DH24@0"__I/U7!?'
MM:,_ZJN5+>UY9.NR6D;\E5@B8$Y?_[[KX1?BQ!B.A:R(,^$\6"MXW PRZC<=
M3,VQ>VUL??C9)<"M4/JK =Y.8!*U&;?0J/P,2[U9FG*7F,YEMEQ'1CGIF#:_
M& [1$!ITX4RB-/H1H/\04ZJ]/T!&^[Z PY!WHFY4U+505'T;E<?]7QNWE,"/
M2F9)2XST,X.3=KA8#*<:/BU7+0OQ.H/LI,;YD,ATGB8+&-$\[@7'.,=QQXT]
MIS;DR95<H2'[O)$1:;36M47>1^+WQP [KXCH,+AU?+^?J*7F>8>+&9^!FCKN
M>8:!(D&>73+;C_J?ADGL5BW5/P'V)C)Z\8&5=G3TAYIDK[*9-;< Q4% 1NAF
MHZ?9_*9;9\<LC^@D(5^4'U*5N[F"VWWXT\FUD,ICJ>*M^M6'*VO+RO*LBW;O
M)#5L%Z_78EU)X6H> [5X5-!8 IQP8NC4]DDW-9O\10'[Q-?7("RV\&VET4Z;
MI# X;^HMEPQ)9& 2A\^^)JB@M6B3&C)=A;MOY!M4R.OZX]-_4)C8N#=12RUU
MDD[_FR%O^^(MBD@DKGABZ3I'I@=V<X+<)(@'->(([?,;8XI5_ZRE.B<TTG0[
M<AE,Q:I!DW]&>.N7] -V.\)#VGHH@_M'/Q_1F$_'M0%F"?\[('.9N5_O02^9
M4S-QM:G&]+>$S('-B,;7;_9', _XYH/Z8#WG3Z3LB'WP79E/7NCY^BJZ1KZ[
MG[OPFQUZ8-E8\) ^1]$MA^NNE#%C=/./O1-S5(3XUEQ;K6<V=\P+74+MYO>C
MX*#UK>L9N:V?]::O XGJZ#3&6'?I1QX'7K4)Q+#R/;=",RC&E*'4%PMU7_U[
M#@]J=[0Y5I0DL?%)H^<C^ Y?'?N\.[GQ>2!HVWR9'"S[H;&6D:"LPEK;DVEB
MHIA.R!GA"[U*0Y@\;]->J_%>V;S0M-3AZ<<@(S I_$^.8O1*O*RYPBQ_[=72
MR SJ+%KTH51PPE?M,C6<7_)$>?[@<^&^C[ NC"[6A(:HEN^,/ZIX*Q7_S+1B
MUM6"#D0]?Y=4PYO&-T7>@'G^Y0LW1Q%4_]/L>4,CQ)5&2T=QR!S+89 $EWB!
M%KV4DYW%3#WK_(QQ%G)-"&8.>VZ"]_N@Q #CU[!=:_-"W7E%X>*'<=^$::SR
M6 +,V+7\ ( KZH,"(D2"JX=&FR<D2OI=5A!EDCT10!,75"G#^,UO>SR7WZW<
MF9<T+8@##+G_9%?0&7XQ'R&#X4<(61-P#>'T'=P'UE#6"G@K:5*U2!$Q7I[8
MG#+3(X38D)8FC]=3>?D'6-L E/0!4B2_D.\\HTRR0)Q$YQ5G=2<D,2EUE266
M!V@P19NMNO\\V]Q7YTJ]09XGP6W?]E*CH1O$YR\J+3%]''1[]7MB[M1%@]9B
MC-Z23?3Y=SN9));1=O]+S08K]YM958[,N33?-UL-M0>PJ:@7M>0B8\9?9JRR
M0#VTJM*5Y8W.3P#%*WDI"7*;0<ZAS".^MCF +<:>\E%1 W]<]S>)[V<UU!.R
M15*3N6*4>0EB=?:U/" "_*-I_=#.[;'*S&OK3'SOC8K.&*.P-KY--[.Q79+W
M<%PM<'N3'(L 8P5GR]_I>J'ZW8)BS1UWXPNU!L+GB\8L1LWQ!<Y]G2H,V+[S
MU7SZ2K"MW)W3LV_U ?RRVOC%W^I=U7H1Q7P&1'<5164X!XSYNZ9A$(; L[2N
M/MGVR=@WK4YNS]I3=L&WMQ5?IZA)"KZ+U_OH*\H7M,D3@)UR@M6.3Y"B]0C$
M%RI.7ZN7MWXSE.8M=FO6-!DE5TY\'%G3WBS 2LE?6U&Z0HBP!IH>Y)\K#28'
MJ"AMH5GR;1*5;8E?4A*F/[@L>]J"FP&EK7_RYQZ^MZ<1(2I3S,$CX#>^11#N
MKR#4^?';?OO\Z9F5?=RRWMK?I@;IN/-1#JFIE!M5U\FPVF.1]<UR5$SKB$"'
M"OVVBBPDVSXEC_&>A-AR('@Q,E)Z1F(PYZ*X.W/IYMI85Y0AI\PZ;E"\+JA$
MR0)3Z^],]'H$L<6/O\&>.\9^-7EM?5T+]>-F&WNMQ/>_67A >]*G%NAZ0"#9
M,;7_I("A;?^5RF,[M9+.NPN2[\F"]0\%5YEM/5';ZL9$D?U_:Z?K[;./.QU
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M4Q&@VG;5GK2)B;8AI!+T-F'/)=K\"? ^Q2!D^$M'B*TQT;_W<*UMUP'=^C,
M<!Q<.>I3_1"KBWA57Q(2_.*J2"(=N'\V/H:[AP9+2Y\H37?D<+@+Z#,FT#%2
MO9;_<F*QY+=)3&-@T(G?-7[S,J.5O>%[.L7RA2O=+I$)X4,/P0C3D!K+\W->
MODT-V4[FJK>JF.("XOSR"@&YS\&;TGW922TT5VCTGLU/QF=C9@50LUOZ6Y1
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M$[0.[,+#J?>:;#7O,(=ZRUZ)1\/?.NUM;3T!?GU0/+V_ZP,YN8P$YD_2%"S
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M__ 8?V-T<KFQ/8#@0P*5$H$T@ A#<Z]R9XW&;T0/7$RDK4CZT&K<V68M92A
M* ;VNSHW4F<:I1V[,/LU.>XE7M45,<)A";(9\^T2*MZ]H>4N_/9N(L47DMA%
M!(0K5028&S64I/_"<J8'].M3\"M=?VR"TYZI#O9J]D^*1@B#L1J@AZJ2SRCI
M4#/4'!P[\F?[*:E]R;3]HW(-87ZV^,EXK*5;263PS72\60 F#[ 2&RC2)N]H
M:W7^(^-E#):+N-GZ9,'JQN$ZB:P)JJ,!Y=Q4:@T;GMOU*?+^9E1\L_OW6V5S
M*37?APJX)I!.O,*T)^)M:23C[TO1CV=G;=0#YIT(D/&^O9C8*>OER+.EVB?
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MIJ_W4<T,?E=;P@<KRVJ]0I#%GI'#8Q*Q;OV%1>,)WN.RAE"C& ( $!!$V7]
M,\PK.#SUL;XXHZ10FC1>LI9:H.]RA(!>HT_C-A>>@T4FH.G7O+NYU4S,T$$9
M#*B>?$LUAU>&E9J #Y8+%(<9GINM]*;;,_ICLZ4']B8FZM+O>[XH#31LZE32
M!"K6NXSO^'!9=R4W9B]-/ &N9G$<8Y371:ZBK*,W>]@Q:$'L>7M<^Y#$S*W\
MP$K6%%BR3@+5Y37 '^//,I@[T4R6?S*S#=6DO:?&K -+SJ25>U.U=W$,;LBC
M'"12#W)2Z=K[9#A^6TSR]F)(5*(";:5.KTEDV'.1ZNWX17]C=&/0*;C!\Y5>
MG^>),?_PGLS890O..H89GV_(V$[=G>'YQE[#J9/T 7/Z%N!01(DVN)!5V(-&
MTJ^_ JV&FN+F?!]VW<D"[;BPXWM,X[AV6X+:2L-V8VQ7B# UIFQ$2L+W:/QH
M-^!^1UH (+ " &T]Z4SPQO+MG\(^47(BMV_!F]S=?5.5T.S02+AA?&J($F6-
M<;XFA(N61*P=Q8ZH^WJZ3NJD-?N'Y@<6JT7>OK?M=PKZ-TL +B%1?R"RVF)K
M+76%7NZ9(P 7P"_6X'-/NC[5X Z4:>Z&9;U]UNDPN* @H<D.N@;_G!$(3V3/
M""2JJ@:QI_VOUM.MAC'*&F8@5D0_-7-3K*\ S!OT\+IY_,'Z!,C,.5G8/THR
M&ZGQO0G5W?MJ<<T6N1%,E!3#X5('T]R'Y=&\%>EE1"^([_S3!C0?R5A]*53B
M/3\>YM@\RE2<YEAHI[NM#5Q5<(#_QOI6>4GU1;@\U,T5 >*0Z,>PG 2(8HS=
M/5/X]<E0S[]XUPFQ-A])SP-@CY &D*3'0JD?>1 78R$JUI-8_J/T3=<4(C1R
M3H@1L6-5ZX4^9:[B)2V!#H8BX=VO>*:V52!@_CFCW^S22H+P6A2/EQ,K-$6+
MFF<6$/<!)Y3(&#.S,U@P-AX6Z(U;0*F:!@))Z.E:[<\MX;.Y>Q/Y_DTR57#U
M[T/D.S&U6COC_ .9G374' >*XQWL7S(VV[:I#8K4Q1#]F\/ #Q1)H5W]?[X]
M\)O0IVUR9S9_;-OG,KC_]!XQ"LHG6HH=^I]YJ#$O_(*OFIO[7PL%'/.41A#\
M_W0K/JW^;U!+ P04    " !:BG1:U<OHX8\:  !^, $ $0   '=L9',M,C R
M-#$R,S$N>'-D[5UM<]LXDOX^OX+GJ[J:K5E'?HGCL2_)EOPB1QD[TEIR',_6
MUA1%0A)G2$(!0-G*KS\ ),57@* D6_ M/\41@<;3Z ;0:#0:[__QY+G&'"#L
M0/_#SOZ;O1T#^!:T'7_R8>=NL-L>G'>[.__X:!@_O?^OW5WC"O@ F038QFAA
MG$-O-K <8XA,'X\A\HR?B?<W8]>8$C([;;4>'Q_?6+0,MAP$, R0!3#[P=C=
MI01CDN<(,(*GQG :&#<F,@[VC(/]T[U?3]^^->Z&Y_3_!T=AE9_>/^%3;$V!
M9QH4N(]/'UT;?]A)M?<(3&2.7&"#N1,V]\9Q6Y3$V_V#PWW*G0L\X),.17L!
MQF;@D@\[WP/3=<8.L'<BJAB17;*8@83TV,2C-Q!-6LM/G.:.04PT >2+Z0$\
M,RU0"TO8F.OX?V6J/8V0R]LZV-L[;+'/(Q.#N/A3H?SC(2^]?W)RTN)?XZ(!
M%G$1?XF8B"CC,K(4Q'[KV\WU@'?[LBS%:)-E^33DHU;X,2YJ$U3.'OW08B@8
MB(/=O</=I$]8&4?2*8Z/B>E;8.>C\9-A,*TP?1\2DU U9JKU$U,O_O-LYOAC
M^#'ZB?[(.N@T[M1;,#9XEYTR(!]VL./-7-;5_+<I N,/.TS%=F.A_>&:HS<4
M8US$1!:"+I#+HS5#< 80<6B'I\3)"11J9QEEGUNT3>!>)Y!W6A\WQ<X,@1=G
MA[:)Z1#DPLIQM3$QV6#\XGS1-AW?*>%J0SQ9IOOB/-$VK< M%56&*U9X2/DP
MV!]WMUV%>9#3/X<^AJYCLQ7@S'39F!Y, :"3AV.'_/^!_A 62E#$.!(9?#PY
M.3K<VZ>KT8"J&I_TZ=]I4D9$R^#$\/M6GD*!>H"!W?,_\K_S6AQ5CXI(JV85
M)5_1D-;-"217.99)*R.4PKC:M+3^Z)N(]L44$(?BPTK"R]>IEN6!NBR-G[/4
M_U8FW$:\$O%VJ17H@65W"T6:+_>QR%]>CH<R.2X_8 ..N86)P!3XV)D#XQKB
MTE':2#(OR<&4JO\4NC:U["^_!PY9,"H'$!UF!"DI]K%*BF]K2'%J^A. #<<W
MTBW^SW__>K!__+]&V'(S0M>2JVP*5J]5*?6C#4M=9:)N=$ X2Y^;>-IQX:-P
M>EX6*!M->>&^JR%<2M=@A!NSJ5IBH=/$S0@I_DUAO3RFHKAPL.5"'"!@Q$X8
MMW3&;+H^.V$Z$]\9TZG%)VW+@H%/''_2ITIMT1U1=I*4EJRV3G_-2RE%T$@H
M&C')9MQ4"J_KSRG+$.5%E?Z]<L4ZR<LE5;N10:4,^J'_8&'Z-ENQ9VP%^)+;
MGXO*E'*6D\_^7EX^,36#DC.6]/YN4(K-C%<ML&M@XMQXB7ZJ&BK[^WE1A!6;
M45*]S!"JK*-%:-/V V1-:<>U)PAPBXE^HZ;4G+GA:'6JWYZ#,42++Y" [!JT
M.AFEL7906*,847:4$UGC<9O&LE$^"E/-&DF[!FNX40X%@]WS',)-YU"$S X
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M4^?=Y>WX;N_+U>]?KJZF9R1X.C_Y!/'!V<'Y[P/2^>?BLDWV)_CQZ+K]Y\,
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M+W+U,A>YVB-,D&G1P18^<L+?]3FEOSG^I$N QY:"'<.,2GW8(2A@SY/P4C.
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M-?3"&!**L'EU</3V\*  315KR'R^.NAUBI6.4JL=_/%[H?#F\C_%8N$.FI
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M?(T7+[[&2YE3]1WQB9SX2/PTD>1Q*Y(B_YM*_\H/BT60F.+K8I+<Z*\/7V7
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MU(T3=GUKYV61TV:V1-/7TNPTAO%94MY2H=,!QW_?)O%CY]=%0-]D*U3$89#
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M*\/'29"[>$2:4)ZB)<P*80V?&SB?=W-P5H? E+KGAZK%H=#D>#_63J2TX2S
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M"K"I M"Y@+RAV4"']XK8OIZK=3NY5#F)*W07YT7E<-EJOR!8]X_L1[#8,D"
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M? \DG7J'G="MW \+?+YYA^(Q^><<WV2/PUR&HC&GHW_VX,'A!^H9W:55W3R
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M%1/.*%<;)WZDK*6=$!;???,:^TF<_>8"?D/GK)G.ZS+OP%R%^VSI?M%FGIB
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M_N"'@,H 7D.?@ZL&-D1[5_XUHI\C^![]#"VL'FT:1"9)::T,6#LU[!H_)K.
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M4AK<EO8J.#4\UU<KOIQ#P6(\JVSJ^>6;SA[CTRMVX3MQ/-^DB)I'-,IM^D+
MY.5UE],_QNE?X[Y?L-+CP89+6(M38< D:U8K'&:EL$47$%0*7&C/3^]704\X
M>@P'DN:;1G&B"-XH;*YB\C]3VF_Z-!B^9_(.<#*(K-\VR_K_25DP<YJ!TGF*
M5O:L+BMUJV2)B-J:3[GE,R+*JLH3[*IUD)C'B36U4]Y#12)%<I5DT+KEN.;)
M#D>7812%S_#"=<^V1[UW"W=*-18$")D%7N)! DZ$7<^6P[E!)I5WG#BCTH7
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M_7WR^T^_/IP>O_GS/]#5<G%QH?WF$%F=\!Y( NJ%16(/LJC$="RD00J9$=7
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MN4?;P!!((',PU<>E<VA<>MO VY"!$^@4U8*@<(J'X^5ZA]VCC\/-) B.CK^
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M]S(/4;B-G'U_-R2R[LV8/TULR#+T4-$&I8TXGD?3]R8*(LNO3IH&K@F;E9?
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MIGS" V9'K;A(P:$5D]@SXS$YK+$'D2T&Q0BFMA$U%1'8W# 8.W33;XMDN?7
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M/>P-_51%?IV5?;,(=4" *1P+?3F>V?RY]QG?P$&'-W?-LA:/00%P%T@%Y5U
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M0.^(=\\#F9 8 ,D1\L7.O)DYGG7R)G8G-9X*L^XW<FOM&$[ I-P&S>*N=;%
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M<_%S7>W W8C.BN>RYQ"IXJ.%-1XTKUA'=-J-6196I#OW''F"%%A %(-=;45
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MV)-247AK<AY?>/!$RYV^J4TE/D,S4UA1&JY; Y-2"CPQ&CH/H>#!F\+* +9
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MTS\*I!5ALW"6U@B7K69?2!@:V6,^6]T!Y$\R]7A9F%;K%;:($G>A7&/M4VO
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M\2?+>D/>=PW$#F$[GBCT24%"/W[Z[2,%"CW2*"FA/]XZ61>^J*A9L=JJ-&?
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M 9</15EW?9RVQWM!I!M$^T&J(\1[0J/$U7Q1"Y-(-D,9#N!80EU1X=#_J$L
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MX_%SAIB0L2[=YP:N]2U#$FW:;D5N\ XN\Z"<+#7I:&=PL,KND.QO!NA/!S)
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MM[$/-MKAG#W:>3CO&/]R^L6NY9$-4,98M/M5/4HBLU[P!:]Q0,-G-<<BK7G
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M*"NIM:VV/9D]>WPH$MW-,9OH@&1+G5]_ 9#L)MD$"8 %@I3U82:V+*(*3Q6
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M!*0OGQL<NCU<&&K(6%U9W2X-=:!!&2B:TBR;30<&C1J6!3(#V"?%JBRV+XM
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M(PU_D4HBHI/P8-ID!A%8=:@QK#195+HD0'2)I6_2*<TKK.*0([W>"!&"RXH
M6WVP@A2..=H=5(P26(($W*J<1!%V?9:7ECG%[\YO)YT79OVH@[]W:@ %F/.@
MZS3,'5]%_N[8J_?]+HU2N$V(NW(B-%D25*I")ND[U" PJE=('0#!DAP 7QIO
M";I(6)9"ON,4GK\^TI^3&5KZ$<M$]LY\@MQ8Z3W!&/$Q&%[FD,\5J;O'"O35
M6GM&< _775D8_'%C6@2Y:@$TCH+WH:4_OL#D#A&>EM6C+^V8]@C.*TU0<R6
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MQDCG 7)C@D/?W7-?MW8%1AX8,;M/:@JKALD?#F([E4*97RQA U#F[O B?J
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M'6=U&U4:,8LH]32(6VE'5QK0:ED)>>FJ@90+TDJ'IQESTX?(R_-[)ZZ;K).
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MN1W>4%3[*PN^'854A!/OD";;S82^=LA7Q-[B^++/5[WD<5/[Z2B.F_I)YU*
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M!.R(3.A8N](O RL"!$=V7R&4]01$"'!-#(U[+F8H8$7N;AW".NRUN2YTU+I
M83<G3AC1^R5/DC3CNV@EI[P^:R&2]V T?*YYN@NF:,J%T4K.[A*7U2^VRIM$
M">+,4+\INROD)0&:+M*(E6L4K["7EMME-Z#CGR)TXZP1E,.C"WD[<F]?COO+
M=B=LK3BW1"R!>4]:"%ATH0 LA%SP;2AV<;6<X@5F1<I(=(U8Q+WD/;?RD8W+
M$23*QRC W9(@C8R37?%?9#=- '.CAO"0MTL='&'<35VE+;\S:DJUN#,.T,P1
M:[A(KO6[H(H<)M$*D3-GY80*>^#11S8=1'IH'L\;W#<TMIWAV/VL<>O5W0_.
MUYL \[!<I92AFL\&NKIK715UL[;A;)XN%KZ+2,H.0M<XC%?![LX)'+*3DD/C
M &.22#,24'N$IL]BIRX8\=>6W;XJ0FF  -3/:]([=Y?<1^C/A"WU+4MB:0\M
MTDI*J5 QY)D3DE&N:E:/BKQ+KG& +B6BR^.:<L@)R5@-)VK3(IZKW"BYWCTN
M.>L7?NB$KN\$AWPQ U=%$15;)YW,,BI:@$*4^HXPRAGB)P"EQE)'TAJ_?KB<
M+FKXC.9TN*C^GXQ<($%9LWE1:ED:I2:/H.*H^NATV^?NJ^75754AJPP>;K46
M-V$%<=5 H[&0NS8[8D[)&<NW!'K0.(QE8]7(;JF56??O2=LS(+\J9( OK@%+
M[PA'RE3"NZ+I6B\ ;+!KY]%?)VLP],KC6;IE-<)7F;%==W]EG;'CQ(#!)J(R
M%H--B!*$IPY(;$:L+S$=R_Z+%KUM$9[0- *0A1'KJ)Z&37-67P##V/BRK+HL
M^WI*>,:\@:U/3,?2"E+=^QJ R@MU]/]N6<N4D1VPB=(@ZD*(-;A5BA!1'$>M
MYA0>,D7?VGZQD$)6./$QOV1V-(RNCMXP-9+!.[H@[QP6E,-OX^660FG1]<NP
M\-P!?4JKD!Z2B[GVV4</4*CW4[50LKH%NV<6N0GQV<O\J1,$R#O9E7]/+NZL
M$X4!&6JUHNZ(GXUW69%6MJYRT4N6PGBVSR<9D2KA8S==I\!J0]MDR-UY0+V5
M-7?B^@[+W?-D.LKO%(>1[Z&T,^P,N<C?\LX4O9RY,L2'OA/K8JI_%0-)K:P]
M0 3%!;-_C:#+;NKQ,(:]O"/*&J9XW6.4GF8\UW+4E;9T.4>-LDY'?5$[B+:D
M@&?()8BWF3<AUGI28UK"S9AE K53U9N=-2L<L%24-'EEAK9L5/X/=YO !P]C
MDZ XK&>&YB-;!L!,PAHELVM:&7<.FBQ5L_&0GU+RL,OC'5Z?XNW!DP=6?6U?
MDZ98V,[$HZ.0COII1K'Y<I;!<ADN,%ES7&L")6L+!3%H.<?T#P=&&P>UM:G)
MS+2L]4)IYFZ!W*^L"OAY&'.W0W>4RR/9,0&$,U)$\ZUZEM&>]&[B>73&$1BF
MU0&M7*7;IJ<(\#N=9Y ##U<^KV8/AG!Y/)O;0L/\%"'^7G-'8 FTIRL66),^
M.G>&N'9 :TK<-#U%A'_04>+*/9,/:_)1M4C NA'?9I747,1+ '6*)2FW![[!
MMT[:4"SW\"D\JDH.-0J\96&Q5%@LOZ'/\6U"W!6]PI495I":Y%"CD)HL+'"O
M#LH'268H2,7-M9\BQZ.E!IK)N]DD\?RB@2Z\IGU+5S0."B;=[8+20#;>#$2S
MT;QZ/1L"SX; LR'P; @\&P+-;I'"2=YRW"D[2*I#Z]Q_BR?"ES>@)YRE*V_]
MC)CRR$BGXA,;JAUHW1TF4.L<YAH4NB6-LD%/DL@/Z:BL7JSCMJ=%M,-;/Z*E
M%R)UE 6 0%;<K[]P_/*:\7%/MU_VM_\/4$L! A0#%     @ 6HIT6E()X9["
M;P, >/L8 !H              ( !     &5A,#(S-#8U-"TR,&9?=V5A<F%B
M;&4N:'1M4$L! A0#%     @ 6HIT6@1/8SY',0  MP$! !X
M ( !^F\# &5A,#(S-#8U-# Q97@Q,2TQ7W=E87)A8FQE+FAT;5!+ 0(4 Q0
M   ( %J*=%I+-.%/3 <  # P   >              "  7VA P!E83 R,S0V
M-30P,65X,3(M,5]W96%R86)L92YH=&U02P$"% ,4    " !:BG1:"H")PUD'
M  "K+P  '@              @ $%J0, 96$P,C,T-C4T,#%E>#$R+3)?=V5A
M<F%B;&4N:'1M4$L! A0#%     @ 6HIT6G(&"Q6# P  =0\  !X
M     ( !FK # &5A,#(S-#8U-# Q97@Q,RTQ7W=E87)A8FQE+FAT;5!+ 0(4
M Q0    ( %J*=%H]9HAS>@,  +$/   >              "  5FT P!E83 R
M,S0V-30P,65X,3,M,E]W96%R86)L92YH=&U02P$"% ,4    " !:BG1:('%\
MZ7T#  "$#0  '@              @ $/N , 96$P,C,T-C4T,#%E>#$U+3%?
M=V5A<F%B;&4N:'1M4$L! A0#%     @ 6HIT6@.<!)UG*P  L/$  !T
M         ( !R+L# &5A,#(S-#8U-# Q97@R+3=?=V5A<F%B;&4N:'1M4$L!
M A0#%     @ 6HIT6O$SU,5]&   HAD   L              ( !:N<# &9I
M;E\P,#$N:G!G4$L! A0#%     @ 6HIT6JO*\.^("0  $ H   T
M     ( !$  $ &EM86=E7S P,2YJ<&=02P$"% ,4    " !:BG1:U\Z%4:9Z
M   &A@  #0              @ '#"00 :6UA9V5?,# R+FIP9U!+ 0(4 Q0
M   ( %J*=%I;;;V5K2<  & J   -              "  92$! !I;6%G95\P
M,#,N:G!G4$L! A0#%     @ 6HIT6EVFR2*&)   G2@   T
M ( !;*P$ &EM86=E7S P-"YJ<&=02P$"% ,4    " !:BG1:B>DY [$?  #.
M)P  #0              @ $=T00 :6UA9V5?,# U+FIP9U!+ 0(4 Q0    (
M %J*=%KT"HR3U#8   ,X   -              "  ?GP! !I;6%G95\P,#8N
M:G!G4$L! A0#%     @ 6HIT6M7+Z.&/&@  ?C ! !$              ( !
M^"<% '=L9',M,C R-#$R,S$N>'-D4$L! A0#%     @ 6HIT6E'='#1T#0
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I9',M,C R-#$R,S%?<')E+GAM;%!+!08     %  4 $$%  "4J@8    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>ea0234654-20f_wearable_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:wlds="http://www.wearabledevices.co.il/20241231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wlds-20241231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wlds:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wlds:WarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-17</startDate>
            <endDate>2025-03-17</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-25</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-24</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-10</startDate>
            <endDate>2024-10-10</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-16</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureMachinesLeaseholdImprovementsAndElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ComputersAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:OfficeFurnitureAndEquipmentAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:ElectronicEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MachinesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">wlds:MachinesAndMoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2024-06-06</startDate>
            <endDate>2024-06-06</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">wlds:IMEIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2021-04-22</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-09-20</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-20</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wlds:ConvertibleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-16</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-07-04</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-09-16</startDate>
            <endDate>2022-09-16</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2022-12-14</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">wlds:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2024-11-27</startDate>
            <endDate>2024-11-27</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wlds:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-27</startDate>
            <endDate>2024-11-27</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-27</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-27</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-23</instant>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-23</instant>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoThousandTwentyFourGlobalEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-15</instant>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoThousandTwentyFousEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-15</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoThousandTwentyFousEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-15</startDate>
            <endDate>2024-08-15</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoThousandTwentyFousEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-15</startDate>
            <endDate>2024-08-15</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">wlds:TwoZeroOneFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2024-08-15</startDate>
            <endDate>2024-08-15</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2024-12-25</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2024-12-25</startDate>
            <endDate>2024-12-25</endDate>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-11-30</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-26</instant>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-26</startDate>
            <endDate>2024-09-26</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2023-04-27</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-27</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-25</startDate>
            <endDate>2024-12-25</endDate>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-25</startDate>
            <endDate>2024-12-25</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-25</startDate>
            <endDate>2024-12-25</endDate>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-31</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-31</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandSeventeenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">wlds:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September132022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September132022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022TwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:September152022TwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:NovemberTwoSevenTwoZeroTwoFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:NovemberTwoSevenTwoZeroTwoFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:NovemberTwoSevenTwoZeroTwoFourOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wlds:NovemberTwoSevenTwoZeroTwoFourOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wlds:CofoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wlds:AsherDahanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-14</endDate>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wlds:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-30</instant>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">wlds:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-30</instant>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-30</instant>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
        </entity>
        <period>
            <instant>2024-11-27</instant>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-06</startDate>
            <endDate>2025-02-06</endDate>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001887673</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-17</startDate>
            <endDate>2025-03-17</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="ilsPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="Vehicles">
        <measure>wlds:Vehicles</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-15916">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0" id="ixv-21">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-32">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-15917">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-15918">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-15919">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-47">false</dei:DocumentTransitionReport>
    <dei:EntityShellCompany contextRef="c0" id="ixv-58">false</dei:EntityShellCompany>
    <dei:EntityFileNumber contextRef="c0" id="ixv-15920">001-41502</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-68">Wearable Devices Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-82">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-91">5 Ha-Tnufa Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0" id="ixv-15921">Yokne&#x2019;am Illit</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-15922">2066736</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c0" id="ixv-15923">IL</dei:EntityAddressCountry>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-15924">Israel</dei:EntityAddressCityOrTown>
    <dei:ContactPersonnelName contextRef="c1" id="ixv-106">Asher Dahan</dei:ContactPersonnelName>
    <dei:CityAreaCode contextRef="c1" id="ixv-15925">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1" id="ixv-15926">4.6185670</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress contextRef="c1" id="ixv-116">asher.dahan@wearabledevices.co.il</dei:ContactPersonnelEmailAddress>
    <dei:EntityAddressAddressLine1 contextRef="c1" id="ixv-120">5 Ha-Tnufa Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c1" id="ixv-15927">Yokne&#x2019;am Illit</dei:EntityAddressAddressLine2>
    <dei:EntityAddressPostalZipCode contextRef="c1" id="ixv-15928">2066736</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c1" id="ixv-15929">IL</dei:EntityAddressCountry>
    <dei:EntityAddressCityOrTown contextRef="c1" id="ixv-15930">Israel</dei:EntityAddressCityOrTown>
    <dei:Security12bTitle contextRef="c2" id="ixv-155">Ordinary Shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2" id="ixv-160">WLDS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2" id="ixv-15931">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c3" id="ixv-168">Warrants to Purchase Ordinary Shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c3" id="ixv-173">WLDSW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c3" id="ixv-15932">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-15933"
      unitRef="shares">707463</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-15934">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-15935">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-15936">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-15937">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-259">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-269">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-275">true</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-285">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-291">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="c0" id="ixv-15938">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:DocumentShellCompanyReport contextRef="c0" id="ixv-336">false</dei:DocumentShellCompanyReport>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-15939">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c0" id="ixv-15940">The audit committee is
involved in oversight of our IT general controls and cybersecurity.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c0" id="ixv-15941">Our IT general controls cybersecurity policies, standards, processes
and practices are fully integrated into our risk management approach.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c0" id="ixv-15942">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c0" id="ixv-10552">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Risk Management and Strategy&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As part of the critical elements
of our overall risk management approach, our cybersecurity program is focused on the following key areas:&lt;/p&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Governance: As discussed in more detail under the heading &#x201c;Governance,&#x201d; the audit committee
oversees our cybersecurity risk management and interacts with the Company&#x2019;s Sarbanes-Oxley Act, or SOX, advisor and the Company&#x2019;s
Information Security advisor and other relevant members of management.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Collaborative Approach: The Company has implemented a comprehensive, cross-functional approach to identifying,
preventing and mitigating cybersecurity threats and incidents, while also implementing controls and procedures that provide for the prompt
escalation of certain cybersecurity incidents so that decisions regarding the public disclosure and reporting of such incidents can be
made by management in a timely manner.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Technical Safeguards: The Company deploys technical safeguards that are designed to protect the Company&#x2019;s
information systems from cybersecurity threats, including firewalls, intrusion prevention and detection systems, anti-malware functionality
and access controls, which are evaluated and improved through vulnerability assessments and cybersecurity threat intelligence.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recovery Planning: The Company has established and maintains comprehensive recovery plans that fully address
the Company&#x2019;s response to a cybersecurity incident, and such plans are tested and evaluated on a regular basis.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Education and Awareness: The Company provides regular, mandatory training for personnel regarding cybersecurity
threats as a means to equip the Company&#x2019;s personnel with effective tools to address cybersecurity threats, and to communicate the
Company&#x2019;s evolving information security policies, standards, processes and practices.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We engage in the periodic
assessment and testing of our policies, standards, processes and practices that are designed to address cybersecurity threats and incidents.
These efforts include a wide range of activities, including audits, assessments, tabletop exercises, threat modeling, vulnerability evaluation,
and other exercises focused on evaluating the effectiveness of our cybersecurity measures and planning. We are engaged with a subcontractor
that monitors the IT system and cybersecurity, including centralized patch management as part of their routine job functions. We regularly
engage third parties to perform assessments on our cybersecurity measures, including information security maturity assessments, audits
and independent reviews of our information security control environment and operating effectiveness. The results of such assessments,
audits and reviews are reported to the Board, and we adjust our cybersecurity policies, standards, processes and practices as necessary
based on the information provided by these assessments, audits and reviews.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c0" id="ixv-15943">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c0" id="ixv-10614">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Governance&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The audit committee interacts
with the Company&#x2019;s SOX advisor and the Company&#x2019;s Information Security advisor and other relevant members of management. &lt;span&gt;The
Company&#x2019;s Information&lt;/span&gt; Security advisor &lt;span&gt;is responsible for assessing and managing cyber
risk management, informs senior management regarding the prevention, detection, mitigation, and remediation of cybersecurity incidents
and supervises such efforts. The Company&#x2019;s Information&lt;/span&gt; Security advisor &lt;span&gt;has experience
selecting, deploying, and operating cybersecurity technologies, initiatives, and processes, and relies on threat intelligence as well
as other information obtained from governmental, public or private sources.&lt;/span&gt; The audit committee receives updates on IT general
controls, and a set of policies and procedures that govern how the Company&#x2019;s IT systems operate and ensure the confidentiality,
integrity, and availability of data as well as on cybersecurity risks, including prevention of data theft, unauthorized access, operational
disruption, and data breaches. The audit committee also receives prompt and timely information regarding any cybersecurity incident that
meets established reporting thresholds, as well as ongoing updates regarding any such incident until it has been addressed. On an annual
basis, the audit committee discusses our approach to IT general controls and cybersecurity risk management with the Company&#x2019;s SOX
advisor.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As of March 19, 2025, we do
not believe that we have experienced any cybersecurity attack. Cybersecurity threats and cybersecurity incidents, if they occur, can materially
affect or are reasonably likely to affect the Company, including its business strategy, results of operations or financial condition.&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c0" id="ixv-15944">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <dei:AuditorFirmId contextRef="c0" id="ixv-15945">1185</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock contextRef="c0" id="ixv-11202">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Opinion on the Consolidated Financial Statements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We have audited the accompanying consolidated
balance sheets of Wearable Devices Ltd. and its subsidiary (&#x201c;the Company&#x201d;) as of December&#160;31, 2024 and 2023, and the
related consolidated statements of comprehensive loss, changes in shareholders&#x2019; equity and cash flows for each of the three&#160;years
in the period ended December 31, 2024, and the related notes (collectively, the &#x201c;consolidated financial statements&#x201d;). In
our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at
December&#160;31, 2024 and 2023, and the results of its operations and its cash flows for each of the three&#160;years in the period
ended December&#160;31, 2024, in conformity with accounting principles generally accepted in the United States of America.&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="c0" id="ixv-11250">Ziv Haft</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-15946">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="-3" id="ixv-15947" unitRef="usd">3089000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c5" decimals="-3" id="ixv-15948" unitRef="usd">810000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DepositsAssetsCurrent contextRef="c4" decimals="-3" id="ixv-15949" unitRef="usd">862000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent contextRef="c5" decimals="-3" id="ixv-15950" unitRef="usd">4045000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:GrantsReceivable contextRef="c4" decimals="-3" id="ixv-15951" unitRef="usd">17000</us-gaap:GrantsReceivable>
    <us-gaap:GrantsReceivable contextRef="c5" decimals="-3" id="ixv-15952" unitRef="usd">108000</us-gaap:GrantsReceivable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="-3" id="ixv-15953" unitRef="usd">322000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c5" decimals="-3" id="ixv-15954" unitRef="usd">757000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:FIFOInventoryAmount contextRef="c4" decimals="-3" id="ixv-15955" unitRef="usd">1226000</us-gaap:FIFOInventoryAmount>
    <us-gaap:FIFOInventoryAmount contextRef="c5" decimals="-3" id="ixv-15956" unitRef="usd">1032000</us-gaap:FIFOInventoryAmount>
    <us-gaap:AssetsCurrent contextRef="c4" decimals="-3" id="ixv-15957" unitRef="usd">5516000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c5" decimals="-3" id="ixv-15958" unitRef="usd">6752000</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c5" decimals="-3" id="ixv-15959" unitRef="usd">54000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="-3" id="ixv-15960" unitRef="usd">330000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-15961" unitRef="usd">592000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="-3" id="ixv-15962" unitRef="usd">130000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-15963" unitRef="usd">194000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetsNoncurrent contextRef="c4" decimals="-3" id="ixv-15964" unitRef="usd">460000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c5" decimals="-3" id="ixv-15965" unitRef="usd">840000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c4" decimals="-3" id="ixv-15966" unitRef="usd">5976000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c5" decimals="-3" id="ixv-15967" unitRef="usd">7592000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c4" decimals="-3" id="ixv-15968" unitRef="usd">157000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c5" decimals="-3" id="ixv-15969" unitRef="usd">410000</us-gaap:AccountsPayableCurrent>
    <wlds:AdvanceFromCustomers contextRef="c4" decimals="-3" id="ixv-15970" unitRef="usd">83000</wlds:AdvanceFromCustomers>
    <wlds:AdvanceFromCustomers contextRef="c5" decimals="-3" id="ixv-15971" unitRef="usd">312000</wlds:AdvanceFromCustomers>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c4" decimals="-3" id="ixv-15972" unitRef="usd">770000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c4" decimals="-3" id="ixv-15973" unitRef="usd">402000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-15974" unitRef="usd">579000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c4" decimals="-3" id="ixv-15975" unitRef="usd">392000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-15976" unitRef="usd">190000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="-3" id="ixv-15977" unitRef="usd">291000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-15978" unitRef="usd">297000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c4" decimals="-3" id="ixv-15979" unitRef="usd">2095000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-15980" unitRef="usd">1788000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="-3" id="ixv-15981" unitRef="usd">21000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c5" decimals="-3" id="ixv-15982" unitRef="usd">278000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c4" decimals="-3" id="ixv-15983" unitRef="usd">2116000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c5" decimals="-3" id="ixv-15984" unitRef="usd">2066000</us-gaap:Liabilities>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c4"
      decimals="INF"
      id="ixv-15985"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c5"
      decimals="INF"
      id="ixv-15986"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c4"
      decimals="INF"
      id="ixv-15987"
      unitRef="shares">707463</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-15988"
      unitRef="shares">707463</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c5"
      decimals="INF"
      id="ixv-15989"
      unitRef="shares">254843</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-15990"
      unitRef="shares">254843</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c4" decimals="-3" id="ixv-15991" unitRef="usd">67000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c5" decimals="-3" id="ixv-15992" unitRef="usd">57000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c4" decimals="-3" id="ixv-15993" unitRef="usd">32895000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c5" decimals="-3" id="ixv-15994" unitRef="usd">26692000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c4" decimals="-3" id="ixv-15995" unitRef="usd">-29102000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c5" decimals="-3" id="ixv-15996" unitRef="usd">-21223000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-3" id="ixv-15997" unitRef="usd">3860000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-15998" unitRef="usd">5526000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c4" decimals="-3" id="ixv-15999" unitRef="usd">5976000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c5" decimals="-3" id="ixv-16000" unitRef="usd">7592000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="-3" id="ixv-16001" unitRef="usd">522000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c6" decimals="-3" id="ixv-16002" unitRef="usd">82000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c7" decimals="-3" id="ixv-16003" unitRef="usd">45000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="-3" id="ixv-16004" unitRef="usd">437000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c6" decimals="-3" id="ixv-16005" unitRef="usd">62000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c7" decimals="-3" id="ixv-16006" unitRef="usd">10000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" id="ixv-16007" unitRef="usd">85000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c6" decimals="-3" id="ixv-16008" unitRef="usd">20000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c7" decimals="-3" id="ixv-16009" unitRef="usd">35000</us-gaap:GrossProfit>
    <wlds:ResearchAndDevelopmentNet contextRef="c0" decimals="-3" id="ixv-16010" unitRef="usd">2964000</wlds:ResearchAndDevelopmentNet>
    <wlds:ResearchAndDevelopmentNet contextRef="c6" decimals="-3" id="ixv-16011" unitRef="usd">3316000</wlds:ResearchAndDevelopmentNet>
    <wlds:ResearchAndDevelopmentNet contextRef="c7" decimals="-3" id="ixv-16012" unitRef="usd">2271000</wlds:ResearchAndDevelopmentNet>
    <us-gaap:SellingAndMarketingExpense contextRef="c0" decimals="-3" id="ixv-16013" unitRef="usd">2096000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c6" decimals="-3" id="ixv-16014" unitRef="usd">2008000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c7" decimals="-3" id="ixv-16015" unitRef="usd">1370000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="-3" id="ixv-16016" unitRef="usd">2845000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c6" decimals="-3" id="ixv-16017" unitRef="usd">2882000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c7" decimals="-3" id="ixv-16018" unitRef="usd">1948000</us-gaap:GeneralAndAdministrativeExpense>
    <wlds:ProspectiveInitialPublicOfferingExpenses contextRef="c7" decimals="-3" id="ixv-16019" unitRef="usd">904000</wlds:ProspectiveInitialPublicOfferingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" id="ixv-16020" unitRef="usd">-7820000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c6" decimals="-3" id="ixv-16021" unitRef="usd">-8186000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c7" decimals="-3" id="ixv-16022" unitRef="usd">-6458000</us-gaap:OperatingIncomeLoss>
    <wlds:FinancingIncomeExpensesNet contextRef="c0" decimals="-3" id="ixv-16023" unitRef="usd">-52000</wlds:FinancingIncomeExpensesNet>
    <wlds:FinancingIncomeExpensesNet contextRef="c6" decimals="-3" id="ixv-16024" unitRef="usd">372000</wlds:FinancingIncomeExpensesNet>
    <wlds:FinancingIncomeExpensesNet contextRef="c7" decimals="-3" id="ixv-16025" unitRef="usd">-38000</wlds:FinancingIncomeExpensesNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-16026" unitRef="usd">-7872000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c6" decimals="-3" id="ixv-16027" unitRef="usd">-7814000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c7" decimals="-3" id="ixv-16028" unitRef="usd">-6496000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-16029" unitRef="usd">7000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-16030" unitRef="usd">-7879000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c6" decimals="-3" id="ixv-16031" unitRef="usd">-7814000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-16032" unitRef="usd">-6496000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="1"
      id="ix_0_fact"
      unitRef="usdPershares">-24.2</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="1"
      id="ix_1_fact"
      unitRef="usdPershares">-24.2</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c6"
      decimals="1"
      id="ix_2_fact"
      unitRef="usdPershares">-38.4</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c6"
      decimals="1"
      id="ix_3_fact"
      unitRef="usdPershares">-38.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c7"
      decimals="1"
      id="ix_4_fact"
      unitRef="usdPershares">-42.4</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c7"
      decimals="1"
      id="ix_5_fact"
      unitRef="usdPershares">-42.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="INF"
      id="ix_6_fact"
      unitRef="shares">325690</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="INF"
      id="ix_7_fact"
      unitRef="shares">325690</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ix_8_fact"
      unitRef="shares">202515</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c6"
      decimals="INF"
      id="ix_9_fact"
      unitRef="shares">202515</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ix_10_fact"
      unitRef="shares">153465</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c7"
      decimals="INF"
      id="ix_11_fact"
      unitRef="shares">153465</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="c8"
      decimals="INF"
      id="ix_12_fact"
      unitRef="shares">139211</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c8" decimals="-3" id="ixv-16047" unitRef="usd">31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="-3" id="ixv-16048" unitRef="usd">7689000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="-3" id="ixv-16049" unitRef="usd">-6913000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="-3" id="ixv-16050" unitRef="usd">807000</us-gaap:StockholdersEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c7" decimals="-5" id="ixv-16051" unitRef="usd">1600000</us-gaap:PaymentsOfStockIssuanceCosts>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares
      contextRef="c12"
      decimals="INF"
      id="ix_13_fact"
      unitRef="shares">46875</wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetShares>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet contextRef="c12" decimals="-3" id="ixv-16053" unitRef="usd">11000</wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet contextRef="c13" decimals="-3" id="ixv-16054" unitRef="usd">14308000</wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet contextRef="c7" decimals="-3" id="ixv-16055" unitRef="usd">14319000</wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet>
    <wlds:ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering
      contextRef="c12"
      decimals="INF"
      id="ix_14_fact"
      unitRef="shares">1477</wlds:ConversionOfSAFEsIntoOrdinarySharesUponCompletionOfInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c12" decimals="-3" id="ixv-16057" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c13" decimals="-3" id="ixv-16058" unitRef="usd">399000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c7" decimals="-3" id="ixv-16059" unitRef="usd">400000</us-gaap:StockIssuedDuringPeriodValueOther>
    <wlds:StockIssuedDuringPeriodSharesStockWarrantsExercised
      contextRef="c12"
      decimals="INF"
      id="ix_15_fact"
      unitRef="shares">500</wlds:StockIssuedDuringPeriodSharesStockWarrantsExercised>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants contextRef="c13" decimals="-3" id="ixv-16061" unitRef="usd">160000</wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants contextRef="c7" decimals="-3" id="ixv-16062" unitRef="usd">160000</wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants>
    <wlds:StockIssuedDuringPeriodShareOfExerciseOfOptions
      contextRef="c12"
      decimals="INF"
      id="ix_16_fact"
      unitRef="shares">58</wlds:StockIssuedDuringPeriodShareOfExerciseOfOptions>
    <us-gaap:ShareBasedCompensation contextRef="c13" decimals="-3" id="ixv-16064" unitRef="usd">790000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-16065" unitRef="usd">790000</us-gaap:ShareBasedCompensation>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c14" decimals="-3" id="ixv-16066" unitRef="usd">-6496000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c7" decimals="-3" id="ixv-16067" unitRef="usd">-6496000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c15"
      decimals="INF"
      id="ix_17_fact"
      unitRef="shares">188121</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="-3" id="ixv-16069" unitRef="usd">43000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="-3" id="ixv-16070" unitRef="usd">23346000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="-3" id="ixv-16071" unitRef="usd">-13409000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c18" decimals="-3" id="ixv-16072" unitRef="usd">9980000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c19"
      decimals="INF"
      id="ix_18_fact"
      unitRef="shares">55556</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c19" decimals="-3" id="ixv-16074" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20" decimals="-3" id="ixv-16075" unitRef="usd">1659000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c6" decimals="-3" id="ixv-16076" unitRef="usd">1670000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <wlds:StockIssuedDuringPeriodSharesInvestors
      contextRef="c19"
      decimals="INF"
      id="ix_19_fact"
      unitRef="shares">2114</wlds:StockIssuedDuringPeriodSharesInvestors>
    <wlds:StockIssuedDuringPeriodValueInvestors contextRef="c19" decimals="-3" id="ixv-16078" unitRef="usd">1000</wlds:StockIssuedDuringPeriodValueInvestors>
    <wlds:StockIssuedDuringPeriodValueInvestors contextRef="c20" decimals="-3" id="ixv-16079" unitRef="usd">-1000</wlds:StockIssuedDuringPeriodValueInvestors>
    <wlds:StockIssuedDuringPeriodValueInvestors contextRef="c6" decimals="-3" id="ixv-16080" unitRef="usd">0</wlds:StockIssuedDuringPeriodValueInvestors>
    <wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="c19"
      decimals="INF"
      id="ix_20_fact"
      unitRef="shares">9052</wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <wlds:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c19" decimals="-3" id="ixv-16082" unitRef="usd">2000</wlds:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <wlds:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c20" decimals="-3" id="ixv-16083" unitRef="usd">1447000</wlds:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <wlds:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c6" decimals="-3" id="ixv-16084" unitRef="usd">1449000</wlds:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <us-gaap:ShareBasedCompensation contextRef="c20" decimals="-3" id="ixv-16085" unitRef="usd">241000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c6" decimals="-3" id="ixv-16086" unitRef="usd">241000</us-gaap:ShareBasedCompensation>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c21" decimals="-3" id="ixv-16087" unitRef="usd">-7814000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c6" decimals="-3" id="ixv-16088" unitRef="usd">-7814000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c22"
      decimals="INF"
      id="ix_21_fact"
      unitRef="shares">254843</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="-3" id="ixv-16090" unitRef="usd">57000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="-3" id="ixv-16091" unitRef="usd">26692000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" id="ixv-16092" unitRef="usd">-21223000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-16093" unitRef="usd">5526000</us-gaap:StockholdersEquity>
    <wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement
      contextRef="c25"
      decimals="INF"
      id="ix_22_fact"
      unitRef="shares">307175</wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement>
    <wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA contextRef="c25" decimals="-3" id="ixv-16095" unitRef="usd">10000</wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA>
    <wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA contextRef="c26" decimals="-3" id="ixv-16096" unitRef="usd">4343000</wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA>
    <wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA contextRef="c0" decimals="-3" id="ixv-16097" unitRef="usd">4353000</wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA>
    <wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares
      contextRef="c25"
      decimals="INF"
      id="ix_23_fact"
      unitRef="shares">127500</wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOfferingShares>
    <wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering contextRef="c26" decimals="-3" id="ixv-16099" unitRef="usd">1578000</wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering>
    <wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering contextRef="c0" decimals="-3" id="ixv-16100" unitRef="usd">1578000</wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c25"
      decimals="INF"
      id="ix_24_fact"
      unitRef="shares">9765</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c26" decimals="-3" id="ixv-16102" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c0" decimals="-3" id="ixv-16103" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <wlds:IssuanceOfOrdinarySharesForTheReverseSplitProcess
      contextRef="c25"
      decimals="INF"
      id="ix_25_fact"
      unitRef="shares">8180</wlds:IssuanceOfOrdinarySharesForTheReverseSplitProcess>
    <us-gaap:ShareBasedCompensation contextRef="c26" decimals="-3" id="ixv-16105" unitRef="usd">182000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-16106" unitRef="usd">182000</us-gaap:ShareBasedCompensation>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c27" decimals="-3" id="ixv-16107" unitRef="usd">-7879000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="-3" id="ixv-16108" unitRef="usd">-7879000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c28"
      decimals="INF"
      id="ix_26_fact"
      unitRef="shares">707463</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c28" decimals="-3" id="ixv-16110" unitRef="usd">67000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c29" decimals="-3" id="ixv-16111" unitRef="usd">32895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c30" decimals="-3" id="ixv-16112" unitRef="usd">-29102000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="-3" id="ixv-16113" unitRef="usd">3860000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-16115" unitRef="usd">-7879000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c6" decimals="-3" id="ixv-16116" unitRef="usd">-7814000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-16117" unitRef="usd">-6496000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" id="ixv-16118" unitRef="usd">107000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c6" decimals="-3" id="ixv-16119" unitRef="usd">68000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c7" decimals="-3" id="ixv-16120" unitRef="usd">23000</us-gaap:Depreciation>
    <wlds:AccruedInterestOnConvertibleSecurities contextRef="c0" decimals="-3" id="ixv-16121" unitRef="usd">4000</wlds:AccruedInterestOnConvertibleSecurities>
    <wlds:AccruedInterestOnDeposits contextRef="c0" decimals="-3" id="ixv-16122" unitRef="usd">-3000</wlds:AccruedInterestOnDeposits>
    <wlds:AccruedInterestOnDeposits contextRef="c6" decimals="-3" id="ixv-16123" unitRef="usd">-45000</wlds:AccruedInterestOnDeposits>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-16124" unitRef="usd">182000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c6" decimals="-3" id="ixv-16125" unitRef="usd">241000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-16126" unitRef="usd">790000</us-gaap:ShareBasedCompensation>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c0" decimals="-3" id="ixv-16127" unitRef="usd">-68000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c6" decimals="-3" id="ixv-16128" unitRef="usd">68000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <wlds:MarketingExpensesPaidInOrdinaryShares contextRef="c0" decimals="-3" id="ixv-16129" unitRef="usd">100000</wlds:MarketingExpensesPaidInOrdinaryShares>
    <us-gaap:InventoryWriteDown contextRef="c0" decimals="-3" id="ixv-16130" unitRef="usd">75000</us-gaap:InventoryWriteDown>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c7" decimals="-3" id="ixv-16131" unitRef="usd">-8000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="-3" id="ixv-16132" unitRef="usd">269000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c6" decimals="-3" id="ixv-16133" unitRef="usd">1026000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c7" decimals="-3" id="ixv-16134" unitRef="usd">-5000</us-gaap:IncreaseDecreaseInInventories>
    <wlds:DecreaseincreaseInGovernmentalGrantsReceivables contextRef="c0" decimals="-3" id="ixv-16135" unitRef="usd">-91000</wlds:DecreaseincreaseInGovernmentalGrantsReceivables>
    <wlds:DecreaseincreaseInGovernmentalGrantsReceivables contextRef="c6" decimals="-3" id="ixv-16136" unitRef="usd">54000</wlds:DecreaseincreaseInGovernmentalGrantsReceivables>
    <wlds:DecreaseincreaseInGovernmentalGrantsReceivables contextRef="c7" decimals="-3" id="ixv-16137" unitRef="usd">-8000</wlds:DecreaseincreaseInGovernmentalGrantsReceivables>
    <wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses contextRef="c0" decimals="-3" id="ixv-16138" unitRef="usd">-357000</wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses>
    <wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses contextRef="c6" decimals="-3" id="ixv-16139" unitRef="usd">136000</wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses>
    <wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses contextRef="c7" decimals="-3" id="ixv-16140" unitRef="usd">496000</wlds:DecreaseIncreaseInOtherReceivablesAndPrepaidExpenses>
    <wlds:IncreaseDecreaseInAdvancePayments contextRef="c0" decimals="-3" id="ixv-16141" unitRef="usd">-228000</wlds:IncreaseDecreaseInAdvancePayments>
    <wlds:IncreaseDecreaseInAdvancePayments contextRef="c6" decimals="-3" id="ixv-16142" unitRef="usd">-41000</wlds:IncreaseDecreaseInAdvancePayments>
    <wlds:IncreaseDecreaseInAdvancePayments contextRef="c7" decimals="-3" id="ixv-16143" unitRef="usd">79000</wlds:IncreaseDecreaseInAdvancePayments>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c6" decimals="-3" id="ixv-16144" unitRef="usd">-12000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c7" decimals="-3" id="ixv-16145" unitRef="usd">-12000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="-3" id="ixv-16146" unitRef="usd">-253000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c6" decimals="-3" id="ixv-16147" unitRef="usd">254000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c7" decimals="-3" id="ixv-16148" unitRef="usd">84000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c0" decimals="-3" id="ixv-16149" unitRef="usd">-177000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c6" decimals="-3" id="ixv-16150" unitRef="usd">163000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c7" decimals="-3" id="ixv-16151" unitRef="usd">194000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c0" decimals="-3" id="ixv-16152" unitRef="usd">212000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c6" decimals="-3" id="ixv-16153" unitRef="usd">36000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c7" decimals="-3" id="ixv-16154" unitRef="usd">99000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-16155" unitRef="usd">-7613000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c6" decimals="-3" id="ixv-16156" unitRef="usd">-8434000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c7" decimals="-3" id="ixv-16157" unitRef="usd">-5714000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-16158" unitRef="usd">43000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c6" decimals="-3" id="ixv-16159" unitRef="usd">194000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c7" decimals="-3" id="ixv-16160" unitRef="usd">48000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <wlds:DecreaseIncreaseInDepositsNet contextRef="c0" decimals="-3" id="ixv-16161" unitRef="usd">-3240000</wlds:DecreaseIncreaseInDepositsNet>
    <wlds:DecreaseIncreaseInDepositsNet contextRef="c6" decimals="-3" id="ixv-16162" unitRef="usd">4054000</wlds:DecreaseIncreaseInDepositsNet>
    <wlds:PrepaymentsOfLeasing contextRef="c7" decimals="-3" id="ixv-16163" unitRef="usd">18000</wlds:PrepaymentsOfLeasing>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-16164" unitRef="usd">3197000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c6" decimals="-3" id="ixv-16165" unitRef="usd">-4248000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c7" decimals="-3" id="ixv-16166" unitRef="usd">-66000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost contextRef="c0" decimals="-3" id="ixv-16167" unitRef="usd">1578000</wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost>
    <wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost contextRef="c6" decimals="-3" id="ixv-16168" unitRef="usd">1670000</wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost>
    <wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses contextRef="c7" decimals="-3" id="ixv-16169" unitRef="usd">14319000</wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses>
    <wlds:ProceedsFromIssuanceOfSAFEs contextRef="c7" decimals="-3" id="ixv-16170" unitRef="usd">500000</wlds:ProceedsFromIssuanceOfSAFEs>
    <wlds:RefundToSAFEInvestors contextRef="c7" decimals="-3" id="ixv-16171" unitRef="usd">100000</wlds:RefundToSAFEInvestors>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c7" decimals="-3" id="ixv-16172" unitRef="usd">800000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c7" decimals="-3" id="ixv-16173" unitRef="usd">800000</us-gaap:RepaymentsOfLinesOfCredit>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants contextRef="c6" decimals="-3" id="ixv-16174" unitRef="usd">1449000</wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants contextRef="c7" decimals="-3" id="ixv-16175" unitRef="usd">160000</wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c0" decimals="-3" id="ixv-16176" unitRef="usd">4353000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c0" decimals="-3" id="ixv-16177" unitRef="usd">1920000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c0" decimals="-3" id="ixv-16178" unitRef="usd">1156000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-16179" unitRef="usd">6695000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c6" decimals="-3" id="ixv-16180" unitRef="usd">3119000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c7" decimals="-3" id="ixv-16181" unitRef="usd">14879000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c0" decimals="-3" id="ixv-16182" unitRef="usd">2279000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c6" decimals="-3" id="ixv-16183" unitRef="usd">-9563000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c7" decimals="-3" id="ixv-16184" unitRef="usd">9099000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="-3" id="ixv-16185" unitRef="usd">810000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c18" decimals="-3" id="ixv-16186" unitRef="usd">10373000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c11" decimals="-3" id="ixv-16187" unitRef="usd">1274000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="-3" id="ixv-16188" unitRef="usd">3089000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="-3" id="ixv-16189" unitRef="usd">810000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c18" decimals="-3" id="ixv-16190" unitRef="usd">10373000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c0" decimals="-3" id="ixv-16191" unitRef="usd">49000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c7" decimals="-3" id="ixv-16192" unitRef="usd">40000</us-gaap:InterestPaidNet>
    <wlds:InterestReceived contextRef="c0" decimals="-3" id="ixv-16193" unitRef="usd">-144000</wlds:InterestReceived>
    <wlds:InterestReceived contextRef="c6" decimals="-3" id="ixv-16194" unitRef="usd">-305000</wlds:InterestReceived>
    <wlds:ConversionOfSAFEToEquity contextRef="c7" decimals="-3" id="ixv-16195" unitRef="usd">400000</wlds:ConversionOfSAFEToEquity>
    <wlds:RightofUseAssetRecognizedAgainstLeaseLiability contextRef="c6" decimals="-3" id="ixv-16196" unitRef="usd">644000</wlds:RightofUseAssetRecognizedAgainstLeaseLiability>
    <wlds:RightofUseAssetRecognizedAgainstLeaseLiability contextRef="c7" decimals="-3" id="ixv-16197" unitRef="usd">229000</wlds:RightofUseAssetRecognizedAgainstLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0" id="ixv-13413">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 1 - GENERAL:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wearable Devices Ltd. (the
    &#x201c;Company&#x201d;) was incorporated in Israel in March 2014. The Company develops&#160;and sells human-machine interface solutions
    for the smart wearables industry. In 2023, the Company started production of its B2C consumer product, the &#x201c;Mudra Band&#x201d;
    and started to generate revenues. The Company&#x2019;s products are designated directly to end users and also designated to businesses
    in integration of its technology in their smart wearable devices. The Company&#x2019;s ordinary shares and warrants began trading
    on the Nasdaq Capital Market (&#x201c;Nasdaq&#x201d;) on September 13, 2022, under the symbols &#x201c;WLDS&#x201d; and &#x201c;WLDSW,&#x201d;
    respectively. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;We qualify as an &#x201c;emerging growth
company,&#x201d; as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the U.S.
Jumpstart Our Business Startups Act of 2012, and we may take advantage of certain exemptions, including exemptions from various reporting
requirements that are otherwise applicable to public traded entities that do not qualify as emerging growth companies. These exemptions
include:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;not being required to comply
    with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;not being required to comply
    with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation
    or a supplement to the auditor&#x2019;s report providing additional information about the audit and the financial statements (i.e.,
    an auditor discussion and analysis).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;We will remain an emerging growth
company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues exceed $1.235 billion; (ii)
the last day of the fiscal year following the fifth anniversary of the date of our initial public offering (i.e., December 31, 2027);
(iii) the date that we become a &#x201c;large accelerated filer&#x201d; as defined in Rule&#160;12b-2&#160;under the&#160;Exchange Act,
which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented by warrants,
held by non-affiliates is at least $700 million as of the last business day of our most recently completed second fiscal quarter; or
(iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any three-year period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s revenues were derived from:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The sales of B2C consumer product, the
&#x201c;Mudra Band&#x201d;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The sales of B2B Mudra
    development kits composed of multiple performance obligations including tangible parts (&#x201c;Hardware&#x201d;) and a limited period
    (generally one year) application programming interface (&#x201c;API&#x201d;) with no commercial rights, to enable the customer to evaluate
    the Company&#x2019;s solution with its own products.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.5in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The sales of pilot transactions
    to evaluate the integration of the Company&#x2019;s solution with the customer&#x2019;s products composed of multiple performance obligations
    including Hardware, tailor-made software applications and technical support during the pilot period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In 2024 and 2023, most of the Company&#x2019;s
revenues were derived from the sales of Mudra Band to B2C customers. In 2022, all of the Company&#x2019;s revenues were derived from the
sales of Mudra development kits. See also note 2.g.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;b.&lt;/p&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In 2018, the
Company established a wholly owned subsidiary in the United States of America for the purpose of marketing and distribution of its solutions
&#x2013; Mudra Wearable, Inc. (the &#x201c;Subsidiary&#x201d;) &#x2013; which commenced its operations in 2020. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In October 2024, the Company effected a one-for-twenty (1-for-20) reverse stock split of its ordinary share (the &#x201c;October Reverse Split&#x201d;). As a result of the October Reverse Split, every twenty (20) shares either issued and outstanding were combined into&#160;one&#160;new ordinary share. All outstanding securities entitling their holders to purchase ordinary shares, including options and warrants were adjusted as a result of the October Reverse Split, as required by the terms of those securities. The October Reverse Split changed the par value per ordinary share from NIS 0.01 to zero par value. On March 17, 2025, the Company effectuated an additional 1-for-4 reverse share split of its issued and outstanding ordinary shares (the &#x201c;March Reverse Split&#x201d; and, together with the October Reverse Split, the &#x201c;Reverse Splits&#x201d;). The March Reverse Split did not change the number of shares authorized for issuance. See also note 10.a below.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All share amounts, share prices, and exercise prices have been adjusted retroactively within these financial statements to reflect the Reverse Splits.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On October
7, 2023, Hamas terrorists infiltrated Israel&#x2019;s southern border from the Gaza Strip and conducted a series of attacks on civilian
and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel&#x2019;s
border with the Gaza Strip and in other areas within the State of Israel. Following the attack, Israel&#x2019;s security cabinet declared
war against Hamas and the Israeli military began to call-up reservists for active duty. As of March 18, 2025, the ceasefire that had been in place since January
2025 has ended, and hostilities have resumed.&lt;/p&gt;
                                   &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Following the attack by Hamas on Israel&#x2019;s
    southern border, Hezbollah, a terrorist organization in Lebanon, has also launched missile, rocket, and shooting attacks against
    Israeli military sites, troops, and Israeli towns in northern Israel. In response to these attacks, the Israeli army has carried
    out a number of targeted strikes on sites belonging to Hezbollah in southern Lebanon, and in October 2024, the Israeli military initiated
    a ground operation in Lebanon, primarily near the Israel-Lebanon border. As of the end of November 2024, Israel entered into a ceasefire
    agreement with Hezbollah, but there are no guarantees as to whether the agreement will hold or whether further hostilities will resume.&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Further, many Israeli citizens are obligated
    to perform several days, and in some cases, more, of annual military reserve duty each year until they reach the age of 40 (or older
    for certain reservists) and, in the event of a military conflict, may be called to active duty. As of March 19,2025, these events
    have had no material impact on the Company&#x2019;s operations.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Going Concern:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The accompanying consolidated financial
statements have been prepared assuming that the Company will continue as a going concern. To date, the Company is still at its development
stage and at an early stage of generating revenues. Therefore, the Company has suffered recurring losses from operations and negative
cash flows from operations since inception. In September 2022, the Company completed an initial public offering (&#x201c;IPO&#x201d;) and
listed its ordinary shares and warrants for trading on Nasdaq and raised net proceeds of $13.3 million. In November 2023, the Company
completed a secondary offering and raised net proceeds of $1.7 million. &lt;span&gt;In June 2024, the Company
entered into a &lt;/span&gt;Standby Equity Purchase Agreement (the &#x201c;SEPA&#x201d;)&lt;span&gt;. During 2024, the
Company issued 307,175 ordinary shares pursuant to SEPA for net proceeds of $4.4 million. &lt;/span&gt;In November 2024, the Company completed
a registered direct offering and raised net proceeds of $1.58 million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2024, the
Company had incurred accumulated losses of $29 million and expects to continue to fund its operations through fundings such as
issuance of convertible securities, ordinary shares and warrants and through Israeli governmental grants. There is no assurance that
such financing will be obtained. Considering the above, the Company&#x2019;s dependency on external funding for our operations raises
a substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any
adjustments that might result from the outcome of these uncertainties.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f.&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November&#160;25, 2022, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#x2019;s minimum bid price requirement because the closing bid price of the ordinary shares was below $1.00 per ordinary share for the previous 30 consecutive business days. On May 23, 2023, the Company received a notification letter from Nasdaq that the Company had been granted an additional 180-day compliance period, or until November 20, 2023, to regain compliance with Nasdaq&#x2019;s minimum bid price rule. On June 9, 2023, the Company received a written notice from Nasdaq Stock Market LLC, indicating that it has regained compliance with the minimum bid price requirement. On October 24, 2023, the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq&#x2019;s minimum bid price requirement because the closing bid price of the ordinary shares was below $1.00 per ordinary share for the previous 30 consecutive business days. The Company was granted 180 calendar days, or until April&#160;22, 2024, to regain compliance with the minimum bid requirement. Since the Company did not regain compliance with the minimum bid price requirement by April 22, 2024, it applied for an additional 180-calendar day grace period. On April 23, 2024, Nasdaq granted the Company an additional 180-day compliance period, or until October 21, 2024, to regain compliance with Nasdaq&#x2019;s minimum bid price rule. On October 10, 2024, the Reverse Share Split at the ratio of 1:20 became effective. As a result, the Company was informed by Nasdaq on October 28, 2024 that the Company had regained compliance.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 16, 2025, the Company received a written notification from
Nasdaq, which stated that the Company was no longer in compliance with the minimum stockholders&#x2019; equity requirement for continued
listing on Nasdaq, due to the Company&#x2019;s failure to maintain a minimum of $2.5 million in stockholders&#x2019; equity.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s stockholders&#x2019; equity was approximately $1.7
million as of June 30, 2024. In accordance with Nasdaq rules, on February 5, 2025, the Company submitted a plan to regain compliance to
Nasdaq to explain the way the Company believes it has regained compliance with the minimum stockholders&#x2019; equity requirement through
the SEPA it entered into with YA II PN, Ltd. (&#x201c;YA&#x201d;) on June 6, 2024, and the registered direct offering, completed on November
27, 2024. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance.
The notification letter has no immediate effect on the Company&#x2019;s listing on Nasdaq, and during the grace period, as may be extended,
the Company&#x2019;s ordinary shares and warrants will continue to trade on Nasdaq under the symbol &#x201c;WLDS&#x201d; and &#x201c;WLDSW,&#x201d;
respectively.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <wlds:AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany contextRef="c0" decimals="-6" id="ixv-16198" unitRef="usd">1235000000</wlds:AnnualGrossRevenueLimitToRemainAsAnEmergingGrowthCompany>
    <wlds:ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus contextRef="c0" decimals="-6" id="ixv-16199" unitRef="usd">700000000</wlds:ValueOfOrdinarySharesHeldByNonAffiliatesToBecomeLargeAcceleratedStatus>
    <wlds:IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue contextRef="c0" decimals="-8" id="ixv-16200" unitRef="usd">1000000000</wlds:IssuanceOfNonconvertibleDebtSecuritiesToBecomeLargeAcceleratedStatusValue>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c31" id="ixv-16201">1-for-20</us-gaap:StockholdersEquityReverseStockSplit>
    <wlds:ReverseStockSplitNumberOfSharesConverted
      contextRef="c31"
      decimals="0"
      id="ixv-16202"
      unitRef="usdPershares">20</wlds:ReverseStockSplitNumberOfSharesConverted>
    <wlds:ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted
      contextRef="c31"
      decimals="0"
      id="ixv-16203"
      unitRef="usdPershares">1</wlds:ReverseStockSplitNumberOfSharesIssuedForEachShareOrLotConverted>
    <wlds:ReverseSplitParValue
      contextRef="c32"
      decimals="2"
      id="ixv-16204"
      unitRef="ilsPershares">0.01</wlds:ReverseSplitParValue>
    <wlds:ReverseSplitParValue
      contextRef="c32"
      decimals="0"
      id="ixv-16205"
      unitRef="usdPershares">0</wlds:ReverseSplitParValue>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c33" id="ixv-16206">1-for-4</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c34" decimals="-5" id="ixv-16207" unitRef="usd">13300000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <wlds:NetProceedsFromIssuanceSecondaryPublicOffering contextRef="c35" decimals="-5" id="ixv-16208" unitRef="usd">1700000</wlds:NetProceedsFromIssuanceSecondaryPublicOffering>
    <wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement
      contextRef="c25"
      decimals="0"
      id="ixv-16209"
      unitRef="shares">307175</wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement>
    <wlds:IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement contextRef="c0" decimals="-5" id="ixv-16210" unitRef="usd">4400000</wlds:IssuanceOfSharesValueAssociatedWithStandbyEquityPurchaseAgreement>
    <wlds:ProceedsFromIssuanceRegisteredDirectOffering contextRef="c36" decimals="-4" id="ixv-16211" unitRef="usd">1580000</wlds:ProceedsFromIssuanceRegisteredDirectOffering>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="-6" id="ixv-16212" unitRef="usd">29000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c37"
      decimals="2"
      id="ixv-16213"
      unitRef="usdPershares">1</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c38"
      decimals="2"
      id="ixv-16214"
      unitRef="usdPershares">1</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c39" id="ixv-16215">1:20</us-gaap:StockholdersEquityReverseStockSplit>
    <wlds:StockholdersEquityRequirementByStockExchanges contextRef="c40" decimals="-5" id="ixv-16216" unitRef="usd">2500000</wlds:StockholdersEquityRequirementByStockExchanges>
    <us-gaap:StockholdersEquity contextRef="c41" decimals="-5" id="ixv-16217" unitRef="usd">1700000</us-gaap:StockholdersEquity>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-13605">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The accompanying consolidated financial
statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;). The significant accounting policies followed in the preparation of the financial statements are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Principles of consolidation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The accompanying consolidated financial
statements include the accounts of the Company and the Subsidiary. All intercompany transactions have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Use of estimates&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The preparation of the consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its estimates, judgments and assumptions.
Management bases its estimates, judgments and assumptions on historical experience and on various other factors that are believed to
be reasonable under the circumstances. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Foreign currency&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The currency of the primary economic
environment in which the operations of the Company are conducted is the U.S. dollar (&#x201c;USD&#x201d;). The Company&#x2019;s funding
and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Transactions and balances originally
denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into USD using historical and
current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other items (stated below)
reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#x2013; exchange rates at transaction
dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation etc.) &#x2013; historical
exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inventories:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inventories are composed of parts
of the Company&#x2019;s products as well as completed products and are stated at the lower of cost or net realizable value. Inventory
cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably
predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase, and other costs
incurred in bringing the inventories to their present location and condition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property and equipment are stated
at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#x202f;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Annual rates of depreciation are as follows:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Furniture and leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Computers and software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Electronic equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Machines and molds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;f.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt; On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#x201c;ASU 2016-02&#x201d;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#x2019;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#x2019;s incremental borrowing rate. The weighted-average&#160;rate applied was 8%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company has the option to extend some of its
lease agreements. In measuring the lease liability and the right-of-use asset, the Company took some of those options into account
since management believes that those options are reasonably certain to be exercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Leases with a lease term of 12 months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;g.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenue recognition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Revenue is recognized when (or as)
control of the promised goods or services is transferred to the customer, and in an amount that reflects the consideration the Company
is contractually due in exchange for those services or goods. The Company follows five steps to record revenue: (i) identify the contract
with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the
transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies its performance
obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company generates revenues from
the sales of B2C &#x201c;Mudra Band&#x201d;, sales of B2B &#x201c;Mudra development kits&#x201d; and sales of pilot transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The &#x201c;Mudra Band&#x201d;, is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#x201c;Mudra Band&#x201d; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point
in time indicating control has been transferred to the customer.&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;A pilot transaction has multiple performance
obligations, and it generally takes a few months but less than one year. Each Mudra development kit sale also has multiple performance
obligations.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The payment terms of the Mudra development
kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions are within the pilot period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In those transactions, each obligation-
Hardware and API (for Mudra development kit) and tailor-made software application and technical support (for a pilot transaction) - is
distinct and separately identifiable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The amount allocated to the delivered
items is recognized upon delivery, the amount allocated to API is recognized over the API period and the amount allocated to technical
support is recognized over the service period (a pilot period).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;h.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cost of revenues&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Costs are expensed as incurred. The primary components
of the cost of revenues include the cost of the product and outbound freight charges.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;i.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Research and development&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.4pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Research and development expenses
consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;j.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Governmental grants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company receives royalty-bearing
grants from the Israeli government for approved research and development projects and marketing efforts. These grants are recognized
at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as provided by the relevant agreement
and included as a deduction from research and development or sales and marketing expenses, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;k.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Finance income and expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.55pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Finance income is composed of interest
on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are composed of interest on senior
secured credit facility, bank charges and net currency exchange rates differences.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;l.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts for income taxes
in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). Deferred
taxes are determined utilizing the assets and liabilities method, which is based on the estimated future tax effects of the differences
between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed
using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets
is provided if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will
not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available
evidence, are not expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company applies ASC 740, which clarifies the accounting
and reporting for uncertainties with respect to income taxes. ASC 740 prescribes a comprehensive model for the financial statement recognition,
measurement, presentation, and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share-based compensation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Share-based compensation expenses
related to employees&#x2019; and consultants&#x2019; options are measured at the grant date based on the fair value of the award and are
generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation expense on a
straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche is separately
expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes option
pricing model, which requires management to make certain assumptions of future expectations based on historical and current data include
the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants and pre-funded warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The warrants&#x2019; mechanism does
not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount of ordinary shares upon exercise.
Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional paid in capital), based on an
assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants are freestanding financial
instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity classification, including
whether the warrants are indexed to the Company&#x2019;s own shares, among other conditions for equity classification.&lt;/p&gt;

&lt;p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;o.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Severance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Israeli labor law generally requires
payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. The Company&#x2019;s
pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section 14 of the Israeli Severance Compensation
Act, 1963 (&#x201c;section 14&#x201d;), the Company&#x2019;s employees are entitled to monthly deposits, at a rate of 8.33% of their monthly
salary, made in their name with insurance companies. Payments in accordance with section 14 relieve the Company from any future severance
payments in respect of those employees and, as such, the Company may only utilize the insurance policies for the purpose of paying severance
pay.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80.3pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;p.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basic and diluted loss per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 80.55pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Basic and diluted loss per share is calculated
by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares and pre-funded warrants
outstanding during the financial year, adjusted for ordinary shares and pre-funded warrants issued during the year, if applicable.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;q.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company measures and discloses
fair value in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), ASC 820, Fair Value Measurements and
Disclosures (&#x201c;ASC 820&#x201d;). ASC 820 defines fair value, establishes a framework and gives guidance regarding the methods
used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the
amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that
market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a
three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 1 &#x2013; unadjusted quoted
prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement
date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 2 &#x2013; pricing inputs are
other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration
with observable market data.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 3 &#x2013; pricing inputs are
unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;This hierarchy requires the Company
to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 79.1pt; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of cash is based on
its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and
liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;r.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company maintains certain cash
balances in a well-known Israeli banks and U.S.-based bank.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the years ended December 31, 2024 and 2023, the
Company partially hedged its foreign currency exchange risk.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Our derivative instruments primarily
include foreign currency forward agreements related to the NIS and associated with certain payroll payments. Our foreign currency forward
agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated as hedges for accounting
purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged item, are recorded within
our consolidated statements of loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;s.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cash and cash equivalents:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Cash equivalents are highly liquid
investments that are readily convertible into cash, with an original maturity of three months or less.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;t.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Segment Information&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company has a single operating and reportable segment. The Company&#x2019;s chief operating decision maker, who is the Company&#x2019;s Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; "&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; width: 0.25in"&gt;&lt;b&gt;u.&lt;/b&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounting Standards Adopted in 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In November 2023, the FASB issued
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#x201c;ASU 2023-07&#x201d;). This ASU
expands public entities&#x2019; segment disclosures by requiring disclosure of significant segment expenses that are regularly
provided to the chief operating decision maker (the &#x201c;CODM&#x201d;) and included within each reported measure of segment profit or loss, an amount and description of its
composition for other segment items, and interim disclosures of a reportable segment&#x2019;s profit or loss and assets. All
disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. The ASU&#x2019;s
amendments are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within
fiscal years beginning after December 15, 2024, with early adoption permitted. After evaluating the impact of this pronouncement on
the Company&#x2019;s financial statements, the Company found that there is no impact on its financial statements.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;v.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;ACCOUNTING STANDARDS ISSUED AND NOT YET ADOPTED IN 2024&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In November 2024, the FASB issued
ASU 2024-03, Income Statement &#x2013; Reporting Comprehensive Income &#x2013; Expense Disaggregation Disclosures (Subtopic 220-40):
Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;), which requires the disaggregation of certain expense
captions into specified categories in disclosures within the notes to the consolidated financial statements to provide enhanced
transparency into the expense captions presented on the face of the statement of income and comprehensive income. ASU 2024-03 is
effective for annual reporting periods beginning after December 15, 2026, with early adoption permitted, and may be applied either
prospectively or retrospectively to financial statements issued for reporting periods after the effective date of ASU 2024-03 or
retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact
that the adoption of ASU 2024-03 will have on its related disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In November 2024, the FASB issued ASU 2024-04, Induced Conversions
of Convertible Debt Instruments (&#x201c;ASU 2024-04&#x201d;). This new guidance is intended to improve the relevance and consistency in
application of the induced conversion guidance in Subtopic 470-20 for (a) convertible debt instruments with cash conversion features and
(b) debt instruments that are not currently convertible. ASU 2024-04 is effective for fiscal years beginning after December 15, 2026.
Early adoption is permitted. The Company does not plan to early adopt this standard. The Company is currently evaluating the effect of adoption of this standard
to its consolidated financial statements and disclosures.&#x2003;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0" id="ixv-13611">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Principles of consolidation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The accompanying consolidated financial
statements include the accounts of the Company and the Subsidiary. All intercompany transactions have been eliminated in consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-13625">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Use of estimates&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The preparation of the consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, as well as to disclose contingent liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting years. On an ongoing basis, management evaluates its estimates, judgments and assumptions.
Management bases its estimates, judgments and assumptions on historical experience and on various other factors that are believed to
be reasonable under the circumstances. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0" id="ixv-13640">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Foreign currency&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The currency of the primary economic
environment in which the operations of the Company are conducted is the U.S. dollar (&#x201c;USD&#x201d;). The Company&#x2019;s funding
and revenues are mostly in USD. Thus, the functional currency of the Company is the USD.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Transactions and balances originally
denominated in USD are presented at their original amounts. Balances in non-USD currencies are translated into USD using historical and
current exchange rates for non-monetary and monetary balances, respectively. For non-USD transactions and other items (stated below)
reflected in the statements of operations, the following exchange rates are used: (i) for transactions &#x2013; exchange rates at transaction
dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation etc.) &#x2013; historical
exchange rates. Currency transaction gains or losses are recorded to finance income or expenses, as appropriate.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="c0" id="ixv-13658">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Inventories:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inventories are composed of parts
of the Company&#x2019;s products as well as completed products and are stated at the lower of cost or net realizable value. Inventory
cost is determined on FIFO basis. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably
predictable costs of completion, disposal, and transportation. The cost of inventories comprises all costs of purchase, and other costs
incurred in bringing the inventories to their present location and condition.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0" id="ixv-13673">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-right: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property and equipment are stated
at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#x202f;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Annual rates of depreciation are as follows:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Furniture and leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Computers and software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Electronic equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Machines and molds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock contextRef="c0" id="ixv-13685">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property and equipment are stated
at cost. Depreciation is computed based on the straight-line method, over the estimated useful life of the assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#x202f;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Annual rates of depreciation are as follows:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Furniture and leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Computers and software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Electronic equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Machines and molds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7-50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</wlds:ScheduleOfAnnualRatesOfDepreciationTableTextBlock>
    <wlds:AnnualRateOfDepreciation contextRef="c43" decimals="2" id="ixv-16218" unitRef="pure">0.07</wlds:AnnualRateOfDepreciation>
    <wlds:AnnualRateOfDepreciation contextRef="c44" decimals="2" id="ixv-16219" unitRef="pure">0.15</wlds:AnnualRateOfDepreciation>
    <wlds:AnnualRateOfDepreciation contextRef="c45" decimals="2" id="ixv-16220" unitRef="pure">0.33</wlds:AnnualRateOfDepreciation>
    <wlds:AnnualRateOfDepreciation contextRef="c46" decimals="2" id="ixv-16221" unitRef="pure">0.15</wlds:AnnualRateOfDepreciation>
    <wlds:AnnualRateOfDepreciation contextRef="c47" decimals="2" id="ixv-16222" unitRef="pure">0.07</wlds:AnnualRateOfDepreciation>
    <wlds:AnnualRateOfDepreciation contextRef="c48" decimals="2" id="ixv-16223" unitRef="pure">0.50</wlds:AnnualRateOfDepreciation>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0" id="ixv-13755">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;f.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt; On January 1, 2022, the Company began to implement ASU 2016-02, Leases (Topic 842) (&#x201c;ASU 2016-02&#x201d;) using the modified retrospective approach for all lease arrangements as of such date. The Company leases office space and vehicles under operating leases.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Arrangements meeting the definition of a lease are classified as operating or financing leases and are recorded on the balance sheet as both a right-of-use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#x2019;s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right-of-use asset is amortized over the lease term.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The lease liability was measured at the present value of the remaining lease payments, discounted using the Company&#x2019;s incremental borrowing rate. The weighted-average&#160;rate applied was 8%. Right-of-use&#160;assets were measured at an amount equal to the lease liability.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company has the option to extend some of its
lease agreements. In measuring the lease liability and the right-of-use asset, the Company took some of those options into account
since management believes that those options are reasonably certain to be exercised.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;For operating leases, interest on the lease liability and the amortization of the right-of-use asset result in straight-line&#160;rent expense over the lease term. Variable lease expenses are recorded when incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Leases with a lease term of 12 months or less at inception are not recorded within the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term in the Consolidated Statements of Operations and Comprehensive Loss.&#160;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:DebtWeightedAverageInterestRate contextRef="c42" decimals="2" id="ixv-16224" unitRef="pure">0.08</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LesseeFinanceLeaseRenewalTerm1 contextRef="c4" id="ixv-16225">P12M</us-gaap:LesseeFinanceLeaseRenewalTerm1>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0" id="ixv-13783">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;g.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenue recognition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Revenue is recognized when (or as)
control of the promised goods or services is transferred to the customer, and in an amount that reflects the consideration the Company
is contractually due in exchange for those services or goods. The Company follows five steps to record revenue: (i) identify the contract
with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the
transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies its performance
obligations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company generates revenues from
the sales of B2C &#x201c;Mudra Band&#x201d;, sales of B2B &#x201c;Mudra development kits&#x201d; and sales of pilot transactions.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The &#x201c;Mudra Band&#x201d;, is an
aftermarket accessory band for the Apple Watch which allows touchless operation and control of the watch and iPhone by using an app which
is considered combined with the band as one performance obligation. Revenue derived from the sale of &#x201c;Mudra Band&#x201d; is recognized
at a point of time when control transfers to the customer. The Company believes that the delivery date is the most appropriate point
in time indicating control has been transferred to the customer.&#160;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company allows return and refund
of Mudra Band within 30 days of having the Mudra Band delivered. The Company records an appropriate provision for such refunds.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Revenue derived from freight charges
is considered as a separate performance obligation recognized when the related product revenue is recognized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;A pilot transaction has multiple performance
obligations, and it generally takes a few months but less than one year. Each Mudra development kit sale also has multiple performance
obligations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The payment terms of the Mudra development
kit sales are upon delivery of the Hardware, while the payment terms of the pilot transactions are within the pilot period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In those transactions, each obligation-
Hardware and API (for Mudra development kit) and tailor-made software application and technical support (for a pilot transaction) - is
distinct and separately identifiable.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The amount allocated to the delivered
items is recognized upon delivery, the amount allocated to API is recognized over the API period and the amount allocated to technical
support is recognized over the service period (a pilot period).&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <wlds:CostOfRevenuesPolicyTextBlock contextRef="c0" id="ixv-13846">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;h.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cost of revenues&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Costs are expensed as incurred. The primary components
of the cost of revenues include the cost of the product and outbound freight charges.&lt;/p&gt;</wlds:CostOfRevenuesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0" id="ixv-13860">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;i.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Research and development&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Research and development expenses
consist primarily of payroll, payroll related expenses, subcontractors, and materials. Costs are expensed as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <wlds:GovernmentalGrantsPolicyTextBlock contextRef="c0" id="ixv-13874">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;j.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Governmental grants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company receives royalty-bearing
grants from the Israeli government for approved research and development projects and marketing efforts. These grants are recognized
at the time the Company is entitled to such grants based on the costs incurred or milestones achieved as provided by the relevant agreement
and included as a deduction from research and development or sales and marketing expenses, respectively.&lt;/p&gt;</wlds:GovernmentalGrantsPolicyTextBlock>
    <wlds:FinanceIncomeAndExpensesPolicyPolicyTextBlock contextRef="c0" id="ixv-13888">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;k.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Finance income and expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Finance income is composed of interest
on deposits and unrealized gain from foreign currency derivative activities, while finance expenses are composed of interest on senior
secured credit facility, bank charges and net currency exchange rates differences.&lt;/p&gt;</wlds:FinanceIncomeAndExpensesPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-13902">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;l.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company accounts for income taxes
in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;). Deferred
taxes are determined utilizing the assets and liabilities method, which is based on the estimated future tax effects of the differences
between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed
using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets
is provided if, based upon the weight of available evidence, it is more likely than not that some or all the deferred tax assets will
not be realized. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available
evidence, are not expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company applies ASC 740, which clarifies the accounting
and reporting for uncertainties with respect to income taxes. ASC 740 prescribes a comprehensive model for the financial statement recognition,
measurement, presentation, and disclosure of uncertain tax positions taken or expected to be taken in income tax returns.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0" id="ixv-13947">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share-based compensation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Share-based compensation expenses
related to employees&#x2019; and consultants&#x2019; options are measured at the grant date based on the fair value of the award and are
generally expensed over the requisite service period (generally the vesting period). The Company recognizes compensation expense on a
straight-line basis from the beginning of the service period. For awards with graded-vesting features, each vesting tranche is separately
expensed over the related vesting period. The Company estimates the fair value of each stock option grant using the Black-Scholes option
pricing model, which requires management to make certain assumptions of future expectations based on historical and current data include
the expected term of the stock option, expected volatility, dividend yield, and risk-free interest rate.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <wlds:WarrantsPolicyPolicyTextBlock contextRef="c0" id="ixv-13962">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants and pre-funded warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The warrants&#x2019; mechanism does
not create any obligation to transfer cash to the investors. Warrants are exercised for a fixed amount of ordinary shares upon exercise.
Therefore, the Company accounts for the warrants as equity-classified instruments (as part of additional paid in capital), based on an
assessment of the applicable U.S. GAAP authoritative guidance. The assessment considers whether the warrants are freestanding financial
instruments, meet the definition of a liability or whether the warrants meet all of the requirements for equity classification, including
whether the warrants are indexed to the Company&#x2019;s own shares, among other conditions for equity classification.&lt;/p&gt;</wlds:WarrantsPolicyPolicyTextBlock>
    <wlds:SeverancePolicyTextBlock contextRef="c0" id="ixv-13976">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;o.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Severance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Israeli labor law generally requires
payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. The Company&#x2019;s
pension and severance pay liabilities are covered mainly by insurance policies. Pursuant to section 14 of the Israeli Severance Compensation
Act, 1963 (&#x201c;section 14&#x201d;), the Company&#x2019;s employees are entitled to monthly deposits, at a rate of 8.33% of their monthly
salary, made in their name with insurance companies. Payments in accordance with section 14 relieve the Company from any future severance
payments in respect of those employees and, as such, the Company may only utilize the insurance policies for the purpose of paying severance
pay.&lt;/p&gt;</wlds:SeverancePolicyTextBlock>
    <wlds:RateOfMonthlySeverancePercentage contextRef="c0" decimals="4" id="ixv-16226" unitRef="pure">0.0833</wlds:RateOfMonthlySeverancePercentage>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-13990">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;p.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basic and diluted loss per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Basic and diluted loss per share is calculated
by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares and pre-funded warrants
outstanding during the financial year, adjusted for ordinary shares and pre-funded warrants issued during the year, if applicable.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0" id="ixv-14034">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;q.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company measures and discloses
fair value in accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;), ASC 820, Fair Value Measurements and
Disclosures (&#x201c;ASC 820&#x201d;). ASC 820 defines fair value, establishes a framework and gives guidance regarding the methods
used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the
amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that
market participants would use in pricing an asset or liability. As a basis for considering such assumptions, there exists a
three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 1 &#x2013; unadjusted quoted
prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement
date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 2 &#x2013; pricing inputs are
other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration
with observable market data.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Level 3 &#x2013; pricing inputs are
unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial
asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or
estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;This hierarchy requires the Company
to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The fair value of cash is based on
its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and
liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0" id="ixv-14066">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;r.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company maintains certain cash
balances in a well-known Israeli banks and U.S.-based bank.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s labor expenses
are denominated mainly in NIS, and therefore, subject to foreign currency risk. During the years ended December 31, 2024 and 2023, the
Company partially hedged its foreign currency exchange risk.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Our derivative instruments primarily
include foreign currency forward agreements related to the NIS and associated with certain payroll payments. Our foreign currency forward
agreements related to foreign currency&#160;balance sheet exposure provide economic hedges but are not designated as hedges for accounting
purposes. Changes in the value of the derivative,&#160;along with the transaction gain or loss on the hedged item, are recorded within
our consolidated statements of loss.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0" id="ixv-14086">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;s.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cash and cash equivalents:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Cash equivalents are highly liquid
investments that are readily convertible into cash, with an original maturity of three months or less.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0" id="ixv-14100">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;t.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Segment Information&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company has a single operating and reportable segment. The Company&#x2019;s chief operating decision maker, who is the Company&#x2019;s Chief Executive Officer, evaluates the performance of its business based on financial data consistent with the presentation in the accompanying consolidated financial statements for the purposes of making operating decisions, assessing financial performance, and allocating resources. &#160;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-14113">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; width: 0.25in"&gt;&lt;b&gt;u.&lt;/b&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounting Standards Adopted in 2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In November 2023, the FASB issued
ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#x201c;ASU 2023-07&#x201d;). This ASU
expands public entities&#x2019; segment disclosures by requiring disclosure of significant segment expenses that are regularly
provided to the chief operating decision maker (the &#x201c;CODM&#x201d;) and included within each reported measure of segment profit or loss, an amount and description of its
composition for other segment items, and interim disclosures of a reportable segment&#x2019;s profit or loss and assets. All
disclosure requirements under ASU 2023-07 are also required for public entities with a single reportable segment. The ASU&#x2019;s
amendments are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within
fiscal years beginning after December 15, 2024, with early adoption permitted. After evaluating the impact of this pronouncement on
the Company&#x2019;s financial statements, the Company found that there is no impact on its financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <wlds:AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock contextRef="c0" id="ixv-14154">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;v.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;ACCOUNTING STANDARDS ISSUED AND NOT YET ADOPTED IN 2024&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In November 2024, the FASB issued
ASU 2024-03, Income Statement &#x2013; Reporting Comprehensive Income &#x2013; Expense Disaggregation Disclosures (Subtopic 220-40):
Disaggregation of Income Statement Expenses (&#x201c;ASU 2024-03&#x201d;), which requires the disaggregation of certain expense
captions into specified categories in disclosures within the notes to the consolidated financial statements to provide enhanced
transparency into the expense captions presented on the face of the statement of income and comprehensive income. ASU 2024-03 is
effective for annual reporting periods beginning after December 15, 2026, with early adoption permitted, and may be applied either
prospectively or retrospectively to financial statements issued for reporting periods after the effective date of ASU 2024-03 or
retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact
that the adoption of ASU 2024-03 will have on its related disclosures.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In November 2024, the FASB issued ASU 2024-04, Induced Conversions
of Convertible Debt Instruments (&#x201c;ASU 2024-04&#x201d;). This new guidance is intended to improve the relevance and consistency in
application of the induced conversion guidance in Subtopic 470-20 for (a) convertible debt instruments with cash conversion features and
(b) debt instruments that are not currently convertible. ASU 2024-04 is effective for fiscal years beginning after December 15, 2026.
Early adoption is permitted. The Company does not plan to early adopt this standard. The Company is currently evaluating the effect of adoption of this standard
to its consolidated financial statements and disclosures.&#x2003;&lt;/p&gt;</wlds:AccountingStandardsIssuedAndNotYetAdoptedIn2024PolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c0" id="ixv-14173">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 3 - INVENTORIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S. dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;212&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;514&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 9pt"&gt;Work-in-progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;206&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;986&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Provision for inventory write-off&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(75&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-71"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,226&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,032&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0" id="ixv-14177">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S. dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;212&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;514&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 9pt"&gt;Work-in-progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;206&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;986&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Provision for inventory write-off&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(75&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-71"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,226&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,032&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c4" decimals="-3" id="ixv-16227" unitRef="usd">212000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c5" decimals="-3" id="ixv-16228" unitRef="usd">514000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c4" decimals="-3" id="ixv-16229" unitRef="usd">103000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c5" decimals="-3" id="ixv-16230" unitRef="usd">206000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c4" decimals="-3" id="ixv-16231" unitRef="usd">986000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c5" decimals="-3" id="ixv-16232" unitRef="usd">312000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <wlds:InventoryWriteoff contextRef="c4" decimals="-3" id="ixv-16233" unitRef="usd">75000</wlds:InventoryWriteoff>
    <us-gaap:FIFOInventoryAmount contextRef="c4" decimals="-3" id="ixv-16234" unitRef="usd">1226000</us-gaap:FIFOInventoryAmount>
    <us-gaap:FIFOInventoryAmount contextRef="c5" decimals="-3" id="ixv-16235" unitRef="usd">1032000</us-gaap:FIFOInventoryAmount>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c0" id="ixv-14260">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE&lt;/b&gt;&#160; &lt;b&gt;4 - PROPERTY AND EQUIPMENT, net&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S. dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;Computers and software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;230&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;204&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Furniture and leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Electronic equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Machines and molds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;86&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;72&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;374&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;334&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Less &lt;span style="font-style: normal; font-weight: normal"&gt;-
    accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;244&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;140&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;130&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;194&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0" id="ixv-14265">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S. dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;Computers and software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;230&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;204&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Furniture and leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Electronic equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"&gt;Machines and molds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;86&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;72&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;374&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;334&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Less &lt;span style="font-style: normal; font-weight: normal"&gt;-
    accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;244&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;140&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;130&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;194&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c49" decimals="-3" id="ixv-16236" unitRef="usd">230000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c50" decimals="-3" id="ixv-16237" unitRef="usd">204000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c51" decimals="-3" id="ixv-16238" unitRef="usd">38000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c52" decimals="-3" id="ixv-16239" unitRef="usd">38000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c53" decimals="-3" id="ixv-16240" unitRef="usd">20000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c54" decimals="-3" id="ixv-16241" unitRef="usd">20000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c55" decimals="-3" id="ixv-16242" unitRef="usd">86000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c56" decimals="-3" id="ixv-16243" unitRef="usd">72000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c4" decimals="-3" id="ixv-16244" unitRef="usd">374000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c5" decimals="-3" id="ixv-16245" unitRef="usd">334000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c4" decimals="-3" id="ixv-16246" unitRef="usd">244000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c5" decimals="-3" id="ixv-16247" unitRef="usd">140000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="-3" id="ixv-16248" unitRef="usd">130000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-16249" unitRef="usd">194000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0" id="ixv-14367">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 5 - LEASES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company has operating leases for
our office and vehicles. The Company&#x2019;s leases have remaining terms of less than one year to approximately 2 years, some of which may include
options to extend the leases for up to 2 years. The Company exercised the option to extend the lease for an additional one year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The cash flows related to leases are classified as part of the cash used to operating activities in the cash flow statement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following table summarizes the classification
of operating lease right-of-use assets and liabilities in the Company&#x2019;s Consolidated Balance Sheets as of December&#160;31, 2024
and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S. dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;330&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;592&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 0.2in"&gt;Short term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;291&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;297&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: 7.3pt"&gt;Long term&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;278&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;312&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;575&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;At December&#160;31, 2024, the future minimum lease payments
under the Company&#x2019;s operating lease liabilities are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S.&#160;dollars&lt;br/&gt; in&#160;thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;302&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total future minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;324&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less operating lease liabilities, current&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(291&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Operating lease liabilities, non-current&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Total expenses under all operating leases were $288 thousand,
$232 thousand, and $74 thousand for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c4" id="ixv-16250">P2Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseOptionToExtend contextRef="c0" id="ixv-16251">2 years</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="c0" id="ixv-14403">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following table summarizes the classification
of operating lease right-of-use assets and liabilities in the Company&#x2019;s Consolidated Balance Sheets as of December&#160;31, 2024
and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S. dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 9pt"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;330&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;592&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 0.2in"&gt;Short term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;291&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;297&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: 7.3pt"&gt;Long term&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;278&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;312&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;575&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="-3" id="ixv-16252" unitRef="usd">330000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-16253" unitRef="usd">592000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="-3" id="ixv-16254" unitRef="usd">291000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-16255" unitRef="usd">297000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="-3" id="ixv-16256" unitRef="usd">21000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c5" decimals="-3" id="ixv-16257" unitRef="usd">278000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c4" decimals="-3" id="ixv-16258" unitRef="usd">312000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c5" decimals="-3" id="ixv-16259" unitRef="usd">575000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0" id="ixv-14486">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;At December&#160;31, 2024, the future minimum lease payments
under the Company&#x2019;s operating lease liabilities are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S.&#160;dollars&lt;br/&gt; in&#160;thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;302&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total future minimum lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;324&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less operating lease liabilities, current&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(291&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Operating lease liabilities, non-current&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;21&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c4" decimals="-3" id="ixv-16260" unitRef="usd">302000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c4" decimals="-3" id="ixv-16261" unitRef="usd">22000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c4" decimals="-3" id="ixv-16262" unitRef="usd">324000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c4" decimals="-3" id="ixv-16263" unitRef="usd">12000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c4" decimals="-3" id="ixv-16264" unitRef="usd">312000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="-3" id="ixv-16265" unitRef="usd">291000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="-3" id="ixv-16266" unitRef="usd">21000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseExpense contextRef="c0" decimals="-3" id="ixv-16267" unitRef="usd">288000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c6" decimals="-3" id="ixv-16268" unitRef="usd">232000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c7" decimals="-3" id="ixv-16269" unitRef="usd">74000</us-gaap:OperatingLeaseExpense>
    <wlds:StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock contextRef="c0" id="ixv-14544">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 6 - STAND BY EQUITY PURCHASE AGREEMENT AND CONVERTIBLE
PROMISSORY NOTE&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;On June
6, 2024, the Company entered into the SEPA with YA, a fund managed by Yorkville Advisors Global, LP. Pursuant to the terms of the SEPA,
YA is committed to purchase up to the commitment amount, of the Company&#x2019;s ordinary shares at any time during the three-year period
following the execution date of the SEPA. The purchase price of the ordinary shares sold to YA is equal to 97% of the lowest volume weighted
average price (&#x201c;VWAP&#x201d;) of the ordinary shares during a pricing period of 3 consecutive trading days commencing on the trading
day of the delivery of advance notice by the Company. During the year ended December 31, 2024, the Company issued 307,175 ordinary shares
for gross proceeds of approximately $4.6 million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;According
to SEPA, the Company will have the sole right in its discretion to sell shares to YA from time to time by issuing advance notices to YA.
In addition, the Company also agreed to pay YA the commitment fee by issuance of the ordinary shares, equal to $100,000, or 1.0% of the
aggregate amount available to be sold under the SEPA, as consideration for its irrevocable commitment to purchase ordinary shares under
SEPA. The Company and YA agreed to postpone the issuance of the Commitment Fee to YA. The Commitment Fee will be paid either by cash or
by the issuance to YA of such number of ordinary shares that is equal to the balance of the Commitment Fee divided by the average of the
daily VWAP of the ordinary shares during the &lt;span style="-sec-ix-hidden: hidden-fact-72"&gt;three&lt;/span&gt; trading days immediately prior to the payment date. The Company has also paid YA a
structuring fee in the amount of $10,000.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;Subject
to certain conditions, according to the SEPA agreement, the Company may request pre-paid advances of the commitment amount, in an
amount up to $3 million, which will be evidenced by one or more convertible promissory notes. In June 2024, the Company requested,
and received, an initial pre-paid advance of $2 million in connection with the execution of SEPA. Each convertible promissory note
will be discounted to 96% of the purchase price and be fully mature 12 months following its issuance and shall accrue interest on
the outstanding principal balance thereon at a rate of 6% per annum, increasing to 18% per annum upon an Event of Default (as
defined in the convertible promissory note). Beginning 60 days after the issuance of a convertible promissory note, the Company
shall pay to YA a monthly installment payment of 10% of the original principal amount of the convertible promissory note and accrued
interest, payable in cash or by submitting an advance notice, where YA will offset the amount due to be paid to us under such notice
against an equal amount of the monthly installment amount, at the Company&#x2019;s option. If the Company elects to pay in cash, the
installment amount shall also include a payment premium in the amount of 5% of the principal amount of the installment payment. Each
convertible promissory note will be convertible at a conversion price equal to $4.00 per ordinary share and contains customary
adjustments in the event of stock dividends, stock splits, reorganizations or similar events affecting the Company&#x2019;s ordinary
shares and the conversion price. Each convertible promissory note will also contain anti-dilution provisions that provide that if
the Company issues ordinary shares, or securities convertible into or exercisable or exchange for, shares of ordinary shares at a
price per share that is less than the conversion price then in effect, then the conversion price of the convertible promissory note
upon each such issuance will be adjusted to the price equal to the consideration per share paid for such ordinary share or other
securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;The embedded
conversion option has not bifurcated due to the fixed nature of the conversion price, which is closely indexed to the Company&#x2019;s
own shares. Additionally, there is no significant premium associated with the convertible promissory note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;Moreover,
the Company retains the option to settle the debt in shares pursuant to the SEPA conditions. Given that the Company will incur an additional
cost, either in cash settlement or in shares settlement (in the form of discounted share price), the convertible promissory note will
bear a 5% premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;The
convertible promissory note was recognized based on the amortized cost method and as of December 31, 2024, the convertible
promissory note, including accrued interest, amounted to approximately $807 thousand. As of
December 31, 2024, the convertible promissory note balance net is $770 thousand. In February 2025, the Company repaid the
entire balance of the convertible promissory note and the commitment fee.&lt;/span&gt;&lt;/p&gt;</wlds:StandByEquityPurchaseAgreementAndConvertiblePromissoryNoteTextBlock>
    <wlds:PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice contextRef="c57" decimals="2" id="ixv-16270" unitRef="pure">0.97</wlds:PurchasePriceOfSharesPercentageOnLowestVolumeWeightedAveragePrice>
    <wlds:CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice contextRef="c57" id="ixv-16271">P3Y</wlds:CalculationOfPurchasePriceOfSharesPeriodForConsideringLowestVolumeWeightedAveragePrice>
    <wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement
      contextRef="c25"
      decimals="0"
      id="ixv-16272"
      unitRef="shares">307175</wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c25" decimals="-5" id="ixv-16273" unitRef="usd">4600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <wlds:NumberOfAmountIssuableAsCommitmentFee contextRef="c0" decimals="-3" id="ixv-16274" unitRef="usd">100000000</wlds:NumberOfAmountIssuableAsCommitmentFee>
    <wlds:PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement contextRef="c0" decimals="3" id="ixv-16275" unitRef="pure">0.01</wlds:PercentageOfAggregateAmountOfSharesAvailableToBeSoldToBeTransferredUnderAgreement>
    <wlds:PaymentsForStructuringFee contextRef="c0" decimals="-3" id="ixv-16276" unitRef="usd">10000000</wlds:PaymentsForStructuringFee>
    <wlds:PrePaidAdvances contextRef="c0" decimals="-6" id="ixv-16277" unitRef="usd">3000000</wlds:PrePaidAdvances>
    <wlds:PrePaidAdvances contextRef="c58" decimals="-6" id="ixv-16278" unitRef="usd">2000000</wlds:PrePaidAdvances>
    <wlds:PurchasePriceDiscount contextRef="c58" decimals="2" id="ixv-16279" unitRef="pure">0.96</wlds:PurchasePriceDiscount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="c59" decimals="2" id="ixv-16280" unitRef="pure">0.06</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="c60" decimals="2" id="ixv-16281" unitRef="pure">0.18</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <wlds:MonthlyInstallmentPayment contextRef="c0" decimals="2" id="ixv-16282" unitRef="pure">0.10</wlds:MonthlyInstallmentPayment>
    <wlds:PrincipalAmountInstallmentPayment contextRef="c0" decimals="2" id="ixv-16283" unitRef="pure">0.05</wlds:PrincipalAmountInstallmentPayment>
    <us-gaap:CommonStockConvertibleConversionPriceIncrease
      contextRef="c0"
      decimals="2"
      id="ixv-16284"
      unitRef="usdPershares">4</us-gaap:CommonStockConvertibleConversionPriceIncrease>
    <wlds:ConvertiblePromissoryNotePremiumPercentage contextRef="c0" decimals="2" id="ixv-16285" unitRef="pure">0.05</wlds:ConvertiblePromissoryNotePremiumPercentage>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest contextRef="c61" decimals="-3" id="ixv-16286" unitRef="usd">807000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c4" decimals="-3" id="ixv-16287" unitRef="usd">770000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-14614">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 7 - COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Royalties to the Israel Innovation Authority (&#x201c;IIA&#x201d;):&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.4pt; text-indent: -0.7pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company receives royalty-bearing
grants from the IIA, for approved research and development projects. The programs include grants for: wages, materials, subcontractors
and miscellaneous. The Company was required to pay royalties at the rate of 3%-3.5% on sales of products developed with the funds provided
by the IIA, up to an amount equal to 100% of the IIA research and development grants received, linked to the dollar including accrued
interest. Until October 25, 2023, the interest was calculated at a rate based on 12-month LIBOR applicable to US Dollar deposits. However,
on October 25, 2023, the IIA published a directive concerning changes in royalties to address the expiration of the LIBOR. Under such
directive, regarding IIA grants approved by the IIA prior to January 1, 2024 but which are outstanding thereafter, as of January 1, 2024
the annual interest is calculated at a rate based on 12-month SOFR, or at an alternative rate published by the Bank of Israel plus 0.71513%;
and, for grants approved on or following January 1, 2024 the annual interest shall be the higher of (i) the 12 months SOFR interest rate,
plus 1%, or (ii) a fixed annual interest rate of 4%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2018, two IIA programs
were completed, while the amounts received for them aggregated to $1.224 million. In addition, another IIA approved plan commenced on
May 1, 2020, and was completed on July 31, 2021, pursuant to which a total of $627 thousand was received. During January 2023, the IIA
approved an additional program to finance further development of the Company&#x2019;s manufacturing process of its wearable neural interface
in Israel. The approved program is in amount of approximately $900 thousand (NIS 3.1 million), of which the IIA will finance 60%; for
the years ended December 31, 2024 and 2023, the Company received $180 thousand and $288 thousand, respectively.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The terms of the grants under the Encouragement
of Research, Development and Technological Innovation in the Industry 1984 require that the manufacturing of products resulting from IIA-funded
programs be carried out in Israel, unless a prior written approval of the IIA is obtained (except for a transfer of up to 10% of the production
rights, for which a notification to the IIA is sufficient). During December 2022, the Company received an approval from the IIA to transfer
some of its manufacturing activities abroad.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As a condition for obtaining approval
to manufacture outside Israel (or following a declaration that up to 10% of the production is transferred abroad), the Company would be
required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate 3%-3.5%, and also the total
amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from the IIA, depending on the manufacturing
volume that is performed outside Israel (less royalties already paid to IIA).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Research and development grants deducted
from research and development expenses amounted to $92 thousand, $415 thousand and &lt;span style="-sec-ix-hidden: hidden-fact-73"&gt;nil&lt;/span&gt; for the years ended December 31, 2024, 2023 and
2022, respectively. As of December 31, 2024, the maximum obligation with respect to the grants received from the IIA, contingent upon
entitled future sales, is $2.4 million plus interest which may be increased, depending on the manufacturing volume that is performed
outside Israel. The Company has obligations regarding know-how, technology, or products, not to transfer the information, rights thereon
and production rights which derive from the research and development, in whole or part, of its Mudra product and its Mudra Band product,
without the IIA Research Committee approval.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Royalties to the Israeli Ministry of Economy and Industry (&#x201c;IMEI&#x201d;):&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During 2020, the Company received a
grant from the IMEI, for approved marketing expenses amounting to $95 thousand. The program includes participation in expenses for: consulting
for marketing, advertising and online marketing, flights to exhibitions and miscellaneous. &#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Under the agreement with the IMEI,
if the export revenues in the defined target market increase by $311 thousand compared to the base year, the Company would be required
to pay royalties at the rate of 3% of the increase, with the funds provided by the IMEI up to an amount equal to 100% of the IMEI marketing
grant received, linked to the consumer price index (&#x201c;CPI&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2024, the maximum
obligation with respect to the grant received from the IMEI, contingent upon entitled future sales, is $95 thousand linked to the CPI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Lease Commitments &#x2013; Operating Leases:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On July 1, 2018, the Company entered
into a lease agreement for a period which expired on September 30, 2022. The monthly lease payment totaled approximately $5 thousand.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;After September 30, 2022, the Company
stayed on the lease on a month-to-month basis. At the end of January 2023, the Company terminated this lease with 60 days&#x2019; termination
notice that ended on March 31, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In January 2023, the Company entered into a new lease agreement in
Yokne&#x2019;am Illit, Israel for a period which started on February 1, 2023, and expires on January 31, 2025, with an option to extend
the lease period by two additional lease periods, each for an additional 12 months. The Company exercised the option to extend the lease
for an additional one year. The Company&#x2019;s monthly rent payment for this facility is approximately $16 thousand during the first
lease year and increased to approximately $20 thousand during the second lease year. During the option lease periods, the lease payment
may be increased up to 10% as compared to the second lease year. The Company exercised the option and extended the lease for another year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Subsidiary, Mudra Wearable, leases
an office located in California. The lease is on a month-to-month basis for $495 per month. Additionally, during 2022, the Company entered
into lease agreements to lease 5 vehicles for a period of 3 years.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <wlds:RoyaltiesRate contextRef="c62" decimals="2" id="ixv-16288" unitRef="pure">0.03</wlds:RoyaltiesRate>
    <wlds:RoyaltiesRate contextRef="c63" decimals="3" id="ixv-16289" unitRef="pure">0.035</wlds:RoyaltiesRate>
    <wlds:GrantsReceivedEqualPercentageRate contextRef="c0" decimals="2" id="ixv-16290" unitRef="pure">1</wlds:GrantsReceivedEqualPercentageRate>
    <wlds:AnnualAlternativeInterestPercentage contextRef="c0" decimals="7" id="ixv-16291" unitRef="pure">0.0071513</wlds:AnnualAlternativeInterestPercentage>
    <wlds:AnnualInterestRate contextRef="c0" decimals="2" id="ixv-16292" unitRef="pure">0.01</wlds:AnnualInterestRate>
    <wlds:FixedAnnualInterestRate contextRef="c0" decimals="2" id="ixv-16293" unitRef="pure">0.04</wlds:FixedAnnualInterestRate>
    <wlds:AmountsReceivedAggregateAmount contextRef="c64" decimals="-3" id="ixv-16294" unitRef="usd">1224000</wlds:AmountsReceivedAggregateAmount>
    <wlds:AmountsReceivedAggregateAmount contextRef="c65" decimals="-3" id="ixv-16295" unitRef="usd">627000</wlds:AmountsReceivedAggregateAmount>
    <wlds:AmountOfDevelopmentProgram contextRef="c66" decimals="-3" id="ixv-16296" unitRef="usd">900000</wlds:AmountOfDevelopmentProgram>
    <wlds:AmountOfDevelopmentProgram contextRef="c66" decimals="-5" id="ixv-16297" unitRef="ils">3100000</wlds:AmountOfDevelopmentProgram>
    <wlds:PercentageOfFinancing contextRef="c4" decimals="2" id="ixv-16298" unitRef="pure">0.60</wlds:PercentageOfFinancing>
    <wlds:TotalCashReceivedFromTheIIA contextRef="c0" decimals="-3" id="ixv-16299" unitRef="usd">180000</wlds:TotalCashReceivedFromTheIIA>
    <wlds:TotalCashReceivedFromTheIIA contextRef="c6" decimals="-3" id="ixv-16300" unitRef="usd">288000</wlds:TotalCashReceivedFromTheIIA>
    <wlds:ExceptTransferProductionRight contextRef="c0" decimals="2" id="ixv-16301" unitRef="pure">0.10</wlds:ExceptTransferProductionRight>
    <wlds:ProductionTransferred contextRef="c0" decimals="2" id="ixv-16302" unitRef="pure">0.10</wlds:ProductionTransferred>
    <wlds:PayIncreasedRoyaltiesDescription contextRef="c0" id="ixv-16303">the Company would be
required to pay increased royalties, which usually amount to 1% in addition to the standard royalties rate 3%-3.5%, and also the total
amount of its liability to the IIA may be increased to between 120% and 300% of the grants received from the IIA, depending on the manufacturing
volume that is performed outside Israel (less royalties already paid to IIA).</wlds:PayIncreasedRoyaltiesDescription>
    <wlds:ResearchAndDevelopmentGrantsDetection contextRef="c67" decimals="-3" id="ixv-16304" unitRef="usd">92000</wlds:ResearchAndDevelopmentGrantsDetection>
    <wlds:ResearchAndDevelopmentGrantsDetection contextRef="c68" decimals="-3" id="ixv-16305" unitRef="usd">415000</wlds:ResearchAndDevelopmentGrantsDetection>
    <wlds:MaximumObligatinAmount contextRef="c70" decimals="-5" id="ixv-16306" unitRef="usd">2400000</wlds:MaximumObligatinAmount>
    <wlds:GrantsReceivedFromTheIMEI contextRef="c71" decimals="-3" id="ixv-16307" unitRef="usd">95000</wlds:GrantsReceivedFromTheIMEI>
    <us-gaap:RevenuesNetOfInterestExpense contextRef="c72" decimals="-3" id="ixv-16308" unitRef="usd">311000</us-gaap:RevenuesNetOfInterestExpense>
    <wlds:RoyaltiesRatePercentage contextRef="c72" decimals="2" id="ixv-16309" unitRef="pure">0.03</wlds:RoyaltiesRatePercentage>
    <wlds:MarketingGrantReceived contextRef="c0" decimals="2" id="ixv-16310" unitRef="pure">1</wlds:MarketingGrantReceived>
    <us-gaap:GrantsReceivableCurrent contextRef="c4" decimals="-3" id="ixv-16311" unitRef="usd">95000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:LeaseCost contextRef="c0" decimals="-3" id="ixv-16312" unitRef="usd">5000</us-gaap:LeaseCost>
    <us-gaap:PaymentsForRent contextRef="c0" decimals="-3" id="ixv-16313" unitRef="usd">16000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c73" decimals="-3" id="ixv-16314" unitRef="usd">20000</us-gaap:PaymentsForRent>
    <wlds:LeasePaymentIncreased contextRef="c0" decimals="2" id="ixv-16315" unitRef="pure">0.10</wlds:LeasePaymentIncreased>
    <wlds:LeaseMonthlyRentalPayments contextRef="c0" decimals="0" id="ixv-16316" unitRef="usd">495</wlds:LeaseMonthlyRentalPayments>
    <wlds:NumberOfVehicles
      contextRef="c74"
      decimals="0"
      id="ixv-16317"
      unitRef="Vehicles">5</wlds:NumberOfVehicles>
    <wlds:LeaseAgreementsPeriod contextRef="c74" id="ixv-16318">P3Y</wlds:LeaseAgreementsPeriod>
    <us-gaap:DebtDisclosureTextBlock contextRef="c0" id="ixv-14719">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 8 - CONVERTIBLE SECURITIES &#x2013; April 2021 investors&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In June 2022,
the Company&#160;received from Alpha Capital Anstalt (&#x201c;Alpha&#x201d;) the contractually required written consent to proceed with
the IPO (the &#x201c;June 2022 Consent&#x201d;) in exchange for a cash payment of $300,000 from the proceeds of the IPO, which was paid
on September 28, 2022, following the completion of the IPO. Pursuant to the share purchase agreements the Company entered into with certain
investors in April 2021 (the &#x201c;April 2021 SPAs&#x201d;), in the event of an initial public offering event or in a Dilutive Issuance
event (as defined below), reflecting a pre-money valuation of $26,400,000, or a lower one, then such investors shall receive additional
ordinary shares and additional shares underlying each warrant, based on 80% of the price per share at the IPO (the &#x201c;Discounted PPS&#x201d;),
less the number of ordinary shares issued to them in the April 2021 financing, and the number of shares underlying each warrant shall
be increased assuming the exercise amount is divided by the Discounted PPS. Additionally, beginning on April 22, 2021 and until the earlier
of (i) the 90th calendar day after the expiration of the applicable lock-ups, following the IPO date (i.e. June 2023) or (ii) three years
from April 22, 2021, if the Company or its subsidiary shall issue any ordinary shares or equivalents of ordinary shares, in an equity
transaction other than an exempt issuance, entitling any person or entity to acquire ordinary shares at an effective price per share less
than the per share purchase price of $180.00 (subject to prior adjustment for reverse and forward stock splits and the like) (a &#x201c;Dilutive
Issuance&#x201d;), then, for no additional consideration, the Company shall immediately issue to the investors in the April 2021 financing
that number of additional ordinary shares equal to (a) the per share purchase price of $180.00 divided by amount actually paid in new
cash consideration by third parties for each ordinary share in the Dilutive Issuance less (b) the number of ordinary shares issued to
Alpha and other investors at the closing of the April 2021 financing pursuant to April 2021 SPAs. Pursuant to the June 2022 Consent, the
investor in the April 2021 financing waived their rights for such adjustments as of the date of the IPO and deferred such adjustments
(if any) to be effected on the 90th calendar day following the closing of the IPO.&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On September 20, 2022, the Company&#x2019;s
volume weighted average stock price was less than the exercise price of $160.00 for the warrants. Accordingly, effective after the closing
of trading on December 14, 2022 (the 90th calendar day immediately following the issuance date of the warrants), the warrants&#x2019; exercise
price was adjusted pursuant to their terms to $160.00 (the &#x201c;Exercise Price Adjustment&#x201d;). Following the Exercise Price Adjustment,
on February 16, 2023, the Company issued an aggregate of 2,114 ordinary shares to the April 2021&#160;investors&#160;as a result of the
IPO.&#160;&#160;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <wlds:CashPayment contextRef="c75" decimals="-3" id="ixv-16319" unitRef="usd">300000000</wlds:CashPayment>
    <wlds:PremoneyValuationAmount contextRef="c76" decimals="-3" id="ixv-16320" unitRef="usd">26400000000</wlds:PremoneyValuationAmount>
    <wlds:WarrantPricePerSharePercentage contextRef="c77" decimals="2" id="ixv-16321" unitRef="pure">0.80</wlds:WarrantPricePerSharePercentage>
    <wlds:PurchasePricePerShare
      contextRef="c78"
      decimals="2"
      id="ixv-16322"
      unitRef="usdPershares">180</wlds:PurchasePricePerShare>
    <wlds:PurchasePricePerShare
      contextRef="c79"
      decimals="2"
      id="ixv-16323"
      unitRef="usdPershares">180</wlds:PurchasePricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c80"
      decimals="2"
      id="ixv-16324"
      unitRef="usdPershares">160</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c81"
      decimals="2"
      id="ixv-16325"
      unitRef="usdPershares">160</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <wlds:AggregateOrdinaryShares
      contextRef="c82"
      decimals="0"
      id="ixv-16326"
      unitRef="shares">2114</wlds:AggregateOrdinaryShares>
    <wlds:CreditFacilityDisclosureTextBlock contextRef="c0" id="ixv-14729">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 9 - CREDIT FACILITY &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On July 4, 2022, the Company
entered into a senior secured credit facility agreement with L.I.A. Pure Capital Ltd. (&#x201c;Pure Capital&#x201d;) to borrow from
time to time amounts until the closing of the IPO in an amount of up to $800 thousand (the &#x201c;Initial Credit&#x201d;), which
Initial Credit could be increased, upon the request of the Company, to an amount not exceeding $1 million (together with the Initial
Credit, the &#x201c;Credit Facility&#x201d;) in aggregate. The underlying outstanding amounts had priority in relation and senior to
any other debts owed by the Company to any third party, and were subject to a registered floating charge, for the benefit of Pure
Capital, against all of the Company&#x2019;s assets. During July, August and September 2022, the Company received an aggregate of
$800 thousand under the Credit Facility. The Credit Facility bore interest at the rate of 4% per annum. The outstanding amounts,
together with interest accrued and unpaid were due and payable on the earlier of (i) June 30, 2024, or (ii) upon receipt of a
certain financing transaction or in the event of certain customary events of default or a change of control. The Credit Facility was
fully repaid on September 19, 2022. The agreement indicates that the Company shall not assume any debt senior to the Credit Facility
during the term of the Credit Facility, unless Pure Capital has provided its advance written consent; and subject to applicable law,
any debt assumed by the Company during such term shall be deemed subordinated to any debt accrued under the agreement, if Pure
Capital had not provided its prior written consent; and without Pure Capital&#x2019;s prior written consent, the Company shall not
pledge in favor of a third-party creditor or lender any of its assets or rights, including by a floating charge, until such time
that the Credit Facility, and any interest accrued thereon, has been repaid in full to Pure Capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Additionally, the Credit Facility
agreement requires the Company to retain Pure Capital for investor relations services and other related strategic services in
exchange for a monthly base fee of $35 thousand, upon the closing of the IPO, under a 3 year consulting agreement. If 70% or more of
the warrants (or other convertible securities) issued in connection with the IPO are exercised during the term of such instrument,
then the base monthly fee will immediately increase to $70 thousand, which increase shall apply retroactively to the closing of the
IPO date. Total expenses for services rendered under Pure Capital agreement were
$420 thousand, $420 thousand and $122 thousand for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/p&gt;</wlds:CreditFacilityDisclosureTextBlock>
    <us-gaap:OtherBorrowings contextRef="c83" decimals="-3" id="ixv-16327" unitRef="usd">800000</us-gaap:OtherBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c83" decimals="-6" id="ixv-16328" unitRef="usd">1000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <wlds:AggregateAmount contextRef="c84" decimals="-3" id="ixv-16329" unitRef="usd">800000</wlds:AggregateAmount>
    <wlds:AggregateAmount contextRef="c85" decimals="-3" id="ixv-16330" unitRef="usd">800000</wlds:AggregateAmount>
    <wlds:AggregateAmount contextRef="c86" decimals="-3" id="ixv-16331" unitRef="usd">800000</wlds:AggregateAmount>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="c4" decimals="2" id="ixv-16332" unitRef="pure">0.04</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <wlds:ServicesInExchangeForMonthlyBaseFee contextRef="c87" decimals="-3" id="ixv-16333" unitRef="usd">35000</wlds:ServicesInExchangeForMonthlyBaseFee>
    <wlds:AggrementTerm contextRef="c87" id="ixv-16334">P3Y</wlds:AggrementTerm>
    <wlds:WarrantsIssuedPercentage contextRef="c87" decimals="2" id="ixv-16335" unitRef="pure">0.70</wlds:WarrantsIssuedPercentage>
    <wlds:BaseMonthlyFeeImmediatelyIncreaseAmount contextRef="c87" decimals="-3" id="ixv-16336" unitRef="usd">70000</wlds:BaseMonthlyFeeImmediatelyIncreaseAmount>
    <wlds:ExpenseOnServiceRendering contextRef="c0" decimals="-3" id="ixv-16337" unitRef="usd">420000</wlds:ExpenseOnServiceRendering>
    <wlds:ExpenseOnServiceRendering contextRef="c6" decimals="-3" id="ixv-16338" unitRef="usd">420000</wlds:ExpenseOnServiceRendering>
    <wlds:ExpenseOnServiceRendering contextRef="c7" decimals="-3" id="ixv-16339" unitRef="usd">122000</wlds:ExpenseOnServiceRendering>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-14762">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 10 - SHAREHOLDERS&#x2019; EQUITY:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The share capital as of December 31, 2024 and 2023, is composed
of as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Issued and outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; padding-bottom: 4pt"&gt;Ordinary shares, NIS 0.01 par value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;50,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;50,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;707,463&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;254,843&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The ordinary shares entitle their holders:
to receive notices of, and to attend, general meetings where each ordinary share shall have one vote for all purposes; to share distributions
as may be declared by the Board of Directors of the Company and approved by the shareholders, if required; and, upon liquidation or dissolution
- to participate in the distribution of the assets of the Company after payment of all debts and other liabilities of the Company, in
accordance with the terms of the Company&#x2019;s Articles of Association.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt; In 2022, the Company issued 58 ordinary shares, upon exercise of employees&#x2019; options.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;In September 2022, the Company completed its IPO whereby the Company issued and sold in connection with
the closing of the IPO 46,875 units, each consisting of one ordinary share and two warrants to purchase one ordinary share each. In addition,
the underwriter exercised its over-allotment option with respect to 14,062 warrants to purchase 14,062 ordinary shares.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The warrants were exercisable immediately
upon issuance, at an exercise price of $320.00 per ordinary share and are exercisable until September 12, 2027. On September 16, 2022,
500 warrants were exercised into 500 ordinary shares. On December 14, 2022, the exercise price of the warrants was adjusted to $160.00
per ordinary share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In connection with the IPO, the Company
received gross proceeds of approximately $16.0 million, before deducting underwriting discounts and commissions and before offering expenses
($14.9 million net proceeds after deducting approximately $1.1 million of underwriting discounts and commissions and approximately $13.3
million after other IPO expenses).&#160;&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(3)&lt;/td&gt;&lt;td style="text-align: justify"&gt;During 2022, the Company entered into a simple agreement for future equity (the &#x201c;SAFEs&#x201d;) for
$500 thousand with 5 investors, $100 thousand each, of which $400 thousand were converted to 1,477&#160;ordinary shares and $100 thousand
of one investor were paid back in cash upon the closing of the IPO. Those&#160;SAFEs were not mandatorily redeemable, nor redeemable at
the option of the holder after a specified date, but in an Equity Financing (as defined in the SAFEs) which under current liquidity circumstances
constitutes a redemption event outside of the Company&#x2019;s control. The Company issued to each SAFE investor a warrant to purchase
ordinary shares of the Company with an exercise price of $507.60 per share in such offering for an aggregate amount of up to $25 thousand
(exercisable for a total of 197 ordinary shares, until the earlier of: (i) eighteen (18) months from January 2022; or (ii) in a change
of control event, which generally covers (a) a transaction in which any person or group becomes the beneficial owner, directly or indirectly,
of more than 50% of the Company&#x2019;s outstanding voting securities with the right to vote for the election of members of the Company&#x2019;s
Board of Directors, or (b) any reorganization, merger or consolidation of the Company, or (c) a sale, lease or other disposition of all
or substantially all of the Company&#x2019;s assets).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(4)&lt;/td&gt;&lt;td style="text-align: justify"&gt;During September 2022, investors exercised 500 warrants into ordinary shares.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(5)&lt;/td&gt;&lt;td style="text-align: justify"&gt;In June 2023, 9,052 warrants were exercised into 9,052 ordinary shares at an exercise price of $160.00
per ordinary share.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(6)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On November 13, 2023, the Company completed a public offering of its securities,
whereby the Company issued and sold 55,556 ordinary shares. The Company received gross proceeds of approximately $2 million, before deducting
underwriting discounts and commissions and before offering expenses ($1.7 million net proceeds after deducting underwriting discounts
and commissions and other expenses).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; "&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(7)&lt;/td&gt;&lt;td style="text-align: justify"&gt;During 2024, the Company issued 307,175 ordinary shares pursuant to the SEPA for net proceeds of $4.4 million (See also Note 6).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; "&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(8)&lt;/td&gt;&lt;td&gt;&lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;On November 27, 2024, the Company completed a registered direct offering and concurrent private placement, for the issuance and sale of 63,000 ordinary shares, 142,500 pre-funded warrants to purchase up to 142,500 ordinary shares in the registered direct offering, and&#160;warrants to purchase up to 205,500 ordinary shares in the concurrent private placement&#160;at a combined purchase price of $9.00 per ordinary share. During December 2024, 64,500 pre-funded warrants were exercised into 64,500 ordinary shares.&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;The warrants issued pursuant to the concurrent private placement have an&#160;exercise price of $10.00 per ordinary share, are immediately exercisable and expire five years following the date of issuance. The Company received gross proceeds of approximately $1.85 million, before deducting underwriting discounts and commissions and before offering expenses ($1.58 million net proceeds after deducting underwriting discounts and commissions and other expenses). See also note 13.b.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;(9)&lt;/td&gt;&lt;td style="text-align: justify"&gt;In December 2024, the Company issued 9,765 ordinary shares to a service provider in return for marketing services.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share-based compensation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In 2015, the Company&#x2019;s Board
of Directors adopted the 2015 Share Option Plan (the &#x201c;2015 Plan&#x201d;), with&#160;12,910 options available for grant, and through
December 31, 2021, the Company&#x2019;s Board of Directors approved, in the aggregate, an increase of&#160;10,000 options available for
grant, for allocation to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that, there
are 22,910 ordinary shares reserved under the 2015 Plan (including those that were exercised into ordinary shares).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On December 15, 2022, the Company&#x2019;s
Board of Directors approved an increase of&#160;a total of 5,308 ordinary shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are 28,218 ordinary
shares underlying options granted (including options that were exercised into ordinary shares) or reserved for future issuance under the
2015 Plan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On August 23, 2023, the Company&#x2019;s
Board of Directors approved an increase of&#160;a total of 11,639 ordinary shares underlying options available for grant, for allocation
to existing and future employees, consultants and directors of the Company and/or its Subsidiary, such that there are 39,857 ordinary
shares underlying options granted (including options that were exercised into ordinary shares) or reserved for future issuance under the
2015.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On August 15, 2024, the
Company&#x2019;s Board of Directors approved the Company&#x2019;s 2024 Global Equity Incentive Plan (the &#x201c;Incentive
Plan&#x201d;), which provides for the issuance of up to 57,132 ordinary shares. The Incentive Plan is subject to the approval of the
Israeli Tax Authorities. In addition, the Incentive Plan includes an annex that governs the grants of awards to employees and other
service providers who are citizens or resident aliens of the United States, subject to the approval of the Company&#x2019;s
shareholders. The Plan was approved at the shareholders meeting held on September 26, 2024. On December 20, 2024, the
Company&#x2019;s Board of Directors approved an increase in the number of ordinary shares reserved for the Incentive Plan to
141,492.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Incentive Plan provides for the
grant of options, shares, restricted shares or restricted share units (&#x201c;RSUs&#x201d;) to employees, non-employee directors, consultants,
advisors, or service providers of the Company, as well as employees, non-employee directors, consultants, advisors, or service providers
of any affiliate of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On August 15, 2024, the
Company&#x2019;s Board of Directors approved the Company&#x2019;s 2024 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;), which
provides for the issuance of up to 62,500 ordinary shares and includes an annex that governs the grants of awards to employees who
are residents of the State of Israel. The ESPP is subject to the approval of the Company&#x2019;s shareholders. The ESPP was approved
at the shareholders meeting held on September 26, 2024. Generally, all the Company&#x2019;s employees will be eligible to participate
in the ESPP if they are employed by the Company, or employees of any participating subsidiary, provided that they have been employed
by the Company or subsidiary for more than five months in a calendar year. The ESPP permits participants to purchase ordinary shares
through payroll deductions in an amount equal to a whole percentage of from one to 15% of their ESPP eligible compensation (or such
other limited established by the administrator in accordance with the terms of our ESPP) in an offering. The purchase price of the
shares will be determined by the Compensation Committee of the Board of Directors in accordance with the terms of the ESPP, but the
option price shall not be less than the lesser of 85 percent of the fair market value of the shares on the offering date, or 85
percent of the fair market value of the shares on the exercise date., there have been no issuances under the ESPP as of December 31,
2024&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of March 19, 2025, the Company
had 9,208 ordinary shares reserved for future issuance under the 2015 Plan.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;Options to employees &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Below is a summary of the Company&#x2019;s
options activity and related information with respect to options granted to employees during the years ended December 31, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;Year ended &lt;br/&gt; December 31,&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;Year ended &lt;br/&gt; December 31,&lt;/b&gt; &#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt; &#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Amount&lt;br/&gt; of &lt;br/&gt; options&lt;/b&gt; &#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average &lt;br/&gt; exercise &lt;br/&gt; price&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Amount&lt;br/&gt; of &lt;br/&gt; options&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Weighted &lt;br/&gt; average &lt;br/&gt; exercise&lt;br/&gt; price&lt;/b&gt; &#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Outstanding - beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;18,184&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;62.16&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;12,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;45.04&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;**4,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;21.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*5,894&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;97.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-75"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-76"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expired or forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(62&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;105.60&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(62&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;53.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Outstanding - end of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,309&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;54.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;62.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Exercisable at end of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;46.56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;48.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The weighted-average grant date fair value of stock-based
awards granted&#160;was $21.76, $97.92 and $14.72 per share during the years ended December 31, 2024, December 31,&#160;2023 and December
31, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The options will expire at the earlier
of (i) ten years from the date of grant or (ii) 90 days following the termination of employment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On August 15, 2024, the Company&#x2019;s Board
of Directors approved the allocation and / or grant of additional options to purchase up to 2,187 ordinary shares
to certain directors, officers and employees, with an exercise price of $34.40 per share. The options will expire at the earlier of (i)
ten years from the date of grant or (ii) 90 days following the termination of respective employment or services. The fair value of each
option as of the grant date was $15.60, determined using the Black-Scholes option pricing model and the total expenses of approximately
$34 thousand will be expensed over the option vesting periods of three years. The options allocated to the Company&#x2019;s Chief Executive
Officer and Chief Scientific Officer were also approved in the shareholders meeting held on September 26, 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On December 25, 2024, the Company&#x2019;s
Board of Directors approved the grant of additional options to purchase up to 2,000 ordinary shares to certain
employees, with an exercise price of $7.63 per share. The options will expire at the earlier of (i) ten years from the date of grant
or (ii) 90 days following the termination of respective employment or services. The fair value of each option as of the grant date was
$4.32, determined using the Black-Scholes option pricing model and the total expenses of approximately $9 thousand will be expensed over
the option vesting periods of three years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following weighted-average assumptions
were used in determining the most recent fair values of stock options using the Black-Scholes valuation model:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;Expected stock price volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;Risk free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;Expected life of options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: justify"&gt;Including the grant of 1,500 options to purchase up to 1,500
ordinary shares to directors, as approved by the Company&#x2019;s shareholders on November 30, 2023, with an exercise price of $105.60
per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of
employment or service. The fair value of each option as of the grant date was $9.60, determined using the Black-Scholes option pricing
model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Including the grant of 1,250 options to purchase up to 1,250
ordinary shares to the Company&#x2019;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#x2019;s shareholders
on September 26, 2024, with an exercise price of $34.40 per share. The options will expire at the earlier of (i) ten years from the date
of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $15.60,
determined using the Black-Scholes option pricing model and the total expenses of $19 thousand will be expensed over the option vesting
periods of three years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;Options to consultants &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s outstanding options
to consultants as of December 31, 2024 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Issuance date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;In connection with&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;No. of&lt;br/&gt; options&lt;br/&gt; issued&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Exercise&lt;br/&gt; price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;No. of&lt;br/&gt; options&lt;br/&gt; exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 40%; text-align: left"&gt;2015&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 22%; text-align: center"&gt;Rendered services&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,383&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; width: 9%; text-align: right"&gt;0.24&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,383&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;2017&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;Rendered services&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;461&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; text-align: right"&gt;0.24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;461&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;Rendered services&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;863&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.24-&lt;/span&gt;$180.00&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;2023*&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;Rendered services&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,250&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; text-align: right"&gt;43.68&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;555&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On April 27, 2023, the Company&#x2019;s Board of Directors approved
the additional grant of options to purchase up to 1,250 ordinary shares to a consultant, with an exercise price of $43.68 per share.
The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The
fair value of each option as of the grant date was $20.80, determined using the Black-Scholes option pricing model and the total expenses
of $26 thousand will be expensed over the option vesting periods of three years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt; &lt;b&gt;RSUs to employees and consultants: &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;I&lt;span&gt;n
August 2024, the Company&#x2019;s Board of Directors approved the Company&#x2019;s
Incentive Plan, which provides for the issuance of up to 57,132 ordinary shares of the Company. On December 20, 2024, the Board
approved the increase of number of ordinary shares reserved under the Incentive Plan to 141,492.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;The
Incentive Plan provides for the grant of options, shares, restricted shares or  RSUs to employees,
non-employee directors, consultants, advisors, or service providers of the Company, as well as employees, non-employee directors, consultants,
advisors, or service providers of any affiliate of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span&gt;On December 25, 2024, the Board &lt;/span&gt;of Directors approved the
grant of &lt;span&gt;131,375 RSUs &lt;/span&gt;to employees and consultants, which will be automatically exercised
into ordinary shares over a vesting period of between 12 months to 24 months, with the vesting starting on January 1, 2025. The unvested
RSUs will expire the termination of employment or service. The fair value of each RSU as of the grant date was $7.12, determined using
the 30 days&#x2019; market price prior to the grant date, and the total expenses of $934 thousand will be expensed over the option vesting
periods.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The share-based compensation expenses
are recognized in the following line items in the consolidated statements of comprehensive loss in the years ended:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S. dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Research and development expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;80&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;180&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;401&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;53&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;97&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;209&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;182&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;241&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;790&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;Equity Warrants to investors and associated with the
IPO and follow on fund raising, as of December 31, 2024:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number&#160;of warrants/ options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Issuance date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercise ratio&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Expiration date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Notes&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;98,261&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 14.5%; text-align: center"&gt;September 13, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;160.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 19.5%; text-align: left"&gt;Each warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; width: 19.5%; text-align: left"&gt;5 years following the issuance date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; width: 19.5%; text-align: left"&gt;Registered for trading (*)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;September 15, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;424.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Each warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;5 years following the issuance date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Owned by underwriter&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;September 15, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;338.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Each warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;10 years following the issuance date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Owned by the legal advisor&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;November 27, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;(**)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Each warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;5 years following the issuance date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Owned by an investor&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;78,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;November 27, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0004&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Each pre funded warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Until exercised in full&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Owned by an investor&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The warrants are exercisable at any time after their original
issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants will be exercisable, at the
option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement
registering the issuance of the ordinary shares underlying the warrants under the Securities Act of 1933, as amended, is effective and
available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary shares purchased
upon such exercise.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;The exercise price per whole ordinary
share purchasable upon exercise of the warrants $320.00 per share (the &#x201c;Initial Exercise Price&#x201d;). The exercise price is subject
to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting ordinary shares and also upon any distributions of assets, including cash, stock or other property to the
Company&#x2019;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until two years from the date of issuance
of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or
sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any ordinary shares or convertible security,
at an effective price per share less than the exercise price of the warrant then in effect, the exercise price of the warrant shall be
reduced to equal the effective price per share in such Dilutive Issuance;&#160;provided, however, that in no event shall the exercise
price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days
immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the &#x201c;Reset Price&#x201d;),
provided that such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of
the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted average price per ordinary share
occurring on any day between the initial exercise date of the warrants and 90 calendar days following the issuance date of the warrants.
The lowest Reset Price is $160.00, which is 50% of the Initial Exercise Price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(**)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On January 30, 2025, the exercise price of the warrants pursuant
to a November 2024 private placement was adjusted to $4.00 per share following the closing of an additional offering.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss
per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt"&gt;Loss per share has been calculated using the weighted average
number of ordinary shares and pre-funded warrants in issue during the relevant financial periods, the weighted average number of equity
shares in issue and profit for the period as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Loss for the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(7,879&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(7,814&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(6,496&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Total number of ordinary shares and pre-funded warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;785,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;254,843&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;188,121&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Weighted average number of ordinary shares and pre-funded warrants&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;325,690&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;202,515&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;153,465&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;Basic and diluted loss per share&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(24.2&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(38.4&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(42.4&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="c0" id="ixv-14778">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The share capital as of December 31, 2024 and 2023, is composed
of as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number of shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Issued and outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; padding-bottom: 4pt"&gt;Ordinary shares, NIS 0.01 par value&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;50,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;50,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;707,463&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;254,843&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c135"
      decimals="2"
      id="ixv-16340"
      unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c136"
      decimals="2"
      id="ixv-16341"
      unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c135"
      decimals="0"
      id="ixv-16342"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c136"
      decimals="0"
      id="ixv-16343"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <wlds:NumberOfSharesIssuedAndOutstanding
      contextRef="c135"
      decimals="INF"
      id="ixv-16344"
      unitRef="shares">707463</wlds:NumberOfSharesIssuedAndOutstanding>
    <wlds:NumberOfSharesIssuedAndOutstanding
      contextRef="c136"
      decimals="INF"
      id="ixv-16345"
      unitRef="shares">254843</wlds:NumberOfSharesIssuedAndOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c15"
      decimals="0"
      id="ixv-16346"
      unitRef="shares">58</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c88"
      decimals="0"
      id="ixv-16347"
      unitRef="shares">46875</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <wlds:NumberOfOrdinaryShares
      contextRef="c88"
      decimals="0"
      id="ixv-16348"
      unitRef="shares">1</wlds:NumberOfOrdinaryShares>
    <wlds:NumberOfWarrants
      contextRef="c89"
      decimals="0"
      id="ixv-16349"
      unitRef="shares">2</wlds:NumberOfWarrants>
    <wlds:NumberOfOrdinaryShares
      contextRef="c89"
      decimals="0"
      id="ixv-16350"
      unitRef="shares">1</wlds:NumberOfOrdinaryShares>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c90"
      decimals="0"
      id="ixv-16351"
      unitRef="shares">14062</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c91"
      decimals="0"
      id="ixv-16352"
      unitRef="shares">14062</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c92"
      decimals="2"
      id="ixv-16353"
      unitRef="usdPershares">320</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <wlds:ExercisableWarrantsToShares
      contextRef="c93"
      decimals="0"
      id="ixv-16354"
      unitRef="shares">500</wlds:ExercisableWarrantsToShares>
    <wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="c93"
      decimals="0"
      id="ixv-16355"
      unitRef="shares">500</wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c94"
      decimals="2"
      id="ixv-16356"
      unitRef="usdPershares">160</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c87" decimals="-5" id="ixv-16357" unitRef="usd">16000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <wlds:UnderwritingNetProceed contextRef="c0" decimals="-5" id="ixv-16358" unitRef="usd">14900000</wlds:UnderwritingNetProceed>
    <wlds:UnderwritingDiscountsAndCommissions contextRef="c0" decimals="-5" id="ixv-16359" unitRef="usd">1100000</wlds:UnderwritingDiscountsAndCommissions>
    <wlds:ProceedAfterInitialPublicOfferingExpenses contextRef="c87" decimals="-5" id="ixv-16360" unitRef="usd">13300000</wlds:ProceedAfterInitialPublicOfferingExpenses>
    <wlds:SAFEsAmount contextRef="c7" decimals="-3" id="ixv-16361" unitRef="usd">500000</wlds:SAFEsAmount>
    <wlds:NumberOfInvestors contextRef="c7" decimals="0" id="ixv-16362" unitRef="pure">5</wlds:NumberOfInvestors>
    <wlds:InvestorAmount contextRef="c7" decimals="-3" id="ixv-16363" unitRef="usd">100000</wlds:InvestorAmount>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="c7" decimals="-3" id="ixv-16364" unitRef="usd">400000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c7"
      decimals="0"
      id="ixv-16365"
      unitRef="shares">1477</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:Cash contextRef="c18" decimals="-3" id="ixv-16366" unitRef="usd">100000</us-gaap:Cash>
    <wlds:NumberOfInvestors contextRef="c95" decimals="0" id="ixv-16367" unitRef="pure">1</wlds:NumberOfInvestors>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c15"
      decimals="2"
      id="ixv-16368"
      unitRef="usdPershares">507.6</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement contextRef="c18" decimals="-3" id="ixv-16369" unitRef="usd">25000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <wlds:ExercisableWarrantsToShares
      contextRef="c12"
      decimals="0"
      id="ixv-16370"
      unitRef="shares">197</wlds:ExercisableWarrantsToShares>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c96" decimals="2" id="ixv-16371" unitRef="pure">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <wlds:InvestorsExercisedWarrants
      contextRef="c89"
      decimals="0"
      id="ixv-16372"
      unitRef="shares">500</wlds:InvestorsExercisedWarrants>
    <wlds:ExercisableWarrantsToShares
      contextRef="c97"
      decimals="0"
      id="ixv-16373"
      unitRef="shares">9052</wlds:ExercisableWarrantsToShares>
    <wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="c97"
      decimals="0"
      id="ixv-16374"
      unitRef="shares">9052</wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <wlds:ExercisePricePerShare
      contextRef="c97"
      decimals="2"
      id="ixv-16375"
      unitRef="usdPershares">160</wlds:ExercisePricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c98"
      decimals="0"
      id="ixv-16376"
      unitRef="shares">55556</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <wlds:GrossProceedsOfOrdinaryShares contextRef="c98" decimals="-6" id="ixv-16377" unitRef="usd">2000000</wlds:GrossProceedsOfOrdinaryShares>
    <wlds:UnderwritingNetProceed contextRef="c98" decimals="-5" id="ixv-16378" unitRef="usd">1700000</wlds:UnderwritingNetProceed>
    <wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement
      contextRef="c25"
      decimals="0"
      id="ixv-16379"
      unitRef="shares">307175</wlds:IssuanceOfSharesAssociatedWithStandbyEquityPurchaseAgreement>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c99" decimals="-5" id="ixv-16380" unitRef="usd">4400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c100"
      decimals="0"
      id="ixv-16381"
      unitRef="shares">63000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <wlds:IssuedAndSoldOrdinaryShares
      contextRef="c101"
      decimals="0"
      id="ixv-16382"
      unitRef="shares">142500</wlds:IssuedAndSoldOrdinaryShares>
    <wlds:PreFundWarrant
      contextRef="c102"
      decimals="0"
      id="ixv-16383"
      unitRef="shares">142500</wlds:PreFundWarrant>
    <wlds:PurchaseOfWarrants
      contextRef="c103"
      decimals="0"
      id="ixv-16384"
      unitRef="shares">205500</wlds:PurchaseOfWarrants>
    <wlds:CombinedPurchasePricePerShare
      contextRef="c103"
      decimals="2"
      id="ixv-16385"
      unitRef="usdPershares">9</wlds:CombinedPurchasePricePerShare>
    <wlds:PreFundedWarrantsToPurchase
      contextRef="c4"
      decimals="0"
      id="ixv-16386"
      unitRef="shares">64500</wlds:PreFundedWarrantsToPurchase>
    <wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants
      contextRef="c104"
      decimals="0"
      id="ixv-16387"
      unitRef="shares">64500</wlds:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <wlds:ExercisePricePerShare
      contextRef="c0"
      decimals="2"
      id="ixv-16388"
      unitRef="usdPershares">10</wlds:ExercisePricePerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c0" id="ixv-16389">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="c105"
      decimals="-4"
      id="ixv-16390"
      unitRef="usd">1850000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <wlds:UnderwritingDiscountsAndCommissions
      contextRef="c105"
      decimals="-4"
      id="ixv-16391"
      unitRef="usd">1580000</wlds:UnderwritingDiscountsAndCommissions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c106"
      decimals="0"
      id="ixv-16392"
      unitRef="shares">9765</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c107"
      decimals="0"
      id="ixv-16393"
      unitRef="shares">12910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c108"
      decimals="0"
      id="ixv-16394"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c11"
      decimals="0"
      id="ixv-16395"
      unitRef="shares">22910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <wlds:OptionsAvailableForGrant
      contextRef="c109"
      decimals="0"
      id="ixv-16396"
      unitRef="shares">5308</wlds:OptionsAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c110"
      decimals="0"
      id="ixv-16397"
      unitRef="shares">28218</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <wlds:OptionsAvailableForGrant
      contextRef="c111"
      decimals="0"
      id="ixv-16398"
      unitRef="shares">11639</wlds:OptionsAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c112"
      decimals="0"
      id="ixv-16399"
      unitRef="shares">39857</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan
      contextRef="c113"
      decimals="0"
      id="ixv-16400"
      unitRef="shares">57132</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c114"
      decimals="0"
      id="ixv-16401"
      unitRef="shares">141492</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP
      contextRef="c115"
      decimals="0"
      id="ixv-16402"
      unitRef="shares">62500</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderESPP>
    <us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
      contextRef="c116"
      decimals="2"
      id="ixv-16403"
      unitRef="pure">0.01</us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage>
    <us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
      contextRef="c117"
      decimals="2"
      id="ixv-16404"
      unitRef="pure">0.15</us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage>
    <wlds:FairMarketValueSharesPercentage
      contextRef="c115"
      decimals="2"
      id="ixv-16405"
      unitRef="pure">0.85</wlds:FairMarketValueSharesPercentage>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c118"
      decimals="0"
      id="ixv-16406"
      unitRef="shares">9208</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0" id="ixv-15002">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Below is a summary of the Company&#x2019;s
options activity and related information with respect to options granted to employees during the years ended December 31, 2024 and 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;Year ended &lt;br/&gt; December 31,&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;&lt;b&gt;Year ended &lt;br/&gt; December 31,&lt;/b&gt; &#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt; &#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Amount&lt;br/&gt; of &lt;br/&gt; options&lt;/b&gt; &#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Weighted&lt;br/&gt; average &lt;br/&gt; exercise &lt;br/&gt; price&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Amount&lt;br/&gt; of &lt;br/&gt; options&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Weighted &lt;br/&gt; average &lt;br/&gt; exercise&lt;br/&gt; price&lt;/b&gt; &#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Outstanding - beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;18,184&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;62.16&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;12,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;45.04&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;**4,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;21.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;*5,894&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;97.92&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-75"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-76"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expired or forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(62&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;105.60&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(62&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;53.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Outstanding - end of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,309&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;54.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;62.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Exercisable at end of year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;46.56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;48.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: justify"&gt;Including the grant of 1,500 options to purchase up to 1,500
ordinary shares to directors, as approved by the Company&#x2019;s shareholders on November 30, 2023, with an exercise price of $105.60
per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of
employment or service. The fair value of each option as of the grant date was $9.60, determined using the Black-Scholes option pricing
model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Including the grant of 1,250 options to purchase up to 1,250
ordinary shares to the Company&#x2019;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#x2019;s shareholders
on September 26, 2024, with an exercise price of $34.40 per share. The options will expire at the earlier of (i) ten years from the date
of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $15.60,
determined using the Black-Scholes option pricing model and the total expenses of $19 thousand will be expensed over the option vesting
periods of three years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c137"
      decimals="0"
      id="ixv-16407"
      unitRef="shares">18184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c137"
      decimals="2"
      id="ixv-16408"
      unitRef="usdPershares">62.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c138"
      decimals="0"
      id="ixv-16409"
      unitRef="shares">12353</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c138"
      decimals="2"
      id="ixv-16410"
      unitRef="usdPershares">45.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c139"
      decimals="0"
      id="ix_28_fact"
      unitRef="shares">4187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c139"
      decimals="2"
      id="ixv-16412"
      unitRef="usdPershares">21.76</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c140"
      decimals="0"
      id="ix_27_fact"
      unitRef="shares">5894</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c140"
      decimals="2"
      id="ixv-16414"
      unitRef="usdPershares">97.92</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c139"
      decimals="0"
      id="ixv-16415"
      unitRef="shares">62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c139"
      decimals="2"
      id="ixv-16416"
      unitRef="usdPershares">105.6</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c140"
      decimals="0"
      id="ixv-16417"
      unitRef="shares">62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c140"
      decimals="2"
      id="ixv-16418"
      unitRef="usdPershares">53.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c141"
      decimals="0"
      id="ixv-16419"
      unitRef="shares">22309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c141"
      decimals="2"
      id="ixv-16420"
      unitRef="usdPershares">54.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c137"
      decimals="0"
      id="ixv-16421"
      unitRef="shares">18184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c137"
      decimals="2"
      id="ixv-16422"
      unitRef="usdPershares">62.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c141"
      decimals="0"
      id="ixv-16423"
      unitRef="shares">18082</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c141"
      decimals="2"
      id="ixv-16424"
      unitRef="usdPershares">46.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c137"
      decimals="0"
      id="ixv-16425"
      unitRef="shares">11114</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c137"
      decimals="2"
      id="ixv-16426"
      unitRef="usdPershares">48.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c0"
      decimals="2"
      id="ixv-16427"
      unitRef="usdPershares">21.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c6"
      decimals="2"
      id="ixv-16428"
      unitRef="usdPershares">97.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c7"
      decimals="2"
      id="ixv-16429"
      unitRef="usdPershares">14.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <wlds:TerminationPeriod contextRef="c0" id="ixv-16430">P10Y</wlds:TerminationPeriod>
    <wlds:NumberOfDaysForTermination contextRef="c0" id="ixv-16431">P90D</wlds:NumberOfDaysForTermination>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c119"
      decimals="0"
      id="ixv-16432"
      unitRef="shares">2187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <wlds:ExercisePricePerShare
      contextRef="c119"
      decimals="2"
      id="ixv-16433"
      unitRef="usdPershares">34.4</wlds:ExercisePricePerShare>
    <wlds:TerminationPeriod contextRef="c119" id="ixv-16434">P10Y</wlds:TerminationPeriod>
    <wlds:NumberOfDaysForTermination contextRef="c119" id="ixv-16435">P90D</wlds:NumberOfDaysForTermination>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate
      contextRef="c119"
      decimals="2"
      id="ixv-16436"
      unitRef="usdPershares">15.6</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate>
    <wlds:OptionsExpenses
      contextRef="c119"
      decimals="-3"
      id="ixv-16437"
      unitRef="usd">34000</wlds:OptionsExpenses>
    <wlds:VestingPeriods contextRef="c119" id="ixv-16438">P3Y</wlds:VestingPeriods>
    <wlds:IssuanceOfSharesOptions
      contextRef="c120"
      decimals="0"
      id="ixv-16439"
      unitRef="shares">2000</wlds:IssuanceOfSharesOptions>
    <wlds:ExercisePricePerShare
      contextRef="c121"
      decimals="2"
      id="ixv-16440"
      unitRef="usdPershares">7.63</wlds:ExercisePricePerShare>
    <wlds:TerminationPeriod contextRef="c121" id="ixv-16441">P10Y</wlds:TerminationPeriod>
    <wlds:NumberOfDaysForTermination contextRef="c121" id="ixv-16442">P90D</wlds:NumberOfDaysForTermination>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate
      contextRef="c121"
      decimals="2"
      id="ixv-16443"
      unitRef="usdPershares">4.32</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate>
    <wlds:OptionsExpenses
      contextRef="c121"
      decimals="-3"
      id="ixv-16444"
      unitRef="usd">9000</wlds:OptionsExpenses>
    <wlds:VestingPeriods contextRef="c121" id="ixv-16445">P3Y</wlds:VestingPeriods>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0" id="ixv-15254">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following weighted-average assumptions
were used in determining the most recent fair values of stock options using the Black-Scholes valuation model:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;Expected stock price volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;Risk free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; text-indent: -11.35pt; padding-left: 11.35pt"&gt;Expected life of options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: justify"&gt;Including the grant of 1,500 options to purchase up to 1,500
ordinary shares to directors, as approved by the Company&#x2019;s shareholders on November 30, 2023, with an exercise price of $105.60
per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of
employment or service. The fair value of each option as of the grant date was $9.60, determined using the Black-Scholes option pricing
model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Including the grant of 1,250 options to purchase up to 1,250
ordinary shares to the Company&#x2019;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#x2019;s shareholders
on September 26, 2024, with an exercise price of $34.40 per share. The options will expire at the earlier of (i) ten years from the date
of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $15.60,
determined using the Black-Scholes option pricing model and the total expenses of $19 thousand will be expensed over the option vesting
periods of three years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="2" id="ixv-16446" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c0" decimals="3" id="ixv-16447" unitRef="pure">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c0" decimals="4" id="ixv-16448" unitRef="pure">0.041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions contextRef="c0" id="ixv-16449">P6Y3M</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpectedLifeOfOptions>
    <wlds:IssuanceOfSharesOptions
      contextRef="c122"
      decimals="0"
      id="ixv-16451"
      unitRef="shares">1500</wlds:IssuanceOfSharesOptions>
    <wlds:IssuanceOfSharesOptions
      contextRef="c123"
      decimals="0"
      id="ixv-16452"
      unitRef="shares">1500</wlds:IssuanceOfSharesOptions>
    <wlds:ExercisePricePerShare
      contextRef="c124"
      decimals="2"
      id="ixv-16453"
      unitRef="usdPershares">105.6</wlds:ExercisePricePerShare>
    <wlds:TerminationPeriod contextRef="c0" id="ixv-16454">P10Y</wlds:TerminationPeriod>
    <wlds:NumberOfDaysForTermination contextRef="c0" id="ixv-16455">P90D</wlds:NumberOfDaysForTermination>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate
      contextRef="c0"
      decimals="2"
      id="ixv-16456"
      unitRef="usdPershares">9.6</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate>
    <wlds:OptionsExpenses contextRef="c0" decimals="-3" id="ixv-16457" unitRef="usd">15000</wlds:OptionsExpenses>
    <wlds:VestingPeriods contextRef="c0" id="ixv-16458">P3Y</wlds:VestingPeriods>
    <wlds:IssuanceOfSharesOptions
      contextRef="c125"
      decimals="0"
      id="ixv-16460"
      unitRef="shares">1250</wlds:IssuanceOfSharesOptions>
    <wlds:IssuanceOfSharesOptions
      contextRef="c125"
      decimals="0"
      id="ixv-16461"
      unitRef="shares">1250</wlds:IssuanceOfSharesOptions>
    <wlds:ExercisePricePerShare
      contextRef="c126"
      decimals="2"
      id="ixv-16462"
      unitRef="usdPershares">34.4</wlds:ExercisePricePerShare>
    <wlds:TerminationPeriod contextRef="c127" id="ixv-16463">P10Y</wlds:TerminationPeriod>
    <wlds:NumberOfDaysForTermination contextRef="c127" id="ixv-16464">P90D</wlds:NumberOfDaysForTermination>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate
      contextRef="c127"
      decimals="2"
      id="ixv-16465"
      unitRef="usdPershares">15.6</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate>
    <wlds:OptionsExpenses
      contextRef="c127"
      decimals="-3"
      id="ixv-16466"
      unitRef="usd">19000</wlds:OptionsExpenses>
    <wlds:VestingPeriods contextRef="c0" id="ixv-16467">P3Y</wlds:VestingPeriods>
    <wlds:ScheduleOfOptionsToConsultantsTableTextBlock contextRef="c0" id="ixv-15337">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company&#x2019;s outstanding options
to consultants as of December 31, 2024 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Issuance date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;In connection with&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;No. of&lt;br/&gt; options&lt;br/&gt; issued&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Exercise&lt;br/&gt; price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;No. of&lt;br/&gt; options&lt;br/&gt; exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 40%; text-align: left"&gt;2015&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 22%; text-align: center"&gt;Rendered services&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,383&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; width: 9%; text-align: right"&gt;0.24&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,383&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;2017&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;Rendered services&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;461&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; text-align: right"&gt;0.24&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;461&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;Rendered services&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;863&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.24-&lt;/span&gt;$180.00&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;2023*&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;Rendered services&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,250&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; text-align: right"&gt;43.68&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;555&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 77.3pt; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On April 27, 2023, the Company&#x2019;s Board of Directors approved
the additional grant of options to purchase up to 1,250 ordinary shares to a consultant, with an exercise price of $43.68 per share.
The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The
fair value of each option as of the grant date was $20.80, determined using the Black-Scholes option pricing model and the total expenses
of $26 thousand will be expensed over the option vesting periods of three years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</wlds:ScheduleOfOptionsToConsultantsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c142" id="ixv-16468">Rendered services</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c142"
      decimals="INF"
      id="ixv-16469"
      unitRef="shares">1383</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c143"
      decimals="2"
      id="ixv-16470"
      unitRef="usdPershares">0.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c143"
      decimals="0"
      id="ixv-16471"
      unitRef="shares">1383</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c144" id="ixv-16472">Rendered services</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c144"
      decimals="INF"
      id="ixv-16473"
      unitRef="shares">461</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c145"
      decimals="2"
      id="ixv-16474"
      unitRef="usdPershares">0.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c145"
      decimals="0"
      id="ixv-16475"
      unitRef="shares">461</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c146" id="ixv-16476">Rendered services</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c146"
      decimals="INF"
      id="ixv-16477"
      unitRef="shares">863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c147"
      decimals="2"
      id="ixv-16478"
      unitRef="usdPershares">0.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c148"
      decimals="2"
      id="ixv-16479"
      unitRef="usdPershares">180</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c149"
      decimals="0"
      id="ixv-16480"
      unitRef="shares">863</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c150" id="ix_29_fact">Rendered services</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="c150"
      decimals="INF"
      id="ix_30_fact"
      unitRef="shares">1250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c151"
      decimals="2"
      id="ix_31_fact"
      unitRef="usdPershares">43.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c151"
      decimals="0"
      id="ix_32_fact"
      unitRef="shares">555</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <wlds:IssuanceOfSharesOptions
      contextRef="c128"
      decimals="0"
      id="ixv-16486"
      unitRef="shares">1250</wlds:IssuanceOfSharesOptions>
    <wlds:ExercisePricePerShare
      contextRef="c129"
      decimals="2"
      id="ixv-16487"
      unitRef="usdPershares">43.68</wlds:ExercisePricePerShare>
    <wlds:TerminationPeriod contextRef="c129" id="ixv-16488">P10Y</wlds:TerminationPeriod>
    <wlds:NumberOfDaysForTermination contextRef="c129" id="ixv-16489">P90D</wlds:NumberOfDaysForTermination>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate
      contextRef="c129"
      decimals="2"
      id="ixv-16490"
      unitRef="usdPershares">20.8</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate>
    <wlds:OptionsExpenses
      contextRef="c129"
      decimals="-3"
      id="ixv-16491"
      unitRef="usd">26000</wlds:OptionsExpenses>
    <wlds:VestingPeriods contextRef="c129" id="ixv-16492">P3Y</wlds:VestingPeriods>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan
      contextRef="c130"
      decimals="0"
      id="ixv-16493"
      unitRef="shares">57132</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOrdinarySharesIssuedUnderIncentivePlan>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c114"
      decimals="0"
      id="ixv-16494"
      unitRef="shares">141492</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c131"
      decimals="0"
      id="ixv-16495"
      unitRef="shares">131375</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c132" id="ixv-16496">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c133" id="ixv-16497">P24M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate
      contextRef="c131"
      decimals="2"
      id="ixv-16498"
      unitRef="usdPershares">7.12</wlds:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionGrantDate>
    <wlds:TerminationPeriod contextRef="c131" id="ixv-16499">P30D</wlds:TerminationPeriod>
    <wlds:OptionsExpenses
      contextRef="c131"
      decimals="-3"
      id="ixv-16500"
      unitRef="usd">934000</wlds:OptionsExpenses>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c0" id="ixv-15453">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The share-based compensation expenses
are recognized in the following line items in the consolidated statements of comprehensive loss in the years ended:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;U.S. dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Research and development expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;80&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;180&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;61&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;401&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;53&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;97&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;209&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;182&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;241&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;790&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="c152"
      decimals="-3"
      id="ixv-16501"
      unitRef="usd">80000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c153"
      decimals="-3"
      id="ixv-16502"
      unitRef="usd">83000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c154"
      decimals="-3"
      id="ixv-16503"
      unitRef="usd">180000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c155"
      decimals="-3"
      id="ixv-16504"
      unitRef="usd">49000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c156"
      decimals="-3"
      id="ixv-16505"
      unitRef="usd">61000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c157"
      decimals="-3"
      id="ixv-16506"
      unitRef="usd">401000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c158"
      decimals="-3"
      id="ixv-16507"
      unitRef="usd">53000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c159"
      decimals="-3"
      id="ixv-16508"
      unitRef="usd">97000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c160"
      decimals="-3"
      id="ixv-16509"
      unitRef="usd">209000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-16510" unitRef="usd">182000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c6" decimals="-3" id="ixv-16511" unitRef="usd">241000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-16512" unitRef="usd">790000</us-gaap:ShareBasedCompensation>
    <wlds:ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock contextRef="c0" id="ixv-15562">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;b&gt;Equity Warrants to investors and associated with the
IPO and follow on fund raising, as of December 31, 2024:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Number&#160;of warrants/ options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Issuance date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Exercise ratio&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Expiration date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Notes&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;98,261&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 14.5%; text-align: center"&gt;September 13, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;160.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 19.5%; text-align: left"&gt;Each warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; width: 19.5%; text-align: left"&gt;5 years following the issuance date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; width: 19.5%; text-align: left"&gt;Registered for trading (*)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;September 15, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;424.80&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Each warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;5 years following the issuance date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Owned by underwriter&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;September 15, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;338.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Each warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;10 years following the issuance date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Owned by the legal advisor&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;November 27, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;(**)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Each warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;5 years following the issuance date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Owned by an investor&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;78,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;November 27, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0004&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Each pre funded warrant is exercisable into 1 ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Until exercised in full&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Owned by an investor&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The warrants are exercisable at any time after their original
issuance and at any time up to the date that is five&#160;years after their original issuance. The warrants will be exercisable, at the
option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement
registering the issuance of the ordinary shares underlying the warrants under the Securities Act of 1933, as amended, is effective and
available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary shares purchased
upon such exercise.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;The exercise price per whole ordinary
share purchasable upon exercise of the warrants $320.00 per share (the &#x201c;Initial Exercise Price&#x201d;). The exercise price is subject
to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications
or similar events affecting ordinary shares and also upon any distributions of assets, including cash, stock or other property to the
Company&#x2019;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until two years from the date of issuance
of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or
sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce
any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any ordinary shares or convertible security,
at an effective price per share less than the exercise price of the warrant then in effect, the exercise price of the warrant shall be
reduced to equal the effective price per share in such Dilutive Issuance;&#160;provided, however, that in no event shall the exercise
price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days
immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the &#x201c;Reset Price&#x201d;),
provided that such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of
the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted average price per ordinary share
occurring on any day between the initial exercise date of the warrants and 90 calendar days following the issuance date of the warrants.
The lowest Reset Price is $160.00, which is 50% of the Initial Exercise Price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(**)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On January 30, 2025, the exercise price of the warrants pursuant
to a November 2024 private placement was adjusted to $4.00 per share following the closing of an additional offering.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</wlds:ScheduleOfIssuanceOfEquityWarrantsToInvestorsAndAssociatTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c161"
      decimals="INF"
      id="ixv-16513"
      unitRef="shares">98261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c162"
      decimals="2"
      id="ixv-16514"
      unitRef="usdPershares">160</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c162" id="ixv-16515">Each warrant is exercisable into 1 ordinary share</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c162" id="ixv-16516">5 years following the issuance date</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c162" id="ix_33_fact">Registered for trading (*)</wlds:ShareBasedCompensationArrangementNotes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c163"
      decimals="INF"
      id="ixv-16518"
      unitRef="shares">2344</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c164"
      decimals="2"
      id="ixv-16519"
      unitRef="usdPershares">424.8</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c164" id="ixv-16520">Each warrant is exercisable into 1 ordinary share</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c164" id="ixv-16521">5 years following the issuance date</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c164" id="ixv-16522">Owned by underwriter</wlds:ShareBasedCompensationArrangementNotes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c165"
      decimals="INF"
      id="ixv-16523"
      unitRef="shares">295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c166"
      decimals="2"
      id="ixv-16524"
      unitRef="usdPershares">338.4</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c166" id="ixv-16525">Each warrant is exercisable into 1 ordinary share</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c166" id="ixv-16526">10 years following the issuance date</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c166" id="ixv-16527">Owned by the legal advisor</wlds:ShareBasedCompensationArrangementNotes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c167"
      decimals="INF"
      id="ixv-16528"
      unitRef="shares">205500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c168"
      decimals="2"
      id="ix_34_fact"
      unitRef="usdPershares">10</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c168" id="ixv-16530">Each warrant is exercisable into 1 ordinary share</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c168" id="ixv-16531">5 years following the issuance date</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c168" id="ixv-16532">Owned by an investor</wlds:ShareBasedCompensationArrangementNotes>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c169"
      decimals="INF"
      id="ixv-16533"
      unitRef="shares">78000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c170"
      decimals="4"
      id="ixv-16534"
      unitRef="usdPershares">0.0004</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio contextRef="c170" id="ixv-16535">Each pre funded warrant is exercisable into 1 ordinary share</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExerciseRatio>
    <wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate contextRef="c170" id="ixv-16536">Until exercised in full</wlds:ShareBasedCompensationArrangementByShareBasedPaymentExpirationDate>
    <wlds:ShareBasedCompensationArrangementNotes contextRef="c170" id="ixv-16537">Owned by an investor</wlds:ShareBasedCompensationArrangementNotes>
    <wlds:ExercisePriceOfWarrants
      contextRef="c4"
      decimals="2"
      id="ixv-16538"
      unitRef="usdPershares">320</wlds:ExercisePriceOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c4" id="ixv-16539">P2Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <wlds:WarrantBeReducedToAnExercisePricePercentage contextRef="c0" decimals="2" id="ixv-16540" unitRef="pure">0.50</wlds:WarrantBeReducedToAnExercisePricePercentage>
    <wlds:InitialExercisePricePercentage contextRef="c0" decimals="2" id="ixv-16541" unitRef="pure">0.50</wlds:InitialExercisePricePercentage>
    <wlds:WeightedAveragePricePercentage contextRef="c0" decimals="2" id="ixv-16542" unitRef="pure">1</wlds:WeightedAveragePricePercentage>
    <wlds:LowestResetPrice
      contextRef="c4"
      decimals="2"
      id="ixv-16543"
      unitRef="usdPershares">160</wlds:LowestResetPrice>
    <wlds:InitialExercisePricesPercentage contextRef="c0" decimals="2" id="ixv-16544" unitRef="pure">0.50</wlds:InitialExercisePricesPercentage>
    <wlds:ExercisePricePerShare
      contextRef="c134"
      decimals="2"
      id="ixv-16546"
      unitRef="usdPershares">4</wlds:ExercisePricePerShare>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0" id="ixv-15729">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt"&gt;Loss per share has been calculated using the weighted average
number of ordinary shares and pre-funded warrants in issue during the relevant financial periods, the weighted average number of equity
shares in issue and profit for the period as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 54pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Loss for the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(7,879&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(7,814&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(6,496&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Total number of ordinary shares and pre-funded warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;785,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;254,843&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;188,121&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Weighted average number of ordinary shares and pre-funded warrants&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;325,690&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;202,515&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;153,465&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;Basic and diluted loss per share&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(24.2&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(38.4&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(42.4&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-16547" unitRef="usd">-7879000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c6" decimals="-3" id="ixv-16548" unitRef="usd">-7814000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-16549" unitRef="usd">-6496000</us-gaap:NetIncomeLoss>
    <wlds:OrdinarySharesAndPrefundedWarrants
      contextRef="c0"
      decimals="INF"
      id="ixv-16550"
      unitRef="shares">785464</wlds:OrdinarySharesAndPrefundedWarrants>
    <wlds:OrdinarySharesAndPrefundedWarrants
      contextRef="c6"
      decimals="INF"
      id="ixv-16551"
      unitRef="shares">254843</wlds:OrdinarySharesAndPrefundedWarrants>
    <wlds:OrdinarySharesAndPrefundedWarrants
      contextRef="c7"
      decimals="INF"
      id="ixv-16552"
      unitRef="shares">188121</wlds:OrdinarySharesAndPrefundedWarrants>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="INF"
      id="ixv-16553"
      unitRef="shares">325690</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c6"
      decimals="INF"
      id="ixv-16554"
      unitRef="shares">202515</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c7"
      decimals="INF"
      id="ixv-16555"
      unitRef="shares">153465</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="1"
      id="ixv-16556"
      unitRef="usdPershares">-24.2</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c6"
      decimals="1"
      id="ixv-16557"
      unitRef="usdPershares">-38.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c7"
      decimals="1"
      id="ixv-16558"
      unitRef="usdPershares">-42.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0" id="ixv-15823">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 11 - TAXES ON INCOME:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company is taxed under the Israeli law.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income of an Israeli company is subject to corporate tax. The corporate tax rate in Israel is&#160;23%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.15pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax assessments - In accordance with the Israeli Income Tax Ordinance, tax assessments of the Company through tax year 2019 are considered final.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Carryforward tax losses of the Company as of December 31, 2024, amounted to approximately $21.1 million; however, a full valuation allowance of $4.85 million was recorded against the potential future tax benefits.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 53.25pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Subsidiary is taxed under the U.S. tax law. The federal tax rate is 21%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <wlds:CorporateTaxRatePercentage
      contextRef="c171"
      decimals="2"
      id="ixv-16559"
      unitRef="pure">0.23</wlds:CorporateTaxRatePercentage>
    <us-gaap:OperatingLossCarryforwards contextRef="c4" decimals="-5" id="ixv-16560" unitRef="usd">21100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c4" decimals="-4" id="ixv-16561" unitRef="usd">4850000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" id="ixv-16562" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0" id="ixv-15869">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 12 - RELATED PARTIES&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The employment expenses of the co-founders:
Asher Dahan (the Chairman of the Board of Directors and the Chief Executive Officer), Guy Wanger (President and Director) and Leeor Langer
(the Chief Technology Officer), for the years ended December 31, 2024, 2023 and 2022 amounted to approximately $287 thousand, $293 thousand,
and $331 thousand, respectively. On March 14, 2022, the Company&#x2019;s shareholders meeting approved the increase of the monthly salary
of each of the Company&#x2019;s co-founders to NIS&#160;70&#160;thousand (approximately $19&#160;thousand), plus social benefits and leased
car, and approved a one-time bonus equal to 6 monthly salaries, upon the closing of the IPO which was accomplished in September 2022.
In November 2024, the Company&#x2019;s founders agreed to temporarily reduce their salaries.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <wlds:EmploymentExpenses
      contextRef="c172"
      decimals="-3"
      id="ixv-16563"
      unitRef="usd">287000</wlds:EmploymentExpenses>
    <wlds:EmploymentExpenses
      contextRef="c173"
      decimals="-3"
      id="ixv-16564"
      unitRef="usd">293000</wlds:EmploymentExpenses>
    <wlds:EmploymentExpenses
      contextRef="c174"
      decimals="-3"
      id="ixv-16565"
      unitRef="usd">331000</wlds:EmploymentExpenses>
    <wlds:OfficerEmployeeMonthlySalary
      contextRef="c175"
      decimals="-3"
      id="ixv-16566"
      unitRef="ils">70000</wlds:OfficerEmployeeMonthlySalary>
    <wlds:RelatedPartyMonthlySalary
      contextRef="c175"
      decimals="-3"
      id="ixv-16567"
      unitRef="usd">19000</wlds:RelatedPartyMonthlySalary>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-15877">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 13 - SUBSEQUENT EVENTS&lt;/b&gt;:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On January 30, 2025, the Company announced the closing of
&#x201c;best efforts&#x201d; public offering with a single institutional investor for the purchase and sale of 86,250 ordinary shares, 538,750
pre-funded warrants to purchase up to 538,750 ordinary shares, and warrants to purchase up to 625,000 ordinary shares, at a combined
offering price of $4.00 per share and accompanying warrant (the &#x201c;Offering&#x201d;). The Company received aggregate gross proceeds
of approximately $2.5 million, before deducting placement agent fees and other offering expenses and assuming no exercise of the warrants.
The warrants have an exercise price of $4.00 per share, are exercisable immediately and expire five years from the issuance date.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In connection with the Offering detailed in Note 12.a. the
Company also agreed to amend existing warrants that were previously issued on November 27, 2024 (see also Note 1.g.) to the investor
participating in the Offering to purchase up to 205,500 ordinary shares of the Company, with an exercise price of $10.00 per share. Such
existing warrants have been amended to reduce the exercise price to $4.00 per share and now expire five years following the closing of
the Offering.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;c.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On February 26, 2025, the Company&#x2019;s shareholders meeting approved a reverse share split of the Company&#x2019;s issued and outstanding ordinary shares at a ratio of up to 6:1, to be effected, if effected, at the discretion of and on such date to be determined by the Board of Directors. On March 17, 2025, the Company effectuated the March Reverse Split. &lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c176"
      decimals="0"
      id="ixv-16568"
      unitRef="shares">86250</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight
      contextRef="c177"
      decimals="0"
      id="ixv-16569"
      unitRef="shares">538750</wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight>
    <wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight
      contextRef="c178"
      decimals="0"
      id="ixv-16570"
      unitRef="shares">538750</wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight>
    <wlds:SaleOfStockNumberOfShareIssuedInTransaction
      contextRef="c179"
      decimals="0"
      id="ixv-16571"
      unitRef="shares">625000</wlds:SaleOfStockNumberOfShareIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c180"
      decimals="2"
      id="ixv-16572"
      unitRef="usdPershares">4</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="c134"
      decimals="-5"
      id="ixv-16573"
      unitRef="usd">2500000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c180"
      decimals="2"
      id="ixv-16574"
      unitRef="usdPershares">4</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c180" id="ixv-16575">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight
      contextRef="c181"
      decimals="0"
      id="ixv-16576"
      unitRef="shares">205500</wlds:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c181"
      decimals="2"
      id="ixv-16577"
      unitRef="usdPershares">10</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantExercisePriceDecrease
      contextRef="c100"
      decimals="2"
      id="ixv-16578"
      unitRef="usdPershares">4</us-gaap:WarrantExercisePriceDecrease>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c181" id="ixv-16579">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c182" id="ixv-16580">On February 26, 2025, the Company&#x2019;s shareholders meeting approved a reverse share split of the Company&#x2019;s issued and outstanding ordinary shares at a ratio of up to 6:1</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c183" id="ixv-16581">Reverse</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="c4"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="c5"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c4"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c5"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockNoParValue
      contextRef="c4"
      id="hidden-fact-4"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:CommonStockNoParValue
      contextRef="c5"
      id="hidden-fact-5"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <wlds:ProspectiveInitialPublicOfferingExpenses
      contextRef="c0"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProspectiveInitialPublicOfferingExpenses
      contextRef="c6"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c6"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c7"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNet
      contextRef="c14"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c14"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants
      contextRef="c12"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants
      contextRef="c14"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c12"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c13"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c14"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c7"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c12"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c14"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c12"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c13"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c21"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:StockIssuedDuringPeriodValueInvestors
      contextRef="c21"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:StockIssuedDuringPeriodValueExerciseOfWarrants
      contextRef="c21"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c19"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c21"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c19"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c20"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:StockIssuedDuringPeriodValueAssociatedWithTheSEPA
      contextRef="c27"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering
      contextRef="c25"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:IssuanceOfUnitsOfOrdinarySharesPreFundedWarrantsAndWarrantsUnderRegisteredDirectOffering
      contextRef="c27"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c25"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c27"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:AccruedInterestOnConvertibleSecurities
      contextRef="c6"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:AccruedInterestOnConvertibleSecurities
      contextRef="c7"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:AccruedInterestOnDeposits
      contextRef="c7"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="c7"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:MarketingExpensesPaidInOrdinaryShares
      contextRef="c6"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:MarketingExpensesPaidInOrdinaryShares
      contextRef="c7"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InventoryWriteDown
      contextRef="c6"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InventoryWriteDown
      contextRef="c7"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c0"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c6"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="c0"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:DecreaseIncreaseInDepositsNet
      contextRef="c7"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:PrepaymentsOfLeasing
      contextRef="c0"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:PrepaymentsOfLeasing
      contextRef="c6"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfSharesIssuedInThePublicOfferingNetOfIssuanceCost
      contextRef="c7"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses
      contextRef="c0"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfUnitsOfOrdinarySharesAndWarrantsInConnectionWithTheInitialPublicOfferingNetOfIssuanceExpenses
      contextRef="c6"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfSAFEs
      contextRef="c0"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfSAFEs
      contextRef="c6"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:RefundToSAFEInvestors
      contextRef="c0"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:RefundToSAFEInvestors
      contextRef="c6"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c0"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c6"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c0"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c6"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ProceedsFromIssuanceOfOrdinarySharesAsAResultOfExerciseOfWarrants
      contextRef="c0"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c6"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c7"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c6"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c7"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="c6"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="c7"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="c6"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:InterestReceived
      contextRef="c7"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ConversionOfSAFEToEquity
      contextRef="c0"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:ConversionOfSAFEToEquity
      contextRef="c6"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:RightofUseAssetRecognizedAgainstLeaseLiability
      contextRef="c0"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:InventoryWriteoff
      contextRef="c5"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <wlds:CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice contextRef="c0" id="hidden-fact-72">P3Y</wlds:CalculationOfSharesUsingCommitmentFeePayableNumberDaysConsideredForTheVolumeWeightedAveragePrice>
    <wlds:ResearchAndDevelopmentGrantsDetection
      contextRef="c69"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c139"
      id="hidden-fact-74"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c139"
      id="hidden-fact-75"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c140"
      id="hidden-fact-76"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c140"
      id="hidden-fact-77"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="1"
      id="hidden-fact-78"
      unitRef="usdPershares">-24.2</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c6"
      decimals="1"
      id="hidden-fact-79"
      unitRef="usdPershares">-38.4</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c7"
      decimals="1"
      id="hidden-fact-80"
      unitRef="usdPershares">-42.4</us-gaap:EarningsPerShareDiluted>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-16666">0001887673</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-16667">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-16668">FY</dei:DocumentFiscalPeriodFocus>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The share and per share information in these financial statements reflects the 1-for-20 reverse share split that became effective on October 10, 2024 and an additional 1-for-4 reverse share split of the Company&#x2019;s issued and outstanding ordinary shares that became effective on March 17, 2025 (the &#x201c;Reverse Share Splits&#x201d;). See also Note 1c.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-14"
          xlink:label="hidden-fact-14"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-12"
          xlink:label="hidden-fact-12"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represent an amount less than $500</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-14"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-12"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The share and per share information in these financial statements
reflects the Reverse Share Splits.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Including the grant of 1,500 options to purchase up to 1,500
ordinary shares to directors, as approved by the Company&#x2019;s shareholders on November 30, 2023, with an exercise price of $105.60
per share. The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of
employment or service. The fair value of each option as of the grant date was $9.60, determined using the Black-Scholes option pricing
model and the total expenses of $15 thousand will be expensed over the option vesting periods of three years.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Including the grant of 1,250 options to purchase up to 1,250
ordinary shares to the Company&#x2019;s Chief Executive Officer and Chief Scientific Officer, as approved by the Company&#x2019;s shareholders
on September 26, 2024, with an exercise price of $34.40 per share. The options will expire at the earlier of (i) ten years from the date
of grant or (ii) 90 days following a termination of employment or service. The fair value of each option as of the grant date was $15.60,
determined using the Black-Scholes option pricing model and the total expenses of $19 thousand will be expensed over the option vesting
periods of three years.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On April 27, 2023, the Company&#x2019;s Board of Directors approved
the additional grant of options to purchase up to 1,250 ordinary shares to a consultant, with an exercise price of $43.68 per share.
The options will expire at the earlier of (i) ten years from the date of grant or (ii) 90 days following a termination of services. The
fair value of each option as of the grant date was $20.80, determined using the Black-Scholes option pricing model and the total expenses
of $26 thousand will be expensed over the option vesting periods of three years.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance. The warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement registering the issuance of the ordinary shares underlying the warrants under the Securities Act of 1933, as amended, is effective and available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary shares purchased upon such exercise. The exercise price per whole ordinary share purchasable upon exercise of the warrants $320.00 per share (the &#x201c;Initial Exercise Price&#x201d;). The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting ordinary shares and also upon any distributions of assets, including cash, stock or other property to the Company&#x2019;s shareholders. Subject to certain exemptions outlined in the warrant, for a period until two years from the date of issuance of the warrant, if the Company shall sell, enter into an agreement to sell and subsequently sells, or grant any option to purchase, or sell, enter into an agreement to sell and subsequently sells, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition the subsequently closes) any ordinary shares or convertible security, at an effective price per share less than the exercise price of the warrant then in effect, the exercise price of the warrant shall be reduced to equal the effective price per share in such Dilutive Issuance; provided, however, that in no event shall the exercise price of the warrant be reduced to an exercise price lower than 50% of the Initial Exercise Price. On the date that is 90 calendar days immediately following the initial issuance date of the warrants, the exercise price of the warrants will adjust (the &#x201c;Reset Price&#x201d;), provided that such value is less than the exercise price in effect on that date. The Reset Price is equal to the greater of (a) 50% of the Initial Exercise Price of the warrants on the issuance date or (b) 100% of the lowest volume weighted average price per ordinary share occurring on any day between the initial exercise date of the warrants and 90 calendar days following the issuance date of the warrants. The lowest Reset Price is $160.00, which is 50% of the Initial Exercise Price.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On January 30, 2025, the exercise price of the warrants pursuant
to a November 2024 private placement was adjusted to $4.00 per share following the closing of an additional offering.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
